1	From	IN	O	from	dep	123	SENT_1	[p1l92t1038r157b1059],
2	the	DT	O	the	dep	123	SENT_1	[p1l166t1035r207b1059],
3	Population	NNP	ORGANIZATION	Population	dep	123	SENT_1	[p1l219t1035r357b1066],
4	Health	NNP	ORGANIZATION	Health	dep	123	SENT_1	[p1l370t1035r454b1059],
5	Research	NNP	ORGANIZATION	Research	dep	123	SENT_1	[p1l467t1035r581b1059],
6	Institute	NNP	ORGANIZATION	Institute	dep	123	SENT_1	[p1l594t1038r626b1059, p1l91t1075r180b1101],
7	,	,	O	,	_	0	SENT_1	[p1l594t1038r626b1059, p1l91t1075r180b1101],
8	Hamilton	NNP	ORGANIZATION	Hamilton	dep	123	SENT_1	[p1l195t1073r316b1097],
9	Health	NNP	ORGANIZATION	Health	dep	123	SENT_1	[p1l331t1073r415b1097],
10	Sciences	NNPS	ORGANIZATION	Sciences	dep	123	SENT_1	[p1l430t1075r542b1097],
11	(	NNP	O	(	dep	123	SENT_1	[p1l558t1075r624b1104],
12	G.P.	NNP	LOCATION	G.P.	dep	123	SENT_1	[p1l558t1075r624b1104],
13	,	,	O	,	_	0	SENT_1	[p1l558t1075r624b1104],
14	S.R.M.	NNP	O	S.R.M.	dep	123	SENT_1	[p1l91t1113r183b1139],
15	,	,	O	,	_	0	SENT_1	[p1l91t1113r183b1139],
16	S.Y.	NNP	O	S.Y.	dep	123	SENT_1	[p1l201t1113r252b1139],
17	,	,	O	,	_	0	SENT_1	[p1l201t1113r252b1139],
18	S.S.A.	NNP	O	S.S.A.	dep	123	SENT_1	[p1l269t1112r354b1139],
19	,	,	O	,	_	0	SENT_1	[p1l269t1112r354b1139],
20	S.J.C.	NNP	O	S.J.C.	dep	123	SENT_1	[p1l371t1112r446b1141],
21	,	,	O	,	_	0	SENT_1	[p1l371t1112r446b1141],
22	J.H.	NNP	PERSON	J.H.	dep	123	SENT_1	[p1l458t1113r518b1141],
23	,	,	O	,	_	0	SENT_1	[p1l458t1113r518b1141],
24	J.W.E.	NNP	O	J.W.E.	dep	123	SENT_1	[p1l530t1113r625b1142],
25	)	CD	NUMBER	)	dep	123	SENT_1	[p1l530t1113r625b1142],
26	;	:	O	;	_	0	SENT_1	[p1l530t1113r625b1142],
27	and	CC	O	and	dep	123	SENT_1	[p1l91t1148r136b1172],
28	the	DT	O	the	dep	123	SENT_1	[p1l148t1148r189b1172],
29	Departments	NNP	MISC	Departments	dep	123	SENT_1	[p1l203t1150r375b1179],
30	of	IN	MISC	of	dep	123	SENT_1	[p1l387t1148r415b1172],
31	Medicine	NNP	MISC	Medicine	dep	123	SENT_1	[p1l425t1148r543b1172],
32	(	NNP	O	(	dep	123	SENT_1	[p1l558t1150r624b1179],
33	G.P.	NNP	LOCATION	G.P.	dep	123	SENT_1	[p1l558t1150r624b1179],
34	,	,	O	,	_	0	SENT_1	[p1l558t1150r624b1179],
35	S.R.M.	NNP	O	S.R.M.	dep	123	SENT_1	[p1l91t1188r183b1214],
36	,	,	O	,	_	0	SENT_1	[p1l91t1188r183b1214],
37	S.Y.	NNP	O	S.Y.	dep	123	SENT_1	[p1l201t1188r252b1214],
38	,	,	O	,	_	0	SENT_1	[p1l201t1188r252b1214],
39	S.S.A.	NNP	O	S.S.A.	dep	123	SENT_1	[p1l269t1187r354b1214],
40	,	,	O	,	_	0	SENT_1	[p1l269t1187r354b1214],
41	S.J.C.	NNP	O	S.J.C.	dep	123	SENT_1	[p1l371t1188r446b1217],
42	,	,	O	,	_	0	SENT_1	[p1l371t1188r446b1217],
43	J.H.	NNP	PERSON	J.H.	dep	123	SENT_1	[p1l458t1188r517b1217],
44	,	,	O	,	_	0	SENT_1	[p1l458t1188r517b1217],
45	J.W.E.	NNP	O	J.W.E.	dep	123	SENT_1	[p1l530t1188r624b1217],
46	)	NNP	O	)	dep	123	SENT_1	[p1l530t1188r624b1217],
47	,	,	O	,	_	0	SENT_1	[p1l530t1188r624b1217],
48	Epidemiology	NNP	O	Epidemiology	dep	123	SENT_1	[p1l92t1219r270b1250],
49	(	NNP	O	(	dep	123	SENT_1	[p1l282t1221r349b1250],
50	G.P.	NNP	LOCATION	G.P.	dep	123	SENT_1	[p1l282t1221r349b1250],
51	,	,	O	,	_	0	SENT_1	[p1l282t1221r349b1250],
52	S.Y.	NNP	O	S.Y.	dep	123	SENT_1	[p1l361t1221r412b1247],
53	,	,	O	,	_	0	SENT_1	[p1l361t1221r412b1247],
54	S.S.A.	NNP	O	S.S.A.	dep	123	SENT_1	[p1l423t1220r518b1250],
55	)	CD	NUMBER	)	dep	123	SENT_1	[p1l423t1220r518b1250],
56	,	,	O	,	_	0	SENT_1	[p1l423t1220r518b1250],
57	and	CC	O	and	dep	123	SENT_1	[p1l529t1219r575b1243],
58	Pathology	NN	O	pathology	dep	123	SENT_1	[p1l588t1221r626b1242, p1l89t1256r188b1287],
59	(	CD	NUMBER	(	dep	123	SENT_1	[p1l206t1258r283b1287],
60	G.P.	NNP	LOCATION	G.P.	dep	123	SENT_1	[p1l206t1258r283b1287],
61	)	NNP	O	)	dep	123	SENT_1	[p1l206t1258r283b1287],
62	,	,	O	,	_	0	SENT_1	[p1l206t1258r283b1287],
63	McMaster	NNP	ORGANIZATION	McMaster	dep	123	SENT_1	[p1l302t1258r434b1279],
64	University	NNP	ORGANIZATION	University	dep	123	SENT_1	[p1l451t1258r581b1287],
65	—	NN	O	—	dep	123	SENT_1	[p1l595t1270r627b1273],
66	both	CC	O	both	dep	123	SENT_1	[p1l91t1293r148b1317],
67	in	IN	O	in	dep	123	SENT_1	[p1l164t1296r184b1317],
68	Hamilton	NNP	LOCATION	Hamilton	dep	123	SENT_1	[p1l202t1293r330b1321],
69	,	,	O	,	_	0	SENT_1	[p1l202t1293r330b1321],
70	ON	NNP	O	ON	dep	123	SENT_1	[p1l345t1295r398b1321],
71	,	,	O	,	_	0	SENT_1	[p1l345t1295r398b1321],
72	Canada	NNP	LOCATION	Canada	dep	123	SENT_1	[p1l413t1293r517b1321],
73	;	:	O	;	_	0	SENT_1	[p1l413t1293r517b1321],
74	BristolMyers	NNP	O	BristolMyers	dep	123	SENT_1	[p1l534t1293r626b1317, p1l92t1333r168b1362],
75	Squibb	NNP	O	Squibb	dep	123	SENT_1	[p1l180t1331r276b1362],
76	,	,	O	,	_	0	SENT_1	[p1l180t1331r276b1362],
77	New	NNP	LOCATION	New	dep	123	SENT_1	[p1l290t1333r347b1355],
78	York	NNP	LOCATION	York	dep	123	SENT_1	[p1l355t1331r412b1355],
79	(	NN	O	(	dep	123	SENT_1	[p1l425t1333r501b1362],
80	K.S.	NNP	LOCATION	K.S.	dep	123	SENT_1	[p1l425t1333r501b1362],
81	)	NNP	O	)	dep	123	SENT_1	[p1l425t1333r501b1362],
82	;	:	O	;	_	0	SENT_1	[p1l425t1333r501b1362],
83	Veterans	NNP	ORGANIZATION	Veterans	dep	123	SENT_1	[p1l512t1333r625b1355],
84	Affairs	NNP	ORGANIZATION	Affairs	dep	123	SENT_1	[p1l89t1368r170b1392],
85	Boston	NNP	ORGANIZATION	Boston	dep	123	SENT_1	[p1l179t1371r265b1392],
86	Healthcare	NNP	ORGANIZATION	Healthcare	dep	123	SENT_1	[p1l274t1368r409b1392],
87	System	NNP	ORGANIZATION	System	dep	123	SENT_1	[p1l415t1370r512b1399],
88	,	,	O	,	_	0	SENT_1	[p1l415t1370r512b1399],
89	Brigham	NNP	ORGANIZATION	Brigham	dep	123	SENT_1	[p1l521t1368r624b1400],
90	and	CC	ORGANIZATION	and	dep	123	SENT_1	[p1l91t1406r135b1430],
91	Women	NNP	ORGANIZATION	Women	dep	123	SENT_1	[p1l142t1408r261b1430],
92	's	POS	ORGANIZATION	's	dep	123	SENT_1	[p1l142t1408r261b1430],
93	Hospital	NNP	ORGANIZATION	Hospital	dep	123	SENT_1	[p1l271t1406r382b1437],
94	,	,	O	,	_	0	SENT_1	[p1l271t1406r382b1437],
95	and	CC	O	and	dep	123	SENT_1	[p1l391t1406r435b1430],
96	Harvard	NNP	ORGANIZATION	Harvard	dep	123	SENT_1	[p1l445t1406r544b1430],
97	Medical	NNP	ORGANIZATION	Medical	dep	123	SENT_1	[p1l554t1406r626b1430, p1l90t1444r124b1467],
98	School	NNP	ORGANIZATION	School	dep	123	SENT_1	[p1l138t1444r224b1467],
99	—	NNP	O	—	dep	123	SENT_1	[p1l236t1458r268b1460],
100	all	DT	O	all	dep	123	SENT_1	[p1l279t1444r306b1467],
101	in	IN	O	in	dep	123	SENT_1	[p1l320t1446r340b1467],
102	Boston	NNP	LOCATION	Boston	dep	123	SENT_1	[p1l356t1446r444b1467],
103	(	CD	NUMBER	(	dep	123	SENT_1	[p1l461t1446r565b1475],
104	D.L.B.	NNP	O	D.L.B.	dep	123	SENT_1	[p1l461t1446r565b1475],
105	)	NN	O	)	dep	123	SENT_1	[p1l461t1446r565b1475],
106	;	:	O	;	_	0	SENT_1	[p1l461t1446r565b1475],
107	and	CC	O	and	dep	123	SENT_1	[p1l579t1444r624b1467],
108	the	DT	O	the	dep	123	SENT_1	[p1l89t1481r130b1505],
109	Centre	NNP	O	Centre	dep	123	SENT_1	[p1l149t1483r234b1505],
110	for	IN	O	for	dep	123	SENT_1	[p1l252t1481r289b1505],
111	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	dep	123	SENT_1	[p1l307t1481r500b1505],
112	Science	NNP	ORGANIZATION	Science	dep	123	SENT_1	[p1l519t1483r624b1509],
113	,	,	O	,	_	0	SENT_1	[p1l519t1483r624b1509],
114	Edinburgh	NNP	ORGANIZATION	Edinburgh	dep	123	SENT_1	[p1l92t1518r224b1549],
115	University	NNP	ORGANIZATION	University	dep	123	SENT_1	[p1l239t1521r369b1549],
116	and	CC	O	and	dep	123	SENT_1	[p1l381t1518r427b1542],
117	Royal	NNP	ORGANIZATION	Royal	dep	123	SENT_1	[p1l442t1518r507b1549],
118	Infirmary	NNP	ORGANIZATION	Infirmary	dep	123	SENT_1	[p1l523t1518r626b1542, p1l92t1564r119b1587],
119	,	,	O	,	_	0	SENT_1	[p1l523t1518r626b1542, p1l92t1564r119b1587],
120	Edinburgh	NNP	LOCATION	Edinburgh	dep	123	SENT_1	[p1l133t1556r265b1587],
121	(	CD	NUMBER	(	dep	123	SENT_1	[p1l279t1557r410b1587],
122	K.A.A.F.	NNP	O	K.A.A.F.	dep	123	SENT_1	[p1l279t1557r410b1587],
123	)	CD	NUMBER	)	_	0	SENT_1	[p1l279t1557r410b1587],
124	.	.	O	.	_	0	SENT_1	[p1l279t1557r410b1587],

1	Address	NN	O	address	nsubj	2	SENT_2	[p1l421t1556r527b1579],
2	reprint	VB	O	reprint	_	0	SENT_2	[p1l540t1558r626b1587],
3	requests	NNS	O	request	dobj	2	SENT_2	[p1l92t1597r200b1620],
4	to	TO	O	to	_	0	SENT_2	[p1l218t1597r243b1617],
5	Dr.	NNP	O	Dr.	nn	6	SENT_2	[p1l263t1595r297b1616],
6	Paré	NNP	PERSON	Paré	prep_to	2	SENT_2	[p1l318t1595r371b1617],
7	at	IN	O	at	_	0	SENT_2	[p1l389t1597r412b1616],
8	the	DT	O	the	det	12	SENT_2	[p1l428t1593r469b1616],
9	Population	NNP	ORGANIZATION	Population	nn	12	SENT_2	[p1l489t1593r624b1620],
10	Health	NNP	ORGANIZATION	Health	nn	12	SENT_2	[p1l92t1627r173b1661],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_2	[p1l182t1637r292b1661],
12	Institute	NNP	ORGANIZATION	Institute	prep_at	6	SENT_2	[p1l302t1640r409b1665],
13	,	,	O	,	_	0	SENT_2	[p1l302t1640r409b1665],
14	Hamilton	NNP	ORGANIZATION	Hamilton	nn	16	SENT_2	[p1l419t1637r534b1661],
15	Health	NNP	ORGANIZATION	Health	nn	16	SENT_2	[p1l544t1637r624b1661],
16	Sciences	NNPS	ORGANIZATION	Sciences	dep	22	SENT_2	[p1l91t1681r198b1703],
17	and	CC	O	and	_	0	SENT_2	[p1l211t1679r256b1703],
18	McMaster	NNP	ORGANIZATION	McMaster	nn	19	SENT_2	[p1l271t1682r398b1703],
19	University	NNP	ORGANIZATION	University	conj_and	16	SENT_2	[p1l411t1682r540b1710],
20	,	,	O	,	_	0	SENT_2	[p1l411t1682r540b1710],
21	David	NNP	PERSON	David	nn	22	SENT_2	[p1l556t1679r624b1703],
22	Braley	NNP	PERSON	Braley	conj_and	2	SENT_2	[p1l92t1717r170b1748],
23	Cardiac	JJ	ORGANIZATION	cardiac	amod	24	SENT_2	[p1l185t1717r283b1741],
24	Vascular	JJ	ORGANIZATION	vascular	amod	22	SENT_2	[p1l297t1717r409b1741],
25	and	CC	ORGANIZATION	and	_	0	SENT_2	[p1l424t1717r470b1741],
26	Stroke	NNP	ORGANIZATION	Stroke	nn	28	SENT_2	[p1l488t1717r569b1741],
27	Research	NNP	ORGANIZATION	Research	nn	28	SENT_2	[p1l587t1719r626b1741, p1l91t1754r173b1778],
28	Institute	NNP	ORGANIZATION	Institute	dep	35	SENT_2	[p1l191t1757r305b1782],
29	,	,	O	,	_	0	SENT_2	[p1l191t1757r305b1782],
30	237	CD	NUMBER	237	appos	28	SENT_2	[p1l321t1757r365b1778],
31	Barton	NNP	LOCATION	Barton	nn	33	SENT_2	[p1l381t1757r466b1778],
32	St.	NNP	LOCATION	St.	nn	33	SENT_2	[p1l482t1756r514b1778],
33	E.	NNP	LOCATION	E.	dep	30	SENT_2	[p1l531t1757r559b1782],
34	,	,	O	,	_	0	SENT_2	[p1l531t1757r559b1782],
35	Rm	NNP	O	Rm	conj_and	2	SENT_2	[p1l577t1757r625b1778],
36	.	.	O	.	_	0	SENT_2	[p1l577t1757r625b1778],

1	C3-103	NN	O	c3-103	_	0	SENT_3	[p1l90t1794r185b1820],
2	,	,	O	,	_	0	SENT_3	[p1l90t1794r185b1820],
3	Hamilton	NNP	PERSON	Hamilton	appos	1	SENT_3	[p1l199t1792r328b1820],
4	,	,	O	,	_	0	SENT_3	[p1l199t1792r328b1820],
5	ON	IN	O	on	_	0	SENT_3	[p1l340t1794r383b1816],
6	L8L	NN	O	l8l	nn	7	SENT_3	[p1l398t1794r442b1816],
7	2X2	NN	O	2x2	prep_on	1	SENT_3	[p1l452t1794r509b1820],
8	,	,	O	,	_	0	SENT_3	[p1l452t1794r509b1820],
9	Canada	NNP	LOCATION	Canada	prep_on	1	SENT_3	[p1l521t1792r625b1820],
10	,	,	O	,	_	0	SENT_3	[p1l521t1792r625b1820],
11	or	CC	O	or	_	0	SENT_3	[p1l90t1838r117b1853],
12	at	IN	O	at	advmod	7	SENT_3	[p1l125t1834r148b1853],
13	pareg@mcmaster.ca	NN	O	pareg@mcmaster.ca	conj_or	7	SENT_3	[p1l158t1832r437b1861],
14	.	.	O	.	_	0	SENT_3	[p1l158t1832r437b1861],

1	This	DT	O	this	det	2	SENT_4	[p1l89t1904r141b1928],
2	article	NN	O	article	nsubjpass	17	SENT_4	[p1l151t1904r226b1928],
3	(	CD	NUMBER	(	number	4	SENT_4	[p1l236t1906r568b1935],
4	10.1056	CD	NUMBER	10.1056	num	2	SENT_4	[p1l236t1906r568b1935],
5	/	:	O	/	punct	7	SENT_4	[p1l236t1906r568b1935],
6	NEjMoal0084l0	NN	O	nejmoal0084l0	nn	7	SENT_4	[p1l236t1906r568b1935],
7	)	NN	O	)	dep	2	SENT_4	[p1l236t1906r568b1935],
8	was	VBD	O	be	auxpass	9	SENT_4	[p1l578t1913r625b1928],
9	published	VBN	O	publish	_	0	SENT_4	[p1l92t1942r217b1973],
10	on	IN	O	on	_	0	SENT_4	[p1l233t1950r264b1965],
11	August	NNP	DATE	August	prep_on	9	SENT_4	[p1l279t1943r373b1973],
12	29	CD	DATE	29	num	11	SENT_4	[p1l387t1944r423b1970],
13	,	,	DATE	,	_	0	SENT_4	[p1l387t1944r423b1970],
14	2010	CD	DATE	2010	num	11	SENT_4	[p1l439t1943r506b1970],
15	,	,	O	,	_	0	SENT_4	[p1l439t1943r506b1970],
16	and	CC	O	and	_	0	SENT_4	[p1l522t1942r568b1965],
17	updated	VBN	O	update	conj_and	9	SENT_4	[p1l585t1950r626b1973, p1l90t1979r161b2003],
18	on	IN	O	on	_	0	SENT_4	[p1l172t1988r203b2003],
19	October	NNP	DATE	October	prep_on	17	SENT_4	[p1l213t1979r322b2003],
20	27	CD	DATE	27	num	19	SENT_4	[p1l330t1982r363b2007],
21	,	,	DATE	,	_	0	SENT_4	[p1l330t1982r363b2007],
22	2010	CD	DATE	2010	num	19	SENT_4	[p1l374t1981r441b2007],
23	,	,	O	,	_	0	SENT_4	[p1l374t1981r441b2007],
24	at	IN	O	at	_	0	SENT_4	[p1l452t1984r474b2003],
25	NEJM.org	NN	O	nejm.org	prep_at	17	SENT_4	[p1l485t1982r617b2010],
26	.	.	O	.	_	0	SENT_4	[p1l485t1982r617b2010],

1	N	NN	MISC	n	nn	3	SENT_5	[p1l92t2057r110b2078],
2	Englj	NNP	MISC	Englj	nn	3	SENT_5	[p1l123t2054r191b2086],
3	Med	NNP	O	Med	_	0	SENT_5	[p1l205t2054r260b2078],
4	2010	CD	DATE	2010	num	3	SENT_5	[p1l270t2056r502b2082],
5	;	:	O	;	_	0	SENT_5	[p1l270t2056r502b2082],
6	363:1704	CD	NUMBER	363:1704	number	7	SENT_5	[p1l270t2056r502b2082],
7	-14	CD	NUMBER	-14	dep	3	SENT_5	[p1l270t2056r502b2082],
8	.	.	O	.	_	0	SENT_5	[p1l270t2056r502b2082],

1	Copyright	NN	O	copyright	_	0	SENT_6	[p1l91t2097r184b2122],
2	©	CD	NUMBER	©	num	6	SENT_6	[p1l193t2099r214b2120],
3	2010	CD	DATE	2010	num	6	SENT_6	[p1l224t2098r274b2116],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_6	[p1l282t2097r422b2116],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_6	[p1l431t2097r508b2116],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_6	[p1l516t2098r588b2122],
7	.	.	O	.	_	0	SENT_6	[p1l516t2098r588b2122],

1	The	DT	O	the	det	4	SENT_7	[p1l957t81r1003b102],
2	NEW	NNP	O	NEW	nn	4	SENT_7	[p1l1021t83r1106b102],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_7	[p1l1126t83r1314b102],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_7	[p1l1333t83r1512b109],
5	of	IN	O	of	_	0	SENT_7	[p1l1532t81r1560b108],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_7	[p1l1572t83r1771b102],

1	l	NN	O	l	_	0	SENT_8	[p1l664t184r667b303],
2	ORIGINAL	NNP	O	ORIGINAL	nn	3	SENT_8	[p1l1154t234r1377b260],
3	ARTICLE	NN	O	article	dep	1	SENT_8	[p1l1389t234r1575b260],
4	l	NN	O	l	tmod	3	SENT_8	[p1l2062t184r2065b303],

1	Effects	NNS	O	effect	_	0	SENT_9	[p1l700t378r903b433],
2	of	IN	O	of	_	0	SENT_9	[p1l934t378r1005b433],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_9	[p1l1021t383r1269b433],
4	Genotype	NN	O	genotype	prep_of	1	SENT_9	[p1l1298t383r1586b448],
5	on	IN	O	on	_	0	SENT_9	[p1l1616t396r1691b433],
6	Outcomes	NNS	O	outcome	prep_on	1	SENT_9	[p1l1720t383r2024b434],
7	of	IN	O	of	_	0	SENT_9	[p1l971t461r1042b516],
8	Clopidogrel	NNP	O	Clopidogrel	nn	9	SENT_9	[p1l1058t461r1416b532],
9	Treatment	NN	O	treatment	prep_of	6	SENT_9	[p1l1442t466r1760b516],

1	Guillaume	NNP	PERSON	Guillaume	nn	2	SENT_10	[p1l688t584r864b615],
2	Paré	NNP	PERSON	Paré	_	0	SENT_10	[p1l879t587r959b621],
3	,	,	O	,	_	0	SENT_10	[p1l879t587r959b621],
4	M.D.	NNP	O	M.D.	dep	2	SENT_10	[p1l976t587r1066b621],
5	,	,	O	,	_	0	SENT_10	[p1l976t587r1066b621],
6	Shamir	NNP	PERSON	Shamir	nn	8	SENT_10	[p1l1081t584r1203b615],
7	R.	NNP	PERSON	R.	nn	8	SENT_10	[p1l1217t587r1245b615],
8	Mehta	NNP	PERSON	Mehta	appos	4	SENT_10	[p1l1262t584r1376b621],
9	,	,	O	,	_	0	SENT_10	[p1l1262t584r1376b621],
10	M.D.	NNP	O	M.D.	appos	4	SENT_10	[p1l1393t587r1483b621],
11	,	,	O	,	_	0	SENT_10	[p1l1393t587r1483b621],
12	Salim	NNP	PERSON	Salim	nn	13	SENT_10	[p1l1498t584r1590b615],
13	Yusuf	NNP	PERSON	Yusuf	appos	4	SENT_10	[p1l1604t584r1709b621],
14	,	,	O	,	_	0	SENT_10	[p1l1604t584r1709b621],
15	D.	NNP	PERSON	D.	nn	16	SENT_10	[p1l1726t584r1846b621],
16	Phil.	NNP	PERSON	Phil.	appos	4	SENT_10	[p1l1726t584r1846b621],
17	,	,	O	,	_	0	SENT_10	[p1l1726t584r1846b621],
18	F.R.C.P.C.	NNP	O	F.R.C.P.C.	appos	4	SENT_10	[p1l1863t587r2038b621],
19	,	,	O	,	_	0	SENT_10	[p1l1863t587r2038b621],

1	Sonia	NNP	PERSON	Sonia	nn	3	SENT_11	[p1l752t636r845b665],
2	S.	NNP	PERSON	S.	nn	3	SENT_11	[p1l859t636r887b665],
3	Anand	NNP	PERSON	Anand	_	0	SENT_11	[p1l900t634r1019b670],
4	,	,	O	,	_	0	SENT_11	[p1l900t634r1019b670],
5	M.D.	NNP	O	M.D.	nn	10	SENT_11	[p1l1037t637r1127b670],
6	,	,	O	,	_	0	SENT_11	[p1l1037t637r1127b670],
7	Ph.D.	NNP	O	Ph.D.	appos	10	SENT_11	[p1l1144t634r1243b670],
8	,	,	O	,	_	0	SENT_11	[p1l1144t634r1243b670],
9	Stuart	NNP	PERSON	Stuart	appos	10	SENT_11	[p1l1258t636r1390b674],
10	]	NNP	O	]	appos	3	SENT_11	[p1l1258t636r1390b674],
11	.	.	O	.	_	0	SENT_11	[p1l1258t636r1390b674],

1	Connolly	NNP	PERSON	Connolly	_	0	SENT_12	[p1l1404t634r1562b674],
2	,	,	O	,	_	0	SENT_12	[p1l1404t634r1562b674],
3	M.D.	NNP	O	M.D.	dep	1	SENT_12	[p1l1579t634r1751b674],
4	,	,	O	,	_	0	SENT_12	[p1l1579t634r1751b674],
5	Jack	NNP	PERSON	Jack	nn	6	SENT_12	[p1l1579t634r1751b674],
6	Hirsh	NNP	PERSON	Hirsh	appos	3	SENT_12	[p1l1766t634r1866b670],
7	,	,	O	,	_	0	SENT_12	[p1l1766t634r1866b670],
8	M.D.	NNP	O	M.D.	appos	3	SENT_12	[p1l1883t637r1973b671],
9	,	,	O	,	_	0	SENT_12	[p1l1883t637r1973b671],
10	Katy	NNP	PERSON	Katy	nn	11	SENT_12	[p1l720t686r789b724],
11	Simonsen	NNP	PERSON	Simonsen	appos	3	SENT_12	[p1l802t685r980b720],
12	,	,	O	,	_	0	SENT_12	[p1l802t685r980b720],
13	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_12	[p1l997t683r1096b720],
14	,	,	O	,	_	0	SENT_12	[p1l997t683r1096b720],
15	Deepak	NNP	PERSON	Deepak	nn	17	SENT_12	[p1l1114t683r1239b724],
16	L.	NNP	PERSON	L.	nn	17	SENT_12	[p1l1253t686r1277b714],
17	Bhatt	NNP	PERSON	Bhatt	appos	3	SENT_12	[p1l1294t683r1390b720],
18	,	,	O	,	_	0	SENT_12	[p1l1294t683r1390b720],
19	M.D.	NNP	O	M.D.	nn	25	SENT_12	[p1l1407t686r1497b720],
20	,	,	O	,	_	0	SENT_12	[p1l1407t686r1497b720],
21	M.P.H.	NNP	ORGANIZATION	M.P.H.	appos	25	SENT_12	[p1l1514t686r1640b720],
22	,	,	O	,	_	0	SENT_12	[p1l1514t686r1640b720],
23	Keith	NNP	PERSON	Keith	appos	25	SENT_12	[p1l1658t683r1739b714],
24	A.A.	NNP	PERSON	A.A.	nn	25	SENT_12	[p1l1752t685r1819b714],
25	Fox	NNP	PERSON	Fox	appos	3	SENT_12	[p1l1836t686r1900b720],
26	,	,	O	,	_	0	SENT_12	[p1l1836t686r1900b720],
27	M.D.	NNP	O	M.D.	appos	3	SENT_12	[p1l1917t686r2007b720],
28	,	,	O	,	_	0	SENT_12	[p1l1917t686r2007b720],

1	andjohn	NN	PERSON	andjohn	nn	3	SENT_13	[p1l1110t733r1259b773],
2	W.	NNP	PERSON	W.	nn	3	SENT_13	[p1l1273t736r1316b764],
3	Eikelboom	NNP	PERSON	Eikelboom	_	0	SENT_13	[p1l1333t733r1519b769],
4	,	,	O	,	_	0	SENT_13	[p1l1333t733r1519b769],
5	M.D.	NNP	O	M.D.	appos	3	SENT_13	[p1l1536t736r1616b764],

1	ABSTRACT	NN	O	abstract	_	0	SENT_14	[p1l1252t867r1475b890],

1	BACKGROUND	NN	O	background	nsubjpass	5	SENT_15	[p1l666t992r881b1011],
2	It	PRP	O	it	nsubjpass	5	SENT_15	[p1l664t1038r689b1066],
3	has	VBZ	O	have	aux	5	SENT_15	[p1l701t1035r757b1066],
4	been	VBN	O	be	auxpass	5	SENT_15	[p1l772t1035r850b1066],
5	suggested	VBN	O	suggest	_	0	SENT_15	[p1l864t1035r1030b1075],
6	that	IN	O	that	complm	11	SENT_15	[p1l1044t1035r1111b1066],
7	clopidogrel	NN	O	clopidogrel	nsubj	11	SENT_15	[p1l1123t1035r1310b1075],
8	may	MD	O	may	aux	11	SENT_15	[p1l1323t1045r1393b1074],
9	be	VB	O	be	cop	11	SENT_15	[p1l1405t1035r1443b1066],
10	less	RBR	O	less	advmod	11	SENT_15	[p1l1456t1035r1517b1066],
11	effective	JJ	O	effective	ccomp	5	SENT_15	[p1l1532t1035r1670b1066],
12	in	IN	O	in	_	0	SENT_15	[p1l1684t1036r1717b1065],
13	reducing	VBG	O	reduce	prepc_in	11	SENT_15	[p1l1730t1035r1877b1075],
14	the	DT	O	the	det	15	SENT_15	[p1l1889t1035r1941b1066],
15	rate	NN	O	rate	dobj	13	SENT_15	[p1l1955t1042r2017b1066],
16	of	IN	O	of	_	0	SENT_15	[p1l2031t1035r2070b1066],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_15	[p1l665t1085r908b1116],
18	events	NNS	O	event	prep_of	15	SENT_15	[p1l921t1092r1024b1116],
19	among	IN	O	among	_	0	SENT_15	[p1l1039t1095r1155b1125],
20	persons	NNS	O	person	prep_among	13	SENT_15	[p1l1167t1095r1298b1124],
21	who	WP	O	who	nsubj	23	SENT_15	[p1l1311t1085r1382b1116],
22	are	VBP	O	be	cop	23	SENT_15	[p1l1396t1096r1447b1116],
23	carriers	NNS	O	carrier	rcmod	20	SENT_15	[p1l1461t1086r1587b1116],
24	of	IN	O	of	_	0	SENT_15	[p1l1603t1085r1641b1116],
25	loss	NN	O	loss	nn	26	SENT_15	[p1l1648t1085r1915b1116],
26	—	NN	O	—	prep_of	23	SENT_15	[p1l1648t1085r1915b1116],
27	of	IN	O	of	_	0	SENT_15	[p1l1648t1085r1915b1116],
28	—	CD	NUMBER	—	num	31	SENT_15	[p1l1648t1085r1915b1116],
29	function	NN	O	function	nn	31	SENT_15	[p1l1648t1085r1915b1116],
30	CYP2Cl9	NN	O	cyp2cl9	nn	31	SENT_15	[p1l1929t1088r2063b1116],
31	alleles	NNS	O	allele	prep_of	26	SENT_15	[p1l664t1136r767b1166],
32	that	WDT	O	that	nsubjpass	34	SENT_15	[p1l783t1136r850b1166],
33	are	VBP	O	be	auxpass	34	SENT_15	[p1l862t1146r912b1166],
34	associated	VBN	O	associate	rcmod	23	SENT_15	[p1l927t1136r1100b1166],
35	with	IN	O	with	_	0	SENT_15	[p1l1113t1136r1188b1166],
36	reduced	VBN	O	reduce	amod	37	SENT_15	[p1l1203t1136r1334b1166],
37	conversion	NN	O	conversion	prep_with	34	SENT_15	[p1l1349t1136r1527b1166],
38	of	IN	O	of	_	0	SENT_15	[p1l1542t1135r1581b1166],
39	clopidogrel	NN	O	clopidogrel	prep_of	37	SENT_15	[p1l1589t1136r1776b1175],
40	to	TO	O	to	_	0	SENT_15	[p1l1791t1142r1822b1166],
41	its	PRP$	O	its	poss	43	SENT_15	[p1l1837t1136r1876b1166],
42	active	JJ	O	active	amod	43	SENT_15	[p1l1891t1136r1984b1166],
43	metabolite	NN	O	metabolite	prep_to	11	SENT_15	[p1l1999t1146r2062b1166, p1l665t1186r799b1217],
44	.	.	O	.	_	0	SENT_15	[p1l1999t1146r2062b1166, p1l665t1186r799b1217],

1	METHODS	NNS	O	method	nsubj	27	SENT_16	[p1l667t1279r819b1298],
2	We	PRP	O	we	nsubj	3	SENT_16	[p1l663t1325r715b1353],
3	genotyped	VBD	O	genotype	rcmod	1	SENT_16	[p1l733t1322r907b1362],
4	patients	NNS	O	patient	dobj	3	SENT_16	[p1l925t1323r1057b1362],
5	from	IN	O	from	_	0	SENT_16	[p1l1076t1322r1158b1353],
6	two	CD	NUMBER	two	num	10	SENT_16	[p1l1176t1329r1237b1353],
7	large	JJ	O	large	amod	10	SENT_16	[p1l1255t1322r1347b1362],
8	,	,	O	,	_	0	SENT_16	[p1l1255t1322r1347b1362],
9	randomized	JJ	O	randomized	amod	10	SENT_16	[p1l1367t1322r1569b1353],
10	trials	NNS	O	trial	prep_from	3	SENT_16	[p1l1587t1322r1672b1353],
11	that	WDT	O	that	nsubj	12	SENT_16	[p1l1691t1322r1758b1353],
12	showed	VBD	O	show	rcmod	10	SENT_16	[p1l1775t1322r1900b1353],
13	that	IN	O	that	complm	21	SENT_16	[p1l1918t1322r1985b1353],
14	clopidogrel	NN	O	clopidogrel	nsubj	21	SENT_16	[p1l2002t1322r2062b1353, p1l664t1372r812b1412],
15	,	,	O	,	_	0	SENT_16	[p1l2002t1322r2062b1353, p1l664t1372r812b1412],
16	as	IN	O	as	mark	14	SENT_16	[p1l827t1383r861b1403],
17	compared	VBN	O	compare	_	0	SENT_16	[p1l876t1372r1041b1411],
18	with	IN	O	with	_	0	SENT_16	[p1l1053t1372r1129b1403],
19	placebo	NN	O	placebo	prep_compared_with	14	SENT_16	[p1l1142t1372r1278b1411],
20	,	,	O	,	_	0	SENT_16	[p1l1142t1372r1278b1411],
21	reduced	VBD	O	reduce	ccomp	12	SENT_16	[p1l1294t1372r1425b1403],
22	the	DT	O	the	det	23	SENT_16	[p1l1439t1372r1490b1403],
23	rate	NN	O	rate	dobj	21	SENT_16	[p1l1504t1379r1566b1403],
24	of	IN	O	of	_	0	SENT_16	[p1l1581t1372r1619b1403],
25	cardiovascular	JJ	O	cardiovascular	amod	26	SENT_16	[p1l1626t1372r1870b1403],
26	events	NNS	O	event	prep_of	23	SENT_16	[p1l1883t1379r1985b1403],
27	(	VBP	O	(	_	0	SENT_16	[p1l2001t1372r2063b1408],
28	the	DT	O	the	det	32	SENT_16	[p1l2001t1372r2063b1408],
29	primary	JJ	O	primary	amod	32	SENT_16	[p1l664t1423r797b1462],
30	efficacy	NN	O	efficacy	nn	32	SENT_16	[p1l805t1422r932b1462],
31	outcome	NN	O	outcome	nn	32	SENT_16	[p1l940t1425r1090b1458],
32	)	NN	O	)	dobj	27	SENT_16	[p1l940t1425r1090b1458],
33	among	IN	O	among	_	0	SENT_16	[p1l1101t1432r1216b1462],
34	patients	NNS	O	patient	prep_among	27	SENT_16	[p1l1223t1423r1353b1462],
35	with	IN	O	with	_	0	SENT_16	[p1l1361t1423r1435b1453],
36	acute	JJ	O	acute	amod	38	SENT_16	[p1l1444t1429r1529b1453],
37	coronary	JJ	O	coronary	amod	38	SENT_16	[p1l1539t1432r1685b1462],
38	syndromes	NNS	O	syndrome	prep_with	34	SENT_16	[p1l1693t1423r1870b1462],
39	and	CC	O	and	_	0	SENT_16	[p1l1880t1423r1940b1453],
40	among	IN	O	among	_	0	SENT_16	[p1l1949t1432r2064b1462],
41	patients	NNS	O	patient	conj_and	34	SENT_16	[p1l664t1473r796b1512],
42	with	IN	O	with	_	0	SENT_16	[p1l808t1473r883b1504],
43	atrial	JJ	O	atrial	amod	44	SENT_16	[p1l896t1473r983b1503],
44	fibrillation	NN	O	fibrillation	prep_with	41	SENT_16	[p1l995t1472r1186b1503],
45	.	.	O	.	_	0	SENT_16	[p1l995t1472r1186b1503],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_17	[p1l1200t1473r1332b1503],
2	were	VBD	O	be	auxpass	3	SENT_17	[p1l1344t1483r1422b1503],
3	genotyped	VBN	O	genotype	dep	8	SENT_17	[p1l1434t1473r1609b1512],
4	for	IN	O	for	_	0	SENT_17	[p1l1621t1472r1669b1503],
5	three	CD	NUMBER	three	num	7	SENT_17	[p1l1680t1473r1765b1503],
6	single-nucleotide	JJ	O	single-nucleotide	amod	7	SENT_17	[p1l1778t1473r2063b1512],
7	polymorphisms	NNS	O	polymorphism	prep_for	3	SENT_17	[p1l664t1522r927b1561],
8	(	VBP	O	(	_	0	SENT_17	[p1l943t1522r1001b1559],
9	*	NN	O	*	dobj	8	SENT_17	[p1l943t1522r1001b1559],
10	2	CD	NUMBER	2	nsubj	8	SENT_17	[p1l943t1522r1001b1559],
11	,	,	O	,	_	0	SENT_17	[p1l943t1522r1001b1559],
12	*	CD	NUMBER	*	number	13	SENT_17	[p1l1016t1522r1063b1559],
13	3	CD	NUMBER	3	num	17	SENT_17	[p1l1016t1522r1063b1559],
14	,	,	O	,	_	0	SENT_17	[p1l1016t1522r1063b1559],
15	*	CD	NUMBER	*	number	16	SENT_17	[p1l1078t1522r1148b1558],
16	17	CD	NUMBER	17	num	17	SENT_17	[p1l1078t1522r1148b1558],
17	)	NN	O	)	appos	10	SENT_17	[p1l1078t1522r1148b1558],
18	that	WDT	O	that	nsubj	19	SENT_17	[p1l1164t1522r1231b1553],
19	deﬁne	VBP	O	deﬁne	rcmod	17	SENT_17	[p1l1242t1522r1347b1553],
20	the	DT	O	the	det	23	SENT_17	[p1l1361t1522r1412b1553],
21	major	JJ	O	major	amod	23	SENT_17	[p1l1426t1523r1523b1561],
22	CYP2C19	NN	O	cyp2c19	nn	23	SENT_17	[p1l1535t1525r1669b1553],
23	alleles	NNS	O	allele	dobj	19	SENT_17	[p1l1682t1522r1794b1553],
24	.	.	O	.	_	0	SENT_17	[p1l1682t1522r1794b1553],

1	RESULTS	NNS	O	result	npadvmod	17	SENT_18	[p1l666t1627r794b1647],
2	Among	IN	O	among	_	0	SENT_18	[p1l663t1678r786b1714],
3	5059	CD	DATE	5059	num	5	SENT_18	[p1l796t1677r872b1706],
4	genotyped	JJ	O	genotyped	amod	5	SENT_18	[p1l883t1675r1055b1714],
5	patients	NNS	O	patient	prep_among	17	SENT_18	[p1l1065t1675r1195b1714],
6	with	IN	O	with	_	0	SENT_18	[p1l1205t1675r1280b1706],
7	acute	JJ	O	acute	amod	9	SENT_18	[p1l1290t1681r1375b1706],
8	coronary	JJ	O	coronary	amod	9	SENT_18	[p1l1386t1685r1532b1714],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_18	[p1l1542t1675r1729b1714],
10	,	,	O	,	_	0	SENT_18	[p1l1542t1675r1729b1714],
11	clopidogrel	NN	O	clopidogrel	nsubj	17	SENT_18	[p1l1742t1675r1925b1714],
12	as	IN	O	as	_	0	SENT_18	[p1l1936t1685r1969b1705],
13	compared	VBN	O	compare	prepc_as	11	SENT_18	[p1l1981t1685r2062b1706, p1l664t1725r756b1764],
14	with	IN	O	with	pcomp	13	SENT_18	[p1l768t1725r844b1756],
15	placebo	NN	O	placebo	pobj	14	SENT_18	[p1l857t1725r984b1764],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_18	[p1l999t1725r1210b1764],
17	reduced	VBD	O	reduce	_	0	SENT_18	[p1l1222t1725r1353b1756],
18	the	DT	O	the	det	19	SENT_18	[p1l1366t1725r1418b1756],
19	rate	NN	O	rate	dobj	17	SENT_18	[p1l1432t1732r1494b1756],
20	of	IN	O	of	_	0	SENT_18	[p1l1508t1725r1547b1756],
21	the	DT	O	the	det	24	SENT_18	[p1l1553t1725r1605b1756],
22	primary	JJ	O	primary	amod	24	SENT_18	[p1l1618t1726r1754b1764],
23	efficacy	NN	O	efficacy	nn	24	SENT_18	[p1l1766t1725r1896b1764],
24	outcome	NN	O	outcome	prep_of	19	SENT_18	[p1l1909t1731r2061b1762],
25	,	,	O	,	_	0	SENT_18	[p1l1909t1731r2061b1762],
26	irrespective	RB	O	irrespective	_	0	SENT_18	[p1l664t1776r856b1814],
27	of	IN	O	of	_	0	SENT_18	[p1l871t1775r910b1806],
28	the	DT	O	the	det	32	SENT_18	[p1l918t1775r969b1806],
29	genetically	RB	O	genetically	advmod	30	SENT_18	[p1l984t1775r1165b1815],
30	determined	VBN	O	determine	amod	32	SENT_18	[p1l1178t1775r1370b1806],
31	metabolizer	NN	O	metabolizer	nn	32	SENT_18	[p1l1384t1775r1585b1806],
32	phenotype	NN	O	phenotype	prep_irrespective_of	17	SENT_18	[p1l1598t1775r1774b1814],
33	(	CD	NUMBER	(	num	34	SENT_18	[p1l1790t1778r1924b1811],
34	P	NN	O	p	npadvmod	35	SENT_18	[p1l1790t1778r1924b1811],
35	=	JJ	O	=	amod	32	SENT_18	[p1l1790t1778r1924b1811],
36	0.12	CD	NUMBER	0.12	dep	35	SENT_18	[p1l1790t1778r1924b1811],
37	for	IN	O	for	_	0	SENT_18	[p1l1939t1775r1987b1806],
38	heterogeneity	NN	O	heterogeneity	nn	39	SENT_18	[p1l2000t1775r2062b1806, p1l665t1826r857b1864],
39	)	NN	O	)	prep_for	35	SENT_18	[p1l2000t1775r2062b1806, p1l665t1826r857b1864],
40	.	.	O	.	_	0	SENT_18	[p1l2000t1775r2062b1806, p1l665t1826r857b1864],

1	The	DT	O	the	dep	100	SENT_19	[p1l874t1825r936b1855],
2	effect	NN	O	effect	dep	100	SENT_19	[p1l953t1825r1047b1855],
3	of	IN	O	of	dep	100	SENT_19	[p1l1061t1825r1100b1856],
4	clopidogrel	NN	O	clopidogrel	dep	100	SENT_19	[p1l1109t1825r1296b1864],
5	in	IN	O	in	dep	100	SENT_19	[p1l1312t1826r1344b1855],
6	reducing	VBG	O	reduce	dep	100	SENT_19	[p1l1360t1825r1507b1864],
7	the	DT	O	the	dep	100	SENT_19	[p1l1522t1825r1573b1855],
8	rate	NN	O	rate	dep	100	SENT_19	[p1l1590t1832r1652b1855],
9	of	IN	O	of	dep	100	SENT_19	[p1l1668t1825r1707b1856],
10	the	DT	O	the	dep	100	SENT_19	[p1l1716t1825r1768b1855],
11	primary	JJ	O	primary	dep	100	SENT_19	[p1l1783t1825r1919b1864],
12	efficacy	NN	O	efficacy	dep	100	SENT_19	[p1l1934t1825r2064b1864],
13	outcome	NN	O	outcome	dep	100	SENT_19	[p1l665t1881r808b1906],
14	was	VBD	O	be	dep	100	SENT_19	[p1l817t1885r881b1906],
15	similar	JJ	O	similar	dep	100	SENT_19	[p1l893t1875r1012b1905],
16	in	IN	O	in	dep	100	SENT_19	[p1l1022t1876r1054b1905],
17	patients	NNS	O	patient	dep	100	SENT_19	[p1l1065t1875r1198b1914],
18	who	WP	O	who	dep	100	SENT_19	[p1l1208t1875r1279b1906],
19	were	VBD	O	be	dep	100	SENT_19	[p1l1289t1885r1368b1906],
20	heterozygous	JJ	O	heterozygous	dep	100	SENT_19	[p1l1379t1875r1600b1914],
21	or	CC	O	or	dep	100	SENT_19	[p1l1613t1885r1647b1906],
22	homozygous	JJ	O	homozygous	dep	100	SENT_19	[p1l1657t1875r1870b1914],
23	for	IN	O	for	dep	100	SENT_19	[p1l1882t1875r1930b1906],
24	loss	NN	O	loss	dep	100	SENT_19	[p1l1939t1875r2062b1906],
25	—	NN	O	—	dep	100	SENT_19	[p1l1939t1875r2062b1906],
26	of	IN	O	of	dep	100	SENT_19	[p1l1939t1875r2062b1906],
27	—	CD	NUMBER	—	dep	100	SENT_19	[p1l1939t1875r2062b1906],
28	function	NN	O	function	dep	100	SENT_19	[p1l664t1925r807b1956],
29	alleles	NNS	O	allele	dep	100	SENT_19	[p1l819t1925r922b1955],
30	and	CC	O	and	dep	100	SENT_19	[p1l935t1925r996b1956],
31	in	IN	O	in	dep	100	SENT_19	[p1l1009t1925r1041b1955],
32	those	DT	O	those	dep	100	SENT_19	[p1l1054t1925r1144b1956],
33	who	WP	O	who	dep	100	SENT_19	[p1l1154t1925r1226b1956],
34	were	VBD	O	be	dep	100	SENT_19	[p1l1237t1935r1315b1956],
35	not	RB	O	not	dep	100	SENT_19	[p1l1328t1932r1383b1956],
36	carriers	NNS	O	carrier	dep	100	SENT_19	[p1l1394t1926r1520b1955],
37	of	IN	O	of	dep	100	SENT_19	[p1l1534t1925r1572b1956],
38	the	DT	O	the	dep	100	SENT_19	[p1l1578t1925r1630b1955],
39	alleles	NNS	O	allele	dep	100	SENT_19	[p1l1642t1925r1745b1955],
40	(	CD	NUMBER	(	dep	100	SENT_19	[p1l1760t1928r1832b1960],
41	rate	NN	O	rate	dep	100	SENT_19	[p1l1760t1928r1832b1960],
42	among	IN	O	among	dep	100	SENT_19	[p1l1845t1935r1961b1964],
43	carriers	NNS	O	carrier	dep	100	SENT_19	[p1l1973t1925r2062b1955, p1l665t1985r721b2012],
44	,	,	O	,	_	0	SENT_19	[p1l1973t1925r2062b1955, p1l665t1985r721b2012],
45	8.0	CD	PERCENT	8.0	dep	100	SENT_19	[p1l739t1977r822b2006],
46	%	NN	PERCENT	%	dep	100	SENT_19	[p1l739t1977r822b2006],
47	with	IN	O	with	dep	100	SENT_19	[p1l836t1975r912b2006],
48	clopidogrel	NN	O	clopidogrel	dep	100	SENT_19	[p1l928t1975r1115b2014],
49	vs.	CC	O	vs.	dep	100	SENT_19	[p1l1129t1985r1171b2006],
50	11.6	CD	PERCENT	11.6	dep	100	SENT_19	[p1l1191t1977r1291b2006],
51	%	NN	PERCENT	%	dep	100	SENT_19	[p1l1191t1977r1291b2006],
52	with	IN	O	with	dep	100	SENT_19	[p1l1305t1975r1381b2006],
53	placebo	NN	O	placebo	dep	100	SENT_19	[p1l1396t1975r1533b2014],
54	;	:	O	;	_	0	SENT_19	[p1l1396t1975r1533b2014],
55	hazard	NN	O	hazard	dep	100	SENT_19	[p1l1551t1975r1666b2006],
56	ratio	NN	O	ratio	dep	100	SENT_19	[p1l1681t1975r1758b2006],
57	with	IN	O	with	dep	100	SENT_19	[p1l1772t1975r1848b2006],
58	clopidogrel	NN	O	clopidogrel	dep	100	SENT_19	[p1l1864t1975r2060b2014],
59	,	,	O	,	_	0	SENT_19	[p1l1864t1975r2060b2014],
60	0.69	CD	NUMBER	0.69	dep	100	SENT_19	[p1l664t2027r742b2062],
61	;	:	O	;	_	0	SENT_19	[p1l664t2027r742b2062],
62	95	CD	NUMBER	95	dep	100	SENT_19	[p1l759t2027r830b2056],
63	°	CD	NUMBER	°	dep	100	SENT_19	[p1l759t2027r830b2056],
64	/	:	O	/	dep	100	SENT_19	[p1l759t2027r830b2056],
65	o	NN	O	o	dep	100	SENT_19	[p1l759t2027r830b2056],
66	confidence	NN	O	confidence	dep	100	SENT_19	[p1l846t2025r1028b2056],
67	interval	NN	O	interval	dep	100	SENT_19	[p1l1043t2025r1170b2056],
68	[	CD	NUMBER	[	dep	100	SENT_19	[p1l1188t2027r1256b2062],
69	CI	NN	O	ci	dep	100	SENT_19	[p1l1188t2027r1256b2062],
70	]	NN	O	]	dep	100	SENT_19	[p1l1188t2027r1256b2062],
71	,	,	O	,	_	0	SENT_19	[p1l1188t2027r1256b2062],
72	0.49	CD	NUMBER	0.49	dep	100	SENT_19	[p1l1274t2027r1341b2056],
73	to	TO	O	to	dep	100	SENT_19	[p1l1357t2032r1389b2056],
74	0.98	CD	NUMBER	0.98	dep	100	SENT_19	[p1l1405t2027r1482b2062],
75	;	:	O	;	_	0	SENT_19	[p1l1405t2027r1482b2062],
76	rate	NN	O	rate	dep	100	SENT_19	[p1l1499t2032r1561b2056],
77	among	IN	O	among	dep	100	SENT_19	[p1l1576t2035r1692b2064],
78	noncarriers	NNS	O	noncarrier	dep	100	SENT_19	[p1l1706t2025r1907b2062],
79	,	,	O	,	_	0	SENT_19	[p1l1706t2025r1907b2062],
80	9.5	CD	PERCENT	9.5	dep	100	SENT_19	[p1l1924t2027r2005b2056],
81	%	NN	PERCENT	%	dep	100	SENT_19	[p1l1924t2027r2005b2056],
82	vs.	CC	O	vs.	dep	100	SENT_19	[p1l2018t2035r2060b2056],
83	13.0	CD	NUMBER	13.0	dep	100	SENT_19	[p1l666t2077r777b2112],
84	°	CD	NUMBER	°	dep	100	SENT_19	[p1l666t2077r777b2112],
85	/	:	O	/	dep	100	SENT_19	[p1l666t2077r777b2112],
86	o	NN	O	o	dep	100	SENT_19	[p1l666t2077r777b2112],
87	;	:	O	;	_	0	SENT_19	[p1l666t2077r777b2112],
88	hazard	NN	O	hazard	dep	100	SENT_19	[p1l793t2075r908b2106],
89	ratio	NN	O	ratio	dep	100	SENT_19	[p1l922t2076r1007b2112],
90	,	,	O	,	_	0	SENT_19	[p1l922t2076r1007b2112],
91	0.72	CD	NUMBER	0.72	dep	100	SENT_19	[p1l1024t2078r1101b2112],
92	;	:	O	;	_	0	SENT_19	[p1l1024t2078r1101b2112],
93	95	CD	PERCENT	95	dep	100	SENT_19	[p1l1117t2077r1189b2106],
94	%	NN	PERCENT	%	dep	100	SENT_19	[p1l1117t2077r1189b2106],
95	CI	NN	O	ci	dep	100	SENT_19	[p1l1202t2078r1247b2113],
96	,	,	O	,	_	0	SENT_19	[p1l1202t2078r1247b2113],
97	0.59	CD	NUMBER	0.59	dep	100	SENT_19	[p1l1264t2078r1332b2106],
98	to	TO	O	to	dep	100	SENT_19	[p1l1347t2082r1378b2106],
99	0.87	CD	NUMBER	0.87	dep	100	SENT_19	[p1l1393t2078r1484b2111],
100	)	CD	NUMBER	)	_	0	SENT_19	[p1l1393t2078r1484b2111],
101	.	.	O	.	_	0	SENT_19	[p1l1393t2078r1484b2111],

1	In	IN	O	in	_	0	SENT_20	[p1l1500t2078r1535b2105],
2	contrast	NN	O	contrast	prep_in	6	SENT_20	[p1l1549t2082r1694b2113],
3	,	,	O	,	_	0	SENT_20	[p1l1549t2082r1694b2113],
4	gain-oﬁfunction	NN	O	gain-oﬁfunction	nn	5	SENT_20	[p1l1710t2075r1985b2115],
5	carriers	NNS	O	carrier	nsubj	6	SENT_20	[p1l2000t2085r2062b2106, p1l664t2125r737b2155],
6	derived	VBN	O	derive	_	0	SENT_20	[p1l756t2125r875b2156],
7	more	RBR	O	more	advmod	6	SENT_20	[p1l892t2135r977b2156],
8	benefit	NN	O	benefit	dobj	6	SENT_20	[p1l995t2125r1113b2156],
9	from	IN	O	from	_	0	SENT_20	[p1l1128t2125r1210b2156],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_20	[p1l1227t2125r1414b2164],
11	treatment	NN	O	treatment	prep_from	6	SENT_20	[p1l1431t2131r1596b2155],
12	as	IN	O	as	mark	17	SENT_20	[p1l1610t2135r1643b2155],
13	compared	VBN	O	compare	csubj	17	SENT_20	[p1l1662t2125r1827b2164],
14	with	IN	O	with	_	0	SENT_20	[p1l1842t2125r1918b2156],
15	placebo	NN	O	placebo	prep_with	13	SENT_20	[p1l1934t2125r2062b2164],
16	than	IN	O	than	prep	13	SENT_20	[p1l664t2174r741b2204],
17	did	VBD	O	do	advcl	6	SENT_20	[p1l760t2174r812b2205],
18	noncarriers	JJ	O	noncarriers	amod	20	SENT_20	[p1l831t2174r1022b2205],
19	(	CD	NUMBER	(	tmod	18	SENT_20	[p1l1044t2177r1116b2209],
20	rate	NN	O	rate	dobj	17	SENT_20	[p1l1044t2177r1116b2209],
21	of	IN	O	of	_	0	SENT_20	[p1l1135t2174r1174b2205],
22	primary	JJ	O	primary	amod	23	SENT_20	[p1l1185t2175r1321b2213],
23	outcome	NN	O	outcome	prep_of	20	SENT_20	[p1l1338t2181r1481b2205],
24	among	IN	O	among	_	0	SENT_20	[p1l1500t2184r1616b2213],
25	carriers	NNS	O	carrier	prep_among	17	SENT_20	[p1l1634t2174r1769b2211],
26	,	,	O	,	_	0	SENT_20	[p1l1634t2174r1769b2211],
27	7.7	CD	NUMBER	7.7	number	28	SENT_20	[p1l1791t2176r1868b2205],
28	°	CD	NUMBER	°	appos	25	SENT_20	[p1l1791t2176r1868b2205],
29	/	:	O	/	punct	30	SENT_20	[p1l1791t2176r1868b2205],
30	o	NN	O	o	dep	28	SENT_20	[p1l1791t2176r1868b2205],
31	vs.	CC	O	vs.	prep	28	SENT_20	[p1l1885t2184r1927b2205],
32	13.0	CD	PERCENT	13.0	num	33	SENT_20	[p1l1949t2176r2061b2211],
33	%	NN	PERCENT	%	dep	31	SENT_20	[p1l1949t2176r2061b2211],
34	;	:	O	;	_	0	SENT_20	[p1l1949t2176r2061b2211],
35	hazard	NN	O	hazard	nn	36	SENT_20	[p1l664t2223r780b2254],
36	ratio	NN	O	ratio	dep	28	SENT_20	[p1l793t2223r879b2260],
37	,	,	O	,	_	0	SENT_20	[p1l793t2223r879b2260],
38	0.55	CD	NUMBER	0.55	appos	36	SENT_20	[p1l895t2225r971b2260],
39	;	:	O	;	_	0	SENT_20	[p1l895t2225r971b2260],
40	95	CD	NUMBER	95	number	41	SENT_20	[p1l987t2225r1058b2254],
41	°	CD	NUMBER	°	dep	28	SENT_20	[p1l987t2225r1058b2254],
42	/	:	O	/	punct	44	SENT_20	[p1l987t2225r1058b2254],
43	o	NN	O	o	nn	44	SENT_20	[p1l987t2225r1058b2254],
44	CI	NN	O	ci	dep	41	SENT_20	[p1l1072t2225r1117b2260],
45	,	,	O	,	_	0	SENT_20	[p1l1072t2225r1117b2260],
46	0.42	CD	NUMBER	0.42	appos	44	SENT_20	[p1l1133t2225r1200b2254],
47	to	TO	O	to	_	0	SENT_20	[p1l1215t2229r1246b2254],
48	0.73	CD	NUMBER	0.73	prep_to	41	SENT_20	[p1l1261t2225r1338b2260],
49	;	:	O	;	_	0	SENT_20	[p1l1261t2225r1338b2260],
50	rate	NN	O	rate	dep	28	SENT_20	[p1l1353t2229r1415b2253],
51	among	IN	O	among	_	0	SENT_20	[p1l1429t2233r1546b2262],
52	noncarriers	NNS	O	noncarrier	prep_among	50	SENT_20	[p1l1558t2223r1759b2260],
53	,	,	O	,	_	0	SENT_20	[p1l1558t2223r1759b2260],
54	10.0	CD	PERCENT	10.0	num	55	SENT_20	[p1l1776t2225r1877b2254],
55	%	NN	PERCENT	%	prep_among	50	SENT_20	[p1l1776t2225r1877b2254],
56	vs.	CC	O	vs.	_	0	SENT_20	[p1l1889t2233r1931b2254],
57	12.2	CD	PERCENT	12.2	num	58	SENT_20	[p1l1948t2225r2061b2260],
58	%	NN	PERCENT	%	prep_among	50	SENT_20	[p1l1948t2225r2061b2260],
59	;	:	O	;	_	0	SENT_20	[p1l1948t2225r2061b2260],
60	hazard	NN	O	hazard	nn	61	SENT_20	[p1l664t2272r780b2303],
61	ratio	NN	O	ratio	dep	28	SENT_20	[p1l794t2272r879b2309],
62	,	,	O	,	_	0	SENT_20	[p1l794t2272r879b2309],
63	0.85	CD	NUMBER	0.85	appos	61	SENT_20	[p1l895t2274r973b2309],
64	;	:	O	;	_	0	SENT_20	[p1l895t2274r973b2309],
65	95	CD	NUMBER	95	number	66	SENT_20	[p1l989t2274r1060b2303],
66	°	CD	NUMBER	°	dep	28	SENT_20	[p1l989t2274r1060b2303],
67	/	:	O	/	punct	69	SENT_20	[p1l989t2274r1060b2303],
68	o	NN	O	o	nn	69	SENT_20	[p1l989t2274r1060b2303],
69	CI	NN	O	ci	dep	66	SENT_20	[p1l1074t2274r1119b2309],
70	,	,	O	,	_	0	SENT_20	[p1l1074t2274r1119b2309],
71	0.68	CD	NUMBER	0.68	appos	69	SENT_20	[p1l1135t2274r1204b2303],
72	to	TO	O	to	_	0	SENT_20	[p1l1219t2279r1251b2303],
73	1.05	CD	NUMBER	1.05	prep_to	66	SENT_20	[p1l1267t2274r1344b2309],
74	;	:	O	;	_	0	SENT_20	[p1l1267t2274r1344b2309],
75	P	NN	O	p	dep	28	SENT_20	[p1l1359t2274r1481b2303],
76	=	JJ	O	=	amod	75	SENT_20	[p1l1359t2274r1481b2303],
77	0.02	CD	NUMBER	0.02	tmod	76	SENT_20	[p1l1359t2274r1481b2303],
78	for	IN	O	for	_	0	SENT_20	[p1l1495t2272r1543b2303],
79	interaction	NN	O	interaction	nn	80	SENT_20	[p1l1556t2272r1757b2307],
80	)	NN	O	)	prep_for	17	SENT_20	[p1l1556t2272r1757b2307],
81	.	.	O	.	_	0	SENT_20	[p1l1556t2272r1757b2307],

1	The	DT	O	the	det	2	SENT_21	[p1l1772t2272r1834b2302],
2	effect	NN	O	effect	nsubj	9	SENT_21	[p1l1849t2272r1943b2302],
3	of	IN	O	of	_	0	SENT_21	[p1l1955t2272r1994b2303],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_21	[p1l2001t2272r2062b2303, p1l664t2321r803b2360],
5	on	IN	O	on	_	0	SENT_21	[p1l817t2331r858b2352],
6	bleeding	NN	O	bleeding	prep_on	4	SENT_21	[p1l873t2321r1017b2360],
7	did	VBD	O	do	aux	9	SENT_21	[p1l1030t2321r1082b2352],
8	not	RB	O	not	neg	9	SENT_21	[p1l1097t2327r1152b2352],
9	vary	VB	O	vary	_	0	SENT_21	[p1l1163t2331r1233b2360],
10	according	VBG	O	accord	_	0	SENT_21	[p1l1246t2321r1411b2360],
11	to	TO	O	to	prepc_according_to	9	SENT_21	[p1l1424t2327r1456b2352],
12	genotypic	JJ	O	genotypic	amod	13	SENT_21	[p1l1471t2321r1633b2360],
13	subgroups	NNS	O	subgroup	pobj	9	SENT_21	[p1l1648t2321r1831b2360],
14	.	.	O	.	_	0	SENT_21	[p1l1648t2321r1831b2360],

1	Among	IN	O	among	_	0	SENT_22	[p1l1846t2324r1970b2360],
2	1156	CD	DATE	1156	num	4	SENT_22	[p1l1984t2323r2062b2352],
3	genotyped	JJ	O	genotyped	amod	4	SENT_22	[p1l664t2370r839b2409],
4	patients	NNS	O	patient	prep_among	10	SENT_22	[p1l852t2370r985b2409],
5	with	IN	O	with	_	0	SENT_22	[p1l998t2370r1074b2401],
6	atrial	JJ	O	atrial	amod	7	SENT_22	[p1l1087t2370r1175b2400],
7	fibrillation	NN	O	fibrillation	prep_with	4	SENT_22	[p1l1189t2370r1380b2407],
8	,	,	O	,	_	0	SENT_22	[p1l1189t2370r1380b2407],
9	there	EX	O	there	expl	10	SENT_22	[p1l1396t2370r1480b2400],
10	was	VBD	O	be	_	0	SENT_22	[p1l1492t2380r1556b2401],
11	no	DT	O	no	det	12	SENT_22	[p1l1570t2380r1611b2401],
12	evidence	NN	O	evidence	nsubj	10	SENT_22	[p1l1626t2370r1768b2401],
13	of	IN	O	of	_	0	SENT_22	[p1l1782t2370r1821b2401],
14	an	DT	O	a	det	15	SENT_22	[p1l1827t2380r1867b2400],
15	interaction	NN	O	interaction	prep_of	12	SENT_22	[p1l1881t2370r2063b2401],
16	with	IN	O	with	_	0	SENT_22	[p1l663t2419r737b2450],
17	respect	NN	O	respect	_	0	SENT_22	[p1l751t2426r868b2458],
18	to	TO	O	to	_	0	SENT_22	[p1l880t2426r911b2450],
19	either	CC	O	either	preconj	20	SENT_22	[p1l926t2419r1020b2449],
20	efficacy	NN	O	efficacy	prep_with_respect_to	15	SENT_22	[p1l1033t2419r1160b2458],
21	or	CC	O	or	_	0	SENT_22	[p1l1172t2429r1207b2450],
22	bleeding	NN	O	bleeding	prep_with_respect_to	15	SENT_22	[p1l1219t2419r1361b2458],
23	between	IN	O	between	_	0	SENT_22	[p1l1373t2419r1510b2450],
24	the	DT	O	the	det	26	SENT_22	[p1l1524t2419r1574b2449],
25	study	NN	O	study	nn	26	SENT_22	[p1l1589t2419r1676b2458],
26	treatment	NN	O	treatment	prep_between	20	SENT_22	[p1l1688t2425r1850b2449],
27	and	CC	O	and	_	0	SENT_22	[p1l1861t2419r1922b2450],
28	the	DT	O	the	det	30	SENT_22	[p1l1935t2419r1986b2449],
29	metabolizer	NN	O	metabolizer	nn	30	SENT_22	[p1l2000t2429r2062b2449, p1l664t2468r808b2499],
30	phenotype	NN	O	phenotype	conj_and	20	SENT_22	[p1l819t2468r997b2507],
31	,	,	O	,	_	0	SENT_22	[p1l819t2468r997b2507],
32	loss	NN	O	loss	nn	33	SENT_22	[p1l1011t2468r1267b2499],
33	—	NN	O	—	conj_or	12	SENT_22	[p1l1011t2468r1267b2499],
34	of	IN	O	of	_	0	SENT_22	[p1l1011t2468r1267b2499],
35	—	CD	NUMBER	—	num	38	SENT_22	[p1l1011t2468r1267b2499],
36	function	NN	O	function	nn	38	SENT_22	[p1l1011t2468r1267b2499],
37	carrier	NN	O	carrier	nn	38	SENT_22	[p1l1279t2468r1386b2498],
38	status	NN	O	status	prep_of	33	SENT_22	[p1l1397t2474r1501b2505],
39	,	,	O	,	_	0	SENT_22	[p1l1397t2474r1501b2505],
40	or	CC	O	or	_	0	SENT_22	[p1l1515t2478r1549b2499],
41	gain	NN	O	gain	nn	42	SENT_22	[p1l1560t2468r1824b2507],
42	—	NN	O	—	conj_or	12	SENT_22	[p1l1560t2468r1824b2507],
43	of	IN	O	of	_	0	SENT_22	[p1l1560t2468r1824b2507],
44	—	CD	NUMBER	—	num	47	SENT_22	[p1l1560t2468r1824b2507],
45	function	NN	O	function	nn	47	SENT_22	[p1l1560t2468r1824b2507],
46	carrier	NN	O	carrier	nn	47	SENT_22	[p1l1837t2468r1943b2498],
47	status	NN	O	status	prep_of	42	SENT_22	[p1l1955t2474r2058b2499],
48	.	.	O	.	_	0	SENT_22	[p1l1955t2474r2058b2499],

1	CONCLUSIONS	NNS	O	conclusion	npadvmod	30	SENT_23	[p1l665t2566r891b2585],
2	Among	IN	O	among	_	0	SENT_23	[p1l663t2609r787b2646],
3	patients	NNS	O	patient	prep_among	30	SENT_23	[p1l801t2607r933b2646],
4	with	IN	O	with	_	0	SENT_23	[p1l947t2606r1023b2637],
5	acute	JJ	O	acute	amod	7	SENT_23	[p1l1037t2613r1124b2637],
6	coronary	JJ	O	coronary	amod	7	SENT_23	[p1l1139t2616r1288b2646],
7	syndromes	NNS	O	syndrome	prep_with	3	SENT_23	[p1l1302t2606r1482b2646],
8	or	CC	O	or	_	0	SENT_23	[p1l1498t2616r1533b2637],
9	atrial	JJ	O	atrial	amod	10	SENT_23	[p1l1546t2606r1634b2637],
10	fibrillation	NN	O	fibrillation	prep_with	3	SENT_23	[p1l1649t2606r1840b2644],
11	,	,	O	,	_	0	SENT_23	[p1l1649t2606r1840b2644],
12	the	DT	O	the	det	13	SENT_23	[p1l1857t2606r1909b2637],
13	effect	NN	O	effect	nsubj	30	SENT_23	[p1l1924t2606r2018b2637],
14	of	IN	O	of	_	0	SENT_23	[p1l2031t2606r2070b2637],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_23	[p1l665t2657r856b2697],
16	as	IN	O	as	_	0	SENT_23	[p1l870t2667r904b2688],
17	compared	VBN	O	compare	prepc_as	15	SENT_23	[p1l919t2657r1087b2697],
18	with	IN	O	with	pcomp	17	SENT_23	[p1l1100t2657r1177b2688],
19	placebo	NN	O	placebo	pobj	18	SENT_23	[p1l1191t2657r1321b2697],
20	is	VBZ	O	be	cop	30	SENT_23	[p1l1335t2658r1362b2688],
21	consistent	JJ	O	consistent	amod	30	SENT_23	[p1l1377t2658r1559b2695],
22	,	,	O	,	_	0	SENT_23	[p1l1377t2658r1559b2695],
23	irrespective	JJ	O	irrespective	_	0	SENT_23	[p1l1576t2658r1772b2697],
24	of	IN	O	of	_	0	SENT_23	[p1l1787t2657r1826b2688],
25	CYP2C19	NN	O	cyp2c19	nn	26	SENT_23	[p1l1833t2660r1970b2688],
26	lossof	NN	O	lossof	prep_irrespective_of	21	SENT_23	[p1l1983t2657r2062b2688, p1l665t2708r856b2739],
27	—	CD	NUMBER	—	num	28	SENT_23	[p1l1983t2657r2062b2688, p1l665t2708r856b2739],
28	function	NN	O	function	dep	21	SENT_23	[p1l1983t2657r2062b2688, p1l665t2708r856b2739],
29	carrier	NN	O	carrier	nn	30	SENT_23	[p1l874t2709r987b2739],
30	status	NN	O	status	_	0	SENT_23	[p1l1004t2715r1114b2739],
31	.	.	O	.	_	0	SENT_23	[p1l1004t2715r1114b2739],

1	(	NN	O	(	nsubj	2	SENT_24	[p1l1136t2708r1274b2744],
2	Funded	VBN	O	fund	_	0	SENT_24	[p1l1136t2708r1274b2744],
3	by	IN	O	by	_	0	SENT_24	[p1l1292t2708r1331b2747],
4	Sanofi	NNP	ORGANIZATION	Sanofi	prep_by	2	SENT_24	[p1l1348t2708r1592b2739],
5	.	.	O	.	_	0	SENT_24	[p1l1348t2708r1592b2739],

1	—	NN	O	—	_	0	SENT_25	[p1l1348t2708r1592b2739],
2	.	.	O	.	_	0	SENT_25	[p1l1348t2708r1592b2739],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_26	[p1l1348t2708r1592b2739],
2	and	CC	O	and	_	0	SENT_26	[p1l1611t2708r1673b2739],
3	Bristol	NNP	LOCATION	Bristol	conj_and	1	SENT_26	[p1l1690t2708r1915b2747],
4	.	.	O	.	_	0	SENT_26	[p1l1690t2708r1915b2747],

1	—	NN	O	—	_	0	SENT_27	[p1l1690t2708r1915b2747],
2	.	.	O	.	_	0	SENT_27	[p1l1690t2708r1915b2747],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_28	[p1l1690t2708r1915b2747],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_28	[p1l1935t2708r2061b2747],
3	;	:	O	;	_	0	SENT_28	[p1l1935t2708r2061b2747],
4	ClinicalTrials	NNP	O	ClinicalTrials	dep	2	SENT_28	[p1l664t2759r962b2798],
5	.	.	O	.	_	0	SENT_28	[p1l664t2759r962b2798],

1	gov	NN	O	gov	nn	2	SENT_29	[p1l664t2759r962b2798],
2	number	NN	O	number	_	0	SENT_29	[p1l974t2759r1112b2796],
3	,	,	O	,	_	0	SENT_29	[p1l974t2759r1112b2796],
4	NCT00249873	NN	O	nct00249873	appos	2	SENT_29	[p1l1126t2761r1383b2794],
5	.	.	O	.	_	0	SENT_29	[p1l1126t2761r1383b2794],
6	)	SYM	O	)	dep	2	SENT_29	[p1l1126t2761r1383b2794],

1	NENGLJ	NN	O	nenglj	nn	2	SENT_30	[p1l880t2867r987b2889],
2	MEo363	NN	O	meo363	_	0	SENT_30	[p1l1001t2861r1140b2889],
3	;	:	O	;	_	0	SENT_30	[p1l1001t2861r1140b2889],
4	18	CD	NUMBER	18	num	6	SENT_30	[p1l1001t2861r1140b2889],
5	NEJM.ORG	NN	O	nejm.org	nn	6	SENT_30	[p1l1175t2867r1299b2889],
6	ocToBER28	NN	O	october28	dep	2	SENT_30	[p1l1334t2861r1564b2887],
7	,2	CD	NUMBER	,2	num	8	SENT_30	[p1l1334t2861r1564b2887],
8	o1o	NN	O	o1o	dep	6	SENT_30	[p1l1334t2861r1564b2887],

1	The	DT	O	the	det	4	SENT_31	[p1l878t2924r929b2948],
2	New	NNP	O	New	nn	4	SENT_31	[p1l938t2925r1000b2948],
3	England	NNP	O	England	nn	4	SENT_31	[p1l1009t2924r1120b2955],
4	Journal	NNP	O	Journal	_	0	SENT_31	[p1l1129t2924r1226b2948],
5	of	IN	O	of	_	0	SENT_31	[p1l1236t2924r1265b2948],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_31	[p1l1271t2924r1396b2948],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_32	[p1l649t3112r770b3132],
2	GENOTYPE	NN	O	genotype	dep	1	SENT_32	[p1l785t3112r958b3131],
3	AND	CC	O	and	_	0	SENT_32	[p1l971t3112r1043b3131],
4	CLOPIDOGREL	NN	O	clopidogrel	nn	5	SENT_32	[p1l1057t3112r1294b3131],
5	TREATMENT	NN	O	treatment	dep	1	SENT_32	[p1l1306t3112r1511b3131],

1	LOPIDOGREL	NNP	LOCATION	LOPIDOGREL	_	0	SENT_33	[p1l322t3347r925b3420],
2	,	,	O	,	_	0	SENT_33	[p1l322t3347r925b3420],
3	WHEN	WRB	O	when	advmod	4	SENT_33	[p1l950t3348r1239b3403],
4	ADDED	VBD	O	add	dep	1	SENT_33	[p1l1262t3347r1577b3402],
5	TO	TO	O	to	xcomp	4	SENT_33	[p1l1597t3347r1717b3403],
6	ASPIRIN	NNP	O	ASPIRIN	dobj	5	SENT_33	[p1l1738t3347r2128b3420],
7	,	,	O	,	_	0	SENT_33	[p1l1738t3347r2128b3420],

1	reduces	VBZ	O	reduce	_	0	SENT_34	[p1l319t3454r642b3533],
2	the	DT	O	the	det	3	SENT_34	[p1l686t3454r818b3532],
3	rate	NN	O	rate	dobj	1	SENT_34	[p1l861t3470r1021b3532],
4	of	IN	O	of	_	0	SENT_34	[p1l1063t3453r1163b3532],
5	major	JJ	O	major	amod	7	SENT_34	[p1l1186t3455r1436b3554],
6	vascular	JJ	O	vascular	amod	7	SENT_34	[p1l1471t3454r1828b3533],
7	events	NNS	O	event	prep_of	3	SENT_34	[p1l1868t3470r2131b3533],
8	among	IN	O	among	_	0	SENT_34	[p1l319t3608r619b3683],
9	patients	NNS	O	patient	prep_among	1	SENT_34	[p1l655t3584r996b3683],
10	with	IN	O	with	_	0	SENT_34	[p1l1035t3583r1230b3661],
11	acute	JJ	O	acute	amod	13	SENT_34	[p1l1271t3599r1493b3661],
12	coronary	JJ	O	coronary	amod	13	SENT_34	[p1l1536t3608r1921b3683],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_34	[p1l1959t3608r2132b3683, p1l12t3711r330b3790],
14	and	CC	O	and	_	0	SENT_34	[p1l378t3711r536b3790],
15	atrial	JJ	O	atrial	amod	16	SENT_34	[p1l582t3711r807b3790],
16	fibrillation	NN	O	fibrillation	conj_and	13	SENT_34	[p1l853t3711r1444b3790],
17	.	.	O	.	_	0	SENT_34	[p1l853t3711r1444b3790],

1	“	NN	O	“	nn	3	SENT_35	[p1l853t3711r1444b3790],
2	Recent	JJ	O	recent	amod	3	SENT_35	[p1l1489t3718r1783b3795],
3	reports	NNS	O	report	nsubj	4	SENT_35	[p1l1825t3728r2131b3812],
4	suggest	VBP	O	suggest	_	0	SENT_35	[p2l13t40r340b124],
5	that	IN	O	that	complm	33	SENT_35	[p2l390t23r562b102],
6	certain	JJ	O	certain	amod	9	SENT_35	[p2l612t24r912b102],
7	common	JJ	O	common	amod	9	SENT_35	[p2l967t49r1349b102],
8	genetic	JJ	O	genetic	amod	9	SENT_35	[p2l1402t24r1711b124],
9	variants	NNS	O	variant	nsubjpass	33	SENT_35	[p2l1760t24r2128b119],
10	,	,	O	,	_	0	SENT_35	[p2l1760t24r2128b119],
11	involving	VBG	O	involve	_	0	SENT_35	[p2l11t151r407b252],
12	the	DT	O	the	det	18	SENT_35	[p2l448t151r581b230],
13	hepatic	JJ	O	hepatic	amod	18	SENT_35	[p2l625t151r936b252],
14	cytochrome	NN	O	cytochrome	nn	18	SENT_35	[p2l980t151r1485b252],
15	P	NN	O	p	nn	18	SENT_35	[p2l1529t157r1767b230],
16	—	CD	NUMBER	—	num	18	SENT_35	[p2l1529t157r1767b230],
17	45O	NN	O	45o	nn	18	SENT_35	[p2l1529t157r1767b230],
18	system	NN	O	system	prep_involving	9	SENT_35	[p2l1813t168r2128b252],
19	,	,	O	,	_	0	SENT_35	[p2l1813t168r2128b252],
20	that	WDT	O	that	nsubjpass	22	SENT_35	[p2l12t279r184b358],
21	are	VBP	O	be	auxpass	22	SENT_35	[p2l212t305r340b358],
22	involved	VBN	O	involve	rcmod	18	SENT_35	[p2l373t279r725b358],
23	in	IN	O	in	_	0	SENT_35	[p2l757t280r840b357],
24	the	DT	O	the	det	25	SENT_35	[p2l875t279r1007b358],
25	conversion	NN	O	conversion	prep_in	22	SENT_35	[p2l1041t280r1502b359],
26	of	IN	O	of	_	0	SENT_35	[p2l1536t279r1636b358],
27	clopidogrel	NN	O	clopidogrel	prep_of	25	SENT_35	[p2l1652t279r2134b380],
28	to	TO	O	to	_	0	SENT_35	[p2l12t425r93b487],
29	its	PRP$	O	its	poss	31	SENT_35	[p2l147t409r246b487],
30	active	JJ	O	active	amod	31	SENT_35	[p2l301t409r541b487],
31	metabolite	NN	O	metabolite	prep_to	22	SENT_35	[p2l595t408r1053b487],
32	are	VBP	O	be	auxpass	33	SENT_35	[p2l1106t435r1235b487],
33	associated	VBN	O	associate	ccomp	4	SENT_35	[p2l1289t408r1733b487],
34	with	IN	O	with	_	0	SENT_35	[p2l1782t408r1977b487],
35	an	DT	O	a	det	37	SENT_35	[p2l2030t434r2133b487],
36	increased	VBN	O	increase	amod	37	SENT_35	[p2l11t535r419b613],
37	rate	NN	O	rate	prep_with	33	SENT_35	[p2l450t552r610b613],
38	of	IN	O	of	_	0	SENT_35	[p2l643t535r742b613],
39	recurrent	JJ	O	recurrent	amod	41	SENT_35	[p2l756t552r1155b614],
40	cardiovascular	JJ	O	cardiovascular	amod	41	SENT_35	[p2l1183t535r1810b614],
41	events	NNS	O	event	prep_of	37	SENT_35	[p2l1840t552r2127b630],
42	,	,	O	,	_	0	SENT_35	[p2l1840t552r2127b630],
43	implying	VBG	O	imply	xcomp	4	SENT_35	[p2l11t663r395b764],
44	that	IN	O	that	complm	51	SENT_35	[p2l429t663r601b742],
45	the	DT	O	the	det	46	SENT_35	[p2l633t663r766b742],
46	benefits	NNS	O	benefit	nsubjpass	51	SENT_35	[p2l804t663r1147b742],
47	of	IN	O	of	_	0	SENT_35	[p2l1187t663r1287b742],
48	clopidogrel	NN	O	clopidogrel	prep_of	46	SENT_35	[p2l1306t663r1788b764],
49	may	MD	O	may	aux	51	SENT_35	[p2l1825t689r2004b764],
50	be	VB	O	be	auxpass	51	SENT_35	[p2l2037t663r2133b742],
51	attenuated	VBN	O	attenuate	ccomp	43	SENT_35	[p2l11t791r463b870],
52	in	IN	O	in	_	0	SENT_35	[p2l518t792r602b869],
53	patients	NNS	O	patient	prep_in	51	SENT_35	[p2l656t792r998b892],
54	with	IN	O	with	_	0	SENT_35	[p2l1051t791r1246b870],
55	these	DT	O	these	det	57	SENT_35	[p2l1302t791r1526b870],
56	genetic	JJ	O	genetic	amod	57	SENT_35	[p2l1582t792r1890b892],
57	variants	NNS	O	variant	prep_with	53	SENT_35	[p2l1941t792r2132b870, p2l11t936r212b998],
58	.	.	O	.	_	0	SENT_35	[p2l1941t792r2132b870, p2l11t936r212b998],

1	Specifically	RB	O	specifically	advmod	38	SENT_36	[p2l257t919r764b1020],
2	,	,	O	,	_	0	SENT_36	[p2l257t919r764b1020],
3	in	IN	O	in	_	0	SENT_36	[p2l806t920r890b997],
4	patients	NNS	O	patient	prep_in	38	SENT_36	[p2l925t920r1266b1020],
5	who	WP	O	who	nsubj	7	SENT_36	[p2l1301t919r1484b999],
6	are	VBP	O	be	cop	7	SENT_36	[p2l1521t945r1649b998],
7	carriers	NNS	O	carrier	rcmod	4	SENT_36	[p2l1688t920r2012b998],
8	of	IN	O	of	_	0	SENT_36	[p2l2051t919r2151b998],
9	a	DT	O	a	det	11	SENT_36	[p2l11t1074r55b1126],
10	loss	NN	O	loss	nn	11	SENT_36	[p2l103t1047r790b1126],
11	—	NN	O	—	prep_of	7	SENT_36	[p2l103t1047r790b1126],
12	of	IN	O	of	_	0	SENT_36	[p2l103t1047r790b1126],
13	—	CD	NUMBER	—	num	16	SENT_36	[p2l103t1047r790b1126],
14	function	NN	O	function	nn	16	SENT_36	[p2l103t1047r790b1126],
15	CYPZCI9	NN	O	cypzci9	nn	16	SENT_36	[p2l840t1054r1185b1126],
16	allele	NN	O	allele	prep_of	11	SENT_36	[p2l1235t1047r1458b1126],
17	(	CD	NUMBER	(	nsubj	26	SENT_36	[p2l1514t1047r1952b1148],
18	including	VBG	O	include	_	0	SENT_36	[p2l1514t1047r1952b1148],
19	the	DT	O	the	det	20	SENT_36	[p2l2001t1047r2133b1126],
20	*	NN	O	*	prep_including	17	SENT_36	[p2l9t1175r108b1253],
21	2	CD	NUMBER	2	dep	20	SENT_36	[p2l9t1175r108b1253],
22	and	CC	O	and	_	0	SENT_36	[p2l150t1175r308b1254],
23	*	CD	NUMBER	*	number	24	SENT_36	[p2l346t1175r443b1254],
24	3	CD	NUMBER	3	num	25	SENT_36	[p2l346t1175r443b1254],
25	alleles	NNS	O	allele	conj_and	20	SENT_36	[p2l488t1175r803b1271],
26	)	RB	O	)	rcmod	16	SENT_36	[p2l488t1175r803b1271],
27	,	,	O	,	_	0	SENT_36	[p2l488t1175r803b1271],
28	the	DT	O	the	det	29	SENT_36	[p2l850t1175r983b1254],
29	conversion	NN	O	conversion	nsubjpass	38	SENT_36	[p2l1026t1176r1486b1254],
30	of	IN	O	of	_	0	SENT_36	[p2l1528t1175r1627b1254],
31	clopidogrel	NN	O	clopidogrel	prep_of	29	SENT_36	[p2l1651t1175r2133b1276],
32	to	TO	O	to	_	0	SENT_36	[p2l11t1320r92b1382],
33	its	PRP$	O	its	poss	35	SENT_36	[p2l125t1304r224b1382],
34	active	JJ	O	active	amod	35	SENT_36	[p2l257t1304r497b1382],
35	metabolite	NN	O	metabolite	prep_to	31	SENT_36	[p2l529t1303r986b1382],
36	may	MD	O	may	aux	38	SENT_36	[p2l1018t1329r1198b1404],
37	be	VB	O	be	auxpass	38	SENT_36	[p2l1226t1303r1321b1382],
38	reduced	VBN	O	reduce	_	0	SENT_36	[p2l1353t1303r1712b1399],
39	,	,	O	,	_	0	SENT_36	[p2l1353t1303r1712b1399],
40	resulting	VBG	O	result	xcomp	38	SENT_36	[p2l1749t1303r2136b1404],
41	in	IN	O	in	_	0	SENT_36	[p2l10t1432r94b1509],
42	decreased	VBN	O	decrease	amod	43	SENT_36	[p2l123t1431r545b1510],
43	inhibition	NN	O	inhibition	prep_in	40	SENT_36	[p2l573t1431r1002b1510],
44	of	IN	O	of	_	0	SENT_36	[p2l1032t1431r1132b1510],
45	platelets	NNS	O	platelet	prep_of	43	SENT_36	[p2l1141t1431r1524b1532],
46	.	.	O	.	_	0	SENT_36	[p2l1141t1431r1524b1532],

1	Analyses	NNS	O	analysis	nsubj	61	SENT_37	[p2l1555t1431r1934b1532],
2	that	WDT	O	that	nsubjpass	4	SENT_37	[p2l1966t1431r2138b1510],
3	were	VBD	O	be	auxpass	4	SENT_37	[p2l7t1585r208b1638],
4	limited	VBN	O	limit	rcmod	1	SENT_37	[p2l239t1559r548b1638],
5	to	TO	O	to	_	0	SENT_37	[p2l581t1576r661b1638],
6	data	NNS	O	datum	prep_to	4	SENT_37	[p2l696t1559r879b1638],
7	from	IN	O	from	_	0	SENT_37	[p2l910t1559r1120b1638],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_37	[p2l1152t1559r1969b1660],
9	—	NN	O	—	prep_from	4	SENT_37	[p2l1152t1559r1969b1660],
10	treated	VBN	O	treat	partmod	9	SENT_37	[p2l1152t1559r1969b1660],
11	patients	NNS	O	patient	nsubj	12	SENT_37	[p2l2000t1585r2132b1660, p2l11t1688r247b1766],
12	showed	VBD	O	show	ccomp	10	SENT_37	[p2l292t1687r614b1766],
13	a	DT	O	a	det	15	SENT_37	[p2l654t1714r698b1766],
14	relative	JJ	O	relative	amod	15	SENT_37	[p2l737t1687r1045b1767],
15	risk	NN	O	risk	nsubj	19	SENT_37	[p2l1086t1687r1249b1767],
16	of	IN	O	of	_	0	SENT_37	[p2l1286t1687r1386b1766],
17	major	JJ	O	major	amod	18	SENT_37	[p2l1408t1688r1658b1788],
18	cardiovas	NNS	O	cardiova	prep_of	15	SENT_37	[p2l1696t1687r2132b1766],
19	—	VBP	O	—	ccomp	12	SENT_37	[p2l1696t1687r2132b1766],
20	cular	JJ	O	cular	amod	21	SENT_37	[p2l12t1815r229b1894],
21	events	NNS	O	event	dobj	19	SENT_37	[p2l256t1832r519b1894],
22	that	WDT	O	that	nsubjpass	24	SENT_37	[p2l551t1815r724b1894],
23	was	VBD	O	be	auxpass	24	SENT_37	[p2l743t1842r906b1894],
24	increased	VBN	O	increase	rcmod	21	SENT_37	[p2l937t1815r1346b1894],
25	by	IN	O	by	_	0	SENT_37	[p2l1375t1815r1472b1916],
26	a	DT	O	a	det	27	SENT_37	[p2l1497t1842r1541b1894],
27	factor	NN	O	factor	agent	24	SENT_37	[p2l1569t1815r1819b1894],
28	of	IN	O	of	_	0	SENT_37	[p2l1846t1815r1946b1894],
29	1.53	CD	NUMBER	1.53	number	31	SENT_37	[p2l1961t1821r2130b1894],
30	to	TO	O	to	dep	31	SENT_37	[p2l11t1960r92b2022],
31	3.69	CD	NUMBER	3.69	prep_of	27	SENT_37	[p2l124t1949r300b2022],
32	among	IN	O	among	_	0	SENT_37	[p2l329t1969r629b2044],
33	carriers	NNS	O	carrier	prep_among	24	SENT_37	[p2l656t1944r981b2022],
34	of	IN	O	of	_	0	SENT_37	[p2l1013t1943r1112b2022],
35	loss	NN	O	loss	nn	36	SENT_37	[p2l1122t1943r1809b2022],
36	—	NN	O	—	prep_of	33	SENT_37	[p2l1122t1943r1809b2022],
37	of	IN	O	of	_	0	SENT_37	[p2l1122t1943r1809b2022],
38	—	CD	NUMBER	—	num	40	SENT_37	[p2l1122t1943r1809b2022],
39	function	NN	O	function	nn	40	SENT_37	[p2l1122t1943r1809b2022],
40	alleles	NNS	O	allele	prep_of	36	SENT_37	[p2l1837t1943r2127b2039],
41	,	,	O	,	_	0	SENT_37	[p2l1837t1943r2127b2039],
42	as	IN	O	as	_	0	SENT_37	[p2l10t2098r96b2150],
43	compared	VBN	O	compare	prepc_as	24	SENT_37	[p2l133t2071r559b2172],
44	with	IN	O	with	pcomp	43	SENT_37	[p2l589t2071r784b2150],
45	noncarriers	NNS	O	noncarrier	nn	46	SENT_37	[p2l819t2072r1436b2150],
46	.3	NN	NUMBER	.3	pobj	44	SENT_37	[p2l819t2072r1436b2150],
47	'	''	O	'	_	0	SENT_37	[p2l819t2072r1436b2150],
48	5	CD	NUMBER	5	dep	12	SENT_37	[p2l819t2072r1436b2150],
49	On	IN	O	on	dep	48	SENT_37	[p2l1474t2077r1600b2150],
50	the	DT	O	the	det	51	SENT_37	[p2l1635t2071r1768b2150],
51	basis	NN	O	basis	pobj	49	SENT_37	[p2l1804t2071r2014b2150],
52	of	IN	O	of	_	0	SENT_37	[p2l2052t2071r2152b2150],
53	these	DT	O	these	det	54	SENT_37	[p2l12t2199r234b2278],
54	findings	NNS	O	finding	prep_of	51	SENT_37	[p2l274t2199r638b2300],
55	and	CC	O	and	_	0	SENT_37	[p2l678t2199r836b2278],
56	related	JJ	O	related	amod	60	SENT_37	[p2l875t2199r1167b2278],
57	pharmacokinetic	JJ	O	pharmacokinetic	amod	60	SENT_37	[p2l1204t2199r1938b2300],
58	and	CC	O	and	_	0	SENT_37	[p2l1975t2199r2133b2278],
59	pharmacodynamic	JJ	O	pharmacodynamic	amod	60	SENT_37	[p2l10t2327r820b2428],
60	data	NNS	O	datum	conj_and	51	SENT_37	[p2l859t2327r1042b2406],
61	(	VBP	O	(	_	0	SENT_37	[p2l1083t2327r1870b2428],
62	ClinicalTrials	NNS	O	clinicaltrial	dobj	61	SENT_37	[p2l1083t2327r1870b2428],
63	.	.	O	.	_	0	SENT_37	[p2l1083t2327r1870b2428],

1	gov	NN	O	gov	nn	2	SENT_38	[p2l1083t2327r1870b2428],
2	number	NN	O	number	nsubj	16	SENT_38	[p2l1905t2353r2132b2406, p2l12t2455r167b2551],
3	,	,	O	,	_	0	SENT_38	[p2l1905t2353r2132b2406, p2l12t2455r167b2551],
4	NCTO1123824	NN	O	ncto1123824	nn	5	SENT_38	[p2l199t2461r864b2551],
5	)	NN	O	)	appos	2	SENT_38	[p2l199t2461r864b2551],
6	,	,	O	,	_	0	SENT_38	[p2l199t2461r864b2551],
7	the	DT	O	the	det	8	SENT_38	[p2l898t2455r1031b2534],
8	Food	NNP	ORGANIZATION	Food	appos	5	SENT_38	[p2l1058t2455r1273b2534],
9	and	CC	ORGANIZATION	and	_	0	SENT_38	[p2l1301t2455r1458b2534],
10	Drug	NNP	ORGANIZATION	Drug	nn	14	SENT_38	[p2l1486t2462r1707b2556],
11	Administration	NNP	ORGANIZATION	Administration	nn	14	SENT_38	[p2l1729t2455r2132b2534, p2l12t2584r301b2662],
12	(	CD	NUMBER	(	num	14	SENT_38	[p2l367t2590r604b2675],
13	FDA	NNP	ORGANIZATION	FDA	nn	14	SENT_38	[p2l367t2590r604b2675],
14	)	NN	O	)	appos	5	SENT_38	[p2l367t2590r604b2675],
15	has	VBZ	O	have	aux	16	SENT_38	[p2l670t2583r814b2662],
16	issued	VBN	O	issue	_	0	SENT_38	[p2l876t2583r1144b2662],
17	a	DT	O	a	det	18	SENT_38	[p2l1204t2610r1248b2662],
18	blacl	NN	O	blacl	nsubj	19	SENT_38	[p2l1307t2583r1718b2663],
19	<	JJR	O	<	xcomp	16	SENT_38	[p2l1307t2583r1718b2663],
20	.	.	O	.	_	0	SENT_38	[p2l1307t2583r1718b2663],

1	—	NN	O	—	_	0	SENT_39	[p2l1307t2583r1718b2663],
2	.	.	O	.	_	0	SENT_39	[p2l1307t2583r1718b2663],

1	boX	NN	O	box	nn	2	SENT_40	[p2l1307t2583r1718b2663],
2	Warning	NN	O	warning	nsubj	22	SENT_40	[p2l1771t2584r2137b2684],
3	about	IN	O	about	_	0	SENT_40	[p2l11t2711r254b2790],
4	the	DT	O	the	det	6	SENT_40	[p2l286t2711r419b2790],
5	reduced	VBN	O	reduce	amod	6	SENT_40	[p2l455t2711r791b2790],
6	effectiveness	NN	O	effectiveness	prep_about	2	SENT_40	[p2l828t2711r1375b2790],
7	of	IN	O	of	_	0	SENT_40	[p2l1414t2711r1514b2790],
8	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_40	[p2l1533t2711r2015b2812],
9	in	IN	O	in	_	0	SENT_40	[p2l2050t2712r2133b2789],
10	patients	NNS	O	patient	prep_in	8	SENT_40	[p2l10t2840r351b2940],
11	who	WP	O	who	nsubj	13	SENT_40	[p2l385t2839r568b2919],
12	are	VBP	O	be	cop	13	SENT_40	[p2l605t2865r733b2918],
13	carriers	NNS	O	carrier	rcmod	10	SENT_40	[p2l771t2840r1096b2918],
14	of	IN	O	of	_	0	SENT_40	[p2l1134t2839r1234b2918],
15	two	CD	NUMBER	two	num	17	SENT_40	[p2l1253t2856r1410b2918],
16	loss	NN	O	loss	nn	17	SENT_40	[p2l1446t2839r2133b2918],
17	—	NN	O	—	prep_of	13	SENT_40	[p2l1446t2839r2133b2918],
18	of	IN	O	of	_	0	SENT_40	[p2l1446t2839r2133b2918],
19	—	CD	NUMBER	—	num	21	SENT_40	[p2l1446t2839r2133b2918],
20	function	NN	O	function	nn	21	SENT_40	[p2l1446t2839r2133b2918],
21	alleles	NNS	O	allele	prep_of	17	SENT_40	[p2l11t2967r276b3046],
22	(	VBP	O	(	_	0	SENT_40	[p2l353t2967r764b3059],
23	so	RB	O	so	advmod	25	SENT_40	[p2l353t2967r764b3059],
24	—	RB	O	—	advmod	25	SENT_40	[p2l353t2967r764b3059],
25	called	VBN	O	call	ccomp	22	SENT_40	[p2l353t2967r764b3059],
26	poor	JJ	O	poor	amod	28	SENT_40	[p2l832t2993r1035b3068],
27	metabolizers	NNS	O	metabolizer	nn	28	SENT_40	[p2l1102t2967r1685b3059],
28	)	NN	O	)	dobj	25	SENT_40	[p2l1102t2967r1685b3059],
29	and	CC	O	and	_	0	SENT_40	[p2l1760t2967r1918b3046],
30	has	VBZ	O	have	aux	31	SENT_40	[p2l1987t2967r2131b3046],
31	suggested	VBN	O	suggest	conj_and	22	SENT_40	[p2l13t3095r439b3196],
32	that	IN	O	that	complm	37	SENT_40	[p2l481t3095r654b3174],
33	carriers	NNS	O	carrier	nsubj	37	SENT_40	[p2l692t3096r1016b3174],
34	of	IN	O	of	_	0	SENT_40	[p2l1061t3095r1161b3174],
35	these	DT	O	these	det	36	SENT_40	[p2l1185t3095r1408b3174],
36	alleles	NNS	O	allele	prep_of	33	SENT_40	[p2l1450t3095r1715b3174],
37	receive	VBP	O	receive	ccomp	31	SENT_40	[p2l1760t3096r2049b3174],
38	a	DT	O	a	det	40	SENT_40	[p2l2090t3122r2135b3174],
39	higher	JJR	O	higher	amod	40	SENT_40	[p2l11t3223r292b3324],
40	dose	NN	O	dose	dobj	37	SENT_40	[p2l325t3223r519b3302],
41	of	IN	O	of	_	0	SENT_40	[p2l555t3223r655b3302],
42	clopidogrel	NN	O	clopidogrel	prep_of	40	SENT_40	[p2l673t3223r1155b3324],
43	or	CC	O	or	_	0	SENT_40	[p2l1191t3249r1280b3302],
44	an	DT	O	a	det	47	SENT_40	[p2l1312t3249r1415b3302],
45	alternative	JJ	O	alternative	amod	47	SENT_40	[p2l1450t3223r1900b3302],
46	antiplatelet	JJ	O	antiplatelet	amod	47	SENT_40	[p2l1935t3224r2132b3302, p2l10t3351r328b3452],
47	agent	NN	O	agent	prep_of	40	SENT_40	[p2l357t3368r614b3452],
48	.	.	O	.	_	0	SENT_40	[p2l357t3368r614b3452],

1	Conversely	RB	O	conversely	dep	15	SENT_41	[p2l140t3479r617b3580],
2	,	,	O	,	_	0	SENT_41	[p2l140t3479r617b3580],
3	carriers	NNS	O	carrier	dep	9	SENT_41	[p2l666t3480r990b3558],
4	of	IN	O	of	_	0	SENT_41	[p2l1035t3479r1136b3558],
5	the	DT	O	the	det	7	SENT_41	[p2l1160t3479r1292b3558],
6	ultrarapid	JJ	O	ultrarapid	amod	7	SENT_41	[p2l1334t3479r1760b3580],
7	enzyme	NN	O	enzyme	prep_of	3	SENT_41	[p2l1804t3505r2133b3580],
8	activity	NN	O	activity	dep	9	SENT_41	[p2l11t3608r327b3708],
9	allele	NN	O	allele	dep	15	SENT_41	[p2l370t3607r598b3686],
10	*	CD	NUMBER	*	dep	9	SENT_41	[p2l644t3607r795b3686],
11	17	CD	NUMBER	17	num	12	SENT_41	[p2l644t3607r795b3686],
12	(	NN	O	(	nsubj	15	SENT_41	[p2l849t3607r1270b3699],
13	so	RB	O	so	advmod	15	SENT_41	[p2l849t3607r1270b3699],
14	—	RB	O	—	advmod	15	SENT_41	[p2l849t3607r1270b3699],
15	called	VBN	O	call	_	0	SENT_41	[p2l849t3607r1270b3699],
16	ultrametabolizers	NNS	O	ultrametabolizer	dobj	15	SENT_41	[p2l1317t3607r2128b3698],
17	)	IN	O	)	prep	15	SENT_41	[p2l1317t3607r2128b3698],

1	have	VB	O	have	ccomp	33	SENT_42	[p3l11t20r197b99],
2	an	DT	O	a	det	5	SENT_42	[p3l231t46r332b99],
3	increased	VBN	O	increase	amod	5	SENT_42	[p3l366t20r766b99],
4	platelet	NN	O	platelet	nn	5	SENT_42	[p3l799t20r1109b121],
5	response	NN	O	response	dobj	1	SENT_42	[p3l1138t46r1511b121],
6	to	TO	O	to	_	0	SENT_42	[p3l1546t37r1626b99],
7	clopidogrel	NN	O	clopidogrel	prep_to	5	SENT_42	[p3l1662t20r2134b121],
8	and	CC	O	and	_	0	SENT_42	[p3l11t148r168b227],
9	an	DT	O	a	det	11	SENT_42	[p3l204t174r307b227],
10	increased	VBN	O	increase	amod	11	SENT_42	[p3l342t148r751b227],
11	risk	NN	O	risk	dobj	1	SENT_42	[p3l787t148r951b228],
12	of	IN	O	of	_	0	SENT_42	[p3l984t148r1084b227],
13	bleeding	VBG	O	bleed	prepc_of	11	SENT_42	[p3l1102t148r1474b249],
14	(	NN	O	(	dobj	13	SENT_42	[p3l1512t148r1681b240],
15	but	CC	O	but	_	0	SENT_42	[p3l1512t148r1681b240],
16	not	RB	O	not	_	0	SENT_42	[p3l1713t165r1856b227],
17	greater	JJR	O	greater	amod	18	SENT_42	[p3l1887t165r2132b249, p3l12t303r92b355],
18	eff1cacy	NN	O	eff1cacy	dobj	13	SENT_42	[p3l119t276r534b377],
19	)	CD	NUMBER	)	number	20	SENT_42	[p3l119t276r534b377],
20	.6	CD	NUMBER	.6	dep	18	SENT_42	[p3l119t276r534b377],
21	However	RB	O	however	advmod	13	SENT_42	[p3l564t284r951b372],
22	,	,	O	,	_	0	SENT_42	[p3l564t284r951b372],
23	observational	JJ	O	observational	amod	24	SENT_42	[p3l988t276r1556b356],
24	analyses	NNS	O	analysis	nsubjpass	33	SENT_42	[p3l1586t276r1937b377],
25	that	WDT	O	that	nsubj	28	SENT_42	[p3l1970t276r2139b355],
26	do	VBP	O	do	aux	28	SENT_42	[p3l12t404r116b483],
27	not	RB	O	not	neg	28	SENT_42	[p3l163t421r307b483],
28	include	VB	O	include	rcmod	24	SENT_42	[p3l347t404r664b483],
29	untreated	JJ	O	untreated	amod	30	SENT_42	[p3l710t404r1131b483],
30	controls	NNS	O	control	dobj	28	SENT_42	[p3l1177t404r1532b483],
31	may	MD	O	may	aux	33	SENT_42	[p3l1579t430r1760b505],
32	be	VB	O	be	auxpass	33	SENT_42	[p3l1802t404r1899b483],
33	confounded	VBN	O	confound	_	0	SENT_42	[p3l1946t430r2132b483, p3l11t532r366b611],
34	by	IN	O	by	_	0	SENT_42	[p3l402t532r499b633],
35	other	JJ	O	other	amod	36	SENT_42	[p3l531t532r758b611],
36	factors	NNS	O	factor	agent	33	SENT_42	[p3l791t532r1106b611],
37	.	.	O	.	_	0	SENT_42	[p3l791t532r1106b611],

1	For	IN	O	for	_	0	SENT_43	[p3l1146t540r1289b611],
2	example	NN	O	example	prep_for	9	SENT_43	[p3l1322t532r1701b633],
3	,	,	O	,	_	0	SENT_43	[p3l1322t532r1701b633],
4	the	DT	O	the	det	7	SENT_43	[p3l1743t532r1875b611],
5	same	JJ	O	same	amod	7	SENT_43	[p3l1913t558r2133b611],
6	genetic	JJ	O	genetic	amod	7	SENT_43	[p3l11t661r326b761],
7	marker	NN	O	marker	nsubj	9	SENT_43	[p3l392t660r709b740],
8	may	MD	O	may	aux	9	SENT_43	[p3l772t686r954b761],
9	have	VB	O	have	_	0	SENT_43	[p3l1016t660r1209b739],
10	pleiotropic	JJ	O	pleiotropic	amod	11	SENT_43	[p3l1275t660r1747b761],
11	effects	NNS	O	effect	dobj	9	SENT_43	[p3l1815t660r2128b756],
12	,	,	O	,	_	0	SENT_43	[p3l1815t660r2128b756],
13	which	WDT	O	which	nsubj	14	SENT_43	[p3l7t788r273b868],
14	influence	VBP	O	influence	rcmod	11	SENT_43	[p3l311t788r723b867],
15	the	DT	O	the	det	16	SENT_43	[p3l762t788r897b867],
16	metabolism	NN	O	metabolism	dobj	14	SENT_43	[p3l935t788r1456b867],
17	of	IN	O	of	_	0	SENT_43	[p3l1494t788r1595b867],
18	drugs	NNS	O	drug	prep_of	16	SENT_43	[p3l1615t788r1863b889],
19	other	JJ	O	other	dep	18	SENT_43	[p3l1904t788r2136b867],
20	than	IN	O	than	_	0	SENT_43	[p3l12t916r205b995],
21	clopidogrel	NN	O	clopidogrel	prep_than	18	SENT_43	[p3l237t916r730b1017],
22	,	,	O	,	_	0	SENT_43	[p3l237t916r730b1017],
23	or	CC	O	or	_	0	SENT_43	[p3l768t942r855b995],
24	may	MD	O	may	aux	25	SENT_43	[p3l884t942r1060b1017],
25	affect	VB	O	affect	conj_or	14	SENT_43	[p3l1086t916r1327b995],
26	outcomes	NNS	O	outcome	dobj	25	SENT_43	[p3l1354t933r1757b995],
27	through	IN	O	through	_	0	SENT_43	[p3l1792t916r2133b1017],
28	independent	JJ	O	independent	amod	29	SENT_43	[p3l11t1044r559b1145],
29	mechanisms	NNS	O	mechanism	prep_through	25	SENT_43	[p3l605t1044r1158b1123],
30	such	JJ	O	such	_	0	SENT_43	[p3l1212t1044r1409b1123],
31	as	IN	O	as	_	0	SENT_43	[p3l1459t1071r1545b1123],
32	linkage	NN	O	linkage	nn	33	SENT_43	[p3l1597t1044r1921b1145],
33	disequilibrium	NN	O	disequilibrium	prep_such_as	29	SENT_43	[p3l1973t1044r2132b1123, p3l12t1172r529b1273],
34	with	IN	O	with	mark	39	SENT_43	[p3l572t1172r770b1252],
35	other	JJ	O	other	amod	38	SENT_43	[p3l818t1172r1049b1251],
36	nearby	JJ	O	nearby	amod	38	SENT_43	[p3l1093t1172r1389b1273],
37	CYP	NN	O	cyp	nn	38	SENT_43	[p3l1431t1179r1586b1250],
38	genes	NNS	O	gene	nsubj	39	SENT_43	[p3l1628t1198r1875b1273],
39	(	VBP	O	(	advcl	25	SENT_43	[p3l1928t1179r2128b1273],
40	e.g.	FW	O	e.g.	dobj	39	SENT_43	[p3l1928t1179r2128b1273],
41	,	,	O	,	_	0	SENT_43	[p3l1928t1179r2128b1273],
42	CYPZC9	NN	O	cypzc9	dobj	39	SENT_43	[p3l11t1307r318b1396],
43	,	,	O	,	_	0	SENT_43	[p3l11t1307r318b1396],
44	CYP2C18	NN	O	cyp2c18	dobj	39	SENT_43	[p3l360t1307r715b1396],
45	,	,	O	,	_	0	SENT_43	[p3l360t1307r715b1396],
46	and	CC	O	and	_	0	SENT_43	[p3l757t1300r913b1379],
47	CYPZC8	NN	O	cypzc8	nn	48	SENT_43	[p3l949t1307r1291b1391],
48	)	NN	O	)	dobj	39	SENT_43	[p3l949t1307r1291b1391],
49	.	.	O	.	_	0	SENT_43	[p3l949t1307r1291b1391],

1	To	TO	O	to	aux	2	SENT_44	[p3l1329t1306r1433b1379],
2	reduce	VB	O	reduce	purpcl	21	SENT_44	[p3l1471t1300r1746b1379],
3	the	DT	O	the	det	4	SENT_44	[p3l1783t1300r1913b1379],
4	possibility	NN	O	possibility	dobj	2	SENT_44	[p3l1948t1326r2132b1401, p3l13t1428r304b1529],
5	of	IN	O	of	_	0	SENT_44	[p3l332t1428r432b1507],
6	confounding	NN	O	confounding	prep_of	4	SENT_44	[p3l447t1428r1022b1529],
7	,	,	O	,	_	0	SENT_44	[p3l447t1428r1022b1529],
8	an	DT	O	a	det	9	SENT_44	[p3l1059t1454r1162b1507],
9	evaluation	NN	O	evaluation	nsubjpass	21	SENT_44	[p3l1195t1428r1636b1507],
10	of	IN	O	of	_	0	SENT_44	[p3l1669t1428r1769b1507],
11	a	DT	O	a	det	13	SENT_44	[p3l1783t1455r1827b1507],
12	potential	JJ	O	potential	amod	13	SENT_44	[p3l1856t1445r2132b1529, p3l12t1556r150b1635],
13	interaction	NN	O	interaction	prep_of	9	SENT_44	[p3l187t1557r655b1635],
14	between	IN	O	between	_	0	SENT_44	[p3l693t1556r1051b1635],
15	genotype	NN	O	genotype	prep_between	13	SENT_44	[p3l1088t1573r1482b1657],
16	and	CC	O	and	_	0	SENT_44	[p3l1520t1556r1677b1635],
17	treatment	NN	O	treatment	prep_between	13	SENT_44	[p3l1716t1573r2139b1635],
18	should	MD	O	should	aux	21	SENT_44	[p3l13t1684r300b1763],
19	ideally	RB	O	ideally	advmod	21	SENT_44	[p3l332t1684r614b1785],
20	be	VB	O	be	auxpass	21	SENT_44	[p3l643t1684r740b1763],
21	conducted	VBN	O	conduct	_	0	SENT_44	[p3l773t1684r1215b1763],
22	as	IN	O	as	_	0	SENT_44	[p3l1247t1711r1332b1763],
23	part	NN	O	part	prep_as	21	SENT_44	[p3l1366t1701r1546b1785],
24	of	IN	O	of	_	0	SENT_44	[p3l1574t1684r1674b1763],
25	a	DT	O	a	prep_of	23	SENT_44	[p3l1688t1711r1732b1763],
26	randomized	VBN	O	randomize	partmod	25	SENT_44	[p3l1764t1684r2132b1763, p3l11t1812r211b1908],
27	,	,	O	,	_	0	SENT_44	[p3l1764t1684r2132b1763, p3l11t1812r211b1908],
28	controlled	VBN	O	control	dep	26	SENT_44	[p3l259t1812r696b1891],
29	trial	NN	O	trial	dobj	26	SENT_44	[p3l738t1812r939b1908],
30	,	,	O	,	_	0	SENT_44	[p3l738t1812r939b1908],
31	because	IN	O	because	mark	47	SENT_44	[p3l987t1812r1323b1891],
32	any	DT	O	any	det	33	SENT_44	[p3l1365t1838r1515b1913],
33	heterogeneity	NN	O	heterogeneity	nsubjpass	47	SENT_44	[p3l1552t1812r2138b1913],
34	in	IN	O	in	_	0	SENT_44	[p3l11t1941r94b2018],
35	event	NN	O	event	nn	36	SENT_44	[p3l128t1957r352b2019],
36	rates	NNS	O	rate	prep_in	33	SENT_44	[p3l380t1957r582b2019],
37	among	IN	O	among	_	0	SENT_44	[p3l617t1966r917b2041],
38	carriers	NNS	O	carrier	prep_among	36	SENT_44	[p3l948t1941r1272b2019],
39	that	WDT	O	that	nsubj	41	SENT_44	[p3l1308t1940r1480b2019],
40	is	VBZ	O	be	cop	41	SENT_44	[p3l1508t1941r1573b2019],
41	unrelated	JJ	O	unrelated	rcmod	38	SENT_44	[p3l1609t1940r2017b2019],
42	to	TO	O	to	_	0	SENT_44	[p3l2050t1957r2132b2019],
43	clopidogrel	NN	O	clopidogrel	prep_to	41	SENT_44	[p3l12t2068r495b2169],
44	will	MD	O	will	aux	47	SENT_44	[p3l537t2068r701b2147],
45	then	RB	O	then	advmod	47	SENT_44	[p3l747t2068r938b2147],
46	be	VB	O	be	auxpass	47	SENT_44	[p3l986t2068r1082b2147],
47	paralleled	VBN	O	parallel	advcl	26	SENT_44	[p3l1128t2068r1553b2169],
48	by	IN	O	by	_	0	SENT_44	[p3l1601t2068r1698b2169],
49	a	DT	O	a	det	51	SENT_44	[p3l1739t2095r1784b2147],
50	similar	JJ	O	similar	amod	51	SENT_44	[p3l1831t2068r2137b2147],
51	effect	NN	O	effect	agent	47	SENT_44	[p3l12t2196r254b2275],
52	on	IN	O	on	_	0	SENT_44	[p3l297t2222r402b2275],
53	event	NN	O	event	nn	54	SENT_44	[p3l451t2213r674b2275],
54	rates	NNS	O	rate	prep_on	51	SENT_44	[p3l716t2213r919b2275],
55	among	IN	O	among	_	0	SENT_44	[p3l968t2222r1267b2297],
56	controls	NNS	O	control	prep_among	47	SENT_44	[p3l1312t2196r1659b2275],
57	who	WP	O	who	nsubjpass	60	SENT_44	[p3l1704t2196r1887b2275],
58	were	VBD	O	be	auxpass	60	SENT_44	[p3l1931t2223r2133b2275],
59	not	RB	O	not	neg	60	SENT_44	[p3l11t2341r154b2403],
60	treated	VBN	O	treat	rcmod	56	SENT_44	[p3l189t2324r487b2403],
61	with	IN	O	with	_	0	SENT_44	[p3l522t2324r717b2403],
62	clopidogrel	NN	O	clopidogrel	prep_with	60	SENT_44	[p3l757t2324r1262b2425],
63	.	.	O	.	_	0	SENT_44	[p3l757t2324r1262b2425],

1	We	PRP	O	we	nsubj	2	SENT_45	[p3l136t2460r269b2531],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_45	[p3l314t2452r888b2553],
3	that	IN	O	that	complm	15	SENT_45	[p3l933t2452r1105b2531],
4	the	DT	O	the	det	5	SENT_45	[p3l1146t2452r1278b2531],
5	benefits	NNS	O	benefit	nsubj	15	SENT_45	[p3l1324t2452r1667b2531],
6	of	IN	O	of	_	0	SENT_45	[p3l1715t2452r1815b2531],
7	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_45	[p3l1842t2452r2132b2553, p3l12t2580r230b2681],
8	as	IN	O	as	_	0	SENT_45	[p3l283t2606r369b2658],
9	compared	VBN	O	compare	prepc_as	7	SENT_45	[p3l426t2580r852b2680],
10	with	IN	O	with	pcomp	9	SENT_45	[p3l902t2580r1097b2659],
11	placebo	NN	O	placebo	pobj	10	SENT_45	[p3l1150t2580r1479b2680],
12	would	MD	O	would	aux	15	SENT_45	[p3l1530t2580r1796b2659],
13	be	VB	O	be	cop	15	SENT_45	[p3l1851t2580r1947b2659],
14	de	IN	O	de	amod	15	SENT_45	[p3l2002t2580r2132b2659],
15	—	CD	NUMBER	—	ccomp	2	SENT_45	[p3l2002t2580r2132b2659],
16	creased	VBN	O	crease	dep	15	SENT_45	[p3l12t2707r332b2786],
17	in	IN	O	in	_	0	SENT_45	[p3l374t2708r457b2785],
18	persons	NNS	O	person	prep_in	16	SENT_45	[p3l498t2733r834b2807],
19	who	WP	O	who	nsubj	20	SENT_45	[p3l875t2707r1058b2787],
20	carry	VBP	O	carry	rcmod	18	SENT_45	[p3l1103t2733r1324b2807],
21	a	DT	O	a	det	23	SENT_45	[p3l1362t2733r1406b2785],
22	loss	NN	O	loss	nn	23	SENT_45	[p3l1446t2706r2133b2787],
23	—	NN	O	—	dobj	20	SENT_45	[p3l1446t2706r2133b2787],
24	of	IN	O	of	_	0	SENT_45	[p3l1446t2706r2133b2787],
25	—	CD	NUMBER	—	num	28	SENT_45	[p3l1446t2706r2133b2787],
26	function	NN	O	function	nn	28	SENT_45	[p3l1446t2706r2133b2787],
27	CYPZCI9	NN	O	cypzci9	nn	28	SENT_45	[p3l11t2843r356b2914],
28	allele	NN	O	allele	prep_of	23	SENT_45	[p3l407t2836r630b2915],
29	and	CC	O	and	_	0	SENT_45	[p3l682t2836r839b2915],
30	increased	VBN	O	increase	conj_and	16	SENT_45	[p3l891t2836r1300b2915],
31	in	IN	O	in	_	0	SENT_45	[p3l1351t2837r1434b2914],
32	carriers	NNS	O	carrier	prep_in	30	SENT_45	[p3l1487t2837r1812b2914],
33	of	IN	O	of	_	0	SENT_45	[p3l1867t2835r1966b2915],
34	the	DT	O	the	det	36	SENT_45	[p3l2001t2836r2133b2915],
35	gain	NN	O	gain	nn	36	SENT_45	[p3l11t2963r719b3065],
36	—	NN	O	—	prep_of	32	SENT_45	[p3l11t2963r719b3065],
37	of	IN	O	of	_	0	SENT_45	[p3l11t2963r719b3065],
38	—	CD	NUMBER	—	num	39	SENT_45	[p3l11t2963r719b3065],
39	function	NN	O	function	prep_of	36	SENT_45	[p3l11t2963r719b3065],
40	*	CD	NUMBER	*	num	42	SENT_45	[p3l761t2964r911b3043],
41	17	CD	NUMBER	17	num	42	SENT_45	[p3l761t2964r911b3043],
42	allele	NN	O	allele	dobj	16	SENT_45	[p3l955t2964r1201b3043],
43	.	.	O	.	_	0	SENT_45	[p3l955t2964r1201b3043],

1	To	TO	O	to	aux	2	SENT_46	[p3l1248t2971r1352b3043],
2	test	VB	O	test	purpcl	7	SENT_46	[p3l1399t2981r1552b3042],
3	this	DT	O	this	det	4	SENT_46	[p3l1592t2964r1751b3042],
4	hypothesis	NN	O	hypothesis	dobj	2	SENT_46	[p3l1798t2964r2132b3064, p3l12t3092r190b3187],
5	,	,	O	,	_	0	SENT_46	[p3l1798t2964r2132b3064, p3l12t3092r190b3187],
6	we	PRP	O	we	nsubj	7	SENT_46	[p3l256t3117r373b3171],
7	examined	VBD	O	examine	_	0	SENT_46	[p3l439t3091r858b3170],
8	the	DT	O	the	det	9	SENT_46	[p3l923t3091r1056b3169],
9	efficacy	NN	O	efficacy	dobj	7	SENT_46	[p3l1120t3090r1457b3191],
10	and	CC	O	and	_	0	SENT_46	[p3l1516t3091r1674b3170],
11	safety	NN	O	safety	dobj	7	SENT_46	[p3l1739t3090r1992b3191],
12	of	IN	O	of	_	0	SENT_46	[p3l2052t3090r2152b3170],
13	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_46	[p3l12t3220r494b3321],
14	as	IN	O	as	_	0	SENT_46	[p3l530t3246r615b3298],
15	compared	VBN	O	compare	prepc_as	7	SENT_46	[p3l655t3220r1081b3320],
16	with	IN	O	with	pcomp	15	SENT_46	[p3l1113t3220r1309b3299],
17	placebo	NN	O	placebo	pobj	16	SENT_46	[p3l1343t3220r1672b3320],
18	according	VBG	O	accord	_	0	SENT_46	[p3l1710t3220r2137b3321],
19	to	TO	O	to	prepc_according_to	7	SENT_46	[p3l12t3364r93b3426],
20	genotype	NN	O	genotype	nn	21	SENT_46	[p3l142t3364r536b3448],
21	status	NN	O	status	pobj	7	SENT_46	[p3l586t3364r837b3426],
22	among	IN	O	among	_	0	SENT_46	[p3l887t3373r1186b3448],
23	patients	NNS	O	patient	prep_among	21	SENT_46	[p3l1230t3349r1571b3447],
24	in	IN	O	in	_	0	SENT_46	[p3l1621t3349r1704b3425],
25	two	CD	NUMBER	two	prep_in	23	SENT_46	[p3l1753t3364r1910b3426],
26	randomized	VBN	O	randomize	partmod	21	SENT_46	[p3l1960t3373r2132b3425, p3l12t3476r386b3555],
27	trials	NNS	O	trial	dobj	26	SENT_46	[p3l429t3476r673b3555],
28	:	:	O	:	_	0	SENT_46	[p3l429t3476r673b3555],
29	the	DT	O	the	det	30	SENT_46	[p3l719t3476r852b3554],
30	Clopidogrel	NNP	O	Clopidogrel	dep	27	SENT_46	[p3l894t3476r1396b3577],
31	in	IN	O	in	_	0	SENT_46	[p3l1437t3477r1520b3554],
32	Unstable	NNP	O	Unstable	nn	33	SENT_46	[p3l1561t3476r1938b3555],
33	Angina	NNP	O	Angina	prep_in	30	SENT_46	[p3l1976t3484r2132b3554, p3l11t3605r201b3705],
34	to	TO	O	to	aux	35	SENT_46	[p3l232t3621r314b3683],
35	Prevent	VB	O	prevent	xcomp	26	SENT_46	[p3l347t3610r666b3683],
36	Recurrent	JJ	O	recurrent	amod	37	SENT_46	[p3l693t3610r1122b3687],
37	Events	NNS	O	event	dobj	35	SENT_46	[p3l1148t3612r1421b3683],
38	(	JJ	O	(	amod	41	SENT_46	[p3l1462t3610r1772b3695],
39	CURE	NN	O	cure	nn	41	SENT_46	[p3l1462t3610r1772b3695],
40	)	NN	O	)	nn	41	SENT_46	[p3l1462t3610r1772b3695],
41	trial	NN	O	trial	tmod	35	SENT_46	[p3l1811t3604r2012b3700],
42	,	,	O	,	_	0	SENT_46	[p3l1811t3604r2012b3700],
43	in	IN	O	in	_	0	SENT_46	[p3l2050t3605r2133b3682],
44	which	WDT	O	which	rel	51	SENT_46	[p4l7t20r269b99],
45	patients	NNS	O	patient	nsubjpass	51	SENT_46	[p4l319t21r661b119],
46	with	IN	O	with	_	0	SENT_46	[p4l711t20r906b99],
47	acute	JJ	O	acute	amod	49	SENT_46	[p4l957t37r1180b99],
48	coronary	JJ	O	coronary	amod	49	SENT_46	[p4l1233t46r1617b119],
49	syndromes	NNS	O	syndrome	prep_with	45	SENT_46	[p4l1667t20r2131b119],
50	were	VBD	O	be	auxpass	51	SENT_46	[p4l7t173r212b226],
51	enrolled	VBN	O	enrol	rcmod	41	SENT_46	[p4l266t147r648b242],
52	,	,	O	,	_	0	SENT_46	[p4l266t147r648b242],
53	and	CC	O	and	_	0	SENT_46	[p4l706t147r866b225],
54	the	DT	O	the	det	60	SENT_46	[p4l920t147r1055b224],
55	Atrial	NNP	O	Atrial	nn	60	SENT_46	[p4l1104t147r1355b224],
56	Fibrillation	NNP	O	Fibrillation	nn	60	SENT_46	[p4l1407t147r1900b225],
57	Clo	NNP	O	Clo	nn	60	SENT_46	[p4l1953t147r2132b225],
58	—	NN	O	—	nn	60	SENT_46	[p4l1953t147r2132b225],
59	pidogrel	NN	O	pidogrel	nn	60	SENT_46	[p4l10t275r367b376],
60	Trial	NN	O	trial	nsubj	68	SENT_46	[p4l408t275r611b353],
61	with	IN	O	with	_	0	SENT_46	[p4l652t275r847b354],
62	Irbesartan	NNP	MISC	Irbesartan	prep_with	60	SENT_46	[p4l890t275r1340b354],
63	for	IN	O	for	_	0	SENT_46	[p4l1385t274r1508b354],
64	Prevention	NNP	O	Prevention	prep_for	62	SENT_46	[p4l1548t276r2006b354],
65	of	IN	O	of	_	0	SENT_46	[p4l2051t274r2151b354],
66	Vascular	JJ	O	vascular	amod	67	SENT_46	[p4l7t403r377b482],
67	Events	NNS	O	event	prep_of	64	SENT_46	[p4l424t410r697b482],
68	(	VBP	O	(	conj_and	7	SENT_46	[p4l756t409r1149b493],
69	ACTIVE	JJ	O	active	amod	71	SENT_46	[p4l756t409r1149b493],
70	)	NN	O	)	nn	71	SENT_46	[p4l756t409r1149b493],
71	A	NN	O	a	dobj	68	SENT_46	[p4l1202t410r1289b498],
72	,	,	O	,	_	0	SENT_46	[p4l1202t410r1289b498],
73	in	IN	O	in	_	0	SENT_46	[p4l1346t404r1430b480],
74	which	WDT	O	which	rel	80	SENT_46	[p4l1477t403r1739b482],
75	patients	NNS	O	patient	nsubjpass	80	SENT_46	[p4l1789t404r2131b502],
76	with	IN	O	with	_	0	SENT_46	[p4l7t531r202b610],
77	atrial	JJ	O	atrial	amod	78	SENT_46	[p4l240t531r466b609],
78	fibrillation	NN	O	fibrillation	prep_with	75	SENT_46	[p4l505t530r976b610],
79	were	VBD	O	be	auxpass	80	SENT_46	[p4l1010t557r1212b610],
80	enrolled	VBN	O	enrol	rcmod	71	SENT_46	[p4l1253t531r1627b610],
81	.	.	O	.	_	0	SENT_46	[p4l1253t531r1627b610],

1	METHODS	NNS	O	method	_	0	SENT_47	[p4l800t827r1343b886],

1	THE	DT	O	the	det	2	SENT_48	[p4l9t1062r161b1110],
2	cum	NN	O	cum	_	0	SENT_48	[p4l196t1061r398b1111],
3	:	:	O	:	_	0	SENT_48	[p4l196t1061r398b1111],
4	sruov	NN	O	sruov	dep	2	SENT_48	[p4l432t1061r688b1111],

1	The	DT	O	the	det	2	SENT_49	[p4l7t1160r168b1238],
2	design	NN	O	design	nsubjpass	11	SENT_49	[p4l213t1160r493b1261],
3	and	CC	O	and	_	0	SENT_49	[p4l537t1160r695b1239],
4	results	NNS	O	result	conj_and	2	SENT_49	[p4l738t1160r1021b1239],
5	of	IN	O	of	_	0	SENT_49	[p4l1068t1159r1168b1239],
6	the	DT	O	the	det	8	SENT_49	[p4l1194t1160r1327b1238],
7	CURE	NN	O	cure	nn	8	SENT_49	[p4l1371t1166r1626b1243],
8	study	NN	O	study	prep_of	2	SENT_49	[p4l1674t1160r1904b1260],
9	have	VBP	O	have	aux	11	SENT_49	[p4l1943t1160r2133b1239],
10	been	VBN	O	be	auxpass	11	SENT_49	[p4l12t1287r213b1366],
11	described	VBN	O	describe	ccomp	26	SENT_49	[p4l248t1287r659b1366],
12	previously	RB	DATE	previously	advmod	13	SENT_49	[p4l692t1287r1293b1387],
13	.2	NN	NUMBER	.2	dep	11	SENT_49	[p4l692t1287r1293b1387],
14	’	NN	O	’	nn	16	SENT_49	[p4l692t1287r1293b1387],
15	7	CD	NUMBER	7	num	16	SENT_49	[p4l692t1287r1293b1387],
16	’	NN	O	’	npadvmod	18	SENT_49	[p4l692t1287r1293b1387],
17	8	CD	NUMBER	8	num	16	SENT_49	[p4l692t1287r1293b1387],
18	In	IN	O	in	dep	13	SENT_49	[p4l1326t1295r1415b1365],
19	brief	NN	O	brief	pobj	18	SENT_49	[p4l1450t1286r1668b1383],
20	,	,	O	,	_	0	SENT_49	[p4l1450t1286r1668b1383],
21	the	DT	O	the	det	23	SENT_49	[p4l1708t1287r1841b1365],
22	CURE	NN	O	cure	nn	23	SENT_49	[p4l1875t1293r2130b1371],
23	study	NN	O	study	nsubjpass	26	SENT_49	[p4l12t1416r242b1515],
24	was	VBD	O	be	auxpass	26	SENT_49	[p4l274t1442r437b1495],
25	a	DT	O	a	dep	26	SENT_49	[p4l479t1442r523b1493],
26	randomized	VBN	O	randomize	_	0	SENT_49	[p4l563t1416r1106b1511],
27	,	,	O	,	_	0	SENT_49	[p4l563t1416r1106b1511],
28	double	JJ	O	double	dep	30	SENT_49	[p4l1153t1416r1723b1511],
29	—	RB	O	—	advmod	30	SENT_49	[p4l1153t1416r1723b1511],
30	blind	JJ	O	blind	dep	33	SENT_49	[p4l1153t1416r1723b1511],
31	,	,	O	,	_	0	SENT_49	[p4l1153t1416r1723b1511],
32	placebocontrolled	JJ	O	placebocontrolled	amod	33	SENT_49	[p4l1767t1416r2132b1515, p4l12t1544r449b1623],
33	trial	NN	O	trial	dobj	26	SENT_49	[p4l485t1544r663b1622],
34	comparing	VBG	O	compare	partmod	33	SENT_49	[p4l699t1545r1169b1645],
35	clopidogrel	NN	O	clopidogrel	nn	36	SENT_49	[p4l1202t1544r1685b1645],
36	(	NN	O	(	dobj	34	SENT_49	[p4l1725t1550r1828b1635],
37	at	IN	O	at	_	0	SENT_49	[p4l1725t1550r1828b1635],
38	a	DT	O	a	det	39	SENT_49	[p4l1859t1570r1903b1622],
39	dose	NN	O	dose	prep_at	34	SENT_49	[p4l1939t1544r2133b1623],
40	of	IN	O	of	_	0	SENT_49	[p4l12t1671r110b1751],
41	75	CD	NUMBER	75	num	42	SENT_49	[p4l126t1680r219b1751],
42	mg	NN	O	mg	prep_of	39	SENT_49	[p4l255t1698r393b1773],
43	per	IN	O	per	_	0	SENT_49	[p4l421t1698r559b1772],
44	day	NN	DURATION	day	prep_per	42	SENT_49	[p4l589t1672r754b1772],
45	)	CD	NUMBER	)	num	44	SENT_49	[p4l589t1672r754b1772],
46	with	IN	O	with	_	0	SENT_49	[p4l787t1672r980b1751],
47	placebo	NN	O	placebo	prep_with	44	SENT_49	[p4l1011t1672r1333b1772],
48	—	CD	NUMBER	—	num	47	SENT_49	[p4l1364t1717r1471b1725],
49	both	CC	O	both	dep	44	SENT_49	[p4l1500t1672r1695b1751],
50	in	IN	O	in	conj	44	SENT_49	[p4l1727t1673r1809b1750],
51	combination	NN	O	combination	pobj	50	SENT_49	[p4l1842t1672r2132b1751, p4l11t1801r282b1879],
52	With	IN	O	with	_	0	SENT_49	[p4l303t1800r495b1879],
53	aspirin	NN	O	aspirin	nn	54	SENT_49	[p4l520t1801r812b1900],
54	—	NN	O	—	prep_with	51	SENT_49	[p4l834t1845r942b1853],
55	among	IN	O	among	_	0	SENT_49	[p4l963t1826r1258b1901],
56	12,562	CD	NUMBER	12,562	num	57	SENT_49	[p4l1284t1806r1559b1896],
57	patients	NNS	O	patient	prep_among	34	SENT_49	[p4l1584t1801r1918b1900],
58	with	IN	O	with	_	0	SENT_49	[p4l1942t1800r2133b1879],
59	acute	JJ	O	acute	amod	61	SENT_49	[p4l11t1945r233b2007],
60	coronary	JJ	O	coronary	amod	61	SENT_49	[p4l288t1954r673b2028],
61	syndromes	NNS	O	syndrome	prep_with	57	SENT_49	[p4l725t1928r1191b2028],
62	without	IN	O	without	_	0	SENT_49	[p4l1244t1928r1583b2007],
63	ST	JJ	O	st	amod	66	SENT_49	[p4l1636t1934r2138b2029],
64	—	NN	O	—	nn	66	SENT_49	[p4l1636t1934r2138b2029],
65	segment	NN	O	segment	nn	66	SENT_49	[p4l1636t1934r2138b2029],
66	elevation	NN	O	elevation	prep_without	34	SENT_49	[p4l12t2056r416b2135],
67	.	.	O	.	_	0	SENT_49	[p4l12t2056r416b2135],

1	For	IN	O	for	_	0	SENT_50	[p4l468t2063r608b2134],
2	the	DT	O	the	det	4	SENT_50	[p4l652t2056r782b2134],
3	current	JJ	DATE	current	amod	4	SENT_50	[p4l830t2073r1137b2135],
4	analyses	NNS	O	analysis	prep_for	7	SENT_50	[p4l1178t2056r1552b2155],
5	,	,	O	,	_	0	SENT_50	[p4l1178t2056r1552b2155],
6	we	PRP	O	we	nsubj	7	SENT_50	[p4l1600t2082r1716b2135],
7	used	VBD	O	use	_	0	SENT_50	[p4l1763t2056r1956b2135],
8	the	DT	O	the	det	11	SENT_50	[p4l2003t2056r2133b2134],
9	same	JJ	O	same	amod	11	SENT_50	[p4l12t2209r229b2261],
10	primary	JJ	O	primary	amod	11	SENT_50	[p4l281t2184r625b2283],
11	efficacy	NN	O	efficacy	dobj	7	SENT_50	[p4l675t2182r1011b2283],
12	and	CC	O	and	_	0	SENT_50	[p4l1061t2183r1218b2262],
13	safety	NN	O	safety	nn	14	SENT_50	[p4l1275t2182r1528b2283],
14	outcomes	NNS	O	outcome	conj_and	11	SENT_50	[p4l1578t2200r1990b2262],
15	as	IN	O	as	_	0	SENT_50	[p4l2046t2209r2131b2261],
16	those	DT	O	those	prep_as	7	SENT_50	[p4l12t2311r243b2390],
17	in	IN	O	in	_	0	SENT_50	[p4l284t2312r367b2389],
18	the	DT	O	the	det	20	SENT_50	[p4l408t2311r541b2389],
19	CURE	NN	O	cure	nn	20	SENT_50	[p4l582t2317r838b2395],
20	trial	NN	O	trial	prep_in	16	SENT_50	[p4l881t2311r1123b2390],
21	?	.	O	?	_	0	SENT_50	[p4l881t2311r1123b2390],

1	The	DT	O	the	det	4	SENT_51	[p4l1161t2311r1322b2389],
2	first	JJ	ORDINAL	first	amod	4	SENT_51	[p4l1363t2310r1547b2389],
3	primary	JJ	O	primary	amod	4	SENT_51	[p4l1582t2312r1932b2411],
4	outcome	NN	O	outcome	nsubj	7	SENT_51	[p4l1969t2328r2132b2391, p4l12t2465r238b2518],
5	Was	VBD	O	be	cop	7	SENT_51	[p4l267t2465r429b2519],
6	the	DT	O	the	det	7	SENT_51	[p4l465t2439r597b2517],
7	composite	NN	O	composite	_	0	SENT_51	[p4l630t2440r1062b2539],
8	of	IN	O	of	_	0	SENT_51	[p4l1093t2438r1192b2518],
9	death	NN	O	death	prep_of	7	SENT_51	[p4l1205t2439r1438b2518],
10	from	IN	O	from	_	0	SENT_51	[p4l1468t2438r1675b2518],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_51	[p4l1706t2439r2132b2519, p4l12t2567r225b2647],
12	causes	NNS	O	cause	prep_from	7	SENT_51	[p4l267t2593r561b2663],
13	,	,	O	,	_	0	SENT_51	[p4l267t2593r561b2663],
14	nonfatal	JJ	O	nonfatal	amod	16	SENT_51	[p4l612t2566r973b2646],
15	myocardial	JJ	O	myocardial	amod	16	SENT_51	[p4l1019t2567r1500b2667],
16	infarction	NN	O	infarction	conj_or	12	SENT_51	[p4l1544t2566r1995b2663],
17	,	,	O	,	_	0	SENT_51	[p4l1544t2566r1995b2663],
18	or	CC	O	or	_	0	SENT_51	[p4l2047t2593r2137b2646],
19	stroke	NN	O	stroke	conj_or	12	SENT_51	[p4l12t2696r298b2791],
20	,	,	O	,	_	0	SENT_51	[p4l12t2696r298b2791],
21	and	CC	O	and	_	0	SENT_51	[p4l336t2696r494b2774],
22	the	DT	O	the	det	25	SENT_51	[p4l528t2696r661b2774],
23	second	JJ	ORDINAL	second	amod	25	SENT_51	[p4l696t2696r992b2774],
24	primary	JJ	O	primary	amod	25	SENT_51	[p4l1024t2697r1374b2795],
25	outcome	NN	O	outcome	nsubj	28	SENT_51	[p4l1404t2713r1773b2775],
26	was	VBD	O	be	cop	28	SENT_51	[p4l1802t2722r1964b2775],
27	the	DT	O	the	det	28	SENT_51	[p4l2001t2696r2133b2774],
28	composite	NN	O	composite	conj_and	7	SENT_51	[p4l12t2824r453b2923],
29	of	IN	O	of	_	0	SENT_51	[p4l502t2822r602b2902],
30	the	DT	O	the	det	33	SENT_51	[p4l632t2823r765b2901],
31	first	JJ	ORDINAL	first	amod	33	SENT_51	[p4l814t2822r998b2901],
32	primary	JJ	O	primary	amod	33	SENT_51	[p4l1040t2824r1390b2923],
33	outcome	NN	O	outcome	prep_of	28	SENT_51	[p4l1435t2840r1826b2919],
34	,	,	O	,	_	0	SENT_51	[p4l1435t2840r1826b2919],
35	recurrent	JJ	O	recurrent	amod	36	SENT_51	[p4l1880t2849r2132b2903, p4l11t2968r183b3029],
36	ischemia	NN	O	ischemia	conj_or	33	SENT_51	[p4l209t2951r615b3047],
37	,	,	O	,	_	0	SENT_51	[p4l209t2951r615b3047],
38	or	CC	O	or	_	0	SENT_51	[p4l653t2977r742b3030],
39	hospitalization	NN	O	hospitalization	conj_or	33	SENT_51	[p4l770t2951r1420b3051],
40	for	IN	O	for	_	0	SENT_51	[p4l1451t2950r1574b3030],
41	unstable	JJ	O	unstable	amod	42	SENT_51	[p4l1602t2951r1967b3031],
42	angina	NN	O	angina	prep_for	39	SENT_51	[p4l1998t2977r2132b3029, p4l11t3081r223b3181],
43	.	.	O	.	_	0	SENT_51	[p4l1998t2977r2132b3029, p4l11t3081r223b3181],

1	The	DT	O	the	det	4	SENT_52	[p4l260t3080r420b3158],
2	main	JJ	O	main	amod	4	SENT_52	[p4l454t3081r676b3158],
3	safety	NN	O	safety	nn	4	SENT_52	[p4l712t3079r965b3180],
4	outcome	NN	O	outcome	nsubj	7	SENT_52	[p4l996t3097r1364b3159],
5	was	VBD	O	be	cop	7	SENT_52	[p4l1394t3106r1557b3159],
6	major	JJ	O	major	amod	7	SENT_52	[p4l1593t3081r1843b3180],
7	bleeding	NN	O	bleeding	_	0	SENT_52	[p4l1876t3080r2132b3159, p4l11t3209r168b3309],
8	.	.	O	.	_	0	SENT_52	[p4l1876t3080r2132b3159, p4l11t3209r168b3309],

1	Results	NNS	O	result	nsubjpass	3	SENT_53	[p4l226t3208r539b3291],
2	are	VBP	O	be	auxpass	3	SENT_53	[p4l594t3234r723b3286],
3	presented	VBN	O	present	_	0	SENT_53	[p4l775t3208r1194b3308],
4	only	RB	O	only	advmod	3	SENT_53	[p4l1249t3208r1432b3308],
5	for	IN	O	for	_	0	SENT_53	[p4l1481t3207r1605b3287],
6	patients	NNS	O	patient	prep_for	3	SENT_53	[p4l1654t3209r1995b3308],
7	of	IN	O	of	_	0	SENT_53	[p4l2052t3207r2152b3287],
8	European	JJ	MISC	european	amod	12	SENT_53	[p4l10t3343r422b3435],
9	or	CC	O	or	_	0	SENT_53	[p4l476t3361r565b3414],
10	Latin	JJ	MISC	latin	amod	12	SENT_53	[p4l613t3337r835b3413],
11	American	JJ	MISC	american	amod	12	SENT_53	[p4l885t3337r1306b3414],
12	ancestry	NN	O	ancestry	prep_of	6	SENT_53	[p4l1358t3352r1734b3435],
13	.	.	O	.	_	0	SENT_53	[p4l1358t3352r1734b3435],

1	Patients	NNS	O	patient	nsubjpass	6	SENT_54	[p4l1792t3337r2131b3414],
2	with	IN	O	with	_	0	SENT_54	[p4l7t3464r202b3543],
3	other	JJ	O	other	amod	4	SENT_54	[p4l250t3464r478b3543],
4	ancestries	NNS	O	ancestry	prep_with	1	SENT_54	[p4l522t3465r950b3543],
5	were	VBD	O	be	auxpass	6	SENT_54	[p4l996t3490r1198b3543],
6	excluded	VBN	O	exclude	_	0	SENT_54	[p4l1246t3464r1618b3543],
7	because	IN	O	because	_	0	SENT_54	[p4l1667t3464r2003b3543],
8	of	IN	O	of	_	0	SENT_54	[p4l2052t3463r2152b3543],
9	small	JJ	O	small	amod	10	SENT_54	[p4l12t3592r247b3670],
10	numbers	NNS	O	number	prep_because_of	6	SENT_54	[p4l296t3592r673b3671],
11	(	VBP	O	(	rcmod	10	SENT_54	[p4l730t3598r857b3683],
12	99	CD	NUMBER	99	num	13	SENT_54	[p4l730t3598r857b3683],
13	patients	NNS	O	patient	nsubj	29	SENT_54	[p4l907t3593r1248b3692],
14	in	IN	O	in	_	0	SENT_54	[p4l1299t3593r1382b3670],
15	the	DT	O	the	det	19	SENT_54	[p4l1432t3592r1565b3670],
16	next	JJ	O	next	amod	19	SENT_54	[p4l1615t3609r1800b3670],
17	largest	JJS	O	largest	amod	19	SENT_54	[p4l1844t3592r2138b3693],
18	group	NN	O	group	nn	19	SENT_54	[p5l11t28r288b122],
19	)	NN	O	)	prep_in	13	SENT_54	[p5l11t28r288b122],
20	and	CC	O	and	_	0	SENT_54	[p5l324t21r482b100],
21	concern	NN	O	concern	prep_in	13	SENT_54	[p5l513t47r853b100],
22	about	IN	O	about	_	0	SENT_54	[p5l884t21r1128b100],
23	the	DT	O	the	det	24	SENT_54	[p5l1154t21r1287b99],
24	potential	NN	O	potential	prep_about	21	SENT_54	[p5l1316t21r1704b121],
25	for	IN	O	for	_	0	SENT_54	[p5l1734t20r1857b100],
26	population	NN	O	population	nn	27	SENT_54	[p5l1884t47r2132b121, p5l10t149r263b228],
27	stratification	NN	O	stratification	prep_for	24	SENT_54	[p5l307t148r882b228],
28	(	CD	NUMBER	(	num	27	SENT_54	[p5l930t156r1090b240],
29	see	VBP	O	see	ccomp	11	SENT_54	[p5l930t156r1090b240],
30	Fig	NN	O	fig	dobj	29	SENT_54	[p5l1132t150r1286b250],
31	.	.	O	.	_	0	SENT_54	[p5l1132t150r1286b250],

1	1	CD	NUMBER	1	_	0	SENT_55	[p5l1338t155r1407b245],
2	,	,	O	,	_	0	SENT_55	[p5l1338t155r1407b245],
3	2	CD	NUMBER	2	num	1	SENT_55	[p5l1455t155r1528b245],
4	,	,	O	,	_	0	SENT_55	[p5l1455t155r1528b245],
5	and	CC	NUMBER	and	_	0	SENT_55	[p5l1576t149r1736b228],
6	3	CD	NUMBER	3	conj_and	1	SENT_55	[p5l1780t155r1824b228],
7	in	IN	O	in	_	0	SENT_55	[p5l1870t150r1955b227],
8	the	DT	O	the	det	10	SENT_55	[p5l1998t149r2133b228],
9	Supplementary	NNP	O	Supplementary	nn	10	SENT_55	[p5l13t276r651b376],
10	Appendix	NNP	O	Appendix	prep_in	1	SENT_55	[p5l683t276r1121b376],
11	,	,	O	,	_	0	SENT_55	[p5l683t276r1121b376],
12	available	JJ	O	available	amod	10	SENT_55	[p5l1167t276r1538b356],
13	with	IN	O	with	_	0	SENT_55	[p5l1575t276r1770b356],
14	the	DT	O	the	det	16	SENT_55	[p5l1812t276r1944b354],
15	full	JJ	O	full	amod	16	SENT_55	[p5l1986t275r2134b356],
16	text	NN	O	text	prep_with	12	SENT_55	[p5l12t422r172b484],
17	of	IN	O	of	_	0	SENT_55	[p5l203t404r302b484],
18	this	DT	O	this	det	19	SENT_55	[p5l319t405r478b483],
19	article	NN	O	article	prep_of	16	SENT_55	[p5l515t405r782b483],
20	at	IN	O	at	_	0	SENT_55	[p5l817t422r895b483],
21	NEJM.org	NN	O	nejm.org	nn	22	SENT_55	[p5l923t412r1399b506],
22	)	NN	O	)	prep_at	1	SENT_55	[p5l923t412r1399b506],
23	.	.	O	.	_	0	SENT_55	[p5l923t412r1399b506],

1	ACTIVE	JJ	O	active	amod	2	SENT_56	[p5l9t680r284b730],
2	A	NN	O	a	nsubjpass	12	SENT_56	[p5l316t681r363b729],
3	The	DT	O	the	det	4	SENT_56	[p5l7t779r168b857],
4	design	NN	O	design	dep	2	SENT_56	[p5l216t779r496b880],
5	and	CC	O	and	_	0	SENT_56	[p5l541t779r699b858],
6	results	NNS	O	result	conj_and	2	SENT_56	[p5l745t779r1028b858],
7	of	IN	O	of	_	0	SENT_56	[p5l1077t778r1177b858],
8	ACTIVE	NNP	O	ACTIVE	nn	9	SENT_56	[p5l1201t785r1541b858],
9	A	NNP	O	A	prep_of	6	SENT_56	[p5l1586t787r1652b857],
10	have	VBP	O	have	aux	12	SENT_56	[p5l1695t779r1885b858],
11	been	VBN	O	be	auxpass	12	SENT_56	[p5l1932t779r2133b858],
12	described	VBN	O	describe	_	0	SENT_56	[p5l12t907r423b985],
13	previously	RB	DATE	previously	advmod	14	SENT_56	[p5l454t907r1000b1006],
14	.19	CD	NUMBER	.19	dobj	12	SENT_56	[p5l454t907r1000b1006],
15	ACTIVE	NNP	O	ACTIVE	nn	16	SENT_56	[p5l1029t913r1369b985],
16	A	NNP	O	A	nsubjpass	19	SENT_56	[p5l1400t914r1466b984],
17	was	VBD	O	be	auxpass	19	SENT_56	[p5l1491t933r1654b986],
18	a	DT	O	a	dep	19	SENT_56	[p5l1689t933r1733b985],
19	randomized	VBN	O	randomize	rcmod	14	SENT_56	[p5l1764t907r2132b985, p5l11t1035r211b1131],
20	,	,	O	,	_	0	SENT_56	[p5l1764t907r2132b985, p5l11t1035r211b1131],
21	double	JJ	O	double	amod	24	SENT_56	[p5l271t1035r817b1114],
22	—	RB	O	—	advmod	23	SENT_56	[p5l271t1035r817b1114],
23	blind	JJ	O	blind	amod	24	SENT_56	[p5l271t1035r817b1114],
24	trial	NN	O	trial	dobj	19	SENT_56	[p5l871t1035r1048b1113],
25	comparing	VBG	O	compare	partmod	24	SENT_56	[p5l1102t1036r1572b1136],
26	clopidogrel	NN	O	clopidogrel	dobj	25	SENT_56	[p5l1623t1035r2128b1136],
27	,	,	O	,	_	0	SENT_56	[p5l1623t1035r2128b1136],
28	at	IN	O	at	_	0	SENT_56	[p5l11t1180r90b1241],
29	a	DT	O	a	det	30	SENT_56	[p5l118t1189r162b1241],
30	dose	NN	O	dose	prep_at	25	SENT_56	[p5l196t1163r390b1242],
31	of	IN	O	of	_	0	SENT_56	[p5l425t1162r525b1242],
32	75	CD	NUMBER	75	num	33	SENT_56	[p5l542t1171r636b1242],
33	mg	NN	O	mg	prep_of	30	SENT_56	[p5l674t1189r812b1264],
34	per	IN	O	per	_	0	SENT_56	[p5l842t1189r982b1263],
35	day	NN	DURATION	day	prep_per	33	SENT_56	[p5l1014t1163r1173b1263],
36	,	,	O	,	_	0	SENT_56	[p5l1014t1163r1173b1263],
37	with	IN	O	with	conj	25	SENT_56	[p5l1209t1163r1404b1242],
38	placebo	NN	O	placebo	pobj	37	SENT_56	[p5l1437t1163r1765b1263],
39	—	CD	NUMBER	—	num	38	SENT_56	[p5l1798t1208r1906b1216],
40	both	CC	O	both	dep	25	SENT_56	[p5l1936t1163r2134b1242],
41	in	IN	O	in	conj	25	SENT_56	[p5l11t1292r94b1369],
42	combination	NN	O	combination	pobj	41	SENT_56	[p5l134t1291r680b1370],
43	with	IN	O	with	_	0	SENT_56	[p5l715t1291r910b1370],
44	aspirin	NN	O	aspirin	nn	45	SENT_56	[p5l949t1292r1248b1391],
45	—	NN	O	—	prep_with	42	SENT_56	[p5l1284t1336r1391b1344],
46	for	IN	O	for	_	0	SENT_56	[p5l1427t1290r1550b1370],
47	reducing	VBG	O	reduce	prepc_for	45	SENT_56	[p5l1586t1291r1964b1392],
48	the	DT	O	the	det	49	SENT_56	[p5l2001t1291r2133b1369],
49	risk	NN	O	risk	dobj	47	SENT_56	[p5l11t1419r175b1498],
50	of	IN	O	of	_	0	SENT_56	[p5l205t1418r305b1498],
51	stroke	NN	O	stroke	prep_of	49	SENT_56	[p5l322t1419r584b1498],
52	among	IN	O	among	_	0	SENT_56	[p5l617t1445r917b1520],
53	patients	NNS	O	patient	prep_among	47	SENT_56	[p5l946t1420r1287b1519],
54	with	IN	O	with	_	0	SENT_56	[p5l1319t1419r1514b1498],
55	atrial	JJ	O	atrial	amod	56	SENT_56	[p5l1547t1419r1772b1497],
56	fibrillation	NN	O	fibrillation	prep_with	53	SENT_56	[p5l1805t1418r2132b1498, p5l12t1548r188b1626],
57	and	CC	O	and	_	0	SENT_56	[p5l230t1547r393b1626],
58	at	IN	O	at	quantmod	60	SENT_56	[p5l435t1564r516b1625],
59	least	JJS	O	least	mwe	58	SENT_56	[p5l554t1547r761b1626],
60	one	CD	NUMBER	one	num	63	SENT_56	[p5l800t1573r955b1626],
61	additional	JJ	O	additional	amod	63	SENT_56	[p5l999t1547r1455b1626],
62	risk	NN	O	risk	nn	63	SENT_56	[p5l1498t1547r1668b1626],
63	factor	NN	O	factor	prep_among	47	SENT_56	[p5l1707t1546r1968b1626],
64	for	IN	O	for	_	0	SENT_56	[p5l2009t1546r2137b1626],
65	stroke	NN	O	stroke	prep_for	63	SENT_56	[p5l12t1675r286b1754],
66	who	WP	O	who	nsubj	69	SENT_56	[p5l323t1675r506b1754],
67	were	VBD	O	be	cop	69	SENT_56	[p5l542t1701r744b1754],
68	not	RB	O	not	neg	69	SENT_56	[p5l784t1692r927b1754],
69	eligible	JJ	O	eligible	rcmod	63	SENT_56	[p5l962t1675r1272b1776],
70	for	IN	O	for	_	0	SENT_56	[p5l1312t1674r1435b1754],
71	warfarin	NN	O	warfarin	nn	72	SENT_56	[p5l1467t1674r1841b1754],
72	therapy	NN	O	therapy	prep_for	69	SENT_56	[p5l1881t1675r2132b1753, p5l9t1828r122b1902],
73	.	.	O	.	_	0	SENT_56	[p5l1881t1675r2132b1753, p5l9t1828r122b1902],

1	We	PRP	O	we	nsubj	2	SENT_57	[p5l154t1810r287b1880],
2	used	VBD	O	use	_	0	SENT_57	[p5l318t1802r514b1882],
3	the	DT	O	the	det	6	SENT_57	[p5l545t1802r678b1880],
4	same	JJ	O	same	amod	6	SENT_57	[p5l709t1828r929b1880],
5	primary	JJ	O	primary	amod	6	SENT_57	[p5l958t1803r1308b1902],
6	efficacy	NN	O	efficacy	dobj	2	SENT_57	[p5l1334t1801r1671b1902],
7	and	CC	O	and	_	0	SENT_57	[p5l1695t1802r1853b1881],
8	safety	NN	O	safety	dobj	2	SENT_57	[p5l1885t1801r2138b1902],

1	N	NN	O	n	nn	3	SENT_58	[p5l546t1971r559b1986],
2	ENGLJ	NN	O	englj	nn	3	SENT_58	[p5l574t1971r652b1993],
3	MED	NN	O	med	_	0	SENT_58	[p5l667t1971r719b1986],
4	3	CD	NUMBER	3	dep	3	SENT_58	[p5l759t1965r806b1993],
5	;	:	O	;	_	0	SENT_58	[p5l759t1965r806b1993],
6	18	CD	NUMBER	18	num	8	SENT_58	[p5l759t1965r806b1993],
7	NEjM.ORG	NN	O	nejm.org	nn	8	SENT_58	[p5l841t1971r965b1993],
8	OCTOBER	NN	DATE	october	dep	4	SENT_58	[p5l1000t1971r1112b1986],
9	28,2010	CD	DATE	28,2010	number	10	SENT_58	[p5l1122t1965r1229b1991],
10	1705	CD	DATE	1705	dep	8	SENT_58	[p5l1940t1961r2015b1984],

1	e	LS	O	e	dep	4	SENT_59	[p5l739t2012r753b2028],
2	New	NNP	O	New	nn	4	SENT_59	[p5l762t2005r824b2028],
3	England	NNP	O	England	nn	4	SENT_59	[p5l833t2004r944b2035],
4	Journal	NNP	O	Journal	_	0	SENT_59	[p5l953t2004r1050b2028],
5	of	IN	O	of	prep	4	SENT_59	[p5l1060t2004r1089b2028],
6	Medicine	NNP	O	Medicine	dep	4	SENT_59	[p5l1095t2004r1220b2028],

1	The	DT	O	the	det	4	SENT_60	[p5l673t2192r719b2213],
2	NEW	NNP	O	NEW	nn	4	SENT_60	[p5l737t2194r822b2213],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_60	[p5l841t2194r1030b2213],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_60	[p5l1049t2194r1228b2220],
5	of	IN	O	of	_	0	SENT_60	[p5l1248t2192r1276b2219],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_60	[p5l1288t2194r1487b2213],

1	outcomes	NNS	O	outcome	nsubj	36	SENT_61	[p5l12t2431r424b2493],
2	as	IN	O	as	_	0	SENT_61	[p5l474t2440r559b2491],
3	those	DT	O	those	prep_as	1	SENT_61	[p5l611t2414r843b2492],
4	in	IN	O	in	_	0	SENT_61	[p5l891t2415r974b2491],
5	ACTIVE	NNP	O	ACTIVE	nn	6	SENT_61	[p5l1019t2420r1359b2492],
6	A.	NNP	O	A.	prep_in	3	SENT_61	[p5l1407t2419r1535b2492],
7	1	CD	NUMBER	1	num	6	SENT_61	[p5l1407t2419r1535b2492],
8	The	DT	O	the	det	11	SENT_61	[p5l1580t2414r1741b2492],
9	primary	JJ	O	primary	amod	11	SENT_61	[p5l1788t2415r2138b2513],
10	efficacy	NN	O	efficacy	nn	11	SENT_61	[p5l12t2540r349b2641],
11	outcome	NN	O	outcome	nsubj	18	SENT_61	[p5l395t2558r763b2620],
12	was	VBD	O	be	cop	18	SENT_61	[p5l809t2567r971b2621],
13	any	DT	O	any	det	18	SENT_61	[p5l1022t2567r1173b2641],
14	major	JJ	O	major	amod	18	SENT_61	[p5l1218t2542r1467b2641],
15	vascular	JJ	O	vascular	amod	18	SENT_61	[p5l1510t2541r1867b2621],
16	event	NN	O	event	nn	18	SENT_61	[p5l1915t2558r2139b2621],
17	(	NN	O	(	nn	18	SENT_61	[p5l17t2670r328b2765],
18	stroke	NN	O	stroke	rcmod	1	SENT_61	[p5l17t2670r328b2765],
19	,	,	O	,	_	0	SENT_61	[p5l17t2670r328b2765],
20	systemic	JJ	O	systemic	amod	21	SENT_61	[p5l389t2671r756b2769],
21	embolism	NN	O	embolism	rcmod	1	SENT_61	[p5l810t2670r1236b2748],
22	outside	IN	O	outside	_	0	SENT_61	[p5l1290t2670r1598b2749],
23	the	DT	O	the	det	26	SENT_61	[p5l1651t2670r1785b2748],
24	central	JJ	O	central	amod	26	SENT_61	[p5l1839t2670r2134b2748],
25	nervous	JJ	O	nervous	amod	26	SENT_61	[p5l12t2823r345b2877],
26	system	NN	O	system	prep_outside	21	SENT_61	[p5l390t2814r705b2897],
27	,	,	O	,	_	0	SENT_61	[p5l390t2814r705b2897],
28	myocardial	JJ	O	myocardial	amod	29	SENT_61	[p5l751t2797r1231b2897],
29	infarction	NN	O	infarction	appos	26	SENT_61	[p5l1272t2796r1722b2893],
30	,	,	O	,	_	0	SENT_61	[p5l1272t2796r1722b2893],
31	or	CC	O	or	_	0	SENT_61	[p5l1769t2823r1858b2876],
32	death	NN	O	death	rcmod	1	SENT_61	[p5l1897t2797r2134b2876],
33	from	IN	O	from	_	0	SENT_61	[p5l12t2925r222b3005],
34	vascular	JJ	O	vascular	amod	35	SENT_61	[p5l278t2926r635b3005],
35	causes	NNS	O	cause	prep_from	32	SENT_61	[p5l693t2933r1020b3017],
36	)	VBP	O	)	_	0	SENT_61	[p5l693t2933r1020b3017],
37	.	.	O	.	_	0	SENT_61	[p5l693t2933r1020b3017],

1	Major	JJ	O	major	amod	2	SENT_62	[p5l1082t2927r1334b3026],
2	hemorrhage	NN	O	hemorrhage	nsubjpass	4	SENT_62	[p5l1391t2926r1914b3027],
3	Was	VBD	O	be	auxpass	4	SENT_62	[p5l1969t2952r2132b3005],
4	defined	VBN	O	define	_	0	SENT_62	[p5l12t3053r339b3133],
5	as	IN	O	as	_	0	SENT_62	[p5l378t3080r464b3132],
6	any	DT	O	any	det	8	SENT_62	[p5l505t3080r655b3154],
7	overt	JJ	O	overt	amod	8	SENT_62	[p5l691t3071r905b3133],
8	bleeding	NN	O	bleeding	prep_as	4	SENT_62	[p5l941t3054r1311b3155],
9	requiring	VBG	O	require	partmod	8	SENT_62	[p5l1348t3055r1753b3155],
10	transfusion	NN	O	transfusion	dobj	9	SENT_62	[p5l1790t3053r2133b3133, p5l13t3182r185b3260],
11	of	IN	O	of	_	0	SENT_62	[p5l217t3180r316b3260],
12	at	IN	O	at	quantmod	14	SENT_62	[p5l328t3198r406b3259],
13	least	JJS	O	least	mwe	12	SENT_62	[p5l430t3181r625b3259],
14	2	CD	NUMBER	2	num	15	SENT_62	[p5l650t3187r697b3259],
15	units	NNS	O	unit	prep_of	10	SENT_62	[p5l729t3182r940b3261],
16	of	IN	O	of	_	0	SENT_62	[p5l973t3180r1072b3260],
17	blood	NN	O	blood	prep_of	15	SENT_62	[p5l1085t3181r1324b3260],
18	or	CC	O	or	_	0	SENT_62	[p5l1355t3207r1443b3260],
19	any	DT	O	any	det	21	SENT_62	[p5l1470t3207r1618b3281],
20	overt	JJ	O	overt	amod	21	SENT_62	[p5l1645t3198r1855b3260],
21	bleeding	NN	O	bleeding	prep_of	10	SENT_62	[p5l1882t3181r2133b3260, p5l11t3311r149b3411],
22	meeting	VBG	O	meet	partmod	21	SENT_62	[p5l190t3311r544b3411],
23	the	DT	O	the	det	24	SENT_62	[p5l586t3310r719b3388],
24	criteria	NNS	O	criterion	dobj	22	SENT_62	[p5l765t3311r1070b3388],
25	for	IN	O	for	_	0	SENT_62	[p5l1113t3309r1236b3389],
26	severe	JJ	O	severe	amod	27	SENT_62	[p5l1280t3336r1538b3389],
27	hemorrhage	NN	O	hemorrhage	prep_for	24	SENT_62	[p5l1583t3310r2129b3411],
28	.	.	O	.	_	0	SENT_62	[p5l1583t3310r2129b3411],

1	The	DT	O	the	det	3	SENT_63	[p5l8t3437r169b3515],
2	58	CD	NUMBER	58	num	3	SENT_63	[p5l217t3443r313b3516],
3	patients	NNS	O	patient	_	0	SENT_63	[p5l359t3438r700b3537],
4	who	WP	O	who	nsubj	5	SENT_63	[p5l743t3437r926b3517],
5	were	VBD	O	be	rcmod	3	SENT_63	[p5l969t3463r1171b3517],
6	of	IN	O	of	_	0	SENT_63	[p5l1217t3436r1316b3516],
7	non	JJ	O	non	prep_of	5	SENT_63	[p5l1344t3445r1954b3537],
8	.	.	O	.	_	0	SENT_63	[p5l1344t3445r1954b3537],

1	—	NN	O	—	_	0	SENT_64	[p5l1344t3445r1954b3537],
2	.	.	O	.	_	0	SENT_64	[p5l1344t3445r1954b3537],

1	European	JJ	MISC	european	amod	2	SENT_65	[p5l1344t3445r1954b3537],
2	ancestry	NN	O	ancestry	nsubjpass	4	SENT_65	[p5l1998t3463r2133b3515, p5l12t3583r263b3666],
3	Were	VBD	O	be	auxpass	4	SENT_65	[p5l285t3592r483b3645],
4	excluded	VBN	O	exclude	_	0	SENT_65	[p5l515t3566r880b3645],
5	(	RB	O	(	advmod	4	SENT_65	[p5l916t3573r1069b3657],
6	see	VB	O	see	ccomp	4	SENT_65	[p5l916t3573r1069b3657],
7	Fig	NN	O	fig	dobj	6	SENT_65	[p5l1098t3567r1246b3667],
8	.	.	O	.	_	0	SENT_65	[p5l1098t3567r1246b3667],

1	7	CD	NUMBER	7	_	0	SENT_66	[p5l1284t3574r1329b3645],
2	in	IN	O	in	_	0	SENT_66	[p5l1361t3567r1443b3644],
3	the	DT	O	the	det	6	SENT_66	[p5l1475t3566r1605b3644],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_66	[p5l1639t3566r2133b3666, p5l12t3710r182b3793],
5	Appendix	NNP	O	Appendix	nn	6	SENT_66	[p5l209t3694r675b3793],
6	)	NN	O	)	prep_in	1	SENT_66	[p5l209t3694r675b3793],
7	.	.	O	.	_	0	SENT_66	[p5l209t3694r675b3793],

1	STU	NNP	O	STU	nn	7	SENT_67	[p6l12t161r154b211],
2	DY	NNP	O	DY	nn	7	SENT_67	[p6l173t162r268b210],
3	OVERSIGHT	NNP	O	OVERSIGHT	nn	7	SENT_67	[p6l300t161r761b211],
4	The	NNP	O	The	nn	7	SENT_67	[p6l8t260r169b338],
5	institutional	JJ	O	institutional	amod	7	SENT_67	[p6l202t260r736b339],
6	review	NN	O	review	nn	7	SENT_67	[p6l768t261r1048b339],
7	board	NN	O	board	nsubj	12	SENT_67	[p6l1079t260r1327b338],
8	at	IN	O	at	_	0	SENT_67	[p6l1360t277r1439b338],
9	each	DT	O	each	det	11	SENT_67	[p6l1467t260r1659b338],
10	participating	VBG	O	participate	amod	11	SENT_67	[p6l1691t261r2133b359, p6l11t389r150b489],
11	center	NN	O	center	prep_at	7	SENT_67	[p6l190t405r452b467],
12	approved	VBD	O	approve	_	0	SENT_67	[p6l491t388r880b488],
13	each	DT	O	each	det	14	SENT_67	[p6l923t388r1115b466],
14	study	NN	O	study	dobj	12	SENT_67	[p6l1158t388r1400b488],
15	,	,	O	,	_	0	SENT_67	[p6l1158t388r1400b488],
16	and	CC	O	and	_	0	SENT_67	[p6l1447t388r1605b467],
17	all	DT	O	all	det	18	SENT_67	[p6l1646t388r1751b466],
18	patients	NNS	O	patient	nsubj	19	SENT_67	[p6l1791t389r2132b488],
19	provided	VBD	O	provide	conj_and	12	SENT_67	[p6l11t515r385b615],
20	written	VBN	O	write	amod	22	SENT_67	[p6l408t516r722b595],
21	informed	VBN	O	inform	amod	22	SENT_67	[p6l748t514r1150b594],
22	consent	NN	O	consent	dobj	19	SENT_67	[p6l1177t532r1533b594],
23	.	.	O	.	_	0	SENT_67	[p6l1177t532r1533b594],

1	Only	RB	O	only	advmod	2	SENT_68	[p6l1565t515r1770b615],
2	patients	NNS	O	patient	nsubj	16	SENT_68	[p6l1791t516r2132b615],
3	who	WP	O	who	nsubj	5	SENT_68	[p6l7t643r190b723],
4	also	RB	O	also	advmod	5	SENT_68	[p6l234t643r405b722],
5	consented	VBD	O	consent	rcmod	2	SENT_68	[p6l450t643r884b722],
6	to	TO	O	to	aux	7	SENT_68	[p6l928t660r1009b722],
7	participate	VB	O	participate	xcomp	5	SENT_68	[p6l1052t644r1512b743],
8	in	IN	O	in	_	0	SENT_68	[p6l1555t644r1638b721],
9	one	CD	NUMBER	one	prep_in	7	SENT_68	[p6l1681t669r1832b722],
10	of	IN	O	of	_	0	SENT_68	[p6l1877t642r1977b722],
11	the	DT	O	the	det	14	SENT_68	[p6l2001t643r2134b721],
12	two	CD	NUMBER	two	num	14	SENT_68	[p6l12t789r167b851],
13	genetic	JJ	O	genetic	amod	14	SENT_68	[p6l202t773r504b873],
14	studies	NNS	O	study	prep_of	9	SENT_68	[p6l538t772r831b851],
15	were	VBD	O	be	cop	16	SENT_68	[p6l862t798r1061b851],
16	eligible	JJ	O	eligible	_	0	SENT_68	[p6l1095t772r1397b873],
17	for	IN	O	for	_	0	SENT_68	[p6l1431t771r1551b851],
18	this	DT	O	this	det	19	SENT_68	[p6l1582t772r1738b850],
19	analysis	NN	O	analysis	prep_for	16	SENT_68	[p6l1773t772r2129b872],
20	.	.	O	.	_	0	SENT_68	[p6l1773t772r2129b872],

1	The	DT	O	the	det	3	SENT_69	[p6l8t900r169b978],
2	academic	JJ	O	academic	amod	3	SENT_69	[p6l211t900r611b979],
3	authors	NNS	O	author	nsubj	4	SENT_69	[p6l652t900r974b979],
4	designed	VBN	O	design	partmod	10	SENT_69	[p6l1019t900r1402b1001],
5	the	DT	O	the	det	6	SENT_69	[p6l1444t900r1577b978],
6	study	NN	O	study	dobj	4	SENT_69	[p6l1621t900r1863b1000],
7	,	,	O	,	_	0	SENT_69	[p6l1621t900r1863b1000],
8	gath	NN	O	gath	nn	9	SENT_69	[p6l1911t900r2133b1001],
9	—	NN	O	—	nsubj	33	SENT_69	[p6l1911t900r2133b1001],
10	ered	VBD	O	ere	_	0	SENT_69	[p6l12t1027r193b1106],
11	and	CC	O	and	_	0	SENT_69	[p6l240t1027r398b1106],
12	analyzed	VBD	O	analyze	conj_and	10	SENT_69	[p6l444t1027r823b1127],
13	the	DT	O	the	det	14	SENT_69	[p6l871t1027r1003b1105],
14	data	NNS	O	datum	nsubj	24	SENT_69	[p6l1052t1027r1257b1123],
15	,	,	O	,	_	0	SENT_69	[p6l1052t1027r1257b1123],
16	vouch	NN	O	vouch	appos	14	SENT_69	[p6l1305t1027r1558b1107],
17	for	IN	O	for	_	0	SENT_69	[p6l1605t1026r1728b1106],
18	the	DT	O	the	det	19	SENT_69	[p6l1773t1027r1905b1105],
19	data	NNS	O	datum	prep_for	16	SENT_69	[p6l1953t1027r2136b1106],
20	and	CC	O	and	_	0	SENT_69	[p6l11t1155r169b1234],
21	the	DT	O	the	det	22	SENT_69	[p6l202t1155r334b1233],
22	analysis	NN	O	analysis	prep_for	16	SENT_69	[p6l365t1155r730b1255],
23	,	,	O	,	_	0	SENT_69	[p6l365t1155r730b1255],
24	Wrote	VBD	O	write	ccomp	12	SENT_69	[p6l763t1172r1010b1235],
25	all	PDT	O	all	predet	27	SENT_69	[p6l1041t1155r1146b1233],
26	the	DT	O	the	det	27	SENT_69	[p6l1178t1155r1311b1233],
27	drafts	NNS	O	draft	dobj	24	SENT_69	[p6l1344t1154r1596b1234],
28	of	IN	O	of	_	0	SENT_69	[p6l1631t1154r1731b1234],
29	the	DT	O	the	det	30	SENT_69	[p6l1745t1155r1878b1233],
30	manuscript	NN	O	manuscript	prep_of	27	SENT_69	[p6l1911t1181r2133b1233, p6l12t1285r331b1383],
31	,	,	O	,	_	0	SENT_69	[p6l1911t1181r2133b1233, p6l12t1285r331b1383],
32	and	CC	O	and	_	0	SENT_69	[p6l394t1284r552b1362],
33	made	VBD	O	make	conj_and	10	SENT_69	[p6l610t1284r842b1362],
34	the	DT	O	the	det	35	SENT_69	[p6l902t1284r1034b1362],
35	decision	NN	O	decision	dobj	33	SENT_69	[p6l1094t1284r1446b1362],
36	to	TO	O	to	aux	37	SENT_69	[p6l1506t1301r1587b1362],
37	submit	VB	O	submit	xcomp	33	SENT_69	[p6l1649t1284r1947b1363],
38	the	DT	O	the	det	39	SENT_69	[p6l2001t1284r2134b1362],
39	manuscript	NN	O	manuscript	dobj	37	SENT_69	[p6l12t1412r505b1511],
40	for	IN	O	for	_	0	SENT_69	[p6l534t1410r657b1490],
41	publication	NN	O	publication	prep_for	39	SENT_69	[p6l688t1411r1199b1511],
42	.	.	O	.	_	0	SENT_69	[p6l688t1411r1199b1511],

1	GENOTYPING	VBG	O	genotype	csubjpass	22	SENT_70	[p6l15t1686r544b1736],
2	AND	CC	O	and	cc	5	SENT_70	[p6l578t1687r748b1735],
3	GENOTYPE	NN	O	genotype	nn	5	SENT_70	[p6l784t1686r1207b1736],
4	CLASSIFICATION	NN	O	classification	nn	5	SENT_70	[p6l1241t1686r1894b1736],
5	Genotyping	NN	O	genotyping	dobj	1	SENT_70	[p6l12t1786r523b1886],
6	of	IN	O	of	_	0	SENT_70	[p6l567t1784r667b1864],
7	three	CD	NUMBER	three	prep_of	5	SENT_70	[p6l696t1785r915b1863],
8	single	JJ	O	single	amod	11	SENT_70	[p6l964t1785r1697b1886],
9	—	NN	O	—	nn	11	SENT_70	[p6l964t1785r1697b1886],
10	nucleotide	NN	O	nucleotide	nn	11	SENT_70	[p6l964t1785r1697b1886],
11	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_70	[p6l1742t1785r2133b1885, p6l11t1913r322b2013],
12	(	VBP	O	(	rcmod	5	SENT_70	[p6l358t1919r506b2004],
13	SN	NN	O	sn	nn	14	SENT_70	[p6l358t1919r506b2004],
14	Ps	NN	O	p	dobj	12	SENT_70	[p6l510t1920r628b2004],
15	)	CD	NUMBER	)	num	14	SENT_70	[p6l510t1920r628b2004],
16	defining	VBG	O	define	xcomp	12	SENT_70	[p6l662t1912r1033b2014],
17	the	DT	O	the	det	20	SENT_70	[p6l1058t1913r1191b1991],
18	major	JJ	O	major	amod	20	SENT_70	[p6l1219t1914r1469b2013],
19	CYPZCI9	NN	O	cypzci9	nn	20	SENT_70	[p6l1494t1920r1839b1991],
20	alleles	NNS	O	allele	dobj	16	SENT_70	[p6l1867t1913r2132b1991],
21	was	VBD	O	be	auxpass	22	SENT_70	[p6l7t2066r170b2120],
22	performed	VBN	O	perform	_	0	SENT_70	[p6l220t2039r677b2140],
23	with	IN	O	with	_	0	SENT_70	[p6l721t2040r916b2120],
24	the	DT	O	the	det	25	SENT_70	[p6l966t2040r1099b2118],
25	use	NN	O	use	prep_with	22	SENT_70	[p6l1148t2066r1289b2120],
26	of	IN	O	of	_	0	SENT_70	[p6l1339t2039r1439b2119],
27	TaqMan	NN	O	taqman	nn	28	SENT_70	[p6l1467t2047r1818b2140],
28	assays	NNS	O	assay	prep_of	25	SENT_70	[p6l1867t2066r2132b2140],
29	from	IN	O	from	_	0	SENT_70	[p6l12t2168r222b2248],
30	stored	VBN	O	store	amod	31	SENT_70	[p6l259t2169r523b2248],
31	DNA	NN	O	dna	prep_from	22	SENT_70	[p6l558t2176r788b2248],
32	.	.	O	.	_	0	SENT_70	[p6l558t2176r788b2248],

1	The	DT	O	the	det	3	SENT_71	[p6l825t2169r986b2247],
2	call	NN	O	call	nn	3	SENT_71	[p6l1022t2169r1173b2247],
3	rate	NN	O	rate	nsubj	8	SENT_71	[p6l1208t2186r1368b2247],
4	was	VBD	O	be	cop	8	SENT_71	[p6l1400t2195r1562b2248],
5	greater	JJR	O	greater	mwe	6	SENT_71	[p6l1600t2186r1905b2270],
6	than	IN	O	than	quantmod	7	SENT_71	[p6l1938t2169r2134b2247],
7	98	CD	PERCENT	98	num	8	SENT_71	[p6l12t2301r199b2375],
8	%	NN	PERCENT	%	_	0	SENT_71	[p6l12t2301r199b2375],
9	for	IN	O	for	_	0	SENT_71	[p6l274t2295r397b2375],
10	each	DT	O	each	prep_for	8	SENT_71	[p6l470t2296r661b2374],
11	of	IN	O	of	_	0	SENT_71	[p6l737t2295r837b2375],
12	rs4244285	NN	O	rs4244285	nn	14	SENT_71	[p6l893t2302r1352b2392],
13	,	,	O	,	_	0	SENT_71	[p6l893t2302r1352b2392],
14	rs4986893	NN	O	rs4986893	prep_of	10	SENT_71	[p6l1433t2302r1897b2392],
15	,	,	O	,	_	0	SENT_71	[p6l1433t2302r1897b2392],
16	and	CC	O	and	_	0	SENT_71	[p6l1977t2296r2134b2375],
17	rs12248560	NN	O	rs12248560	prep_of	10	SENT_71	[p6l12t2431r526b2521],
18	,	,	O	,	_	0	SENT_71	[p6l12t2431r526b2521],
19	defining	VBG	O	define	partmod	14	SENT_71	[p6l578t2424r949b2526],
20	the	DT	O	the	det	21	SENT_71	[p6l991t2425r1124b2503],
21	*	NN	O	*	dobj	19	SENT_71	[p6l1168t2425r1291b2521],
22	2	CD	NUMBER	2	num	21	SENT_71	[p6l1168t2425r1291b2521],
23	,	,	O	,	_	0	SENT_71	[p6l1168t2425r1291b2521],
24	*	CD	NUMBER	*	number	28	SENT_71	[p6l1341t2425r1437b2504],
25	3	CD	NUMBER	3	number	28	SENT_71	[p6l1341t2425r1437b2504],
26	and	CC	O	and	_	0	SENT_71	[p6l1485t2425r1643b2504],
27	*	CD	NUMBER	*	num	29	SENT_71	[p6l1687t2425r1836b2504],
28	17	CD	NUMBER	17	num	29	SENT_71	[p6l1687t2425r1836b2504],
29	allele	NN	O	allele	rcmod	21	SENT_71	[p6l1882t2425r2129b2521],
30	,	,	O	,	_	0	SENT_71	[p6l1882t2425r2129b2521],
31	respectively	RB	O	respectively	advmod	29	SENT_71	[p6l12t2553r526b2653],
32	.	.	O	.	_	0	SENT_71	[p6l12t2553r526b2653],

1	Hardy	NNP	PERSON	Hardy	_	0	SENT_72	[p6l600t2553r1331b2654],
2	.	.	O	.	_	0	SENT_72	[p6l600t2553r1331b2654],

1	—	NN	O	—	_	0	SENT_73	[p6l600t2553r1331b2654],
2	.	.	O	.	_	0	SENT_73	[p6l600t2553r1331b2654],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_74	[p6l600t2553r1331b2654],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_74	[p6l1398t2553r1905b2653],
3	was	VBD	O	be	auxpass	4	SENT_74	[p6l1969t2579r2132b2632],
4	tested	VBN	O	test	_	0	SENT_74	[p6l12t2681r266b2760],
5	within	IN	O	within	_	0	SENT_74	[p6l295t2681r580b2760],
6	each	DT	O	each	det	8	SENT_74	[p6l614t2681r806b2759],
7	ethnic	JJ	O	ethnic	amod	8	SENT_74	[p6l840t2681r1109b2759],
8	group	NN	O	group	prep_within	4	SENT_74	[p6l1141t2707r1393b2782],
9	and	CC	O	and	_	0	SENT_74	[p6l1427t2681r1585b2760],
10	was	VBD	O	be	cop	13	SENT_74	[p6l1614t2707r1777b2760],
11	nonsig	JJ	O	nonsig	amod	13	SENT_74	[p6l1812t2682r2133b2782],
12	—	NN	O	—	nn	13	SENT_74	[p6l1812t2682r2133b2782],
13	nificant	NN	O	nificant	conj_and	4	SENT_74	[p6l12t2808r355b2887],
14	for	IN	O	for	_	0	SENT_74	[p6l385t2808r508b2888],
15	all	DT	O	all	det	17	SENT_74	[p6l538t2809r643b2887],
16	SN	NNP	O	SN	nn	17	SENT_74	[p6l680t2815r800b2889],
17	Ps	NNP	O	Ps	prep_for	13	SENT_74	[p6l804t2816r896b2887],
18	(	CD	NUMBER	(	num	19	SENT_74	[p6l938t2815r1312b2900],
19	P	NN	O	p	npadvmod	20	SENT_74	[p6l938t2815r1312b2900],
20	>	JJR	O	>	amod	17	SENT_74	[p6l938t2815r1312b2900],
21	0.05	CD	NUMBER	0.05	num	22	SENT_74	[p6l938t2815r1312b2900],
22	)	NN	O	)	dobj	4	SENT_74	[p6l938t2815r1312b2900],
23	.	.	O	.	_	0	SENT_74	[p6l938t2815r1312b2900],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_75	[p6l140t2939r471b3016],
2	were	VBD	O	be	auxpass	3	SENT_75	[p6l509t2964r707b3017],
3	classified	VBN	O	classify	_	0	SENT_75	[p6l747t2937r1143b3017],
4	into	IN	O	into	_	0	SENT_75	[p6l1182t2939r1347b3017],
5	categories	NNS	O	category	prep_into	3	SENT_75	[p6l1389t2939r1811b3039],
6	of	IN	O	of	_	0	SENT_75	[p6l1853t2937r1952b3017],
7	metabolizer	NN	O	metabolizer	nn	8	SENT_75	[p6l1973t2964r2133b3017, p6l12t3065r388b3144],
8	phenotypes	NNS	O	phenotype	prep_of	5	SENT_75	[p6l425t3065r911b3165],
9	with	IN	O	with	_	0	SENT_75	[p6l951t3065r1142b3145],
10	the	DT	O	the	det	11	SENT_75	[p6l1186t3065r1316b3143],
11	use	NN	O	use	prep_with	8	SENT_75	[p6l1358t3091r1497b3145],
12	of	IN	O	of	_	0	SENT_75	[p6l1539t3064r1639b3144],
13	established	JJ	O	established	amod	16	SENT_75	[p6l1663t3065r2134b3144],
14	common	JJ	O	common	amod	16	SENT_75	[p6l12t3221r857b3274],
15	—	NN	O	—	nn	16	SENT_75	[p6l12t3221r857b3274],
16	consensus	NN	O	consensus	prep_of	11	SENT_75	[p6l12t3221r857b3274],
17	star	NN	O	star	nn	19	SENT_75	[p6l905t3212r1063b3273],
18	allele	NN	O	allele	nn	19	SENT_75	[p6l1103t3195r1320b3273],
19	nomenclature	NN	O	nomenclature	dep	16	SENT_75	[p6l1364t3195r2134b3274],
20	.1	CD	NUMBER	.1	number	21	SENT_75	[p6l1364t3195r2134b3274],
21	°	CD	NUMBER	°	npadvmod	22	SENT_75	[p6l1364t3195r2134b3274],
22	>	JJR	O	>	amod	19	SENT_75	[p6l1364t3195r2134b3274],
23	11	CD	NUMBER	11	npadvmod	24	SENT_75	[p6l1364t3195r2134b3274],
24	Thus	RB	O	thus	advmod	19	SENT_75	[p6l8t3323r239b3418],
25	,	,	O	,	_	0	SENT_75	[p6l8t3323r239b3418],
26	patients	NNS	O	patient	appos	16	SENT_75	[p6l279t3324r612b3422],
27	Without	IN	O	without	dep	30	SENT_75	[p6l645t3323r978b3402],
28	a	DT	O	a	det	29	SENT_75	[p6l1007t3349r1052b3400],
29	*	NN	O	*	pobj	27	SENT_75	[p6l1083t3323r1204b3418],
30	2	CD	NUMBER	2	rcmod	26	SENT_75	[p6l1083t3323r1204b3418],
31	,	,	O	,	_	0	SENT_75	[p6l1083t3323r1204b3418],
32	*	CD	NUMBER	*	number	33	SENT_75	[p6l1242t3323r1363b3418],
33	3	CD	NUMBER	3	appos	16	SENT_75	[p6l1242t3323r1363b3418],
34	,	,	O	,	_	0	SENT_75	[p6l1242t3323r1363b3418],
35	or	CC	O	or	_	0	SENT_75	[p6l1404t3349r1491b3401],
36	*	NN	O	*	conj_or	33	SENT_75	[p6l1521t3323r1669b3401],
37	17	CD	NUMBER	17	num	36	SENT_75	[p6l1521t3323r1669b3401],
38	allele	NN	O	allele	dep	36	SENT_75	[p6l1704t3323r1921b3401],
39	(	CD	NUMBER	(	num	38	SENT_75	[p6l1961t3324r2129b3418],
40	i.e.	FW	O	i.e.	dobj	3	SENT_75	[p6l1961t3324r2129b3418],
41	,	,	O	,	_	0	SENT_75	[p6l1961t3324r2129b3418],
42	*	NN	O	*	appos	40	SENT_75	[p6l10t3450r264b3541],
43	1	CD	NUMBER	1	num	42	SENT_75	[p6l10t3450r264b3541],
44	/	:	O	/	punct	49	SENT_75	[p6l10t3450r264b3541],
45	*	CD	NUMBER	*	number	46	SENT_75	[p6l10t3450r264b3541],
46	1	CD	NUMBER	1	num	47	SENT_75	[p6l10t3450r264b3541],
47	)	NN	O	)	nsubjpass	49	SENT_75	[p6l10t3450r264b3541],
48	were	VBD	O	be	auxpass	49	SENT_75	[p6l295t3476r494b3529],
49	classified	VBN	O	classify	dep	40	SENT_75	[p6l525t3449r921b3529],
50	as	IN	O	as	_	0	SENT_75	[p6l951t3476r1035b3528],
51	“	NN	O	“	nn	53	SENT_75	[p6l1072t3451r1491b3529],
52	extensive	JJ	O	extensive	amod	53	SENT_75	[p6l1072t3451r1491b3529],
53	metabolizers	NNS	O	metabolizer	prep_as	49	SENT_75	[p6l1522t3450r2130b3546],
54	,	,	O	,	_	0	SENT_75	[p6l1522t3450r2130b3546],
55	”	CD	NUMBER	”	dep	49	SENT_75	[p6l1522t3450r2130b3546],
56	those	DT	O	those	dep	55	SENT_75	[p6l12t3578r239b3656],
57	with	IN	O	with	_	0	SENT_75	[p6l266t3578r459b3657],
58	one	CD	NUMBER	one	num	59	SENT_75	[p6l491t3603r639b3656],
59	*	NN	O	*	prep_with	56	SENT_75	[p6l670t3578r767b3655],
60	2	CD	NUMBER	2	number	63	SENT_75	[p6l670t3578r767b3655],
61	or	CC	O	or	_	0	SENT_75	[p6l800t3603r888b3656],
62	*	CD	NUMBER	*	conj_or	63	SENT_75	[p6l915t3578r1010b3656],
63	3	CD	NUMBER	3	num	64	SENT_75	[p6l915t3578r1010b3656],
64	allele	NN	O	allele	dep	40	SENT_75	[p6l1044t3578r1262b3655],
65	(	CD	NUMBER	(	dep	40	SENT_75	[p6l1298t3579r1466b3673],
66	i.e.	FW	O	i.e.	dep	65	SENT_75	[p6l1298t3579r1466b3673],
67	,	,	O	,	_	0	SENT_75	[p6l1298t3579r1466b3673],
68	*	NN	O	*	appos	65	SENT_75	[p6l1501t3578r1729b3667],
69	1	CD	NUMBER	1	num	68	SENT_75	[p6l1501t3578r1729b3667],
70	/	:	O	/	punct	75	SENT_75	[p6l1501t3578r1729b3667],
71	*	CD	NUMBER	*	number	75	SENT_75	[p6l1501t3578r1729b3667],
72	2	CD	NUMBER	2	number	75	SENT_75	[p6l1501t3578r1729b3667],
73	or	CC	O	or	_	0	SENT_75	[p6l1762t3603r1850b3656],
74	*	CD	NUMBER	*	conj_or	75	SENT_75	[p6l1876t3578r2129b3668],
75	1	CD	NUMBER	1	dep	68	SENT_75	[p6l1876t3578r2129b3668],
76	/	:	O	/	punct	75	SENT_75	[p6l1876t3578r2129b3668],
77	*	CD	NUMBER	*	number	78	SENT_75	[p6l1876t3578r2129b3668],
78	3	CD	NUMBER	3	num	79	SENT_75	[p6l1876t3578r2129b3668],
79	)	NN	O	)	nsubjpass	81	SENT_75	[p6l1876t3578r2129b3668],
80	were	VBD	O	be	auxpass	81	SENT_75	[p6l7t3731r206b3784],
81	classified	VBN	O	classify	rcmod	68	SENT_75	[p6l270t3704r666b3784],
82	as	IN	O	as	_	0	SENT_75	[p6l728t3731r812b3783],
83	“	NN	O	“	nn	85	SENT_75	[p6l882t3705r1459b3784],
84	intermediate	JJ	O	intermediate	amod	85	SENT_75	[p6l882t3705r1459b3784],
85	metabolizers	NNS	O	metabolizer	prep_as	81	SENT_75	[p6l1522t3705r2130b3801],
86	,	,	O	,	_	0	SENT_75	[p6l1522t3705r2130b3801],
87	”	IN	O	”	amod	40	SENT_75	[p6l1522t3705r2130b3801],

1	and	CC	O	and	cc	33	SENT_76	[p7l11t23r167b101],
2	those	DT	O	those	nsubjpass	33	SENT_76	[p7l214t23r442b101],
3	with	IN	O	with	prep	2	SENT_76	[p7l484t23r676b102],
4	two	CD	NUMBER	two	num	5	SENT_76	[p7l723t39r879b102],
5	*	NN	O	*	dep	11	SENT_76	[p7l925t23r1023b100],
6	2	CD	NUMBER	2	dep	5	SENT_76	[p7l925t23r1023b100],
7	or	CC	O	or	_	0	SENT_76	[p7l1072t48r1159b101],
8	*	CD	NUMBER	*	dep	5	SENT_76	[p7l1201t23r1297b101],
9	3	CD	NUMBER	3	num	10	SENT_76	[p7l1201t23r1297b101],
10	alleles	NNS	O	allele	dep	11	SENT_76	[p7l1347t23r1606b101],
11	(	CD	NUMBER	(	dep	18	SENT_76	[p7l1659t24r1827b118],
12	i.e.	FW	O	i.e.	dep	11	SENT_76	[p7l1659t24r1827b118],
13	,	,	O	,	_	0	SENT_76	[p7l1659t24r1827b118],
14	*	NN	O	*	appos	12	SENT_76	[p7l1878t23r2129b118],
15	2	CD	NUMBER	2	num	14	SENT_76	[p7l1878t23r2129b118],
16	/	:	O	/	punct	18	SENT_76	[p7l1878t23r2129b118],
17	*	CD	NUMBER	*	num	18	SENT_76	[p7l1878t23r2129b118],
18	2	CD	NUMBER	2	dep	3	SENT_76	[p7l1878t23r2129b118],
19	,	,	O	,	_	0	SENT_76	[p7l1878t23r2129b118],
20	*	CD	NUMBER	*	number	21	SENT_76	[p7l10t150r235b240],
21	2	CD	NUMBER	2	appos	2	SENT_76	[p7l10t150r235b240],
22	/	:	O	/	punct	27	SENT_76	[p7l10t150r235b240],
23	*	CD	NUMBER	*	number	27	SENT_76	[p7l10t150r235b240],
24	3	CD	NUMBER	3	number	27	SENT_76	[p7l10t150r235b240],
25	or	CC	O	or	_	0	SENT_76	[p7l280t176r368b229],
26	*	CD	NUMBER	*	conj_or	27	SENT_76	[p7l404t150r655b241],
27	3	CD	NUMBER	3	dep	21	SENT_76	[p7l404t150r655b241],
28	/	:	O	/	punct	27	SENT_76	[p7l404t150r655b241],
29	*	CD	NUMBER	*	number	30	SENT_76	[p7l404t150r655b241],
30	3	CD	NUMBER	3	num	31	SENT_76	[p7l404t150r655b241],
31	)	NN	O	)	dep	21	SENT_76	[p7l404t150r655b241],
32	were	VBD	O	be	auxpass	33	SENT_76	[p7l697t176r895b230],
33	classified	VBN	O	classify	_	0	SENT_76	[p7l937t149r1333b229],
34	as	IN	O	as	_	0	SENT_76	[p7l1373t176r1458b228],
35	“	NN	O	“	nn	37	SENT_76	[p7l1505t155r1745b250],
36	poor	JJ	O	poor	amod	37	SENT_76	[p7l1505t155r1745b250],
37	metabolizers	NNS	O	metabolizer	prep_as	33	SENT_76	[p7l1783t150r2133b229, p7l11t279r300b358],
38	.	.	O	.	_	0	SENT_76	[p7l1783t150r2133b229, p7l11t279r300b358],

1	”	NN	O	”	nn	2	SENT_77	[p7l1783t150r2133b229, p7l11t279r300b358],
2	Carriers	NNS	O	carrier	dep	9	SENT_77	[p7l338t280r673b358],
3	of	IN	O	of	_	0	SENT_77	[p7l710t278r808b358],
4	a	DT	O	a	det	6	SENT_77	[p7l823t305r867b357],
5	single	JJ	O	single	amod	6	SENT_77	[p7l901t279r1146b380],
6	*	NN	O	*	prep_of	2	SENT_77	[p7l1179t279r1326b358],
7	17	CD	NUMBER	17	num	8	SENT_77	[p7l1179t279r1326b358],
8	allele	NN	O	allele	dep	9	SENT_77	[p7l1360t279r1578b357],
9	(	CD	NUMBER	(	dep	20	SENT_77	[p7l1616t280r1783b375],
10	i.e.	FW	O	i.e.	dep	9	SENT_77	[p7l1616t280r1783b375],
11	,	,	O	,	_	0	SENT_77	[p7l1616t280r1783b375],
12	*	CD	NUMBER	*	dep	16	SENT_77	[p7l1821t279r2129b370],
13	1l	NN	O	1l	dep	12	SENT_77	[p7l1821t279r2129b370],
14	*	CD	NUMBER	*	dep	16	SENT_77	[p7l1821t279r2129b370],
15	17	CD	NUMBER	17	num	16	SENT_77	[p7l1821t279r2129b370],
16	)	NN	O	)	dep	20	SENT_77	[p7l1821t279r2129b370],
17	and	CC	O	and	_	0	SENT_77	[p7l11t407r167b486],
18	*	NN	O	*	dep	20	SENT_77	[p7l216t407r363b486],
19	17	CD	NUMBER	17	num	20	SENT_77	[p7l216t407r363b486],
20	homozygotes	NNS	O	homozygote	_	0	SENT_77	[p7l416t407r977b508],
21	were	VBD	O	be	auxpass	22	SENT_77	[p7l1026t433r1225b486],
22	classified	VBN	O	classify	rcmod	20	SENT_77	[p7l1276t406r1672b486],
23	as	IN	O	as	_	0	SENT_77	[p7l1723t433r1808b485],
24	“	NN	O	“	nn	27	SENT_77	[p7l1864t407r2133b486],
25	ultra	NN	O	ultra	nn	27	SENT_77	[p7l1864t407r2133b486],
26	—	CD	NUMBER	—	num	27	SENT_77	[p7l1864t407r2133b486],
27	metabolizers	NNS	O	metabolizer	prep_as	22	SENT_77	[p7l12t535r619b630],
28	,	,	O	,	_	0	SENT_77	[p7l12t535r619b630],
29	”	NN	O	”	prep_as	22	SENT_77	[p7l12t535r619b630],
30	and	CC	O	and	_	0	SENT_77	[p7l676t535r832b613],
31	patients	NNS	O	patient	prep_as	22	SENT_77	[p7l884t536r1217b634],
32	with	IN	O	with	_	0	SENT_77	[p7l1268t535r1461b614],
33	one	CD	NUMBER	one	num	34	SENT_77	[p7l1515t561r1664b613],
34	*	NN	O	*	prep_with	20	SENT_77	[p7l1716t535r1863b613],
35	17	CD	NUMBER	17	num	36	SENT_77	[p7l1716t535r1863b613],
36	allele	NN	O	allele	dep	34	SENT_77	[p7l1917t535r2134b613],
37	and	CC	O	and	_	0	SENT_77	[p7l11t662r167b741],
38	one	CD	NUMBER	one	num	40	SENT_77	[p7l233t688r381b741],
39	loss	NN	O	loss	nn	40	SENT_77	[p7l446t661r1117b741],
40	—	NN	O	—	conj_and	34	SENT_77	[p7l446t661r1117b741],
41	of	IN	O	of	_	0	SENT_77	[p7l446t661r1117b741],
42	—	CD	NUMBER	—	num	43	SENT_77	[p7l446t661r1117b741],
43	function	NN	O	function	amod	69	SENT_77	[p7l446t661r1117b741],
44	allele	NN	O	allele	dep	43	SENT_77	[p7l1182t662r1399b740],
45	(	CD	NUMBER	(	num	44	SENT_77	[p7l1469t663r1637b758],
46	i.e.	FW	O	i.e.	dep	44	SENT_77	[p7l1469t663r1637b758],
47	,	,	O	,	_	0	SENT_77	[p7l1469t663r1637b758],
48	*	NN	O	*	appos	44	SENT_77	[p7l1706t662r1983b752],
49	2	CD	NUMBER	2	num	48	SENT_77	[p7l1706t662r1983b752],
50	/	:	O	/	punct	55	SENT_77	[p7l1706t662r1983b752],
51	*	CD	NUMBER	*	number	55	SENT_77	[p7l1706t662r1983b752],
52	17	CD	NUMBER	17	number	55	SENT_77	[p7l1706t662r1983b752],
53	or	CC	O	or	_	0	SENT_77	[p7l2050t688r2137b741],
54	*	CD	NUMBER	*	dep	48	SENT_77	[p7l10t791r315b882],
55	3	CD	NUMBER	3	dep	48	SENT_77	[p7l10t791r315b882],
56	/	:	O	/	punct	55	SENT_77	[p7l10t791r315b882],
57	*	CD	NUMBER	*	number	58	SENT_77	[p7l10t791r315b882],
58	17	CD	NUMBER	17	num	59	SENT_77	[p7l10t791r315b882],
59	)	NN	O	)	nsubjpass	61	SENT_77	[p7l10t791r315b882],
60	were	VBD	O	be	auxpass	61	SENT_77	[p7l359t817r557b870],
61	classified	VBN	O	classify	rcmod	48	SENT_77	[p7l601t790r997b870],
62	as	IN	O	as	_	0	SENT_77	[p7l1039t817r1123b869],
63	having	VBG	O	have	prepc_as	61	SENT_77	[p7l1168t791r1454b892],
64	an	DT	O	a	det	68	SENT_77	[p7l1493t817r1595b869],
65	“	NN	O	“	nn	68	SENT_77	[p7l1641t791r2129b870],
66	unknown	JJ	O	unknown	amod	68	SENT_77	[p7l1641t791r2129b870],
67	”	NN	O	”	nn	68	SENT_77	[p7l1641t791r2129b870],
68	metabolizer	NN	O	metabolizer	dobj	63	SENT_77	[p7l12t918r519b997],
69	phenotype	NN	O	phenotype	prep_of	40	SENT_77	[p7l568t918r1034b1018],
70	.	.	O	.	_	0	SENT_77	[p7l568t918r1034b1018],

1	Carriers	NNS	O	carrier	nsubjpass	22	SENT_78	[p7l1093t919r1428b997],
2	of	IN	O	of	_	0	SENT_78	[p7l1484t917r1583b997],
3	at	IN	O	at	quantmod	5	SENT_78	[p7l1617t935r1694b996],
4	least	JJS	O	least	mwe	3	SENT_78	[p7l1742t918r1937b996],
5	one	CD	NUMBER	one	num	7	SENT_78	[p7l1985t944r2134b997],
6	loss	NN	O	loss	nn	7	SENT_78	[p7l11t1045r665b1125],
7	—	NN	O	—	prep_of	1	SENT_78	[p7l11t1045r665b1125],
8	of	IN	O	of	_	0	SENT_78	[p7l11t1045r665b1125],
9	—	CD	NUMBER	—	num	11	SENT_78	[p7l11t1045r665b1125],
10	function	NN	O	function	nn	11	SENT_78	[p7l11t1045r665b1125],
11	allele	NN	O	allele	prep_of	7	SENT_78	[p7l693t1046r906b1124],
12	(	CD	NUMBER	(	dep	11	SENT_78	[p7l939t1047r1102b1142],
13	i.e.	FW	O	i.e.	dep	11	SENT_78	[p7l939t1047r1102b1142],
14	,	,	O	,	_	0	SENT_78	[p7l939t1047r1102b1142],
15	*	NN	O	*	prep_of	7	SENT_78	[p7l1134t1046r1231b1124],
16	2	CD	NUMBER	2	num	15	SENT_78	[p7l1134t1046r1231b1124],
17	or	CC	O	or	_	0	SENT_78	[p7l1262t1072r1349b1125],
18	*	CD	NUMBER	*	number	19	SENT_78	[p7l1373t1046r1493b1137],
19	3	CD	NUMBER	3	num	20	SENT_78	[p7l1373t1046r1493b1137],
20	)	NN	O	)	conj_or	11	SENT_78	[p7l1373t1046r1493b1137],
21	were	VBD	O	be	auxpass	22	SENT_78	[p7l1523t1072r1719b1125],
22	classified	VBN	O	classify	_	0	SENT_78	[p7l1748t1045r2134b1125],
23	as	IN	O	as	mark	30	SENT_78	[p7l11t1201r96b1253],
24	“	JJ	O	“	amod	29	SENT_78	[p7l132t1174r843b1254],
25	loss	NN	O	loss	nn	29	SENT_78	[p7l132t1174r843b1254],
26	—	NN	O	—	nn	29	SENT_78	[p7l132t1174r843b1254],
27	offunction	NN	O	offunction	nn	29	SENT_78	[p7l132t1174r843b1254],
28	allele	NN	O	allele	nn	29	SENT_78	[p7l873t1175r1090b1253],
29	carriers	NNS	O	carrier	nsubj	30	SENT_78	[p7l1123t1176r1481b1253],
30	”	VBP	O	”	dep	22	SENT_78	[p7l1123t1176r1481b1253],
31	and	CC	O	and	_	0	SENT_78	[p7l1516t1175r1671b1254],
32	carriers	NNS	O	carrier	dep	38	SENT_78	[p7l1703t1176r2020b1254],
33	of	IN	O	of	_	0	SENT_78	[p7l2054t1174r2152b1254],
34	at	IN	O	at	quantmod	36	SENT_78	[p7l11t1320r89b1381],
35	least	JJS	O	least	mwe	34	SENT_78	[p7l119t1303r313b1381],
36	one	CD	NUMBER	one	prep_of	32	SENT_78	[p7l345t1329r493b1382],
37	gain	NN	O	gain	dep	38	SENT_78	[p7l529t1302r1221b1404],
38	—	NN	O	—	dep	42	SENT_78	[p7l529t1302r1221b1404],
39	of	IN	O	of	_	0	SENT_78	[p7l529t1302r1221b1404],
40	—	CD	NUMBER	—	num	41	SENT_78	[p7l529t1302r1221b1404],
41	function	NN	O	function	prep_of	38	SENT_78	[p7l529t1302r1221b1404],
42	allele	NN	O	allele	dep	50	SENT_78	[p7l1256t1303r1474b1382],
43	(	CD	NUMBER	(	num	42	SENT_78	[p7l1515t1304r1682b1399],
44	i.e.	FW	O	i.e.	nsubjpass	50	SENT_78	[p7l1515t1304r1682b1399],
45	,	,	O	,	_	0	SENT_78	[p7l1515t1304r1682b1399],
46	*	CD	NUMBER	*	number	47	SENT_78	[p7l1722t1303r1899b1394],
47	17	CD	NUMBER	17	num	48	SENT_78	[p7l1722t1303r1899b1394],
48	)	NN	O	)	appos	44	SENT_78	[p7l1722t1303r1899b1394],
49	were	VBD	O	be	auxpass	50	SENT_78	[p7l1936t1329r2134b1382],
50	classified	VBN	O	classify	conj_and	30	SENT_78	[p7l12t1430r408b1510],
51	as	IN	O	as	_	0	SENT_78	[p7l445t1457r529b1509],
52	“	CD	NUMBER	“	num	54	SENT_78	[p7l573t1430r1303b1532],
53	gain	NN	O	gain	nn	54	SENT_78	[p7l573t1430r1303b1532],
54	—	NN	O	—	prep_as	50	SENT_78	[p7l573t1430r1303b1532],
55	of	IN	O	of	_	0	SENT_78	[p7l573t1430r1303b1532],
56	—	CD	NUMBER	—	num	59	SENT_78	[p7l573t1430r1303b1532],
57	function	NN	O	function	nn	59	SENT_78	[p7l573t1430r1303b1532],
58	allele	NN	O	allele	nn	59	SENT_78	[p7l1340t1431r1558b1509],
59	carriers	NNS	O	carrier	prep_of	54	SENT_78	[p7l1596t1432r1975b1510],
60	.	.	O	.	_	0	SENT_78	[p7l1596t1432r1975b1510],

1	”	RB	O	”	dep	3	SENT_79	[p7l1596t1432r1975b1510],
2	STATISTICAL	JJ	O	statistical	amod	3	SENT_79	[p7l20t1556r507b1606],
3	ANALYSIS	NN	O	analysis	_	0	SENT_79	[p7l537t1556r911b1606],

1	We	PRP	O	we	nsubj	3	SENT_80	[p7l16t1672r149b1742],
2	first	RB	ORDINAL	first	advmod	3	SENT_80	[p7l178t1663r362b1742],
3	explored	VBD	O	explore	_	0	SENT_80	[p7l387t1664r754b1764],
4	the	DT	O	the	det	7	SENT_80	[p7l784t1664r916b1742],
5	effect	NN	O	effect	nn	7	SENT_80	[p7l946t1663r1187b1742],
6	ofCYP2C19	NN	O	ofcyp2c19	nn	7	SENT_80	[p7l1213t1663r1668b1743],
7	genotypes	NNS	O	genotype	dobj	3	SENT_80	[p7l1697t1681r2132b1765],
8	on	IN	O	on	_	0	SENT_80	[p7l20t1818r126b1871],
9	efficacy	NN	O	efficacy	nn	12	SENT_80	[p7l169t1791r504b1892],
10	and	CC	O	and	_	0	SENT_80	[p7l542t1792r699b1871],
11	safety	NN	O	safety	nn	12	SENT_80	[p7l742t1791r994b1892],
12	outcomes	NNS	O	outcome	prep_on	3	SENT_80	[p7l1034t1809r1443b1871],
13	among	IN	O	among	_	0	SENT_80	[p7l1487t1818r1786b1893],
14	participants	NNS	O	participant	prep_among	3	SENT_80	[p7l1824t1793r2133b1892, p7l19t1936r253b2018],
15	of	IN	O	of	_	0	SENT_80	[p7l288t1918r387b1997],
16	European	JJ	MISC	european	amod	20	SENT_80	[p7l400t1927r812b2018],
17	or	CC	O	or	_	0	SENT_80	[p7l845t1945r933b1997],
18	Latin	JJ	MISC	latin	conj_or	16	SENT_80	[p7l961t1920r1182b1996],
19	American	JJ	MISC	american	amod	20	SENT_80	[p7l1211t1920r1630b1996],
20	ancestry	NN	O	ancestry	prep_of	14	SENT_80	[p7l1661t1936r2023b2018],
21	in	IN	O	in	_	0	SENT_80	[p7l2051t1920r2134b1995],
22	the	DT	O	the	det	24	SENT_80	[p7l20t2047r153b2125],
23	CURE	NN	O	cure	nn	24	SENT_80	[p7l186t2053r440b2130],
24	trial	NN	O	trial	prep_in	20	SENT_80	[p7l475t2047r675b2125],
25	.	.	O	.	_	0	SENT_80	[p7l475t2047r675b2125],

1	The	DT	O	the	det	2	SENT_81	[p7l710t2047r870b2125],
2	effect	NN	O	effect	_	0	SENT_81	[p7l903t2046r1144b2125],
3	of	IN	O	of	_	0	SENT_81	[p7l1173t2046r1272b2126],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_81	[p7l1287t2047r1768b2148],
5	as	IN	O	as	mark	18	SENT_81	[p7l1799t2073r1885b2125],
6	compared	VBN	O	compare	_	0	SENT_81	[p7l1920t2073r2133b2126, p7l19t2175r260b2274],
7	with	IN	O	with	prepc_compared_with	18	SENT_81	[p7l299t2175r493b2253],
8	placebo	NN	O	placebo	dep	18	SENT_81	[p7l535t2175r863b2274],
9	according	VBG	O	accord	_	0	SENT_81	[p7l907t2175r1332b2275],
10	to	TO	O	to	prepc_according_to	8	SENT_81	[p7l1373t2191r1453b2253],
11	the	DT	O	the	det	14	SENT_81	[p7l1499t2175r1630b2252],
12	genetically	RB	O	genetically	advmod	13	SENT_81	[p7l1674t2175r2139b2275],
13	derived	VBN	O	derive	amod	14	SENT_81	[p7l20t2302r327b2381],
14	CYP2C19	NN	O	cyp2c19	pobj	8	SENT_81	[p7l372t2308r715b2379],
15	metabolizer	NN	O	metabolizer	nn	16	SENT_81	[p7l759t2302r1275b2380],
16	phenotype	NN	O	phenotype	nsubjpass	18	SENT_81	[p7l1315t2302r1766b2401],
17	was	VBD	O	be	auxpass	18	SENT_81	[p7l1806t2328r1968b2381],
18	assessed	VBN	O	assess	dep	4	SENT_81	[p7l2014t2328r2133b2379, p7l21t2429r294b2507],
19	with	IN	O	with	_	0	SENT_81	[p7l326t2429r520b2508],
20	the	DT	O	the	det	21	SENT_81	[p7l557t2429r689b2506],
21	use	NN	O	use	prep_with	18	SENT_81	[p7l724t2455r865b2508],
22	of	IN	O	of	_	0	SENT_81	[p7l901t2428r1001b2507],
23	Cox	NN	O	cox	nn	25	SENT_81	[p7l1018t2435r1182b2507],
24	proportional-hazards	NNS	O	proportional-hazard	nn	25	SENT_81	[p7l1213t2429r2132b2528],
25	regression	NN	O	regression	prep_of	21	SENT_81	[p7l20t2558r488b2658],
26	.	.	O	.	_	0	SENT_81	[p7l20t2558r488b2658],

1	No	DT	O	no	det	4	SENT_82	[p7l556t2565r679b2636],
2	significant	JJ	O	significant	amod	4	SENT_82	[p7l747t2556r1213b2658],
3	effect	NN	O	effect	nn	4	SENT_82	[p7l1273t2556r1514b2635],
4	modification	NN	O	modification	nsubjpass	9	SENT_82	[p7l1573t2556r2134b2636],
5	according	VBG	O	accord	_	0	SENT_82	[p7l19t2685r444b2786],
6	to	TO	O	to	prepc_according_to	4	SENT_82	[p7l471t2702r552b2764],
7	ancestry	NN	O	ancestry	pobj	4	SENT_82	[p7l582t2702r944b2785],
8	was	VBD	O	be	auxpass	9	SENT_82	[p7l964t2711r1126b2764],
9	observed	VBN	O	observe	_	0	SENT_82	[p7l1159t2685r1538b2764],
10	for	IN	O	for	_	0	SENT_82	[p7l1567t2684r1689b2764],
11	any	DT	O	any	nsubj	16	SENT_82	[p7l1716t2711r1865b2785],
12	of	IN	O	of	_	0	SENT_82	[p7l1891t2684r1990b2764],
13	the	DT	O	the	det	15	SENT_82	[p7l2002t2685r2134b2763],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_82	[p7l19t2813r765b2914],
15	effects	NNS	O	effect	prep_of	11	SENT_82	[p7l847t2812r1127b2891],
16	described	VBD	O	describe	prepc_for	9	SENT_82	[p7l1212t2813r1622b2892],
17	(	CD	NUMBER	(	num	18	SENT_82	[p7l1709t2813r1916b2904],
18	data	NNS	O	datum	npadvmod	19	SENT_82	[p7l1709t2813r1916b2904],
19	not	RB	O	not	neg	20	SENT_82	[p7l1997t2830r2139b2892],
20	shown	VBN	O	show	dep	16	SENT_82	[p7l21t2940r352b3035],
21	)	NN	O	)	dobj	20	SENT_82	[p7l21t2940r352b3035],
22	,	,	O	,	_	0	SENT_82	[p7l21t2940r352b3035],
23	and	CC	O	and	_	0	SENT_82	[p7l389t2940r546b3018],
24	the	DT	O	the	det	25	SENT_82	[p7l579t2940r711b3017],
25	results	NNS	O	result	conj_and	20	SENT_82	[p7l743t2940r1025b3019],
26	from	IN	O	from	_	0	SENT_82	[p7l1059t2939r1269b3018],
27	Europeans	NNPS	MISC	Europeans	prep_from	25	SENT_82	[p7l1300t2948r1752b3039],
28	and	CC	O	and	_	0	SENT_82	[p7l1787t2940r1944b3018],
29	Latin	NNPS	MISC	Latin	nn	30	SENT_82	[p7l1974t2948r2133b3017, p7l19t3068r102b3143],
30	Americans	NNPS	MISC	Americans	nsubjpass	33	SENT_82	[p7l134t3068r595b3144],
31	were	VBD	O	be	auxpass	33	SENT_82	[p7l628t3093r829b3146],
32	therefore	RB	O	therefore	advmod	33	SENT_82	[p7l865t3066r1253b3145],
33	combined	VBN	O	combine	conj_and	16	SENT_82	[p7l1289t3067r1712b3145],
34	(	CD	NUMBER	(	dobj	33	SENT_82	[p7l1752t3067r1969b3157],
35	With	IN	O	with	_	0	SENT_82	[p7l1752t3067r1969b3157],
36	adjustment	NN	O	adjustment	prep_with	16	SENT_82	[p7l2004t3067r2133b3145, p7l6t3195r397b3293],
37	for	IN	O	for	_	0	SENT_82	[p7l426t3193r549b3272],
38	ancestry	NN	O	ancestry	nn	39	SENT_82	[p7l580t3201r989b3293],
39	)	NN	O	)	prep_for	36	SENT_82	[p7l580t3201r989b3293],
40	.	.	O	.	_	0	SENT_82	[p7l580t3201r989b3293],

1	We	PRP	O	we	nsubj	2	SENT_83	[p7l145t3330r277b3400],
2	used	VBD	O	use	_	0	SENT_83	[p7l310t3322r507b3401],
3	one	CD	NUMBER	one	num	4	SENT_83	[p7l541t3348r691b3401],
4	model	NN	O	model	dobj	2	SENT_83	[p7l725t3322r992b3401],
5	to	TO	O	to	aux	6	SENT_83	[p7l1025t3339r1106b3401],
6	adjust	VB	O	adjust	xcomp	2	SENT_83	[p7l1140t3322r1396b3422],
7	for	IN	O	for	_	0	SENT_83	[p7l1424t3321r1547b3401],
8	age	NN	O	age	prep_for	6	SENT_83	[p7l1577t3348r1742b3423],
9	,	,	O	,	_	0	SENT_83	[p7l1577t3348r1742b3423],
10	sex	NN	O	sex	conj_and	8	SENT_83	[p7l1783t3348r1938b3418],
11	,	,	O	,	_	0	SENT_83	[p7l1783t3348r1938b3418],
12	and	CC	O	and	_	0	SENT_83	[p7l1977t3322r2134b3401],
13	ancestry	NN	O	ancestry	prep_for	6	SENT_83	[p7l19t3467r387b3550],
14	and	CC	O	and	_	0	SENT_83	[p7l432t3450r591b3529],
15	another	DT	O	another	det	16	SENT_83	[p7l641t3450r981b3529],
16	model	NN	O	model	prep_for	6	SENT_83	[p7l1029t3450r1299b3529],
17	to	TO	O	to	aux	18	SENT_83	[p7l1349t3467r1431b3529],
18	adjust	VB	O	adjust	xcomp	6	SENT_83	[p7l1482t3450r1743b3550],
19	for	IN	O	for	_	0	SENT_83	[p7l1788t3449r1913b3529],
20	age	NN	O	age	nn	27	SENT_83	[p7l1959t3476r2128b3551],
21	,	,	O	,	_	0	SENT_83	[p7l1959t3476r2128b3551],
22	sex	NN	O	sex	dep	27	SENT_83	[p7l21t3605r173b3674],
23	,	,	O	,	_	0	SENT_83	[p7l21t3605r173b3674],
24	ancestry	NN	O	ancestry	dep	27	SENT_83	[p7l215t3595r582b3678],
25	,	,	O	,	_	0	SENT_83	[p7l215t3595r582b3678],
26	revascularization	NN	O	revascularization	dep	27	SENT_83	[p7l624t3579r1344b3658],
27	procedure	NN	O	procedure	prep_for	18	SENT_83	[p7l1379t3579r1801b3678],
28	(	CD	NUMBER	(	num	34	SENT_83	[p7l1843t3585r2133b3678, p7l20t3723r348b3786],
29	percutaneous	JJ	O	percutaneous	amod	34	SENT_83	[p7l1843t3585r2133b3678, p7l20t3723r348b3786],
30	coronary	JJ	O	coronary	amod	34	SENT_83	[p7l382t3732r758b3806],
31	intervention	NN	O	intervention	nn	34	SENT_83	[p7l785t3708r1295b3786],
32	[	CD	NUMBER	[	num	34	SENT_83	[p7l1336t3712r1539b3797],
33	PCI	NN	O	pcus	nn	34	SENT_83	[p7l1336t3712r1539b3797],
34	]	NN	O	]	dobj	18	SENT_83	[p7l1336t3712r1539b3797],
35	with	IN	O	with	prep	34	SENT_83	[p7l1576t3707r1767b3786],
36	or	CC	O	or	_	0	SENT_83	[p7l1799t3732r1887b3785],
37	without	IN	O	without	prep	34	SENT_83	[p7l1911t3707r2133b3786, p8l20t39r159b101],

1	stenting	VBG	O	stent	_	0	SENT_84	[p8l189t23r540b123],
2	and	CC	O	and	_	0	SENT_84	[p8l570t22r727b101],
3	coronary	JJ	O	coronary	amod	6	SENT_84	[p8l761t39r1431b122],
4	—	NN	O	—	nn	6	SENT_84	[p8l761t39r1431b122],
5	artery	NN	O	artery	nn	6	SENT_84	[p8l761t39r1431b122],
6	bypass	NN	O	bypass	nsubj	7	SENT_84	[p8l1461t22r1746b122],
7	grafting	VBG	O	graft	conj_and	1	SENT_84	[p8l1782t21r2137b123],
8	[	CD	NUMBER	[	num	9	SENT_84	[p8l29t155r393b245],
9	CABG	NN	O	cabg	dobj	7	SENT_84	[p8l29t155r393b245],
10	]	CD	NUMBER	]	num	11	SENT_84	[p8l29t155r393b245],
11	)	NN	O	)	dep	9	SENT_84	[p8l29t155r393b245],
12	,	,	O	,	_	0	SENT_84	[p8l29t155r393b245],
13	smoking	NN	O	smoking	nn	14	SENT_84	[p8l433t150r802b250],
14	status	NN	O	status	dobj	7	SENT_84	[p8l833t166r1102b245],
15	,	,	O	,	_	0	SENT_84	[p8l833t166r1102b245],
16	waist-to-hip	NN	O	waist-to-hip	nn	17	SENT_84	[p8l1136t150r1639b249],
17	ratio	NN	O	ratio	appos	14	SENT_84	[p8l1674t151r1887b245],
18	,	,	O	,	_	0	SENT_84	[p8l1674t151r1887b245],
19	presence	NN	O	presence	appos	14	SENT_84	[p8l1924t175r2133b249, p8l20t302r209b353],
20	or	CC	O	or	_	0	SENT_84	[p8l246t302r334b354],
21	absence	NN	O	absence	conj_or	19	SENT_84	[p8l366t276r702b354],
22	of	IN	O	of	_	0	SENT_84	[p8l739t275r838b354],
23	diabetes	NN	O	diabetes	prep_of	19	SENT_84	[p8l856t276r1233b371],
24	,	,	O	,	_	0	SENT_84	[p8l856t276r1233b371],
25	blood	NN	O	blood	nn	26	SENT_84	[p8l1275t276r1517b354],
26	pressure	NN	O	pressure	appos	14	SENT_84	[p8l1550t302r1936b375],
27	,	,	O	,	_	0	SENT_84	[p8l1550t302r1936b375],
28	and	CC	O	and	_	0	SENT_84	[p8l1977t276r2134b354],
29	country	NN	O	country	dobj	7	SENT_84	[p8l20t421r352b504],
30	of	IN	O	of	_	0	SENT_84	[p8l390t403r489b483],
31	origin	NN	O	origin	prep_of	29	SENT_84	[p8l513t405r794b505],
32	.	.	O	.	_	0	SENT_84	[p8l513t405r794b505],

1	Similar	JJ	O	similar	amod	2	SENT_85	[p8l843t404r1155b483],
2	results	NNS	O	result	nsubj	14	SENT_85	[p8l1193t404r1475b483],
3	were	VBD	O	be	auxpass	4	SENT_85	[p8l1514t430r1715b483],
4	obtained	VBN	O	obtain	_	0	SENT_85	[p8l1757t404r2134b483],
5	with	IN	O	with	_	0	SENT_85	[p8l15t531r210b610],
6	the	DT	O	the	det	8	SENT_85	[p8l247t531r380b608],
7	two	CD	NUMBER	two	num	8	SENT_85	[p8l417t548r574b610],
8	models	NNS	O	model	prep_with	4	SENT_85	[p8l612t531r944b626],
9	,	,	O	,	_	0	SENT_85	[p8l612t531r944b626],
10	and	CC	O	and	_	0	SENT_85	[p8l986t531r1143b609],
11	therefore	RB	O	therefore	advmod	14	SENT_85	[p8l1180t530r1591b626],
12	,	,	O	,	_	0	SENT_85	[p8l1180t530r1591b626],
13	only	RB	O	only	advmod	14	SENT_85	[p8l1634t531r1817b630],
14	results	VBZ	O	result	conj_and	4	SENT_85	[p8l1850t531r2131b610],
15	obtained	VBN	O	obtain	csubjpass	21	SENT_85	[p8l20t659r405b737],
16	with	IN	O	with	_	0	SENT_85	[p8l438t659r636b738],
17	the	DT	O	the	det	19	SENT_85	[p8l674t659r808b736],
18	parsimonious	JJ	O	parsimonious	amod	19	SENT_85	[p8l844t660r1447b758],
19	model	NN	O	model	prep_with	15	SENT_85	[p8l1486t659r1757b737],
20	are	VBP	O	be	auxpass	21	SENT_85	[p8l1793t685r1924b736],
21	presented	VBN	O	present	ccomp	14	SENT_85	[p8l1960t685r2133b758, p8l21t787r326b866],
22	.	.	O	.	_	0	SENT_85	[p8l1960t685r2133b758, p8l21t787r326b866],

1	Treatment	NN	O	treatment	nn	2	SENT_86	[p8l383t793r839b865],
2	effect	NN	O	effect	nsubjpass	12	SENT_86	[p8l890t786r1136b865],
3	according	VBG	O	accord	_	0	SENT_86	[p8l1186t787r1619b888],
4	to	TO	O	to	prepc_according_to	2	SENT_86	[p8l1672t804r1754b866],
5	loss-of	JJ	O	loss-of	amod	6	SENT_86	[p8l1810t786r2133b866],
6	function	NN	O	function	pobj	2	SENT_86	[p8l20t914r385b994],
7	and	CC	O	and	_	0	SENT_86	[p8l423t915r580b994],
8	gain-of-function	NN	O	gain-of-function	nn	10	SENT_86	[p8l618t914r1323b1016],
9	carrier	NN	O	carrier	nn	10	SENT_86	[p8l1363t916r1646b993],
10	status	NN	O	status	conj_and	6	SENT_86	[p8l1683t932r1934b994],
11	was	VBD	O	be	auxpass	12	SENT_86	[p8l1969t941r2131b994],
12	examined	VBN	O	examine	_	0	SENT_86	[p8l20t1043r447b1122],
13	with	IN	O	with	_	0	SENT_86	[p8l498t1043r696b1122],
14	the	DT	O	the	det	15	SENT_86	[p8l753t1043r888b1121],
15	use	NN	O	use	prep_with	12	SENT_86	[p8l944t1069r1087b1122],
16	of	IN	O	of	_	0	SENT_86	[p8l1144t1042r1245b1122],
17	analogous	JJ	O	analogous	amod	18	SENT_86	[p8l1282t1043r1731b1144],
18	models	NNS	O	model	prep_of	15	SENT_86	[p8l1790t1043r2129b1122],
19	.	.	O	.	_	0	SENT_86	[p8l1790t1043r2129b1122],

1	Power	NN	O	power	nn	2	SENT_87	[p8l19t1177r286b1249],
2	estimates	NNS	O	estimate	nsubjpass	4	SENT_87	[p8l332t1172r746b1248],
3	were	VBD	O	be	auxpass	4	SENT_87	[p8l792t1196r996b1249],
4	derived	VBN	O	derive	_	0	SENT_87	[p8l1045t1171r1359b1249],
5	through	IN	O	through	_	0	SENT_87	[p8l1407t1171r1760b1271],
6	simulations	NNS	O	simulation	prep_through	4	SENT_87	[p8l1810t1171r2133b1249, p8l20t1299r235b1377],
7	of	IN	O	of	_	0	SENT_87	[p8l287t1297r388b1377],
8	genetic	JJ	O	genetic	amod	9	SENT_87	[p8l418t1299r732b1399],
9	effects	NNS	O	effect	prep_of	6	SENT_87	[p8l782t1297r1069b1376],
10	(	VBP	O	(	rcmod	9	SENT_87	[p8l1126t1304r1366b1389],
11	5000	CD	NUMBER	5000	num	12	SENT_87	[p8l1126t1304r1366b1389],
12	simulations	NNS	O	simulation	dobj	10	SENT_87	[p8l1418t1298r1956b1389],
13	)	CD	NUMBER	)	nsubj	26	SENT_87	[p8l1418t1298r1956b1389],
14	according	VBG	O	accord	_	0	SENT_87	[p8l2011t1324r2133b1376, p8l20t1426r357b1527],
15	to	TO	O	to	prepc_according_to	13	SENT_87	[p8l394t1443r475b1505],
16	the	DT	O	the	det	18	SENT_87	[p8l518t1426r650b1504],
17	specified	VBN	O	specify	amod	18	SENT_87	[p8l692t1425r1077b1526],
18	models	NNS	O	model	pobj	13	SENT_87	[p8l1117t1426r1425b1505],
19	with	IN	O	with	_	0	SENT_87	[p8l1463t1426r1658b1505],
20	the	DT	O	the	det	21	SENT_87	[p8l1699t1426r1831b1504],
21	use	NN	O	use	prep_with	18	SENT_87	[p8l1872t1452r2012b1505],
22	of	IN	O	of	_	0	SENT_87	[p8l2053t1425r2153b1505],
23	logistic	JJ	O	logistic	amod	24	SENT_87	[p8l19t1554r325b1654],
24	regression	NN	O	regression	prep_of	21	SENT_87	[p8l354t1555r790b1654],
25	to	TO	O	to	aux	26	SENT_87	[p8l821t1570r901b1632],
26	ensure	VB	O	ensure	infmod	12	SENT_87	[p8l934t1579r1209b1632],
27	that	IN	O	that	complm	29	SENT_87	[p8l1241t1554r1409b1631],
28	we	PRP	O	we	nsubj	29	SENT_87	[p8l1429t1580r1546b1632],
29	had	VBD	O	have	ccomp	26	SENT_87	[p8l1576t1554r1730b1631],
30	adequate	JJ	O	adequate	amod	31	SENT_87	[p8l1760t1554r2133b1653],
31	power	NN	O	power	dobj	29	SENT_87	[p8l19t1707r285b1781],
32	to	TO	O	to	aux	33	SENT_87	[p8l314t1698r395b1760],
33	detect	VB	O	detect	infmod	31	SENT_87	[p8l430t1681r687b1760],
34	the	DT	O	the	det	35	SENT_87	[p8l714t1681r846b1759],
35	range	NN	O	range	dobj	33	SENT_87	[p8l878t1707r1118b1782],
36	of	IN	O	of	_	0	SENT_87	[p8l1151t1680r1250b1760],
37	interactions	NNS	O	interaction	prep_of	35	SENT_87	[p8l1263t1682r1771b1760],
38	that	WDT	O	that	nsubjpass	41	SENT_87	[p8l1805t1681r1971b1759],
39	has	VBZ	O	have	aux	41	SENT_87	[p8l1993t1681r2132b1759],
40	been	VBN	O	be	auxpass	41	SENT_87	[p8l20t1808r224b1886],
41	reported	VBN	O	report	rcmod	37	SENT_87	[p8l263t1808r636b1907],
42	previously	RB	DATE	previously	advmod	41	SENT_87	[p8l673t1808r1134b1907],
43	.	.	O	.	_	0	SENT_87	[p8l673t1808r1134b1907],

1	Two-sided	JJ	O	two-sided	amod	3	SENT_88	[p8l1175t1808r1621b1887],
2	P	NN	O	p	nn	3	SENT_88	[p8l1659t1815r1711b1884],
3	Values	NNS	O	value	nsubjpass	9	SENT_88	[p8l1743t1808r2010b1887],
4	of	IN	O	of	_	0	SENT_88	[p8l2051t1807r2152b1886],
5	less	JJR	O	less	mwe	6	SENT_88	[p8l19t1936r171b2013],
6	than	IN	O	than	quantmod	7	SENT_88	[p8l205t1936r397b2013],
7	0.05	CD	NUMBER	0.05	prep_of	3	SENT_88	[p8l429t1941r598b2014],
8	were	VBD	O	be	auxpass	9	SENT_88	[p8l629t1961r827b2014],
9	considered	VBN	O	consider	_	0	SENT_88	[p8l859t1936r1311b2014],
10	to	TO	O	to	aux	11	SENT_88	[p8l1343t1952r1423b2014],
11	indicate	VB	O	indicate	xcomp	9	SENT_88	[p8l1455t1936r1787b2014],
12	statistical	JJ	O	statistical	acomp	11	SENT_88	[p8l1820t1937r2133b2013, p8l20t2063r138b2141],

1	significance	NN	O	significance	_	0	SENT_89	[p8l173t2062r704b2164],
2	.	.	O	.	_	0	SENT_89	[p8l173t2062r704b2164],

1	The	DT	O	the	det	3	SENT_90	[p8l739t2063r898b2141],
2	same	JJ	O	same	amod	3	SENT_90	[p8l932t2089r1148b2141],
3	approach	NN	O	approach	nsubjpass	5	SENT_90	[p8l1181t2063r1567b2163],
4	was	VBD	O	be	auxpass	5	SENT_90	[p8l1595t2089r1755b2142],
5	used	VBN	O	use	_	0	SENT_90	[p8l1790t2063r1984b2142],
6	for	IN	O	for	_	0	SENT_90	[p8l2017t2062r2137b2142],
7	the	DT	O	the	det	8	SENT_90	[p8l20t2190r150b2267],
8	analyses	NNS	O	analysis	prep_for	5	SENT_90	[p8l187t2190r537b2289],
9	of	IN	O	of	_	0	SENT_90	[p8l577t2189r676b2268],
10	data	NNS	O	datum	prep_of	8	SENT_90	[p8l695t2190r874b2268],
11	from	IN	O	from	_	0	SENT_90	[p8l909t2189r1116b2268],
12	the	DT	O	the	det	13	SENT_90	[p8l1153t2190r1283b2267],
13	CURE	NN	O	cure	prep_from	5	SENT_90	[p8l1320t2196r1572b2273],
14	and	CC	O	and	_	0	SENT_90	[p8l1611t2190r1765b2268],
15	ACTIVE	NNP	O	ACTIVE	nn	17	SENT_90	[p8l1799t2196r2132b2268],
16	A	NNP	O	A	nn	17	SENT_90	[p8l16t2325r82b2394],
17	trials	NNS	O	trial	prep_from	5	SENT_90	[p8l119t2318r362b2396],
18	.	.	O	.	_	0	SENT_90	[p8l119t2318r362b2396],

1	RESULTS	NNS	O	result	_	0	SENT_91	[p8l841t2617r1314b2676],

1	THE	DT	O	the	det	2	SENT_92	[p8l17t2851r169b2899],
2	cum	NN	O	cum	_	0	SENT_92	[p8l204t2850r406b2900],
3	;	:	O	;	_	0	SENT_92	[p8l204t2850r406b2900],
4	sruov	NN	O	sruov	dep	2	SENT_92	[p8l440t2850r695b2900],

1	The	DT	O	the	det	2	SENT_93	[p8l16t2950r176b3028],
2	characteristics	NNS	O	characteristic	nsubjpass	8	SENT_93	[p8l211t2950r830b3028],
3	of	IN	O	of	_	0	SENT_93	[p8l867t2949r966b3029],
4	the	DT	O	the	det	6	SENT_93	[p8l982t2950r1115b3028],
5	genotyped	JJ	O	genotyped	amod	6	SENT_93	[p8l1148t2950r1597b3051],
6	patients	NNS	O	patient	prep_of	2	SENT_93	[p8l1630t2951r1970b3050],
7	are	VBP	O	be	auxpass	8	SENT_93	[p8l2005t2976r2134b3028],
8	presented	VBN	O	present	_	0	SENT_93	[p8l19t3077r435b3176],
9	in	IN	O	in	_	0	SENT_93	[p8l467t3078r551b3153],
10	Table	NNP	O	Table	prep_in	8	SENT_93	[p8l579t3077r809b3155],
11	1	CD	NUMBER	1	num	10	SENT_93	[p8l845t3083r912b3155],
12	.	.	O	.	_	0	SENT_93	[p8l845t3083r912b3155],

1	A	DT	O	a	det	2	SENT_94	[p8l946t3085r1012b3153],
2	total	NN	O	total	nsubj	9	SENT_94	[p8l1043t3077r1238b3155],
3	of	IN	O	of	_	0	SENT_94	[p8l1271t3076r1371b3155],
4	5059	CD	DATE	5059	num	5	SENT_94	[p8l1387t3083r1585b3155],
5	participants	NNS	O	participant	prep_of	2	SENT_94	[p8l1617t3078r2132b3176],
6	of	IN	O	of	_	0	SENT_94	[p8l20t3203r120b3282],
7	self	NN	O	self	nn	8	SENT_94	[p8l140t3203r684b3303],
8	—	NN	O	—	prep_of	5	SENT_94	[p8l140t3203r684b3303],
9	reported	VBD	O	report	_	0	SENT_94	[p8l140t3203r684b3303],
10	European	JJ	MISC	european	amod	14	SENT_94	[p8l719t3212r1131b3303],
11	or	CC	O	or	_	0	SENT_94	[p8l1169t3230r1256b3282],
12	Latin	JJ	MISC	latin	conj_or	10	SENT_94	[p8l1289t3205r1511b3281],
13	American	JJ	MISC	american	amod	14	SENT_94	[p8l1544t3205r1962b3281],
14	ancestry	NN	O	ancestry	nsubjpass	17	SENT_94	[p8l1999t3230r2133b3281, p8l20t3349r275b3432],
15	were	VBD	O	be	auxpass	17	SENT_94	[p8l332t3358r533b3411],
16	successfully	RB	O	successfully	advmod	17	SENT_94	[p8l601t3331r1116b3432],
17	genotyped	VBN	O	genotype	ccomp	9	SENT_94	[p8l1177t3332r1648b3433],
18	,	,	O	,	_	0	SENT_94	[p8l1177t3332r1648b3433],
19	of	IN	O	of	dep	25	SENT_94	[p8l1721t3331r1820b3411],
20	whom	WP	O	whom	pobj	19	SENT_94	[p8l1864t3332r2134b3411],
21	2549	CD	DATE	2549	nsubjpass	25	SENT_94	[p8l20t3465r222b3538],
22	had	VBD	O	have	aux	25	SENT_94	[p8l259t3460r415b3538],
23	been	VBN	O	be	auxpass	25	SENT_94	[p8l450t3460r650b3538],
24	randomly	RB	O	randomly	advmod	25	SENT_94	[p8l685t3460r1098b3559],
25	assigned	VBN	O	assign	ccomp	17	SENT_94	[p8l1129t3460r1500b3560],
26	to	TO	O	to	_	0	SENT_94	[p8l1536t3476r1617b3538],
27	clopidogrel	NN	O	clopidogrel	prep_to	25	SENT_94	[p8l1654t3460r2135b3560],
28	and	CC	O	and	_	0	SENT_94	[p8l19t3587r176b3666],
29	2510	CD	DATE	2510	prep_to	25	SENT_94	[p8l226t3592r421b3666],
30	to	TO	O	to	_	0	SENT_94	[p8l470t3604r550b3666],
31	placebo	NN	O	placebo	prep_to	25	SENT_94	[p8l597t3587r940b3687],
32	.	.	O	.	_	0	SENT_94	[p8l597t3587r940b3687],

1	The	DT	O	the	det	2	SENT_95	[p8l990t3587r1147b3665],
2	benefit	NN	O	benefit	_	0	SENT_95	[p8l1196t3586r1493b3666],
3	of	IN	O	of	_	0	SENT_95	[p8l1536t3586r1635b3666],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_95	[p8l1665t3587r2135b3688],
5	treatment	NN	O	treatment	prep_of	2	SENT_95	[p9l20t36r434b97],
6	as	IN	O	as	mark	45	SENT_95	[p9l463t46r547b97],
7	compared	VBN	O	compare	_	0	SENT_95	[p9l585t20r1002b119],
8	with	IN	O	with	prepc_compared_with	45	SENT_95	[p9l1034t20r1224b99],
9	placebo	NN	O	placebo	pobj	45	SENT_95	[p9l1258t20r1580b119],
10	with	IN	O	with	_	0	SENT_95	[p9l1612t20r1803b99],
11	respect	NN	O	respect	_	0	SENT_95	[p9l1838t36r2139b119],
12	to	TO	O	to	_	0	SENT_95	[p9l20t164r100b225],
13	the	DT	O	the	det	18	SENT_95	[p9l148t147r278b224],
14	first	JJ	ORDINAL	first	amod	18	SENT_95	[p9l323t146r503b224],
15	primary	JJ	O	primary	amod	18	SENT_95	[p9l542t148r885b246],
16	composite	JJ	O	composite	amod	18	SENT_95	[p9l927t148r1358b246],
17	efﬁcacy	NN	O	efﬁcacy	nn	18	SENT_95	[p9l1404t146r1731b246],
18	outcome	NN	O	outcome	prep_with_respect_to	9	SENT_95	[p9l1774t164r2134b226],
19	was	VBD	O	be	cop	20	SENT_95	[p9l15t301r175b353],
20	similar	JJ	O	similar	rcmod	18	SENT_95	[p9l211t275r510b352],
21	between	IN	O	between	_	0	SENT_95	[p9l540t275r890b353],
22	participants	NNS	O	participant	prep_between	20	SENT_95	[p9l922t276r1425b374],
23	who	WP	O	who	nsubjpass	25	SENT_95	[p9l1455t275r1635b353],
24	were	VBD	O	be	auxpass	25	SENT_95	[p9l1665t301r1863b353],
25	genotyped	VBN	O	genotype	rcmod	22	SENT_95	[p9l1896t300r2133b375, p9l20t401r253b500],
26	for	IN	O	for	_	0	SENT_95	[p9l290t400r410b479],
27	our	PRP$	O	we	poss	28	SENT_95	[p9l444t427r587b480],
28	analysis	NN	O	analysis	prep_for	25	SENT_95	[p9l621t401r952b500],
29	and	CC	O	and	_	0	SENT_95	[p9l990t401r1145b479],
30	the	DT	O	the	det	32	SENT_95	[p9l1182t401r1312b478],
31	total	JJ	O	total	amod	32	SENT_95	[p9l1350t401r1542b479],
32	cohort	NN	O	cohort	conj_and	28	SENT_95	[p9l1579t401r1854b479],
33	in	IN	O	in	_	0	SENT_95	[p9l1884t402r1967b477],
34	the	DT	O	the	det	36	SENT_95	[p9l2004t401r2134b478],
35	parent	NN	O	parent	nn	36	SENT_95	[p9l19t545r291b628],
36	studyzz	NN	O	studyzz	prep_in	25	SENT_95	[p9l322t529r600b628],
37	among	IN	O	among	_	0	SENT_95	[p9l638t554r933b629],
38	the	DT	O	the	det	40	SENT_95	[p9l964t529r1094b606],
39	genotyped	JJ	O	genotyped	amod	40	SENT_95	[p9l1129t529r1569b629],
40	participants	NNS	O	participant	prep_among	36	SENT_95	[p9l1602t530r2128b628],
41	,	,	O	,	_	0	SENT_95	[p9l1602t530r2128b628],
42	the	DT	O	the	det	44	SENT_95	[p9l20t655r150b732],
43	primary	JJ	O	primary	amod	44	SENT_95	[p9l186t656r529b754],
44	outcome	NN	O	outcome	nsubj	45	SENT_95	[p9l562t672r922b734],
45	occurred	VBD	O	occur	dep	2	SENT_95	[p9l960t655r1330b734],
46	in	IN	O	in	_	0	SENT_95	[p9l1366t656r1448b731],
47	9.1	CD	PERCENT	9.1	num	48	SENT_95	[p9l1485t660r1683b734],
48	%	NN	PERCENT	%	prep_in	45	SENT_95	[p9l1485t660r1683b734],
49	of	IN	O	of	_	0	SENT_95	[p9l1720t654r1818b733],
50	the	DT	O	the	det	51	SENT_95	[p9l1838t655r1968b732],
51	pa1706	NN	O	pa1706	prep_of	48	SENT_95	[p9l2004t681r2133b754, p9l149t812r225b835],

1	N	NN	O	n	nn	3	SENT_96	[p9l938t823r951b838],
2	ENGLJ	NN	O	englj	nn	3	SENT_96	[p9l966t823r1044b845],
3	MED363	NN	O	med363	_	0	SENT_96	[p9l1059t817r1197b845],
4	;	:	O	;	_	0	SENT_96	[p9l1059t817r1197b845],
5	18	CD	NUMBER	18	num	7	SENT_96	[p9l1059t817r1197b845],
6	NEJM.ORG	NN	O	nejm.org	nn	7	SENT_96	[p9l1232t823r1356b845],
7	OCTOBER	NN	DATE	october	dep	3	SENT_96	[p9l1392t823r1504b839],
8	28	CD	DATE	28	dep	7	SENT_96	[p9l1514t817r1549b843],
9	,	,	DATE	,	_	0	SENT_96	[p9l1514t817r1549b843],
10	2010	CD	DATE	2010	appos	8	SENT_96	[p9l1560t823r1621b839],

1	The	DT	O	the	det	4	SENT_97	[p9l935t856r986b880],
2	New	NNP	O	New	nn	4	SENT_97	[p9l995t857r1057b880],
3	England	NNP	O	England	nn	4	SENT_97	[p9l1066t856r1177b887],
4	Journal	NNP	O	Journal	_	0	SENT_97	[p9l1186t856r1283b880],
5	of	IN	O	of	_	0	SENT_97	[p9l1293t856r1322b880],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_97	[p9l1329t856r1454b880],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_98	[p9l505t981r626b1001],
2	GENOTYPE	NN	O	genotype	dep	1	SENT_98	[p9l641t981r814b1000],
3	AND	CC	O	and	_	0	SENT_98	[p9l827t981r899b1000],
4	CLOPIDOGREL	NN	O	clopidogrel	nn	5	SENT_98	[p9l913t981r1150b1000],
5	TREATMENT	NN	O	treatment	dep	1	SENT_98	[p9l1162t981r1367b1000],

1	Table	NNP	O	Table	_	0	SENT_99	[p9l119t1103r193b1128],
2	1	CD	NUMBER	1	dep	1	SENT_99	[p9l203t1106r225b1128],
3	.	.	O	.	_	0	SENT_99	[p9l203t1106r225b1128],

1	Baseline	NN	O	baseline	nn	2	SENT_100	[p9l236t1103r350b1128],
2	Characteristics	NNS	O	characteristic	_	0	SENT_100	[p9l358t1103r561b1128],
3	of	IN	O	of	_	0	SENT_100	[p9l571t1103r753b1136],
4	'	''	O	'	_	0	SENT_100	[p9l571t1103r753b1136],
5	Genotyped	JJ	O	genotyped	amod	6	SENT_100	[p9l571t1103r753b1136],
6	Patients	NNS	O	patient	prep_of	2	SENT_100	[p9l766t1104r874b1128],
7	in	IN	O	in	_	0	SENT_100	[p9l884t1104r907b1128],
8	the	DT	O	the	det	9	SENT_100	[p9l916t1103r960b1128],
9	CURE	NN	O	cure	prep_in	2	SENT_100	[p9l969t1105r1048b1128],
10	and	CC	O	and	_	0	SENT_100	[p9l1058t1103r1107b1128],
11	ACTIVE	NNP	O	ACTIVE	nn	13	SENT_100	[p9l1117t1105r1221b1129],
12	A	NNP	O	A	nn	13	SENT_100	[p9l1230t1106r1250b1128],
13	Trials	NNPS	O	Trials	conj_and	9	SENT_100	[p9l1257t1103r1358b1128],
14	.	.	O	.	_	0	SENT_100	[p9l1257t1103r1358b1128],

1	‘	SYM	O	‘	dep	3	SENT_101	[p9l1257t1103r1358b1128],
2	-	:	O	-	_	0	SENT_101	[p9l1257t1103r1358b1128],
3	‘	NN	O	‘	_	0	SENT_101	[p9l1257t1103r1358b1128],

1	Characteristic	JJ	MISC	characteristic	amod	3	SENT_102	[p9l120t1178r308b1204],
2	CURE	NN	MISC	cure	nn	3	SENT_102	[p9l871t1180r950b1204],
3	Trial	NN	MISC	trial	_	0	SENT_102	[p9l960t1178r1020b1204],
4	ACTIVE	NNP	MISC	ACTIVE	nn	5	SENT_102	[p9l1625t1180r1729b1204],
5	A	NNP	MISC	A	dep	3	SENT_102	[p9l1739t1181r1759b1203],

1	Placebo	NNP	O	Placebo	nn	6	SENT_103	[p9l646t1236r750b1261],
2	Clopidogrel	NNP	O	Clopidogrel	nn	6	SENT_103	[p9l867t1236r1023b1269],
3	Total	NNP	O	Total	nn	6	SENT_103	[p9l1160t1236r1227b1261],
4	Placebo	NNP	O	Placebo	nn	6	SENT_103	[p9l1393t1236r1497b1261],
5	Clopidogrel	NNP	O	Clopidogrel	nn	6	SENT_103	[p9l1614t1236r1770b1269],
6	Total	NNP	O	Total	_	0	SENT_103	[p9l1906t1236r1973b1261],
7	(	CD	NUMBER	(	num	8	SENT_103	[p9l630t1275r764b1307],
8	N	NN	O	n	npadvmod	9	SENT_103	[p9l630t1275r764b1307],
9	=	JJ	O	=	amod	6	SENT_103	[p9l630t1275r764b1307],
10	2510	CD	DATE	2510	number	11	SENT_103	[p9l630t1275r764b1307],
11	)	CD	NUMBER	)	num	33	SENT_103	[p9l630t1275r764b1307],
12	(	NN	O	(	nn	33	SENT_103	[p9l879t1276r1013b1306],
13	N	NN	O	n	nn	33	SENT_103	[p9l879t1276r1013b1306],
14	=	JJ	O	=	amod	33	SENT_103	[p9l879t1276r1013b1306],
15	2549	CD	DATE	2549	number	16	SENT_103	[p9l879t1276r1013b1306],
16	)	CD	NUMBER	)	num	33	SENT_103	[p9l879t1276r1013b1306],
17	(	NN	O	(	nn	33	SENT_103	[p9l1128t1275r1262b1307],
18	N	NN	O	n	nn	33	SENT_103	[p9l1128t1275r1262b1307],
19	=	JJ	O	=	amod	33	SENT_103	[p9l1128t1275r1262b1307],
20	5059	CD	NUMBER	5059	number	21	SENT_103	[p9l1128t1275r1262b1307],
21	)	CD	NUMBER	)	num	33	SENT_103	[p9l1128t1275r1262b1307],
22	(	NN	O	(	nn	33	SENT_103	[p9l1385t1275r1503b1307],
23	N	NN	O	n	nn	33	SENT_103	[p9l1385t1275r1503b1307],
24	=	JJ	O	=	amod	33	SENT_103	[p9l1385t1275r1503b1307],
25	586	CD	NUMBER	586	number	26	SENT_103	[p9l1385t1275r1503b1307],
26	)	CD	NUMBER	)	num	33	SENT_103	[p9l1385t1275r1503b1307],
27	(	NN	O	(	nn	33	SENT_103	[p9l1634t1275r1752b1307],
28	N	NN	O	n	nn	33	SENT_103	[p9l1634t1275r1752b1307],
29	=	JJ	O	=	amod	33	SENT_103	[p9l1634t1275r1752b1307],
30	570	CD	NUMBER	570	number	31	SENT_103	[p9l1634t1275r1752b1307],
31	)	CD	NUMBER	)	num	33	SENT_103	[p9l1634t1275r1752b1307],
32	(	NN	O	(	nn	33	SENT_103	[p9l1874t1276r2009b1307],
33	N	NN	O	n	dep	6	SENT_103	[p9l1874t1276r2009b1307],
34	=	JJ	O	=	amod	33	SENT_103	[p9l1874t1276r2009b1307],
35	1156	CD	DATE	1156	number	36	SENT_103	[p9l1874t1276r2009b1307],
36	)	CD	NUMBER	)	dep	34	SENT_103	[p9l1874t1276r2009b1307],

1	Ancestry	NN	O	ancestry	nsubj	4	SENT_104	[p9l119t1333r237b1364],
2	(	CD	PERCENT	(	number	3	SENT_104	[p9l249t1332r315b1364],
3	%	NN	PERCENT	%	amod	1	SENT_104	[p9l249t1332r315b1364],
4	)	NN	O	)	_	0	SENT_104	[p9l249t1332r315b1364],
5	'	''	O	'	_	0	SENT_104	[p9l249t1332r315b1364],
6	i	FW	O	i	dobj	4	SENT_104	[p9l249t1332r315b1364],
7	'	''	O	'	_	0	SENT_104	[p9l249t1332r315b1364],

1	European	JJ	MISC	european	dep	17	SENT_105	[p9l172t1391r299b1422],
2	85.7	CD	NUMBER	85.7	number	3	SENT_105	[p9l669t1390r725b1414],
3	86.2	CD	NUMBER	86.2	num	5	SENT_105	[p9l918t1390r974b1414],
4	85.9	CD	NUMBER	85.9	number	5	SENT_105	[p9l1167t1390r1223b1414],
5	100 100 100	CD	NUMBER	100 100 100	npadvmod	6	SENT_105	[p9l1904t1390r1950b1414],[p9l1406t1390r1452b1414],
6	Latin	JJ	MISC	latin	dep	1	SENT_105	[p9l172t1449r236b1472],
7	American	JJ	MISC	american	amod	6	SENT_105	[p9l246t1448r375b1472],
8	14.3	CD	NUMBER	14.3	number	9	SENT_105	[p9l671t1449r723b1472],
9	13.8	CD	NUMBER	13.8	num	6	SENT_105	[p9l920t1448r974b1472],
10	14.1	CD	NUMBER	14.1	num	13	SENT_105	[p9l1169t1449r1222b1472],
11	o	NN	O	o	nn	13	SENT_105	[p9l1437t1448r1452b1472],
12	o	NN	O	o	nn	13	SENT_105	[p9l1686t1448r1701b1472],
13	o	NN	O	o	dep	6	SENT_105	[p9l1935t1448r1950b1472],
14	Female	JJ	O	female	amod	15	SENT_105	[p9l122t1504r219b1529],
15	sex	NN	O	sex	dep	17	SENT_105	[p9l229t1513r271b1529],
16	(	CD	PERCENT	(	num	17	SENT_105	[p9l283t1505r328b1537],
17	%	NN	PERCENT	%	dep	87	SENT_105	[p9l283t1505r328b1537],
18	)	CD	NUMBER	)	number	19	SENT_105	[p9l283t1505r328b1537],
19	40.9	CD	NUMBER	40.9	num	21	SENT_105	[p9l668t1506r725b1529],
20	41.2	CD	NUMBER	41.2	number	21	SENT_105	[p9l917t1506r973b1529],
21	41.0	CD	NUMBER	41.0	dep	17	SENT_105	[p9l1166t1506r1223b1529],
22	45.2	CD	NUMBER	45.2	num	36	SENT_105	[p9l1420t1506r1476b1529],
23	45.6	CD	NUMBER	45.6	number	24	SENT_105	[p9l1669t1506r1726b1529],
24	45.4	CD	NUMBER	45.4	num	28	SENT_105	[p9l1918t1506r1975b1529],
25	Age	NNP	O	Age	nn	28	SENT_105	[p9l119t1563r170b1595],
26	(	CD	NUMBER	(	num	28	SENT_105	[p9l183t1564r224b1595],
27	yr	NN	DURATION	yr	nn	28	SENT_105	[p9l183t1564r224b1595],
28	)	NN	O	)	npadvmod	35	SENT_105	[p9l183t1564r224b1595],
29	63.9111.1	CD	NUMBER	63.9111.1	number	30	SENT_105	[p9l637t1564r767b1587],
30	63.8111.0	CD	NUMBER	63.8111.0	num	28	SENT_105	[p9l886t1563r1018b1587],
31	63.8111.0	CD	NUMBER	63.8111.0	number	32	SENT_105	[p9l1135t1563r1267b1587],
32	71.119.7	CD	NUMBER	71.119.7	num	28	SENT_105	[p9l1385t1564r1499b1587],
33	70.8110.1	CD	NUMBER	70.8110.1	number	34	SENT_105	[p9l1634t1563r1764b1587],
34	71.019.9	CD	NUMBER	71.019.9	num	28	SENT_105	[p9l1883t1563r1997b1587],
35	Body-mass	JJ	MISC	body-mass	amod	36	SENT_105	[p9l122t1619r269b1652],
36	index	NN	O	index	dep	21	SENT_105	[p9l281t1619r370b1652],
37	:	:	O	:	_	0	SENT_105	[p9l281t1619r370b1652],
38	i	FW	O	i	nn	39	SENT_105	[p9l281t1619r370b1652],
39	_	FW	O	_	dep	21	SENT_105	[p9l281t1619r370b1652],
40	:	:	O	:	_	0	SENT_105	[p9l281t1619r370b1652],
41	27.614.1	CD	NUMBER	27.614.1	number	42	SENT_105	[p9l636t1621r751b1645],
42	27.714.2	CD	NUMBER	27.714.2	dep	39	SENT_105	[p9l885t1622r1001b1644],
43	27.614.2	CD	NUMBER	27.614.2	num	44	SENT_105	[p9l1134t1621r1250b1645],
44	29.115.5	CD	NUMBER	29.115.5	dep	49	SENT_105	[p9l1383t1622r1498b1645],
45	28.915.7	CD	NUMBER	28.915.7	num	46	SENT_105	[p9l1632t1621r1748b1645],
46	29.015.6	CD	NUMBER	29.015.6	dep	44	SENT_105	[p9l1881t1621r1997b1645],
47	Diabetes	NNP	O	Diabetes	dep	49	SENT_105	[p9l122t1677r239b1702],
48	(	CD	PERCENT	(	num	49	SENT_105	[p9l253t1678r297b1710],
49	%	NN	PERCENT	%	dep	58	SENT_105	[p9l253t1678r297b1710],
50	)	CD	NUMBER	)	number	51	SENT_105	[p9l253t1678r297b1710],
51	21.5	CD	NUMBER	21.5	dep	49	SENT_105	[p9l669t1679r723b1702],
52	20.7	CD	NUMBER	20.7	num	53	SENT_105	[p9l918t1679r974b1702],
53	21.1	CD	NUMBER	21.1	dep	51	SENT_105	[p9l1167t1679r1222b1702],
54	20.6	CD	NUMBER	20.6	num	58	SENT_105	[p9l1421t1679r1477b1702],
55	21.8	CD	NUMBER	21.8	number	56	SENT_105	[p9l1670t1679r1725b1702],
56	21.2	CD	NUMBER	21.2	amod	58	SENT_105	[p9l1919t1679r1974b1702],
57	Current	JJ	DATE	current	amod	58	SENT_105	[p9l120t1737r223b1760],
58	smoker	NN	O	smoker	dep	61	SENT_105	[p9l233t1735r334b1760],
59	(	CD	PERCENT	(	num	60	SENT_105	[p9l346t1736r391b1768],
60	%	NN	PERCENT	%	dep	58	SENT_105	[p9l346t1736r391b1768],
61	)	CD	NUMBER	)	dep	73	SENT_105	[p9l346t1736r391b1768],
62	21.6	CD	NUMBER	21.6	number	63	SENT_105	[p9l669t1737r725b1760],
63	23.1	CD	NUMBER	23.1	num	65	SENT_105	[p9l918t1737r973b1760],
64	22.4	CD	NUMBER	22.4	number	65	SENT_105	[p9l1167t1737r1223b1760],
65	6.8	CD	NUMBER	6.8	dep	61	SENT_105	[p9l1438t1736r1476b1760],
66	8.4	CD	NUMBER	8.4	number	67	SENT_105	[p9l1686t1736r1726b1760],
67	7.6	CD	NUMBER	7.6	num	72	SENT_105	[p9l1937t1737r1975b1760],
68	Blood	NN	O	blood	nn	72	SENT_105	[p9l122t1792r198b1817],
69	pressure	NN	O	pressure	nn	72	SENT_105	[p9l211t1801r327b1825],
70	(	CD	NUMBER	(	num	72	SENT_105	[p9l339t1794r401b1825],
71	mm	NN	O	mm	nn	72	SENT_105	[p9l339t1794r401b1825],
72	Hg	NN	O	hg	dep	65	SENT_105	[p9l415t1794r463b1825],
73	)	CD	NUMBER	)	dep	39	SENT_105	[p9l415t1794r463b1825],
74	Systolic	JJ	O	systolic	amod	76	SENT_105	[p9l171t1850r274b1883],
75	134.6122.0	CD	NUMBER	134.6122.0	number	76	SENT_105	[p9l621t1852r769b1875],
76	135.5122.3	CD	NUMBER	135.5122.3	dep	73	SENT_105	[p9l870t1852r1016b1875],
77	135.0122.1	CD	NUMBER	135.0122.1	number	78	SENT_105	[p9l1120t1852r1266b1875],
78	136.3118.9	CD	NUMBER	136.3118.9	num	80	SENT_105	[p9l1368t1852r1516b1875],
79	136.6119.0	CD	NUMBER	136.6119.0	number	80	SENT_105	[p9l1617t1852r1765b1875],
80	136.4118.9	CD	NUMBER	136.4118.9	npadvmod	81	SENT_105	[p9l1866t1852r2014b1875],
81	Diastolic	JJ	MISC	diastolic	amod	76	SENT_105	[p9l172t1908r290b1933],
82	78.3113.8	CD	NUMBER	78.3113.8	number	83	SENT_105	[p9l638t1909r769b1933],
83	78.6113.6	CD	NUMBER	78.6113.6	num	85	SENT_105	[p9l887t1909r1018b1933],
84	78.4113.7	CD	NUMBER	78.4113.7	number	85	SENT_105	[p9l1136t1909r1267b1933],
85	80.3111.4	CD	NUMBER	80.3111.4	dep	39	SENT_105	[p9l1383t1909r1516b1933],
86	80.9111.5	CD	NUMBER	80.9111.5	num	87	SENT_105	[p9l1632t1909r1763b1933],
87	80.6111.5	CD	NUMBER	80.6111.5	_	0	SENT_105	[p9l1881t1909r2012b1933],

1	PCI	NN	O	pcus	dep	29	SENT_106	[p9l122t1967r164b1990],
2	(	CD	PERCENT	(	num	3	SENT_106	[p9l180t1966r224b1998],
3	%	NN	PERCENT	%	dep	1	SENT_106	[p9l180t1966r224b1998],
4	)	CD	NUMBER	)	dep	21	SENT_106	[p9l180t1966r224b1998],
5	Without	IN	O	without	_	0	SENT_106	[p9l169t2023r280b2048],
6	stent	NN	O	stent	nn	12	SENT_106	[p9l290t2028r357b2048],
7	3.9	CD	NUMBER	3.9	num	12	SENT_106	[p9l687t2025r725b2048],
8	3.2	CD	NUMBER	3.2	num	12	SENT_106	[p9l936t2025r974b2048],
9	3.5	CD	NUMBER	3.5	num	12	SENT_106	[p9l1185t2025r1222b2048],
10	NA	NNP	O	NA	nn	12	SENT_106	[p9l1425t2025r1466b2048],
11	NA	NNP	O	NA	nn	12	SENT_106	[p9l1674t2025r1715b2048],
12	NA	NNP	O	NA	prep_without	4	SENT_106	[p9l1922t2025r1963b2048],
13	With	IN	O	with	_	0	SENT_106	[p9l169t2080r232b2106],
14	stent	NN	O	stent	prep_with	12	SENT_106	[p9l244t2085r311b2106],
15	13.5	CD	NUMBER	13.5	num	14	SENT_106	[p9l671t2083r724b2106],
16	15.5	CD	NUMBER	15.5	number	17	SENT_106	[p9l920t2083r973b2106],
17	14.5	CD	NUMBER	14.5	num	14	SENT_106	[p9l1170t2083r1222b2106],
18	NA	NNP	O	NA	nn	21	SENT_106	[p9l1425t2082r1466b2105],
19	NA	NNP	O	NA	nn	21	SENT_106	[p9l1674t2082r1715b2105],
20	NA	NNP	O	NA	nn	21	SENT_106	[p9l1922t2082r1964b2105],
21	CABG	NNP	O	CABG	dep	3	SENT_106	[p9l121t2140r200b2163],
22	(	CD	PERCENT	(	num	23	SENT_106	[p9l214t2139r259b2171],
23	%	NN	PERCENT	%	dep	29	SENT_106	[p9l214t2139r259b2171],
24	)	CD	NUMBER	)	num	29	SENT_106	[p9l214t2139r259b2171],
25	10.4	CD	NUMBER	10.4	num	29	SENT_106	[p9l672t2140r726b2163],
26	9.8	CD	NUMBER	9.8	num	29	SENT_106	[p9l936t2140r974b2163],
27	10.1	CD	NUMBER	10.1	num	29	SENT_106	[p9l1170t2140r1222b2163],
28	NA	NNP	O	NA	nn	29	SENT_106	[p9l1425t2140r1466b2163],
29	NA	NNP	O	NA	dep	34	SENT_106	[p9l1674t2140r1715b2163],
30	NA	NNP	O	NA	nn	32	SENT_106	[p9l1922t2140r1964b2163],
31	Metabolizer	NNP	O	Metabolizer	nn	32	SENT_106	[p9l122t2196r284b2221],
32	phenotype	NN	O	phenotype	dep	29	SENT_106	[p9l294t2196r436b2229],
33	(	CD	PERCENT	(	num	34	SENT_106	[p9l449t2196r509b2229],
34	%	NN	PERCENT	%	dep	36	SENT_106	[p9l449t2196r509b2229],
35	)	CD	NUMBER	)	num	36	SENT_106	[p9l449t2196r509b2229],
36	§	NN	O	§	_	0	SENT_106	[p9l449t2196r509b2229],

1	Poor	NNP	O	Poor	_	0	SENT_107	[p9l172t2256r235b2279],
2	.	.	O	.	_	0	SENT_107	[p9l704t2274r708b2278],

1	.	.	O	.	_	0	SENT_108	[p9l953t2274r957b2278],

1	2.3	CD	NUMBER	2.3	_	0	SENT_109	[p9l1184t2255r1222b2278],
2	.	.	O	.	_	0	SENT_109	[p9l1455t2274r1459b2278],

1	1.6	CD	NUMBER	1.6	_	0	SENT_110	[p9l1688t2255r1726b2279],
2	Intermediate	NNP	O	Intermediate	dep	1	SENT_110	[p9l173t2311r345b2336],
3	Extensive	JJ	O	extensive	amod	4	SENT_110	[p9l173t2371r297b2394],
4	Ultra	NNP	O	Ultra	dep	5	SENT_110	[p9l172t2426r236b2452],
5	Unknown	JJ	O	unknown	amod	2	SENT_110	[p9l172t2484r300b2509],

1	*	NN	O	*	nn	2	SENT_111	[p9l93t2571r109b2586],
2	Plus	NN	O	plus	nsubj	7	SENT_111	[p9l121t2569r280b2594],
3	—	CD	NUMBER	—	nsubj	6	SENT_111	[p9l121t2569r280b2594],
4	minus	CC	O	minus	prep	3	SENT_111	[p9l121t2569r280b2594],
5	values	NNS	O	value	dep	4	SENT_111	[p9l291t2569r376b2594],
6	are	VBP	O	be	rcmod	2	SENT_111	[p9l389t2578r429b2594],
7	means	VBZ	O	mean	_	0	SENT_111	[p9l442t2578r530b2594],
8	1SD	NN	O	1sd	dobj	7	SENT_111	[p9l542t2571r607b2594],
9	.	.	O	.	_	0	SENT_111	[p9l542t2571r607b2594],

1	ACTIVE	JJ	O	active	dep	2	SENT_112	[p9l619t2570r722b2594],
2	denotes	VBZ	O	denote	_	0	SENT_112	[p9l734t2569r841b2594],
3	Atrial	NNP	O	Atrial	nn	6	SENT_112	[p9l853t2569r923b2594],
4	Fibrillation	NNP	O	Fibrillation	nn	6	SENT_112	[p9l938t2569r1082b2594],
5	Clopidogrel	NNP	O	Clopidogrel	nn	6	SENT_112	[p9l1095t2569r1251b2602],
6	Trial	NN	O	trial	dobj	2	SENT_112	[p9l1262t2569r1321b2594],
7	with	IN	O	with	_	0	SENT_112	[p9l1333t2569r1389b2594],
8	Irbesartan	NNP	MISC	Irbesartan	prep_with	2	SENT_112	[p9l1404t2569r1539b2594],
9	for	IN	O	for	_	0	SENT_112	[p9l1551t2568r1589b2594],
10	Prevention	NNP	O	Prevention	nn	11	SENT_112	[p9l1601t2571r1744b2594],
11	ofVascular	NNP	O	ofVascular	prep_for	8	SENT_112	[p9l1757t2568r1910b2594],
12	Events	NNS	O	event	nsubj	2	SENT_112	[p9l1923t2571r2017b2598],
13	,	,	O	,	_	0	SENT_112	[p9l1923t2571r2017b2598],
14	CABG	NNP	O	CABG	nn	17	SENT_112	[p9l119t2608r198b2632],
15	coronary-artery	JJ	O	coronary-artery	amod	17	SENT_112	[p9l211t2611r417b2640],
16	bypass	NN	O	bypass	nn	17	SENT_112	[p9l429t2606r520b2640],
17	grafting	NN	O	grafting	appos	12	SENT_112	[p9l532t2606r644b2640],
18	,	,	O	,	_	0	SENT_112	[p9l532t2606r644b2640],
19	CURE	VB	O	cure	dep	17	SENT_112	[p9l657t2608r735b2632],
20	Clopidogrel	NNP	O	Clopidogrel	dobj	19	SENT_112	[p9l747t2606r903b2640],
21	in	IN	O	in	_	0	SENT_112	[p9l917t2609r938b2631],
22	Unstable	NNP	O	Unstable	nn	23	SENT_112	[p9l953t2606r1073b2632],
23	Angina	NNP	O	Angina	prep_in	20	SENT_112	[p9l1083t2608r1178b2640],
24	to	TO	O	to	aux	25	SENT_112	[p9l1190t2611r1216b2632],
25	Prevent	VB	O	prevent	xcomp	19	SENT_112	[p9l1230t2609r1330b2632],
26	Recurrent	JJ	O	recurrent	amod	27	SENT_112	[p9l1344t2609r1474b2632],
27	Events	NNS	O	event	dobj	25	SENT_112	[p9l1487t2609r1582b2636],
28	,	,	O	,	_	0	SENT_112	[p9l1487t2609r1582b2636],
29	NA	NNP	O	NA	appos	12	SENT_112	[p9l1597t2608r1638b2632],
30	not	RB	O	not	neg	31	SENT_112	[p9l1650t2611r1693b2632],
31	applicable	JJ	O	applicable	amod	29	SENT_112	[p9l1705t2606r1849b2640],
32	,	,	O	,	_	0	SENT_112	[p9l1705t2606r1849b2640],
33	and	CC	O	and	_	0	SENT_112	[p9l1862t2606r1910b2632],
34	PCI	NN	O	pcus	conj_and	17	SENT_112	[p9l1925t2608r1967b2632],
35	percutaneous	JJ	O	percutaneous	amod	37	SENT_112	[p9l1982t2615r2033b2640, p9l119t2649r259b2669],
36	coronary	JJ	O	coronary	amod	37	SENT_112	[p9l272t2653r391b2677],
37	intervention	NN	O	intervention	dep	34	SENT_112	[p9l402t2646r573b2669],
38	.	.	O	.	_	0	SENT_112	[p9l402t2646r573b2669],

1	1	CD	NUMBER	1	dep	5	SENT_113	[p9l94t2684r110b2714],
2	'	''	O	'	_	0	SENT_113	[p9l94t2684r110b2714],
3	Ancestry	NN	O	ancestry	nsubj	5	SENT_113	[p9l117t2683r235b2714],
4	was	VBD	O	be	cop	5	SENT_113	[p9l245t2690r296b2706],
5	self-reported	JJ	O	self-reported	_	0	SENT_113	[p9l309t2681r488b2714],
6	.	.	O	.	_	0	SENT_113	[p9l309t2681r488b2714],

1	:	:	O	:	_	0	SENT_114	[p9l94t2721r110b2752],
2	§	CD	NUMBER	§	nsubj	9	SENT_114	[p9l94t2721r110b2752],
3	:	:	O	:	_	0	SENT_114	[p9l94t2721r110b2752],
4	The	DT	O	the	det	6	SENT_114	[p9l117t2718r168b2744],
5	body-mass	JJ	O	body-mass	amod	6	SENT_114	[p9l181t2718r326b2752],
6	index	NN	O	index	dep	2	SENT_114	[p9l339t2718r410b2744],
7	is	VBZ	O	be	cop	9	SENT_114	[p9l422t2721r441b2744],
8	the	DT	O	the	det	9	SENT_114	[p9l452t2718r495b2744],
9	weight	NN	O	weight	_	0	SENT_114	[p9l505t2718r596b2752],
10	in	IN	O	in	_	0	SENT_114	[p9l608t2721r629b2743],
11	kilograms	NNS	O	kilogram	prep_in	9	SENT_114	[p9l643t2718r775b2752],
12	divided	VBN	O	divide	partmod	11	SENT_114	[p9l788t2718r885b2744],
13	by	IN	O	by	_	0	SENT_114	[p9l899t2718r927b2752],
14	the	DT	O	the	det	17	SENT_114	[p9l937t2718r980b2744],
15	square	JJ	O	square	amod	17	SENT_114	[p9l992t2727r1082b2751],
16	ofthe	NN	O	ofthe	nn	17	SENT_114	[p9l1093t2718r1171b2744],
17	height	NN	O	height	agent	12	SENT_114	[p9l1184t2718r1268b2752],
18	in	IN	O	in	_	0	SENT_114	[p9l1280t2721r1301b2743],
19	meters	NNS	O	meter	prep_in	17	SENT_114	[p9l1315t2723r1415b2744],
20	.	.	O	.	_	0	SENT_114	[p9l1315t2723r1415b2744],

1	§	NN	O	§	dep	164	SENT_115	[p9l94t2755r104b2789],
2	Patients	NNS	O	patient	dep	164	SENT_115	[p9l121t2758r228b2781],
3	with	IN	O	with	dep	164	SENT_115	[p9l239t2755r295b2781],
4	two	CD	NUMBER	two	dep	164	SENT_115	[p9l307t2760r355b2781],
5	*	NN	O	*	dep	164	SENT_115	[p9l367t2758r398b2780],
6	2	CD	NUMBER	2	dep	164	SENT_115	[p9l367t2758r398b2780],
7	or	CC	O	or	dep	164	SENT_115	[p9l410t2764r437b2781],
8	*	CD	NUMBER	*	dep	164	SENT_115	[p9l447t2757r477b2781],
9	3	CD	NUMBER	3	dep	164	SENT_115	[p9l447t2757r477b2781],
10	alleles	NNS	O	allele	dep	164	SENT_115	[p9l491t2755r573b2781],
11	(	CD	NUMBER	(	dep	164	SENT_115	[p9l588t2757r643b2789],
12	i.e.	FW	O	i.e.	dep	164	SENT_115	[p9l588t2757r643b2789],
13	,	,	O	,	_	0	SENT_115	[p9l588t2757r643b2789],
14	*	NN	O	*	dep	164	SENT_115	[p9l655t2758r741b2789],
15	2	CD	NUMBER	2	dep	164	SENT_115	[p9l655t2758r741b2789],
16	/	:	O	/	dep	164	SENT_115	[p9l655t2758r741b2789],
17	*	CD	NUMBER	*	dep	164	SENT_115	[p9l655t2758r741b2789],
18	2	CD	NUMBER	2	dep	164	SENT_115	[p9l655t2758r741b2789],
19	,	,	O	,	_	0	SENT_115	[p9l655t2758r741b2789],
20	*	CD	NUMBER	*	dep	164	SENT_115	[p9l753t2757r839b2789],
21	2	CD	NUMBER	2	dep	164	SENT_115	[p9l753t2757r839b2789],
22	/	:	O	/	dep	164	SENT_115	[p9l753t2757r839b2789],
23	*	CD	NUMBER	*	dep	164	SENT_115	[p9l753t2757r839b2789],
24	3	CD	NUMBER	3	dep	164	SENT_115	[p9l753t2757r839b2789],
25	,	,	O	,	_	0	SENT_115	[p9l753t2757r839b2789],
26	or	CC	O	or	dep	164	SENT_115	[p9l851t2764r879b2781],
27	*	NN	O	*	dep	164	SENT_115	[p9l889t2757r977b2789],
28	3	CD	NUMBER	3	dep	164	SENT_115	[p9l889t2757r977b2789],
29	/	:	O	/	dep	164	SENT_115	[p9l889t2757r977b2789],
30	*	CD	NUMBER	*	dep	164	SENT_115	[p9l889t2757r977b2789],
31	3	CD	NUMBER	3	dep	164	SENT_115	[p9l889t2757r977b2789],
32	)	NN	O	)	dep	164	SENT_115	[p9l889t2757r977b2789],
33	were	VBD	O	be	dep	164	SENT_115	[p9l990t2764r1054b2781],
34	classified	VBN	O	classify	dep	164	SENT_115	[p9l1065t2755r1189b2781],
35	as	IN	O	as	dep	164	SENT_115	[p9l1203t2764r1230b2781],
36	having	VBG	O	have	dep	164	SENT_115	[p9l1243t2755r1333b2789],
37	the	DT	O	the	dep	164	SENT_115	[p9l1342t2755r1385b2781],
38	poor-metabolizer	NN	O	poor-metabolizer	dep	164	SENT_115	[p9l1398t2755r1633b2789],
39	phenotype	NN	O	phenotype	dep	164	SENT_115	[p9l1645t2755r1793b2789],
40	,	,	O	,	_	0	SENT_115	[p9l1645t2755r1793b2789],
41	those	DT	O	those	dep	164	SENT_115	[p9l1805t2755r1880b2781],
42	with	IN	O	with	dep	164	SENT_115	[p9l1891t2755r1947b2781],
43	one	CD	NUMBER	one	dep	164	SENT_115	[p9l1960t2764r2009b2781],
44	*	NN	O	*	dep	164	SENT_115	[p9l118t2795r149b2817],
45	2	CD	NUMBER	2	dep	164	SENT_115	[p9l118t2795r149b2817],
46	or	CC	O	or	dep	164	SENT_115	[p9l161t2801r189b2818],
47	*	CD	NUMBER	*	dep	164	SENT_115	[p9l199t2794r229b2818],
48	3	CD	NUMBER	3	dep	164	SENT_115	[p9l199t2794r229b2818],
49	allele	NN	O	allele	dep	164	SENT_115	[p9l242t2792r311b2818],
50	(	CD	NUMBER	(	dep	164	SENT_115	[p9l325t2794r380b2826],
51	i.e.	FW	O	i.e.	dep	164	SENT_115	[p9l325t2794r380b2826],
52	,	,	O	,	_	0	SENT_115	[p9l325t2794r380b2826],
53	*	NN	O	*	dep	164	SENT_115	[p9l392t2795r470b2826],
54	1	CD	NUMBER	1	dep	164	SENT_115	[p9l392t2795r470b2826],
55	/	:	O	/	dep	164	SENT_115	[p9l392t2795r470b2826],
56	*	CD	NUMBER	*	dep	164	SENT_115	[p9l392t2795r470b2826],
57	2	CD	NUMBER	2	dep	164	SENT_115	[p9l392t2795r470b2826],
58	or	CC	O	or	dep	164	SENT_115	[p9l482t2801r510b2818],
59	*	CD	NUMBER	*	dep	164	SENT_115	[p9l519t2794r607b2826],
60	1	CD	NUMBER	1	dep	164	SENT_115	[p9l519t2794r607b2826],
61	/	:	O	/	dep	164	SENT_115	[p9l519t2794r607b2826],
62	*	CD	NUMBER	*	dep	164	SENT_115	[p9l519t2794r607b2826],
63	3	CD	NUMBER	3	dep	164	SENT_115	[p9l519t2794r607b2826],
64	)	NN	O	)	dep	164	SENT_115	[p9l519t2794r607b2826],
65	were	VBD	O	be	dep	164	SENT_115	[p9l620t2801r684b2818],
66	classiﬁed	VBN	O	classiﬁed	dep	164	SENT_115	[p9l695t2792r820b2818],
67	as	IN	O	as	dep	164	SENT_115	[p9l833t2801r860b2818],
68	having	VBG	O	have	dep	164	SENT_115	[p9l874t2792r963b2826],
69	the	DT	O	the	dep	164	SENT_115	[p9l973t2792r1015b2818],
70	intermediate-metabolizer	JJ	O	intermediate-metabolizer	dep	164	SENT_115	[p9l1028t2792r1374b2818],
71	phenotype	NN	O	phenotype	dep	164	SENT_115	[p9l1386t2792r1534b2826],
72	,	,	O	,	_	0	SENT_115	[p9l1386t2792r1534b2826],
73	those	DT	O	those	dep	164	SENT_115	[p9l1546t2792r1621b2818],
74	without	IN	O	without	dep	164	SENT_115	[p9l1632t2792r1736b2818],
75	a	DT	O	a	dep	164	SENT_115	[p9l1747t2801r1759b2818],
76	*	NN	O	*	dep	164	SENT_115	[p9l1771t2795r1810b2822],
77	2	CD	NUMBER	2	dep	164	SENT_115	[p9l1771t2795r1810b2822],
78	,	,	O	,	_	0	SENT_115	[p9l1771t2795r1810b2822],
79	*	CD	NUMBER	*	dep	164	SENT_115	[p9l1822t2794r1861b2822],
80	3	CD	NUMBER	3	dep	164	SENT_115	[p9l1822t2794r1861b2822],
81	,	,	O	,	_	0	SENT_115	[p9l1822t2794r1861b2822],
82	or	CC	O	or	dep	164	SENT_115	[p9l1873t2801r1901b2818],
83	*	NN	O	*	dep	164	SENT_115	[p9l1911t2795r1959b2818],
84	17	CD	NUMBER	17	dep	164	SENT_115	[p9l1911t2795r1959b2818],
85	allele	NN	O	allele	dep	164	SENT_115	[p9l1971t2792r2040b2818],
86	(	CD	NUMBER	(	dep	164	SENT_115	[p9l121t2831r176b2863],
87	i.e.	FW	O	i.e.	dep	164	SENT_115	[p9l121t2831r176b2863],
88	,	,	O	,	_	0	SENT_115	[p9l121t2831r176b2863],
89	*	NN	O	*	dep	164	SENT_115	[p9l188t2831r276b2863],
90	1	CD	NUMBER	1	dep	164	SENT_115	[p9l188t2831r276b2863],
91	/	:	O	/	dep	164	SENT_115	[p9l188t2831r276b2863],
92	*	CD	NUMBER	*	dep	164	SENT_115	[p9l188t2831r276b2863],
93	1	CD	NUMBER	1	dep	164	SENT_115	[p9l188t2831r276b2863],
94	)	NN	O	)	dep	164	SENT_115	[p9l188t2831r276b2863],
95	were	VBD	O	be	dep	164	SENT_115	[p9l289t2838r353b2855],
96	classified	VBN	O	classify	dep	164	SENT_115	[p9l364t2829r489b2855],
97	as	IN	O	as	dep	164	SENT_115	[p9l502t2838r529b2855],
98	having	VBG	O	have	dep	164	SENT_115	[p9l542t2829r632b2863],
99	the	DT	O	the	dep	164	SENT_115	[p9l641t2829r684b2855],
100	extensive-metabolizer	JJ	O	extensive-metabolizer	dep	164	SENT_115	[p9l695t2829r994b2855],
101	phenotype	NN	O	phenotype	dep	164	SENT_115	[p9l1006t2829r1154b2863],
102	,	,	O	,	_	0	SENT_115	[p9l1006t2829r1154b2863],
103	those	DT	O	those	dep	164	SENT_115	[p9l1166t2829r1241b2855],
104	with	IN	O	with	dep	164	SENT_115	[p9l1252t2829r1308b2855],
105	a	DT	O	a	dep	164	SENT_115	[p9l1321t2838r1334b2855],
106	single	JJ	O	single	dep	164	SENT_115	[p9l1346t2829r1425b2863],
107	*	NN	O	*	dep	164	SENT_115	[p9l1436t2832r1484b2855],
108	17	CD	NUMBER	17	dep	164	SENT_115	[p9l1436t2832r1484b2855],
109	allele	NN	O	allele	dep	164	SENT_115	[p9l1496t2829r1565b2855],
110	(	CD	NUMBER	(	dep	164	SENT_115	[p9l1579t2831r1634b2863],
111	i.e.	FW	O	i.e.	dep	164	SENT_115	[p9l1579t2831r1634b2863],
112	,	,	O	,	_	0	SENT_115	[p9l1579t2831r1634b2863],
113	*	NN	O	*	dep	164	SENT_115	[p9l1646t2831r1750b2863],
114	1	CD	NUMBER	1	dep	164	SENT_115	[p9l1646t2831r1750b2863],
115	/	:	O	/	dep	164	SENT_115	[p9l1646t2831r1750b2863],
116	*	CD	NUMBER	*	dep	164	SENT_115	[p9l1646t2831r1750b2863],
117	17	CD	NUMBER	17	dep	164	SENT_115	[p9l1646t2831r1750b2863],
118	)	NN	O	)	dep	164	SENT_115	[p9l1646t2831r1750b2863],
119	and	CC	O	and	dep	164	SENT_115	[p9l1765t2829r1813b2855],
120	*	NN	O	*	dep	164	SENT_115	[p9l1825t2832r1873b2855],
121	17	CD	NUMBER	17	dep	164	SENT_115	[p9l1825t2832r1873b2855],
122	homozygotes	NNS	O	homozygote	dep	164	SENT_115	[p9l1886t2829r2002b2863, p9l119t2871r191b2900],
123	were	VBD	O	be	dep	164	SENT_115	[p9l202t2875r266b2892],
124	classified	VBN	O	classify	dep	164	SENT_115	[p9l277t2866r401b2892],
125	as	IN	O	as	dep	164	SENT_115	[p9l415t2875r442b2892],
126	having	VBG	O	have	dep	164	SENT_115	[p9l455t2866r545b2900],
127	the	DT	O	the	dep	164	SENT_115	[p9l554t2866r597b2892],
128	ultrametabolizer	NN	O	ultrametabolizer	dep	164	SENT_115	[p9l610t2866r834b2892],
129	phenotype	NN	O	phenotype	dep	164	SENT_115	[p9l846t2866r995b2900],
130	,	,	O	,	_	0	SENT_115	[p9l846t2866r995b2900],
131	and	CC	O	and	dep	164	SENT_115	[p9l1008t2866r1056b2892],
132	those	DT	O	those	dep	164	SENT_115	[p9l1068t2866r1143b2892],
133	with	IN	O	with	dep	164	SENT_115	[p9l1153t2866r1209b2892],
134	one	CD	NUMBER	one	dep	164	SENT_115	[p9l1222t2875r1271b2892],
135	*	NN	O	*	dep	164	SENT_115	[p9l1282t2869r1331b2892],
136	17	CD	NUMBER	17	dep	164	SENT_115	[p9l1282t2869r1331b2892],
137	allele	NN	O	allele	dep	164	SENT_115	[p9l1342t2866r1411b2892],
138	and	CC	O	and	dep	164	SENT_115	[p9l1423t2866r1471b2892],
139	one	CD	NUMBER	one	dep	164	SENT_115	[p9l1483t2875r1533b2892],
140	loss-of-function	NN	O	loss-of-function	dep	164	SENT_115	[p9l1545t2866r1757b2892],
141	allele	NN	O	allele	dep	164	SENT_115	[p9l1770t2866r1838b2892],
142	(	CD	NUMBER	(	dep	164	SENT_115	[p9l1852t2868r1907b2900],
143	i.e.	FW	O	i.e.	dep	164	SENT_115	[p9l1852t2868r1907b2900],
144	,	,	O	,	_	0	SENT_115	[p9l1852t2868r1907b2900],
145	*	NN	O	*	dep	164	SENT_115	[p9l1919t2869r2014b2900],
146	2	CD	NUMBER	2	dep	164	SENT_115	[p9l1919t2869r2014b2900],
147	/	:	O	/	dep	164	SENT_115	[p9l1919t2869r2014b2900],
148	*	CD	NUMBER	*	dep	164	SENT_115	[p9l1919t2869r2014b2900],
149	17	CD	NUMBER	17	dep	164	SENT_115	[p9l1919t2869r2014b2900],
150	or	CC	O	or	dep	164	SENT_115	[p9l119t2912r146b2929],
151	*	CD	NUMBER	*	dep	164	SENT_115	[p9l156t2905r261b2937],
152	3	CD	NUMBER	3	dep	164	SENT_115	[p9l156t2905r261b2937],
153	/	:	O	/	dep	164	SENT_115	[p9l156t2905r261b2937],
154	*	CD	NUMBER	*	dep	164	SENT_115	[p9l156t2905r261b2937],
155	17	CD	NUMBER	17	dep	164	SENT_115	[p9l156t2905r261b2937],
156	)	NN	O	)	dep	164	SENT_115	[p9l156t2905r261b2937],
157	were	VBD	O	be	dep	164	SENT_115	[p9l274t2912r337b2929],
158	classified	VBN	O	classify	dep	164	SENT_115	[p9l349t2903r473b2929],
159	as	IN	O	as	dep	164	SENT_115	[p9l486t2912r514b2929],
160	having	VBG	O	have	dep	164	SENT_115	[p9l527t2903r616b2937],
161	an	DT	O	a	dep	164	SENT_115	[p9l627t2912r657b2929],
162	unknown	JJ	O	unknown	dep	164	SENT_115	[p9l672t2903r794b2929],
163	metabolizer	NN	O	metabolizer	dep	164	SENT_115	[p9l809t2903r970b2929],
164	phenotype	NN	O	phenotype	_	0	SENT_115	[p9l982t2903r1130b2937],
165	.	.	O	.	_	0	SENT_115	[p9l982t2903r1130b2937],

1	tients	NNS	O	tient	nsubj	2	SENT_116	[p9l12t3118r242b3195],
2	receiving	VBG	O	receive	_	0	SENT_116	[p9l280t3118r661b3218],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_116	[p9l694t3117r1167b3218],
4	(	NN	O	(	dobj	2	SENT_116	[p9l1206t3123r1381b3208],
5	231	CD	NUMBER	231	num	4	SENT_116	[p9l1206t3123r1381b3208],
6	of	IN	O	of	_	0	SENT_116	[p9l1418t3116r1516b3196],
7	2549	CD	DATE	2549	num	8	SENT_116	[p9l1534t3123r1734b3196],
8	patients	NNS	O	patient	prep_of	2	SENT_116	[p9l1770t3118r2129b3217],
9	)	CD	NUMBER	)	nsubj	15	SENT_116	[p9l1770t3118r2129b3217],
10	versus	CC	O	versus	prep	9	SENT_116	[p9l7t3271r268b3324],
11	12.6	CD	PERCENT	12.6	num	12	SENT_116	[p9l321t3250r579b3324],
12	%	NN	PERCENT	%	dep	10	SENT_116	[p9l321t3250r579b3324],
13	of	IN	O	of	_	0	SENT_116	[p9l627t3244r726b3324],
14	those	DT	O	those	prep_of	12	SENT_116	[p9l756t3245r983b3324],
15	receiving	VBG	O	receive	rcmod	8	SENT_116	[p9l1031t3246r1413b3346],
16	placebo	NN	O	placebo	nn	17	SENT_116	[p9l1457t3245r1779b3345],
17	(	NN	O	(	dobj	15	SENT_116	[p9l1833t3251r2004b3336],
18	316	CD	NUMBER	316	num	17	SENT_116	[p9l1833t3251r2004b3336],
19	of	IN	O	of	_	0	SENT_116	[p9l2054t3244r2152b3324],
20	2510	CD	DATE	2510	number	21	SENT_116	[p9l11t3379r233b3464],
21	)	CD	NUMBER	)	num	24	SENT_116	[p9l11t3379r233b3464],
22	(	NN	O	(	nn	24	SENT_116	[p9l294t3373r613b3464],
23	hazard	NN	O	hazard	nn	24	SENT_116	[p9l294t3373r613b3464],
24	ratio	NN	O	ratio	prep_of	15	SENT_116	[p9l665t3374r858b3452],
25	with	IN	O	with	_	0	SENT_116	[p9l907t3373r1098b3452],
26	clopidogrel	NN	O	clopidogrel	prep_with	24	SENT_116	[p9l1151t3373r1645b3474],
27	,	,	O	,	_	0	SENT_116	[p9l1151t3373r1645b3474],
28	0.71	CD	NUMBER	0.71	appos	24	SENT_116	[p9l1703t3379r1896b3469],
29	;	:	O	;	_	0	SENT_116	[p9l1703t3379r1896b3469],
30	95	CD	PERCENT	95	number	31	SENT_116	[p9l1952t3378r2134b3452],
31	%	NN	PERCENT	%	amod	32	SENT_116	[p9l1952t3378r2134b3452],
32	confidence	NN	O	confidence	dep	28	SENT_116	[p9l12t3499r474b3579],
33	interval	NN	O	interval	nn	36	SENT_116	[p9l525t3500r843b3579],
34	[	CD	NUMBER	[	num	36	SENT_116	[p9l903t3506r1074b3596],
35	CI	NN	O	ci	nn	36	SENT_116	[p9l903t3506r1074b3596],
36	]	NN	O	]	dep	32	SENT_116	[p9l903t3506r1074b3596],
37	,	,	O	,	_	0	SENT_116	[p9l903t3506r1074b3596],
38	0.60	CD	NUMBER	0.60	appos	24	SENT_116	[p9l1132t3506r1307b3579],
39	to	TO	O	to	_	0	SENT_116	[p9l1360t3517r1440b3579],
40	0.84	CD	NUMBER	0.84	prep_to	38	SENT_116	[p9l1493t3506r1694b3596],
41	;	:	O	;	_	0	SENT_116	[p9l1493t3506r1694b3596],
42	P	NN	O	p	dep	43	SENT_116	[p9l1748t3506r2128b3596],
43	<	JJR	O	<	dep	24	SENT_116	[p9l1748t3506r2128b3596],
44	0.001	CD	NUMBER	0.001	num	45	SENT_116	[p9l1748t3506r2128b3596],
45	)	NN	O	)	dep	43	SENT_116	[p9l1748t3506r2128b3596],
46	,	,	O	,	_	0	SENT_116	[p9l1748t3506r2128b3596],
47	and	CC	O	and	_	0	SENT_116	[p9l11t3629r166b3707],
48	in	IN	O	in	_	0	SENT_116	[p9l201t3630r283b3706],
49	the	DT	O	the	det	51	SENT_116	[p9l319t3629r450b3707],
50	parent	NN	O	parent	nn	51	SENT_116	[p9l484t3646r758b3728],
51	study	NN	O	study	prep_in	56	SENT_116	[p9l790t3629r1027b3728],
52	,	,	O	,	_	0	SENT_116	[p9l790t3629r1027b3728],
53	the	DT	O	the	det	55	SENT_116	[p9l1068t3629r1199b3707],
54	primary	JJ	O	primary	amod	55	SENT_116	[p9l1233t3630r1577b3728],
55	outcome	NN	O	outcome	nsubj	56	SENT_116	[p9l1609t3646r1971b3708],
56	occurred	VBD	O	occur	conj_and	2	SENT_116	[p9l2007t3655r2132b3707, p10l12t22r284b101],

1	in	IN	O	in	quantmod	2	SENT_117	[p10l307t23r389b100],
2	9.3	CD	PERCENT	9.3	num	3	SENT_117	[p10l413t27r618b101],
3	%	NN	PERCENT	%	_	0	SENT_117	[p10l413t27r618b101],
4	of	IN	O	of	_	0	SENT_117	[p10l642t21r741b101],
5	the	DT	O	the	det	6	SENT_117	[p10l747t22r877b100],
6	patients	NNS	O	patient	prep_of	3	SENT_117	[p10l900t23r1234b122],
7	receiving	VBG	O	receive	partmod	6	SENT_117	[p10l1259t23r1641b123],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_117	[p10l1662t22r2134b123],
9	(	NN	O	(	dobj	7	SENT_117	[p10l16t156r190b241],
10	582	CD	NUMBER	582	num	9	SENT_117	[p10l16t156r190b241],
11	of	IN	O	of	_	0	SENT_117	[p10l226t149r325b229],
12	6259	CD	NUMBER	6259	number	13	SENT_117	[p10l341t156r564b241],
13	)	CD	NUMBER	)	prep_of	3	SENT_117	[p10l341t156r564b241],
14	versus	CC	O	versus	cc	13	SENT_117	[p10l600t176r860b229],
15	11.4	CD	PERCENT	11.4	number	16	SENT_117	[p10l901t155r1154b229],
16	%	NN	PERCENT	%	amod	13	SENT_117	[p10l901t155r1154b229],
17	of	IN	O	of	_	0	SENT_117	[p10l1188t149r1287b229],
18	those	DT	O	those	prep_of	3	SENT_117	[p10l1303t150r1530b229],
19	receiving	VBG	O	receive	partmod	18	SENT_117	[p10l1565t151r1946b251],
20	placebo	NN	O	placebo	nn	21	SENT_117	[p10l1975t150r2132b250, p10l12t277r203b356],
21	(	NN	O	(	dobj	19	SENT_117	[p10l258t283r435b368],
22	719	CD	NUMBER	719	num	21	SENT_117	[p10l258t283r435b368],
23	of	IN	O	of	_	0	SENT_117	[p10l485t276r585b356],
24	6303	CD	NUMBER	6303	number	25	SENT_117	[p10l615t283r837b368],
25	)	CD	NUMBER	)	num	28	SENT_117	[p10l615t283r837b368],
26	(	NN	O	(	nn	28	SENT_117	[p10l896t277r1214b368],
27	hazard	NN	O	hazard	nn	28	SENT_117	[p10l896t277r1214b368],
28	ratio	NN	O	ratio	prep_of	19	SENT_117	[p10l1263t278r1477b373],
29	,	,	O	,	_	0	SENT_117	[p10l1263t278r1477b373],
30	0.80	CD	NUMBER	0.80	appos	28	SENT_117	[p10l1531t283r1733b372],
31	;	:	O	;	_	0	SENT_117	[p10l1531t283r1733b372],
32	95	CD	PERCENT	95	num	34	SENT_117	[p10l1786t282r1968b356],
33	%	NN	PERCENT	%	nn	34	SENT_117	[p10l1786t282r1968b356],
34	CI	NN	O	ci	dep	28	SENT_117	[p10l2015t283r2128b373],
35	,	,	O	,	_	0	SENT_117	[p10l2015t283r2128b373],
36	0.72	CD	NUMBER	0.72	number	38	SENT_117	[p10l11t412r183b484],
37	to	TO	O	to	dep	38	SENT_117	[p10l217t422r297b484],
38	0.90	CD	NUMBER	0.90	appos	34	SENT_117	[p10l332t412r530b501],
39	;	:	O	;	_	0	SENT_117	[p10l332t412r530b501],
40	P	NN	O	p	dep	41	SENT_117	[p10l565t412r945b496],
41	<	JJR	O	<	dep	28	SENT_117	[p10l565t412r945b496],
42	0.001	CD	NUMBER	0.001	num	43	SENT_117	[p10l565t412r945b496],
43	)	NN	O	)	dep	41	SENT_117	[p10l565t412r945b496],
44	.	.	O	.	_	0	SENT_117	[p10l565t412r945b496],

1	Figure	NNP	O	Figure	nsubj	3	SENT_118	[p10l138t535r411b635],
2	1	CD	NUMBER	1	num	1	SENT_118	[p10l463t540r507b612],
3	shows	VBZ	O	show	_	0	SENT_118	[p10l558t534r821b613],
4	the	DT	O	the	det	5	SENT_118	[p10l872t534r1004b612],
5	estimates	NNS	O	estimate	dobj	3	SENT_118	[p10l1054t535r1462b612],
6	of	IN	O	of	_	0	SENT_118	[p10l1513t533r1613b613],
7	the	DT	O	the	det	9	SENT_118	[p10l1643t534r1776b613],
8	relative	JJ	O	relative	amod	9	SENT_118	[p10l1824t534r2133b613],
9	risk	NN	O	risk	prep_of	5	SENT_118	[p10l11t661r175b741],
10	of	IN	O	of	_	0	SENT_118	[p10l218t660r318b740],
11	the	DT	O	the	dep	12	SENT_118	[p10l346t661r479b739],
12	first	JJ	ORDINAL	first	prep_of	9	SENT_118	[p10l527t660r710b739],
13	and	CC	ORDINAL	and	_	0	SENT_118	[p10l751t661r909b740],
14	second	JJ	ORDINAL	second	amod	18	SENT_118	[p10l957t661r1253b740],
15	primary	JJ	O	primary	amod	18	SENT_118	[p10l1299t662r1649b761],
16	composite	JJ	O	composite	amod	18	SENT_118	[p10l1692t662r2133b761],
17	efficacy	NN	O	efficacy	nn	18	SENT_118	[p10l12t789r348b890],
18	outcomes	NNS	O	outcome	conj_and	12	SENT_118	[p10l394t807r805b869],
19	among	IN	O	among	_	0	SENT_118	[p10l857t816r1156b891],
20	patients	NNS	O	patient	prep_among	12	SENT_118	[p10l1201t791r1542b890],
21	treated	VBN	O	treat	partmod	20	SENT_118	[p10l1595t790r1893b869],
22	with	IN	O	with	_	0	SENT_118	[p10l1939t790r2134b869],
23	clopidogrel	NN	O	clopidogrel	prep_with	21	SENT_118	[p10l12t918r495b1019],
24	as	IN	O	as	prep	21	SENT_118	[p10l561t944r647b996],
25	compared	VBN	O	compare	_	0	SENT_118	[p10l718t918r1144b1018],
26	with	IN	O	with	prepc_compared_with	21	SENT_118	[p10l1208t918r1403b997],
27	those	DT	O	those	pobj	21	SENT_118	[p10l1471t918r1703b997],
28	who	WP	O	who	nsubj	29	SENT_118	[p10l1767t918r1950b997],
29	received	VBD	O	receive	rcmod	27	SENT_118	[p10l2019t944r2132b996, p10l12t1046r272b1125],
30	placebo	NN	O	placebo	dobj	29	SENT_118	[p10l320t1046r671b1146],
31	,	,	O	,	_	0	SENT_118	[p10l320t1046r671b1146],
32	stratified	VBN	O	stratify	partmod	30	SENT_118	[p10l728t1045r1122b1125],
33	according	VBG	O	accord	_	0	SENT_118	[p10l1170t1046r1596b1147],
34	to	TO	O	to	prepc_according_to	32	SENT_118	[p10l1643t1063r1725b1125],
35	metabolizer	NN	O	metabolizer	nn	36	SENT_118	[p10l1775t1046r2132b1125, p10l7t1174r201b1253],
36	phenotype	NN	O	phenotype	pobj	32	SENT_118	[p10l240t1174r719b1275],
37	.	.	O	.	_	0	SENT_118	[p10l240t1174r719b1275],

1	The	DT	O	the	det	2	SENT_119	[p10l763t1174r926b1253],
2	effects	NNS	O	effect	nsubj	6	SENT_119	[p10l969t1173r1252b1253],
3	of	IN	O	of	_	0	SENT_119	[p10l1297t1173r1398b1254],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_119	[p10l1422t1174r1909b1276],
5	were	VBD	O	be	cop	6	SENT_119	[p10l1946t1200r2149b1254],
6	consistent	JJ	O	consistent	_	0	SENT_119	[p10l9t1304r452b1383],
7	in	IN	O	in	_	0	SENT_119	[p10l512t1304r595b1381],
8	subgroups	NNS	O	subgroup	prep_in	6	SENT_119	[p10l662t1303r1112b1405],
9	defined	VBN	O	define	partmod	8	SENT_119	[p10l1180t1302r1509b1383],
10	according	VBG	O	accord	_	0	SENT_119	[p10l1574t1303r2004b1405],
11	to	TO	O	to	prepc_according_to	9	SENT_119	[p10l2066t1320r2148b1383],
12	metabolizer	NN	O	metabolizer	nn	13	SENT_119	[p10l8t1433r531b1513],
13	status	NN	O	status	pobj	9	SENT_119	[p10l568t1450r822b1513],
14	for	IN	O	for	mark	24	SENT_119	[p10l862t1432r987b1513],
15	both	CC	O	both	preconj	17	SENT_119	[p10l1023t1433r1223b1513],
16	the	DT	O	the	det	17	SENT_119	[p10l1261t1433r1395b1512],
17	first	JJ	ORDINAL	first	nsubj	24	SENT_119	[p10l1434t1432r1620b1512],
18	and	CC	ORDINAL	and	_	0	SENT_119	[p10l1652t1433r1812b1513],
19	second	JJ	ORDINAL	second	amod	23	SENT_119	[p10l1851t1433r2151b1513],
20	primary	JJ	O	primary	amod	23	SENT_119	[p10l7t1564r360b1664],
21	composite	JJ	O	composite	amod	23	SENT_119	[p10l417t1564r862b1664],
22	efficacy	NN	O	efficacy	nn	23	SENT_119	[p10l923t1562r1262b1664],
23	outcomes	NNS	O	outcome	nsubj	24	SENT_119	[p10l1319t1580r1733b1643],
24	(	VBP	O	(	advcl	6	SENT_119	[p10l1800t1569r2148b1655],
25	P	NN	O	p	dobj	24	SENT_119	[p10l1800t1569r2148b1655],
26	=	JJ	O	=	amod	25	SENT_119	[p10l1800t1569r2148b1655],
27	0.12	CD	NUMBER	0.12	dep	25	SENT_119	[p10l1800t1569r2148b1655],
28	and	CC	O	and	_	0	SENT_119	[p10l8t1692r167b1772],
29	P	NN	O	p	conj_and	25	SENT_119	[p10l208t1699r529b1772],
30	=	JJ	O	=	amod	29	SENT_119	[p10l208t1699r529b1772],
31	0.29	CD	NUMBER	0.29	tmod	30	SENT_119	[p10l208t1699r529b1772],
32	for	IN	O	for	_	0	SENT_119	[p10l573t1691r697b1772],
33	heterogeneity	NN	O	heterogeneity	prep_for	24	SENT_119	[p10l737t1692r1341b1794],
34	,	,	O	,	_	0	SENT_119	[p10l737t1692r1341b1794],
35	respectively	RB	O	respectively	advmod	33	SENT_119	[p10l1389t1692r1942b1793],
36	)	CD	NUMBER	)	dep	33	SENT_119	[p10l1389t1692r1942b1793],
37	.	.	O	.	_	0	SENT_119	[p10l1389t1692r1942b1793],

1	The	DT	O	the	det	2	SENT_120	[p10l1987t1692r2149b1771],
2	effect	NN	O	effect	_	0	SENT_120	[p10l9t1820r253b1900],
3	of	IN	O	of	_	0	SENT_120	[p10l297t1820r398b1901],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_120	[p10l428t1821r915b1923],
5	as	IN	O	as	mark	22	SENT_120	[p10l962t1848r1048b1900],
6	compared	VBN	O	compare	_	0	SENT_120	[p10l1099t1821r1530b1922],
7	with	IN	O	with	prepc_compared_with	22	SENT_120	[p10l1573t1821r1770b1901],
8	placebo	NN	O	placebo	pobj	22	SENT_120	[p10l1817t1821r2148b1922],
9	in	IN	O	in	_	0	SENT_120	[p10l8t1951r92b2028],
10	reducing	VBG	O	reduce	prepc_in	8	SENT_120	[p10l132t1950r512b2052],
11	the	DT	O	the	det	13	SENT_120	[p10l550t1950r684b2029],
12	first	JJ	ORDINAL	first	amod	13	SENT_120	[p10l723t1949r909b2029],
13	(	NN	O	(	dobj	10	SENT_120	[p10l948t1950r1132b2042],
14	and	CC	O	and	_	0	SENT_120	[p10l948t1950r1132b2042],
15	second	JJ	ORDINAL	second	amod	16	SENT_120	[p10l1173t1950r1501b2042],
16	)	NN	O	)	dobj	10	SENT_120	[p10l1173t1950r1501b2042],
17	primary	JJ	O	primary	amod	20	SENT_120	[p10l1545t1951r1898b2051],
18	composite	JJ	O	composite	amod	20	SENT_120	[p10l1934t1976r2148b2030, p10l7t2081r261b2181],
19	efﬁcacy	NN	O	efﬁcacy	nn	20	SENT_120	[p10l299t2079r631b2181],
20	outcome	NN	O	outcome	nsubj	22	SENT_120	[p10l663t2097r1028b2160],
21	was	VBD	O	be	cop	22	SENT_120	[p10l1060t2107r1222b2160],
22	similar	JJ	O	similar	dep	2	SENT_120	[p10l1262t2080r1564b2159],
23	between	IN	O	between	_	0	SENT_120	[p10l1598t2080r1953b2160],
24	carriers	NNS	O	carrier	prep_between	22	SENT_120	[p10l1990t2106r2148b2159, p10l8t2211r194b2289],
25	of	IN	O	of	_	0	SENT_120	[p10l245t2209r346b2290],
26	loss	NN	O	loss	nn	27	SENT_120	[p10l378t2209r1070b2290],
27	—	NN	O	—	prep_of	24	SENT_120	[p10l378t2209r1070b2290],
28	of	IN	O	of	_	0	SENT_120	[p10l378t2209r1070b2290],
29	—	CD	NUMBER	—	num	31	SENT_120	[p10l378t2209r1070b2290],
30	function	NN	O	function	nn	31	SENT_120	[p10l378t2209r1070b2290],
31	alleles	NNS	O	allele	prep_of	27	SENT_120	[p10l1121t2210r1388b2289],
32	and	CC	O	and	_	0	SENT_120	[p10l1441t2210r1600b2290],
33	noncarriers	NNS	O	noncarrier	prep_of	27	SENT_120	[p10l1650t2211r2148b2290],

1	(	NN	O	(	nn	3	SENT_121	[p10l13t2340r342b2432],
2	hazard	NN	O	hazard	nn	3	SENT_121	[p10l13t2340r342b2432],
3	ratio	NN	O	ratio	_	0	SENT_121	[p10l396t2341r594b2420],
4	with	IN	O	with	_	0	SENT_121	[p10l646t2340r843b2420],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_121	[p10l898t2340r1384b2442],
6	among	IN	O	among	_	0	SENT_121	[p10l1438t2366r1741b2442],
7	carriers	NNS	O	carrier	prep_among	5	SENT_121	[p10l1792t2341r2144b2437],
8	,	,	O	,	_	0	SENT_121	[p10l1792t2341r2144b2437],
9	0.69	CD	NUMBER	0.69	appos	7	SENT_121	[p10l9t2476r211b2566],
10	;	:	O	;	_	0	SENT_121	[p10l9t2476r211b2566],
11	95	CD	PERCENT	95	num	13	SENT_121	[p10l261t2475r446b2550],
12	%	NN	PERCENT	%	nn	13	SENT_121	[p10l261t2475r446b2550],
13	CI	NN	O	ci	dep	3	SENT_121	[p10l491t2476r607b2567],
14	,	,	O	,	_	0	SENT_121	[p10l491t2476r607b2567],
15	0.49	CD	NUMBER	0.49	number	17	SENT_121	[p10l659t2476r835b2550],
16	to	TO	O	to	dep	17	SENT_121	[p10l881t2487r964b2550],
17	0.98	CD	NUMBER	0.98	appos	13	SENT_121	[p10l1010t2476r1212b2566],
18	;	:	O	;	_	0	SENT_121	[p10l1010t2476r1212b2566],
19	hazard	NN	O	hazard	nn	20	SENT_121	[p10l1261t2470r1561b2550],
20	ratio	NN	O	ratio	dep	3	SENT_121	[p10l1606t2471r1804b2550],
21	among	IN	O	among	_	0	SENT_121	[p10l1851t2496r2153b2572],
22	noncarriers	NNS	O	noncarrier	prep_among	20	SENT_121	[p10l8t2601r531b2696],
23	,	,	O	,	_	0	SENT_121	[p10l8t2601r531b2696],
24	0.72	CD	NUMBER	0.72	appos	22	SENT_121	[p10l582t2606r782b2696],
25	;	:	O	;	_	0	SENT_121	[p10l582t2606r782b2696],
26	95	CD	PERCENT	95	number	27	SENT_121	[p10l832t2605r1017b2679],
27	%	NN	PERCENT	%	amod	28	SENT_121	[p10l832t2605r1017b2679],
28	CI	NN	O	ci	dep	3	SENT_121	[p10l1062t2606r1177b2696],
29	,	,	O	,	_	0	SENT_121	[p10l1062t2606r1177b2696],
30	0.59	CD	NUMBER	0.59	num	32	SENT_121	[p10l1229t2606r1405b2679],
31	to	TO	O	to	dep	32	SENT_121	[p10l1452t2616r1534b2679],
32	0.87	CD	NUMBER	0.87	appos	28	SENT_121	[p10l1581t2606r1778b2696],
33	;	:	O	;	_	0	SENT_121	[p10l1581t2606r1778b2696],
34	P	NN	O	p	dep	3	SENT_121	[p10l1826t2606r2150b2679],
35	=	JJ	O	=	amod	34	SENT_121	[p10l1826t2606r2150b2679],
36	0.84	CD	NUMBER	0.84	tmod	35	SENT_121	[p10l1826t2606r2150b2679],
37	for	IN	O	for	_	0	SENT_121	[p10l8t2727r131b2808],
38	the	DT	O	the	det	40	SENT_121	[p10l171t2728r302b2807],
39	interaction	NN	O	interaction	nn	40	SENT_121	[p10l344t2729r854b2820],
40	)	NN	O	)	prep_for	34	SENT_121	[p10l344t2729r854b2820],
41	.	.	O	.	_	0	SENT_121	[p10l344t2729r854b2820],

1	In	IN	O	in	_	0	SENT_122	[p10l901t2736r990b2806],
2	contrast	NN	O	contrast	prep_in	8	SENT_122	[p10l1032t2745r1400b2825],
3	,	,	O	,	_	0	SENT_122	[p10l1032t2745r1400b2825],
4	a	DT	O	a	det	6	SENT_122	[p10l1448t2755r1492b2807],
5	significant	JJ	O	significant	amod	6	SENT_122	[p10l1535t2727r1996b2830],
6	interaction	NN	O	interaction	nsubjpass	8	SENT_122	[p10l2033t2729r2148b2806, p10l9t2858r392b2937],
7	was	VBD	O	be	auxpass	8	SENT_122	[p10l422t2884r586b2937],
8	observed	VBN	O	observe	_	0	SENT_122	[p10l622t2857r1007b2937],
9	between	IN	O	between	_	0	SENT_122	[p10l1041t2857r1402b2937],
10	gain	NN	O	gain	nn	11	SENT_122	[p10l1436t2856r2150b2959],
11	—	NN	O	—	prep_between	8	SENT_122	[p10l1436t2856r2150b2959],
12	of	IN	O	of	_	0	SENT_122	[p10l1436t2856r2150b2959],
13	—	CD	NUMBER	—	num	14	SENT_122	[p10l1436t2856r2150b2959],
14	function	NN	O	function	prep_of	11	SENT_122	[p10l1436t2856r2150b2959],

1	N	NN	O	n	nn	3	SENT_123	[p10l546t3027r559b3042],
2	ENGLJ	NN	O	englj	nn	3	SENT_123	[p10l574t3027r652b3049],
3	MED	NN	O	med	_	0	SENT_123	[p10l667t3027r719b3042],
4	363	CD	NUMBER	363	dep	3	SENT_123	[p10l729t3021r805b3049],
5	;	:	O	;	_	0	SENT_123	[p10l729t3021r805b3049],
6	18	CD	NUMBER	18	num	8	SENT_123	[p10l729t3021r805b3049],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_123	[p10l841t3027r965b3049],
8	OCTOBER	NN	DATE	october	dep	4	SENT_123	[p10l1000t3027r1112b3043],
9	28	CD	DATE	28	dep	8	SENT_123	[p10l1122t3021r1157b3047],
10	,	,	DATE	,	_	0	SENT_123	[p10l1122t3021r1157b3047],
11	2010	CD	DATE	2010	num	12	SENT_123	[p10l1169t3027r1229b3043],
12	1707	CD	DATE	1707	appos	9	SENT_123	[p10l1940t3017r2016b3039],

1	The	DT	O	the	det	5	SENT_124	[p10l702t3060r753b3084],
2	New	NNP	O	New	nn	5	SENT_124	[p10l762t3061r824b3084],
3	England	NNP	O	England	nn	5	SENT_124	[p10l833t3060r944b3091],
4	J	NNP	O	J	nn	5	SENT_124	[p10l952t3061r965b3084],
5	oumal	NN	O	oumal	_	0	SENT_124	[p10l966t3060r1050b3084],
6	of	IN	O	of	_	0	SENT_124	[p10l1059t3060r1088b3084],
7	Medicine	NN	O	medicine	prep_of	5	SENT_124	[p10l1095t3060r1220b3084],

1	Downloaded	VBN	O	download	_	0	SENT_125	[p10l144t3101r314b3124],
2	from	IN	O	from	_	0	SENT_125	[p10l323t3101r387b3124],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_125	[p10l396t3101r514b3131],
4	at	IN	O	at	_	0	SENT_125	[p10l524t3105r547b3124],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_125	[p10l556t3101r738b3124],
6	on	IN	O	on	_	0	SENT_125	[p10l748t3108r780b3124],
7	January	NNP	DATE	January	prep_on	1	SENT_125	[p10l789t3101r892b3131],
8	5	CD	DATE	5	num	7	SENT_125	[p10l902t3101r924b3129],
9	,	,	DATE	,	_	0	SENT_125	[p10l902t3101r924b3129],
10	2014	CD	DATE	2014	num	7	SENT_125	[p10l935t3101r1007b3124],
11	.	.	O	.	_	0	SENT_125	[p10l935t3101r1007b3124],

1	For	IN	O	for	_	0	SENT_126	[p10l1018t3101r1064b3124],
2	personal	JJ	O	personal	amod	3	SENT_126	[p10l1072t3101r1185b3131],
3	use	NN	O	use	pobj	1	SENT_126	[p10l1194t3108r1237b3124],
4	only	RB	O	only	advmod	3	SENT_126	[p10l1247t3101r1312b3131],
5	.	.	O	.	_	0	SENT_126	[p10l1247t3101r1312b3131],

1	No	DT	O	no	det	3	SENT_127	[p10l1322t3101r1362b3124],
2	other	JJ	O	other	amod	3	SENT_127	[p10l1372t3101r1440b3124],
3	uses	NNS	O	use	_	0	SENT_127	[p10l1448t3108r1504b3124],
4	without	IN	O	without	dep	3	SENT_127	[p10l1514t3101r1616b3124],
5	permission	NN	O	permission	pobj	4	SENT_127	[p10l1624t3101r1770b3131],

1	Th	NN	O	th	_	0	SENT_128	[p10l816t3185r847b3206],
2	e	SYM	O	e	dep	5	SENT_128	[p10l854t3192r862b3206],
3	N	NN	O	n	nn	5	SENT_128	[p10l880t3187r904b3206],
4	E	NN	O	e	nn	5	SENT_128	[p10l912t3187r929b3206],
5	W	NN	O	w	dep	13	SENT_128	[p10l935t3187r966b3206],
6	E	NN	O	e	nn	11	SENT_128	[p10l985t3187r1002b3206],
7	N	NN	O	n	nn	11	SENT_128	[p10l1009t3187r1033b3206],
8	G	NN	O	g	nn	11	SENT_128	[p10l1040t3187r1062b3206],
9	L	NN	O	l	nn	11	SENT_128	[p10l1069t3187r1085b3206],
10	A	NN	O	a	nn	11	SENT_128	[p10l1092t3187r1112b3206],
11	ND	NN	O	nd	dep	5	SENT_128	[p10l1120t3187r1173b3206],
12	I	PRP	O	I	nsubj	13	SENT_128	[p10l1192t3187r1204b3213],
13	O	VBP	O	o	dep	1	SENT_128	[p10l1211t3187r1232b3206],
14	U	NNP	O	U	nn	18	SENT_128	[p10l1239t3187r1261b3206],
15	R	NNP	O	R	nn	18	SENT_128	[p10l1269t3187r1291b3206],
16	N	NNP	O	N	nn	18	SENT_128	[p10l1298t3187r1321b3206],
17	A	NNP	O	A	nn	18	SENT_128	[p10l1327t3187r1348b3206],
18	L	NN	O	l	nsubj	23	SENT_128	[p10l1355t3187r1372b3206],
19	of	IN	O	of	_	0	SENT_128	[p10l1391t3185r1419b3212],
20	M	NN	O	m	nn	22	SENT_128	[p10l1431t3187r1458b3206],
21	E	NN	O	e	nn	22	SENT_128	[p10l1467t3187r1483b3206],
22	D	NN	O	d	prep_of	18	SENT_128	[p10l1491t3187r1513b3206],
23	I	PRP	O	I	xcomp	13	SENT_128	[p10l1520t3187r1530b3206],
24	C	NN	O	c	prep	13	SENT_128	[p10l1537t3187r1555b3206],
25	I	PRP	O	I	dep	26	SENT_128	[p10l1563t3187r1573b3206],
26	NE	NNS	O	ne	dep	24	SENT_128	[p10l1582t3187r1630b3206],

1	Outcome	NN	O	outcome	nn	4	SENT_129	[p11l129t91r249b113],
2	and	CC	O	and	_	0	SENT_129	[p11l258t89r304b113],
3	P	NN	O	p	conj_and	1	SENT_129	[p11l1865t92r1880b113],
4	Value	NN	O	value	dep	18	SENT_129	[p11l1888t90r1960b113],
5	for	IN	O	for	_	0	SENT_129	[p11l1968t89r2004b113],
6	Metabolizer	NNP	O	Metabolizer	nn	11	SENT_129	[p11l131t124r281b148],
7	Phenotype	NNP	O	Phenotype	nn	11	SENT_129	[p11l291t124r425b155],
8	Placebo	NNP	O	Placebo	nn	11	SENT_129	[p11l689t125r786b149],
9	Clopidogrel	NNP	O	Clopidogrel	nn	11	SENT_129	[p11l932t125r1078b156],
10	Hazard	NNP	O	Hazard	nn	11	SENT_129	[p11l1328t125r1418b149],
11	Ratio	NNP	O	Ratio	prep_for	4	SENT_129	[p11l1430t126r1494b149],
12	(	CD	PERCENT	(	number	13	SENT_129	[p11l1505t126r1569b156],
13	95	CD	PERCENT	95	dep	14	SENT_129	[p11l1505t126r1569b156],
14	%	NN	PERCENT	%	dep	11	SENT_129	[p11l1505t126r1569b156],
15	Cl	NN	O	cl	dep	18	SENT_129	[p11l1578t127r1613b156],
16	)	CD	NUMBER	)	num	15	SENT_129	[p11l1578t127r1613b156],
17	Heterogeneity	NN	O	heterogeneity	nn	18	SENT_129	[p11l1845t126r2025b156],
18	patients	NNS	O	patient	dep	24	SENT_129	[p11l636t172r727b200],
19	with	IN	O	with	_	0	SENT_129	[p11l736t171r783b193],
20	events/total	JJ	O	events/total	amod	22	SENT_129	[p11l792t171r928b200],
21	no.	NN	O	no.	nn	22	SENT_129	[p11l936t179r969b193],
22	ofpatients	NNS	O	ofpatient	prep_with	18	SENT_129	[p11l980t171r1142b200],
23	(	CD	PERCENT	(	num	24	SENT_129	[p11l980t171r1142b200],
24	%	NN	PERCENT	%	dep	25	SENT_129	[p11l980t171r1142b200],
25	)	CD	NUMBER	)	_	0	SENT_129	[p11l980t171r1142b200],

1	First	JJ	ORDINAL	first	dep	272	SENT_130	[p11l130t219r181b239],
2	primary	JJ	O	primary	dep	272	SENT_130	[p11l191t219r281b246],
3	composite	JJ	O	composite	dep	272	SENT_130	[p11l290t219r415b246],
4	outcome	NN	O	outcome	dep	272	SENT_130	[p11l425t221r530b239],
5	Poor	NNP	O	Poor	dep	272	SENT_130	[p11l159t261r213b281],
6	6/55	CD	NUMBER	6/55	dep	272	SENT_130	[p11l690t260r742b287],
7	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t260r820b287],
8	10.9	CD	NUMBER	10.9	dep	272	SENT_130	[p11l755t260r820b287],
9	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t260r820b287],
10	4/61	CD	NUMBER	4/61	dep	272	SENT_130	[p11l964t261r1017b288],
11	(	NN	O	(	dep	272	SENT_130	[p11l1030t261r1081b288],
12	6.6	CD	NUMBER	6.6	dep	272	SENT_130	[p11l1030t261r1081b288],
13	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t261r1081b288],
14	0.44	CD	NUMBER	0.44	dep	272	SENT_130	[p11l1646t260r1695b280],
15	(	NN	O	(	dep	272	SENT_130	[p11l1707t260r1840b287],
16	0.12	CD	NUMBER	0.12	dep	272	SENT_130	[p11l1707t260r1840b287],
17	—	CD	NUMBER	—	dep	272	SENT_130	[p11l1707t260r1840b287],
18	1.61	CD	NUMBER	1.61	dep	272	SENT_130	[p11l1707t260r1840b287],
19	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t260r1840b287],
20	Intermediate	NNP	O	Intermediate	dep	272	SENT_130	[p11l159t300r310b322],
21	54/442	CD	NUMBER	54/442	dep	272	SENT_130	[p11l661t302r743b329],
22	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t302r821b329],
23	12.2	CD	NUMBER	12.2	dep	272	SENT_130	[p11l755t302r821b329],
24	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t302r821b329],
25	37/437	CD	NUMBER	37/437	dep	272	SENT_130	[p11l936t302r1018b329],
26	(	NN	O	(	dep	272	SENT_130	[p11l1030t302r1081b329],
27	8.5	CD	NUMBER	8.5	dep	272	SENT_130	[p11l1030t302r1081b329],
28	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t302r1081b329],
29	0.72	CD	NUMBER	0.72	dep	272	SENT_130	[p11l1646t301r1695b322],
30	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t301r1840b329],
31	0.48	CD	NUMBER	0.48	dep	272	SENT_130	[p11l1707t301r1840b329],
32	—	NN	O	—	dep	272	SENT_130	[p11l1707t301r1840b329],
33	1.10	CD	NUMBER	1.10	dep	272	SENT_130	[p11l1707t301r1840b329],
34	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t301r1840b329],
35	Extensive	JJ	O	extensive	dep	272	SENT_130	[p11l159t344r268b364],
36	121/987	CD	NUMBER	121/987	dep	272	SENT_130	[p11l648t343r743b371],
37	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t344r820b371],
38	12.3	CD	NUMBER	12.3	dep	272	SENT_130	[p11l755t344r820b371],
39	)	NN	O	)	dep	272	SENT_130	[p11l755t344r820b371],
40	112/1033	CD	NUMBER	112/1033	dep	272	SENT_130	[p11l908t344r1017b371],
41	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1030t344r1096b371],
42	10.8	CD	NUMBER	10.8	dep	272	SENT_130	[p11l1030t344r1096b371],
43	)	NN	O	)	dep	272	SENT_130	[p11l1030t344r1096b371],
44	0.92	CD	NUMBER	0.92	dep	272	SENT_130	[p11l1646t343r1695b363],
45	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t343r1840b370],
46	0.71	CD	NUMBER	0.71	dep	272	SENT_130	[p11l1707t343r1840b370],
47	—	NN	O	—	dep	272	SENT_130	[p11l1707t343r1840b370],
48	1.19	CD	NUMBER	1.19	dep	272	SENT_130	[p11l1707t343r1840b370],
49	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t343r1840b370],
50	Ultra	NNP	O	Ultra	dep	272	SENT_130	[p11l158t384r215b406],
51	112/826	CD	NUMBER	112/826	dep	272	SENT_130	[p11l648t385r743b413],
52	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t386r821b413],
53	13.6	CD	NUMBER	13.6	dep	272	SENT_130	[p11l755t386r821b413],
54	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t386r821b413],
55	66/847	CD	NUMBER	66/847	dep	272	SENT_130	[p11l936t385r1018b413],
56	(	NN	O	(	dep	272	SENT_130	[p11l1030t385r1081b413],
57	7.8	CD	NUMBER	7.8	dep	272	SENT_130	[p11l1030t385r1081b413],
58	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t385r1081b413],
59	0.53	CD	NUMBER	0.53	dep	272	SENT_130	[p11l1646t384r1694b405],
60	(	NN	O	(	dep	272	SENT_130	[p11l1707t384r1840b412],
61	0.39	CD	NUMBER	0.39	dep	272	SENT_130	[p11l1707t384r1840b412],
62	—	CD	NUMBER	—	dep	272	SENT_130	[p11l1707t384r1840b412],
63	0.72	CD	NUMBER	0.72	dep	272	SENT_130	[p11l1707t384r1840b412],
64	)	NN	O	)	dep	272	SENT_130	[p11l1707t384r1840b412],
65	Unknown	JJ	O	unknown	dep	272	SENT_130	[p11l158t425r270b448],
66	18/176	CD	NUMBER	18/176	dep	272	SENT_130	[p11l662t427r743b454],
67	(	NN	O	(	dep	272	SENT_130	[p11l755t427r820b454],
68	10.2	CD	NUMBER	10.2	dep	272	SENT_130	[p11l755t427r820b454],
69	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t427r820b454],
70	11/152	CD	NUMBER	11/152	dep	272	SENT_130	[p11l937t427r1018b454],
71	(	NN	O	(	dep	272	SENT_130	[p11l1030t427r1081b454],
72	7.2	CD	NUMBER	7.2	dep	272	SENT_130	[p11l1030t427r1081b454],
73	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t427r1081b454],
74	0.69	CD	NUMBER	0.69	dep	272	SENT_130	[p11l1646t426r1695b446],
75	(	NN	O	(	dep	272	SENT_130	[p11l1707t426r1840b453],
76	0.33	CD	NUMBER	0.33	dep	272	SENT_130	[p11l1707t426r1840b453],
77	—	CD	NUMBER	—	dep	272	SENT_130	[p11l1707t426r1840b453],
78	1.47	CD	NUMBER	1.47	dep	272	SENT_130	[p11l1707t426r1840b453],
79	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t426r1840b453],
80	Total	JJ	O	total	dep	272	SENT_130	[p11l156t467r215b489],
81	311/2486	CD	NUMBER	311/2486	dep	272	SENT_130	[p11l632t468r743b496],
82	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t469r821b496],
83	26.7	CD	NUMBER	26.7	dep	272	SENT_130	[p11l755t469r821b496],
84	)	NN	O	)	dep	272	SENT_130	[p11l755t469r821b496],
85	230/2530	CD	NUMBER	230/2530	dep	272	SENT_130	[p11l907t469r1019b496],
86	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1030t469r1081b496],
87	9.1	CD	NUMBER	9.1	dep	272	SENT_130	[p11l1030t469r1081b496],
88	)	NN	O	)	dep	272	SENT_130	[p11l1030t469r1081b496],
89	0.71	CD	NUMBER	0.71	dep	272	SENT_130	[p11l1646t467r1694b488],
90	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t467r1840b495],
91	0.60	CD	NUMBER	0.60	dep	272	SENT_130	[p11l1707t467r1840b495],
92	—	NN	O	—	dep	272	SENT_130	[p11l1707t467r1840b495],
93	0.84	CD	NUMBER	0.84	dep	272	SENT_130	[p11l1707t467r1840b495],
94	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t467r1840b495],
95	Second	JJ	ORDINAL	second	dep	272	SENT_130	[p11l128t509r214b531],
96	primary	JJ	O	primary	dep	272	SENT_130	[p11l226t511r316b537],
97	composite	JJ	O	composite	dep	272	SENT_130	[p11l325t511r451b537],
98	outcome	NN	O	outcome	dep	272	SENT_130	[p11l460t513r565b531],
99	Poor	NNP	O	Poor	dep	272	SENT_130	[p11l159t552r213b572],
100	11/55	CD	NUMBER	11/55	dep	272	SENT_130	[p11l677t552r742b579],
101	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t552r821b579],
102	20.0	CD	NUMBER	20.0	dep	272	SENT_130	[p11l755t552r821b579],
103	)	NN	O	)	dep	272	SENT_130	[p11l755t552r821b579],
104	13/61	CD	NUMBER	13/61	dep	272	SENT_130	[p11l952t552r1017b579],
105	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1030t552r1096b579],
106	21.3	CD	NUMBER	21.3	dep	272	SENT_130	[p11l1030t552r1096b579],
107	)	NN	O	)	dep	272	SENT_130	[p11l1030t552r1096b579],
108	0.93	CD	NUMBER	0.93	dep	272	SENT_130	[p11l1646t552r1694b573],
109	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t552r1840b580],
110	0.41	CD	NUMBER	0.41	dep	272	SENT_130	[p11l1707t552r1840b580],
111	—	NN	O	—	dep	272	SENT_130	[p11l1707t552r1840b580],
112	2.11	CD	NUMBER	2.11	dep	272	SENT_130	[p11l1707t552r1840b580],
113	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t552r1840b580],
114	Intermediate	NNP	O	Intermediate	dep	272	SENT_130	[p11l159t592r310b614],
115	84/442	CD	NUMBER	84/442	dep	272	SENT_130	[p11l661t593r743b621],
116	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t593r820b621],
117	19.0	CD	NUMBER	19.0	dep	272	SENT_130	[p11l755t593r820b621],
118	)	NN	O	)	dep	272	SENT_130	[p11l755t593r820b621],
119	70/437	CD	NUMBER	70/437	dep	272	SENT_130	[p11l937t594r1018b621],
120	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1030t594r1096b621],
121	16.0	CD	NUMBER	16.0	dep	272	SENT_130	[p11l1030t594r1096b621],
122	)	NN	O	)	dep	272	SENT_130	[p11l1030t594r1096b621],
123	0.87	CD	NUMBER	0.87	dep	272	SENT_130	[p11l1646t594r1695b615],
124	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t594r1840b621],
125	0.63	CD	NUMBER	0.63	dep	272	SENT_130	[p11l1707t594r1840b621],
126	—	NN	O	—	dep	272	SENT_130	[p11l1707t594r1840b621],
127	1.19	CD	NUMBER	1.19	dep	272	SENT_130	[p11l1707t594r1840b621],
128	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t594r1840b621],
129	Extensive	JJ	O	extensive	dep	272	SENT_130	[p11l159t636r268b656],
130	206/987	CD	NUMBER	206/987	dep	272	SENT_130	[p11l646t635r743b663],
131	(	NN	O	(	dep	272	SENT_130	[p11l755t635r821b663],
132	20.9	CD	NUMBER	20.9	dep	272	SENT_130	[p11l755t635r821b663],
133	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t635r821b663],
134	193/1033	CD	NUMBER	193/1033	dep	272	SENT_130	[p11l908t635r1017b663],
135	(	NN	O	(	dep	272	SENT_130	[p11l1030t635r1096b663],
136	18.7	CD	NUMBER	18.7	dep	272	SENT_130	[p11l1030t635r1096b663],
137	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t635r1096b663],
138	0.90	CD	NUMBER	0.90	dep	272	SENT_130	[p11l1646t635r1696b656],
139	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t635r1840b663],
140	0.74	CD	NUMBER	0.74	dep	272	SENT_130	[p11l1707t635r1840b663],
141	—	NN	O	—	dep	272	SENT_130	[p11l1707t635r1840b663],
142	1.10	CD	NUMBER	1.10	dep	272	SENT_130	[p11l1707t635r1840b663],
143	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t635r1840b663],
144	Ultra	NNP	O	Ultra	dep	272	SENT_130	[p11l158t675r215b698],
145	167/826	CD	NUMBER	167/826	dep	272	SENT_130	[p11l648t677r743b704],
146	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t677r820b704],
147	13.6	CD	NUMBER	13.6	dep	272	SENT_130	[p11l755t677r820b704],
148	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t677r820b704],
149	123/847	CD	NUMBER	123/847	dep	272	SENT_130	[p11l923t677r1018b704],
150	(	NN	O	(	dep	272	SENT_130	[p11l1030t677r1096b704],
151	14.5	CD	NUMBER	14.5	dep	272	SENT_130	[p11l1030t677r1096b704],
152	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t677r1096b704],
153	0.68	CD	NUMBER	0.68	dep	272	SENT_130	[p11l1646t677r1695b697],
154	(	NN	O	(	dep	272	SENT_130	[p11l1707t677r1840b704],
155	0.53	CD	NUMBER	0.53	dep	272	SENT_130	[p11l1707t677r1840b704],
156	—	CD	NUMBER	—	dep	272	SENT_130	[p11l1707t677r1840b704],
157	0.85	CD	NUMBER	0.85	dep	272	SENT_130	[p11l1707t677r1840b704],
158	)	NN	O	)	dep	272	SENT_130	[p11l1707t677r1840b704],
159	Unknown	JJ	O	unknown	dep	272	SENT_130	[p11l158t717r270b739],
160	34/176	CD	NUMBER	34/176	dep	272	SENT_130	[p11l661t719r743b746],
161	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t719r821b746],
162	19.3	CD	NUMBER	19.3	dep	272	SENT_130	[p11l755t719r821b746],
163	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t719r821b746],
164	19/152	CD	NUMBER	19/152	dep	272	SENT_130	[p11l937t719r1018b746],
165	(	NN	O	(	dep	272	SENT_130	[p11l1030t719r1096b746],
166	12.5	CD	NUMBER	12.5	dep	272	SENT_130	[p11l1030t719r1096b746],
167	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t719r1096b746],
168	0.63	CD	NUMBER	0.63	dep	272	SENT_130	[p11l1645t718r1693b739],
169	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1706t718r1840b745],
170	0.36	CD	NUMBER	0.36	dep	272	SENT_130	[p11l1706t718r1840b745],
171	—	NN	O	—	dep	272	SENT_130	[p11l1706t718r1840b745],
172	1.11	CD	NUMBER	1.11	dep	272	SENT_130	[p11l1706t718r1840b745],
173	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1706t718r1840b745],
174	Total	JJ	O	total	dep	272	SENT_130	[p11l156t759r215b781],
175	502/2486	CD	NUMBER	502/2486	dep	272	SENT_130	[p11l632t760r743b788],
176	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t760r820b788],
177	20.2	CD	NUMBER	20.2	dep	272	SENT_130	[p11l755t760r820b788],
178	)	NN	O	)	dep	272	SENT_130	[p11l755t760r820b788],
179	418/2530	CD	NUMBER	418/2530	dep	272	SENT_130	[p11l906t760r1019b788],
180	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1030t761r1096b788],
181	16.5	CD	NUMBER	16.5	dep	272	SENT_130	[p11l1030t761r1096b788],
182	)	NN	O	)	dep	272	SENT_130	[p11l1030t761r1096b788],
183	0.79	CD	NUMBER	0.79	dep	272	SENT_130	[p11l1646t759r1695b780],
184	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t759r1840b787],
185	0.70	CD	NUMBER	0.70	dep	272	SENT_130	[p11l1707t759r1840b787],
186	—	NN	O	—	dep	272	SENT_130	[p11l1707t759r1840b787],
187	0.90	CD	NUMBER	0.90	dep	272	SENT_130	[p11l1707t759r1840b787],
188	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t759r1840b787],
189	Major	JJ	O	major	dep	272	SENT_130	[p11l130t802r199b829],
190	bleeding	NN	O	bleeding	dep	272	SENT_130	[p11l208t800r309b830],
191	Poor	NNP	O	Poor	dep	272	SENT_130	[p11l159t844r213b864],
192	1/55	CD	NUMBER	1/55	dep	272	SENT_130	[p11l691t844r742b871],
193	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t844r806b871],
194	1.8	CD	NUMBER	1.8	dep	272	SENT_130	[p11l755t844r806b871],
195	)	NN	O	)	dep	272	SENT_130	[p11l755t844r806b871],
196	0/61	CD	NUMBER	0/61	dep	272	SENT_130	[p11l964t844r1017b871],
197	N/A	NNP	O	N/A	dep	272	SENT_130	[p11l1721t843r1770b870],
198	Intermediate	NNP	O	Intermediate	dep	272	SENT_130	[p11l159t884r310b906],
199	13/442	CD	NUMBER	13/442	dep	272	SENT_130	[p11l662t886r743b913],
200	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t886r806b913],
201	2.9	CD	NUMBER	2.9	dep	272	SENT_130	[p11l755t886r806b913],
202	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t886r806b913],
203	19/437	CD	NUMBER	19/437	dep	272	SENT_130	[p11l937t886r1018b913],
204	(	NN	O	(	dep	272	SENT_130	[p11l1030t886r1081b913],
205	4.3	CD	NUMBER	4.3	dep	272	SENT_130	[p11l1030t886r1081b913],
206	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t886r1081b913],
207	1.61	CD	NUMBER	1.61	dep	272	SENT_130	[p11l1648t885r1694b905],
208	(	NN	O	(	dep	272	SENT_130	[p11l1707t884r1840b912],
209	0.79	CD	NUMBER	0.79	dep	272	SENT_130	[p11l1707t884r1840b912],
210	—	CD	NUMBER	—	dep	272	SENT_130	[p11l1707t884r1840b912],
211	3.28	CD	NUMBER	3.28	dep	272	SENT_130	[p11l1707t884r1840b912],
212	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t884r1840b912],
213	Extensive	JJ	O	extensive	dep	272	SENT_130	[p11l159t928r268b948],
214	29/987	CD	NUMBER	29/987	dep	272	SENT_130	[p11l660t927r743b954],
215	(	NN	O	(	dep	272	SENT_130	[p11l755t927r806b954],
216	2.9	CD	NUMBER	2.9	dep	272	SENT_130	[p11l755t927r806b954],
217	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t927r806b954],
218	42/1033	CD	NUMBER	42/1033	dep	272	SENT_130	[p11l920t927r1017b955],
219	(	NN	O	(	dep	272	SENT_130	[p11l1030t927r1081b955],
220	4.1	CD	NUMBER	4.1	dep	272	SENT_130	[p11l1030t927r1081b955],
221	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1030t927r1081b955],
222	1.43	CD	NUMBER	1.43	dep	272	SENT_130	[p11l1648t926r1694b946],
223	(	NN	O	(	dep	272	SENT_130	[p11l1707t925r1840b953],
224	0.89	CD	NUMBER	0.89	dep	272	SENT_130	[p11l1707t925r1840b953],
225	—	CD	NUMBER	—	dep	272	SENT_130	[p11l1707t925r1840b953],
226	2.30	CD	NUMBER	2.30	dep	272	SENT_130	[p11l1707t925r1840b953],
227	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t925r1840b953],
228	Ultra	NNP	O	Ultra	dep	272	SENT_130	[p11l158t967r215b989],
229	31/826	CD	NUMBER	31/826	dep	272	SENT_130	[p11l661t968r743b996],
230	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t968r806b996],
231	3.8	CD	NUMBER	3.8	dep	272	SENT_130	[p11l755t968r806b996],
232	)	CD	NUMBER	)	dep	272	SENT_130	[p11l755t968r806b996],
233	39/847	CD	NUMBER	39/847	dep	272	SENT_130	[p11l936t969r1018b996],
234	(	NN	O	(	dep	272	SENT_130	[p11l1030t969r1081b996],
235	4.6	CD	NUMBER	4.6	dep	272	SENT_130	[p11l1030t969r1081b996],
236	)	NN	O	)	dep	272	SENT_130	[p11l1030t969r1081b996],
237	1.19	CD	NUMBER	1.19	dep	272	SENT_130	[p11l1648t967r1695b988],
238	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t967r1840b994],
239	0.74	CD	NUMBER	0.74	dep	272	SENT_130	[p11l1707t967r1840b994],
240	—	NN	O	—	dep	272	SENT_130	[p11l1707t967r1840b994],
241	1.91	CD	NUMBER	1.91	dep	272	SENT_130	[p11l1707t967r1840b994],
242	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1707t967r1840b994],
243	Unknown	JJ	O	unknown	dep	272	SENT_130	[p11l158t1009r270b1031],
244	1/176	CD	NUMBER	1/176	dep	272	SENT_130	[p11l677t1011r743b1038],
245	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t1010r806b1038],
246	0.6	CD	NUMBER	0.6	dep	272	SENT_130	[p11l755t1010r806b1038],
247	)	NN	O	)	dep	272	SENT_130	[p11l755t1010r806b1038],
248	2/152	CD	NUMBER	2/152	dep	272	SENT_130	[p11l950t1011r1018b1038],
249	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1030t1011r1081b1038],
250	1.3	CD	NUMBER	1.3	dep	272	SENT_130	[p11l1030t1011r1081b1038],
251	)	NN	O	)	dep	272	SENT_130	[p11l1030t1011r1081b1038],
252	1.77	CD	NUMBER	1.77	dep	272	SENT_130	[p11l1649t1009r1696b1029],
253	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1708t1008r1855b1036],
254	0.15	CD	NUMBER	0.15	dep	272	SENT_130	[p11l1708t1008r1855b1036],
255	—	NN	O	—	dep	272	SENT_130	[p11l1708t1008r1855b1036],
256	20.33	CD	NUMBER	20.33	dep	272	SENT_130	[p11l1708t1008r1855b1036],
257	)	CD	NUMBER	)	dep	272	SENT_130	[p11l1708t1008r1855b1036],
258	Total	JJ	O	total	dep	272	SENT_130	[p11l156t1050r215b1073],
259	75/2486	CD	NUMBER	75/2486	dep	272	SENT_130	[p11l647t1052r743b1079],
260	(	CD	NUMBER	(	dep	272	SENT_130	[p11l755t1052r806b1079],
261	3.0	CD	NUMBER	3.0	dep	272	SENT_130	[p11l755t1052r806b1079],
262	)	NN	O	)	dep	272	SENT_130	[p11l755t1052r806b1079],
263	102/2530	CD	NUMBER	102/2530	dep	272	SENT_130	[p11l908t1052r1019b1079],
264	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1030t1052r1081b1080],
265	4.0	CD	NUMBER	4.0	dep	272	SENT_130	[p11l1030t1052r1081b1080],
266	)	NN	O	)	dep	272	SENT_130	[p11l1030t1052r1081b1080],
267	1.34	CD	NUMBER	1.34	dep	272	SENT_130	[p11l1648t1050r1695b1070],
268	(	CD	NUMBER	(	dep	272	SENT_130	[p11l1707t1050r1840b1077],
269	1.00	CD	NUMBER	1.00	dep	272	SENT_130	[p11l1707t1050r1840b1077],
270	—	NN	O	—	dep	272	SENT_130	[p11l1707t1050r1840b1077],
271	1.81	CD	NUMBER	1.81	dep	272	SENT_130	[p11l1707t1050r1840b1077],
272	)	NN	O	)	_	0	SENT_130	[p11l1707t1050r1840b1077],

1	Figure	NNP	O	Figure	_	0	SENT_131	[p11l122t1209r206b1242],
2	1	CD	NUMBER	1	dep	1	SENT_131	[p11l218t1211r240b1234],
3	.	.	O	.	_	0	SENT_131	[p11l218t1211r240b1234],

1	Effect	NN	O	effect	_	0	SENT_132	[p11l253t1208r332b1234],
2	of	IN	O	of	_	0	SENT_132	[p11l342t1208r373b1234],
3	Clopidogrel	NNP	O	Clopidogrel	prep_of	1	SENT_132	[p11l378t1209r537b1242],
4	as	IN	O	as	prep	1	SENT_132	[p11l548t1217r577b1234],
5	Compared	VBN	O	compare	_	0	SENT_132	[p11l588t1209r731b1241],
6	with	IN	O	with	prepc_compared_with	1	SENT_132	[p11l742t1209r800b1234],
7	Placebo	NN	O	placebo	pobj	1	SENT_132	[p11l814t1209r920b1234],
8	on	IN	O	on	_	0	SENT_132	[p11l930t1217r963b1234],
9	Clinical	JJ	O	clinical	amod	10	SENT_132	[p11l975t1209r1075b1234],
10	Outcomes	NNS	O	outcome	prep_on	1	SENT_132	[p11l1087t1211r1231b1234],
11	among	IN	O	among	_	0	SENT_132	[p11l1242t1217r1338b1242],
12	Patients	NNS	O	patient	prep_among	1	SENT_132	[p11l1349t1209r1460b1234],
13	with	IN	O	with	_	0	SENT_132	[p11l1470t1209r1529b1234],
14	Acute	JJ	O	acute	amod	16	SENT_132	[p11l1540t1211r1619b1234],
15	Coronary	JJ	O	coronary	amod	16	SENT_132	[p11l1629t1211r1756b1242],
16	Syndromes	NNS	O	syndrome	prep_with	1	SENT_132	[p11l1766t1209r1920b1242],
17	in	IN	O	in	_	0	SENT_132	[p11l120t1251r143b1275],
18	the	DT	O	the	det	20	SENT_132	[p11l154t1250r198b1276],
19	CURE	NN	O	cure	nn	20	SENT_132	[p11l208t1252r288b1276],
20	trial	NN	O	trial	prep_in	1	SENT_132	[p11l298t1250r360b1281],
21	,	,	O	,	_	0	SENT_132	[p11l298t1250r360b1281],
22	Stratiﬁed	NNP	O	Stratiﬁed	appos	20	SENT_132	[p11l371t1250r498b1276],
23	According	VBG	O	accord	_	0	SENT_132	[p11l509t1250r649b1283],
24	to	TO	O	to	prepc_according_to	1	SENT_132	[p11l658t1255r686b1276],
25	Metabolizer	NNP	O	Metabolizer	nn	26	SENT_132	[p11l698t1250r862b1276],
26	Phenotype	NN	O	phenotype	pobj	1	SENT_132	[p11l873t1250r1027b1283],
27	.	.	O	.	_	0	SENT_132	[p11l873t1250r1027b1283],

1	Hazard	NN	O	hazard	nn	2	SENT_133	[p11l122t1300r219b1326],
2	ratios	NNS	O	ratio	nsubjpass	10	SENT_133	[p11l234t1303r309b1326],
3	for	IN	O	for	_	0	SENT_133	[p11l320t1300r359b1326],
4	clopidogrel	NN	O	clopidogrel	prep_for	2	SENT_133	[p11l369t1300r523b1334],
5	as	IN	O	as	_	0	SENT_133	[p11l537t1309r564b1326],
6	compared	VBN	O	compare	prepc_as	4	SENT_133	[p11l576t1300r714b1333],
7	with	IN	O	with	pcomp	6	SENT_133	[p11l726t1300r783b1326],
8	placebo	NN	O	placebo	pobj	7	SENT_133	[p11l797t1300r903b1333],
9	are	VBP	O	be	auxpass	10	SENT_133	[p11l915t1309r956b1326],
10	shown	VBN	O	show	_	0	SENT_133	[p11l968t1300r1056b1326],
11	for	IN	O	for	_	0	SENT_133	[p11l1068t1300r1107b1326],
12	efficacy	NN	O	efficacy	nn	15	SENT_133	[p11l1117t1300r1223b1333],
13	and	CC	O	and	_	0	SENT_133	[p11l1234t1300r1283b1326],
14	bleeding	NN	O	bleeding	nn	15	SENT_133	[p11l1297t1300r1415b1334],
15	outcomes	NNS	O	outcome	prep_for	10	SENT_133	[p11l1426t1305r1562b1326],
16	according	VBG	O	accord	_	0	SENT_133	[p11l1575t1300r1710b1334],
17	to	TO	O	to	prepc_according_to	10	SENT_133	[p11l1719t1305r1746b1326],
18	metabolizer	NN	O	metabolizer	nn	19	SENT_133	[p11l1759t1300r1924b1326],
19	phenotype	NN	O	phenotype	pobj	10	SENT_133	[p11l1936t1300r2032b1333, p11l119t1347r185b1375],
20	.	.	O	.	_	0	SENT_133	[p11l1936t1300r2032b1333, p11l119t1347r185b1375],

1	The	DT	O	the	det	4	SENT_134	[p11l197t1342r248b1367],
2	size	NN	O	size	nn	4	SENT_134	[p11l260t1344r311b1367],
3	ofeach	NN	O	ofeach	nn	4	SENT_134	[p11l323t1342r421b1367],
4	symbol	NN	O	symbol	nsubj	5	SENT_134	[p11l434t1342r532b1375],
5	is	VBZ	O	be	_	0	SENT_134	[p11l546t1344r565b1367],
6	in	IN	O	in	_	0	SENT_134	[p11l578t1344r600b1367],
7	inverse	JJ	O	inverse	amod	8	SENT_134	[p11l614t1344r711b1367],
8	proportion	NN	O	proportion	prep_in	5	SENT_134	[p11l724t1344r871b1375],
9	to	TO	O	to	_	0	SENT_134	[p11l883t1347r910b1367],
10	the	DT	O	the	det	15	SENT_134	[p11l920t1342r964b1367],
11	standard	JJ	O	standard	amod	15	SENT_134	[p11l976t1342r1096b1367],
12	deviation	NN	O	deviation	nn	15	SENT_134	[p11l1109t1342r1234b1367],
13	ofthe	NN	O	ofthe	nn	15	SENT_134	[p11l1247t1342r1326b1367],
14	effect-size	JJ	O	effect-size	amod	15	SENT_134	[p11l1338t1342r1479b1367],
15	estimates	NNS	O	estimate	prep_to	5	SENT_134	[p11l1490t1344r1632b1367],
16	.	.	O	.	_	0	SENT_134	[p11l1490t1344r1632b1367],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_135	[p11l1643t1342r1764b1375],
2	were	VBD	O	be	auxpass	3	SENT_135	[p11l1776t1351r1840b1367],
3	performed	VBN	O	perform	_	0	SENT_135	[p11l1853t1342r1998b1375],
4	on	IN	O	on	_	0	SENT_135	[p11l2011t1351r2044b1367],
5	data	NNS	O	datum	prep_on	3	SENT_135	[p11l120t1384r178b1409],
6	from	IN	O	from	_	0	SENT_135	[p11l190t1383r254b1409],
7	patients	NNS	O	patient	prep_from	3	SENT_135	[p11l268t1386r378b1417],
8	of	IN	O	of	_	0	SENT_135	[p11l390t1383r420b1409],
9	European	JJ	MISC	european	amod	13	SENT_135	[p11l429t1386r557b1417],
10	or	CC	O	or	_	0	SENT_135	[p11l570t1393r598b1409],
11	Latin	JJ	MISC	latin	amod	13	SENT_135	[p11l611t1386r676b1409],
12	American	JJ	MISC	american	amod	13	SENT_135	[p11l687t1385r820b1409],
13	ancestry	NN	O	ancestry	prep_of	7	SENT_135	[p11l833t1389r955b1417],
14	,	,	O	,	_	0	SENT_135	[p11l833t1389r955b1417],
15	with	IN	O	with	_	0	SENT_135	[p11l966t1384r1024b1409],
16	adjustment	NN	O	adjustment	prep_with	3	SENT_135	[p11l1037t1384r1195b1417],
17	for	IN	O	for	_	0	SENT_135	[p11l1205t1383r1244b1409],
18	age	NN	O	age	prep_for	16	SENT_135	[p11l1255t1393r1308b1417],
19	,	,	O	,	_	0	SENT_135	[p11l1255t1393r1308b1417],
20	sex	NN	O	sex	prep_for	16	SENT_135	[p11l1322t1393r1372b1413],
21	,	,	O	,	_	0	SENT_135	[p11l1322t1393r1372b1413],
22	and	CC	O	and	_	0	SENT_135	[p11l1385t1384r1433b1409],
23	ancestry	NN	O	ancestry	prep_for	16	SENT_135	[p11l1446t1389r1568b1417],
24	.	.	O	.	_	0	SENT_135	[p11l1446t1389r1568b1417],

1	Patients	NNS	O	patient	dep	164	SENT_136	[p11l1583t1386r1692b1409],
2	with	IN	O	with	dep	164	SENT_136	[p11l1703t1384r1760b1409],
3	two	CD	NUMBER	two	dep	164	SENT_136	[p11l1772t1389r1823b1409],
4	*	NN	O	*	dep	164	SENT_136	[p11l1834t1386r1866b1409],
5	2	CD	NUMBER	2	dep	164	SENT_136	[p11l1834t1386r1866b1409],
6	or	CC	O	or	dep	164	SENT_136	[p11l1878t1393r1906b1409],
7	"	``	O	"	dep	164	SENT_136	[p11l1916t1386r1945b1409],
8	3	CD	NUMBER	3	dep	164	SENT_136	[p11l1916t1386r1945b1409],
9	alleles	NNS	O	allele	dep	164	SENT_136	[p11l1959t1384r2044b1409],
10	(	CD	NUMBER	(	dep	164	SENT_136	[p11l123t1427r178b1458],
11	i.e.	FW	O	i.e.	dep	164	SENT_136	[p11l123t1427r178b1458],
12	,	,	O	,	_	0	SENT_136	[p11l123t1427r178b1458],
13	*	NN	O	*	dep	164	SENT_136	[p11l190t1428r275b1458],
14	2	CD	NUMBER	2	dep	164	SENT_136	[p11l190t1428r275b1458],
15	/	:	O	/	dep	164	SENT_136	[p11l190t1428r275b1458],
16	*	CD	NUMBER	*	dep	164	SENT_136	[p11l190t1428r275b1458],
17	2	CD	NUMBER	2	dep	164	SENT_136	[p11l190t1428r275b1458],
18	,	,	O	,	_	0	SENT_136	[p11l190t1428r275b1458],
19	*	CD	NUMBER	*	dep	164	SENT_136	[p11l287t1427r371b1458],
20	2	CD	NUMBER	2	dep	164	SENT_136	[p11l287t1427r371b1458],
21	/	:	O	/	dep	164	SENT_136	[p11l287t1427r371b1458],
22	*	CD	NUMBER	*	dep	164	SENT_136	[p11l287t1427r371b1458],
23	3	CD	NUMBER	3	dep	164	SENT_136	[p11l287t1427r371b1458],
24	,	,	O	,	_	0	SENT_136	[p11l287t1427r371b1458],
25	or	CC	O	or	dep	164	SENT_136	[p11l383t1434r411b1451],
26	*	NN	O	*	dep	164	SENT_136	[p11l420t1427r504b1458],
27	3	CD	NUMBER	3	dep	164	SENT_136	[p11l420t1427r504b1458],
28	/	:	O	/	dep	164	SENT_136	[p11l420t1427r504b1458],
29	*	CD	NUMBER	*	dep	164	SENT_136	[p11l420t1427r504b1458],
30	3	CD	NUMBER	3	dep	164	SENT_136	[p11l420t1427r504b1458],
31	)	NN	O	)	dep	164	SENT_136	[p11l420t1427r504b1458],
32	were	VBD	O	be	dep	164	SENT_136	[p11l516t1434r580b1451],
33	classified	VBN	O	classify	dep	164	SENT_136	[p11l591t1425r715b1451],
34	as	IN	O	as	dep	164	SENT_136	[p11l728t1434r755b1451],
35	having	VBG	O	have	dep	164	SENT_136	[p11l768t1425r856b1459],
36	the	DT	O	the	dep	164	SENT_136	[p11l865t1425r908b1451],
37	poor-metabolizer	NN	O	poor-metabolizer	dep	164	SENT_136	[p11l920t1425r1155b1458],
38	phenotype	NN	O	phenotype	dep	164	SENT_136	[p11l1166t1425r1317b1458],
39	,	,	O	,	_	0	SENT_136	[p11l1166t1425r1317b1458],
40	those	DT	O	those	dep	164	SENT_136	[p11l1328t1425r1403b1451],
41	with	IN	O	with	dep	164	SENT_136	[p11l1413t1425r1469b1451],
42	one	CD	NUMBER	one	dep	164	SENT_136	[p11l1481t1434r1530b1451],
43	*	NN	O	*	dep	164	SENT_136	[p11l1541t1428r1572b1450],
44	2	CD	NUMBER	2	dep	164	SENT_136	[p11l1541t1428r1572b1450],
45	or	CC	O	or	dep	164	SENT_136	[p11l1583t1434r1611b1451],
46	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1620t1427r1649b1450],
47	3	CD	NUMBER	3	dep	164	SENT_136	[p11l1620t1427r1649b1450],
48	allele	NN	O	allele	dep	164	SENT_136	[p11l1662t1425r1731b1451],
49	(	CD	NUMBER	(	dep	164	SENT_136	[p11l1744t1427r1799b1458],
50	i.e.	FW	O	i.e.	dep	164	SENT_136	[p11l1744t1427r1799b1458],
51	,	,	O	,	_	0	SENT_136	[p11l1744t1427r1799b1458],
52	*	NN	O	*	dep	164	SENT_136	[p11l1810t1428r1885b1458],
53	1	CD	NUMBER	1	dep	164	SENT_136	[p11l1810t1428r1885b1458],
54	/	:	O	/	dep	164	SENT_136	[p11l1810t1428r1885b1458],
55	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1810t1428r1885b1458],
56	2	CD	NUMBER	2	dep	164	SENT_136	[p11l1810t1428r1885b1458],
57	or	CC	O	or	dep	164	SENT_136	[p11l1896t1434r1924b1451],
58	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1933t1427r2016b1458],
59	1	CD	NUMBER	1	dep	164	SENT_136	[p11l1933t1427r2016b1458],
60	/	:	O	/	dep	164	SENT_136	[p11l1933t1427r2016b1458],
61	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1933t1427r2016b1458],
62	3	CD	NUMBER	3	dep	164	SENT_136	[p11l1933t1427r2016b1458],
63	)	NN	O	)	dep	164	SENT_136	[p11l1933t1427r2016b1458],
64	were	VBD	O	be	dep	164	SENT_136	[p11l119t1476r184b1492],
65	classified	VBN	O	classify	dep	164	SENT_136	[p11l195t1467r323b1492],
66	as	IN	O	as	dep	164	SENT_136	[p11l336t1476r364b1492],
67	having	VBG	O	have	dep	164	SENT_136	[p11l377t1467r467b1500],
68	the	DT	O	the	dep	164	SENT_136	[p11l476t1467r520b1492],
69	intermediate-metabolizer	JJ	O	intermediate-metabolizer	dep	164	SENT_136	[p11l532t1467r887b1492],
70	phenotype	NN	O	phenotype	dep	164	SENT_136	[p11l899t1467r1053b1500],
71	,	,	O	,	_	0	SENT_136	[p11l899t1467r1053b1500],
72	those	DT	O	those	dep	164	SENT_136	[p11l1064t1467r1141b1492],
73	without	IN	O	without	dep	164	SENT_136	[p11l1151t1467r1257b1492],
74	a	DT	O	a	dep	164	SENT_136	[p11l1269t1476r1281b1492],
75	*	NN	O	*	dep	164	SENT_136	[p11l1293t1469r1332b1497],
76	2	CD	NUMBER	2	dep	164	SENT_136	[p11l1293t1469r1332b1497],
77	,	,	O	,	_	0	SENT_136	[p11l1293t1469r1332b1497],
78	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1344t1469r1383b1497],
79	3	CD	NUMBER	3	dep	164	SENT_136	[p11l1344t1469r1383b1497],
80	,	,	O	,	_	0	SENT_136	[p11l1344t1469r1383b1497],
81	or	CC	O	or	dep	164	SENT_136	[p11l1396t1476r1424b1492],
82	*	NN	O	*	dep	164	SENT_136	[p11l1434t1469r1479b1492],
83	17	CD	NUMBER	17	dep	164	SENT_136	[p11l1434t1469r1479b1492],
84	allele	NN	O	allele	dep	164	SENT_136	[p11l1491t1467r1561b1492],
85	(	CD	NUMBER	(	dep	164	SENT_136	[p11l1575t1469r1631b1500],
86	i.e.	FW	O	i.e.	dep	164	SENT_136	[p11l1575t1469r1631b1500],
87	,	,	O	,	_	0	SENT_136	[p11l1575t1469r1631b1500],
88	*	NN	O	*	dep	164	SENT_136	[p11l1643t1469r1726b1500],
89	1	CD	NUMBER	1	dep	164	SENT_136	[p11l1643t1469r1726b1500],
90	/	:	O	/	dep	164	SENT_136	[p11l1643t1469r1726b1500],
91	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1643t1469r1726b1500],
92	1	CD	NUMBER	1	dep	164	SENT_136	[p11l1643t1469r1726b1500],
93	)	NN	O	)	dep	164	SENT_136	[p11l1643t1469r1726b1500],
94	were	VBD	O	be	dep	164	SENT_136	[p11l1739t1476r1804b1492],
95	classified	VBN	O	classify	dep	164	SENT_136	[p11l1815t1467r1943b1492],
96	as	IN	O	as	dep	164	SENT_136	[p11l1956t1476r1984b1492],
97	having	VBG	O	have	dep	164	SENT_136	[p11l121t1509r211b1542],
98	the	DT	O	the	dep	164	SENT_136	[p11l221t1509r264b1534],
99	extensive-metabolizer	JJ	O	extensive-metabolizer	dep	164	SENT_136	[p11l275t1509r583b1534],
100	phenotype	NN	O	phenotype	dep	164	SENT_136	[p11l594t1509r748b1542],
101	,	,	O	,	_	0	SENT_136	[p11l594t1509r748b1542],
102	those	DT	O	those	dep	164	SENT_136	[p11l760t1509r836b1534],
103	with	IN	O	with	dep	164	SENT_136	[p11l846t1509r903b1534],
104	a	DT	O	a	dep	164	SENT_136	[p11l917t1518r929b1534],
105	single	JJ	O	single	dep	164	SENT_136	[p11l942t1509r1022b1542],
106	*	NN	O	*	dep	164	SENT_136	[p11l1033t1511r1078b1534],
107	17	CD	NUMBER	17	dep	164	SENT_136	[p11l1033t1511r1078b1534],
108	allele	NN	O	allele	dep	164	SENT_136	[p11l1090t1509r1160b1534],
109	(	CD	NUMBER	(	dep	164	SENT_136	[p11l1175t1511r1230b1542],
110	i.e.	FW	O	i.e.	dep	164	SENT_136	[p11l1175t1511r1230b1542],
111	,	,	O	,	_	0	SENT_136	[p11l1175t1511r1230b1542],
112	*	NN	O	*	dep	164	SENT_136	[p11l1243t1511r1343b1542],
113	1	CD	NUMBER	1	dep	164	SENT_136	[p11l1243t1511r1343b1542],
114	/	:	O	/	dep	164	SENT_136	[p11l1243t1511r1343b1542],
115	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1243t1511r1343b1542],
116	17	CD	NUMBER	17	dep	164	SENT_136	[p11l1243t1511r1343b1542],
117	)	NN	O	)	dep	164	SENT_136	[p11l1243t1511r1343b1542],
118	and	CC	O	and	dep	164	SENT_136	[p11l1358t1509r1406b1534],
119	*	NN	O	*	dep	164	SENT_136	[p11l1418t1511r1464b1534],
120	17	CD	NUMBER	17	dep	164	SENT_136	[p11l1418t1511r1464b1534],
121	homozygotes	NNS	O	homozygote	dep	164	SENT_136	[p11l1476t1509r1661b1542],
122	were	VBD	O	be	dep	164	SENT_136	[p11l1672t1518r1737b1534],
123	classified	VBN	O	classify	dep	164	SENT_136	[p11l1749t1508r1877b1534],
124	as	IN	O	as	dep	164	SENT_136	[p11l1890t1518r1917b1534],
125	having	VBG	O	have	dep	164	SENT_136	[p11l1930t1509r2020b1542],
126	the	DT	O	the	dep	164	SENT_136	[p11l119t1550r162b1576],
127	ultrametabolizer	NN	O	ultrametabolizer	dep	164	SENT_136	[p11l175t1550r405b1576],
128	phenotype	NN	O	phenotype	dep	164	SENT_136	[p11l416t1550r570b1583],
129	,	,	O	,	_	0	SENT_136	[p11l416t1550r570b1583],
130	and	CC	O	and	dep	164	SENT_136	[p11l583t1550r631b1576],
131	those	DT	O	those	dep	164	SENT_136	[p11l643t1550r719b1576],
132	with	IN	O	with	dep	164	SENT_136	[p11l730t1550r787b1576],
133	one	CD	NUMBER	one	dep	164	SENT_136	[p11l800t1559r850b1576],
134	*	NN	O	*	dep	164	SENT_136	[p11l861t1553r906b1575],
135	17	CD	NUMBER	17	dep	164	SENT_136	[p11l861t1553r906b1575],
136	allele	NN	O	allele	dep	164	SENT_136	[p11l918t1550r988b1576],
137	and	CC	O	and	dep	164	SENT_136	[p11l1000t1550r1048b1576],
138	one	CD	NUMBER	one	dep	164	SENT_136	[p11l1061t1559r1111b1576],
139	loss-of-function	NN	O	loss-of-function	dep	164	SENT_136	[p11l1124t1550r1341b1576],
140	allele	NN	O	allele	dep	164	SENT_136	[p11l1354t1550r1424b1576],
141	(	CD	NUMBER	(	dep	164	SENT_136	[p11l1439t1552r1494b1583],
142	i.e.	FW	O	i.e.	dep	164	SENT_136	[p11l1439t1552r1494b1583],
143	,	,	O	,	_	0	SENT_136	[p11l1439t1552r1494b1583],
144	"	``	O	"	dep	164	SENT_136	[p11l1507t1553r1599b1583],
145	=	JJ	O	=	dep	164	SENT_136	[p11l1507t1553r1599b1583],
146	2	CD	NUMBER	2	dep	164	SENT_136	[p11l1507t1553r1599b1583],
147	/	:	O	/	dep	164	SENT_136	[p11l1507t1553r1599b1583],
148	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1507t1553r1599b1583],
149	17	CD	NUMBER	17	dep	164	SENT_136	[p11l1507t1553r1599b1583],
150	or	CC	O	or	dep	164	SENT_136	[p11l1611t1559r1639b1576],
151	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1649t1552r1750b1583],
152	3	CD	NUMBER	3	dep	164	SENT_136	[p11l1649t1552r1750b1583],
153	/	:	O	/	dep	164	SENT_136	[p11l1649t1552r1750b1583],
154	*	CD	NUMBER	*	dep	164	SENT_136	[p11l1649t1552r1750b1583],
155	17	CD	NUMBER	17	dep	164	SENT_136	[p11l1649t1552r1750b1583],
156	)	NN	O	)	dep	164	SENT_136	[p11l1649t1552r1750b1583],
157	were	VBD	O	be	dep	164	SENT_136	[p11l1763t1559r1828b1576],
158	classified	VBN	O	classify	dep	164	SENT_136	[p11l1839t1550r1967b1576],
159	as	IN	O	as	dep	164	SENT_136	[p11l1980t1559r2008b1576],
160	having	VBG	O	have	dep	164	SENT_136	[p11l121t1592r211b1625],
161	an	DT	O	a	dep	164	SENT_136	[p11l222t1601r252b1617],
162	unknown	JJ	O	unknown	dep	164	SENT_136	[p11l266t1592r391b1617],
163	metabolizer	NN	O	metabolizer	dep	164	SENT_136	[p11l405t1592r570b1617],
164	phenotype	NN	O	phenotype	_	0	SENT_136	[p11l581t1592r735b1625],
165	.	.	O	.	_	0	SENT_136	[p11l581t1592r735b1625],

1	Only	RB	O	only	advmod	2	SENT_137	[p11l748t1592r812b1625],
2	patients	NNS	O	patient	nsubjpass	13	SENT_137	[p11l824t1594r934b1625],
3	who	WP	O	who	nsubjpass	6	SENT_137	[p11l945t1592r1003b1617],
4	were	VBD	O	be	auxpass	6	SENT_137	[p11l1014t1601r1078b1617],
5	successfully	RB	O	successfully	advmod	6	SENT_137	[p11l1090t1592r1255b1625],
6	genotyped	VBN	O	genotype	rcmod	2	SENT_137	[p11l1266t1592r1411b1625],
7	for	IN	O	for	_	0	SENT_137	[p11l1423t1592r1462b1617],
8	all	DT	O	all	det	11	SENT_137	[p11l1473t1592r1501b1617],
9	three	CD	NUMBER	three	num	11	SENT_137	[p11l1512t1592r1583b1617],
10	single-nucleotide	JJ	O	single-nucleotide	amod	11	SENT_137	[p11l1595t1592r1834b1625],
11	polymorphisms	NNS	O	polymorphism	prep_for	6	SENT_137	[p11l1847t1592r1969b1625, p11l121t1634r220b1667],
12	were	VBD	O	be	auxpass	13	SENT_137	[p11l231t1643r296b1659],
13	included	VBN	O	include	_	0	SENT_137	[p11l308t1634r425b1659],
14	in	IN	O	in	_	0	SENT_137	[p11l439t1636r460b1659],
15	these	DT	O	these	det	16	SENT_137	[p11l472t1634r547b1659],
16	analyses	NNS	O	analysis	prep_in	13	SENT_137	[p11l558t1634r682b1667],
17	.	.	O	.	_	0	SENT_137	[p11l558t1634r682b1667],

1	allele	NN	O	allele	nn	3	SENT_138	[p11l7t1900r232b1978],
2	carrier	NN	O	carrier	nn	3	SENT_138	[p11l273t1901r560b1978],
3	status	NN	O	status	_	0	SENT_138	[p11l599t1917r852b1979],
4	(	CD	NUMBER	(	dep	3	SENT_138	[p11l900t1901r1074b1996],
5	i.e.	FW	O	i.e.	dep	4	SENT_138	[p11l900t1901r1074b1996],
6	,	,	O	,	_	0	SENT_138	[p11l900t1901r1074b1996],
7	*	NN	O	*	appos	5	SENT_138	[p11l1118t1900r1415b1996],
8	1	CD	NUMBER	1	num	7	SENT_138	[p11l1118t1900r1415b1996],
9	/	:	O	/	punct	23	SENT_138	[p11l1118t1900r1415b1996],
10	*	CD	NUMBER	*	num	11	SENT_138	[p11l1118t1900r1415b1996],
11	17	CD	NUMBER	17	dep	23	SENT_138	[p11l1118t1900r1415b1996],
12	,	,	O	,	_	0	SENT_138	[p11l1118t1900r1415b1996],
13	*	CD	NUMBER	*	number	14	SENT_138	[p11l1459t1900r1802b1996],
14	17	CD	NUMBER	17	appos	11	SENT_138	[p11l1459t1900r1802b1996],
15	/	:	O	/	punct	17	SENT_138	[p11l1459t1900r1802b1996],
16	*	CD	NUMBER	*	num	17	SENT_138	[p11l1459t1900r1802b1996],
17	17	CD	NUMBER	17	dep	14	SENT_138	[p11l1459t1900r1802b1996],
18	,	,	O	,	_	0	SENT_138	[p11l1459t1900r1802b1996],
19	*	CD	NUMBER	*	num	20	SENT_138	[p11l1846t1900r2144b1996],
20	2	CD	NUMBER	2	appos	17	SENT_138	[p11l1846t1900r2144b1996],
21	/	:	O	/	punct	17	SENT_138	[p11l1846t1900r2144b1996],
22	*	CD	NUMBER	*	num	23	SENT_138	[p11l1846t1900r2144b1996],
23	17	CD	NUMBER	17	dep	7	SENT_138	[p11l1846t1900r2144b1996],
24	,	,	O	,	_	0	SENT_138	[p11l1846t1900r2144b1996],

1	or	CC	O	or	dep	21	SENT_139	[p11l9t2056r98b2110],
2	*	CD	NUMBER	*	number	3	SENT_139	[p11l136t2030r449b2122],
3	3	CD	NUMBER	3	dep	21	SENT_139	[p11l136t2030r449b2122],
4	/	:	O	/	punct	7	SENT_139	[p11l136t2030r449b2122],
5	*	CD	NUMBER	*	num	7	SENT_139	[p11l136t2030r449b2122],
6	17	CD	NUMBER	17	num	7	SENT_139	[p11l136t2030r449b2122],
7	)	NN	O	)	dep	3	SENT_139	[p11l136t2030r449b2122],
8	and	CC	O	and	_	0	SENT_139	[p11l496t2030r655b2110],
9	study-group	JJ	O	study-group	amod	10	SENT_139	[p11l698t2030r1217b2132],
10	assignment	NN	O	assignment	dep	3	SENT_139	[p11l1259t2031r1764b2132],
11	with	IN	O	with	_	0	SENT_139	[p11l1795t2030r1992b2110],
12	respect	NN	O	respect	prep_with_respect_to	21	SENT_139	[p11l2034t2056r2148b2109, p11l9t2177r234b2261],
13	to	TO	O	to	_	0	SENT_139	[p11l294t2177r377b2240],
14	the	DT	O	the	det	19	SENT_139	[p11l444t2160r577b2239],
15	first	JJ	ORDINAL	first	amod	19	SENT_139	[p11l643t2159r830b2239],
16	primary	JJ	O	primary	amod	19	SENT_139	[p11l888t2161r1241b2261],
17	composite	JJ	O	composite	amod	19	SENT_139	[p11l1303t2161r1748b2261],
18	efficacy	NN	O	efficacy	nn	19	SENT_139	[p11l1815t2159r2153b2261],
19	outcome	NN	O	outcome	pobj	21	SENT_139	[p11l9t2306r404b2385],
20	,	,	O	,	_	0	SENT_139	[p11l9t2306r404b2385],
21	such	JJ	O	such	_	0	SENT_139	[p11l474t2289r670b2368],
22	that	IN	O	that	complm	24	SENT_139	[p11l733t2289r907b2367],
23	carriers	NNS	O	carrier	nsubj	24	SENT_139	[p11l966t2290r1293b2367],
24	had	VBD	O	have	ccomp	21	SENT_139	[p11l1358t2289r1517b2368],
25	a	DT	O	a	det	27	SENT_139	[p11l1579t2315r1623b2367],
26	more	RBR	O	more	advmod	27	SENT_139	[p11l1685t2315r1906b2368],
27	pronounced	JJ	O	pronounced	dobj	24	SENT_139	[p11l1968t2315r2148b2389, p11l8t2419r379b2498],

1	reduction	NN	O	reduction	_	0	SENT_140	[p11l415t2419r828b2498],
2	in	IN	O	in	_	0	SENT_140	[p11l864t2420r948b2497],
3	cardiovascular	JJ	O	cardiovascular	amod	4	SENT_140	[p11l985t2419r1618b2498],
4	events	NNS	O	event	prep_in	1	SENT_140	[p11l1652t2436r1918b2498],
5	with	IN	O	with	_	0	SENT_140	[p11l1952t2419r2149b2498],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_140	[p11l9t2548r495b2650],
7	treatment	NN	O	treatment	prep_with	1	SENT_140	[p11l534t2565r961b2627],
8	as	IN	O	as	mark	13	SENT_140	[p11l993t2574r1079b2627],
9	compared	VBN	O	compare	csubj	13	SENT_140	[p11l1120t2548r1549b2649],
10	with	IN	O	with	_	0	SENT_140	[p11l1583t2548r1780b2628],
11	placebo	NN	O	placebo	prep_with	9	SENT_140	[p11l1816t2548r2148b2649],
12	than	IN	O	than	prep	9	SENT_140	[p11l8t2677r206b2755],
13	did	VBD	O	do	dep	1	SENT_140	[p11l255t2677r391b2756],
14	noncarriers	JJ	O	noncarriers	amod	17	SENT_140	[p11l438t2678r935b2756],
15	(	NN	O	(	nn	17	SENT_140	[p11l991t2677r1319b2768],
16	hazard	NN	O	hazard	nn	17	SENT_140	[p11l991t2677r1319b2768],
17	ratio	NN	O	ratio	dobj	13	SENT_140	[p11l1366t2678r1565b2756],
18	with	IN	O	with	_	0	SENT_140	[p11l1609t2677r1807b2756],
19	clopidogrel	NN	O	clopidogrel	prep_with	13	SENT_140	[p11l1855t2677r2148b2777, p11l9t2807r229b2909],

1	among	IN	O	among	dep	4	SENT_141	[p11l264t2833r567b2909],
2	carriers	NNS	O	carrier	pobj	1	SENT_141	[p11l600t2808r952b2904],
3	,	,	O	,	_	0	SENT_141	[p11l600t2808r952b2904],
4	0.55	CD	NUMBER	0.55	_	0	SENT_141	[p11l994t2813r1193b2904],
5	;	:	O	;	_	0	SENT_141	[p11l994t2813r1193b2904],
6	95	CD	PERCENT	95	number	7	SENT_141	[p11l1234t2812r1419b2887],
7	%	NN	PERCENT	%	amod	8	SENT_141	[p11l1234t2812r1419b2887],
8	CI	NN	O	ci	dep	4	SENT_141	[p11l1454t2813r1570b2904],
9	,	,	O	,	_	0	SENT_141	[p11l1454t2813r1570b2904],
10	0.42	CD	NUMBER	0.42	num	12	SENT_141	[p11l1613t2813r1788b2887],
11	to	TO	O	to	dep	12	SENT_141	[p11l1825t2824r1907b2887],
12	0.73	CD	NUMBER	0.73	appos	8	SENT_141	[p11l1945t2813r2145b2904],
13	;	:	O	;	_	0	SENT_141	[p11l1945t2813r2145b2904],
14	hazard	NN	O	hazard	nn	15	SENT_141	[p11l8t2937r307b3017],
15	ratio	NN	O	ratio	dep	8	SENT_141	[p11l357t2938r556b3017],
16	among	IN	O	among	_	0	SENT_141	[p11l607t2963r909b3039],
17	noncarriers	NNS	O	noncarrier	prep_among	15	SENT_141	[p11l956t2938r1478b3034],
18	,	,	O	,	_	0	SENT_141	[p11l956t2938r1478b3034],
19	0.85	CD	NUMBER	0.85	amod	17	SENT_141	[p11l1535t2943r1736b3034],
20	;	:	O	;	_	0	SENT_141	[p11l1535t2943r1736b3034],
21	95	CD	PERCENT	95	number	22	SENT_141	[p11l1790t2942r1976b3017],
22	%	NN	PERCENT	%	amod	23	SENT_141	[p11l1790t2942r1976b3017],
23	CI	NN	O	ci	dep	8	SENT_141	[p11l2025t2943r2144b3034],
24	,	,	O	,	_	0	SENT_141	[p11l2025t2943r2144b3034],
25	0.68	CD	NUMBER	0.68	num	27	SENT_141	[p11l8t3074r186b3147],
26	to	TO	O	to	dep	27	SENT_141	[p11l227t3084r308b3147],
27	1.05	CD	NUMBER	1.05	appos	23	SENT_141	[p11l352t3074r548b3163],
28	;	:	O	;	_	0	SENT_141	[p11l352t3074r548b3163],
29	P	NN	O	p	dep	8	SENT_141	[p11l589t3074r902b3147],
30	=	JJ	O	=	amod	29	SENT_141	[p11l589t3074r902b3147],
31	0.02	CD	NUMBER	0.02	tmod	30	SENT_141	[p11l589t3074r902b3147],
32	for	IN	O	for	_	0	SENT_141	[p11l942t3066r1065b3147],
33	the	DT	O	the	det	35	SENT_141	[p11l1100t3067r1233b3146],
34	interaction	NN	O	interaction	nn	35	SENT_141	[p11l1272t3068r1789b3159],
35	)	NN	O	)	prep_for	29	SENT_141	[p11l1272t3068r1789b3159],
36	.	.	O	.	_	0	SENT_141	[p11l1272t3068r1789b3159],

1	A	DT	O	a	dep	2	SENT_142	[p11l1829t3075r1896b3146],
2	similar	JJ	O	similar	_	0	SENT_142	[p11l1932t3068r2148b3146, p11l7t3196r124b3274],

1	interaction	NN	O	interaction	nsubjpass	3	SENT_143	[p11l162t3197r634b3275],
2	was	VBD	O	be	auxpass	3	SENT_143	[p11l672t3222r835b3275],
3	observed	VBN	O	observe	_	0	SENT_143	[p11l880t3196r1264b3275],
4	with	IN	O	with	_	0	SENT_143	[p11l1302t3196r1499b3275],
5	respect	NN	O	respect	prep_with	3	SENT_143	[p11l1541t3213r1852b3296],
6	to	TO	O	to	_	0	SENT_143	[p11l1890t3213r1971b3275],
7	the	DT	O	the	det	14	SENT_143	[p11l2015t3196r2149b3274],
8	second	JJ	ORDINAL	second	amod	14	SENT_143	[p11l9t3325r309b3404],
9	composite	JJ	O	composite	amod	14	SENT_143	[p11l354t3326r800b3425],
10	primary	JJ	O	primary	amod	14	SENT_143	[p11l844t3326r1197b3425],
11	outcome	NN	O	outcome	nn	14	SENT_143	[p11l1238t3342r1610b3404],
12	(	NN	O	(	nn	14	SENT_143	[p11l1661t3325r1989b3416],
13	hazard	NN	O	hazard	nn	14	SENT_143	[p11l1661t3325r1989b3416],
14	ratio	NN	O	ratio	prep_to	3	SENT_143	[p11l2034t3351r2148b3403, p11l8t3456r120b3535],

1	with	IN	O	with	_	0	SENT_144	[p11l167t3455r364b3535],
2	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_144	[p11l414t3455r900b3557],
3	among	IN	O	among	_	0	SENT_144	[p11l949t3481r1251b3557],
4	carriers	NNS	O	carrier	pobj	3	SENT_144	[p11l1298t3456r1651b3552],
5	,	,	O	,	_	0	SENT_144	[p11l1298t3456r1651b3552],
6	0.66	CD	NUMBER	0.66	appos	4	SENT_144	[p11l1705t3461r1911b3551],
7	;	:	O	;	_	0	SENT_144	[p11l1705t3461r1911b3551],
8	95	CD	PERCENT	95	number	9	SENT_144	[p11l1964t3460r2150b3535],
9	%	NN	PERCENT	%	amod	10	SENT_144	[p11l1964t3460r2150b3535],
10	CI	NN	O	ci	dep	3	SENT_144	[p11l8t3591r124b3682],
11	,	,	O	,	_	0	SENT_144	[p11l8t3591r124b3682],
12	0.54	CD	NUMBER	0.54	num	14	SENT_144	[p11l180t3591r360b3665],
13	to	TO	O	to	dep	14	SENT_144	[p11l409t3602r491b3665],
14	0.82	CD	NUMBER	0.82	appos	10	SENT_144	[p11l543t3591r746b3681],
15	;	:	O	;	_	0	SENT_144	[p11l543t3591r746b3681],
16	hazard	NN	O	hazard	nn	17	SENT_144	[p11l799t3585r1099b3665],
17	ratio	NN	O	ratio	dep	3	SENT_144	[p11l1148t3586r1347b3665],
18	among	IN	O	among	_	0	SENT_144	[p11l1397t3611r1699b3687],
19	noncarriers	NNS	O	noncarrier	prep_among	17	SENT_144	[p11l1745t3586r2148b3665, p11l9t3741r155b3812],
20	,	,	O	,	_	0	SENT_144	[p11l1745t3586r2148b3665, p11l9t3741r155b3812],
21	0.90	CD	NUMBER	0.90	appos	19	SENT_144	[p11l206t3722r411b3812],
22	;	:	O	;	_	0	SENT_144	[p11l206t3722r411b3812],
23	95	CD	PERCENT	95	number	24	SENT_144	[p11l460t3720r646b3795],
24	%	NN	PERCENT	%	amod	25	SENT_144	[p11l460t3720r646b3795],
25	CI	NN	O	ci	dep	3	SENT_144	[p11l690t3722r806b3812],
26	,	,	O	,	_	0	SENT_144	[p11l690t3722r806b3812],
27	0.76	CD	NUMBER	0.76	num	29	SENT_144	[p11l858t3722r1030b3795],
28	to	TO	O	to	dep	29	SENT_144	[p11l1077t3732r1159b3795],
29	1.06	CD	NUMBER	1.06	appos	25	SENT_144	[p11l1209t3721r1411b3812],
30	;	:	O	;	_	0	SENT_144	[p11l1209t3721r1411b3812],
31	P	NN	O	p	dep	3	SENT_144	[p11l1459t3722r1773b3795],
32	=	JJ	O	=	amod	31	SENT_144	[p11l1459t3722r1773b3795],
33	0.03	CD	NUMBER	0.03	tmod	32	SENT_144	[p11l1459t3722r1773b3795],
34	for	IN	O	for	_	0	SENT_144	[p11l1821t3714r1946b3795],
35	heterogeneity	NN	O	heterogeneity	nn	36	SENT_144	[p11l1988t3715r2148b3794, p12l9t30r508b131],
36	)	NN	O	)	prep_for	31	SENT_144	[p11l1988t3715r2148b3794, p12l9t30r508b131],
37	.	.	O	.	_	0	SENT_144	[p11l1988t3715r2148b3794, p12l9t30r508b131],

1	The	DT	O	the	det	2	SENT_145	[p12l590t29r753b108],
2	corresponding	JJ	O	corresponding	_	0	SENT_145	[p12l833t29r1469b131],
3	Kaplan	NNP	PERSON	Kaplan	dep	2	SENT_145	[p12l1544t29r2153b130],
4	.	.	O	.	_	0	SENT_145	[p12l1544t29r2153b130],

1	—	NN	O	—	_	0	SENT_146	[p12l1544t29r2153b130],
2	.	.	O	.	_	0	SENT_146	[p12l1544t29r2153b130],

1	Meier	JJR	PERSON	meier	amod	3	SENT_147	[p12l1544t29r2153b130],
2	survival	NN	O	survival	nn	3	SENT_147	[p12l9t159r344b239],
3	curves	NNS	O	curve	nsubjpass	5	SENT_147	[p12l391t185r664b239],
4	are	VBP	O	be	auxpass	5	SENT_147	[p12l712t185r842b238],
5	shown	VBN	O	show	dep	10	SENT_147	[p12l890t159r1175b239],
6	in	IN	O	in	_	0	SENT_147	[p12l1220t160r1304b237],
7	Figure	NN	O	figure	prep_in	5	SENT_147	[p12l1350t160r1624b261],
8	2	CD	NUMBER	2	num	9	SENT_147	[p12l1671t165r1718b237],
9	(	CD	NUMBER	(	nsubj	10	SENT_147	[p12l1770t166r1928b251],
10	see	VBP	O	see	_	0	SENT_147	[p12l1770t166r1928b251],
11	also	RB	O	also	advmod	10	SENT_147	[p12l1975t159r2148b239],
12	Fig	NN	O	fig	dobj	10	SENT_147	[p12l11t289r162b389],
13	.	.	O	.	_	0	SENT_147	[p12l11t289r162b389],

1	4	CD	NUMBER	4	_	0	SENT_148	[p12l201t294r251b367],
2	in	IN	O	in	_	0	SENT_148	[p12l286t289r370b366],
3	the	DT	O	the	det	6	SENT_148	[p12l406t288r539b366],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_148	[p12l577t288r1228b388],
5	Appendix	NNP	O	Appendix	nn	6	SENT_148	[p12l1256t288r1724b388],
6	)	NN	O	)	prep_in	1	SENT_148	[p12l1256t288r1724b388],
7	.	.	O	.	_	0	SENT_148	[p12l1256t288r1724b388],

1	The	DT	O	the	det	2	SENT_149	[p12l1762t288r1923b366],
2	beneﬁts	NNS	O	beneﬁts	nsubj	10	SENT_149	[p12l1959t288r2147b367, p12l12t415r194b495],
3	of	IN	O	of	_	0	SENT_149	[p12l259t415r359b496],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_149	[p12l403t416r878b518],
5	as	IN	O	as	_	0	SENT_149	[p12l939t443r1024b495],
6	compared	VBN	O	compare	prepc_as	4	SENT_149	[p12l1089t416r1510b517],
7	with	IN	O	with	pcomp	6	SENT_149	[p12l1568t416r1761b496],
8	placebo	NN	O	placebo	pobj	7	SENT_149	[p12l1822t416r2147b517],
9	were	VBD	O	be	cop	10	SENT_149	[p12l7t571r207b624],
10	similar	JJ	O	similar	_	0	SENT_149	[p12l269t545r577b623],
11	between	IN	O	between	_	0	SENT_149	[p12l637t545r997b624],
12	patients	NNS	O	patient	prep_between	10	SENT_149	[p12l1057t546r1401b645],
13	with	IN	O	with	_	0	SENT_149	[p12l1461t545r1657b624],
14	the	DT	O	the	det	16	SENT_149	[p12l1719t545r1853b623],
15	poormetabolizer	NN	O	poormetabolizer	nn	16	SENT_149	[p12l1914t571r2147b645, p12l12t674r523b753],
16	phenotype	NN	O	phenotype	prep_with	12	SENT_149	[p12l548t674r994b774],
17	and	CC	O	and	_	0	SENT_149	[p12l1023t674r1180b753],
18	patients	NNS	O	patient	conj_and	16	SENT_149	[p12l1209t675r1544b774],
19	with	IN	O	with	_	0	SENT_149	[p12l1572t674r1765b753],
20	all	DT	O	all	det	23	SENT_149	[p12l1794t674r1897b752],
21	other	JJ	O	other	amod	23	SENT_149	[p12l1927t674r2152b753],
22	metabolizer	NN	O	metabolizer	nn	23	SENT_149	[p12l12t802r533b881],
23	phenotypes	NNS	O	phenotype	prep_with	10	SENT_149	[p12l569t802r1092b902],
24	,	,	O	,	_	0	SENT_149	[p12l569t802r1092b902],
25	irrespective	RB	O	irrespective	_	0	SENT_149	[p12l1137t803r1635b902],
26	of	IN	O	of	_	0	SENT_149	[p12l1676t801r1777b881],
27	whether	IN	O	whether	complm	36	SENT_149	[p12l1794t802r2152b882],
28	the	DT	O	the	det	29	SENT_149	[p12l12t931r146b1009],
29	patients	NNS	O	patient	nsubjpass	36	SENT_149	[p12l197t932r541b1031],
30	with	IN	O	with	_	0	SENT_149	[p12l591t931r787b1010],
31	the	DT	O	the	det	34	SENT_149	[p12l840t931r973b1009],
32	intermediate	JJ	O	intermediate	amod	34	SENT_149	[p12l1025t931r1577b1010],
33	metabolizer	NN	O	metabolizer	nn	34	SENT_149	[p12l1630t931r2151b1010],
34	phenotype	NN	O	phenotype	prep_with	29	SENT_149	[p12l11t1060r466b1160],
35	were	VBD	O	be	auxpass	36	SENT_149	[p12l501t1086r704b1140],
36	included	VBN	O	include	prepc_irrespective_of	23	SENT_149	[p12l744t1060r1113b1139],
37	(	RB	O	(	advmod	36	SENT_149	[p12l1157t1060r1366b1151],
38	data	NNS	O	datum	dobj	36	SENT_149	[p12l1157t1060r1366b1151],
39	not	RB	O	not	neg	40	SENT_149	[p12l1405t1077r1548b1139],
40	shown	VBN	O	show	partmod	38	SENT_149	[p12l1584t1060r1919b1151],
41	)	NN	O	)	dep	23	SENT_149	[p12l1584t1060r1919b1151],
42	.	.	O	.	_	0	SENT_149	[p12l1584t1060r1919b1151],

1	The	DT	O	the	dep	100	SENT_150	[p12l138t1189r298b1268],
2	rate	NN	O	rate	dep	100	SENT_150	[p12l334t1206r491b1268],
3	of	IN	O	of	dep	100	SENT_150	[p12l529t1188r628b1269],
4	major	JJ	O	major	dep	100	SENT_150	[p12l646t1190r893b1290],
5	bleeding	NN	O	bleeding	dep	100	SENT_150	[p12l926t1189r1292b1291],
6	with	IN	O	with	dep	100	SENT_150	[p12l1321t1189r1514b1269],
7	clopidogrel	NN	O	clopidogrel	dep	100	SENT_150	[p12l1551t1189r2026b1291],
8	as	IN	O	as	dep	100	SENT_150	[p12l2061t1216r2145b1268],
9	compared	VBN	O	compare	dep	100	SENT_150	[p12l12t1318r427b1418],
10	with	IN	O	with	dep	100	SENT_150	[p12l453t1318r642b1397],
11	placebo	NN	O	placebo	dep	100	SENT_150	[p12l672t1318r990b1418],
12	was	VBD	O	be	dep	100	SENT_150	[p12l1017t1344r1177b1397],
13	similar	JJ	O	similar	dep	100	SENT_150	[p12l1211t1318r1506b1396],
14	between	IN	O	between	dep	100	SENT_150	[p12l1534t1318r1882b1397],
15	genotyped	JJ	O	genotyped	dep	100	SENT_150	[p12l1911t1344r2147b1419, p12l12t1446r242b1546],
16	patients	NNS	O	patient	dep	100	SENT_150	[p12l277t1447r620b1546],
17	and	CC	O	and	dep	100	SENT_150	[p12l660t1446r819b1525],
18	the	DT	O	the	dep	100	SENT_150	[p12l857t1446r990b1524],
19	total	JJ	O	total	dep	100	SENT_150	[p12l1029t1446r1226b1525],
20	cohort	NN	O	cohort	dep	100	SENT_150	[p12l1265t1446r1548b1525],
21	in	IN	O	in	dep	100	SENT_150	[p12l1580t1447r1664b1524],
22	the	DT	O	the	dep	100	SENT_150	[p12l1702t1446r1836b1524],
23	parent	NN	O	parent	dep	100	SENT_150	[p12l1872t1463r2153b1546],
24	study	NN	O	study	dep	100	SENT_150	[p12l13t1574r258b1674],
25	:	:	O	:	_	0	SENT_150	[p12l13t1574r258b1674],
26	4.0	CD	PERCENT	4.0	dep	100	SENT_150	[p12l291t1580r504b1653],
27	%	NN	PERCENT	%	dep	100	SENT_150	[p12l291t1580r504b1653],
28	(	CD	NUMBER	(	dep	100	SENT_150	[p12l539t1580r709b1665],
29	102	CD	NUMBER	102	dep	100	SENT_150	[p12l539t1580r709b1665],
30	of	IN	O	of	dep	100	SENT_150	[p12l742t1573r842b1653],
31	2549	CD	DATE	2549	dep	100	SENT_150	[p12l854t1580r1056b1653],
32	patients	NNS	O	patient	dep	100	SENT_150	[p12l1087t1575r1448b1674],
33	)	CD	NUMBER	)	dep	100	SENT_150	[p12l1087t1575r1448b1674],
34	versus	CC	O	versus	dep	100	SENT_150	[p12l1480t1600r1743b1654],
35	3.0	CD	PERCENT	3.0	dep	100	SENT_150	[p12l1776t1579r1987b1653],
36	%	NN	PERCENT	%	dep	100	SENT_150	[p12l1776t1579r1987b1653],
37	(	CD	NUMBER	(	dep	100	SENT_150	[p12l2022t1580r2147b1665],
38	76	CD	NUMBER	76	dep	100	SENT_150	[p12l2022t1580r2147b1665],
39	of	IN	O	of	dep	100	SENT_150	[p12l12t1702r112b1783],
40	2510	CD	DATE	2510	dep	100	SENT_150	[p12l128t1709r350b1795],
41	)	NN	O	)	dep	100	SENT_150	[p12l128t1709r350b1795],
42	among	IN	O	among	dep	100	SENT_150	[p12l390t1729r687b1805],
43	genotyped	JJ	O	genotyped	dep	100	SENT_150	[p12l717t1703r1162b1805],
44	patients	NNS	O	patient	dep	100	SENT_150	[p12l1195t1704r1531b1804],
45	(	IN	O	(	dep	100	SENT_150	[p12l1572t1703r1893b1795],
46	hazard	NN	O	hazard	dep	100	SENT_150	[p12l1572t1703r1893b1795],
47	ratio	NN	O	ratio	dep	100	SENT_150	[p12l1927t1704r2143b1800],
48	,	,	O	,	_	0	SENT_150	[p12l1927t1704r2143b1800],
49	1.33	CD	NUMBER	1.33	dep	100	SENT_150	[p12l15t1837r208b1927],
50	;	:	O	;	_	0	SENT_150	[p12l15t1837r208b1927],
51	95	CD	PERCENT	95	dep	100	SENT_150	[p12l244t1836r428b1910],
52	%	NN	PERCENT	%	dep	100	SENT_150	[p12l244t1836r428b1910],
53	CI	NN	O	ci	dep	100	SENT_150	[p12l459t1837r572b1927],
54	,	,	O	,	_	0	SENT_150	[p12l459t1837r572b1927],
55	0.99	CD	NUMBER	0.99	dep	100	SENT_150	[p12l610t1837r785b1910],
56	to	TO	O	to	dep	100	SENT_150	[p12l818t1848r899b1910],
57	1.79	CD	NUMBER	1.79	dep	100	SENT_150	[p12l936t1837r1155b1927],
58	)	CD	NUMBER	)	dep	100	SENT_150	[p12l936t1837r1155b1927],
59	,	,	O	,	_	0	SENT_150	[p12l936t1837r1155b1927],
60	and	CC	O	and	dep	100	SENT_150	[p12l1192t1831r1348b1910],
61	3.7	CD	NUMBER	3.7	dep	100	SENT_150	[p12l1382t1836r1590b1910],
62	°	CD	NUMBER	°	dep	100	SENT_150	[p12l1382t1836r1590b1910],
63	/	:	O	/	dep	100	SENT_150	[p12l1382t1836r1590b1910],
64	o	NN	O	o	dep	100	SENT_150	[p12l1382t1836r1590b1910],
65	(	CD	NUMBER	(	dep	100	SENT_150	[p12l1626t1837r1801b1922],
66	231	CD	NUMBER	231	dep	100	SENT_150	[p12l1626t1837r1801b1922],
67	of	IN	O	of	dep	100	SENT_150	[p12l1835t1830r1934b1910],
68	6259	CD	DATE	6259	dep	100	SENT_150	[p12l1948t1837r2147b1910],
69	patients	NNS	O	patient	dep	100	SENT_150	[p12l11t1960r380b2059],
70	)	CD	NUMBER	)	dep	100	SENT_150	[p12l11t1960r380b2059],
71	Versus	NNP	O	Versus	dep	100	SENT_150	[p12l427t1985r695b2039],
72	2.7	CD	PERCENT	2.7	dep	100	SENT_150	[p12l744t1964r958b2039],
73	%	NN	PERCENT	%	dep	100	SENT_150	[p12l744t1964r958b2039],
74	(	CD	NUMBER	(	dep	100	SENT_150	[p12l1008t1965r1182b2050],
75	169	CD	NUMBER	169	dep	100	SENT_150	[p12l1008t1965r1182b2050],
76	of	IN	O	of	dep	100	SENT_150	[p12l1231t1958r1331b2038],
77	6303	CD	NUMBER	6303	dep	100	SENT_150	[p12l1360t1965r1587b2050],
78	)	CD	NUMBER	)	dep	100	SENT_150	[p12l1360t1965r1587b2050],
79	in	IN	O	in	dep	100	SENT_150	[p12l1639t1960r1722b2037],
80	the	DT	O	the	dep	100	SENT_150	[p12l1770t1959r1903b2037],
81	total	JJ	O	total	dep	100	SENT_150	[p12l1950t1959r2148b2038],
82	cohort	NN	O	cohort	dep	100	SENT_150	[p12l12t2088r296b2167],
83	in	IN	O	in	dep	100	SENT_150	[p12l343t2089r427b2166],
84	the	DT	O	the	dep	100	SENT_150	[p12l481t2088r614b2166],
85	parent	NN	O	parent	dep	100	SENT_150	[p12l666t2105r947b2188],
86	study	NN	O	study	dep	100	SENT_150	[p12l997t2088r1228b2188],
87	(	NN	O	(	dep	100	SENT_150	[p12l1281t2088r1609b2179],
88	hazard	NN	O	hazard	dep	100	SENT_150	[p12l1281t2088r1609b2179],
89	ratio	NN	O	ratio	dep	100	SENT_150	[p12l1662t2089r1882b2184],
90	,	,	O	,	_	0	SENT_150	[p12l1662t2089r1882b2184],
91	1.38	CD	NUMBER	1.38	dep	100	SENT_150	[p12l1944t2094r2144b2183],
92	;	:	O	;	_	0	SENT_150	[p12l1944t2094r2144b2183],
93	95	CD	PERCENT	95	dep	100	SENT_150	[p12l12t2223r197b2297],
94	%	NN	PERCENT	%	dep	100	SENT_150	[p12l12t2223r197b2297],
95	CI	NN	O	ci	dep	100	SENT_150	[p12l232t2224r348b2314],
96	,	,	O	,	_	0	SENT_150	[p12l232t2224r348b2314],
97	1.13	CD	NUMBER	1.13	dep	100	SENT_150	[p12l392t2223r565b2297],
98	to	TO	O	to	dep	100	SENT_150	[p12l605t2234r686b2297],
99	1.67	CD	NUMBER	1.67	dep	100	SENT_150	[p12l727t2224r959b2309],
100	)	CD	NUMBER	)	_	0	SENT_150	[p12l727t2224r959b2309],
101	.	.	O	.	_	0	SENT_150	[p12l727t2224r959b2309],

1	The	DT	O	the	det	2	SENT_151	[p12l996t2217r1158b2296],
2	effects	NNS	O	effect	_	0	SENT_151	[p12l1195t2216r1477b2296],
3	of	IN	O	of	_	0	SENT_151	[p12l1516t2216r1616b2297],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_151	[p12l1634t2217r2143b2319],
5	,	,	O	,	_	0	SENT_151	[p12l1634t2217r2143b2319],
6	as	IN	O	as	_	0	SENT_151	[p12l11t2372r95b2424],
7	compared	VBN	O	compare	conj_as	2	SENT_151	[p12l129t2346r542b2446],
8	with	IN	O	with	_	0	SENT_151	[p12l569t2346r759b2425],
9	placebo	NN	O	placebo	prep_with	7	SENT_151	[p12l788t2346r1126b2446],
10	,	,	O	,	_	0	SENT_151	[p12l788t2346r1126b2446],
11	on	IN	O	on	_	0	SENT_151	[p12l1164t2372r1268b2425],
12	major	JJ	O	major	amod	13	SENT_151	[p12l1299t2347r1542b2446],
13	bleeding	NN	O	bleeding	prep_on	7	SENT_151	[p12l1570t2346r1929b2447],
14	were	VBD	O	be	partmod	13	SENT_151	[p12l1952t2372r2148b2425],

1	1703	CD	DATE	1703	num	4	SENT_152	[p12l149t2522r224b2544],
2	N	NN	O	n	nn	4	SENT_152	[p12l938t2532r951b2547],
3	ENGLJ	NN	O	englj	nn	4	SENT_152	[p12l966t2532r1044b2554],
4	MED	NN	O	med	_	0	SENT_152	[p12l1059t2532r1110b2547],
5	363	CD	NUMBER	363	dep	4	SENT_152	[p12l1121t2526r1197b2554],
6	;	:	O	;	_	0	SENT_152	[p12l1121t2526r1197b2554],
7	18	CD	NUMBER	18	num	9	SENT_152	[p12l1121t2526r1197b2554],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_152	[p12l1232t2532r1356b2554],
9	OCTOBER	NN	DATE	october	dep	5	SENT_152	[p12l1392t2532r1504b2547],
10	28	CD	DATE	28	dep	9	SENT_152	[p12l1514t2526r1549b2552],
11	,	,	DATE	,	_	0	SENT_152	[p12l1514t2526r1549b2552],
12	2010	CD	DATE	2010	appos	10	SENT_152	[p12l1560t2532r1621b2548],

1	The	DT	O	the	det	4	SENT_153	[p12l935t2565r986b2589],
2	New	NNP	O	New	nn	4	SENT_153	[p12l995t2566r1057b2589],
3	England	NNP	O	England	nn	4	SENT_153	[p12l1066t2565r1177b2596],
4	Journal	NNP	O	Journal	_	0	SENT_153	[p12l1186t2565r1283b2589],
5	of	IN	O	of	_	0	SENT_153	[p12l1293t2565r1322b2589],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_153	[p12l1329t2565r1454b2589],

1	EEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE	NNP	O	EEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE	nn	2	SENT_154	[p12l649t2753r1462b2773],
2	NT	NNP	O	NT	_	0	SENT_154	[p12l1467t2753r1511b2772],

1	consistent	JJ	O	consistent	_	0	SENT_155	[p12l12t2969r431b3047],
2	in	IN	O	in	_	0	SENT_155	[p12l465t2969r546b3046],
3	subgroups	NNS	O	subgroup	prep_in	1	SENT_155	[p12l586t2968r1016b3069],
4	defined	VBN	O	define	partmod	3	SENT_155	[p12l1057t2967r1371b3047],
5	according	VBG	O	accord	_	0	SENT_155	[p12l1409t2968r1818b3069],
6	to	TO	O	to	prepc_according_to	4	SENT_155	[p12l1855t2985r1934b3047],
7	metabolizer	NN	O	metabolizer	nn	8	SENT_155	[p12l1974t2994r2132b3047, p12l12t3096r394b3175],
8	phenotype	NN	O	phenotype	pobj	4	SENT_155	[p12l434t3096r886b3196],
9	(	CD	NUMBER	(	num	10	SENT_155	[p12l936t3097r1115b3197],
10	Fig	NN	O	fig	dep	8	SENT_155	[p12l936t3097r1115b3197],
11	.	.	O	.	_	0	SENT_155	[p12l936t3097r1115b3197],

1	1	CD	NUMBER	1	number	2	SENT_156	[p12l1169t3102r1239b3187],
2	)	CD	NUMBER	)	amod	5	SENT_156	[p12l1169t3102r1239b3187],
3	or	CC	O	or	_	0	SENT_156	[p12l1289t3122r1378b3175],
4	functional	JJ	O	functional	amod	5	SENT_156	[p12l1420t3095r1867b3175],
5	allele	NN	O	allele	_	0	SENT_156	[p12l1911t3096r2133b3174],
6	carrier	NN	O	carrier	nn	7	SENT_156	[p12l12t3225r296b3301],
7	status	NN	O	status	dep	5	SENT_156	[p12l334t3240r586b3302],
8	(	CD	NUMBER	(	num	9	SENT_156	[p12l632t3225r812b3324],
9	Fig	NN	O	fig	dep	7	SENT_156	[p12l632t3225r812b3324],
10	.	.	O	.	_	0	SENT_156	[p12l632t3225r812b3324],

1	2	CD	NUMBER	2	num	2	SENT_157	[p12l857t3230r956b3314],
2	)	CD	NUMBER	)	_	0	SENT_157	[p12l857t3230r956b3314],
3	.	.	O	.	_	0	SENT_157	[p12l857t3230r956b3314],

1	ACTIVE	JJ	O	active	amod	2	SENT_158	[p12l9t3498r284b3548],
2	A	NN	O	a	nsubjpass	10	SENT_158	[p12l316t3499r363b3547],
3	The	DT	O	the	det	4	SENT_158	[p12l7t3597r166b3675],
4	characteristics	NNS	O	characteristic	dep	2	SENT_158	[p12l208t3597r813b3675],
5	of	IN	O	of	_	0	SENT_158	[p12l857t3596r955b3676],
6	the	DT	O	the	det	8	SENT_158	[p12l978t3597r1109b3676],
7	genotyped	JJ	O	genotyped	amod	8	SENT_158	[p12l1150t3597r1591b3698],
8	patients	NNS	O	patient	prep_of	2	SENT_158	[p12l1631t3598r1964b3697],
9	are	VBP	O	be	auxpass	10	SENT_158	[p12l2006t3623r2133b3676],
10	summarized	VBN	O	summarize	_	0	SENT_158	[p13l12t20r545b99],
11	in	IN	O	in	_	0	SENT_158	[p13l591t21r673b98],
12	Table	NNP	O	Table	prep_in	10	SENT_158	[p13l716t20r942b99],
13	1	CD	NUMBER	1	num	12	SENT_158	[p13l992t26r1058b99],
14	.	.	O	.	_	0	SENT_158	[p13l992t26r1058b99],

1	A	DT	O	a	det	2	SENT_159	[p13l1106t28r1172b98],
2	total	NN	O	total	nsubj	9	SENT_159	[p13l1216t20r1409b99],
3	of	IN	O	of	_	0	SENT_159	[p13l1455t19r1554b99],
4	1156	CD	DATE	1156	num	5	SENT_159	[p13l1586t26r1783b99],
5	participants	NNS	O	participant	prep_of	2	SENT_159	[p13l1829t21r2132b120, p13l9t165r240b248],
6	of	IN	O	of	_	0	SENT_159	[p13l270t147r368b227],
7	self	NN	O	self	nn	8	SENT_159	[p13l377t147r911b248],
8	—	NN	O	—	prep_of	5	SENT_159	[p13l377t147r911b248],
9	reported	VBD	O	report	_	0	SENT_159	[p13l377t147r911b248],
10	European	JJ	MISC	european	amod	11	SENT_159	[p13l936t156r1341b248],
11	ancestry	NN	O	ancestry	nsubjpass	14	SENT_159	[p13l1366t165r1723b248],
12	were	VBD	O	be	auxpass	14	SENT_159	[p13l1740t174r1938b228],
13	successfully	RB	O	successfully	advmod	14	SENT_159	[p13l1966t174r2132b227, p13l12t276r377b377],
14	genotyped	VBN	O	genotype	ccomp	9	SENT_159	[p13l412t277r875b378],
15	,	,	O	,	_	0	SENT_159	[p13l412t277r875b378],
16	of	IN	O	of	dep	22	SENT_159	[p13l921t276r1020b356],
17	Whom	WP	O	whom	pobj	16	SENT_159	[p13l1037t277r1305b356],
18	570	CD	NUMBER	570	nsubjpass	22	SENT_159	[p13l1346t283r1490b356],
19	had	VBD	O	have	aux	22	SENT_159	[p13l1531t277r1685b356],
20	been	VBN	O	be	auxpass	22	SENT_159	[p13l1725t277r1923b356],
21	randomly	RB	O	randomly	advmod	22	SENT_159	[p13l1962t303r2132b355, p13l12t405r276b505],
22	assigned	VBN	O	assign	ccomp	14	SENT_159	[p13l301t405r666b506],
23	to	TO	O	to	_	0	SENT_159	[p13l697t422r777b484],
24	clopidogrel	NN	O	clopidogrel	prep_to	22	SENT_159	[p13l808t405r1280b506],
25	and	CC	O	and	_	0	SENT_159	[p13l1308t405r1464b484],
26	586	CD	NUMBER	586	prep_to	22	SENT_159	[p13l1495t411r1643b484],
27	to	TO	O	to	_	0	SENT_159	[p13l1673t422r1754b484],
28	placebo	NN	O	placebo	prep_to	22	SENT_159	[p13l1783t405r2127b505],
29	.	.	O	.	_	0	SENT_159	[p13l1783t405r2127b505],

1	The	DT	O	the	dep	131	SENT_160	[p13l7t533r166b611],
2	effect	NN	O	effect	dep	131	SENT_160	[p13l205t532r441b612],
3	of	IN	O	of	dep	131	SENT_160	[p13l475t532r573b612],
4	clopidogrel	NN	O	clopidogrel	dep	131	SENT_160	[p13l594t533r1065b634],
5	in	IN	O	in	dep	131	SENT_160	[p13l1102t534r1184b611],
6	reducing	VBG	O	reduce	dep	131	SENT_160	[p13l1222t533r1592b634],
7	the	DT	O	the	dep	131	SENT_160	[p13l1627t533r1757b611],
8	primary	JJ	O	primary	dep	131	SENT_160	[p13l1794t534r2138b633],
9	composite	JJ	O	composite	dep	131	SENT_160	[p13l12t661r444b760],
10	efficacy	NN	O	efficacy	dep	131	SENT_160	[p13l484t659r812b760],
11	outcome	NN	O	outcome	dep	131	SENT_160	[p13l848t677r1209b740],
12	was	VBD	O	be	dep	131	SENT_160	[p13l1244t686r1404b740],
13	similar	JJ	O	similar	dep	131	SENT_160	[p13l1446t660r1746b738],
14	between	IN	O	between	dep	131	SENT_160	[p13l1782t660r2133b740],
15	the	DT	O	the	dep	131	SENT_160	[p13l12t789r142b867],
16	genotyped	JJ	O	genotyped	dep	131	SENT_160	[p13l173t789r615b890],
17	patients	NNS	O	patient	dep	131	SENT_160	[p13l645t790r979b889],
18	and	CC	O	and	dep	131	SENT_160	[p13l1012t789r1168b868],
19	the	DT	O	the	dep	131	SENT_160	[p13l1200t789r1330b867],
20	total	JJ	O	total	dep	131	SENT_160	[p13l1362t789r1555b868],
21	cohort	NN	O	cohort	dep	131	SENT_160	[p13l1587t789r1863b868],
22	in	IN	O	in	dep	131	SENT_160	[p13l1889t790r1971b867],
23	the	DT	O	the	dep	131	SENT_160	[p13l2002t789r2133b868],
24	parent	NN	O	parent	dep	131	SENT_160	[p13l9t933r283b1016],
25	studyl	NN	O	studyl	dep	131	SENT_160	[p13l333t916r612b1016],
26	;	:	O	;	_	0	SENT_160	[p13l333t916r612b1016],
27	the	DT	O	the	dep	131	SENT_160	[p13l669t916r799b994],
28	rate	NN	O	rate	dep	131	SENT_160	[p13l852t933r1009b994],
29	of	IN	O	of	dep	131	SENT_160	[p13l1063t915r1162b995],
30	the	DT	O	the	dep	131	SENT_160	[p13l1196t916r1327b994],
31	primary	JJ	O	primary	dep	131	SENT_160	[p13l1378t917r1723b1016],
32	outcome	NN	O	outcome	dep	131	SENT_160	[p13l1771t933r2133b996],
33	among	IN	O	among	dep	131	SENT_160	[p13l11t1071r306b1146],
34	the	DT	O	the	dep	131	SENT_160	[p13l338t1045r469b1123],
35	genotyped	JJ	O	genotyped	dep	131	SENT_160	[p13l505t1045r946b1146],
36	patients	NNS	O	patient	dep	131	SENT_160	[p13l981t1046r1314b1145],
37	was	VBD	O	be	dep	131	SENT_160	[p13l1347t1071r1508b1124],
38	20.00	CD	NUMBER	20.00	dep	131	SENT_160	[p13l1546t1050r1806b1124],
39	/	:	O	/	dep	131	SENT_160	[p13l1546t1050r1806b1124],
40	o	NN	O	o	dep	131	SENT_160	[p13l1546t1050r1806b1124],
41	(	CD	NUMBER	(	dep	131	SENT_160	[p13l1846t1051r2017b1136],
42	114	CD	NUMBER	114	dep	131	SENT_160	[p13l1846t1051r2017b1136],
43	of	IN	O	of	dep	131	SENT_160	[p13l2053t1044r2152b1124],
44	570	CD	NUMBER	570	dep	131	SENT_160	[p13l13t1179r158b1252],
45	patients	NNS	O	patient	dep	131	SENT_160	[p13l227t1174r586b1273],
46	)	RB	O	)	dep	131	SENT_160	[p13l227t1174r586b1273],
47	in	IN	O	in	dep	131	SENT_160	[p13l661t1174r742b1251],
48	the	DT	O	the	dep	131	SENT_160	[p13l813t1173r944b1251],
49	clopidogrel	NN	O	clopidogrel	dep	131	SENT_160	[p13l1014t1173r1487b1274],
50	group	NN	O	group	dep	131	SENT_160	[p13l1556t1199r1804b1274],
51	Versus	NNP	O	Versus	dep	131	SENT_160	[p13l1870t1199r2131b1252],
52	26.3	CD	PERCENT	26.3	dep	131	SENT_160	[p13l11t1306r270b1380],
53	%	NN	PERCENT	%	dep	131	SENT_160	[p13l11t1306r270b1380],
54	(	CD	NUMBER	(	dep	131	SENT_160	[p13l314t1307r491b1392],
55	154	CD	NUMBER	154	dep	131	SENT_160	[p13l314t1307r491b1392],
56	of	IN	O	of	dep	131	SENT_160	[p13l530t1300r629b1380],
57	586	CD	NUMBER	586	dep	131	SENT_160	[p13l651t1307r826b1392],
58	)	NN	O	)	dep	131	SENT_160	[p13l651t1307r826b1392],
59	in	IN	O	in	dep	131	SENT_160	[p13l870t1302r952b1379],
60	the	DT	O	the	dep	131	SENT_160	[p13l991t1301r1122b1379],
61	placebo	NN	O	placebo	dep	131	SENT_160	[p13l1159t1301r1482b1401],
62	group	NN	O	group	dep	131	SENT_160	[p13l1521t1327r1769b1402],
63	(	CD	NUMBER	(	dep	131	SENT_160	[p13l1815t1301r2134b1392],
64	hazard	NN	O	hazard	dep	131	SENT_160	[p13l1815t1301r2134b1392],
65	ratio	NN	O	ratio	dep	131	SENT_160	[p13l11t1430r203b1508],
66	with	IN	O	with	dep	131	SENT_160	[p13l237t1429r429b1508],
67	clopidogrel	NN	O	clopidogrel	dep	131	SENT_160	[p13l466t1429r959b1530],
68	,	,	O	,	_	0	SENT_160	[p13l466t1429r959b1530],
69	0.74	CD	NUMBER	0.74	dep	131	SENT_160	[p13l1001t1435r1190b1525],
70	;	:	O	;	_	0	SENT_160	[p13l1001t1435r1190b1525],
71	95	CD	PERCENT	95	dep	131	SENT_160	[p13l1231t1434r1412b1508],
72	%	NN	PERCENT	%	dep	131	SENT_160	[p13l1231t1434r1412b1508],
73	CI	NN	O	ci	dep	131	SENT_160	[p13l1448t1435r1561b1525],
74	,	,	O	,	_	0	SENT_160	[p13l1448t1435r1561b1525],
75	0.58	CD	NUMBER	0.58	dep	131	SENT_160	[p13l1603t1435r1775b1508],
76	to	TO	O	to	dep	131	SENT_160	[p13l1814t1446r1894b1508],
77	0.94	CD	NUMBER	0.94	dep	131	SENT_160	[p13l1932t1435r2129b1525],
78	;	:	O	;	_	0	SENT_160	[p13l1932t1435r2129b1525],
79	P	NN	O	p	dep	131	SENT_160	[p13l10t1562r365b1651],
80	=	JJ	O	=	dep	131	SENT_160	[p13l10t1562r365b1651],
81	0.01	CD	NUMBER	0.01	dep	131	SENT_160	[p13l10t1562r365b1651],
82	)	NN	O	)	dep	131	SENT_160	[p13l10t1562r365b1651],
83	,	,	O	,	_	0	SENT_160	[p13l10t1562r365b1651],
84	and	CC	O	and	dep	131	SENT_160	[p13l417t1556r573b1634],
85	the	DT	O	the	dep	131	SENT_160	[p13l621t1556r752b1633],
86	rate	NN	O	rate	dep	131	SENT_160	[p13l800t1572r957b1633],
87	in	IN	O	in	dep	131	SENT_160	[p13l1004t1557r1086b1633],
88	the	DT	O	the	dep	131	SENT_160	[p13l1134t1556r1265b1634],
89	total	JJ	O	total	dep	131	SENT_160	[p13l1314t1556r1506b1634],
90	cohort	NN	O	cohort	dep	131	SENT_160	[p13l1555t1556r1831b1634],
91	in	IN	O	in	dep	131	SENT_160	[p13l1873t1557r1955b1633],
92	the	DT	O	the	dep	131	SENT_160	[p13l2003t1556r2134b1634],
93	parent	NN	O	parent	dep	131	SENT_160	[p13l9t1700r283b1783],
94	study	NN	O	study	dep	131	SENT_160	[p13l311t1683r536b1783],
95	was	VBD	O	be	dep	131	SENT_160	[p13l559t1709r719b1763],
96	22.1	CD	PERCENT	22.1	dep	131	SENT_160	[p13l752t1688r1007b1762],
97	%	NN	PERCENT	%	dep	131	SENT_160	[p13l752t1688r1007b1762],
98	(	CD	NUMBER	(	dep	131	SENT_160	[p13l1043t1689r1214b1774],
99	832	CD	NUMBER	832	dep	131	SENT_160	[p13l1043t1689r1214b1774],
100	of	IN	O	of	dep	131	SENT_160	[p13l1247t1682r1346b1762],
101	3772	CD	NUMBER	3772	dep	131	SENT_160	[p13l1360t1689r1556b1762],
102	patients	NNS	O	patient	dep	131	SENT_160	[p13l1587t1684r1946b1783],
103	)	CD	NUMBER	)	dep	131	SENT_160	[p13l1587t1684r1946b1783],
104	versus	CC	O	versus	dep	131	SENT_160	[p13l1978t1709r2132b1763, p13l12t1837r144b1890],
105	24.4	CD	NUMBER	24.4	dep	131	SENT_160	[p13l186t1816r440b1890],
106	°	CD	NUMBER	°	dep	131	SENT_160	[p13l186t1816r440b1890],
107	/	:	O	/	dep	131	SENT_160	[p13l186t1816r440b1890],
108	o	NN	O	o	dep	131	SENT_160	[p13l186t1816r440b1890],
109	(	CD	NUMBER	(	dep	131	SENT_160	[p13l484t1817r656b1902],
110	924	CD	NUMBER	924	dep	131	SENT_160	[p13l484t1817r656b1902],
111	of	IN	O	of	dep	131	SENT_160	[p13l697t1810r795b1890],
112	3782	CD	NUMBER	3782	dep	131	SENT_160	[p13l818t1817r1039b1902],
113	)	CD	NUMBER	)	dep	131	SENT_160	[p13l818t1817r1039b1902],
114	(	NN	O	(	dep	131	SENT_160	[p13l1090t1811r1409b1902],
115	hazard	NN	O	hazard	dep	131	SENT_160	[p13l1090t1811r1409b1902],
116	ratio	NN	O	ratio	dep	131	SENT_160	[p13l1449t1812r1662b1907],
117	,	,	O	,	_	0	SENT_160	[p13l1449t1812r1662b1907],
118	0.89	CD	NUMBER	0.89	dep	131	SENT_160	[p13l1709t1817r1907b1907],
119	;	:	O	;	_	0	SENT_160	[p13l1709t1817r1907b1907],
120	95	CD	PERCENT	95	dep	131	SENT_160	[p13l1952t1817r2134b1890],
121	%	NN	PERCENT	%	dep	131	SENT_160	[p13l1952t1817r2134b1890],
122	CI	NN	O	ci	dep	131	SENT_160	[p13l11t1945r123b2034],
123	,	,	O	,	_	0	SENT_160	[p13l11t1945r123b2034],
124	0.81	CD	NUMBER	0.81	dep	131	SENT_160	[p13l163t1945r337b2017],
125	to	TO	O	to	dep	131	SENT_160	[p13l372t1956r452b2017],
126	0.98	CD	NUMBER	0.98	dep	131	SENT_160	[p13l487t1945r682b2034],
127	;	:	O	;	_	0	SENT_160	[p13l487t1945r682b2034],
128	P	NN	O	p	dep	131	SENT_160	[p13l717t1945r1073b2029],
129	=	JJ	O	=	dep	131	SENT_160	[p13l717t1945r1073b2029],
130	0.01	CD	NUMBER	0.01	dep	131	SENT_160	[p13l717t1945r1073b2029],
131	)	NN	O	)	_	0	SENT_160	[p13l717t1945r1073b2029],
132	.	.	O	.	_	0	SENT_160	[p13l717t1945r1073b2029],

1	The	DT	O	the	det	2	SENT_161	[p13l1108t1939r1266b2016],
2	results	NNS	O	result	nsubj	4	SENT_161	[p13l1299t1939r1576b2018],
3	were	VBD	O	be	cop	4	SENT_161	[p13l1607t1965r1805b2018],
4	consistent	JJ	O	consistent	_	0	SENT_161	[p13l1839t1940r2132b2017, p13l12t2084r175b2145],
5	in	IN	O	in	_	0	SENT_161	[p13l215t2068r297b2145],
6	subgroups	NNS	O	subgroup	prep_in	4	SENT_161	[p13l344t2067r781b2168],
7	defined	VBN	O	define	partmod	6	SENT_161	[p13l830t2066r1150b2146],
8	according	VBG	O	accord	_	0	SENT_161	[p13l1195t2067r1613b2168],
9	to	TO	O	to	prepc_according_to	7	SENT_161	[p13l1655t2084r1735b2146],
10	metabolizer	NN	O	metabolizer	nn	11	SENT_161	[p13l1782t2067r2132b2146, p13l10t2195r198b2273],
11	phenotype	NN	O	phenotype	pobj	7	SENT_161	[p13l225t2195r669b2295],
12	(	CD	NUMBER	(	num	13	SENT_161	[p13l705t2196r880b2296],
13	Fig	NN	O	fig	dep	11	SENT_161	[p13l705t2196r880b2296],
14	.	.	O	.	_	0	SENT_161	[p13l705t2196r880b2296],

1	3	CD	NUMBER	3	num	2	SENT_162	[p13l917t2201r989b2286],
2	)	NN	O	)	nn	5	SENT_162	[p13l917t2201r989b2286],
3	or	CC	O	or	_	0	SENT_162	[p13l1026t2221r1113b2274],
4	functional	JJ	O	functional	nn	5	SENT_162	[p13l1141t2194r1578b2274],
5	allele	NN	O	allele	_	0	SENT_162	[p13l1609t2195r1826b2274],
6	carrier	NN	O	carrier	nn	7	SENT_162	[p13l1858t2196r2137b2273],
7	status	NN	O	status	dep	5	SENT_162	[p13l12t2340r259b2402],
8	(	CD	NUMBER	(	num	9	SENT_162	[p13l296t2324r470b2424],
9	Fig	NN	O	fig	dep	7	SENT_162	[p13l296t2324r470b2424],
10	.	.	O	.	_	0	SENT_162	[p13l296t2324r470b2424],

1	4	CD	NUMBER	4	_	0	SENT_163	[p13l503t2329r574b2419],
2	,	,	O	,	_	0	SENT_163	[p13l503t2329r574b2419],
3	and	CC	O	and	_	0	SENT_163	[p13l609t2323r764b2402],
4	Fig	NN	O	fig	conj_and	1	SENT_163	[p13l792t2324r940b2424],
5	.	.	O	.	_	0	SENT_163	[p13l792t2324r940b2424],

1	8	CD	NUMBER	8	_	0	SENT_164	[p13l975t2329r1021b2402],
2	in	IN	O	in	_	0	SENT_164	[p13l1052t2324r1134b2401],
3	the	DT	O	the	det	6	SENT_164	[p13l1164t2323r1294b2402],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_164	[p13l1326t2323r1960b2423],
5	Appendix	NNP	O	Appendix	nn	6	SENT_164	[p13l1982t2331r2132b2423, p13l10t2451r346b2551],
6	)	NN	O	)	prep_in	1	SENT_164	[p13l1982t2331r2132b2423, p13l10t2451r346b2551],
7	.	.	O	.	_	0	SENT_164	[p13l1982t2331r2132b2423, p13l10t2451r346b2551],

1	The	DT	O	the	det	2	SENT_165	[p13l405t2451r563b2529],
2	effect	NN	O	effect	_	0	SENT_165	[p13l620t2450r857b2530],
3	of	IN	O	of	_	0	SENT_165	[p13l908t2450r1007b2530],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_165	[p13l1045t2451r1516b2552],
5	as	IN	O	as	mark	17	SENT_165	[p13l1571t2477r1656b2529],
6	compared	VBN	O	compare	csubj	17	SENT_165	[p13l1715t2451r2134b2551],
7	with	IN	O	with	_	0	SENT_165	[p13l7t2579r198b2658],
8	placebo	NN	O	placebo	prep_with	6	SENT_165	[p13l223t2579r546b2679],
9	in	IN	O	in	_	0	SENT_165	[p13l573t2580r655b2657],
10	reducing	VBG	O	reduce	prepc_in	6	SENT_165	[p13l681t2579r1052b2680],
11	the	DT	O	the	det	12	SENT_165	[p13l1075t2579r1205b2657],
12	rate	NN	O	rate	dobj	10	SENT_165	[p13l1232t2596r1389b2657],
13	of	IN	O	of	_	0	SENT_165	[p13l1415t2578r1515b2658],
14	cardiovascular	JJ	O	cardiovascular	amod	15	SENT_165	[p13l1523t2579r2137b2658],
15	events	NNS	O	event	prep_of	12	SENT_165	[p13l12t2724r269b2786],
16	was	VBD	O	be	cop	17	SENT_165	[p13l324t2733r485b2786],
17	similar	JJ	O	similar	dep	2	SENT_165	[p13l546t2707r845b2785],
18	between	IN	O	between	_	0	SENT_165	[p13l900t2707r1252b2786],
19	carriers	NNS	O	carrier	prep_between	17	SENT_165	[p13l1310t2708r1626b2785],
20	of	IN	O	of	_	0	SENT_165	[p13l1686t2706r1786b2786],
21	loss	NN	O	loss	nn	22	SENT_165	[p13l1823t2706r2132b2786],
22	—	NN	O	—	prep_of	19	SENT_165	[p13l1823t2706r2132b2786],
23	of	IN	O	of	_	0	SENT_165	[p13l1823t2706r2132b2786],
24	—	NN	O	—	prep_of	22	SENT_165	[p13l1823t2706r2132b2786],

1	function	NN	O	function	nn	2	SENT_166	[p13l11t2834r377b2915],
2	alleles	NNS	O	allele	_	0	SENT_166	[p13l439t2835r704b2914],
3	and	CC	O	and	_	0	SENT_166	[p13l768t2835r925b2914],
4	noncarriers	NNS	O	noncarrier	conj_and	2	SENT_166	[p13l986t2836r1480b2914],
5	(	CD	NUMBER	(	num	7	SENT_166	[p13l1548t2835r1874b2926],
6	hazard	NN	O	hazard	nn	7	SENT_166	[p13l1548t2835r1874b2926],
7	ratio	NN	O	ratio	dep	2	SENT_166	[p13l1935t2836r2132b2914],
8	among	IN	O	among	_	0	SENT_166	[p13l11t2990r310b3065],
9	carriers	NNS	O	carrier	prep_among	7	SENT_166	[p13l337t2965r678b3060],
10	,	,	O	,	_	0	SENT_166	[p13l337t2965r678b3060],
11	0.78	CD	NUMBER	0.78	appos	9	SENT_166	[p13l712t2970r906b3059],
12	;	:	O	;	_	0	SENT_166	[p13l712t2970r906b3059],
13	95	CD	PERCENT	95	num	15	SENT_166	[p13l938t2969r1120b3043],
14	%	NN	PERCENT	%	nn	15	SENT_166	[p13l938t2969r1120b3043],
15	CI	NN	O	ci	dep	7	SENT_166	[p13l1148t2970r1261b3060],
16	,	,	O	,	_	0	SENT_166	[p13l1148t2970r1261b3060],
17	0.48	CD	NUMBER	0.48	number	19	SENT_166	[p13l1296t2970r1469b3043],
18	to	TO	O	to	dep	19	SENT_166	[p13l1500t2981r1581b3043],
19	1.28	CD	NUMBER	1.28	appos	15	SENT_166	[p13l1614t2970r1809b3060],
20	;	:	O	;	_	0	SENT_166	[p13l1614t2970r1809b3060],
21	hazard	NN	O	hazard	nn	22	SENT_166	[p13l1842t2964r2133b3043],
22	ratio	NN	O	ratio	dep	7	SENT_166	[p13l11t3093r208b3170],
23	among	IN	O	among	_	0	SENT_166	[p13l257t3117r557b3192],
24	noncarriers	NNS	O	noncarrier	prep_among	22	SENT_166	[p13l601t3093r1119b3187],
25	,	,	O	,	_	0	SENT_166	[p13l601t3093r1119b3187],
26	0.72	CD	NUMBER	0.72	appos	24	SENT_166	[p13l1173t3098r1371b3187],
27	;	:	O	;	_	0	SENT_166	[p13l1173t3098r1371b3187],
28	95	CD	PERCENT	95	number	29	SENT_166	[p13l1423t3097r1608b3170],
29	%	NN	PERCENT	%	amod	30	SENT_166	[p13l1423t3097r1608b3170],
30	CI	NN	O	ci	dep	7	SENT_166	[p13l1655t3098r1769b3187],
31	,	,	O	,	_	0	SENT_166	[p13l1655t3098r1769b3187],
32	0.54	CD	NUMBER	0.54	num	34	SENT_166	[p13l1823t3098r2002b3170],
33	to	TO	O	to	dep	34	SENT_166	[p13l2050t3108r2132b3170],
34	0.95	CD	NUMBER	0.95	appos	30	SENT_166	[p13l11t3226r209b3316],
35	;	:	O	;	_	0	SENT_166	[p13l11t3226r209b3316],
36	P	NN	O	p	dep	7	SENT_166	[p13l256t3226r567b3299],
37	=	JJ	O	=	amod	36	SENT_166	[p13l256t3226r567b3299],
38	0.73	CD	NUMBER	0.73	tmod	37	SENT_166	[p13l256t3226r567b3299],
39	for	IN	O	for	_	0	SENT_166	[p13l613t3219r737b3299],
40	heterogeneity	NN	O	heterogeneity	nn	41	SENT_166	[p13l777t3220r1411b3321],
41	)	NN	O	)	prep_for	2	SENT_166	[p13l777t3220r1411b3321],
42	.	.	O	.	_	0	SENT_166	[p13l777t3220r1411b3321],

1	The	DT	O	the	det	2	SENT_167	[p13l1456t3220r1617b3298],
2	benefits	NNS	O	benefit	nsubj	10	SENT_167	[p13l1662t3219r2005b3299],
3	of	IN	O	of	_	0	SENT_167	[p13l2052t3219r2152b3299],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_167	[p13l12t3348r483b3449],
5	as	IN	O	as	_	0	SENT_167	[p13l520t3374r604b3426],
6	compared	VBN	O	compare	prepc_as	4	SENT_167	[p13l645t3348r1064b3448],
7	with	IN	O	with	pcomp	6	SENT_167	[p13l1097t3348r1289b3427],
8	placebo	NN	O	placebo	pobj	7	SENT_167	[p13l1326t3348r1648b3448],
9	were	VBD	O	be	cop	10	SENT_167	[p13l1683t3374r1881b3427],
10	similar	JJ	O	similar	_	0	SENT_167	[p13l1921t3349r2132b3426, p13l10t3476r123b3553],
11	in	IN	O	in	_	0	SENT_167	[p13l162t3477r243b3553],
12	patients	NNS	O	patient	prep_in	10	SENT_167	[p13l284t3477r618b3575],
13	with	IN	O	with	_	0	SENT_167	[p13l657t3476r849b3555],
14	the	DT	O	the	det	16	SENT_167	[p13l892t3476r1022b3554],
15	poor-metabolizer	NN	O	poor-metabolizer	nn	16	SENT_167	[p13l1063t3476r1800b3575],
16	phenotype	NN	O	phenotype	prep_with	12	SENT_167	[p13l1837t3476r2132b3575, p13l12t3621r189b3703],
17	and	CC	O	and	_	0	SENT_167	[p13l240t3604r396b3682],
18	in	IN	O	in	_	0	SENT_167	[p13l447t3605r528b3681],
19	patients	NNS	O	patient	conj_and	12	SENT_167	[p13l578t3605r912b3703],
20	with	IN	O	with	_	0	SENT_167	[p13l961t3604r1153b3683],
21	all	DT	O	all	det	24	SENT_167	[p13l1204t3604r1306b3681],
22	other	JJ	O	other	amod	24	SENT_167	[p13l1358t3604r1581b3682],
23	metabolizer	NN	O	metabolizer	nn	24	SENT_167	[p13l1629t3604r2137b3682],
24	phenotypes	NNS	O	phenotype	prep_with	19	SENT_167	[p14l9t21r518b121],
25	,	,	O	,	_	0	SENT_167	[p14l9t21r518b121],
26	irrespective	RB	O	irrespective	_	0	SENT_167	[p14l572t22r1055b121],
27	of	IN	O	of	_	0	SENT_167	[p14l1103t20r1202b100],
28	whether	IN	O	whether	complm	37	SENT_167	[p14l1227t21r1576b101],
29	the	DT	O	the	det	30	SENT_167	[p14l1621t21r1751b99],
30	patients	NNS	O	patient	nsubjpass	37	SENT_167	[p14l1797t22r2132b121],
31	with	IN	O	with	_	0	SENT_167	[p14l7t150r205b229],
32	the	DT	O	the	det	35	SENT_167	[p14l267t150r402b228],
33	intermediate	JJ	O	intermediate	amod	35	SENT_167	[p14l464t150r1024b228],
34	metabolizer	NN	O	metabolizer	nn	35	SENT_167	[p14l1086t150r1615b228],
35	phenotype	NN	O	phenotype	prep_with	30	SENT_167	[p14l1672t150r2134b249],
36	were	VBD	O	be	auxpass	37	SENT_167	[p14l7t304r211b357],
37	included	VBN	O	include	prepc_irrespective_of	24	SENT_167	[p14l246t278r605b357],
38	(	RB	O	(	advmod	37	SENT_167	[p14l642t278r846b368],
39	data	NNS	O	datum	dobj	37	SENT_167	[p14l642t278r846b368],
40	not	RB	O	not	neg	41	SENT_167	[p14l877t295r1017b356],
41	shown	VBN	O	show	partmod	39	SENT_167	[p14l1046t278r1372b368],
42	)	NN	O	)	dep	24	SENT_167	[p14l1046t278r1372b368],
43	.	.	O	.	_	0	SENT_167	[p14l1046t278r1372b368],

1	The	DT	O	the	det	2	SENT_168	[p14l136t406r299b485],
2	rate	NN	O	rate	nsubj	13	SENT_168	[p14l345t423r508b485],
3	of	IN	O	of	_	0	SENT_168	[p14l554t405r655b485],
4	major	JJ	O	major	amod	5	SENT_168	[p14l683t407r937b506],
5	bleeding	NN	O	bleeding	prep_of	2	SENT_168	[p14l979t406r1358b507],
6	with	IN	O	with	_	0	SENT_168	[p14l1396t406r1594b485],
7	clopidogrel	NN	O	clopidogrel	prep_with	5	SENT_168	[p14l1640t406r2134b507],
8	as	IN	O	as	_	0	SENT_168	[p14l11t560r96b611],
9	compared	VBN	O	compare	prepc_as	7	SENT_168	[p14l138t534r572b633],
10	with	IN	O	with	pcomp	9	SENT_168	[p14l607t534r805b613],
11	placebo	NN	O	placebo	pobj	10	SENT_168	[p14l842t534r1177b633],
12	was	VBD	O	be	cop	13	SENT_168	[p14l1213t560r1378b613],
13	similar	JJ	O	similar	_	0	SENT_168	[p14l1420t534r1733b612],
14	between	IN	O	between	_	0	SENT_168	[p14l1769t534r2133b613],
15	genotyped	JJ	O	genotyped	amod	16	SENT_168	[p14l11t662r452b763],
16	patients	NNS	O	patient	prep_between	13	SENT_168	[p14l506t663r839b762],
17	and	CC	O	and	_	0	SENT_168	[p14l896t662r1052b741],
18	the	DT	O	the	det	20	SENT_168	[p14l1107t662r1237b740],
19	total	JJ	O	total	amod	20	SENT_168	[p14l1293t662r1485b741],
20	cohort	NN	O	cohort	prep_between	13	SENT_168	[p14l1540t662r1817b741],
21	in	IN	O	in	_	0	SENT_168	[p14l1866t663r1948b740],
22	the	DT	O	the	det	24	SENT_168	[p14l2003t662r2134b740],
23	parent	NN	O	parent	nn	24	SENT_168	[p14l9t806r283b889],
24	study	NN	O	study	prep_in	20	SENT_168	[p14l340t789r582b889],
25	:	:	O	:	_	0	SENT_168	[p14l340t789r582b889],
26	5.8	CD	PERCENT	5.8	num	27	SENT_168	[p14l648t795r857b868],
27	%	NN	PERCENT	%	dep	20	SENT_168	[p14l648t795r857b868],
28	(	CD	NUMBER	(	number	29	SENT_168	[p14l920t795r1041b880],
29	33	CD	NUMBER	33	num	27	SENT_168	[p14l920t795r1041b880],
30	of	IN	O	of	_	0	SENT_168	[p14l1105t788r1204b868],
31	570	CD	NUMBER	570	num	32	SENT_168	[p14l1247t795r1391b868],
32	patients	NNS	O	patient	prep_of	27	SENT_168	[p14l1451t790r1809b889],
33	)	CD	NUMBER	)	dep	32	SENT_168	[p14l1451t790r1809b889],
34	versus	CC	O	versus	_	0	SENT_168	[p14l1871t815r2131b869],
35	3.9	CD	PERCENT	3.9	num	36	SENT_168	[p14l12t923r220b997],
36	%	NN	PERCENT	%	prep_of	27	SENT_168	[p14l12t923r220b997],
37	(	CD	NUMBER	(	number	38	SENT_168	[p14l258t924r381b1009],
38	23	CD	NUMBER	23	num	36	SENT_168	[p14l258t924r381b1009],
39	of	IN	O	of	_	0	SENT_168	[p14l419t917r518b997],
40	586	CD	NUMBER	586	num	41	SENT_168	[p14l535t924r710b1009],
41	)	NN	O	)	prep_of	36	SENT_168	[p14l535t924r710b1009],
42	among	IN	O	among	_	0	SENT_168	[p14l749t944r1044b1019],
43	genotyped	JJ	O	genotyped	amod	44	SENT_168	[p14l1075t918r1516b1019],
44	patients	NNS	O	patient	prep_among	41	SENT_168	[p14l1548t919r1882b1018],
45	(	IN	O	(	_	0	SENT_168	[p14l1923t918r2132b1009, p14l11t1045r146b1123],
46	hazard	NN	O	hazard	nn	47	SENT_168	[p14l1923t918r2132b1009, p14l11t1045r146b1123],
47	ratio	NN	O	ratio	prep_(	44	SENT_168	[p14l192t1046r406b1140],
48	,	,	O	,	_	0	SENT_168	[p14l192t1046r406b1140],
49	1.50	CD	NUMBER	1.50	appos	32	SENT_168	[p14l461t1051r656b1140],
50	;	:	O	;	_	0	SENT_168	[p14l461t1051r656b1140],
51	95	CD	PERCENT	95	number	52	SENT_168	[p14l706t1050r888b1123],
52	%	NN	PERCENT	%	amod	53	SENT_168	[p14l706t1050r888b1123],
53	CI	NN	O	ci	dep	20	SENT_168	[p14l933t1051r1046b1140],
54	,	,	O	,	_	0	SENT_168	[p14l933t1051r1046b1140],
55	0.88	CD	NUMBER	0.88	appos	53	SENT_168	[p14l1097t1051r1273b1123],
56	to	TO	O	to	_	0	SENT_168	[p14l1321t1061r1402b1123],
57	2.55	CD	NUMBER	2.55	number	58	SENT_168	[p14l1449t1051r1674b1140],
58	)	CD	NUMBER	)	prep_to	55	SENT_168	[p14l1449t1051r1674b1140],
59	,	,	O	,	_	0	SENT_168	[p14l1449t1051r1674b1140],
60	and	CC	O	and	_	0	SENT_168	[p14l1725t1045r1880b1123],
61	6.7	CD	PERCENT	6.7	num	62	SENT_168	[p14l1926t1050r2134b1124],
62	%	NN	PERCENT	%	prep_to	55	SENT_168	[p14l1926t1050r2134b1124],
63	(	CD	NUMBER	(	number	64	SENT_168	[p14l16t1178r190b1263],
64	251	CD	NUMBER	251	num	62	SENT_168	[p14l16t1178r190b1263],
65	of	IN	O	of	_	0	SENT_168	[p14l235t1171r334b1251],
66	3772	CD	NUMBER	3772	num	67	SENT_168	[p14l360t1178r558b1251],
67	patients	NNS	O	patient	prep_of	62	SENT_168	[p14l600t1173r959b1272],
68	)	CD	NUMBER	)	dep	73	SENT_168	[p14l600t1173r959b1272],
69	versus	CC	O	versus	prep	68	SENT_168	[p14l1004t1198r1265b1251],
70	4.3	CD	PERCENT	4.3	num	71	SENT_168	[p14l1309t1177r1519b1251],
71	%	NN	PERCENT	%	dep	69	SENT_168	[p14l1309t1177r1519b1251],
72	(	CD	NUMBER	(	dep	73	SENT_168	[p14l1566t1178r1737b1263],
73	162	CD	NUMBER	162	dep	55	SENT_168	[p14l1566t1178r1737b1263],
74	of	IN	O	of	_	0	SENT_168	[p14l1782t1171r1881b1251],
75	3782	CD	NUMBER	3782	num	76	SENT_168	[p14l1907t1178r2128b1263],
76	)	NN	O	)	prep_of	73	SENT_168	[p14l1907t1178r2128b1263],
77	among	IN	O	among	_	0	SENT_168	[p14l11t1327r306b1402],
78	patients	NNS	O	patient	prep_among	76	SENT_168	[p14l341t1302r674b1401],
79	in	IN	O	in	_	0	SENT_168	[p14l715t1302r798b1379],
80	the	DT	O	the	det	85	SENT_168	[p14l837t1301r968b1379],
81	total	JJ	O	total	amod	85	SENT_168	[p14l1008t1301r1200b1380],
82	cohort	NN	O	cohort	nn	85	SENT_168	[p14l1240t1301r1516b1380],
83	(	NN	O	(	nn	85	SENT_168	[p14l1556t1301r1875b1392],
84	hazard	NN	O	hazard	nn	85	SENT_168	[p14l1556t1301r1875b1392],
85	ratio	NN	O	ratio	prep_in	78	SENT_168	[p14l1914t1302r2128b1397],
86	,	,	O	,	_	0	SENT_168	[p14l1914t1302r2128b1397],
87	1.57	CD	NUMBER	1.57	tmod	53	SENT_168	[p14l15t1434r202b1523],
88	;	:	O	;	_	0	SENT_168	[p14l15t1434r202b1523],
89	95	CD	PERCENT	95	number	90	SENT_168	[p14l260t1433r442b1506],
90	%	NN	PERCENT	%	amod	91	SENT_168	[p14l260t1433r442b1506],
91	CI	NN	O	ci	dep	20	SENT_168	[p14l495t1434r608b1523],
92	,	,	O	,	_	0	SENT_168	[p14l495t1434r608b1523],
93	1.29	CD	NUMBER	1.29	appos	91	SENT_168	[p14l671t1434r843b1506],
94	to	TO	O	to	_	0	SENT_168	[p14l899t1444r979b1506],
95	1.92	CD	NUMBER	1.92	num	96	SENT_168	[p14l1038t1434r1256b1518],
96	)	CD	NUMBER	)	prep_to	13	SENT_168	[p14l1038t1434r1256b1518],
97	.	.	O	.	_	0	SENT_168	[p14l1038t1434r1256b1518],

1	No	DT	O	no	det	2	SENT_169	[p14l1314t1435r1437b1507],
2	interaction	NN	O	interaction	_	0	SENT_169	[p14l1492t1429r1948b1506],
3	between	IN	O	between	_	0	SENT_169	[p14l2003t1428r2132b1506, p14l12t1573r262b1635],
4	metabolizer	NN	O	metabolizer	nn	5	SENT_169	[p14l310t1556r817b1635],
5	phenotype	NN	O	phenotype	prep_between	2	SENT_169	[p14l861t1556r1305b1656],
6	(	CD	NUMBER	(	num	7	SENT_169	[p14l1357t1557r1532b1657],
7	Fig	NN	O	fig	dep	5	SENT_169	[p14l1357t1557r1532b1657],
8	.	.	O	.	_	0	SENT_169	[p14l1357t1557r1532b1657],

1	3	CD	NUMBER	3	num	2	SENT_170	[p14l1587t1562r1657b1647],
2	)	NN	O	)	nn	5	SENT_170	[p14l1587t1562r1657b1647],
3	and	CC	O	and	_	0	SENT_170	[p14l1710t1556r1866b1635],
4	functional	JJ	O	functional	nn	5	SENT_170	[p14l1913t1555r2132b1635, p14l12t1684r256b1763],
5	allele	NN	O	allele	_	0	SENT_170	[p14l299t1684r516b1763],
6	carrier	NN	O	carrier	nn	7	SENT_170	[p14l561t1685r840b1762],
7	status	NN	O	status	dep	5	SENT_170	[p14l883t1701r1129b1763],
8	(	CD	NUMBER	(	num	9	SENT_170	[p14l1180t1685r1355b1785],
9	Fig	NN	O	fig	dep	7	SENT_170	[p14l1180t1685r1355b1785],
10	.	.	O	.	_	0	SENT_170	[p14l1180t1685r1355b1785],

1	4	CD	NUMBER	4	num	2	SENT_171	[p14l1404t1690r1479b1775],
2	)	NN	O	)	nsubjpass	4	SENT_171	[p14l1404t1690r1479b1775],
3	was	VBD	O	be	auxpass	4	SENT_171	[p14l1524t1710r1684b1763],
4	observed	VBN	O	observe	_	0	SENT_171	[p14l1732t1684r2128b1763],
5	.	.	O	.	_	0	SENT_171	[p14l1732t1684r2128b1763],

1	Nevertheless	RB	O	nevertheless	advmod	27	SENT_172	[p14l9t1812r567b1908],
2	,	,	O	,	_	0	SENT_172	[p14l9t1812r567b1908],
3	in	IN	O	in	_	0	SENT_172	[p14l605t1813r687b1890],
4	an	DT	O	a	det	5	SENT_172	[p14l720t1838r821b1890],
5	analysis	NN	O	analysis	prep_in	27	SENT_172	[p14l854t1812r1186b1912],
6	of	IN	O	of	_	0	SENT_172	[p14l1222t1811r1320b1891],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_172	[p14l1336t1812r2133b1913],
8	—	NN	O	—	prep_of	5	SENT_172	[p14l1336t1812r2133b1913],
9	treated	VBN	O	treat	partmod	8	SENT_172	[p14l1336t1812r2133b1913],
10	patients	NNS	O	patient	dobj	9	SENT_172	[p14l9t1940r344b2039],
11	only	RB	O	only	advmod	9	SENT_172	[p14l393t1939r585b2039],
12	,	,	O	,	_	0	SENT_172	[p14l393t1939r585b2039],
13	carriers	NNS	O	carrier	dobj	9	SENT_172	[p14l638t1940r954b2017],
14	of	IN	O	of	_	0	SENT_172	[p14l1004t1938r1102b2018],
15	loss	NN	O	loss	nn	16	SENT_172	[p14l1129t1938r1799b2019],
16	—	NN	O	—	prep_of	13	SENT_172	[p14l1129t1938r1799b2019],
17	of	IN	O	of	_	0	SENT_172	[p14l1129t1938r1799b2019],
18	—	CD	NUMBER	—	num	20	SENT_172	[p14l1129t1938r1799b2019],
19	function	NN	O	function	nn	20	SENT_172	[p14l1129t1938r1799b2019],
20	alleles	NNS	O	allele	prep_of	16	SENT_172	[p14l1845t1939r2128b2035],
21	,	,	O	,	_	0	SENT_172	[p14l1845t1939r2128b2035],
22	as	IN	O	as	_	0	SENT_172	[p14l11t2094r95b2145],
23	compared	VBN	O	compare	prepc_as	8	SENT_172	[p14l141t2068r560b2167],
24	with	IN	O	with	pcomp	23	SENT_172	[p14l600t2068r791b2147],
25	noncarriers	NNS	O	noncarrier	pobj	24	SENT_172	[p14l836t2069r1342b2163],
26	,	,	O	,	_	0	SENT_172	[p14l836t2069r1342b2163],
27	had	VBD	O	have	_	0	SENT_172	[p14l1391t2068r1546b2146],
28	an	DT	O	a	det	30	SENT_172	[p14l1588t2094r1690b2146],
29	increased	VBN	O	increase	amod	30	SENT_172	[p14l1734t2068r2134b2146],
30	risk	NN	O	risk	dobj	27	SENT_172	[p14l10t2196r172b2276],
31	of	IN	O	of	_	0	SENT_172	[p14l201t2195r301b2276],
32	bleeding	VBG	O	bleed	prepc_of	30	SENT_172	[p14l317t2196r684b2298],
33	(	CD	NUMBER	(	num	34	SENT_172	[p14l718t2202r1057b2288],
34	P	NN	O	p	nsubj	35	SENT_172	[p14l718t2202r1057b2288],
35	=	JJ	O	=	xcomp	32	SENT_172	[p14l718t2202r1057b2288],
36	0.01	CD	NUMBER	0.01	tmod	35	SENT_172	[p14l718t2202r1057b2288],
37	by	IN	O	by	_	0	SENT_172	[p14l1091t2196r1188b2297],
38	log-rank	JJ	O	log-rank	amod	39	SENT_172	[p14l1216t2196r1581b2298],
39	test	NN	O	test	prep_by	35	SENT_172	[p14l1610t2203r1784b2288],
40	)	CD	NUMBER	)	num	43	SENT_172	[p14l1610t2203r1784b2288],
41	(	NN	O	(	nn	43	SENT_172	[p14l1828t2196r2149b2288],
42	hazard	NN	O	hazard	nn	43	SENT_172	[p14l1828t2196r2149b2288],
43	ratio	NN	O	ratio	nsubj	27	SENT_172	[p14l10t2327r226b2422],
44	,	,	O	,	_	0	SENT_172	[p14l10t2327r226b2422],
45	2.47	CD	NUMBER	2.47	appos	43	SENT_172	[p14l269t2332r459b2422],
46	;	:	O	;	_	0	SENT_172	[p14l269t2332r459b2422],
47	95	CD	NUMBER	95	number	48	SENT_172	[p14l500t2331r684b2405],
48	°	CD	NUMBER	°	dep	45	SENT_172	[p14l500t2331r684b2405],
49	/	:	O	/	punct	51	SENT_172	[p14l500t2331r684b2405],
50	o	NN	O	o	nn	51	SENT_172	[p14l500t2331r684b2405],
51	CI	NN	O	ci	dep	48	SENT_172	[p14l721t2332r834b2422],
52	,	,	O	,	_	0	SENT_172	[p14l721t2332r834b2422],
53	1.23	CD	NUMBER	1.23	num	55	SENT_172	[p14l881t2332r1053b2405],
54	to	TO	O	to	dep	55	SENT_172	[p14l1094t2342r1175b2405],
55	4.97	CD	NUMBER	4.97	appos	51	SENT_172	[p14l1213t2332r1404b2421],
56	;	:	O	;	_	0	SENT_172	[p14l1213t2332r1404b2421],
57	P	NN	O	p	dep	45	SENT_172	[p14l1444t2332r1778b2417],
58	=	JJ	O	=	advmod	62	SENT_172	[p14l1444t2332r1778b2417],
59	0.01	CD	NUMBER	0.01	dep	58	SENT_172	[p14l1444t2332r1778b2417],
60	)	CD	NUMBER	)	number	61	SENT_172	[p14l1444t2332r1778b2417],
61	(	CD	NUMBER	(	num	62	SENT_172	[p14l1825t2327r2002b2427],
62	Fig	NN	O	fig	rcmod	57	SENT_172	[p14l1825t2327r2002b2427],
63	.	.	O	.	_	0	SENT_172	[p14l1825t2327r2002b2427],

1	4	CD	NUMBER	4	_	0	SENT_173	[p14l2043t2332r2144b2417],
2	)	NN	O	)	dep	1	SENT_173	[p14l2043t2332r2144b2417],
3	.	.	O	.	_	0	SENT_173	[p14l2043t2332r2144b2417],

1	However	RB	O	however	advmod	15	SENT_174	[p14l10t2462r400b2550],
2	,	,	O	,	_	0	SENT_174	[p14l10t2462r400b2550],
3	when	WRB	O	when	advmod	9	SENT_174	[p14l468t2454r699b2534],
4	patients	NNS	O	patient	nsubjpass	9	SENT_174	[p14l765t2455r1102b2554],
5	who	WP	O	who	nsubj	6	SENT_174	[p14l1167t2454r1349b2533],
6	received	VBD	O	receive	rcmod	4	SENT_174	[p14l1417t2454r1758b2533],
7	placebo	NN	O	placebo	dobj	6	SENT_174	[p14l1823t2454r2148b2554],
8	were	VBD	O	be	auxpass	9	SENT_174	[p14l6t2609r205b2662],
9	included	VBN	O	include	advcl	15	SENT_174	[p14l256t2583r618b2662],
10	in	IN	O	in	_	0	SENT_174	[p14l668t2584r751b2661],
11	the	DT	O	the	det	12	SENT_174	[p14l802t2583r933b2661],
12	comparison	NN	O	comparison	prep_in	9	SENT_174	[p14l985t2584r1512b2683],
13	,	,	O	,	_	0	SENT_174	[p14l985t2584r1512b2683],
14	there	EX	O	there	expl	15	SENT_174	[p14l1569t2583r1782b2661],
15	was	VBD	O	be	_	0	SENT_174	[p14l1829t2609r1990b2662],
16	no	DT	O	no	det	17	SENT_174	[p14l2043t2609r2149b2662],
17	evidence	NN	O	evidence	nsubj	15	SENT_174	[p14l11t2711r372b2790],
18	of	IN	O	of	_	0	SENT_174	[p14l428t2710r528b2790],
19	an	DT	O	a	det	20	SENT_174	[p14l564t2737r667b2789],
20	interaction	NN	O	interaction	prep_of	17	SENT_174	[p14l722t2712r1183b2790],
21	between	IN	O	between	_	0	SENT_174	[p14l1239t2711r1594b2791],
22	study	NN	O	study	nn	23	SENT_174	[p14l1651t2711r1877b2811],
23	treatment	NN	O	treatment	prep_between	20	SENT_174	[p14l1929t2728r2148b2789, p14l10t2857r230b2919],
24	and	CC	O	and	_	0	SENT_174	[p14l268t2840r425b2919],
25	loss	NN	O	loss	nn	26	SENT_174	[p14l469t2839r1144b2920],
26	—	NN	O	—	conj_and	23	SENT_174	[p14l469t2839r1144b2920],
27	of	IN	O	of	_	0	SENT_174	[p14l469t2839r1144b2920],
28	—	CD	NUMBER	—	num	31	SENT_174	[p14l469t2839r1144b2920],
29	function	NN	O	function	nn	31	SENT_174	[p14l469t2839r1144b2920],
30	carrier	NN	O	carrier	nn	31	SENT_174	[p14l1189t2841r1470b2919],
31	status	NN	O	status	prep_of	23	SENT_174	[p14l1513t2857r1761b2920],
32	(	CD	NUMBER	(	num	33	SENT_174	[p14l1813t2846r2149b2931],
33	P	NN	O	p	npadvmod	34	SENT_174	[p14l1813t2846r2149b2931],
34	=	JJ	O	=	amod	31	SENT_174	[p14l1813t2846r2149b2931],
35	O.	NNP	O	O.	dep	15	SENT_174	[p14l1813t2846r2149b2931],
36	16	CD	NUMBER	16	num	35	SENT_174	[p14l1813t2846r2149b2931],
37	for	IN	O	for	_	0	SENT_174	[p14l10t2968r132b3049],
38	heterogeneity	NN	O	heterogeneity	nn	39	SENT_174	[p14l181t2969r804b3071],
39	)	NN	O	)	prep_for	15	SENT_174	[p14l181t2969r804b3071],
40	,	,	O	,	_	0	SENT_174	[p14l181t2969r804b3071],
41	since	IN	O	since	mark	53	SENT_174	[p14l865t2970r1076b3048],
42	a	DT	O	a	det	44	SENT_174	[p14l1129t2996r1174b3048],
43	similar	JJ	O	similar	amod	44	SENT_174	[p14l1227t2969r1529b3048],
44	trend	NN	O	trend	nsubjpass	53	SENT_174	[p14l1579t2969r1803b3049],
45	among	IN	O	among	_	0	SENT_174	[p14l1855t2995r2153b3071],
46	carriers	NNS	O	carrier	prep_among	44	SENT_174	[p14l11t3099r330b3176],
47	as	IN	O	as	_	0	SENT_174	[p14l382t3124r467b3176],
48	compared	VBN	O	compare	prepc_as	46	SENT_174	[p14l520t3098r942b3198],
49	with	IN	O	with	pcomp	48	SENT_174	[p14l988t3098r1181b3178],
50	noncarriers	NNS	O	noncarrier	pobj	49	SENT_174	[p14l1231t3099r1717b3177],
51	was	VBD	O	be	auxpass	53	SENT_174	[p14l1765t3124r1927b3178],
52	also	RB	O	also	advmod	53	SENT_174	[p14l1978t3098r2148b3177],
53	noted	VBN	O	note	advcl	15	SENT_174	[p14l10t3226r249b3305],
54	for	IN	O	for	_	0	SENT_174	[p14l285t3225r407b3305],
55	the	DT	O	the	det	56	SENT_174	[p14l440t3226r572b3304],
56	patients	NNS	O	patient	prep_for	53	SENT_174	[p14l606t3227r943b3326],
57	who	WP	O	who	nsubj	58	SENT_174	[p14l977t3226r1158b3306],
58	received	VBD	O	receive	rcmod	56	SENT_174	[p14l1196t3226r1537b3306],
59	placebo	NN	O	placebo	nn	62	SENT_174	[p14l1571t3226r1895b3326],
60	(	NN	O	(	nn	62	SENT_174	[p14l1938t3226r2148b3317, p14l10t3355r147b3434],
61	hazard	NN	O	hazard	nn	62	SENT_174	[p14l1938t3226r2148b3317, p14l10t3355r147b3434],
62	ratio	NN	O	ratio	dobj	58	SENT_174	[p14l184t3356r400b3451],
63	,	,	O	,	_	0	SENT_174	[p14l184t3356r400b3451],
64	1.13	CD	NUMBER	1.13	appos	62	SENT_174	[p14l447t3361r642b3451],
65	;	:	O	;	_	0	SENT_174	[p14l447t3361r642b3451],
66	95	CD	PERCENT	95	number	67	SENT_174	[p14l683t3360r867b3434],
67	%	NN	PERCENT	%	amod	68	SENT_174	[p14l683t3360r867b3434],
68	CI	NN	O	ci	dep	62	SENT_174	[p14l903t3361r1018b3451],
69	,	,	O	,	_	0	SENT_174	[p14l903t3361r1018b3451],
70	0.45	CD	NUMBER	0.45	num	72	SENT_174	[p14l1061t3361r1230b3434],
71	to	TO	O	to	dep	72	SENT_174	[p14l1271t3372r1352b3434],
72	2.89	CD	NUMBER	2.89	appos	68	SENT_174	[p14l1391t3361r1594b3450],
73	;	:	O	;	_	0	SENT_174	[p14l1391t3361r1594b3450],
74	P	NN	O	p	dep	62	SENT_174	[p14l1634t3361r1993b3446],
75	=	JJ	O	=	amod	76	SENT_174	[p14l1634t3361r1993b3446],
76	O.	NNP	O	O.	dep	74	SENT_174	[p14l1634t3361r1993b3446],
77	79	CD	NUMBER	79	number	78	SENT_174	[p14l1634t3361r1993b3446],
78	)	CD	NUMBER	)	dep	76	SENT_174	[p14l1634t3361r1993b3446],
79	.	.	O	.	_	0	SENT_174	[p14l1634t3361r1993b3446],

1	SECONDARY	JJ	O	secondary	amod	2	SENT_175	[p14l10t3631r494b3682],
2	ANALYSIS	NN	O	analysis	_	0	SENT_175	[p14l525t3631r902b3682],

1	Previous	JJ	O	previous	amod	2	SENT_176	[p15l8t33r373b112],
2	studies	NNS	O	study	nsubj	6	SENT_176	[p15l409t32r711b112],
3	of	IN	O	of	_	0	SENT_176	[p15l746t31r846b112],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_176	[p15l860t32r1346b134],
5	have	VBP	O	have	aux	6	SENT_176	[p15l1377t32r1568b112],
6	shown	VBN	O	show	ccomp	39	SENT_176	[p15l1601t32r1885b112],
7	a	DT	O	a	det	9	SENT_176	[p15l1916t59r1961b111],
8	deleterious	JJ	O	deleterious	amod	9	SENT_176	[p15l1991t32r2148b112, p15l11t163r360b242],
9	effect	NN	O	effect	dobj	6	SENT_176	[p15l411t161r660b242],
10	of	IN	O	of	_	0	SENT_176	[p15l704t161r806b242],
11	loss	NN	O	loss	nn	12	SENT_176	[p15l834t161r1543b242],
12	—	NN	O	—	prep_of	9	SENT_176	[p15l834t161r1543b242],
13	of	IN	O	of	_	0	SENT_176	[p15l834t161r1543b242],
14	—	CD	NUMBER	—	num	16	SENT_176	[p15l834t161r1543b242],
15	function	NN	O	function	nn	16	SENT_176	[p15l834t161r1543b242],
16	alleles	NNS	O	allele	prep_of	12	SENT_176	[p15l1591t162r1864b241],
17	when	WRB	O	when	advmod	19	SENT_176	[p15l1911t162r2149b242],
18	carriers	NNS	O	carrier	nsubj	19	SENT_176	[p15l11t292r346b369],
19	are	VBP	O	be	advcl	6	SENT_176	[p15l403t317r535b369],
20	compared	VBN	O	compare	_	0	SENT_176	[p15l592t291r1030b391],
21	with	IN	O	with	prepc_compared_with	19	SENT_176	[p15l1081t291r1282b370],
22	noncarriers	NNS	O	noncarrier	pobj	19	SENT_176	[p15l1338t292r1846b370],
23	in	IN	O	in	_	0	SENT_176	[p15l1904t292r1989b369],
24	an	DT	O	a	det	25	SENT_176	[p15l2045t317r2149b369],
25	analysis	NN	O	analysis	prep_in	22	SENT_176	[p15l10t420r344b520],
26	that	WDT	O	that	nsubj	27	SENT_176	[p15l382t420r552b498],
27	includes	VBZ	O	include	rcmod	25	SENT_176	[p15l582t420r930b499],
28	clopidogrel	NN	O	clopidogrel	nn	29	SENT_176	[p15l968t420r1772b521],
29	—	NN	O	—	dobj	27	SENT_176	[p15l968t420r1772b521],
30	treated	VBN	O	treat	partmod	29	SENT_176	[p15l968t420r1772b521],
31	patients	NNS	O	patient	dobj	30	SENT_176	[p15l1805t421r2147b520],
32	only	RB	O	only	prep	31	SENT_176	[p15l11t547r317b647],
33	.3	NN	NUMBER	.3	pobj	32	SENT_176	[p15l11t547r317b647],
34	'	''	O	'	_	0	SENT_176	[p15l11t547r317b647],
35	5	CD	NUMBER	5	tmod	30	SENT_176	[p15l11t547r317b647],
36	Therefore	RB	O	therefore	advmod	35	SENT_176	[p15l379t546r832b643],
37	,	,	O	,	_	0	SENT_176	[p15l379t546r832b643],
38	We	PRP	O	we	nsubj	39	SENT_176	[p15l895t573r1015b627],
39	tested	VBD	O	test	_	0	SENT_176	[p15l1079t547r1340b626],
40	whether	IN	O	whether	complm	49	SENT_176	[p15l1398t547r1763b627],
41	loss	NN	O	loss	nn	42	SENT_176	[p15l1821t546r2148b626],
42	—	NN	O	—	nsubjpass	49	SENT_176	[p15l1821t546r2148b626],
43	of	IN	O	of	_	0	SENT_176	[p15l1821t546r2148b626],
44	—	CD	NUMBER	—	num	47	SENT_176	[p15l1821t546r2148b626],
45	function	NN	O	function	nn	47	SENT_176	[p15l10t676r379b757],
46	carrier	NN	O	carrier	nn	47	SENT_176	[p15l429t678r716b756],
47	status	NN	O	status	prep_of	42	SENT_176	[p15l763t694r1017b757],
48	was	VBD	O	be	auxpass	49	SENT_176	[p15l1063t704r1227b757],
49	associated	VBN	O	associate	ccomp	39	SENT_176	[p15l1277t677r1725b757],
50	with	IN	O	with	_	0	SENT_176	[p15l1769t677r1967b757],
51	the	DT	O	the	det	52	SENT_176	[p15l2016t677r2149b756],
52	outcome	NN	O	outcome	prep_with	49	SENT_176	[p15l11t823r382b885],
53	in	IN	O	in	_	0	SENT_176	[p15l410t807r494b884],
54	an	DT	O	a	det	55	SENT_176	[p15l522t832r626b884],
55	analysis	NN	O	analysis	prep_in	52	SENT_176	[p15l654t806r997b906],
56	that	WDT	O	that	nsubj	58	SENT_176	[p15l1028t806r1201b884],
57	was	VBD	O	be	cop	58	SENT_176	[p15l1220t832r1384b886],
58	restricted	JJ	O	restricted	rcmod	55	SENT_176	[p15l1415t806r1825b885],
59	to	TO	O	to	_	0	SENT_176	[p15l1854t823r1936b885],
60	data	NNS	O	datum	prep_to	58	SENT_176	[p15l1967t806r2151b885],
61	from	IN	O	from	_	0	SENT_176	[p15l10t934r222b1015],
62	clopidogrel	NN	O	clopidogrel	nn	63	SENT_176	[p15l270t935r1093b1037],
63	—	NN	O	—	prep_from	58	SENT_176	[p15l270t935r1093b1037],
64	treated	VBN	O	treat	partmod	63	SENT_176	[p15l270t935r1093b1037],
65	patients	NNS	O	patient	dobj	64	SENT_176	[p15l1138t936r1508b1036],
66	.	.	O	.	_	0	SENT_176	[p15l1138t936r1508b1036],

1	Among	IN	O	among	_	0	SENT_177	[p15l1557t943r1880b1037],
2	these	DT	O	these	det	3	SENT_177	[p15l1924t935r2149b1014],
3	patients	NNS	O	patient	prep_among	6	SENT_177	[p15l9t1065r369b1165],
4	,	,	O	,	_	0	SENT_177	[p15l9t1065r369b1165],
5	there	EX	O	there	expl	6	SENT_177	[p15l403t1064r617b1143],
6	were	VBD	O	be	_	0	SENT_177	[p15l640t1090r841b1144],
7	no	DT	O	no	det	9	SENT_177	[p15l869t1090r974b1144],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_177	[p15l1005t1063r1466b1166],
9	increases	NNS	O	increase	nsubj	6	SENT_177	[p15l1488t1065r1877b1143],
10	in	IN	O	in	_	0	SENT_177	[p15l1907t1065r1989b1142],
11	the	DT	O	the	det	12	SENT_177	[p15l2018t1064r2149b1143],
12	rates	NNS	O	rate	prep_in	9	SENT_177	[p15l10t1209r214b1270],
13	of	IN	O	of	_	0	SENT_177	[p15l258t1191r359b1271],
14	the	DT	O	the	det	18	SENT_177	[p15l382t1192r516b1270],
15	first	JJ	ORDINAL	first	amod	18	SENT_177	[p15l557t1191r742b1270],
16	primary	JJ	O	primary	amod	18	SENT_177	[p15l777t1193r1130b1292],
17	composite	JJ	O	composite	amod	18	SENT_177	[p15l1167t1193r1612b1292],
18	outcome	NN	O	outcome	prep_of	12	SENT_177	[p15l1653t1209r2025b1271],
19	in	IN	O	in	_	0	SENT_177	[p15l2066t1193r2150b1270],
20	the	DT	O	the	det	25	SENT_177	[p15l11t1321r144b1399],
21	CURE	NN	O	cure	nn	25	SENT_177	[p15l183t1327r441b1404],
22	trial	NN	O	trial	nn	25	SENT_177	[p15l483t1321r661b1399],
23	(	NN	O	(	nn	25	SENT_177	[p15l705t1321r1033b1412],
24	hazard	NN	O	hazard	nn	25	SENT_177	[p15l705t1321r1033b1412],
25	ratio	NN	O	ratio	prep_in	18	SENT_177	[p15l1072t1322r1292b1417],
26	,	,	O	,	_	0	SENT_177	[p15l1072t1322r1292b1417],
27	0.86	CD	NUMBER	0.86	appos	9	SENT_177	[p15l1337t1327r1543b1417],
28	;	:	O	;	_	0	SENT_177	[p15l1337t1327r1543b1417],
29	95	CD	PERCENT	95	number	30	SENT_177	[p15l1587t1326r1772b1400],
30	%	NN	PERCENT	%	amod	31	SENT_177	[p15l1587t1326r1772b1400],
31	CI	NN	O	ci	dep	27	SENT_177	[p15l1810t1327r1926b1417],
32	,	,	O	,	_	0	SENT_177	[p15l1810t1327r1926b1417],
33	0.63	CD	NUMBER	0.63	number	35	SENT_177	[p15l1971t1327r2146b1400],
34	to	TO	O	to	dep	35	SENT_177	[p15l11t1467r92b1529],
35	1.17	CD	NUMBER	1.17	appos	9	SENT_177	[p15l134t1456r362b1546],
36	)	CD	NUMBER	)	dep	35	SENT_177	[p15l134t1456r362b1546],
37	,	,	O	,	_	0	SENT_177	[p15l134t1456r362b1546],
38	the	DT	O	the	det	42	SENT_177	[p15l405t1450r539b1529],
39	second	JJ	ORDINAL	second	amod	42	SENT_177	[p15l577t1450r876b1529],
40	primary	JJ	O	primary	amod	42	SENT_177	[p15l911t1451r1264b1550],
41	composite	JJ	O	composite	amod	42	SENT_177	[p15l1296t1451r1741b1550],
42	outcome	NN	O	outcome	appos	9	SENT_177	[p15l1778t1467r2149b1529],
43	in	IN	O	in	_	0	SENT_177	[p15l10t1580r93b1657],
44	the	DT	O	the	det	49	SENT_177	[p15l145t1579r279b1657],
45	CURE	NN	O	cure	nn	49	SENT_177	[p15l331t1585r589b1662],
46	trial	NN	O	trial	nn	49	SENT_177	[p15l643t1579r823b1657],
47	(	NN	O	(	nn	49	SENT_177	[p15l878t1579r1206b1670],
48	hazard	NN	O	hazard	nn	49	SENT_177	[p15l878t1579r1206b1670],
49	ratio	NN	O	ratio	prep_in	42	SENT_177	[p15l1258t1580r1479b1675],
50	,	,	O	,	_	0	SENT_177	[p15l1258t1580r1479b1675],
51	0.93	CD	NUMBER	0.93	appos	9	SENT_177	[p15l1537t1585r1735b1674],
52	;	:	O	;	_	0	SENT_177	[p15l1537t1585r1735b1674],
53	95	CD	PERCENT	95	number	54	SENT_177	[p15l1791t1584r1976b1658],
54	%	NN	PERCENT	%	amod	55	SENT_177	[p15l1791t1584r1976b1658],
55	CI	NN	O	ci	dep	51	SENT_177	[p15l2028t1585r2144b1675],
56	,	,	O	,	_	0	SENT_177	[p15l2028t1585r2144b1675],
57	0.74	CD	NUMBER	0.74	number	60	SENT_177	[p15l10t1714r182b1787],
58	to	TO	O	to	dep	60	SENT_177	[p15l218t1725r300b1787],
59	1.16	CD	NUMBER	1.16	number	60	SENT_177	[p15l340t1714r565b1804],
60	)	CD	NUMBER	)	appos	9	SENT_177	[p15l340t1714r565b1804],
61	,	,	O	,	_	0	SENT_177	[p15l340t1714r565b1804],
62	or	CC	O	or	_	0	SENT_177	[p15l608t1734r697b1787],
63	the	DT	O	the	det	65	SENT_177	[p15l730t1708r864b1786],
64	primary	JJ	O	primary	amod	65	SENT_177	[p15l898t1709r1251b1808],
65	outcome	NN	O	outcome	appos	9	SENT_177	[p15l1283t1725r1654b1787],
66	in	IN	O	in	_	0	SENT_177	[p15l1690t1709r1773b1786],
67	ACTIVE	NNP	O	ACTIVE	nn	71	SENT_177	[p15l1805t1714r2148b1787],
68	A	NNP	O	A	nn	71	SENT_177	[p15l6t1845r73b1915],
69	(	NN	O	(	nn	71	SENT_177	[p15l104t1837r433b1928],
70	hazard	NN	O	hazard	nn	71	SENT_177	[p15l104t1837r433b1928],
71	ratio	NN	O	ratio	prep_in	65	SENT_177	[p15l462t1838r683b1933],
72	,	,	O	,	_	0	SENT_177	[p15l462t1838r683b1933],
73	1.07	CD	NUMBER	1.07	appos	9	SENT_177	[p15l721t1843r913b1933],
74	;	:	O	;	_	0	SENT_177	[p15l721t1843r913b1933],
75	95	CD	PERCENT	95	number	76	SENT_177	[p15l947t1842r1132b1916],
76	%	NN	PERCENT	%	amod	77	SENT_177	[p15l947t1842r1132b1916],
77	CI	NN	O	ci	dep	73	SENT_177	[p15l1162t1843r1278b1933],
78	,	,	O	,	_	0	SENT_177	[p15l1162t1843r1278b1933],
79	0.70	CD	NUMBER	0.70	number	81	SENT_177	[p15l1314t1843r1487b1916],
80	to	TO	O	to	dep	81	SENT_177	[p15l1519t1854r1600b1916],
81	1.63	CD	NUMBER	1.63	appos	9	SENT_177	[p15l1635t1843r1862b1928],
82	)	CD	NUMBER	)	dep	81	SENT_177	[p15l1635t1843r1862b1928],
83	.	.	O	.	_	0	SENT_177	[p15l1635t1843r1862b1928],

1	When	WRB	O	when	advmod	3	SENT_178	[p15l1894t1837r2149b1915],
2	we	PRP	O	we	nsubj	3	SENT_178	[p15l6t1992r124b2045],
3	compared	VBD	O	compare	advcl	16	SENT_178	[p15l188t1966r617b2066],
4	the	DT	O	the	det	8	SENT_178	[p15l681t1966r814b2044],
5	poor	JJ	O	poor	amod	8	SENT_178	[p15l876t1966r1635b2066],
6	—	NN	O	—	nn	8	SENT_178	[p15l876t1966r1635b2066],
7	metabolizer	NN	O	metabolizer	nn	8	SENT_178	[p15l876t1966r1635b2066],
8	phenotype	NN	O	phenotype	dobj	3	SENT_178	[p15l1693t1966r2150b2066],
9	with	IN	O	with	_	0	SENT_178	[p15l6t2095r202b2174],
10	all	DT	O	all	det	13	SENT_178	[p15l233t2095r339b2173],
11	other	JJ	O	other	amod	13	SENT_178	[p15l370t2095r599b2174],
12	metabolizer	NN	O	metabolizer	nn	13	SENT_178	[p15l628t2095r1150b2174],
13	phenotypes	NNS	O	phenotype	prep_with	3	SENT_178	[p15l1177t2095r1701b2195],
14	,	,	O	,	_	0	SENT_178	[p15l1177t2095r1701b2195],
15	there	EX	O	there	expl	16	SENT_178	[p15l1739t2095r1957b2173],
16	was	VBD	O	be	_	0	SENT_178	[p15l1984t2121r2148b2174],
17	no	DT	O	no	det	18	SENT_178	[p15l10t2249r116b2302],
18	evidence	NN	O	evidence	nsubj	16	SENT_178	[p15l158t2223r526b2302],
19	of	IN	O	of	_	0	SENT_178	[p15l566t2222r667b2302],
20	an	DT	O	a	det	22	SENT_178	[p15l687t2249r791b2301],
21	increased	VBN	O	increase	amod	22	SENT_178	[p15l830t2223r1242b2302],
22	risk	NN	O	risk	prep_of	18	SENT_178	[p15l1281t2223r1447b2303],
23	of	IN	O	of	_	0	SENT_178	[p15l1482t2222r1583b2302],
24	the	DT	O	the	det	28	SENT_178	[p15l1604t2223r1738b2301],
25	first	JJ	ORDINAL	first	amod	28	SENT_178	[p15l1778t2222r1963b2301],
26	primary	JJ	O	primary	amod	28	SENT_178	[p15l1996t2224r2148b2323, p15l10t2378r235b2452],
27	composite	JJ	O	composite	amod	28	SENT_178	[p15l263t2353r708b2452],
28	outcome	NN	O	outcome	prep_of	22	SENT_178	[p15l741t2369r1112b2431],
29	in	IN	O	in	_	0	SENT_178	[p15l1144t2353r1227b2430],
30	the	DT	O	the	det	35	SENT_178	[p15l1260t2352r1394b2430],
31	CURE	NN	O	cure	nn	35	SENT_178	[p15l1426t2358r1683b2436],
32	trial	NN	O	trial	nn	35	SENT_178	[p15l1718t2352r1897b2430],
33	(	NN	O	(	nn	35	SENT_178	[p15l1933t2352r2148b2443, p15l10t2481r149b2560],
34	hazard	NN	O	hazard	nn	35	SENT_178	[p15l1933t2352r2148b2443, p15l10t2481r149b2560],
35	ratio	NN	O	ratio	prep_in	28	SENT_178	[p15l184t2482r405b2577],
36	,	,	O	,	_	0	SENT_178	[p15l184t2482r405b2577],
37	0.69	CD	NUMBER	0.69	appos	35	SENT_178	[p15l447t2487r649b2577],
38	;	:	O	;	_	0	SENT_178	[p15l447t2487r649b2577],
39	95	CD	NUMBER	95	number	40	SENT_178	[p15l689t2486r874b2560],
40	°	CD	NUMBER	°	dep	35	SENT_178	[p15l689t2486r874b2560],
41	/	:	O	/	punct	40	SENT_178	[p15l689t2486r874b2560],
42	o	NN	O	o	nn	43	SENT_178	[p15l689t2486r874b2560],
43	CI	NN	O	ci	dep	35	SENT_178	[p15l909t2487r1025b2577],
44	,	,	O	,	_	0	SENT_178	[p15l909t2487r1025b2577],
45	0.26	CD	NUMBER	0.26	number	47	SENT_178	[p15l1067t2487r1245b2560],
46	to	TO	O	to	dep	47	SENT_178	[p15l1283t2498r1365b2560],
47	1.87	CD	NUMBER	1.87	appos	28	SENT_178	[p15l1405t2487r1638b2577],
48	)	CD	NUMBER	)	dep	47	SENT_178	[p15l1405t2487r1638b2577],
49	,	,	O	,	_	0	SENT_178	[p15l1405t2487r1638b2577],
50	the	DT	O	the	det	54	SENT_178	[p15l1680t2481r1814b2559],
51	second	JJ	ORDINAL	second	amod	54	SENT_178	[p15l1851t2481r2150b2560],
52	primary	JJ	O	primary	amod	54	SENT_178	[p15l8t2611r361b2710],
53	composite	JJ	O	composite	amod	54	SENT_178	[p15l411t2611r855b2710],
54	outcome	NN	O	outcome	appos	28	SENT_178	[p15l909t2627r1280b2689],
55	in	IN	O	in	_	0	SENT_178	[p15l1333t2611r1417b2688],
56	the	DT	O	the	det	61	SENT_178	[p15l1471t2610r1604b2688],
57	CURE	NN	O	cure	nn	61	SENT_178	[p15l1657t2616r1915b2694],
58	trial	NN	O	trial	nn	61	SENT_178	[p15l1971t2610r2150b2688],
59	(	NN	O	(	nn	61	SENT_178	[p15l15t2739r343b2830],
60	hazard	NN	O	hazard	nn	61	SENT_178	[p15l15t2739r343b2830],
61	ratio	NN	O	ratio	prep_in	54	SENT_178	[p15l381t2740r602b2835],
62	,	,	O	,	_	0	SENT_178	[p15l381t2740r602b2835],
63	1.29	CD	NUMBER	1.29	appos	28	SENT_178	[p15l649t2745r851b2835],
64	;	:	O	;	_	0	SENT_178	[p15l649t2745r851b2835],
65	95	CD	PERCENT	95	number	66	SENT_178	[p15l894t2744r1080b2818],
66	%	NN	PERCENT	%	amod	67	SENT_178	[p15l894t2744r1080b2818],
67	CI	NN	O	ci	dep	63	SENT_178	[p15l1117t2745r1233b2835],
68	,	,	O	,	_	0	SENT_178	[p15l1117t2745r1233b2835],
69	0.74	CD	NUMBER	0.74	number	72	SENT_178	[p15l1277t2745r1448b2818],
70	to	TO	O	to	dep	72	SENT_178	[p15l1487t2756r1569b2818],
71	2.25	CD	NUMBER	2.25	number	72	SENT_178	[p15l1609t2745r1846b2835],
72	)	CD	NUMBER	)	appos	28	SENT_178	[p15l1609t2745r1846b2835],
73	,	,	O	,	_	0	SENT_178	[p15l1609t2745r1846b2835],
74	or	CC	O	or	_	0	SENT_178	[p15l1890t2765r1980b2818],
75	the	DT	O	the	det	77	SENT_178	[p15l2016t2739r2149b2817],
76	primary	JJ	O	primary	amod	77	SENT_178	[p15l8t2869r361b2968],
77	outcome	NN	O	outcome	conj_or	72	SENT_178	[p15l421t2885r792b2947],
78	in	IN	O	in	_	0	SENT_178	[p15l854t2869r938b2946],
79	ACTIVE	NNP	O	ACTIVE	nn	83	SENT_178	[p15l997t2874r1340b2947],
80	A	NNP	O	A	nn	83	SENT_178	[p15l1401t2876r1468b2946],
81	(	NN	O	(	nn	83	SENT_178	[p15l1532t2868r1860b2959],
82	hazard	NN	O	hazard	nn	83	SENT_178	[p15l1532t2868r1860b2959],
83	ratio	NN	O	ratio	prep_in	77	SENT_178	[p15l1923t2869r2144b2964],
84	,	,	O	,	_	0	SENT_178	[p15l1923t2869r2144b2964],
85	0.59	CD	NUMBER	0.59	appos	28	SENT_178	[p15l10t3003r211b3093],
86	;	:	O	;	_	0	SENT_178	[p15l10t3003r211b3093],
87	95	CD	PERCENT	95	num	89	SENT_178	[p15l250t3002r435b3076],
88	%	NN	PERCENT	%	nn	89	SENT_178	[p15l250t3002r435b3076],
89	CI	NN	O	ci	dep	28	SENT_178	[p15l470t3003r586b3093],
90	,	,	O	,	_	0	SENT_178	[p15l470t3003r586b3093],
91	0.08	CD	NUMBER	0.08	number	93	SENT_178	[p15l627t3003r806b3076],
92	to	TO	O	to	dep	93	SENT_178	[p15l843t3013r925b3076],
93	4.24	CD	NUMBER	4.24	num	94	SENT_178	[p15l960t3003r1192b3088],
94	)	CD	NUMBER	)	appos	28	SENT_178	[p15l960t3003r1192b3088],
95	.	.	O	.	_	0	SENT_178	[p15l960t3003r1192b3088],

1	sru	NN	O	sru	nn	6	SENT_179	[p15l10t3273r154b3324],
2	DY	NN	O	dy	nn	6	SENT_179	[p15l172t3274r268b3323],
3	powen	NN	O	powen	nn	6	SENT_179	[p15l306t3273r581b3324],
4	A	NN	O	a	nn	6	SENT_179	[p15l6t3382r73b3453],
5	hazard	NN	O	hazard	nn	6	SENT_179	[p15l106t3374r404b3454],
6	ratio	NN	O	ratio	nsubj	12	SENT_179	[p15l440t3375r639b3454],
7	of	IN	O	of	_	0	SENT_179	[p15l677t3373r777b3454],
8	1.53	CD	NUMBER	1.53	prep_of	6	SENT_179	[p15l798t3380r969b3454],
9	is	VBZ	O	be	cop	12	SENT_179	[p15l1007t3375r1074b3453],
10	the	DT	O	the	det	12	SENT_179	[p15l1112t3374r1245b3453],
11	smallest	JJS	O	smallest	amod	12	SENT_179	[p15l1284t3374r1646b3454],
12	increase	NN	O	increase	_	0	SENT_179	[p15l1675t3375r2030b3453],
13	in	IN	O	in	_	0	SENT_179	[p15l2065t3375r2149b3453],
14	the	DT	O	the	det	15	SENT_179	[p15l11t3504r144b3583],
15	risk	NN	O	risk	prep_in	12	SENT_179	[p15l193t3504r359b3584],
16	of	IN	O	of	_	0	SENT_179	[p15l404t3503r504b3584],
17	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_179	[p15l535t3504r1168b3584],
18	events	NNS	O	event	prep_of	15	SENT_179	[p15l1215t3521r1480b3584],
19	that	WDT	O	that	nsubjpass	22	SENT_179	[p15l1532t3504r1706b3583],
20	has	VBZ	O	have	aux	22	SENT_179	[p15l1749t3504r1894b3583],
21	been	VBN	O	be	auxpass	22	SENT_179	[p15l1946t3504r2149b3584],
22	reported	VBN	O	report	rcmod	12	SENT_179	[p15l10t3632r379b3732],
23	to	TO	O	to	_	0	SENT_179	[p15l415t3649r498b3711],
24	date	NN	O	date	prep_to	22	SENT_179	[p15l535t3632r715b3711],
25	in	IN	O	in	_	0	SENT_179	[p15l750t3633r834b3710],
26	analyses	NNS	O	analysis	prep_in	22	SENT_179	[p15l869t3632r1231b3732],
27	of	IN	O	of	_	0	SENT_179	[p15l1270t3631r1370b3711],
28	data	NNS	O	datum	prep_of	26	SENT_179	[p15l1388t3632r1573b3711],
29	from	IN	O	from	_	0	SENT_179	[p15l1608t3631r1819b3711],
30	clopid	JJ	O	clopid	amod	31	SENT_179	[p15l1856t3632r2148b3732],
31	—	NN	O	—	prep_from	28	SENT_179	[p15l1856t3632r2148b3732],

1	ogrel	NN	O	ogrel	nn	2	SENT_180	[p16l11t22r568b124],
2	—	NN	O	—	nsubj	3	SENT_180	[p16l11t22r568b124],
3	treated	VBN	O	treat	_	0	SENT_180	[p16l11t22r568b124],
4	patients	NNS	O	patient	dobj	3	SENT_180	[p16l605t23r949b123],
5	who	WP	O	who	nsubj	7	SENT_180	[p16l985t22r1170b102],
6	are	VBP	O	be	cop	7	SENT_180	[p16l1209t48r1339b101],
7	carriers	NNS	O	carrier	rcmod	4	SENT_180	[p16l1379t23r1706b101],
8	of	IN	O	of	_	0	SENT_180	[p16l1747t21r1848b102],
9	a	DT	O	a	det	11	SENT_180	[p16l1868t49r1912b101],
10	lossof-function	JJ	O	lossof-function	amod	11	SENT_180	[p16l1948t22r2148b102, p16l11t150r495b231],
11	allele	NN	O	allele	prep_of	7	SENT_180	[p16l524t151r816b231],
12	.4	CD	NUMBER	.4	num	11	SENT_180	[p16l524t151r816b231],
13	Among	IN	O	among	_	0	SENT_180	[p16l840t159r1163b253],
14	the	DT	O	the	det	15	SENT_180	[p16l1189t151r1323b230],
15	participants	NNS	O	participant	prep_among	29	SENT_180	[p16l1350t152r1872b252],
16	in	IN	O	in	_	0	SENT_180	[p16l1902t152r1986b229],
17	the	DT	O	the	det	19	SENT_180	[p16l2015t151r2149b230],
18	CURE	NN	O	cure	nn	19	SENT_180	[p16l10t286r268b364],
19	trial	NN	O	trial	prep_in	15	SENT_180	[p16l298t280r477b358],
20	who	WP	O	who	nsubj	21	SENT_180	[p16l500t280r685b360],
21	had	VBD	O	have	rcmod	19	SENT_180	[p16l713t280r871b359],
22	an	DT	O	a	det	25	SENT_180	[p16l898t306r1002b358],
23	acute	JJ	O	acute	amod	25	SENT_180	[p16l1029t297r1253b359],
24	coronary	JJ	O	coronary	amod	25	SENT_180	[p16l1282t306r1669b380],
25	syndrome	NN	O	syndrome	dobj	21	SENT_180	[p16l1694t280r2144b380],
26	,	,	O	,	_	0	SENT_180	[p16l1694t280r2144b380],
27	our	PRP$	O	we	poss	28	SENT_180	[p16l11t435r158b488],
28	study	NN	O	study	nsubj	29	SENT_180	[p16l189t409r421b509],
29	had	VBD	O	have	rcmod	11	SENT_180	[p16l449t409r607b488],
30	more	JJR	O	more	mwe	31	SENT_180	[p16l639t435r860b488],
31	than	IN	O	than	quantmod	32	SENT_180	[p16l894t409r1092b487],
32	85	CD	PERCENT	85	dep	33	SENT_180	[p16l1125t414r1309b488],
33	%	NN	PERCENT	%	dep	34	SENT_180	[p16l1125t414r1309b488],
34	power	NN	O	power	dobj	29	SENT_180	[p16l1340t435r1610b509],
35	to	TO	O	to	aux	36	SENT_180	[p16l1640t426r1722b488],
36	detect	VB	O	detect	xcomp	29	SENT_180	[p16l1757t409r2018b488],
37	an	DT	O	a	det	38	SENT_180	[p16l2046t435r2149b487],
38	interaction	NN	O	interaction	dobj	36	SENT_180	[p16l10t540r481b619],
39	of	IN	O	of	_	0	SENT_180	[p16l521t538r621b619],
40	treatment	NN	O	treatment	prep_of	38	SENT_180	[p16l643t556r1070b619],
41	with	IN	O	with	_	0	SENT_180	[p16l1100t539r1297b619],
42	carrier	NN	O	carrier	nn	43	SENT_180	[p16l1337t540r1624b619],
43	status	NN	O	status	prep_with	36	SENT_180	[p16l1662t556r1916b619],
44	with	IN	O	with	_	0	SENT_180	[p16l1953t539r2149b619],
45	respect	NN	O	respect	prep_with	36	SENT_180	[p16l10t685r312b769],
46	to	TO	O	to	_	0	SENT_180	[p16l335t685r416b748],
47	the	DT	O	the	det	50	SENT_180	[p16l445t668r576b747],
48	primary	JJ	O	primary	amod	50	SENT_180	[p16l603t669r946b769],
49	efficacy	NN	O	efficacy	nn	50	SENT_180	[p16l970t667r1299b769],
50	outcome	NN	O	outcome	prep_to	3	SENT_180	[p16l1322t685r1707b765],
51	,	,	O	,	_	0	SENT_180	[p16l1322t685r1707b765],
52	assuming	VBG	O	assume	partmod	3	SENT_180	[p16l1739t669r2153b770],
53	such	PDT	O	such	predet	56	SENT_180	[p16l12t797r207b877],
54	an	DT	O	a	det	56	SENT_180	[p16l243t823r347b876],
55	effect	NN	O	effect	nn	56	SENT_180	[p16l384t796r628b876],
56	size	NN	O	size	dobj	52	SENT_180	[p16l662t798r848b894],
57	,	,	O	,	_	0	SENT_180	[p16l662t798r848b894],
58	and	CC	O	and	_	0	SENT_180	[p16l890t797r1049b877],
59	greater	JJR	O	greater	mwe	60	SENT_180	[p16l1085t814r1393b899],
60	than	IN	O	than	quantmod	61	SENT_180	[p16l1427t797r1625b876],
61	95	CD	PERCENT	95	dep	62	SENT_180	[p16l1662t803r1848b877],
62	%	NN	PERCENT	%	dep	63	SENT_180	[p16l1662t803r1848b877],
63	power	NN	O	power	nsubj	65	SENT_180	[p16l1883t823r2153b898],
64	to	TO	O	to	aux	65	SENT_180	[p16l11t943r92b1005],
65	detect	VB	O	detect	conj_and	3	SENT_180	[p16l137t926r398b1005],
66	an	DT	O	a	det	67	SENT_180	[p16l435t952r539b1004],
67	interaction	NN	O	interaction	dobj	65	SENT_180	[p16l581t927r1053b1005],
68	with	IN	O	with	_	0	SENT_180	[p16l1091t926r1288b1005],
69	respect	NN	O	respect	prep_with	67	SENT_180	[p16l1331t943r1642b1026],
70	to	TO	O	to	_	0	SENT_180	[p16l1679t943r1762b1005],
71	the	DT	O	the	det	75	SENT_180	[p16l1807t926r1940b1004],
72	second	JJ	ORDINAL	second	amod	75	SENT_180	[p16l1985t952r2148b1004, p16l11t1055r170b1134],
73	primary	JJ	O	primary	amod	75	SENT_180	[p16l201t1056r547b1155],
74	composite	JJ	O	composite	amod	75	SENT_180	[p16l575t1056r1011b1155],
75	outcome	NN	O	outcome	prep_to	65	SENT_180	[p16l1044t1072r1431b1134],
76	.	.	O	.	_	0	SENT_180	[p16l1044t1072r1431b1134],

1	Among	IN	O	among	_	0	SENT_181	[p16l1465t1063r1784b1156],
2	patients	NNS	O	patient	prep_among	12	SENT_181	[p16l1811t1056r2148b1155],
3	with	IN	O	with	_	0	SENT_181	[p16l6t1182r205b1262],
4	atrial	JJ	O	atrial	amod	5	SENT_181	[p16l251t1182r484b1260],
5	fibrillation	NN	O	fibrillation	prep_with	2	SENT_181	[p16l530t1181r1015b1261],
6	in	IN	O	in	_	0	SENT_181	[p16l1062t1183r1146b1260],
7	ACTIVE	NNP	O	ACTIVE	nn	8	SENT_181	[p16l1189t1188r1537b1261],
8	A	NNP	O	A	prep_in	5	SENT_181	[p16l1582t1190r1672b1278],
9	,	,	O	,	_	0	SENT_181	[p16l1582t1190r1672b1278],
10	our	PRP$	O	we	poss	11	SENT_181	[p16l1725t1208r1873b1262],
11	study	NN	O	study	nsubj	12	SENT_181	[p16l1918t1182r2154b1282],
12	had	VBD	O	have	_	0	SENT_181	[p16l10t1311r167b1390],
13	much	RB	O	much	advmod	14	SENT_181	[p16l206t1311r446b1390],
14	lower	JJR	O	lower	amod	15	SENT_181	[p16l484t1311r724b1391],
15	power	NN	O	power	dobj	12	SENT_181	[p16l757t1337r1028b1411],
16	(	CD	PERCENT	(	number	17	SENT_181	[p16l1068t1316r1300b1402],
17	45	CD	PERCENT	45	dep	18	SENT_181	[p16l1068t1316r1300b1402],
18	%	NN	PERCENT	%	dep	15	SENT_181	[p16l1068t1316r1300b1402],
19	)	CD	NUMBER	)	tmod	15	SENT_181	[p16l1068t1316r1300b1402],
20	to	TO	O	to	aux	21	SENT_181	[p16l1344t1328r1426b1390],
21	detect	VB	O	detect	infmod	15	SENT_181	[p16l1467t1311r1728b1390],
22	a	DT	O	a	det	23	SENT_181	[p16l1761t1337r1806b1389],
23	similar	JJ	O	similar	dobj	21	SENT_181	[p16l1844t1311r2153b1389],

1	N	NN	O	n	nn	3	SENT_182	[p16l546t1496r559b1511],
2	ENGLJ	NN	O	englj	nn	3	SENT_182	[p16l574t1496r652b1518],
3	MED	NN	O	med	_	0	SENT_182	[p16l667t1496r719b1511],
4	363	CD	NUMBER	363	dep	3	SENT_182	[p16l729t1490r805b1518],
5	;	:	O	;	_	0	SENT_182	[p16l729t1490r805b1518],
6	18	CD	NUMBER	18	num	8	SENT_182	[p16l729t1490r805b1518],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_182	[p16l841t1496r965b1518],
8	OCTOBER	NN	DATE	october	dep	4	SENT_182	[p16l1000t1496r1112b1511],
9	28	CD	DATE	28	dep	8	SENT_182	[p16l1122t1490r1157b1516],
10	,	,	DATE	,	_	0	SENT_182	[p16l1122t1490r1157b1516],
11	2010	CD	DATE	2010	num	12	SENT_182	[p16l1169t1496r1229b1512],
12	1709	CD	DATE	1709	appos	9	SENT_182	[p16l1940t1486r2016b1509],

1	The	DT	O	the	det	4	SENT_183	[p16l702t1529r753b1553],
2	New	NNP	O	New	nn	4	SENT_183	[p16l762t1530r824b1553],
3	England	NNP	O	England	nn	4	SENT_183	[p16l833t1529r944b1560],
4	Journal	NNP	O	Journal	_	0	SENT_183	[p16l952t1529r1050b1553],
5	of	IN	O	of	_	0	SENT_183	[p16l1059t1529r1088b1553],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_183	[p16l1095t1529r1220b1553],

1	The	DT	O	the	det	4	SENT_184	[p16l816t1654r862b1675],
2	NEW	NNP	O	NEW	nn	4	SENT_184	[p16l880t1656r966b1675],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_184	[p16l985t1656r1173b1675],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_184	[p16l1192t1656r1372b1682],
5	of	IN	O	of	_	0	SENT_184	[p16l1391t1654r1419b1681],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_184	[p16l1431t1656r1630b1675],

1	A	DT	O	a	det	5	SENT_185	[p17l111t33r133b58],
2	First	JJ	ORDINAL	first	amod	5	SENT_185	[p17l157t36r213b59],
3	Primary	JJ	O	primary	amod	5	SENT_185	[p17l223t36r321b66],
4	Composite	NN	O	composite	nn	5	SENT_185	[p17l330t36r469b66],
5	Outcome	NNP	O	Outcome	_	0	SENT_185	[p17l478t37r598b59],
6	According	VBG	O	accord	_	0	SENT_185	[p17l606t35r736b66],
7	to	TO	O	to	prepc_according_to	5	SENT_185	[p17l744t39r769b59],
8	Loss-of-Function	NNP	O	Loss-of-Function	pobj	5	SENT_185	[p17l780t35r992b59],

1	Allele	NN	O	allele	nn	3	SENT_186	[p17l184t70r254b94],
2	Carrier	NN	O	carrier	nn	3	SENT_186	[p17l263t71r350b94],
3	Status	NN	O	status	_	0	SENT_186	[p17l358t72r438b94],
4	1.00	CD	NUMBER	1.00	dep	3	SENT_186	[p17l424t113r472b134],

1	0	CD	NUMBER	0	num	2	SENT_187	[p17l422t306r470b327],
2	‘	CD	NUMBER	‘	_	0	SENT_187	[p17l422t306r470b327],
3	85	CD	NUMBER	85	num	4	SENT_187	[p17l422t306r470b327],
4	P	NN	O	p	dep	2	SENT_187	[p17l549t320r620b338],
5	=	JJ	O	=	amod	4	SENT_187	[p17l549t320r620b338],
6	0.21	CD	NUMBER	0.21	tmod	5	SENT_187	[p17l549t320r620b338],
7	by	IN	O	by	_	0	SENT_187	[p17l630t319r651b344],
8	log-rank	JJ	O	log-rank	amod	9	SENT_187	[p17l660t319r742b344],
9	test	NN	O	test	prep_by	5	SENT_187	[p17l748t323r786b338],
10	for	IN	O	for	_	0	SENT_187	[p17l793t319r822b338],
11	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	12	SENT_187	[p17l548t348r741b373],
12	participants	NNS	O	participant	prep_for	4	SENT_187	[p17l750t350r870b373],

1	—	NN	O	—	nn	2	SENT_188	[p17l511t419r538b422],
2	Carriers	NNS	O	carrier	_	0	SENT_188	[p17l544t411r629b432],
3	,	,	O	,	_	0	SENT_188	[p17l544t411r629b432],
4	clopidogrel	NN	O	clopidogrel	appos	2	SENT_188	[p17l637t410r751b435],
5	(	CD	NUMBER	(	number	6	SENT_188	[p17l762t411r792b434],
6	52	CD	NUMBER	52	num	7	SENT_188	[p17l762t411r792b434],
7	events	NNS	O	event	dep	2	SENT_188	[p17l800t411r872b434],
8	)	IN	O	)	amod	7	SENT_188	[p17l800t411r872b434],

1	0-75	CD	NUMBER	0-75	num	3	SENT_189	[p17l422t434r470b455],
2	—	CD	NUMBER	—	num	3	SENT_189	[p17l511t447r538b451],
3	Noncarriers	NNS	O	noncarrier	_	0	SENT_189	[p17l545t440r671b461],
4	,	,	O	,	_	0	SENT_189	[p17l545t440r671b461],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_189	[p17l679t439r793b464],
6	(	NN	O	(	appos	3	SENT_189	[p17l804t440r846b464],
7	179	CD	NUMBER	179	num	8	SENT_189	[p17l804t440r846b464],
8	events	NNS	O	event	dep	3	SENT_189	[p17l854t440r927b464],
9	)	IN	O	)	amod	8	SENT_189	[p17l854t440r927b464],

1	—	NN	O	—	nn	2	SENT_190	[p17l511t477r538b480],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_190	[p17l544t469r629b490],
3	,	,	O	,	_	0	SENT_190	[p17l544t469r629b490],
4	placebo	NN	O	placebo	nn	5	SENT_190	[p17l639t468r717b493],
5	(	NN	O	(	appos	2	SENT_190	[p17l727t469r757b493],
6	78	CD	NUMBER	78	num	7	SENT_190	[p17l727t469r757b493],
7	events	NNS	O	event	dep	5	SENT_190	[p17l765t470r837b493],
8	)	VBP	O	)	_	0	SENT_190	[p17l765t470r837b493],
9	—	CD	NUMBER	—	num	10	SENT_190	[p17l511t506r538b509],
10	Noncarriers	NNS	O	noncarrier	dobj	8	SENT_190	[p17l545t499r671b520],
11	,	,	O	,	_	0	SENT_190	[p17l545t499r671b520],
12	placebo	NN	O	placebo	nn	13	SENT_190	[p17l680t497r758b522],
13	(	NN	O	(	appos	10	SENT_190	[p17l769t499r811b522],
14	236	CD	NUMBER	236	num	15	SENT_190	[p17l769t499r811b522],
15	events	NNS	O	event	dep	13	SENT_190	[p17l819t499r892b522],
16	)	IN	O	)	prep	8	SENT_190	[p17l819t499r892b522],

1	Freedom	NNP	O	Freedom	_	0	SENT_191	[p17l333t396r356b507],
2	from	IN	O	from	_	0	SENT_191	[p17l332t327r356b386],
3	First	NNP	ORDINAL	First	prep_from	1	SENT_191	[p17l333t259r356b314],
4	Primary	JJ	O	primary	amod	6	SENT_191	[p17l333t150r363b248],
5	Composite	NNP	O	Composite	nn	6	SENT_191	[p17l369t325r398b464],
6	Outcome	NNP	O	Outcome	dep	1	SENT_191	[p17l370t196r392b316],

1	Days	NNS	DURATION	day	_	0	SENT_192	[p17l597t608r658b636],
2	after	IN	O	after	_	0	SENT_192	[p17l668t605r726b629],
3	Randomization	NN	O	randomization	prep_after	1	SENT_192	[p17l736t605r927b629],

1	No.	NN	O	no.	_	0	SENT_193	[p17l145t662r189b684],
2	at	IN	O	at	_	0	SENT_193	[p17l199t664r223b684],
3	Risk	NN	O	risk	nn	4	SENT_193	[p17l233t660r285b684],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_193	[p17l144t699r243b723],
5	,	,	O	,	_	0	SENT_193	[p17l144t699r243b723],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_193	[p17l253t697r385b726],
7	651 632 608 545	CD	NUMBER	651 632 608 545	number	8	SENT_193	[p17l700t699r741b719],[p17l476t699r516b719],
8	484 425 358	CD	NUMBER	484 425 358	num	9	SENT_193	[p17l918t699r959b719],[p17l775t699r817b719],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_193	[p17l146t730r434b760],
10	,	,	O	,	_	0	SENT_193	[p17l146t730r434b760],
11	c	NN	O	c	nn	13	SENT_193	[p17l146t730r434b760],
12	|	NN	O	|	nn	13	SENT_193	[p17l146t730r434b760],
13	opidogre	NN	O	opidogre	appos	4	SENT_193	[p17l146t730r434b760],
14	|	CD	NUMBER	|	num	17	SENT_193	[p17l146t730r434b760],
15	1886 1778 1723 1541	CD	NUMBER	1886 1778 1723 1541	num	17	SENT_193	[p17l687t732r741b753],[p17l462t732r517b753],
16	1352 1191 960	CD	NUMBER	1352 1191 960	num	17	SENT_193	[p17l918t732r960b753],[p17l762t732r816b753],
17	Carriers	NNS	O	carrier	dep	13	SENT_193	[p17l144t766r243b790],
18	,	,	O	,	_	0	SENT_193	[p17l144t766r243b790],
19	placebo	NN	O	placebo	appos	17	SENT_193	[p17l254t764r345b793],
20	674 626 609 551	CD	NUMBER	674 626 609 551	number	21	SENT_193	[p17l701t766r741b786],[p17l476t766r517b786],
21	483 423 356	CD	NUMBER	483 423 356	num	22	SENT_193	[p17l918t766r959b786],[p17l774t765r815b786],
22	Noncarriers	NNS	O	noncarrier	dep	19	SENT_193	[p17l146t799r292b823],
23	,	,	O	,	_	0	SENT_193	[p17l146t799r292b823],
24	placebo	NN	O	placebo	dep	1	SENT_193	[p17l303t797r394b826],
25	1819 1686 1634 1456	CD	NUMBER	1819 1686 1634 1456	number	26	SENT_193	[p17l687t799r742b819],[p17l463t799r517b819],
26	1259 1103 922	CD	NUMBER	1259 1103 922	dep	24	SENT_193	[p17l918t799r959b819],[p17l762t799r816b819],

1	C	NN	O	c	_	0	SENT_194	[p17l112t887r133b913],
2	Second	JJ	ORDINAL	second	amod	4	SENT_194	[p17l155t890r248b913],
3	Primary	JJ	O	primary	amod	4	SENT_194	[p17l260t890r358b920],
4	Composite	NN	O	composite	nn	5	SENT_194	[p17l366t890r506b920],
5	Outcome	NNP	O	Outcome	dep	1	SENT_194	[p17l514t891r635b913],
6	According	VBG	O	accord	_	0	SENT_194	[p17l643t890r773b920],
7	to	TO	O	to	prepc_according_to	1	SENT_194	[p17l781t893r806b913],
8	Loss-of-Function	NNP	O	Loss-of-Function	pobj	1	SENT_194	[p17l817t889r1029b913],

1	Allele	NN	O	allele	_	0	SENT_195	[p17l184t925r254b949],
2	Carrier	NN	O	carrier	nn	3	SENT_195	[p17l263t926r350b949],
3	Status	NN	O	status	dep	1	SENT_195	[p17l358t927r438b949],

1	1	CD	NUMBER	1	num	2	SENT_196	[p17l424t968r472b988],
2	'00	CD	NUMBER	'00	_	0	SENT_196	[p17l424t968r472b988],
3	P	NN	O	p	dep	2	SENT_196	[p17l584t985r656b1003],
4	=	JJ	O	=	amod	3	SENT_196	[p17l584t985r656b1003],
5	0.39	CD	NUMBER	0.39	tmod	4	SENT_196	[p17l584t985r656b1003],
6	by	IN	O	by	_	0	SENT_196	[p17l665t983r686b1008],
7	log-rank	JJ	O	log-rank	amod	8	SENT_196	[p17l694t983r777b1008],
8	test	NN	O	test	prep_by	4	SENT_196	[p17l783t987r821b1002],
9	for	IN	O	for	_	0	SENT_196	[p17l828t983r857b1002],
10	0.95	CD	NUMBER	0.95	num	12	SENT_196	[p17l422t1032r470b1053],
11	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	12	SENT_196	[p17l582t1013r775b1038],
12	participants	NNS	O	participant	prep_for	3	SENT_196	[p17l785t1014r905b1037],

1	—	NN	O	—	nn	2	SENT_197	[p17l511t1273r538b1276],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_197	[p17l544t1266r629b1286],
3	,	,	O	,	_	0	SENT_197	[p17l544t1266r629b1286],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_197	[p17l638t1264r751b1289],
5	(	NN	O	(	appos	2	SENT_197	[p17l762t1265r804b1289],
6	102	CD	NUMBER	102	num	7	SENT_197	[p17l762t1265r804b1289],
7	events	NNS	O	event	dep	5	SENT_197	[p17l812t1266r885b1289],
8	)	VBP	O	)	_	0	SENT_197	[p17l812t1266r885b1289],
9	0-75	CD	NUMBER	0-75	num	11	SENT_197	[p17l422t1289r470b1310],
10	—	CD	NUMBER	—	num	11	SENT_197	[p17l511t1302r538b1306],
11	Noncarriers	NNS	O	noncarrier	dobj	8	SENT_197	[p17l545t1295r671b1316],
12	,	,	O	,	_	0	SENT_197	[p17l545t1295r671b1316],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_197	[p17l679t1293r793b1318],
14	(	NN	O	(	appos	11	SENT_197	[p17l804t1295r846b1318],
15	317	CD	NUMBER	317	num	16	SENT_197	[p17l804t1295r846b1318],
16	events	NNS	O	event	dep	14	SENT_197	[p17l854t1295r927b1318],
17	)	IN	O	)	prep	8	SENT_197	[p17l854t1295r927b1318],

1	—	NN	O	—	nn	2	SENT_198	[p17l511t1331r538b1335],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_198	[p17l544t1324r629b1345],
3	,	,	O	,	_	0	SENT_198	[p17l544t1324r629b1345],
4	placebo	NN	O	placebo	nn	5	SENT_198	[p17l638t1323r717b1347],
5	(	NN	O	(	appos	2	SENT_198	[p17l727t1324r769b1347],
6	128	CD	NUMBER	128	num	7	SENT_198	[p17l727t1324r769b1347],
7	events	NNS	O	event	dep	5	SENT_198	[p17l777t1324r850b1347],
8	)	VBP	O	)	_	0	SENT_198	[p17l777t1324r850b1347],
9	—	CD	NUMBER	—	num	10	SENT_198	[p17l511t1361r538b1363],
10	Noncarriers	NNS	O	noncarrier	dobj	8	SENT_198	[p17l545t1353r671b1374],
11	,	,	O	,	_	0	SENT_198	[p17l545t1353r671b1374],
12	placebo	NN	O	placebo	nn	13	SENT_198	[p17l680t1352r759b1376],
13	(	NN	O	(	appos	10	SENT_198	[p17l769t1353r811b1377],
14	376	CD	NUMBER	376	num	15	SENT_198	[p17l769t1353r811b1377],
15	events	NNS	O	event	npadvmod	16	SENT_198	[p17l819t1353r892b1377],
16	)	JJ	O	)	amod	17	SENT_198	[p17l819t1353r892b1377],
17	ooo	NN	O	ooo	dep	13	SENT_198	[p17l422t1378r472b1399],
18	I	PRP	O	I	dep	21	SENT_198	[p17l488t1391r490b1404],
19	I	PRP	O	I	dep	18	SENT_198	[p17l563t1391r565b1404],
20	I	PRP	O	I	dep	21	SENT_198	[p17l638t1391r640b1404],
21	I	PRP	O	I	dep	23	SENT_198	[p17l787t1389r790b1404],
22	I	PRP	O	I	dep	21	SENT_198	[p17l862t1389r865b1404],
23	I	PRP	O	I	dep	8	SENT_198	[p17l937t1389r940b1404],

1	I	PRP	O	I	_	0	SENT_199	[p17l1012t1389r1015b1404],
2	o	NN	O	o	dep	1	SENT_199	[p17l483t1411r496b1432],
3	50 100 150 200	CD	NUMBER	50 100 150 200	number	4	SENT_199	[p17l768t1411r810b1432],[p17l551t1411r578b1432],
4	250 300 350	CD	NUMBER	250 300 350	dep	2	SENT_199	[p17l993t1411r1035b1432],[p17l843t1411r885b1432],

1	Days	NNS	DURATION	day	_	0	SENT_200	[p17l597t1462r658b1491],
2	after	IN	O	after	_	0	SENT_200	[p17l668t1459r726b1483],
3	Randomization	NN	O	randomization	prep_after	1	SENT_200	[p17l736t1460r927b1483],

1	Composite	NNP	O	Composite	nn	3	SENT_201	[p17l369t1179r399b1318],
2	Outcome	NNP	O	Outcome	nn	3	SENT_201	[p17l370t1050r392b1170],
3	E	NNP	O	E	nsubj	5	SENT_201	[p17l341t987r363b1009],
4	‘	CD	NUMBER	‘	npadvmod	5	SENT_201	[p17l341t987r363b1009],
5	en	IN	O	en	_	0	SENT_201	[p17l340t1011r356b1025],
6	.	.	O	.	_	0	SENT_201	[p17l333t1027r356b1058],

1	E	NN	O	e	_	0	SENT_202	[p17l333t1027r356b1058],
2	.	.	O	.	_	0	SENT_202	[p17l341t1059r356b1068],

1	.	.	O	.	_	0	SENT_203	[p17l341t1059r356b1068],

1	A.	NN	O	a.	_	0	SENT_204	[p17l335t1070r356b1085],
2	-	:	O	-	_	0	SENT_204	[p17l332t1097r356b1111],
3	o	NN	O	o	dep	1	SENT_204	[p17l332t1097r356b1111],
4	:	:	O	:	_	0	SENT_204	[p17l341t1113r356b1127],
5	c	NN	O	c	nn	7	SENT_204	[p17l340t1129r356b1144],
6	U	NNP	O	U	nn	7	SENT_204	[p17l340t1145r356b1158],
7	cu	NNP	O	cu	dep	1	SENT_204	[p17l340t1159r356b1173],
8	in	IN	O	in	_	0	SENT_204	[p17l334t1174r356b1189],
9	E	NNP	O	E	nn	12	SENT_204	[p17l341t1200r356b1222],
10	o	NN	O	o	nn	12	SENT_204	[p17l340t1224r356b1239],
11	LI	NNP	O	LI	nn	12	SENT_204	[p17l332t1240r356b1259],
12	‘	NNP	O	‘	prep_in	7	SENT_204	[p17l332t1240r356b1259],
13	:	:	O	:	_	0	SENT_204	[p17l332t1240r356b1259],
14	E	NN	O	e	nn	15	SENT_204	[p17l341t1269r356b1291],
15	o	NN	O	o	dep	1	SENT_204	[p17l340t1294r356b1309],
16	-5	CD	NUMBER	-5	dep	15	SENT_204	[p17l333t1311r356b1325],
17	on	IN	O	on	_	0	SENT_204	[p17l340t1326r356b1340],
18	2	CD	NUMBER	2	num	19	SENT_204	[p17l340t1341r356b1364],
19	LL	NN	O	ll	prep_on	1	SENT_204	[p17l335t1366r356b1379],

1	No.	NN	O	no.	dep	14	SENT_205	[p17l145t1517r189b1538],
2	at	IN	O	at	_	0	SENT_205	[p17l199t1519r223b1538],
3	Risk	NN	O	risk	nn	4	SENT_205	[p17l233t1515r285b1538],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_205	[p17l144t1553r243b1578],
5	,	,	O	,	_	0	SENT_205	[p17l144t1553r243b1578],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_205	[p17l253t1552r385b1581],
7	651 609 578 510	CD	NUMBER	651 609 578 510	number	8	SENT_205	[p17l701t1553r742b1574],[p17l476t1553r516b1574],
8	450 397 332	CD	NUMBER	450 397 332	num	9	SENT_205	[p17l918t1553r959b1574],[p17l774t1553r817b1574],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_205	[p17l146t1585r434b1614],
10	,	,	O	,	_	0	SENT_205	[p17l146t1585r434b1614],
11	clopidogrel	NN	O	clopidogrel	dep	14	SENT_205	[p17l146t1585r434b1614],
12	1886 1695 1622 1444	CD	NUMBER	1886 1695 1622 1444	num	11	SENT_205	[p17l687t1587r742b1607],[p17l462t1586r517b1607],
13	1248 1091 871	CD	NUMBER	1248 1091 871	num	14	SENT_205	[p17l918t1586r958b1607],[p17l762t1586r816b1607],
14	Carriers	NNS	O	carrier	dep	24	SENT_205	[p17l144t1620r243b1644],
15	,	,	O	,	_	0	SENT_205	[p17l144t1620r243b1644],
16	placebo	NN	O	placebo	appos	14	SENT_205	[p17l254t1618r345b1647],
17	674 599 574 514	CD	NUMBER	674 599 574 514	number	18	SENT_205	[p17l700t1620r742b1640],[p17l476t1620r517b1640],
18	446 389 323	CD	NUMBER	446 389 323	num	19	SENT_205	[p17l918t1620r958b1640],[p17l775t1620r817b1640],
19	Noncarriers	NNS	O	noncarrier	dep	16	SENT_205	[p17l146t1654r292b1678],
20	,	,	O	,	_	0	SENT_205	[p17l146t1654r292b1678],
21	placebo	NN	O	placebo	prep	14	SENT_205	[p17l303t1652r394b1680],
22	1819 1595 1530 1349	CD	NUMBER	1819 1595 1530 1349	dep	21	SENT_205	[p17l687t1654r742b1674],[p17l463t1653r517b1674],
23	11521004	CD	NUMBER	11521004	num	24	SENT_205	[p17l762t1653r884b1674],
24	832	CD	NUMBER	832	_	0	SENT_205	[p17l918t1653r959b1674],

1	B	NNP	O	B	nn	5	SENT_206	[p17l1110t33r1128b58],
2	First	NNP	ORDINAL	First	nn	5	SENT_206	[p17l1153t36r1209b59],
3	Primary	JJ	O	primary	amod	5	SENT_206	[p17l1219t36r1317b66],
4	Composite	NNP	O	Composite	nn	5	SENT_206	[p17l1326t36r1465b66],
5	Outcome	NNP	O	Outcome	_	0	SENT_206	[p17l1474t37r1594b59],
6	According	VBG	O	accord	_	0	SENT_206	[p17l1602t35r1732b66],
7	to	TO	O	to	prepc_according_to	5	SENT_206	[p17l1740t39r1765b59],
8	Gain-of-Function	NNP	O	Gain-of-Function	pobj	5	SENT_206	[p17l1774t35r1991b59],

1	Allele	NN	O	allele	nn	3	SENT_207	[p17l1180t70r1250b94],
2	Carrier	NN	O	carrier	nn	3	SENT_207	[p17l1259t71r1346b94],
3	Status	NN	O	status	_	0	SENT_207	[p17l1354t72r1434b94],
4	1.00	CD	NUMBER	1.00	dep	3	SENT_207	[p17l1420t113r1468b134],

1	0-85	NN	O	0-85	nn	2	SENT_208	[p17l1418t306r1466b327],
2	P	NN	O	p	_	0	SENT_208	[p17l1545t316r1617b334],
3	=	JJ	O	=	amod	2	SENT_208	[p17l1545t316r1617b334],
4	0.06	CD	NUMBER	0.06	tmod	3	SENT_208	[p17l1545t316r1617b334],
5	by	IN	O	by	dep	2	SENT_208	[p17l1626t315r1648b340],
6	log-rank	JJ	O	log-rank	amod	7	SENT_208	[p17l1656t315r1738b340],
7	test	NN	O	test	pobj	5	SENT_208	[p17l1745t319r1783b334],
8	for	IN	O	for	_	0	SENT_208	[p17l1789t315r1818b334],
9	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	10	SENT_208	[p17l1544t344r1737b369],
10	participants	NNS	O	participant	prep_for	7	SENT_208	[p17l1747t346r1866b369],

1	—	NN	O	—	nn	2	SENT_209	[p17l1507t419r1534b422],
2	Carriers	NNS	O	carrier	_	0	SENT_209	[p17l1540t411r1625b432],
3	,	,	O	,	_	0	SENT_209	[p17l1540t411r1625b432],
4	clopidogrel	NN	O	clopidogrel	appos	2	SENT_209	[p17l1634t410r1747b435],
5	(	CD	NUMBER	(	number	6	SENT_209	[p17l1758t411r1788b434],
6	77	CD	NUMBER	77	num	7	SENT_209	[p17l1758t411r1788b434],
7	events	NNS	O	event	dep	2	SENT_209	[p17l1796t411r1869b434],
8	)	IN	O	)	amod	7	SENT_209	[p17l1796t411r1869b434],

1	0-75	CD	NUMBER	0-75	num	3	SENT_210	[p17l1418t434r1466b455],
2	—	CD	NUMBER	—	num	3	SENT_210	[p17l1507t447r1534b451],
3	Noncarriers	NNS	O	noncarrier	_	0	SENT_210	[p17l1541t440r1667b461],
4	,	,	O	,	_	0	SENT_210	[p17l1541t440r1667b461],
5	clopiclogrel	NN	O	clopiclogrel	nn	6	SENT_210	[p17l1676t439r1789b464],
6	(	NN	O	(	appos	3	SENT_210	[p17l1800t440r1841b464],
7	153	CD	NUMBER	153	num	8	SENT_210	[p17l1800t440r1841b464],
8	events	NNS	O	event	dep	3	SENT_210	[p17l1850t440r1923b464],
9	)	IN	O	)	amod	8	SENT_210	[p17l1850t440r1923b464],

1	.	.	O	.	_	0	SENT_211	[p17l1507t469r1625b490],

1	—	NN	O	—	_	0	SENT_212	[p17l1507t469r1625b490],
2	.	.	O	.	_	0	SENT_212	[p17l1507t469r1625b490],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_213	[p17l1507t469r1625b490],
2	,	,	O	,	_	0	SENT_213	[p17l1507t469r1625b490],
3	placebo	NN	O	placebo	nn	4	SENT_213	[p17l1635t468r1713b493],
4	(	NN	O	(	appos	1	SENT_213	[p17l1723t470r1765b493],
5	131	CD	NUMBER	131	num	6	SENT_213	[p17l1723t470r1765b493],
6	events	NNS	O	event	dep	4	SENT_213	[p17l1774t470r1846b493],
7	)	VBP	O	)	_	0	SENT_213	[p17l1774t470r1846b493],
8	—	CD	NUMBER	—	num	9	SENT_213	[p17l1507t506r1534b509],
9	Noncarriers	NNS	O	noncarrier	dobj	7	SENT_213	[p17l1541t499r1667b520],
10	,	,	O	,	_	0	SENT_213	[p17l1541t499r1667b520],
11	placebo	NN	O	placebo	nn	12	SENT_213	[p17l1677t497r1755b522],
12	(	NN	O	(	appos	9	SENT_213	[p17l1765t498r1806b522],
13	181	CD	NUMBER	181	num	14	SENT_213	[p17l1765t498r1806b522],
14	events	NNS	O	event	dep	12	SENT_213	[p17l1815t499r1888b522],
15	)	IN	O	)	prep	7	SENT_213	[p17l1815t499r1888b522],

1	Freedom	NNP	O	Freedom	_	0	SENT_214	[p17l1329t396r1352b507],
2	from	IN	O	from	_	0	SENT_214	[p17l1328t327r1352b386],
3	First	NNP	ORDINAL	First	prep_from	1	SENT_214	[p17l1329t259r1352b314],
4	Primary	JJ	O	primary	amod	6	SENT_214	[p17l1329t150r1360b248],
5	Composite	NNP	O	Composite	nn	6	SENT_214	[p17l1365t325r1395b464],
6	Outcome	NNP	O	Outcome	dep	1	SENT_214	[p17l1366t196r1388b316],

1	Days	NNS	DURATION	day	_	0	SENT_215	[p17l1593t608r1654b636],
2	after	IN	O	after	_	0	SENT_215	[p17l1664t605r1722b629],
3	Randomization	NN	O	randomization	prep_after	1	SENT_215	[p17l1732t605r1924b629],

1	No.	NN	O	no.	_	0	SENT_216	[p17l1141t662r1185b684],
2	at	IN	O	at	_	0	SENT_216	[p17l1195t664r1219b684],
3	Risk	NN	O	risk	nn	4	SENT_216	[p17l1229t660r1281b684],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_216	[p17l1140t699r1239b723],
5	,	,	O	,	_	0	SENT_216	[p17l1140t699r1239b723],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_216	[p17l1249t697r1381b726],
7	1001 960 932 828	CD	NUMBER	1001 960 932 828	number	8	SENT_216	[p17l1696t699r1738b719],[p17l1459t699r1512b719],
8	715 640 513	CD	NUMBER	715 640 513	num	9	SENT_216	[p17l1914t699r1954b719],[p17l1772t699r1811b719],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_216	[p17l1142t730r1430b760],
10	,	,	O	,	_	0	SENT_216	[p17l1142t730r1430b760],
11	c	NN	O	c	nn	13	SENT_216	[p17l1142t730r1430b760],
12	|	NN	O	|	nn	13	SENT_216	[p17l1142t730r1430b760],
13	opidogre	NN	O	opidogre	appos	4	SENT_216	[p17l1142t730r1430b760],
14	|	CD	NUMBER	|	num	17	SENT_216	[p17l1142t730r1430b760],
15	1536 1451 1400 1258	CD	NUMBER	1536 1451 1400 1258	num	17	SENT_216	[p17l1683t732r1738b753],[p17l1459t732r1513b753],
16	1122 977 805	CD	NUMBER	1122 977 805	num	17	SENT_216	[p17l1914t732r1954b753],[p17l1758t732r1812b752],
17	Carriers	NNS	O	carrier	dep	13	SENT_216	[p17l1140t766r1239b790],
18	,	,	O	,	_	0	SENT_216	[p17l1140t766r1239b790],
19	placebo	NN	O	placebo	appos	17	SENT_216	[p17l1251t764r1342b793],
20	1004 926 899 789	CD	NUMBER	1004 926 899 789	number	21	SENT_216	[p17l1697t765r1738b786],[p17l1459t765r1513b786],
21	678 596 494	CD	NUMBER	678 596 494	num	22	SENT_216	[p17l1913t766r1955b786],[p17l1771t765r1812b786],
22	Noncarriers	NNS	O	noncarrier	dep	19	SENT_216	[p17l1142t799r1288b823],
23	,	,	O	,	_	0	SENT_216	[p17l1142t799r1288b823],
24	placebo	NN	O	placebo	dep	1	SENT_216	[p17l1299t797r1390b826],
25	1489 1386 1343 1218	CD	NUMBER	1489 1386 1343 1218	number	26	SENT_216	[p17l1683t799r1738b819],[p17l1459t799r1513b819],
26	1066 931 783	CD	NUMBER	1066 931 783	dep	24	SENT_216	[p17l1915t799r1954b819],[p17l1758t799r1813b819],

1	D	NN	O	d	_	0	SENT_217	[p17l1108t888r1131b913],
2	Second	JJ	ORDINAL	second	amod	4	SENT_217	[p17l1151t890r1244b913],
3	Primary	JJ	O	primary	amod	4	SENT_217	[p17l1256t890r1354b920],
4	Composite	NN	O	composite	nn	5	SENT_217	[p17l1363t890r1502b920],
5	Outcome	NNP	O	Outcome	dep	1	SENT_217	[p17l1511t891r1631b913],
6	According	VBG	O	accord	_	0	SENT_217	[p17l1639t890r1769b920],
7	to	TO	O	to	prepc_according_to	1	SENT_217	[p17l1777t893r1802b913],
8	Gain-of-Function	NNP	O	Gain-of-Function	pobj	1	SENT_217	[p17l1811t889r2027b913],

1	Allele	NN	O	allele	_	0	SENT_218	[p17l1180t925r1250b949],
2	Carrier	NN	O	carrier	nn	3	SENT_218	[p17l1259t926r1346b949],
3	Status	NN	O	status	dep	1	SENT_218	[p17l1354t927r1434b949],

1	1	CD	NUMBER	1	num	2	SENT_219	[p17l1420t968r1468b988],
2	'00	CD	NUMBER	'00	_	0	SENT_219	[p17l1420t968r1468b988],
3	P	NN	O	p	dep	2	SENT_219	[p17l1580t985r1652b1002],
4	=	JJ	O	=	amod	3	SENT_219	[p17l1580t985r1652b1002],
5	0.02	CD	NUMBER	0.02	tmod	4	SENT_219	[p17l1580t985r1652b1002],
6	by	IN	O	by	_	0	SENT_219	[p17l1661t983r1682b1008],
7	log-rank	JJ	O	log-rank	amod	8	SENT_219	[p17l1691t983r1773b1008],
8	test	NN	O	test	prep_by	4	SENT_219	[p17l1779t987r1817b1002],
9	for	IN	O	for	_	0	SENT_219	[p17l1824t983r1853b1002],
10	0-95	CD	NUMBER	0-95	num	12	SENT_219	[p17l1418t1032r1466b1053],
11	clopiclogrel-treated	JJ	O	clopiclogrel-treated	amod	12	SENT_219	[p17l1579t1013r1771b1038],
12	participants	NNS	O	participant	prep_for	3	SENT_219	[p17l1781t1014r1901b1037],

1	.	.	O	.	_	0	SENT_220	[p17l1507t1266r1625b1286],

1	—	NN	O	—	_	0	SENT_221	[p17l1507t1266r1625b1286],
2	.	.	O	.	_	0	SENT_221	[p17l1507t1266r1625b1286],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_222	[p17l1507t1266r1625b1286],
2	,	,	O	,	_	0	SENT_222	[p17l1507t1266r1625b1286],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_222	[p17l1634t1264r1747b1289],
4	(	NN	O	(	appos	1	SENT_222	[p17l1758t1266r1800b1289],
5	142	CD	NUMBER	142	num	6	SENT_222	[p17l1758t1266r1800b1289],
6	events	NNS	O	event	dep	4	SENT_222	[p17l1809t1266r1881b1289],
7	)	VBP	O	)	_	0	SENT_222	[p17l1809t1266r1881b1289],
8	0-75	CD	NUMBER	0-75	num	10	SENT_222	[p17l1418t1289r1466b1310],
9	—	CD	NUMBER	—	num	10	SENT_222	[p17l1507t1302r1534b1306],
10	Noncarriers	NNS	O	noncarrier	dobj	7	SENT_222	[p17l1541t1295r1667b1316],
11	,	,	O	,	_	0	SENT_222	[p17l1541t1295r1667b1316],
12	clopidogrel	NN	O	clopidogrel	nn	13	SENT_222	[p17l1676t1293r1789b1318],
13	(	NN	O	(	appos	10	SENT_222	[p17l1800t1295r1842b1318],
14	276	CD	NUMBER	276	num	15	SENT_222	[p17l1800t1295r1842b1318],
15	events	NNS	O	event	dep	13	SENT_222	[p17l1850t1295r1923b1318],
16	)	IN	O	)	prep	7	SENT_222	[p17l1850t1295r1923b1318],

1	.	.	O	.	_	0	SENT_223	[p17l1507t1324r1625b1345],

1	—	NN	O	—	_	0	SENT_224	[p17l1507t1324r1625b1345],
2	.	.	O	.	_	0	SENT_224	[p17l1507t1324r1625b1345],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_225	[p17l1507t1324r1625b1345],
2	,	,	O	,	_	0	SENT_225	[p17l1507t1324r1625b1345],
3	placebo	NN	O	placebo	nn	4	SENT_225	[p17l1635t1323r1713b1347],
4	(	NN	O	(	appos	1	SENT_225	[p17l1723t1324r1765b1347],
5	202	CD	NUMBER	202	num	6	SENT_225	[p17l1723t1324r1765b1347],
6	events	NNS	O	event	dep	4	SENT_225	[p17l1774t1324r1846b1347],
7	)	VBP	O	)	_	0	SENT_225	[p17l1774t1324r1846b1347],
8	—	CD	NUMBER	—	num	9	SENT_225	[p17l1507t1361r1534b1363],
9	Noncarriers	NNS	O	noncarrier	dobj	7	SENT_225	[p17l1541t1353r1667b1374],
10	,	,	O	,	_	0	SENT_225	[p17l1541t1353r1667b1374],
11	placebo	NN	O	placebo	nn	12	SENT_225	[p17l1677t1352r1755b1376],
12	(	NN	O	(	appos	9	SENT_225	[p17l1765t1353r1807b1377],
13	301	CD	NUMBER	301	num	14	SENT_225	[p17l1765t1353r1807b1377],
14	events	NNS	O	event	dep	18	SENT_225	[p17l1815t1353r1888b1377],
15	)	JJ	O	)	amod	16	SENT_225	[p17l1815t1353r1888b1377],
16	o-oo	NN	O	o-oo	dep	14	SENT_225	[p17l1418t1378r1468b1399],
17	I	PRP	O	I	dep	18	SENT_225	[p17l1559t1391r1561b1404],
18	I	PRP	O	I	dep	20	SENT_225	[p17l1634t1391r1636b1404],
19	I	PRP	O	I	dep	18	SENT_225	[p17l1858t1389r1861b1404],
20	I	PRP	O	I	dep	7	SENT_225	[p17l1933t1389r1936b1404],

1	I	PRP	O	I	_	0	SENT_226	[p17l2008t1389r2011b1404],
2	o	NN	O	o	dep	1	SENT_226	[p17l1479t1411r1492b1432],
3	50 100 150 200	CD	NUMBER	50 100 150 200	number	4	SENT_226	[p17l1764t1391r1806b1432],[p17l1547t1411r1574b1432],
4	250 300 350	CD	NUMBER	250 300 350	dep	2	SENT_226	[p17l1989t1411r2031b1432],[p17l1839t1411r1881b1432],

1	Days	NNS	DURATION	day	_	0	SENT_227	[p17l1593t1462r1655b1491],
2	after	IN	O	after	_	0	SENT_227	[p17l1664t1459r1722b1483],
3	Randomization	NN	O	randomization	prep_after	1	SENT_227	[p17l1733t1460r1924b1483],

1	Freedom	NNP	O	Freedom	_	0	SENT_228	[p17l1319t1269r1343b1379],
2	from	IN	O	from	_	0	SENT_228	[p17l1319t1200r1343b1259],
3	Second	NNP	DURATION	Second	prep_from	1	SENT_228	[p17l1319t1097r1343b1189],
4	Primary	JJ	O	primary	amod	6	SENT_228	[p17l1319t987r1350b1085],
5	Composite	NNP	O	Composite	nn	6	SENT_228	[p17l1356t1179r1385b1318],
6	Outcome	NNP	O	Outcome	dep	1	SENT_228	[p17l1356t1050r1378b1170],

1	No.	NN	O	no.	dep	14	SENT_229	[p17l1141t1517r1185b1538],
2	at	IN	O	at	_	0	SENT_229	[p17l1195t1519r1219b1538],
3	Risk	NN	O	risk	nn	4	SENT_229	[p17l1229t1515r1281b1538],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_229	[p17l1140t1553r1239b1578],
5	,	,	O	,	_	0	SENT_229	[p17l1140t1553r1239b1578],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_229	[p17l1249t1552r1381b1581],
7	1001 919 882 780	CD	NUMBER	1001 919 882 780	number	8	SENT_229	[p17l1697t1553r1738b1574],[p17l1459t1553r1512b1574],
8	664 592 467	CD	NUMBER	664 592 467	num	9	SENT_229	[p17l1913t1553r1955b1574],[p17l1771t1553r1813b1574],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_229	[p17l1142t1585r1430b1614],
10	,	,	O	,	_	0	SENT_229	[p17l1142t1585r1430b1614],
11	clopidogrel	NN	O	clopidogrel	dep	14	SENT_229	[p17l1142t1585r1430b1614],
12	1536 1386 1319 1174	CD	NUMBER	1536 1386 1319 1174	num	11	SENT_229	[p17l1683t1587r1738b1607],[p17l1459t1587r1513b1607],
13	1035 897 736	CD	NUMBER	1035 897 736	num	14	SENT_229	[p17l1915t1587r1955b1607],[p17l1758t1586r1811b1607],
14	Carriers	NNS	O	carrier	_	0	SENT_229	[p17l1140t1620r1239b1644],
15	,	,	O	,	_	0	SENT_229	[p17l1140t1620r1239b1644],
16	placebo	NN	O	placebo	appos	14	SENT_229	[p17l1251t1618r1342b1647],
17	1004 883 851 740	CD	NUMBER	1004 883 851 740	number	18	SENT_229	[p17l1697t1620r1738b1640],[p17l1459t1620r1513b1640],
18	629 551 453	CD	NUMBER	629 551 453	num	19	SENT_229	[p17l1913t1620r1954b1640],[p17l1772t1620r1813b1641],
19	Noncarriers	NNS	O	noncarrier	dep	16	SENT_229	[p17l1142t1654r1288b1678],
20	,	,	O	,	_	0	SENT_229	[p17l1142t1654r1288b1678],
21	placebo	NN	O	placebo	prep	14	SENT_229	[p17l1299t1652r1390b1680],
22	1489 1310 1251 1122	CD	NUMBER	1489 1310 1251 1122	num	23	SENT_229	[p17l1683t1654r1738b1673],[p17l1459t1653r1513b1674],
23	970 842 701	CD	NUMBER	970 842 701	dep	21	SENT_229	[p17l1915t1653r1954b1674],[p17l1771t1653r1813b1674],

1	E	NNP	O	E	nn	2	SENT_230	[p17l115t1742r131b1767],
2	Freedom	NNP	O	Freedom	_	0	SENT_230	[p17l157t1744r268b1768],
3	from	IN	O	from	_	0	SENT_230	[p17l277t1744r337b1768],
4	Major	NNP	O	Major	nn	5	SENT_230	[p17l350t1745r424b1775],
5	Bleeding	NNP	O	Bleeding	prep_from	2	SENT_230	[p17l434t1744r544b1775],
6	According	VBG	O	accord	_	0	SENT_230	[p17l552t1744r682b1775],
7	to	TO	O	to	prepc_according_to	2	SENT_230	[p17l689t1748r715b1768],
8	Loss-of-Function	NNP	O	Loss-of-Function	pobj	2	SENT_230	[p17l726t1744r938b1768],

1	Allele	NN	O	allele	_	0	SENT_231	[p17l184t1779r254b1803],
2	Carrier	NN	O	carrier	nn	3	SENT_231	[p17l263t1780r350b1803],
3	Status	NN	O	status	dep	1	SENT_231	[p17l358t1781r438b1803],

1	1	CD	NUMBER	1	num	2	SENT_232	[p17l424t1822r472b1843],
2	'00	CD	NUMBER	'00	_	0	SENT_232	[p17l424t1822r472b1843],
3	P	NN	O	p	dep	2	SENT_232	[p17l584t1839r655b1857],
4	=	JJ	O	=	amod	3	SENT_232	[p17l584t1839r655b1857],
5	0.21	CD	NUMBER	0.21	tmod	4	SENT_232	[p17l584t1839r655b1857],
6	by	IN	O	by	_	0	SENT_232	[p17l665t1838r686b1863],
7	log-rank	JJ	O	log-rank	amod	8	SENT_232	[p17l694t1838r776b1863],
8	test	NN	O	test	prep_by	4	SENT_232	[p17l783t1841r821b1857],
9	for	IN	O	for	_	0	SENT_232	[p17l828t1838r857b1857],
10	0-95	CD	NUMBER	0-95	num	12	SENT_232	[p17l422t1886r470b1907],
11	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	12	SENT_232	[p17l583t1867r775b1892],
12	participants	NNS	O	participant	prep_for	3	SENT_232	[p17l785t1869r905b1892],

1	.	.	O	.	_	0	SENT_233	[p17l511t2120r629b2141],

1	—	NN	O	—	_	0	SENT_234	[p17l511t2120r629b2141],
2	.	.	O	.	_	0	SENT_234	[p17l511t2120r629b2141],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_235	[p17l511t2120r629b2141],
2	,	,	O	,	_	0	SENT_235	[p17l511t2120r629b2141],
3	clopidogrel	NN	O	clopidogrel	appos	1	SENT_235	[p17l638t2119r751b2144],
4	(	CD	NUMBER	(	number	5	SENT_235	[p17l762t2120r791b2144],
5	21	CD	NUMBER	21	num	6	SENT_235	[p17l762t2120r791b2144],
6	events	NNS	O	event	dep	3	SENT_235	[p17l800t2120r872b2144],
7	)	VBP	O	)	_	0	SENT_235	[p17l800t2120r872b2144],
8	0-75	CD	NUMBER	0-75	num	10	SENT_235	[p17l422t2143r470b2164],
9	—	CD	NUMBER	—	num	10	SENT_235	[p17l511t2156r538b2160],
10	Noncarriers	NNS	O	noncarrier	dobj	7	SENT_235	[p17l545t2150r671b2170],
11	,	,	O	,	_	0	SENT_235	[p17l545t2150r671b2170],
12	clopidogrel	NN	O	clopidogrel	appos	10	SENT_235	[p17l679t2148r793b2173],
13	(	CD	NUMBER	(	number	14	SENT_235	[p17l804t2149r833b2173],
14	81	CD	NUMBER	81	num	15	SENT_235	[p17l804t2149r833b2173],
15	events	NNS	O	event	dep	12	SENT_235	[p17l842t2149r914b2173],
16	)	IN	O	)	prep	7	SENT_235	[p17l842t2149r914b2173],

1	.	.	O	.	_	0	SENT_236	[p17l511t2178r629b2199],

1	—	NN	O	—	_	0	SENT_237	[p17l511t2178r629b2199],
2	.	.	O	.	_	0	SENT_237	[p17l511t2178r629b2199],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_238	[p17l511t2178r629b2199],
2	,	,	O	,	_	0	SENT_238	[p17l511t2178r629b2199],
3	placebo	NN	O	placebo	appos	1	SENT_238	[p17l639t2177r717b2202],
4	(	CD	NUMBER	(	number	5	SENT_238	[p17l727t2179r756b2202],
5	15	CD	NUMBER	15	num	6	SENT_238	[p17l727t2179r756b2202],
6	events	NNS	O	event	dep	3	SENT_238	[p17l765t2179r837b2202],
7	)	VBP	O	)	_	0	SENT_238	[p17l765t2179r837b2202],
8	—	CD	NUMBER	—	num	9	SENT_238	[p17l511t2215r538b2218],
9	Noncarriers	NNS	O	noncarrier	dobj	7	SENT_238	[p17l545t2208r671b2229],
10	,	,	O	,	_	0	SENT_238	[p17l545t2208r671b2229],
11	placebo	NN	O	placebo	appos	9	SENT_238	[p17l680t2206r758b2231],
12	(	CD	NUMBER	(	number	13	SENT_238	[p17l769t2207r799b2231],
13	60	CD	NUMBER	60	num	14	SENT_238	[p17l769t2207r799b2231],
14	events	NNS	O	event	dep	11	SENT_238	[p17l807t2208r879b2231],
15	)	IN	O	)	prep	7	SENT_238	[p17l807t2208r879b2231],

1	Freedom	NNP	O	Freedom	_	0	SENT_239	[p17l370t2120r394b2231],
2	from	IN	O	from	_	0	SENT_239	[p17l370t2051r394b2111],
3	Major	NNP	O	Major	nn	4	SENT_239	[p17l371t1964r401b2038],
4	Bleeding	NNP	O	Bleeding	prep_from	1	SENT_239	[p17l370t1844r401b1954],

1	Days	NNS	DURATION	day	_	0	SENT_240	[p17l597t2317r658b2345],
2	after	IN	O	after	_	0	SENT_240	[p17l668t2314r726b2338],
3	Randomization	NN	O	randomization	prep_after	1	SENT_240	[p17l736t2314r927b2338],

1	No.	NN	O	no.	_	0	SENT_241	[p17l145t2371r189b2393],
2	at	IN	O	at	_	0	SENT_241	[p17l199t2373r223b2393],
3	Risk	NN	O	risk	nn	4	SENT_241	[p17l233t2369r285b2393],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_241	[p17l144t2408r243b2432],
5	,	,	O	,	_	0	SENT_241	[p17l144t2408r243b2432],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_241	[p17l253t2406r385b2435],
7	651 630 613 548	CD	NUMBER	651 630 613 548	number	8	SENT_241	[p17l700t2408r742b2428],[p17l476t2408r516b2428],
8	485 426 362	CD	NUMBER	485 426 362	num	9	SENT_241	[p17l918t2408r959b2428],[p17l774t2408r815b2428],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_241	[p17l146t2440r434b2469],
10	,	,	O	,	_	0	SENT_241	[p17l146t2440r434b2469],
11	c	NN	O	c	nn	13	SENT_241	[p17l146t2440r434b2469],
12	|	NN	O	|	nn	13	SENT_241	[p17l146t2440r434b2469],
13	opidogrel	NN	O	opidogrel	appos	4	SENT_241	[p17l146t2440r434b2469],
14	1886 1782 1726 1549	CD	NUMBER	1886 1782 1726 1549	number	15	SENT_241	[p17l687t2441r742b2462],[p17l462t2441r517b2462],
15	1365 1198 971	CD	NUMBER	1365 1198 971	num	16	SENT_241	[p17l918t2441r958b2462],[p17l762t2441r815b2462],
16	Carriers	NNS	O	carrier	dep	13	SENT_241	[p17l144t2475r243b2499],
17	,	,	O	,	_	0	SENT_241	[p17l144t2475r243b2499],
18	placebo	NN	O	placebo	appos	4	SENT_241	[p17l254t2473r345b2502],
19	674 647 633 577	CD	NUMBER	674 647 633 577	number	20	SENT_241	[p17l701t2475r742b2495],[p17l476t2475r517b2495],
20	504 444 371	CD	NUMBER	504 444 371	num	21	SENT_241	[p17l918t2475r958b2495],[p17l775t2474r817b2495],
21	Noncarriers	NNS	O	noncarrier	dep	18	SENT_241	[p17l146t2508r292b2532],
22	,	,	O	,	_	0	SENT_241	[p17l146t2508r292b2532],
23	placebo	NN	O	placebo	appos	4	SENT_241	[p17l303t2506r394b2535],
24	1819 1737 1693 1513	CD	NUMBER	1819 1737 1693 1513	number	25	SENT_241	[p17l687t2508r740b2528],[p17l463t2508r517b2528],
25	1314 1146 954	CD	NUMBER	1314 1146 954	dep	23	SENT_241	[p17l918t2508r959b2528],[p17l762t2508r817b2528],

1	F	NN	O	f	nn	2	SENT_242	[p17l1112t1742r1127b1767],
2	Freedom	NN	O	freedom	_	0	SENT_242	[p17l1153t1744r1264b1768],
3	from	IN	O	from	_	0	SENT_242	[p17l1273t1744r1333b1768],
4	Major	JJ	O	major	amod	5	SENT_242	[p17l1346t1745r1420b1775],
5	Bleeding	NNP	O	Bleeding	prep_from	2	SENT_242	[p17l1430t1744r1540b1775],
6	According	VBG	O	accord	_	0	SENT_242	[p17l1548t1744r1678b1775],
7	to	TO	O	to	prepc_according_to	2	SENT_242	[p17l1685t1748r1711b1768],
8	Gain-of-Function	NNP	O	Gain-of-Function	pobj	2	SENT_242	[p17l1720t1744r1936b1768],

1	Allele	NN	O	allele	_	0	SENT_243	[p17l1180t1779r1250b1803],
2	Carrier	NN	O	carrier	nn	3	SENT_243	[p17l1259t1780r1346b1803],
3	Status	NN	O	status	dep	1	SENT_243	[p17l1354t1781r1434b1803],

1	1	CD	NUMBER	1	number	2	SENT_244	[p17l1420t1822r1468b1843],
2	'00	CD	NUMBER	'00	num	3	SENT_244	[p17l1420t1822r1468b1843],
3	P	NN	O	p	_	0	SENT_244	[p17l1580t1839r1652b1857],
4	=	JJ	O	=	amod	3	SENT_244	[p17l1580t1839r1652b1857],
5	0.86	CD	NUMBER	0.86	tmod	4	SENT_244	[p17l1580t1839r1652b1857],
6	by	IN	O	by	_	0	SENT_244	[p17l1661t1838r1682b1863],
7	log	NN	O	log	nn	9	SENT_244	[p17l1691t1838r1772b1863],
8	~	NN	O	~	nn	9	SENT_244	[p17l1691t1838r1772b1863],
9	ranl	NN	O	ranl	prep_by	4	SENT_244	[p17l1691t1838r1772b1863],
10	<	JJR	O	<	amod	11	SENT_244	[p17l1691t1838r1772b1863],
11	test	NN	O	test	dep	3	SENT_244	[p17l1779t1842r1817b1857],
12	for	IN	O	for	_	0	SENT_244	[p17l1824t1838r1853b1857],
13	0.95	CD	NUMBER	0.95	num	15	SENT_244	[p17l1418t1886r1466b1907],
14	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	15	SENT_244	[p17l1579t1867r1771b1892],
15	participants	NNS	O	participant	prep_for	11	SENT_244	[p17l1781t1869r1901b1892],

1	.	.	O	.	_	0	SENT_245	[p17l1507t2120r1625b2141],

1	—	NN	O	—	_	0	SENT_246	[p17l1507t2120r1625b2141],
2	.	.	O	.	_	0	SENT_246	[p17l1507t2120r1625b2141],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_247	[p17l1507t2120r1625b2141],
2	,	,	O	,	_	0	SENT_247	[p17l1507t2120r1625b2141],
3	clopiclogrel	NN	O	clopiclogrel	appos	1	SENT_247	[p17l1634t2119r1747b2144],
4	(	CD	NUMBER	(	number	5	SENT_247	[p17l1758t2120r1787b2144],
5	41	CD	NUMBER	41	num	6	SENT_247	[p17l1758t2120r1787b2144],
6	events	NNS	O	event	dep	3	SENT_247	[p17l1796t2120r1868b2144],
7	)	VBP	O	)	_	0	SENT_247	[p17l1796t2120r1868b2144],
8	0-75	CD	NUMBER	0-75	num	10	SENT_247	[p17l1418t2143r1466b2164],
9	—	CD	NUMBER	—	num	10	SENT_247	[p17l1507t2157r1534b2160],
10	Nor1carriers	NNS	O	nor1carrier	dobj	7	SENT_247	[p17l1541t2148r1789b2173],
11	,	,	O	,	_	0	SENT_247	[p17l1541t2148r1789b2173],
12	clopidogrel	NN	O	clopidogrel	appos	10	SENT_247	[p17l1541t2148r1789b2173],
13	(	CD	NUMBER	(	number	14	SENT_247	[p17l1800t2149r1829b2173],
14	61	CD	NUMBER	61	num	15	SENT_247	[p17l1800t2149r1829b2173],
15	events	NNS	O	event	dep	12	SENT_247	[p17l1838t2149r1910b2173],
16	)	IN	O	)	prep	7	SENT_247	[p17l1838t2149r1910b2173],

1	—	NN	O	—	nn	2	SENT_248	[p17l1507t2186r1534b2189],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_248	[p17l1540t2178r1625b2199],
3	,	,	O	,	_	0	SENT_248	[p17l1540t2178r1625b2199],
4	placebo	NN	O	placebo	appos	2	SENT_248	[p17l1635t2177r1713b2202],
5	(	CD	NUMBER	(	number	6	SENT_248	[p17l1723t2179r1753b2202],
6	32	CD	NUMBER	32	num	7	SENT_248	[p17l1723t2179r1753b2202],
7	events	NNS	O	event	dep	4	SENT_248	[p17l1761t2179r1834b2202],
8	)	VBP	O	)	_	0	SENT_248	[p17l1761t2179r1834b2202],
9	—	CD	NUMBER	—	num	10	SENT_248	[p17l1507t2215r1534b2218],
10	Noncarriers	NNS	O	noncarrier	dobj	8	SENT_248	[p17l1541t2208r1667b2229],
11	,	,	O	,	_	0	SENT_248	[p17l1541t2208r1667b2229],
12	placebo	NN	O	placebo	appos	10	SENT_248	[p17l1677t2206r1755b2231],
13	(	CD	NUMBER	(	number	14	SENT_248	[p17l1765t2208r1794b2231],
14	43	CD	NUMBER	43	num	15	SENT_248	[p17l1765t2208r1794b2231],
15	events	NNS	O	event	dep	12	SENT_248	[p17l1803t2208r1875b2231],
16	)	IN	O	)	prep	8	SENT_248	[p17l1803t2208r1875b2231],

1	Freedom	NNP	O	Freedom	_	0	SENT_249	[p17l1366t2120r1390b2231],
2	from	IN	O	from	_	0	SENT_249	[p17l1366t2051r1390b2111],
3	Major	NNP	O	Major	nn	4	SENT_249	[p17l1367t1964r1397b2038],
4	Bleeding	NNP	O	Bleeding	prep_from	1	SENT_249	[p17l1366t1844r1397b1954],

1	Days	NNS	DURATION	day	_	0	SENT_250	[p17l1593t2317r1654b2345],
2	after	IN	O	after	_	0	SENT_250	[p17l1664t2314r1722b2338],
3	Randomization	NN	O	randomization	prep_after	1	SENT_250	[p17l1732t2314r1924b2338],

1	No.	NN	O	no.	_	0	SENT_251	[p17l1141t2371r1185b2393],
2	at	IN	O	at	_	0	SENT_251	[p17l1195t2373r1219b2393],
3	Risk	NN	O	risk	nn	4	SENT_251	[p17l1229t2369r1281b2393],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_251	[p17l1140t2408r1239b2432],
5	,	,	O	,	_	0	SENT_251	[p17l1140t2408r1239b2432],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_251	[p17l1249t2406r1381b2435],
7	1001 957 929 828	CD	NUMBER	1001 957 929 828	number	8	SENT_251	[p17l1696t2408r1738b2428],[p17l1459t2408r1512b2428],
8	718 637 512	CD	NUMBER	718 637 512	num	9	SENT_251	[p17l1914t2408r1955b2428],[p17l1772t2408r1812b2428],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_251	[p17l1142t2440r1430b2469],
10	,	,	O	,	_	0	SENT_251	[p17l1142t2440r1430b2469],
11	c	NN	O	c	nn	13	SENT_251	[p17l1142t2440r1430b2469],
12	|	NN	O	|	nn	13	SENT_251	[p17l1142t2440r1430b2469],
13	opidogrel	NN	O	opidogrel	appos	4	SENT_251	[p17l1142t2440r1430b2469],
14	1536 1456 1411 1269	CD	NUMBER	1536 1456 1411 1269	number	15	SENT_251	[p17l1683t2441r1738b2462],[p17l1459t2441r1513b2462],
15	1133 988 821	CD	NUMBER	1133 988 821	num	16	SENT_251	[p17l1914t2441r1954b2462],[p17l1758t2441r1811b2462],
16	Carriers	NNS	O	carrier	dep	13	SENT_251	[p17l1140t2475r1239b2499],
17	,	,	O	,	_	0	SENT_251	[p17l1140t2475r1239b2499],
18	placebo	NN	O	placebo	appos	4	SENT_251	[p17l1251t2473r1342b2502],
19	1004 957 938 827	CD	NUMBER	1004 957 938 827	number	20	SENT_251	[p17l1696t2474r1738b2495],[p17l1459t2474r1513b2495],
20	715 625 517	CD	NUMBER	715 625 517	num	21	SENT_251	[p17l1914t2475r1955b2495],[p17l1772t2475r1811b2495],
21	Noncarriers	NNS	O	noncarrier	dep	18	SENT_251	[p17l1142t2508r1288b2532],
22	,	,	O	,	_	0	SENT_251	[p17l1142t2508r1288b2532],
23	placebo	NN	O	placebo	appos	4	SENT_251	[p17l1299t2506r1390b2535],
24	1489 1427 1388 1264	CD	NUMBER	1489 1427 1388 1264	number	25	SENT_251	[p17l1683t2508r1738b2528],[p17l1459t2508r1513b2528],
25	1106 967 807	CD	NUMBER	1106 967 807	dep	23	SENT_251	[p17l1914t2508r1955b2528],[p17l1758t2508r1813b2528],

1	NENGL	NN	O	nengl	nn	3	SENT_252	[p17l883t2653r990b2675],
2	)	CD	NUMBER	)	num	3	SENT_252	[p17l883t2653r990b2675],
3	MED363	NN	O	med363	_	0	SENT_252	[p17l1004t2647r1143b2675],
4	;	:	O	;	_	0	SENT_252	[p17l1004t2647r1143b2675],
5	18	CD	NUMBER	18	num	6	SENT_252	[p17l1004t2647r1143b2675],
6	NE	NNS	O	ne	dep	3	SENT_252	[p17l1178t2653r1302b2675],
7	)	VBP	O	)	rcmod	6	SENT_252	[p17l1178t2653r1302b2675],
8	M.ORG	NN	O	m.org	nn	9	SENT_252	[p17l1178t2653r1302b2675],
9	ocTo3ER28	NN	O	octo3er28	nsubj	15	SENT_252	[p17l1337t2647r1567b2673],
10	,2	CD	NUMBER	,2	num	11	SENT_252	[p17l1337t2647r1567b2673],
11	o1o	NN	O	o1o	dep	9	SENT_252	[p17l1337t2647r1567b2673],
12	The	DT	O	the	det	15	SENT_252	[p17l881t2686r932b2710],
13	New	NNP	O	New	nn	15	SENT_252	[p17l941t2687r1003b2710],
14	England	NNP	O	England	nn	15	SENT_252	[p17l1012t2686r1123b2717],
15	Journal	NNP	O	Journal	xcomp	7	SENT_252	[p17l1132t2686r1229b2710],
16	of	IN	O	of	_	0	SENT_252	[p17l1239t2686r1268b2710],
17	Medicine	NNP	O	Medicine	prep_of	15	SENT_252	[p17l1274t2686r1399b2710],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_253	[p17l649t2874r770b2894],
2	GENOTYPE	NN	O	genotype	dep	1	SENT_253	[p17l785t2874r958b2893],
3	AND	CC	O	and	_	0	SENT_253	[p17l971t2874r1043b2893],
4	CLOPIDOGREL	NN	O	clopidogrel	nn	5	SENT_253	[p17l1057t2874r1294b2893],
5	TREATMENT	NN	O	treatment	dep	1	SENT_253	[p17l1306t2874r1511b2893],

1	Figure	NN	O	figure	_	0	SENT_254	[p18l83t174r301b256],
2	2	CD	NUMBER	2	number	3	SENT_254	[p18l328t179r367b236],
3	(	CD	NUMBER	(	dep	1	SENT_254	[p18l399t171r637b258],
4	facing	VBG	O	face	partmod	1	SENT_254	[p18l399t171r637b258],
5	page	NN	O	page	nn	6	SENT_254	[p18l666t179r877b258],
6	)	NN	O	)	dobj	4	SENT_254	[p18l666t179r877b258],
7	.	.	O	.	_	0	SENT_254	[p18l666t179r877b258],

1	Kap	NN	O	kap	_	0	SENT_255	[p18l911t172r1410b256],
2	|	CD	NUMBER	|	num	1	SENT_255	[p18l911t172r1410b256],
3	an	DT	O	a	dep	1	SENT_255	[p18l911t172r1410b256],
4	.	.	O	.	_	0	SENT_255	[p18l911t172r1410b256],

1	—	NN	O	—	_	0	SENT_256	[p18l911t172r1410b256],
2	.	.	O	.	_	0	SENT_256	[p18l911t172r1410b256],

1	Meier	NNP	O	Meier	nn	2	SENT_257	[p18l911t172r1410b256],
2	Curves	NNP	O	Curves	_	0	SENT_257	[p18l1435t177r1679b237],
3	for	IN	O	for	_	0	SENT_257	[p18l1706t171r1807b237],
4	Eventfree	NNP	O	Eventfree	nn	5	SENT_257	[p18l1837t179r2052b237, p18l76t279r213b344],
5	Survival	NNP	O	Survival	prep_for	2	SENT_257	[p18l239t279r521b344],
6	According	VBG	O	accord	_	0	SENT_257	[p18l550t279r911b364],
7	to	TO	O	to	prepc_according_to	5	SENT_257	[p18l934t291r1004b344],
8	CYP2C19	NN	O	cyp2c19	nn	9	SENT_257	[p18l1032t284r1361b344],
9	Loss-of-Function	NN	O	loss-of-function	pobj	5	SENT_257	[p18l1392t279r1986b344],
10	and	CC	O	and	_	0	SENT_257	[p18l79t388r206b452],
11	Gain-of-Function	NNP	O	Gain-of-Function	nn	14	SENT_257	[p18l236t386r840b452],
12	Allele	NN	O	allele	nn	14	SENT_257	[p18l869t388r1066b452],
13	Carrier	NN	O	carrier	nn	14	SENT_257	[p18l1093t389r1338b452],
14	Status	NN	O	status	pobj	5	SENT_257	[p18l1362t393r1585b452],
15	among	IN	O	among	_	0	SENT_257	[p18l1614t409r1861b472],
16	European	JJ	MISC	european	amod	20	SENT_257	[p18l1891t393r2076b452, p18l81t517r247b579],
17	and	CC	O	and	_	0	SENT_257	[p18l279t495r406b559],
18	Latin	JJ	MISC	latin	conj_and	16	SENT_257	[p18l441t496r609b559],
19	American	JJ	MISC	american	amod	20	SENT_257	[p18l638t496r977b559],
20	Patients	NNS	O	patient	prep_among	2	SENT_257	[p18l1013t496r1297b559],
21	with	IN	O	with	_	0	SENT_257	[p18l1324t495r1475b559],
22	Acute	JJ	O	acute	amod	24	SENT_257	[p18l1503t501r1707b559],
23	Coronary	JJ	O	coronary	amod	24	SENT_257	[p18l1734t500r2062b580],
24	Syndromes	NNS	O	syndrome	prep_with	2	SENT_257	[p18l78t602r475b687],
25	in	IN	O	in	_	0	SENT_257	[p18l506t604r564b665],
26	the	DT	O	the	det	28	SENT_257	[p18l593t602r707b667],
27	CURE	NN	O	cure	nn	28	SENT_257	[p18l734t607r938b667],
28	Trial	NN	O	trial	prep_in	2	SENT_257	[p18l965t602r1138b667],
29	.	.	O	.	_	0	SENT_257	[p18l965t602r1138b667],

1	Loss-of-function	JJ	O	loss-of-function	dep	115	SENT_258	[p18l85t731r651b796],
2	allele	NN	O	allele	dep	115	SENT_258	[p18l684t731r860b796],
3	carriers	NNS	O	carrier	dep	115	SENT_258	[p18l888t737r1148b796],
4	were	VBD	O	be	dep	115	SENT_258	[p18l1175t754r1340b796],
5	defined	VBN	O	define	dep	115	SENT_258	[p18l1368t731r1629b796],
6	as	IN	O	as	dep	115	SENT_258	[p18l1662t754r1732b796],
7	patients	NNS	O	patient	dep	115	SENT_258	[p18l1765t737r2041b815],
8	with	IN	O	with	dep	115	SENT_258	[p18l77t839r221b904],
9	at	IN	O	at	dep	115	SENT_258	[p18l254t851r316b904],
10	least	JJS	O	least	dep	115	SENT_258	[p18l346t839r505b904],
11	one	CD	NUMBER	one	dep	115	SENT_258	[p18l532t861r659b904],
12	loss-of-function	NN	O	loss-of-function	dep	115	SENT_258	[p18l690t838r1236b904],
13	allele	NN	O	allele	dep	115	SENT_258	[p18l1269t839r1445b904],
14	(	CD	NUMBER	(	dep	115	SENT_258	[p18l1481t844r1620b923],
15	i.e.	FW	O	i.e.	dep	115	SENT_258	[p18l1481t844r1620b923],
16	,	,	O	,	_	0	SENT_258	[p18l1481t844r1620b923],
17	*	NN	O	*	dep	115	SENT_258	[p18l1650t844r1730b902],
18	2	CD	NUMBER	2	dep	115	SENT_258	[p18l1650t844r1730b902],
19	or	CC	O	or	dep	115	SENT_258	[p18l1760t861r1831b904],
20	*	CD	NUMBER	*	dep	115	SENT_258	[p18l1855t844r1979b923],
21	3	CD	NUMBER	3	dep	115	SENT_258	[p18l1855t844r1979b923],
22	)	NN	O	)	dep	115	SENT_258	[p18l1855t844r1979b923],
23	:	:	O	:	_	0	SENT_258	[p18l1855t844r1979b923],
24	7	CD	NUMBER	7	dep	115	SENT_258	[p18l78t952r291b1031],
25	'	''	O	'	_	0	SENT_258	[p18l78t952r291b1031],
26	:	:	O	:	_	0	SENT_258	[p18l78t952r291b1031],
27	]	CD	NUMBER	]	dep	115	SENT_258	[p18l78t952r291b1031],
28	_	CD	NUMBER	_	dep	115	SENT_258	[p18l78t952r291b1031],
29	/	:	O	/	dep	115	SENT_258	[p18l78t952r291b1031],
30	:	:	O	:	_	0	SENT_258	[p18l78t952r291b1031],
31	'	''	O	'	_	0	SENT_258	[p18l78t952r291b1031],
32	:2	CD	NUMBER	:2	dep	115	SENT_258	[p18l78t952r291b1031],
33	,	,	O	,	_	0	SENT_258	[p18l78t952r291b1031],
34	7	CD	NUMBER	7	dep	115	SENT_258	[p18l320t951r530b1031],
35	'	''	O	'	_	0	SENT_258	[p18l320t951r530b1031],
36	<	JJR	O	<	dep	115	SENT_258	[p18l320t951r530b1031],
37	]	CD	NUMBER	]	dep	115	SENT_258	[p18l320t951r530b1031],
38	_	NN	O	_	dep	115	SENT_258	[p18l320t951r530b1031],
39	/	:	O	/	dep	115	SENT_258	[p18l320t951r530b1031],
40	*	CD	NUMBER	*	dep	115	SENT_258	[p18l320t951r530b1031],
41	3	CD	NUMBER	3	dep	115	SENT_258	[p18l320t951r530b1031],
42	,	,	O	,	_	0	SENT_258	[p18l320t951r530b1031],
43	*	CD	NUMBER	*	dep	115	SENT_258	[p18l560t952r780b1031],
44	2/7	CD	NUMBER	2/7	dep	115	SENT_258	[p18l560t952r780b1031],
45	'	''	O	'	_	0	SENT_258	[p18l560t952r780b1031],
46	:2	CD	NUMBER	:2	dep	115	SENT_258	[p18l560t952r780b1031],
47	,	,	O	,	_	0	SENT_258	[p18l560t952r780b1031],
48	7	CD	NUMBER	7	dep	115	SENT_258	[p18l809t951r1026b1031],
49	'	''	O	'	_	0	SENT_258	[p18l809t951r1026b1031],
50	:2	CD	NUMBER	:2	dep	115	SENT_258	[p18l809t951r1026b1031],
51	/	:	O	/	dep	115	SENT_258	[p18l809t951r1026b1031],
52	*	CD	NUMBER	*	dep	115	SENT_258	[p18l809t951r1026b1031],
53	3	CD	NUMBER	3	dep	115	SENT_258	[p18l809t951r1026b1031],
54	,	,	O	,	_	0	SENT_258	[p18l809t951r1026b1031],
55	7	CD	NUMBER	7	dep	115	SENT_258	[p18l1056t951r1267b1031],
56	'	''	O	'	_	0	SENT_258	[p18l1056t951r1267b1031],
57	<	JJR	O	<	dep	115	SENT_258	[p18l1056t951r1267b1031],
58	3/9	CD	NUMBER	3/9	dep	115	SENT_258	[p18l1056t951r1267b1031],
59	:3	NN	O	:3	dep	115	SENT_258	[p18l1056t951r1267b1031],
60	,	,	O	,	_	0	SENT_258	[p18l1056t951r1267b1031],
61	*	NN	O	*	dep	115	SENT_258	[p18l1297t952r1543b1031],
62	2	CD	NUMBER	2	dep	115	SENT_258	[p18l1297t952r1543b1031],
63	/	:	O	/	dep	115	SENT_258	[p18l1297t952r1543b1031],
64	=	JJ	O	=	dep	115	SENT_258	[p18l1297t952r1543b1031],
65	'	''	O	'	_	0	SENT_258	[p18l1297t952r1543b1031],
66	<	JJR	O	<	dep	115	SENT_258	[p18l1297t952r1543b1031],
67	]	CD	NUMBER	]	dep	115	SENT_258	[p18l1297t952r1543b1031],
68	_	NN	O	_	dep	115	SENT_258	[p18l1297t952r1543b1031],
69	7	CD	NUMBER	7	dep	115	SENT_258	[p18l1297t952r1543b1031],
70	’	NN	O	’	dep	115	SENT_258	[p18l1297t952r1543b1031],
71	or	CC	O	or	dep	115	SENT_258	[p18l1575t969r1647b1011],
72	9:3	CD	NUMBER	9:3	dep	115	SENT_258	[p18l1671t951r1916b1031],
73	/	:	O	/	dep	115	SENT_258	[p18l1671t951r1916b1031],
74	7	CD	NUMBER	7	dep	115	SENT_258	[p18l1671t951r1916b1031],
75	'	''	O	'	_	0	SENT_258	[p18l1671t951r1916b1031],
76	<	JJR	O	<	dep	115	SENT_258	[p18l1671t951r1916b1031],
77	]	CD	NUMBER	]	dep	115	SENT_258	[p18l1671t951r1916b1031],
78	_	NN	O	_	dep	115	SENT_258	[p18l1671t951r1916b1031],
79	7	CD	NUMBER	7	dep	115	SENT_258	[p18l1671t951r1916b1031],
80	;	:	O	;	_	0	SENT_258	[p18l1671t951r1916b1031],
81	loss-of-function	JJ	O	loss-of-function	dep	115	SENT_258	[p18l83t1053r629b1118],
82	noncarriers	NNS	O	noncarrier	dep	115	SENT_258	[p18l665t1060r1061b1118],
83	were	VBD	O	be	dep	115	SENT_258	[p18l1088t1076r1252b1118],
84	defined	VBN	O	define	dep	115	SENT_258	[p18l1280t1053r1541b1118],
85	as	IN	O	as	dep	115	SENT_258	[p18l1574t1076r1644b1118],
86	patients	NNS	O	patient	dep	115	SENT_258	[p18l1677t1060r1954b1137],
87	with	IN	O	with	dep	115	SENT_258	[p18l77t1161r221b1226],
88	no	DT	O	no	dep	115	SENT_258	[p18l257t1184r339b1226],
89	loss-of-function	JJ	O	loss-of-function	dep	115	SENT_258	[p18l371t1160r917b1226],
90	allele	NN	O	allele	dep	115	SENT_258	[p18l950t1161r1145b1226],
91	:	:	O	:	_	0	SENT_258	[p18l950t1161r1145b1226],
92	*	CD	NUMBER	*	dep	115	SENT_258	[p18l1174t1167r1379b1246],
93	1	CD	NUMBER	1	dep	115	SENT_258	[p18l1174t1167r1379b1246],
94	/	:	O	/	dep	115	SENT_258	[p18l1174t1167r1379b1246],
95	*	CD	NUMBER	*	dep	115	SENT_258	[p18l1174t1167r1379b1246],
96	1	CD	NUMBER	1	dep	115	SENT_258	[p18l1174t1167r1379b1246],
97	,	,	O	,	_	0	SENT_258	[p18l1174t1167r1379b1246],
98	*	CD	NUMBER	*	dep	115	SENT_258	[p18l1409t1167r1649b1246],
99	1	CD	NUMBER	1	dep	115	SENT_258	[p18l1409t1167r1649b1246],
100	/	:	O	/	dep	115	SENT_258	[p18l1409t1167r1649b1246],
101	"	``	O	"	dep	115	SENT_258	[p18l1409t1167r1649b1246],
102	'	''	O	'	_	0	SENT_258	[p18l1409t1167r1649b1246],
103	\	SYM	O	\	dep	115	SENT_258	[p18l1409t1167r1649b1246],
104	‘	CD	NUMBER	‘	dep	115	SENT_258	[p18l1409t1167r1649b1246],
105	17	CD	NUMBER	17	dep	115	SENT_258	[p18l1409t1167r1649b1246],
106	,	,	O	,	_	0	SENT_258	[p18l1409t1167r1649b1246],
107	or	CC	O	or	dep	115	SENT_258	[p18l1680t1184r1751b1226],
108	*	NN	O	*	dep	115	SENT_258	[p18l1775t1167r2051b1246],
109	17	CD	NUMBER	17	dep	115	SENT_258	[p18l1775t1167r2051b1246],
110	/	:	O	/	dep	115	SENT_258	[p18l1775t1167r2051b1246],
111	"	``	O	"	dep	115	SENT_258	[p18l1775t1167r2051b1246],
112	'	''	O	'	_	0	SENT_258	[p18l1775t1167r2051b1246],
113	~	FW	O	~	dep	115	SENT_258	[p18l1775t1167r2051b1246],
114	‘	FW	O	‘	dep	115	SENT_258	[p18l1775t1167r2051b1246],
115	17	CD	NUMBER	17	_	0	SENT_258	[p18l1775t1167r2051b1246],
116	.	.	O	.	_	0	SENT_258	[p18l1775t1167r2051b1246],

1	Gain-of-function	NN	O	gain-of-function	dep	122	SENT_259	[p18l80t1268r656b1333],
2	carriers	NNS	O	carrier	dep	122	SENT_259	[p18l688t1275r949b1333],
3	were	VBD	O	be	dep	122	SENT_259	[p18l976t1292r1140b1333],
4	defined	VBN	O	define	dep	122	SENT_259	[p18l1168t1268r1429b1333],
5	as	IN	O	as	dep	122	SENT_259	[p18l1462t1292r1532b1333],
6	carriers	NNS	O	carrier	dep	122	SENT_259	[p18l1562t1275r1822b1333],
7	of	IN	O	of	dep	122	SENT_259	[p18l1851t1268r1928b1333],
8	at	IN	O	at	dep	122	SENT_259	[p18l1944t1281r2005b1333],
9	least	JJS	O	least	dep	122	SENT_259	[p18l83t1376r242b1440],
10	one	CD	NUMBER	one	dep	122	SENT_259	[p18l269t1399r396b1440],
11	gain-of-function	NN	O	gain-of-function	dep	122	SENT_259	[p18l425t1375r985b1461],
12	allele	NN	O	allele	dep	122	SENT_259	[p18l1017t1376r1194b1440],
13	(	CD	NUMBER	(	dep	122	SENT_259	[p18l1229t1382r1368b1461],
14	i.e.	FW	O	i.e.	dep	122	SENT_259	[p18l1229t1382r1368b1461],
15	,	,	O	,	_	0	SENT_259	[p18l1229t1382r1368b1461],
16	"	``	O	"	dep	122	SENT_259	[p18l1398t1382r1563b1461],
17	'	''	O	'	_	0	SENT_259	[p18l1398t1382r1563b1461],
18	~	FW	O	~	dep	122	SENT_259	[p18l1398t1382r1563b1461],
19	’	FW	O	’	dep	122	SENT_259	[p18l1398t1382r1563b1461],
20	17	CD	NUMBER	17	dep	122	SENT_259	[p18l1398t1382r1563b1461],
21	)	CD	NUMBER	)	dep	122	SENT_259	[p18l1398t1382r1563b1461],
22	:	:	O	:	_	0	SENT_259	[p18l1398t1382r1563b1461],
23	"	``	O	"	dep	122	SENT_259	[p18l1592t1382r1831b1461],
24	'	''	O	'	_	0	SENT_259	[p18l1592t1382r1831b1461],
25	~	FW	O	~	dep	122	SENT_259	[p18l1592t1382r1831b1461],
26	‘	FW	O	‘	dep	122	SENT_259	[p18l1592t1382r1831b1461],
27	1	CD	NUMBER	1	dep	122	SENT_259	[p18l1592t1382r1831b1461],
28	/	:	O	/	dep	122	SENT_259	[p18l1592t1382r1831b1461],
29	"	``	O	"	dep	122	SENT_259	[p18l1592t1382r1831b1461],
30	'	''	O	'	_	0	SENT_259	[p18l1592t1382r1831b1461],
31	~	FW	O	~	dep	122	SENT_259	[p18l1592t1382r1831b1461],
32	‘	FW	O	‘	dep	122	SENT_259	[p18l1592t1382r1831b1461],
33	17	CD	NUMBER	17	dep	122	SENT_259	[p18l1592t1382r1831b1461],
34	,	,	O	,	_	0	SENT_259	[p18l1592t1382r1831b1461],
35	"	``	O	"	dep	122	SENT_259	[p18l78t1489r354b1568],
36	'	''	O	'	_	0	SENT_259	[p18l78t1489r354b1568],
37	~	FW	O	~	dep	122	SENT_259	[p18l78t1489r354b1568],
38	‘	FW	O	‘	dep	122	SENT_259	[p18l78t1489r354b1568],
39	17	CD	NUMBER	17	dep	122	SENT_259	[p18l78t1489r354b1568],
40	/	:	O	/	dep	122	SENT_259	[p18l78t1489r354b1568],
41	"	``	O	"	dep	122	SENT_259	[p18l78t1489r354b1568],
42	'	''	O	'	_	0	SENT_259	[p18l78t1489r354b1568],
43	~	FW	O	~	dep	122	SENT_259	[p18l78t1489r354b1568],
44	‘	FW	O	‘	dep	122	SENT_259	[p18l78t1489r354b1568],
45	17	CD	NUMBER	17	dep	122	SENT_259	[p18l78t1489r354b1568],
46	,	,	O	,	_	0	SENT_259	[p18l78t1489r354b1568],
47	‘	CD	NUMBER	‘	dep	122	SENT_259	[p18l384t1489r630b1568],
48	*	NN	O	*	dep	122	SENT_259	[p18l384t1489r630b1568],
49	2	CD	NUMBER	2	dep	122	SENT_259	[p18l384t1489r630b1568],
50	/	:	O	/	dep	122	SENT_259	[p18l384t1489r630b1568],
51	"	``	O	"	dep	122	SENT_259	[p18l384t1489r630b1568],
52	'	''	O	'	_	0	SENT_259	[p18l384t1489r630b1568],
53	~	FW	O	~	dep	122	SENT_259	[p18l384t1489r630b1568],
54	‘	FW	O	‘	dep	122	SENT_259	[p18l384t1489r630b1568],
55	17	CD	NUMBER	17	dep	122	SENT_259	[p18l384t1489r630b1568],
56	,	,	O	,	_	0	SENT_259	[p18l384t1489r630b1568],
57	or	CC	O	or	dep	122	SENT_259	[p18l662t1506r733b1548],
58	"	``	O	"	dep	122	SENT_259	[p18l757t1489r1003b1568],
59	"	``	O	"	dep	122	SENT_259	[p18l757t1489r1003b1568],
60	3	CD	NUMBER	3	dep	122	SENT_259	[p18l757t1489r1003b1568],
61	/	:	O	/	dep	122	SENT_259	[p18l757t1489r1003b1568],
62	"	``	O	"	dep	122	SENT_259	[p18l757t1489r1003b1568],
63	'	''	O	'	_	0	SENT_259	[p18l757t1489r1003b1568],
64	\	SYM	O	\	dep	122	SENT_259	[p18l757t1489r1003b1568],
65	‘	CD	NUMBER	‘	dep	122	SENT_259	[p18l757t1489r1003b1568],
66	17	CD	NUMBER	17	dep	122	SENT_259	[p18l757t1489r1003b1568],
67	;	:	O	;	_	0	SENT_259	[p18l757t1489r1003b1568],
68	gain-of-function	NN	O	gain-of-function	dep	122	SENT_259	[p18l1034t1483r1594b1569],
69	noncarriers	NNS	O	noncarrier	dep	122	SENT_259	[p18l1629t1489r2026b1548],
70	were	VBD	O	be	dep	122	SENT_259	[p18l77t1614r241b1656],
71	defined	VBN	O	define	dep	122	SENT_259	[p18l269t1591r531b1656],
72	as	IN	O	as	dep	122	SENT_259	[p18l563t1614r633b1656],
73	patients	NNS	O	patient	dep	122	SENT_259	[p18l666t1597r943b1675],
74	with	IN	O	with	dep	122	SENT_259	[p18l970t1591r1115b1656],
75	no	DT	O	no	dep	122	SENT_259	[p18l1150t1614r1233b1656],
76	gain-of-function	NN	O	gain-of-function	dep	122	SENT_259	[p18l1262t1591r1822b1676],
77	allele	NN	O	allele	dep	122	SENT_259	[p18l1855t1591r2049b1656],
78	:	:	O	:	_	0	SENT_259	[p18l1855t1591r2049b1656],
79	7	CD	NUMBER	7	dep	122	SENT_259	[p18l78t1704r283b1783],
80	'	''	O	'	_	0	SENT_259	[p18l78t1704r283b1783],
81	:	:	O	:	_	0	SENT_259	[p18l78t1704r283b1783],
82	]	CD	NUMBER	]	dep	122	SENT_259	[p18l78t1704r283b1783],
83	_	CD	NUMBER	_	dep	122	SENT_259	[p18l78t1704r283b1783],
84	/	:	O	/	dep	122	SENT_259	[p18l78t1704r283b1783],
85	7	CD	NUMBER	7	dep	122	SENT_259	[p18l78t1704r283b1783],
86	'	''	O	'	_	0	SENT_259	[p18l78t1704r283b1783],
87	:	:	O	:	_	0	SENT_259	[p18l78t1704r283b1783],
88	]	CD	NUMBER	]	dep	122	SENT_259	[p18l78t1704r283b1783],
89	_	NN	O	_	dep	122	SENT_259	[p18l78t1704r283b1783],
90	,	,	O	,	_	0	SENT_259	[p18l78t1704r283b1783],
91	7	CD	NUMBER	7	dep	122	SENT_259	[p18l314t1704r526b1783],
92	'	''	DATE	'	_	0	SENT_259	[p18l314t1704r526b1783],
93	61	CD	DATE	61	dep	122	SENT_259	[p18l314t1704r526b1783],
94	/	:	O	/	dep	122	SENT_259	[p18l314t1704r526b1783],
95	*	CD	NUMBER	*	dep	122	SENT_259	[p18l314t1704r526b1783],
96	2	CD	NUMBER	2	dep	122	SENT_259	[p18l314t1704r526b1783],
97	,	,	O	,	_	0	SENT_259	[p18l314t1704r526b1783],
98	*	CD	NUMBER	*	dep	122	SENT_259	[p18l556t1704r765b1783],
99	1	CD	NUMBER	1	dep	122	SENT_259	[p18l556t1704r765b1783],
100	/	:	O	/	dep	122	SENT_259	[p18l556t1704r765b1783],
101	*	CD	NUMBER	*	dep	122	SENT_259	[p18l556t1704r765b1783],
102	3	CD	NUMBER	3	dep	122	SENT_259	[p18l556t1704r765b1783],
103	,	,	O	,	_	0	SENT_259	[p18l556t1704r765b1783],
104	7	CD	NUMBER	7	dep	122	SENT_259	[p18l795t1704r1015b1783],
105	'	''	O	'	_	0	SENT_259	[p18l795t1704r1015b1783],
106	<	JJR	O	<	dep	122	SENT_259	[p18l795t1704r1015b1783],
107	2	CD	NUMBER	2	dep	122	SENT_259	[p18l795t1704r1015b1783],
108	/	:	O	/	dep	122	SENT_259	[p18l795t1704r1015b1783],
109	*	CD	NUMBER	*	dep	122	SENT_259	[p18l795t1704r1015b1783],
110	2	CD	NUMBER	2	dep	122	SENT_259	[p18l795t1704r1015b1783],
111	,	,	O	,	_	0	SENT_259	[p18l795t1704r1015b1783],
112	*	CD	NUMBER	*	dep	122	SENT_259	[p18l1045t1704r1261b1783],
113	2/7	CD	NUMBER	2/7	dep	122	SENT_259	[p18l1045t1704r1261b1783],
114	'	''	O	'	_	0	SENT_259	[p18l1045t1704r1261b1783],
115	:3	CD	NUMBER	:3	dep	122	SENT_259	[p18l1045t1704r1261b1783],
116	,	,	O	,	_	0	SENT_259	[p18l1045t1704r1261b1783],
117	or	CC	O	or	dep	122	SENT_259	[p18l1293t1721r1364b1763],
118	*	NN	O	*	dep	122	SENT_259	[p18l1388t1704r1599b1783],
119	3	CD	NUMBER	3	dep	122	SENT_259	[p18l1388t1704r1599b1783],
120	/	:	O	/	dep	122	SENT_259	[p18l1388t1704r1599b1783],
121	*	CD	NUMBER	*	dep	122	SENT_259	[p18l1388t1704r1599b1783],
122	3	CD	NUMBER	3	_	0	SENT_259	[p18l1388t1704r1599b1783],
123	.	.	O	.	_	0	SENT_259	[p18l1388t1704r1599b1783],

1	interaction	NN	O	interaction	_	0	SENT_260	[p18l11t2039r501b2117],
2	.	.	O	.	_	0	SENT_260	[p18l11t2039r501b2117],

1	However	RB	O	however	advmod	10	SENT_261	[p18l564t2046r959b2134],
2	,	,	O	,	_	0	SENT_261	[p18l564t2046r959b2134],
3	the	DT	O	the	det	5	SENT_261	[p18l1024t2038r1156b2116],
4	consistent	JJ	O	consistent	amod	5	SENT_261	[p18l1216t2039r1655b2117],
5	effects	NNS	O	effect	nsubj	10	SENT_261	[p18l1709t2037r1990b2116],
6	in	IN	O	in	_	0	SENT_261	[p18l2050t2039r2133b2116],
7	our	PRP$	O	we	poss	9	SENT_261	[p18l12t2193r157b2246],
8	two	CD	NUMBER	two	num	9	SENT_261	[p18l198t2184r355b2246],
9	trials	NNS	O	trial	prep_in	5	SENT_261	[p18l400t2167r620b2245],
10	reinforce	VB	O	reinforce	_	0	SENT_261	[p18l665t2166r1051b2246],
11	our	PRP$	O	we	poss	12	SENT_261	[p18l1095t2193r1240b2246],
12	results	NNS	O	result	dobj	10	SENT_261	[p18l1280t2167r1563b2246],
13	and	CC	O	and	_	0	SENT_261	[p18l1608t2167r1766b2246],
14	suggest	VBP	O	suggest	conj_and	10	SENT_261	[p18l1810t2184r2138b2268],
15	that	IN	O	that	complm	17	SENT_261	[p18l12t2295r184b2373],
16	there	EX	O	there	expl	17	SENT_261	[p18l214t2295r431b2373],
17	was	VBD	O	be	ccomp	14	SENT_261	[p18l462t2321r624b2374],
18	no	DT	O	no	det	19	SENT_261	[p18l661t2321r767b2374],
19	difference	NN	O	difference	nsubj	17	SENT_261	[p18l804t2294r1235b2374],
20	in	IN	O	in	_	0	SENT_261	[p18l1271t2296r1354b2373],
21	outcomes	NNS	O	outcome	prep_in	19	SENT_261	[p18l1390t2312r1800b2374],
22	among	IN	O	among	_	0	SENT_261	[p18l1837t2321r2137b2396],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_261	[p18l12t2423r809b2524],
24	—	NN	O	—	prep_among	21	SENT_261	[p18l12t2423r809b2524],
25	treated	VBN	O	treat	partmod	24	SENT_261	[p18l12t2423r809b2524],
26	patients	NNS	O	patient	dobj	25	SENT_261	[p18l844t2424r1178b2523],
27	in	IN	O	in	_	0	SENT_261	[p18l1216t2424r1298b2501],
28	subgroups	NNS	O	subgroup	prep_in	25	SENT_261	[p18l1336t2423r1774b2524],
29	defined	VBN	O	define	partmod	28	SENT_261	[p18l1814t2422r2133b2502],
30	according	VBG	O	accord	_	0	SENT_261	[p18l11t2551r437b2652],
31	to	TO	O	to	prepc_according_to	29	SENT_261	[p18l469t2568r550b2630],
32	loss	NN	O	loss	nn	33	SENT_261	[p18l585t2550r1271b2630],
33	—	NN	O	—	pobj	29	SENT_261	[p18l585t2550r1271b2630],
34	offunction	NN	O	offunction	nn	36	SENT_261	[p18l585t2550r1271b2630],
35	carrier	NN	O	carrier	nn	36	SENT_261	[p18l1307t2552r1592b2629],
36	status	NN	O	status	dep	33	SENT_261	[p18l1625t2568r1902b2630],
37	.	.	O	.	_	0	SENT_261	[p18l1625t2568r1902b2630],

1	suacnoup	NN	O	suacnoup	nn	2	SENT_262	[p18l11t2826r451b2876],
2	ANALYSES	NNS	O	analysis	npadvmod	27	SENT_262	[p18l481t2826r874b2876],
3	Among	IN	O	among	_	0	SENT_262	[p18l7t2933r332b3026],
4	the	DT	O	the	det	6	SENT_262	[p18l363t2925r497b3003],
5	genotyped	JJ	O	genotyped	amod	6	SENT_262	[p18l531t2925r990b3026],
6	participants	NNS	O	participant	prep_among	27	SENT_262	[p18l1022t2926r1550b3025],
7	in	IN	O	in	_	0	SENT_262	[p18l1586t2926r1670b3003],
8	the	DT	O	the	det	10	SENT_262	[p18l1704t2925r1839b3003],
9	CURE	NN	O	cure	nn	10	SENT_262	[p18l1872t2931r2131b3008],
10	trial	NN	O	trial	prep_in	6	SENT_262	[p18l12t3052r217b3148],
11	,	,	O	,	_	0	SENT_262	[p18l12t3052r217b3148],
12	the	DT	O	the	det	13	SENT_262	[p18l256t3052r390b3130],
13	results	NNS	O	result	nsubj	27	SENT_262	[p18l423t3052r713b3132],
14	of	IN	O	of	_	0	SENT_262	[p18l749t3051r849b3131],
15	our	PRP$	O	we	poss	16	SENT_262	[p18l865t3078r1012b3131],
16	analyses	NNS	O	analysis	prep_of	13	SENT_262	[p18l1041t3052r1408b3152],
17	of	IN	O	of	_	0	SENT_262	[p18l1444t3051r1545b3131],
18	the	DT	O	the	det	19	SENT_262	[p18l1559t3052r1694b3130],
19	effects	NNS	O	effect	prep_of	16	SENT_262	[p18l1727t3051r2015b3130],
20	of	IN	O	of	_	0	SENT_262	[p18l2051t3051r2152b3131],
21	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_262	[p18l12t3181r505b3282],
22	as	IN	O	as	_	0	SENT_262	[p18l535t3207r621b3259],
23	compared	VBN	O	compare	prepc_as	21	SENT_262	[p18l656t3181r1090b3281],
24	with	IN	O	with	pcomp	23	SENT_262	[p18l1116t3181r1315b3260],
25	placebo	NN	O	placebo	pobj	24	SENT_262	[p18l1345t3181r1680b3281],
26	were	VBD	O	be	cop	27	SENT_262	[p18l1708t3207r1913b3260],
27	consistent	JJ	O	consistent	_	0	SENT_262	[p18l1945t3207r2132b3260, p18l12t3310r300b3387],
28	across	IN	O	across	_	0	SENT_262	[p18l345t3335r616b3388],
29	subgroups	NNS	O	subgroup	prep_across	27	SENT_262	[p18l672t3309r1127b3410],
30	defined	VBN	O	define	partmod	29	SENT_262	[p18l1181t3308r1514b3388],
31	according	VBG	O	accord	_	0	SENT_262	[p18l1565t3309r2000b3410],
32	to	TO	O	to	prepc_according_to	30	SENT_262	[p18l2049t3326r2132b3388],
33	loss	NN	O	loss	nn	34	SENT_262	[p18l10t3435r713b3515],
34	—	NN	O	—	pobj	30	SENT_262	[p18l10t3435r713b3515],
35	of	IN	O	of	_	0	SENT_262	[p18l10t3435r713b3515],
36	—	CD	NUMBER	—	num	39	SENT_262	[p18l10t3435r713b3515],
37	function	NN	O	function	nn	39	SENT_262	[p18l10t3435r713b3515],
38	carrier	NN	O	carrier	nn	39	SENT_262	[p18l765t3437r1057b3514],
39	status	NN	O	status	prep_of	34	SENT_262	[p18l1107t3453r1390b3532],
40	,	,	O	,	_	0	SENT_262	[p18l1107t3453r1390b3532],
41	whether	IN	O	whether	complm	45	SENT_262	[p18l1444t3436r1805b3515],
42	or	CC	O	or	_	0	SENT_262	[p18l1855t3462r1944b3515],
43	not	RB	O	not	ccomp	27	SENT_262	[p18l1993t3453r2138b3515],
44	participants	NNS	O	participant	nsubj	45	SENT_262	[p18l10t3566r538b3665],
45	underwent	VBD	O	undergo	ccomp	27	SENT_262	[p18l579t3565r1053b3644],
46	PCI	NNP	O	PCI	nsubj	48	SENT_262	[p18l1085t3571r1237b3644],
47	(	CD	NUMBER	(	num	46	SENT_262	[p18l1280t3571r1440b3656],
48	see	VB	O	see	ccomp	45	SENT_262	[p18l1280t3571r1440b3656],
49	Fig	NN	O	fig	dobj	48	SENT_262	[p18l1477t3566r1631b3666],
50	.	.	O	.	_	0	SENT_262	[p18l1477t3566r1631b3666],

1	5	CD	NUMBER	5	_	0	SENT_263	[p18l1678t3573r1721b3644],
2	and	CC	O	and	_	0	SENT_263	[p18l1763t3565r1923b3644],
3	6	CD	NUMBER	6	conj_and	1	SENT_263	[p18l1962t3571r2009b3644],
4	in	IN	O	in	_	0	SENT_263	[p18l2049t3566r2133b3643],
5	the	DT	O	the	det	8	SENT_263	[p18l12t3693r146b3771],
6	Supplementary	NNP	O	Supplementary	nn	8	SENT_263	[p18l180t3693r839b3793],
7	Appendix	NNP	O	Appendix	nn	8	SENT_263	[p18l862t3693r1337b3793],
8	)	NN	O	)	prep_in	1	SENT_263	[p18l862t3693r1337b3793],
9	.	.	O	.	_	0	SENT_263	[p18l862t3693r1337b3793],

1	Even	RB	O	even	advmod	2	SENT_264	[p18l1373t3701r1574b3772],
2	though	IN	O	though	_	0	SENT_264	[p18l1606t3693r1919b3794],
3	only	RB	O	only	advmod	2	SENT_264	[p18l1951t3693r2138b3793],

1	736	CD	NUMBER	736	num	2	SENT_265	[p19l12t26r163b99],
2	patients	NNS	O	patient	tmod	14	SENT_265	[p19l205t21r554b119],
3	who	WP	O	who	nsubj	4	SENT_265	[p19l594t20r779b99],
4	received	VBD	O	receive	rcmod	2	SENT_265	[p19l822t20r1176b99],
5	stents	NNS	O	stent	nsubjpass	7	SENT_265	[p19l1219t36r1472b98],
6	were	VBD	O	be	auxpass	7	SENT_265	[p19l1512t46r1718b99],
7	included	VBN	O	include	ccomp	4	SENT_265	[p19l1759t20r2133b99],
8	in	IN	O	in	_	0	SENT_265	[p19l11t149r95b226],
9	the	DT	O	the	det	11	SENT_265	[p19l140t148r274b226],
10	genetic	JJ	O	genetic	amod	11	SENT_265	[p19l318t149r633b249],
11	analysis	NN	O	analysis	prep_in	7	SENT_265	[p19l676t148r1049b248],
12	,	,	O	,	_	0	SENT_265	[p19l676t148r1049b248],
13	there	EX	O	there	expl	14	SENT_265	[p19l1099t148r1320b226],
14	was	VBD	O	be	dep	35	SENT_265	[p19l1360t174r1525b227],
15	a	DT	O	a	det	18	SENT_265	[p19l1570t174r1615b226],
16	significant	JJ	O	significant	amod	18	SENT_265	[p19l1659t147r2138b249],
17	treatment	NN	O	treatment	nn	18	SENT_265	[p19l12t293r444b354],
18	effect	NN	O	effect	nsubj	14	SENT_265	[p19l472t275r719b354],
19	of	IN	O	of	_	0	SENT_265	[p19l748t275r849b355],
20	clopidogrel	NN	O	clopidogrel	prep_of	18	SENT_265	[p19l864t276r1358b377],
21	on	IN	O	on	_	0	SENT_265	[p19l1391t302r1497b355],
22	the	DT	O	the	det	26	SENT_265	[p19l1531t276r1666b354],
23	first	JJ	ORDINAL	first	amod	26	SENT_265	[p19l1699t275r1887b354],
24	composite	JJ	O	composite	amod	26	SENT_265	[p19l1916t302r2132b355, p19l9t405r272b504],
25	primary	JJ	O	primary	amod	26	SENT_265	[p19l305t405r661b504],
26	outcome	NN	O	outcome	prep_on	14	SENT_265	[p19l690t421r1065b483],
27	among	IN	O	among	_	0	SENT_265	[p19l1098t430r1402b505],
28	loss	NN	O	loss	nn	29	SENT_265	[p19l1431t403r2133b483],
29	—	NN	O	—	prep_among	26	SENT_265	[p19l1431t403r2133b483],
30	of	IN	O	of	_	0	SENT_265	[p19l1431t403r2133b483],
31	—	CD	NUMBER	—	num	34	SENT_265	[p19l1431t403r2133b483],
32	function	NN	O	function	nn	34	SENT_265	[p19l1431t403r2133b483],
33	allele	NN	O	allele	nn	34	SENT_265	[p19l11t531r239b608],
34	carriers	NNS	O	carrier	prep_of	29	SENT_265	[p19l284t532r616b608],
35	(	VBP	O	(	_	0	SENT_265	[p19l666t531r998b621],
36	hazard	NN	O	hazard	nn	37	SENT_265	[p19l666t531r998b621],
37	ratio	NN	O	ratio	dobj	35	SENT_265	[p19l1042t532r1267b626],
38	,	,	O	,	_	0	SENT_265	[p19l1042t532r1267b626],
39	0.37	CD	NUMBER	0.37	appos	37	SENT_265	[p19l1317t537r1514b625],
40	;	:	O	;	_	0	SENT_265	[p19l1317t537r1514b625],
41	95	CD	PERCENT	95	num	42	SENT_265	[p19l1562t536r1747b610],
42	%	NN	PERCENT	%	dep	37	SENT_265	[p19l1562t536r1747b610],
43	CI	NN	O	ci	nsubj	35	SENT_265	[p19l1791t537r1908b626],
44	,	,	O	,	_	0	SENT_265	[p19l1791t537r1908b626],
45	0.14	CD	NUMBER	0.14	number	47	SENT_265	[p19l1958t537r2133b609],
46	to	TO	O	to	dep	47	SENT_265	[p19l12t675r94b737],
47	0.96	CD	NUMBER	0.96	appos	43	SENT_265	[p19l130t664r336b752],
48	;	:	O	;	_	0	SENT_265	[p19l130t664r336b752],
49	P	NN	O	p	dep	47	SENT_265	[p19l373t664r754b748],
50	=	JJ	O	=	amod	52	SENT_265	[p19l373t664r754b748],
51	0.04	CD	NUMBER	0.04	tmod	50	SENT_265	[p19l373t664r754b748],
52	)	NN	O	)	dep	49	SENT_265	[p19l373t664r754b748],
53	.	.	O	.	_	0	SENT_265	[p19l373t664r754b748],

1	A	DT	O	a	det	4	SENT_266	[p19l790t666r856b735],
2	similar	JJ	O	similar	amod	4	SENT_266	[p19l888t658r1200b736],
3	treatment	NN	O	treatment	nn	4	SENT_266	[p19l1232t675r1665b736],
4	effect	NN	O	effect	nsubjpass	6	SENT_266	[p19l1694t657r1942b736],
5	was	VBD	O	be	auxpass	6	SENT_266	[p19l1966t684r2131b737],
6	observed	VBN	O	observe	_	0	SENT_266	[p19l12t786r400b865],
7	among	IN	O	among	_	0	SENT_266	[p19l430t812r733b887],
8	noncarriers	JJ	O	noncarriers	amod	11	SENT_266	[p19l760t787r1265b865],
9	(	NN	O	(	nn	11	SENT_266	[p19l1302t786r1634b877],
10	hazard	NN	O	hazard	nn	11	SENT_266	[p19l1302t786r1634b877],
11	ratio	NN	O	ratio	prep_among	6	SENT_266	[p19l1664t787r1889b882],
12	,	,	O	,	_	0	SENT_266	[p19l1664t787r1889b882],
13	0.62	CD	NUMBER	0.62	dep	17	SENT_266	[p19l1925t792r2129b882],
14	;	:	O	;	_	0	SENT_266	[p19l1925t792r2129b882],
15	95	CD	PERCENT	95	number	16	SENT_266	[p19l11t918r197b992],
16	%	NN	PERCENT	%	amod	17	SENT_266	[p19l11t918r197b992],
17	CI	NN	O	ci	conj_and	6	SENT_266	[p19l230t919r348b1008],
18	,	,	O	,	_	0	SENT_266	[p19l230t919r348b1008],
19	0.37	CD	NUMBER	0.37	number	21	SENT_266	[p19l388t919r566b991],
20	to	TO	O	to	dep	21	SENT_266	[p19l601t930r684b991],
21	1.02	CD	NUMBER	1.02	appos	17	SENT_266	[p19l723t919r923b1007],
22	;	:	O	;	_	0	SENT_266	[p19l723t919r923b1007],
23	P	NN	O	p	dep	21	SENT_266	[p19l960t919r1341b1008],
24	=	JJ	O	=	amod	26	SENT_266	[p19l960t919r1341b1008],
25	0.06	CD	NUMBER	0.06	tmod	24	SENT_266	[p19l960t919r1341b1008],
26	)	NN	O	)	dep	23	SENT_266	[p19l960t919r1341b1008],
27	,	,	O	,	_	0	SENT_266	[p19l960t919r1341b1008],
28	and	CC	O	and	_	0	SENT_266	[p19l1379t913r1540b991],
29	there	EX	O	there	expl	30	SENT_266	[p19l1574t913r1795b990],
30	was	VBD	O	be	conj_and	6	SENT_266	[p19l1825t939r1990b992],
31	no	DT	O	no	det	32	SENT_266	[p19l2025t938r2132b991],
32	evidence	NN	O	evidence	nsubj	30	SENT_266	[p19l12t1041r384b1120],
33	of	IN	O	of	_	0	SENT_266	[p19l431t1040r532b1120],
34	an	DT	O	a	det	35	SENT_266	[p19l559t1067r662b1119],
35	interaction	NN	O	interaction	prep_of	32	SENT_266	[p19l707t1042r1186b1120],
36	between	IN	O	between	_	0	SENT_266	[p19l1232t1041r1596b1120],
37	carrier	NN	O	carrier	nn	38	SENT_266	[p19l1643t1042r1934b1119],
38	status	NN	O	status	prep_between	35	SENT_266	[p19l1978t1058r2132b1119, p19l12t1186r140b1248],
39	and	CC	O	and	_	0	SENT_266	[p19l190t1169r350b1247],
40	study	NN	O	study	nn	41	SENT_266	[p19l399t1169r633b1268],
41	treatment	NN	O	treatment	prep_between	35	SENT_266	[p19l677t1185r1109b1247],
42	with	IN	O	with	_	0	SENT_266	[p19l1147t1169r1346b1248],
43	respect	NN	O	respect	prep_with	38	SENT_266	[p19l1394t1185r1709b1268],
44	to	TO	O	to	_	0	SENT_266	[p19l1752t1186r1835b1247],
45	either	CC	O	either	preconj	47	SENT_266	[p19l1884t1169r2137b1247],
46	the	DT	O	the	det	47	SENT_266	[p19l12t1296r146b1374],
47	first	JJ	ORDINAL	first	prep_to	30	SENT_266	[p19l190t1295r379b1374],
48	or	CC	O	or	_	0	SENT_266	[p19l418t1322r509b1375],
49	the	DT	O	the	det	53	SENT_266	[p19l550t1296r684b1374],
50	second	JJ	ORDINAL	second	amod	53	SENT_266	[p19l730t1296r1032b1375],
51	composite	JJ	O	composite	amod	53	SENT_266	[p19l1077t1297r1527b1396],
52	primary	JJ	O	primary	amod	53	SENT_266	[p19l1570t1297r1926b1396],
53	outcome	NN	O	outcome	prep_to	30	SENT_266	[p19l1966t1313r2132b1375, p19l12t1451r242b1503],
54	(	CD	NUMBER	(	num	55	SENT_266	[p19l311t1431r663b1515],
55	P	NN	O	p	dep	47	SENT_266	[p19l311t1431r663b1515],
56	=	JJ	O	=	amod	55	SENT_266	[p19l311t1431r663b1515],
57	0.37	CD	NUMBER	0.37	tmod	56	SENT_266	[p19l311t1431r663b1515],
58	and	CC	O	and	_	0	SENT_266	[p19l728t1425r887b1503],
59	P	NN	O	p	conj_and	47	SENT_266	[p19l950t1431r1301b1520],
60	=	JJ	O	=	amod	59	SENT_266	[p19l950t1431r1301b1520],
61	O.	NNP	O	O.	dep	59	SENT_266	[p19l950t1431r1301b1520],
62	28	CD	NUMBER	28	num	61	SENT_266	[p19l950t1431r1301b1520],
63	,	,	O	,	_	0	SENT_266	[p19l950t1431r1301b1520],
64	respectively	RB	O	respectively	advmod	59	SENT_266	[p19l1371t1425r1933b1524],
65	)	CD	NUMBER	)	tmod	30	SENT_266	[p19l1371t1425r1933b1524],
66	.	.	O	.	_	0	SENT_266	[p19l1371t1425r1933b1524],

1	We	PRP	O	we	nsubj	3	SENT_267	[p19l1999t1432r2133b1503],
2	also	RB	O	also	advmod	3	SENT_267	[p19l10t1553r185b1632],
3	tested	VBD	O	test	_	0	SENT_267	[p19l235t1553r495b1632],
4	for	IN	O	for	_	0	SENT_267	[p19l543t1552r669b1632],
5	an	DT	O	a	det	6	SENT_267	[p19l715t1579r818b1631],
6	interaction	NN	O	interaction	prep_for	3	SENT_267	[p19l867t1554r1346b1632],
7	between	IN	O	between	_	0	SENT_267	[p19l1396t1553r1760b1632],
8	loss	NN	O	loss	nn	12	SENT_267	[p19l1808t1552r2132b1632, p19l11t1680r385b1760],
9	—	NN	O	—	nn	12	SENT_267	[p19l1808t1552r2132b1632, p19l11t1680r385b1760],
10	offunction	NN	O	offunction	nn	12	SENT_267	[p19l1808t1552r2132b1632, p19l11t1680r385b1760],
11	carrier	NN	O	carrier	nn	12	SENT_267	[p19l429t1682r720b1759],
12	status	NN	O	status	prep_between	6	SENT_267	[p19l761t1698r1018b1760],
13	and	CC	O	and	_	0	SENT_267	[p19l1063t1681r1222b1760],
14	both	DT	O	both	det	17	SENT_267	[p19l1266t1681r1467b1760],
15	current	JJ	DATE	current	amod	17	SENT_267	[p19l1511t1698r1831b1760],
16	smoking	NN	O	smoking	nn	17	SENT_267	[p19l1871t1681r2132b1760, p19l10t1810r152b1910],
17	status12	NN	O	status12	conj_and	12	SENT_267	[p19l204t1814r635b1888],
18	’13	CD	NUMBER	’13	dep	17	SENT_267	[p19l204t1814r635b1888],
19	and	CC	O	and	_	0	SENT_267	[p19l690t1809r851b1888],
20	the	DT	O	the	det	21	SENT_267	[p19l905t1809r1039b1887],
21	time	NN	O	time	conj_and	6	SENT_267	[p19l1094t1810r1290b1887],
22	to	TO	O	to	_	0	SENT_267	[p19l1345t1826r1427b1888],
23	the	DT	O	the	det	25	SENT_267	[p19l1484t1809r1618b1887],
24	first	JJ	ORDINAL	first	amod	25	SENT_267	[p19l1672t1808r1861b1887],
25	event	NN	O	event	prep_to	21	SENT_267	[p19l1911t1826r2138b1888],
26	after	IN	O	after	mark	45	SENT_267	[p19l11t1936r217b2015],
27	the	DT	O	the	det	28	SENT_267	[p19l245t1937r380b2015],
28	initiation	NN	O	initiation	nsubj	45	SENT_267	[p19l410t1938r820b2016],
29	of	IN	O	of	_	0	SENT_267	[p19l851t1936r952b2016],
30	clopidogrel	NN	O	clopidogrel	nn	32	SENT_267	[p19l965t1937r1458b2038],
31	treatment	NN	O	treatment	nn	32	SENT_267	[p19l1489t1954r1921b2015],
32	(	NN	O	(	prep_of	28	SENT_267	[p19l1952t1943r2134b2028],
33	<	JJR	O	<	amod	32	SENT_267	[p19l1952t1943r2134b2028],
34	24	CD	DURATION	24	num	35	SENT_267	[p19l1952t1943r2134b2028],
35	hours	NNS	NUMBER	hour	dep	33	SENT_267	[p19l11t2065r284b2161],
36	,	,	O	,	_	0	SENT_267	[p19l11t2065r284b2161],
37	<	JJR	O	<	conj_or	33	SENT_267	[p19l342t2073r442b2144],
38	7	CD	DURATION	7	num	39	SENT_267	[p19l342t2073r442b2144],
39	days	NNS	NUMBER	day	tmod	37	SENT_267	[p19l494t2065r708b2165],
40	,	,	O	,	_	0	SENT_267	[p19l494t2065r708b2165],
41	or	CC	O	or	_	0	SENT_267	[p19l764t2091r854b2144],
42	<	JJR	O	<	conj_or	33	SENT_267	[p19l904t2071r1061b2144],
43	30	CD	DURATION	30	num	44	SENT_267	[p19l904t2071r1061b2144],
44	days	NNS	NUMBER	day	tmod	33	SENT_267	[p19l1113t2065r1433b2165],
45	)	VBP	O	)	advcl	3	SENT_267	[p19l1113t2065r1433b2165],
46	.14	CD	NUMBER	.14	dobj	45	SENT_267	[p19l1113t2065r1433b2165],
47	No	DT	O	no	det	49	SENT_267	[p19l1480t2073r1605b2144],
48	significant	JJ	O	significant	amod	49	SENT_267	[p19l1659t2064r2138b2166],
49	interactions	NNS	O	interaction	nsubjpass	51	SENT_267	[p19l11t2194r532b2271],
50	were	VBD	O	be	auxpass	51	SENT_267	[p19l566t2219r771b2272],
51	observed	VBN	O	observe	rcmod	46	SENT_267	[p19l809t2193r1197b2272],
52	(	RB	O	(	advmod	51	SENT_267	[p19l1239t2193r1451b2283],
53	data	NNS	O	datum	npadvmod	54	SENT_267	[p19l1239t2193r1451b2283],
54	not	RB	O	not	neg	51	SENT_267	[p19l1486t2209r1631b2271],
55	shown	VBN	O	show	dep	51	SENT_267	[p19l1664t2193r2003b2283],
56	)	NN	O	)	dobj	51	SENT_267	[p19l1664t2193r2003b2283],
57	.	.	O	.	_	0	SENT_267	[p19l1664t2193r2003b2283],

1	DISCUSSION	NN	O	discussion	_	0	SENT_268	[p19l733t2489r1411b2548],

1	Our	PRP$	O	we	poss	2	SENT_269	[p19l11t2712r178b2785],
2	results	NNS	O	result	nsubj	3	SENT_269	[p19l203t2706r486b2785],
3	suggest	VBP	O	suggest	_	0	SENT_269	[p19l518t2723r846b2807],
4	that	IN	O	that	complm	17	SENT_269	[p19l870t2706r1042b2784],
5	the	DT	O	the	det	6	SENT_269	[p19l1066t2706r1198b2784],
6	efficacy	NN	O	efficacy	nsubjpass	17	SENT_269	[p19l1227t2705r1564b2806],
7	and	CC	O	and	_	0	SENT_269	[p19l1587t2706r1745b2785],
8	safety	NN	O	safety	nsubjpass	17	SENT_269	[p19l1774t2705r2027b2806],
9	of	IN	O	of	_	0	SENT_269	[p19l2052t2705r2152b2785],
10	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_269	[p19l12t2834r494b2935],
11	as	IN	O	as	_	0	SENT_269	[p19l550t2860r635b2912],
12	compared	VBN	O	compare	prepc_as	10	SENT_269	[p19l695t2834r1121b2934],
13	with	IN	O	with	pcomp	12	SENT_269	[p19l1173t2834r1368b2913],
14	placebo	NN	O	placebo	pobj	13	SENT_269	[p19l1423t2834r1752b2934],
15	are	VBP	O	be	auxpass	17	SENT_269	[p19l1810t2860r1939b2912],
16	not	RB	O	not	neg	17	SENT_269	[p19l1996t2851r2138b2913],
17	modified	VBN	O	modify	ccomp	3	SENT_269	[p19l11t2960r407b3040],
18	by	IN	O	by	_	0	SENT_269	[p19l444t2961r541b3061],
19	CYPZCI9	NN	O	cypzci9	nn	21	SENT_269	[p19l573t2968r918b3039],
20	loss	NN	O	loss	nn	21	SENT_269	[p19l954t2960r1640b3041],
21	—	NN	O	—	agent	17	SENT_269	[p19l954t2960r1640b3041],
22	of	IN	O	of	_	0	SENT_269	[p19l954t2960r1640b3041],
23	—	CD	NUMBER	—	num	25	SENT_269	[p19l954t2960r1640b3041],
24	function	NN	O	function	nn	25	SENT_269	[p19l954t2960r1640b3041],
25	alleles	NNS	O	allele	prep_of	21	SENT_269	[p19l1677t2961r1967b3040],
26	.	.	O	.	_	0	SENT_269	[p19l1677t2961r1967b3040],

1	No	DT	O	no	det	3	SENT_270	[p19l2007t2969r2132b3040],
2	significant	JJ	O	significant	amod	3	SENT_270	[p19l12t3089r481b3191],
3	difference	NN	O	difference	nsubjpass	14	SENT_270	[p19l525t3089r957b3169],
4	in	IN	O	in	_	0	SENT_270	[p19l1005t3091r1089b3168],
5	the	DT	O	the	det	6	SENT_270	[p19l1138t3090r1271b3168],
6	effects	NNS	O	effect	prep_in	3	SENT_270	[p19l1320t3089r1601b3168],
7	of	IN	O	of	_	0	SENT_270	[p19l1653t3089r1753b3169],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_270	[p19l1784t3090r2132b3190, p19l11t3218r176b3319],
9	treatment	NN	O	treatment	prep_of	6	SENT_270	[p19l203t3235r626b3296],
10	on	IN	O	on	_	0	SENT_270	[p19l650t3244r755b3297],
11	clinical	JJ	O	clinical	amod	12	SENT_270	[p19l783t3218r1097b3296],
12	outcomes	NNS	O	outcome	prep_on	9	SENT_270	[p19l1124t3235r1535b3297],
13	was	VBD	O	be	auxpass	14	SENT_270	[p19l1560t3244r1723b3297],
14	observed	VBN	O	observe	_	0	SENT_270	[p19l1753t3218r2134b3297],
15	when	WRB	O	when	advmod	18	SENT_270	[p19l7t3346r240b3425],
16	patients	NNS	O	patient	nsubjpass	18	SENT_270	[p19l287t3347r628b3446],
17	were	VBD	O	be	auxpass	18	SENT_270	[p19l674t3372r876b3425],
18	stratified	VBN	O	stratify	advcl	14	SENT_270	[p19l926t3345r1320b3425],
19	according	VBG	O	accord	_	0	SENT_270	[p19l1368t3346r1794b3447],
20	to	TO	O	to	prepc_according_to	18	SENT_270	[p19l1840t3363r1921b3425],
21	metabolizer	NN	O	metabolizer	nn	22	SENT_270	[p19l1970t3372r2132b3424, p19l12t3474r395b3553],
22	phenotype	NN	O	phenotype	pobj	18	SENT_270	[p19l440t3474r915b3574],
23	.	.	O	.	_	0	SENT_270	[p19l440t3474r915b3574],

1	In	IN	O	in	dep	10	SENT_271	[p19l969t3482r1057b3552],
2	contrast	NN	O	contrast	pobj	1	SENT_271	[p19l1107t3491r1460b3553],
3	to	TO	O	to	_	0	SENT_271	[p19l1504t3491r1586b3553],
4	findings	NNS	O	finding	prep_to	2	SENT_271	[p19l1636t3473r2000b3575],
5	in	IN	O	in	_	0	SENT_271	[p19l2050t3475r2134b3552],
6	previous	JJ	O	previous	amod	7	SENT_271	[p19l9t3602r372b3701],
7	studies	NNS	O	study	prep_in	4	SENT_271	[p19l441t3601r960b3697],
8	,3	CD	NUMBER	,3	dep	7	SENT_271	[p19l441t3601r960b3697],
9	'	''	O	'	_	0	SENT_271	[p19l441t3601r960b3697],
10	5	CD	NUMBER	5	_	0	SENT_271	[p19l441t3601r960b3697],
11	»	CD	NUMBER	»	number	12	SENT_271	[p19l441t3601r960b3697],
12	15	CD	NUMBER	15	num	14	SENT_271	[p19l441t3601r960b3697],
13	the	DT	O	the	det	14	SENT_271	[p19l1030t3601r1162b3679],
14	presence	NN	O	presence	dep	10	SENT_271	[p19l1227t3627r1602b3701],
15	of	IN	O	of	_	0	SENT_271	[p19l1669t3600r1769b3680],
16	loss	NN	O	loss	nn	18	SENT_271	[p19l1815t3600r2132b3680, p20l11t20r377b100],
17	—	NN	O	—	nn	18	SENT_271	[p19l1815t3600r2132b3680, p20l11t20r377b100],
18	offunction	NN	O	offunction	prep_of	10	SENT_271	[p19l1815t3600r2132b3680, p20l11t20r377b100],

1	alleles	NNS	O	allele	nsubjpass	13	SENT_272	[p20l422t21r687b99],
2	in	IN	O	in	_	0	SENT_272	[p20l734t22r817b99],
3	patients	NNS	O	patient	prep_in	1	SENT_272	[p20l861t22r1203b121],
4	with	IN	O	with	_	0	SENT_272	[p20l1245t21r1440b101],
5	acute	JJ	O	acute	amod	7	SENT_272	[p20l1485t38r1707b100],
6	coronary	JJ	O	coronary	amod	7	SENT_272	[p20l1753t47r2138b121],
7	syndromes	NNS	O	syndrome	prep_with	3	SENT_272	[p20l12t149r478b249],
8	or	CC	O	or	_	0	SENT_272	[p20l528t175r616b228],
9	atrial	JJ	O	atrial	amod	10	SENT_272	[p20l660t149r885b227],
10	fibrillation	NN	O	fibrillation	prep_with	3	SENT_272	[p20l932t148r1402b228],
11	was	VBD	O	be	auxpass	13	SENT_272	[p20l1445t175r1607b228],
12	not	RB	O	not	neg	13	SENT_272	[p20l1657t166r1799b228],
13	associated	VBN	O	associate	_	0	SENT_272	[p20l1841t150r2132b228, p20l11t277r189b356],
14	with	IN	O	with	_	0	SENT_272	[p20l215t277r410b357],
15	an	DT	O	a	det	17	SENT_272	[p20l440t303r544b355],
16	increased	VBN	O	increase	amod	17	SENT_272	[p20l574t277r982b356],
17	risk	NN	O	risk	prep_with	13	SENT_272	[p20l1013t277r1177b357],
18	of	IN	O	of	_	0	SENT_272	[p20l1204t276r1304b356],
19	major	JJ	O	major	amod	21	SENT_272	[p20l1316t278r1567b377],
20	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_272	[p20l1595t277r2132b357, p20l10t406r126b483],
21	events	NNS	O	event	prep_of	17	SENT_272	[p20l152t422r440b501],
22	,	,	O	,	_	0	SENT_272	[p20l152t422r440b501],
23	even	RB	O	even	advmod	24	SENT_272	[p20l475t432r664b485],
24	when	WRB	O	when	advmod	28	SENT_272	[p20l688t406r921b485],
25	the	DT	O	the	det	26	SENT_272	[p20l950t406r1083b484],
26	analyses	NNS	O	analysis	nsubj	28	SENT_272	[p20l1111t406r1470b505],
27	were	VBD	O	be	cop	28	SENT_272	[p20l1496t432r1698b485],
28	restricted	JJ	O	restricted	dep	21	SENT_272	[p20l1726t406r2133b484],
29	to	TO	O	to	_	0	SENT_272	[p20l12t551r92b613],
30	data	NNS	O	datum	prep_to	28	SENT_272	[p20l142t534r325b613],
31	on	IN	O	on	_	0	SENT_272	[p20l371t560r477b613],
32	homozygous	JJ	O	homozygous	amod	33	SENT_272	[p20l524t534r1070b635],
33	patients	NNS	O	patient	prep_on	30	SENT_272	[p20l1118t535r1459b634],
34	(	IN	O	(	_	0	SENT_272	[p20l1513t534r2132b634],
35	poor	JJ	O	poor	amod	37	SENT_272	[p20l1513t534r2132b634],
36	—	NN	O	—	nn	37	SENT_272	[p20l1513t534r2132b634],
37	metabo	NN	O	metabo	prep_(	28	SENT_272	[p20l1513t534r2132b634],
38	—	CD	NUMBER	—	num	41	SENT_272	[p20l1513t534r2132b634],
39	lizer	NN	O	lizer	nn	41	SENT_272	[p20l10t662r202b740],
40	phenotype	NN	O	phenotype	nn	41	SENT_272	[p20l253t662r755b762],
41	)	NN	O	)	dep	37	SENT_272	[p20l253t662r755b762],
42	.	.	O	.	_	0	SENT_272	[p20l253t662r755b762],

1	However	RB	O	however	advmod	4	SENT_273	[p20l816t670r1211b758],
2	,	,	O	,	_	0	SENT_273	[p20l816t670r1211b758],
3	clopidogrel	NN	O	clopidogrel	nsubj	4	SENT_273	[p20l1272t662r1755b763],
4	showed	VBD	O	show	_	0	SENT_273	[p20l1811t662r2134b741],
5	enhanced	VBN	O	enhance	amod	6	SENT_273	[p20l12t789r425b868],
6	efficacy	NN	O	efficacy	dobj	4	SENT_273	[p20l469t788r804b889],
7	for	IN	O	for	_	0	SENT_273	[p20l843t788r965b868],
8	the	DT	O	the	det	9	SENT_273	[p20l1005t789r1137b867],
9	reduction	NN	O	reduction	prep_for	6	SENT_273	[p20l1180t789r1589b869],
10	of	IN	O	of	_	0	SENT_273	[p20l1632t788r1732b868],
11	ischemic	JJ	O	ischemic	amod	12	SENT_273	[p20l1755t789r2134b867],
12	events	NNS	O	event	prep_of	9	SENT_273	[p20l12t934r275b997],
13	in	IN	O	in	_	0	SENT_273	[p20l305t919r388b995],
14	patients	NNS	O	patient	prep_in	12	SENT_273	[p20l415t919r756b1017],
15	with	IN	O	with	_	0	SENT_273	[p20l782t918r977b997],
16	acute	JJ	O	acute	amod	18	SENT_273	[p20l1005t935r1227b997],
17	coronary	JJ	O	coronary	amod	18	SENT_273	[p20l1256t944r1640b1017],
18	syndromes	NNS	O	syndrome	prep_with	14	SENT_273	[p20l1666t918r2131b1017],
19	who	WP	O	who	nsubj	21	SENT_273	[p20l7t1046r189b1125],
20	were	VBD	O	be	cop	21	SENT_273	[p20l227t1072r429b1125],
21	carriers	NNS	O	carrier	rcmod	6	SENT_273	[p20l470t1047r794b1124],
22	of	IN	O	of	_	0	SENT_273	[p20l838t1045r937b1125],
23	the	DT	O	the	det	25	SENT_273	[p20l960t1046r1093b1124],
24	gain	NN	O	gain	nn	25	SENT_273	[p20l1133t1045r1841b1147],
25	—	NN	O	—	prep_of	21	SENT_273	[p20l1133t1045r1841b1147],
26	of	IN	O	of	_	0	SENT_273	[p20l1133t1045r1841b1147],
27	—	CD	NUMBER	—	num	29	SENT_273	[p20l1133t1045r1841b1147],
28	function	NN	O	function	nn	29	SENT_273	[p20l1133t1045r1841b1147],
29	allele	NN	O	allele	prep_of	25	SENT_273	[p20l1881t1046r2128b1142],
30	,	,	O	,	_	0	SENT_273	[p20l1881t1046r2128b1142],
31	although	IN	O	although	mark	36	SENT_273	[p20l11t1174r397b1275],
32	this	DT	O	this	det	33	SENT_273	[p20l431t1174r590b1252],
33	effect	NN	O	effect	nsubjpass	36	SENT_273	[p20l626t1173r868b1252],
34	was	VBD	O	be	auxpass	36	SENT_273	[p20l892t1200r1054b1253],
35	not	RB	O	not	neg	36	SENT_273	[p20l1089t1191r1232b1253],
36	observed	VBN	O	observe	advcl	21	SENT_273	[p20l1261t1174r1642b1253],
37	in	IN	O	in	_	0	SENT_273	[p20l1675t1175r1758b1252],
38	patients	NNS	O	patient	prep_in	36	SENT_273	[p20l1789t1175r2130b1274],
39	with	IN	O	with	_	0	SENT_273	[p20l7t1302r202b1381],
40	atrial	JJ	O	atrial	amod	41	SENT_273	[p20l247t1302r472b1380],
41	fibrillation	NN	O	fibrillation	prep_with	36	SENT_273	[p20l517t1301r986b1381],
42	who	WP	O	who	nsubj	44	SENT_273	[p20l1027t1302r1211b1381],
43	were	VBD	O	be	cop	44	SENT_273	[p20l1253t1328r1454b1381],
44	carriers	NNS	O	carrier	rcmod	41	SENT_273	[p20l1501t1303r1825b1380],
45	of	IN	O	of	_	0	SENT_273	[p20l1873t1301r1973b1381],
46	the	DT	O	the	det	50	SENT_273	[p20l2001t1302r2133b1380],
47	gain	NN	O	gain	npadvmod	49	SENT_273	[p20l11t1429r719b1531],
48	—	CD	NUMBER	—	num	47	SENT_273	[p20l11t1429r719b1531],
49	of-function	JJ	O	of-function	amod	50	SENT_273	[p20l11t1429r719b1531],
50	allele	NN	O	allele	prep_of	44	SENT_273	[p20l753t1430r999b1509],
51	.	.	O	.	_	0	SENT_273	[p20l753t1430r999b1509],

1	The	DT	O	the	det	2	SENT_274	[p20l136t1558r297b1636],
2	absence	NN	O	absence	_	0	SENT_274	[p20l337t1558r674b1637],
3	of	IN	O	of	_	0	SENT_274	[p20l715t1557r814b1637],
4	an	DT	O	a	det	5	SENT_274	[p20l835t1584r938b1636],
5	effect	NN	O	effect	prep_of	2	SENT_274	[p20l979t1557r1220b1636],
6	of	IN	O	of	_	0	SENT_274	[p20l1256t1557r1356b1637],
7	the	DT	O	the	det	9	SENT_274	[p20l1378t1558r1510b1636],
8	CYPZCI9	NN	O	cypzci9	nn	9	SENT_274	[p20l1551t1565r1895b1636],
9	lossof	NN	O	lossof	prep_of	5	SENT_274	[p20l1934t1558r2132b1637, p20l12t1685r492b1765],
10	—	CD	NUMBER	—	num	11	SENT_274	[p20l1934t1558r2132b1637, p20l12t1685r492b1765],
11	function	NN	O	function	dep	2	SENT_274	[p20l1934t1558r2132b1637, p20l12t1685r492b1765],

1	alleles	NNS	O	allele	nsubj	10	SENT_275	[p20l529t1686r795b1764],
2	on	IN	O	on	_	0	SENT_275	[p20l835t1712r941b1765],
3	cardiovascular	JJ	O	cardiovascular	amod	4	SENT_275	[p20l979t1686r1607b1765],
4	risk	NN	O	risk	prep_on	1	SENT_275	[p20l1641t1686r1805b1765],
5	among	IN	O	among	_	0	SENT_275	[p20l1837t1712r2137b1787],
6	patients	NNS	O	patient	prep_among	4	SENT_275	[p20l9t1815r350b1914],
7	treated	VBN	O	treat	partmod	6	SENT_275	[p20l386t1814r684b1893],
8	with	IN	O	with	_	0	SENT_275	[p20l712t1814r907b1893],
9	clopidogrel	NN	O	clopidogrel	prep_with	7	SENT_275	[p20l941t1814r1422b1915],
10	is	VBZ	O	be	_	0	SENT_275	[p20l1454t1815r1520b1892],
11	in	IN	O	in	_	0	SENT_275	[p20l1553t1815r1636b1892],
12	contrast	NN	O	contrast	prep_in	10	SENT_275	[p20l1670t1831r2022b1893],
13	to	TO	O	to	_	0	SENT_275	[p20l2050t1831r2132b1893],
14	findings	NNS	O	finding	prep_to	10	SENT_275	[p20l11t1941r375b2043],
15	from	IN	O	from	_	0	SENT_275	[p20l443t1941r653b2021],
16	previous	JJ	O	previous	amod	17	SENT_275	[p20l718t1943r1080b2042],
17	studies	NNS	O	study	prep_from	14	SENT_275	[p20l1150t1942r1475b2021],
18	.	.	O	.	_	0	SENT_275	[p20l1150t1942r1475b2021],

1	One	CD	NUMBER	one	num	3	SENT_276	[p20l1546t1948r1718b2021],
2	possible	JJ	O	possible	amod	3	SENT_276	[p20l1783t1942r2133b2042],
3	explanation	NN	O	explanation	nsubj	23	SENT_276	[p20l12t2070r518b2170],
4	for	IN	O	for	_	0	SENT_276	[p20l598t2069r722b2149],
5	the	DT	O	the	det	6	SENT_276	[p20l800t2070r932b2148],
6	divergence	NN	O	divergence	prep_for	3	SENT_276	[p20l1014t2070r1470b2171],
7	between	IN	O	between	_	0	SENT_276	[p20l1552t2070r1910b2149],
8	our	PRP$	O	we	poss	9	SENT_276	[p20l1991t2096r2137b2149],
9	findings	NNS	O	finding	prep_between	6	SENT_276	[p20l11t2197r375b2299],
10	and	CC	O	and	_	0	SENT_276	[p20l414t2198r572b2277],
11	those	DT	O	those	prep_for	3	SENT_276	[p20l610t2198r842b2277],
12	of	IN	O	of	_	0	SENT_276	[p20l880t2197r980b2277],
13	previous	JJ	O	previous	amod	14	SENT_276	[p20l998t2199r1360b2298],
14	studies	NNS	O	study	prep_of	11	SENT_276	[p20l1401t2198r1701b2277],
15	involving	VBG	O	involve	partmod	14	SENT_276	[p20l1740t2198r2137b2299],
16	patients	NNS	O	patient	dobj	15	SENT_276	[p20l9t2327r351b2425],
17	with	IN	O	with	_	0	SENT_276	[p20l402t2326r597b2405],
18	acute	JJ	O	acute	amod	20	SENT_276	[p20l649t2343r871b2405],
19	coronary	JJ	O	coronary	amod	20	SENT_276	[p20l925t2352r1310b2425],
20	syndromes	NNS	O	syndrome	prep_with	15	SENT_276	[p20l1360t2326r1825b2425],
21	is	VBZ	O	be	cop	23	SENT_276	[p20l1879t2327r1945b2403],
22	the	DT	O	the	det	23	SENT_276	[p20l2001t2326r2133b2404],
23	difference	NN	O	difference	_	0	SENT_276	[p20l12t2453r443b2533],
24	in	IN	O	in	_	0	SENT_276	[p20l478t2455r561b2532],
25	the	DT	O	the	det	26	SENT_276	[p20l595t2454r727b2532],
26	rates	NNS	O	rate	prep_in	23	SENT_276	[p20l761t2471r964b2532],
27	of	IN	O	of	_	0	SENT_276	[p20l1001t2453r1101b2533],
28	PCI	NN	O	pcus	prep_of	26	SENT_276	[p20l1115t2460r1264b2533],
29	with	IN	O	with	_	0	SENT_276	[p20l1293t2454r1488b2533],
30	stenting	NN	O	stenting	prep_with	28	SENT_276	[p20l1524t2455r1894b2555],
31	.	.	O	.	_	0	SENT_276	[p20l1524t2455r1894b2555],

1	Only	RB	O	only	quantmod	2	SENT_277	[p20l1933t2454r2138b2554],
2	18.0	CD	PERCENT	18.0	num	3	SENT_277	[p20l15t2586r277b2660],
3	%	NN	PERCENT	%	nsubj	10	SENT_277	[p20l15t2586r277b2660],
4	of	IN	O	of	_	0	SENT_277	[p20l331t2580r430b2660],
5	patients	NNS	O	patient	prep_of	3	SENT_277	[p20l464t2582r806b2681],
6	in	IN	O	in	_	0	SENT_277	[p20l861t2582r944b2659],
7	the	DT	O	the	det	9	SENT_277	[p20l997t2581r1130b2659],
8	CURE	NN	O	cure	nn	9	SENT_277	[p20l1184t2587r1439b2665],
9	population	NN	O	population	prep_in	5	SENT_277	[p20l1494t2581r1965b2681],
10	included	VBD	O	include	_	0	SENT_277	[p20l2018t2582r2132b2659, p20l12t2710r290b2789],
11	in	IN	O	in	mark	14	SENT_277	[p20l350t2711r433b2787],
12	our	PRP$	O	we	poss	13	SENT_277	[p20l493t2736r639b2789],
13	study	NN	O	study	nsubj	14	SENT_277	[p20l697t2710r927b2809],
14	underwent	VBD	O	undergo	advcl	10	SENT_277	[p20l982t2710r1447b2789],
15	PCI	NNP	O	PCI	dobj	14	SENT_277	[p20l1499t2716r1671b2805],
16	,	,	O	,	_	0	SENT_277	[p20l1499t2716r1671b2805],
17	and	CC	O	and	_	0	SENT_277	[p20l1736t2710r1894b2788],
18	only	RB	O	only	quantmod	19	SENT_277	[p20l1954t2710r2138b2809],
19	14.5	CD	PERCENT	14.5	num	20	SENT_277	[p20l15t2843r269b2917],
20	%	NN	PERCENT	%	nsubj	21	SENT_277	[p20l15t2843r269b2917],
21	underwent	VBD	O	undergo	conj_and	10	SENT_277	[p20l307t2837r772b2917],
22	PCI	NN	O	pcus	dobj	21	SENT_277	[p20l803t2843r953b2916],
23	with	IN	O	with	_	0	SENT_277	[p20l986t2837r1181b2917],
24	placement	NN	O	placement	prep_with	21	SENT_277	[p20l1217t2837r1663b2937],
25	of	IN	O	of	_	0	SENT_277	[p20l1697t2836r1797b2916],
26	a	DT	O	a	det	27	SENT_277	[p20l1816t2863r1860b2915],
27	stent	NN	O	stent	prep_of	24	SENT_277	[p20l1898t2854r2128b2933],
28	,	,	O	,	_	0	SENT_277	[p20l1898t2854r2128b2933],
29	as	IN	O	as	mark	55	SENT_277	[p20l11t2992r96b3043],
30	compared	VBN	O	compare	_	0	SENT_277	[p20l152t2966r578b3065],
31	with	IN	O	with	prepc_compared_with	55	SENT_277	[p20l626t2966r821b3045],
32	more	JJR	O	more	mwe	33	SENT_277	[p20l875t2992r1094b3044],
33	than	IN	O	than	quantmod	35	SENT_277	[p20l1148t2966r1344b3043],
34	70	CD	NUMBER	70	number	35	SENT_277	[p20l1398t2971r1582b3045],
35	°	CD	NUMBER	°	pobj	55	SENT_277	[p20l1398t2971r1582b3045],
36	/	:	O	/	punct	37	SENT_277	[p20l1398t2971r1582b3045],
37	o	NN	O	o	dep	35	SENT_277	[p20l1398t2971r1582b3045],
38	in	IN	O	in	_	0	SENT_277	[p20l1634t2967r1717b3043],
39	previous	JJ	O	previous	amod	41	SENT_277	[p20l1769t2967r2130b3065],
40	studies	NNS	O	study	nn	41	SENT_277	[p20l12t3093r531b3172],
41	.3	NN	NUMBER	.3	prep_in	37	SENT_277	[p20l12t3093r531b3172],
42	'	''	O	'	_	0	SENT_277	[p20l12t3093r531b3172],
43	-	:	O	-	_	0	SENT_277	[p20l12t3093r531b3172],
44	‘	CD	NUMBER	‘	num	45	SENT_277	[p20l12t3093r531b3172],
45	~	NN	O	~	nsubj	55	SENT_277	[p20l12t3093r531b3172],
46	15	CD	NUMBER	15	num	47	SENT_277	[p20l12t3093r531b3172],
47	Results	NNS	O	result	npadvmod	48	SENT_277	[p20l587t3093r899b3176],
48	of	IN	O	of	advmod	49	SENT_277	[p20l956t3092r1056b3172],
49	randomized	VBN	O	randomize	partmod	45	SENT_277	[p20l1092t3093r1635b3189],
50	,	,	O	,	_	0	SENT_277	[p20l1092t3093r1635b3189],
51	controlled	VBN	O	control	dep	49	SENT_277	[p20l1696t3093r2133b3172],
52	trials	NNS	O	trial	dobj	49	SENT_277	[p20l12t3222r230b3300],
53	have	VBP	O	have	aux	55	SENT_277	[p20l279t3222r469b3301],
54	consistently	RB	O	consistently	advmod	55	SENT_277	[p20l515t3222r1030b3322],
55	shown	VBN	O	show	advcl	21	SENT_277	[p20l1073t3222r1354b3301],
56	that	IN	O	that	complm	82	SENT_277	[p20l1401t3222r1573b3300],
57	the	DT	O	the	det	59	SENT_277	[p20l1614t3222r1747b3300],
58	greatest	JJS	O	greatest	amod	59	SENT_277	[p20l1793t3239r2138b3323],
59	benefit	NN	O	benefit	nsubj	82	SENT_277	[p20l12t3349r317b3429],
60	of	IN	O	of	_	0	SENT_277	[p20l355t3349r455b3429],
61	clopidogrel	NN	O	clopidogrel	prep_of	59	SENT_277	[p20l481t3350r986b3451],
62	,	,	O	,	_	0	SENT_277	[p20l481t3350r986b3451],
63	including	VBG	O	include	_	0	SENT_277	[p20l1035t3350r1445b3451],
64	its	PRP$	O	its	poss	65	SENT_277	[p20l1485t3351r1583b3428],
65	use	NN	O	use	prep_including	61	SENT_277	[p20l1628t3376r1769b3429],
66	in	IN	O	in	_	0	SENT_277	[p20l1812t3351r1895b3428],
67	high	JJ	O	high	amod	68	SENT_277	[p20l1938t3350r2133b3451],
68	doses	NNS	O	dose	prep_in	65	SENT_277	[p20l12t3478r248b3557],
69	(	RB	O	(	advmod	68	SENT_277	[p20l306t3485r416b3569],
70	as	IN	O	as	dep	68	SENT_277	[p20l306t3485r416b3569],
71	in	IN	O	in	_	0	SENT_277	[p20l468t3479r551b3556],
72	the	DT	O	the	det	73	SENT_277	[p20l603t3478r735b3556],
73	Clopidogrel	NNP	O	Clopidogrel	prep_in	68	SENT_277	[p20l786t3478r1288b3579],
74	and	CC	O	and	_	0	SENT_277	[p20l1338t3478r1496b3557],
75	Aspirin	NNP	O	Aspirin	nn	80	SENT_277	[p20l1542t3479r1862b3578],
76	Opti	NNP	O	Opti	nn	80	SENT_277	[p20l1912t3479r2132b3578],
77	—	NNP	O	—	nn	80	SENT_277	[p20l1912t3479r2132b3578],
78	mal	NNP	O	mal	nn	80	SENT_277	[p20l11t3606r174b3684],
79	Dose	NNP	O	Dose	nn	80	SENT_277	[p20l239t3612r453b3685],
80	Usage	NNP	O	Usage	conj_and	73	SENT_277	[p20l519t3614r777b3707],
81	to	TO	O	to	aux	82	SENT_277	[p20l845t3623r927b3685],
82	Reduce	VB	O	reduce	ccomp	55	SENT_277	[p20l993t3606r1302b3689],
83	Recurrent	JJ	O	recurrent	amod	84	SENT_277	[p20l1369t3612r1797b3689],
84	Events	NNS	O	event	dobj	82	SENT_277	[p20l1858t3614r2131b3685],

1	[	RB	O	[	advmod	4	SENT_278	[p21l20t26r541b111],
2	CURRENT	JJ	DATE	current	amod	4	SENT_278	[p21l20t26r541b111],
3	]	CD	NUMBER	]	num	4	SENT_278	[p21l20t26r541b111],
4	study	NN	O	study	nsubj	22	SENT_278	[p21l588t20r830b120],
5	,	,	O	,	_	0	SENT_278	[p21l588t20r830b120],
6	NCTOO335452	NN	O	nctoo335452	nn	7	SENT_278	[p21l870t26r1526b116],
7	)	NN	O	)	appos	4	SENT_278	[p21l870t26r1526b116],
8	,	,	O	,	_	0	SENT_278	[p21l870t26r1526b116],
9	and	CC	O	and	_	0	SENT_278	[p21l1566t20r1724b99],
10	of	IN	O	of	_	0	SENT_278	[p21l1760t19r1859b99],
11	newer	JJR	O	newer	amod	14	SENT_278	[p21l1876t46r2136b100],
12	generation	NN	O	generation	nn	14	SENT_278	[p21l11t150r470b250],
13	P2Y12	NN	O	p2y12	nn	14	SENT_278	[p21l528t155r787b227],
14	inhibitors	NNS	O	inhibitor	prep_of	16	SENT_278	[p21l846t149r1268b228],
15	such	JJ	O	such	mwe	16	SENT_278	[p21l1330t149r1524b228],
16	as	IN	O	as	conj_and	4	SENT_278	[p21l1583t175r1668b227],
17	prasugrel	NN	O	prasugrel	pobj	16	SENT_278	[p21l1728t149r2134b250],
18	and	CC	O	and	_	0	SENT_278	[p21l11t277r168b356],
19	ticagrelor	NN	O	ticagrelor	conj_and	17	SENT_278	[p21l229t277r644b378],
20	is	VBZ	O	be	cop	22	SENT_278	[p21l702t278r767b355],
21	the	DT	O	the	det	22	SENT_278	[p21l831t277r963b355],
22	reduction	NN	O	reduction	_	0	SENT_278	[p21l1024t277r1433b356],
23	in	IN	O	in	_	0	SENT_278	[p21l1493t278r1576b355],
24	the	DT	O	the	det	25	SENT_278	[p21l1637t277r1770b355],
25	rate	NN	O	rate	prep_in	22	SENT_278	[p21l1831t294r1991b355],
26	of	IN	O	of	_	0	SENT_278	[p21l2052t276r2152b356],
27	stent	JJ	O	stent	amod	28	SENT_278	[p21l12t422r221b483],
28	thrombosis	NN	O	thrombosis	prep_of	25	SENT_278	[p21l267t405r784b484],
29	.	.	O	.	_	0	SENT_278	[p21l267t405r784b484],

1	We	PRP	O	we	nsubj	2	SENT_279	[p21l836t413r969b483],
2	found	VBD	O	find	_	0	SENT_279	[p21l1021t404r1273b484],
3	no	DT	O	no	det	4	SENT_279	[p21l1324t431r1429b484],
4	evidence	NN	O	evidence	dobj	2	SENT_279	[p21l1481t405r1847b484],
5	of	IN	O	of	_	0	SENT_279	[p21l1898t404r1998b484],
6	an	DT	O	a	det	7	SENT_279	[p21l2030t431r2133b483],
7	interaction	NN	O	interaction	prep_of	4	SENT_279	[p21l11t534r478b612],
8	between	IN	O	between	_	0	SENT_279	[p21l529t533r887b612],
9	study	NN	O	study	nn	10	SENT_279	[p21l938t533r1168b633],
10	treatment	NN	O	treatment	prep_between	7	SENT_279	[p21l1214t550r1638b611],
11	and	CC	O	and	_	0	SENT_279	[p21l1682t533r1840b612],
12	genotype	NN	O	genotype	conj_and	10	SENT_279	[p21l1890t559r2132b634, p21l12t678r193b761],
13	with	IN	O	with	_	0	SENT_279	[p21l217t661r412b740],
14	respect	NN	O	respect	prep_with	2	SENT_279	[p21l442t678r750b761],
15	to	TO	O	to	_	0	SENT_279	[p21l776t678r857b740],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_279	[p21l888t661r1516b740],
17	events	NNS	O	event	prep_to	2	SENT_279	[p21l1543t678r1806b740],
18	among	IN	O	among	_	0	SENT_279	[p21l1837t687r2137b762],
19	patients	NNS	O	patient	prep_among	2	SENT_279	[p21l9t790r351b888],
20	who	WP	O	who	nsubj	21	SENT_279	[p21l413t789r596b868],
21	underwent	VBD	O	undergo	conj_or	21	SENT_279	[p21l662t789r1127b868],
22	PCI	NN	O	pcus	dobj	21	SENT_279	[p21l1184t795r1334b867],
23	with	IN	O	with	_	0	SENT_279	[p21l1393t789r1588b868],
24	or	CC	O	or	_	0	SENT_279	[p21l1654t815r1742b867],
25	without	IN	O	without	_	0	SENT_279	[p21l1800t789r2139b868],
26	stenting	VBG	O	stent	prepc_with	21	SENT_279	[p21l12t918r383b1018],
27	,	,	O	,	_	0	SENT_279	[p21l12t918r383b1018],
28	but	CC	O	but	_	0	SENT_279	[p21l447t917r587b996],
29	we	PRP	O	we	nsubj	33	SENT_279	[p21l635t943r753b996],
30	can	MD	O	can	aux	33	SENT_279	[p21l812t934r1110b996],
31	not	RB	O	not	neg	33	SENT_279	[p21l812t934r1110b996],
32	definitely	RB	O	definitely	advmod	33	SENT_279	[p21l1163t916r1573b1017],
33	exclude	VB	O	exclude	conj_but	2	SENT_279	[p21l1627t917r1942b996],
34	the	DT	O	the	det	35	SENT_279	[p21l2001t917r2133b995],
35	possibility	NN	O	possibility	dobj	33	SENT_279	[p21l10t1045r459b1145],
36	of	IN	O	of	_	0	SENT_279	[p21l501t1044r601b1124],
37	an	DT	O	a	det	38	SENT_279	[p21l629t1071r731b1123],
38	interaction	NN	O	interaction	prep_of	35	SENT_279	[p21l777t1046r1244b1124],
39	in	IN	O	in	_	0	SENT_279	[p21l1290t1046r1373b1123],
40	the	DT	O	the	det	41	SENT_279	[p21l1420t1045r1552b1123],
41	subgroup	NN	O	subgroup	prep_in	33	SENT_279	[p21l1600t1045r2004b1146],
42	of	IN	O	of	_	0	SENT_279	[p21l2052t1044r2152b1124],
43	patients	NNS	O	patient	prep_of	41	SENT_279	[p21l9t1174r351b1272],
44	who	WP	O	who	nsubj	45	SENT_279	[p21l409t1173r592b1252],
45	receive	VBP	O	receive	rcmod	43	SENT_279	[p21l654t1174r942b1252],
46	stents	NNS	O	stent	dobj	45	SENT_279	[p21l1005t1189r1278b1268],
47	,	,	O	,	_	0	SENT_279	[p21l1005t1189r1278b1268],
48	particularly	RB	O	particularly	advmod	46	SENT_279	[p21l1343t1173r1845b1272],
49	those	DT	O	those	dep	46	SENT_279	[p21l1902t1173r2133b1251],
50	who	WP	O	who	nsubj	51	SENT_279	[p21l7t1301r189b1380],
51	receive	VBP	O	receive	rcmod	49	SENT_279	[p21l231t1302r519b1380],
52	drug	NN	O	drug	nn	53	SENT_279	[p21l561t1301r1103b1402],
53	—	NN	O	—	dobj	51	SENT_279	[p21l561t1301r1103b1402],
54	eluting	VBG	O	elute	partmod	53	SENT_279	[p21l561t1301r1103b1402],
55	stents	NNS	O	stent	dobj	54	SENT_279	[p21l1142t1318r1414b1397],
56	,	,	O	,	_	0	SENT_279	[p21l1142t1318r1414b1397],
57	which	WDT	O	which	nsubj	58	SENT_279	[p21l1455t1301r1718b1380],
58	were	VBD	O	be	rcmod	46	SENT_279	[p21l1754t1327r1955b1380],
59	not	RB	O	not	neg	58	SENT_279	[p21l1996t1318r2138b1380],
60	in	IN	O	in	_	0	SENT_279	[p21l11t1429r94b1506],
61	use	NN	O	use	prep_in	58	SENT_279	[p21l127t1454r268b1507],
62	at	IN	O	at	_	0	SENT_279	[p21l301t1445r380b1506],
63	the	DT	O	the	det	64	SENT_279	[p21l409t1428r542b1506],
64	time	NN	O	time	prep_at	45	SENT_279	[p21l576t1429r769b1506],
65	of	IN	O	of	_	0	SENT_279	[p21l804t1427r904b1507],
66	the	DT	O	the	det	68	SENT_279	[p21l920t1428r1052b1506],
67	CURE	NN	O	cure	nn	68	SENT_279	[p21l1086t1434r1342b1512],
68	trial	NN	O	trial	prep_of	64	SENT_279	[p21l1378t1428r1578b1507],
69	.	.	O	.	_	0	SENT_279	[p21l1378t1428r1578b1507],

1	In	IN	O	in	_	0	SENT_280	[p21l1617t1436r1706b1506],
2	the	DT	O	the	det	3	SENT_280	[p21l1739t1428r1872b1506],
3	study	NN	O	study	conj_and	3	SENT_280	[p21l1908t1428r2138b1528],
4	by	IN	O	by	_	0	SENT_280	[p21l12t1557r109b1656],
5	Collet	NNP	PERSON	Collet	prep_by	3	SENT_280	[p21l153t1557r407b1635],
6	et	FW	O	et	nn	7	SENT_280	[p21l451t1574r528b1635],
7	al.	FW	O	al.	dep	5	SENT_280	[p21l570t1557r706b1635],
8	3	CD	NUMBER	3	dep	7	SENT_280	[p21l570t1557r706b1635],
9	and	CC	O	and	_	0	SENT_280	[p21l756t1557r914b1635],
10	in	IN	O	in	_	0	SENT_280	[p21l961t1558r1044b1634],
11	the	DT	O	the	det	12	SENT_280	[p21l1093t1557r1226b1635],
12	Trial	NN	O	trial	prep_in	3	SENT_280	[p21l1271t1557r1473b1634],
13	to	TO	O	to	aux	14	SENT_280	[p21l1521t1573r1603b1635],
14	Assess	VB	O	assess	infmod	12	SENT_280	[p21l1649t1564r1933b1635],
15	Improvement	NN	O	improvement	dobj	14	SENT_280	[p21l1982t1564r2132b1634, p21l9t1702r469b1784],
16	in	IN	O	in	_	0	SENT_280	[p21l494t1686r577b1762],
17	Therapeutic	JJ	O	therapeutic	amod	18	SENT_280	[p21l606t1685r1119b1784],
18	Outcomes	NNS	O	outcome	prep_in	15	SENT_280	[p21l1150t1691r1582b1764],
19	by	IN	O	by	_	0	SENT_280	[p21l1618t1685r1715b1784],
20	Optimizing	VBG	O	optimize	prepc_by	14	SENT_280	[p21l1742t1686r2132b1784, p21l11t1814r150b1914],
21	Platelet	NN	O	platelet	nn	22	SENT_280	[p21l190t1813r505b1891],
22	Inhibition	NN	O	inhibition	dobj	20	SENT_280	[p21l543t1813r977b1892],
23	with	IN	O	with	_	0	SENT_280	[p21l1017t1813r1212b1892],
24	Prasugrel	NN	O	prasugrel	nn	26	SENT_280	[p21l1255t1813r1661b1914],
25	(	CD	NUMBER	(	num	26	SENT_280	[p21l1709t1819r2129b1909],
26	TRITON	NNP	ORGANIZATION	TRITON	prep_with	20	SENT_280	[p21l1709t1819r2129b1909],
27	;	:	O	;	_	0	SENT_280	[p21l1709t1819r2129b1909],
28	NCTOOO97591	NN	O	nctooo97591	dep	26	SENT_280	[p21l9t1946r717b2037],
29	)	CD	NUMBER	)	number	30	SENT_280	[p21l9t1946r717b2037],
30	,4	CD	NUMBER	,4	dep	28	SENT_280	[p21l9t1946r717b2037],
31	the	DT	O	the	det	33	SENT_280	[p21l778t1941r910b2019],
32	greatest	JJS	O	greatest	amod	33	SENT_280	[p21l972t1958r1317b2042],
33	effect	NN	O	effect	tmod	20	SENT_280	[p21l1374t1940r1616b2019],
34	of	IN	O	of	_	0	SENT_280	[p21l1673t1940r1773b2020],
35	loss	NN	O	loss	nn	36	SENT_280	[p21l1815t1940r2132b2020],
36	—	NN	O	—	prep_of	33	SENT_280	[p21l1815t1940r2132b2020],
37	of	IN	O	of	_	0	SENT_280	[p21l1815t1940r2132b2020],
38	—	CD	NUMBER	—	num	40	SENT_280	[p21l1815t1940r2132b2020],
39	function	NN	O	function	nn	40	SENT_280	[p21l11t2068r377b2148],
40	alleles	NNS	O	allele	prep_of	36	SENT_280	[p21l431t2069r690b2147],
41	on	IN	O	on	_	0	SENT_280	[p21l744t2095r848b2148],
42	the	DT	O	the	det	43	SENT_280	[p21l901t2069r1031b2147],
43	outcome	NN	O	outcome	prep_on	40	SENT_280	[p21l1084t2086r1445b2148],
44	in	IN	O	in	_	0	SENT_280	[p21l1497t2070r1578b2147],
45	clopidogrel	NN	O	clopidogrel	nn	46	SENT_280	[p21l1631t2069r2132b2170],
46	—	NN	O	—	prep_in	43	SENT_280	[p21l1631t2069r2132b2170],

1	N	NN	O	n	nn	3	SENT_281	[p21l546t2255r559b2270],
2	ENGLJ	NN	O	englj	nn	3	SENT_281	[p21l574t2255r652b2277],
3	MED	NN	O	med	_	0	SENT_281	[p21l667t2255r719b2270],
4	363	CD	NUMBER	363	dep	3	SENT_281	[p21l729t2249r805b2277],
5	;	:	O	;	_	0	SENT_281	[p21l729t2249r805b2277],
6	18	CD	NUMBER	18	num	8	SENT_281	[p21l729t2249r805b2277],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_281	[p21l841t2255r965b2277],
8	OCTOBER	NN	DATE	october	dep	4	SENT_281	[p21l1000t2255r1112b2271],
9	28	CD	DATE	28	dep	8	SENT_281	[p21l1122t2249r1157b2275],
10	,	,	DATE	,	_	0	SENT_281	[p21l1122t2249r1157b2275],
11	2010	CD	DATE	2010	num	12	SENT_281	[p21l1169t2255r1229b2271],
12	1711	CD	DATE	1711	appos	9	SENT_281	[p21l1940t2245r2016b2267],

1	The	DT	O	the	det	4	SENT_282	[p21l702t2288r753b2312],
2	New	NNP	O	New	nn	4	SENT_282	[p21l762t2289r824b2312],
3	England	NNP	O	England	nn	4	SENT_282	[p21l833t2288r944b2319],
4	Journal	NNP	O	Journal	_	0	SENT_282	[p21l952t2288r1050b2312],
5	of	IN	O	of	_	0	SENT_282	[p21l1059t2288r1088b2312],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_282	[p21l1095t2288r1220b2312],

1	The	DT	O	the	det	4	SENT_283	[p21l816t2413r862b2434],
2	NEW	NNP	O	NEW	nn	4	SENT_283	[p21l880t2415r966b2434],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_283	[p21l985t2415r1173b2434],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_283	[p21l1192t2415r1372b2441],
5	of	IN	O	of	_	0	SENT_283	[p21l1391t2413r1419b2440],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_283	[p21l1431t2415r1630b2434],

1	Outcome	NN	O	outcome	nn	4	SENT_284	[p21l188t2557r308b2579],
2	and	CC	O	and	_	0	SENT_284	[p21l317t2555r363b2579],
3	P	NN	O	p	conj_and	1	SENT_284	[p21l1872t2558r1886b2579],
4	Value	NN	O	value	dep	18	SENT_284	[p21l1894t2555r1966b2579],
5	for	IN	O	for	_	0	SENT_284	[p21l1974t2555r2010b2579],
6	Metabolizer	NNP	O	Metabolizer	nn	11	SENT_284	[p21l130t2591r281b2614],
7	Phenotype	NNP	O	Phenotype	nn	11	SENT_284	[p21l291t2591r425b2622],
8	Placebo	NNP	O	Placebo	nn	11	SENT_284	[p21l607t2591r705b2614],
9	Clopidogrel	NNP	O	Clopidogrel	nn	11	SENT_284	[p21l871t2591r1018b2622],
10	Hazard	NNP	O	Hazard	nn	11	SENT_284	[p21l1335t2591r1425b2614],
11	Ratio	NNP	O	Ratio	prep_for	4	SENT_284	[p21l1437t2591r1500b2614],
12	(	CD	PERCENT	(	number	13	SENT_284	[p21l1511t2592r1575b2622],
13	95	CD	PERCENT	95	dep	14	SENT_284	[p21l1511t2592r1575b2622],
14	%	NN	PERCENT	%	dep	11	SENT_284	[p21l1511t2592r1575b2622],
15	Cl	NN	O	cl	dep	18	SENT_284	[p21l1585t2593r1620b2622],
16	)	CD	NUMBER	)	num	15	SENT_284	[p21l1585t2593r1620b2622],
17	Heterogeneity	NN	O	heterogeneity	nn	18	SENT_284	[p21l1851t2591r2031b2622],
18	patients	NNS	O	patient	dep	25	SENT_284	[p21l550t2638r641b2666],
19	with	IN	O	with	_	0	SENT_284	[p21l650t2637r698b2659],
20	events/total	JJ	O	events/total	amod	21	SENT_284	[p21l707t2637r843b2666],
21	no.	NN	O	no.	prep_with	18	SENT_284	[p21l851t2645r883b2659],
22	of	IN	O	of	_	0	SENT_284	[p21l894t2637r921b2666],
23	patients	NNS	O	patient	prep_of	21	SENT_284	[p21l922t2638r1056b2666],
24	(	CD	PERCENT	(	num	25	SENT_284	[p21l922t2638r1056b2666],
25	%	NN	PERCENT	%	dep	26	SENT_284	[p21l922t2638r1056b2666],
26	)	CD	NUMBER	)	_	0	SENT_284	[p21l922t2638r1056b2666],

1	Primary	JJ	O	primary	amod	3	SENT_285	[p21l136t2685r226b2712],
2	composite	JJ	O	composite	amod	3	SENT_285	[p21l235t2685r360b2712],
3	outcome	NN	O	outcome	_	0	SENT_285	[p21l370t2687r475b2705],
4	Poor	NNP	O	Poor	dep	3	SENT_285	[p21l165t2727r219b2747],
5	1/12	CD	NUMBER	1/12	num	4	SENT_285	[p21l585t2727r637b2753],
6	(	CD	NUMBER	(	number	7	SENT_285	[p21l649t2726r700b2753],
7	8.3	CD	NUMBER	8.3	num	8	SENT_285	[p21l649t2726r700b2753],
8	)	NN	O	)	dep	4	SENT_285	[p21l649t2726r700b2753],
9	1/9	CD	NUMBER	1/9	number	10	SENT_285	[p21l908t2727r945b2754],
10	(	CD	NUMBER	(	dep	3	SENT_285	[p21l957t2726r1023b2754],
11	11.1	CD	NUMBER	11.1	num	12	SENT_285	[p21l957t2726r1023b2754],
12	)	NN	O	)	dep	10	SENT_285	[p21l957t2726r1023b2754],
13	0.74	CD	NUMBER	0.74	number	14	SENT_285	[p21l1653t2725r1703b2746],
14	(	CD	NUMBER	(	dep	3	SENT_285	[p21l1715t2725r1862b2753],
15	0.05	CD	NUMBER	0.05	num	16	SENT_285	[p21l1715t2725r1862b2753],
16	—	NN	O	—	dep	14	SENT_285	[p21l1715t2725r1862b2753],
17	12	CD	NUMBER	12	dep	14	SENT_285	[p21l1715t2725r1862b2753],
18	.	.	O	.	_	0	SENT_285	[p21l1715t2725r1862b2753],

1	o4	NN	O	o4	nn	3	SENT_286	[p21l1715t2725r1862b2753],
2	)	CD	NUMBER	)	num	3	SENT_286	[p21l1715t2725r1862b2753],
3	Intermediate	NNP	O	Intermediate	dep	11	SENT_286	[p21l165t2766r316b2788],
4	24/92	CD	NUMBER	24/92	number	5	SENT_286	[p21l569t2768r637b2795],
5	(	CD	NUMBER	(	dep	3	SENT_286	[p21l649t2768r714b2795],
6	26.1	CD	NUMBER	26.1	dep	5	SENT_286	[p21l649t2768r714b2795],
7	)	NN	O	)	dep	11	SENT_286	[p21l649t2768r714b2795],
8	21/93	CD	NUMBER	21/93	num	7	SENT_286	[p21l877t2768r944b2795],
9	(	CD	NUMBER	(	num	11	SENT_286	[p21l957t2768r1023b2795],
10	22.6	CD	NUMBER	22.6	num	11	SENT_286	[p21l957t2768r1023b2795],
11	)	NN	O	)	dep	15	SENT_286	[p21l957t2768r1023b2795],
12	0.85	CD	NUMBER	0.85	number	13	SENT_286	[p21l1652t2767r1700b2787],
13	(	CD	NUMBER	(	dep	11	SENT_286	[p21l1713t2767r1846b2794],
14	0.47	CD	NUMBER	0.47	dep	13	SENT_286	[p21l1713t2767r1846b2794],
15	—	NN	O	—	dep	17	SENT_286	[p21l1713t2767r1846b2794],
16	1.54	CD	NUMBER	1.54	num	15	SENT_286	[p21l1713t2767r1846b2794],
17	)	NN	O	)	dep	23	SENT_286	[p21l1713t2767r1846b2794],
18	'	''	O	'	_	0	SENT_286	[p21l243t2810r246b2813],
19	68/235	CD	NUMBER	68/235	number	20	SENT_286	[p21l555t2809r636b2837],
20	(	CD	NUMBER	(	dep	17	SENT_286	[p21l649t2809r714b2837],
21	28.9	CD	NUMBER	28.9	num	22	SENT_286	[p21l649t2809r714b2837],
22	)	NN	O	)	dep	20	SENT_286	[p21l649t2809r714b2837],
23	34/199	CD	NUMBER	34/199	dep	33	SENT_286	[p21l863t2810r945b2837],
24	(	CD	NUMBER	(	number	25	SENT_286	[p21l957t2810r1023b2837],
25	17.1	CD	NUMBER	17.1	num	26	SENT_286	[p21l957t2810r1023b2837],
26	)	NN	O	)	dep	23	SENT_286	[p21l957t2810r1023b2837],
27	0.55	CD	NUMBER	0.55	number	28	SENT_286	[p21l1652t2807r1700b2828],
28	(	CD	NUMBER	(	num	26	SENT_286	[p21l1713t2807r1846b2834],
29	O.	NNP	O	O.	dep	26	SENT_286	[p21l1713t2807r1846b2834],
30	36	CD	NUMBER	36	num	29	SENT_286	[p21l1713t2807r1846b2834],
31	—	CD	NUMBER	—	num	33	SENT_286	[p21l1713t2807r1846b2834],
32	0.83	CD	NUMBER	0.83	num	33	SENT_286	[p21l1713t2807r1846b2834],
33	)	NN	O	)	dep	38	SENT_286	[p21l1713t2807r1846b2834],
34	50/200	CD	NUMBER	50/200	number	35	SENT_286	[p21l555t2851r638b2879],
35	(	CD	NUMBER	(	dep	33	SENT_286	[p21l649t2851r714b2879],
36	25.0	CD	NUMBER	25.0	num	37	SENT_286	[p21l649t2851r714b2879],
37	)	NN	O	)	dep	35	SENT_286	[p21l649t2851r714b2879],
38	49/222	CD	NUMBER	49/222	dep	47	SENT_286	[p21l862t2852r945b2879],
39	(	CD	NUMBER	(	number	40	SENT_286	[p21l957t2851r1023b2879],
40	22.1	CD	NUMBER	22.1	num	41	SENT_286	[p21l957t2851r1023b2879],
41	)	NN	O	)	dep	38	SENT_286	[p21l957t2851r1023b2879],
42	0.97	CD	NUMBER	0.97	number	43	SENT_286	[p21l1652t2851r1702b2871],
43	(	CD	NUMBER	(	num	41	SENT_286	[p21l1713t2851r1846b2878],
44	O.	NNP	O	O.	dep	41	SENT_286	[p21l1713t2851r1846b2878],
45	65	CD	NUMBER	65	num	44	SENT_286	[p21l1713t2851r1846b2878],
46	—	CD	NUMBER	—	num	47	SENT_286	[p21l1713t2851r1846b2878],
47	1.45	CD	NUMBER	1.45	dep	53	SENT_286	[p21l1713t2851r1846b2878],
48	)	NN	O	)	dep	47	SENT_286	[p21l1713t2851r1846b2878],
49	10/35	CD	NUMBER	10/35	num	48	SENT_286	[p21l570t2893r636b2920],
50	(	CD	NUMBER	(	number	51	SENT_286	[p21l649t2893r714b2920],
51	28.6	CD	NUMBER	28.6	num	52	SENT_286	[p21l649t2893r714b2920],
52	)	NN	O	)	dep	48	SENT_286	[p21l649t2893r714b2920],
53	7/37	CD	NUMBER	7/37	dep	62	SENT_286	[p21l893t2893r946b2920],
54	(	CD	NUMBER	(	number	55	SENT_286	[p21l957t2893r1023b2920],
55	18.9	CD	NUMBER	18.9	num	56	SENT_286	[p21l957t2893r1023b2920],
56	)	NN	O	)	dep	53	SENT_286	[p21l957t2893r1023b2920],
57	0.55	CD	NUMBER	0.55	number	58	SENT_286	[p21l1652t2892r1700b2913],
58	(	CD	NUMBER	(	num	56	SENT_286	[p21l1713t2892r1846b2920],
59	0.21	CD	NUMBER	0.21	num	60	SENT_286	[p21l1713t2892r1846b2920],
60	—	NN	O	—	dep	56	SENT_286	[p21l1713t2892r1846b2920],
61	1.47	CD	NUMBER	1.47	num	62	SENT_286	[p21l1713t2892r1846b2920],
62	)	CD	NUMBER	)	dep	68	SENT_286	[p21l1713t2892r1846b2920],
63	153/574	CD	NUMBER	153/574	num	64	SENT_286	[p21l541t2935r637b2962],
64	(	NN	O	(	dep	62	SENT_286	[p21l649t2935r714b2962],
65	26.7	CD	NUMBER	26.7	number	66	SENT_286	[p21l649t2935r714b2962],
66	)	CD	NUMBER	)	dep	64	SENT_286	[p21l649t2935r714b2962],
67	112/560	CD	NUMBER	112/560	num	68	SENT_286	[p21l850t2935r946b2962],
68	(	NN	O	(	dep	72	SENT_286	[p21l957t2935r1023b2962],
69	20.0	CD	NUMBER	20.0	number	70	SENT_286	[p21l957t2935r1023b2962],
70	)	CD	NUMBER	)	dep	68	SENT_286	[p21l957t2935r1023b2962],
71	0.74	CD	NUMBER	0.74	dep	70	SENT_286	[p21l1652t2933r1701b2954],
72	(	NN	O	(	dep	75	SENT_286	[p21l1713t2933r1846b2961],
73	053-094	CD	NUMBER	053-094	num	72	SENT_286	[p21l1713t2933r1846b2961],
74	)	CD	NUMBER	)	num	75	SENT_286	[p21l1713t2933r1846b2961],
75	0.32	CD	NUMBER	0.32	_	0	SENT_286	[p21l1939t2935r1988b2955],

1	2/12	CD	NUMBER	2/12	dep	10	SENT_287	[p21l583t3018r637b3045],
2	(	CD	NUMBER	(	number	3	SENT_287	[p21l649t3018r714b3045],
3	16.7	CD	NUMBER	16.7	num	4	SENT_287	[p21l649t3018r714b3045],
4	)	NN	O	)	dep	1	SENT_287	[p21l649t3018r714b3045],
5	0/9	CD	NUMBER	0/9	num	6	SENT_287	[p21l905t3018r945b3045],
6	N/A	NN	O	n/a	dep	4	SENT_287	[p21l1728t3017r1776b3045],
7	2/92	CD	NUMBER	2/92	num	8	SENT_287	[p21l583t3060r637b3087],
8	(	NN	O	(	dep	10	SENT_287	[p21l649t3060r700b3087],
9	2.2	CD	NUMBER	2.2	num	10	SENT_287	[p21l649t3060r700b3087],
10	)	CD	NUMBER	)	dep	16	SENT_287	[p21l649t3060r700b3087],
11	10/93	CD	NUMBER	10/93	num	12	SENT_287	[p21l879t3060r944b3087],
12	(	NN	O	(	dep	10	SENT_287	[p21l957t3060r1023b3087],
13	10.8	CD	NUMBER	10.8	number	14	SENT_287	[p21l957t3060r1023b3087],
14	)	CD	NUMBER	)	dep	12	SENT_287	[p21l957t3060r1023b3087],
15	5.84	CD	NUMBER	5.84	num	16	SENT_287	[p21l1653t3059r1702b3080],
16	(	NN	O	(	dep	22	SENT_287	[p21l1714t3059r1862b3086],
17	1.26	CD	NUMBER	1.26	number	18	SENT_287	[p21l1714t3059r1862b3086],
18	—	CD	NUMBER	—	dep	16	SENT_287	[p21l1714t3059r1862b3086],
19	27.06	CD	NUMBER	27.06	num	20	SENT_287	[p21l1714t3059r1862b3086],
20	)	CD	NUMBER	)	dep	18	SENT_287	[p21l1714t3059r1862b3086],
21	11/235	CD	NUMBER	11/235	num	22	SENT_287	[p21l556t3102r636b3129],
22	(	NN	O	(	dep	26	SENT_287	[p21l649t3102r700b3129],
23	4.7	CD	NUMBER	4.7	number	24	SENT_287	[p21l649t3102r700b3129],
24	)	CD	NUMBER	)	dep	22	SENT_287	[p21l649t3102r700b3129],
25	10/199	CD	NUMBER	10/199	dep	24	SENT_287	[p21l864t3101r945b3129],
26	(	NN	O	(	dep	29	SENT_287	[p21l957t3101r1008b3129],
27	5.0	CD	NUMBER	5.0	num	26	SENT_287	[p21l957t3101r1008b3129],
28	)	CD	NUMBER	)	num	29	SENT_287	[p21l957t3101r1008b3129],
29	0.91	CD	NUMBER	0.91	_	0	SENT_287	[p21l1652t3101r1700b3121],
30	(	CD	NUMBER	(	num	69	SENT_287	[p21l1713t3100r1846b3128],
31	O.	NNP	O	O.	nn	69	SENT_287	[p21l1713t3100r1846b3128],
32	38	CD	NUMBER	38	num	69	SENT_287	[p21l1713t3100r1846b3128],
33	—	CD	NUMBER	—	num	69	SENT_287	[p21l1713t3100r1846b3128],
34	2.18	CD	NUMBER	2.18	num	69	SENT_287	[p21l1713t3100r1846b3128],
35	)	CD	NUMBER	)	num	69	SENT_287	[p21l1713t3100r1846b3128],
36	6/200	CD	NUMBER	6/200	num	69	SENT_287	[p21l569t3143r637b3170],
37	(	NN	O	(	nn	69	SENT_287	[p21l649t3143r700b3170],
38	3.0	CD	NUMBER	3.0	num	69	SENT_287	[p21l649t3143r700b3170],
39	)	CD	NUMBER	)	num	69	SENT_287	[p21l649t3143r700b3170],
40	8/222	CD	NUMBER	8/222	num	69	SENT_287	[p21l877t3143r945b3171],
41	(	NN	O	(	nn	69	SENT_287	[p21l957t3143r1008b3171],
42	3.6	CD	NUMBER	3.6	num	69	SENT_287	[p21l957t3143r1008b3171],
43	)	NN	O	)	nn	69	SENT_287	[p21l957t3143r1008b3171],
44	1.24	CD	NUMBER	1.24	num	69	SENT_287	[p21l1654t3142r1701b3162],
45	(	CD	NUMBER	(	num	69	SENT_287	[p21l1713t3142r1846b3169],
46	043-359	CD	NUMBER	043-359	num	69	SENT_287	[p21l1713t3142r1846b3169],
47	)	CD	NUMBER	)	num	69	SENT_287	[p21l1713t3142r1846b3169],
48	2/35	CD	NUMBER	2/35	num	69	SENT_287	[p21l583t3185r636b3212],
49	(	NN	O	(	nn	69	SENT_287	[p21l649t3185r700b3212],
50	5.7	CD	NUMBER	5.7	num	69	SENT_287	[p21l649t3185r700b3212],
51	)	CD	NUMBER	)	num	69	SENT_287	[p21l649t3185r700b3212],
52	4/37	CD	NUMBER	4/37	num	69	SENT_287	[p21l891t3185r946b3212],
53	(	CD	NUMBER	(	num	69	SENT_287	[p21l957t3185r1023b3212],
54	10.8	CD	NUMBER	10.8	num	69	SENT_287	[p21l957t3185r1023b3212],
55	)	NN	O	)	nn	69	SENT_287	[p21l957t3185r1023b3212],
56	1.84	CD	NUMBER	1.84	num	69	SENT_287	[p21l1655t3183r1702b3204],
57	(	CD	NUMBER	(	num	69	SENT_287	[p21l1714t3183r1862b3211],
58	0.34	CD	NUMBER	0.34	num	69	SENT_287	[p21l1714t3183r1862b3211],
59	—	NN	O	—	nn	69	SENT_287	[p21l1714t3183r1862b3211],
60	10.08	CD	NUMBER	10.08	num	69	SENT_287	[p21l1714t3183r1862b3211],
61	)	CD	NUMBER	)	num	69	SENT_287	[p21l1714t3183r1862b3211],
62	23/574	CD	NUMBER	23/574	num	69	SENT_287	[p21l554t3227r637b3254],
63	(	NN	O	(	nn	69	SENT_287	[p21l649t3226r700b3254],
64	4.0	CD	NUMBER	4.0	num	69	SENT_287	[p21l649t3226r700b3254],
65	)	CD	NUMBER	)	num	69	SENT_287	[p21l649t3226r700b3254],
66	32/560	CD	NUMBER	32/560	num	69	SENT_287	[p21l863t3226r946b3254],
67	(	NN	O	(	nn	69	SENT_287	[p21l957t3227r1008b3254],
68	5.7	CD	NUMBER	5.7	num	69	SENT_287	[p21l957t3227r1008b3254],
69	)	NN	O	)	nsubj	76	SENT_287	[p21l957t3227r1008b3254],
70	1.49	CD	NUMBER	1.49	advmod	76	SENT_287	[p21l1654t3226r1701b3246],
71	(	CD	NUMBER	(	dep	70	SENT_287	[p21l1713t3226r1846b3253],
72	0.88	CD	NUMBER	0.88	num	73	SENT_287	[p21l1713t3226r1846b3253],
73	—	NN	O	—	dep	70	SENT_287	[p21l1713t3226r1846b3253],
74	2.5	CD	NUMBER	2.5	num	75	SENT_287	[p21l1713t3226r1846b3253],
75	s	NNS	O	s	dep	70	SENT_287	[p21l1713t3226r1846b3253],
76	)	VBP	O	)	rcmod	29	SENT_287	[p21l1713t3226r1846b3253],
77	0.08	CD	NUMBER	0.08	dobj	76	SENT_287	[p21l1939t3226r1988b3247],

1	Figure	NNP	O	Figure	_	0	SENT_288	[p21l122t3381r206b3413],
2	3	CD	NUMBER	3	dep	1	SENT_288	[p21l217t3383r239b3406],
3	.	.	O	.	_	0	SENT_288	[p21l217t3383r239b3406],

1	Effect	NN	O	effect	_	0	SENT_289	[p21l253t3380r332b3406],
2	of	IN	O	of	_	0	SENT_289	[p21l341t3380r373b3406],
3	Clopidogrel	NNP	O	Clopidogrel	prep_of	1	SENT_289	[p21l378t3381r536b3413],
4	as	IN	O	as	prep	1	SENT_289	[p21l548t3389r577b3406],
5	Compared	VBN	O	compare	_	0	SENT_289	[p21l588t3381r730b3413],
6	with	IN	O	with	prepc_compared_with	1	SENT_289	[p21l741t3381r800b3406],
7	Placebo	NN	O	placebo	pobj	1	SENT_289	[p21l814t3381r920b3406],
8	on	IN	O	on	_	0	SENT_289	[p21l930t3389r963b3406],
9	Clinical	JJ	O	clinical	amod	10	SENT_289	[p21l975t3381r1075b3406],
10	Outcomes	NNS	O	outcome	prep_on	1	SENT_289	[p21l1086t3383r1230b3406],
11	among	IN	O	among	_	0	SENT_289	[p21l1242t3389r1337b3413],
12	Patients	NNS	O	patient	prep_among	1	SENT_289	[p21l1349t3381r1459b3406],
13	with	IN	O	with	_	0	SENT_289	[p21l1470t3381r1528b3406],
14	Atrial	NNP	O	Atrial	nn	15	SENT_289	[p21l1539t3381r1612b3406],
15	Fibrillation	NNP	O	Fibrillation	prep_with	1	SENT_289	[p21l1626t3381r1771b3406],
16	in	IN	O	in	_	0	SENT_289	[p21l1784t3381r1807b3405],
17	ACTIVE	NNP	O	ACTIVE	nn	18	SENT_289	[p21l1818t3383r1923b3406],
18	A	NNP	O	A	prep_in	1	SENT_289	[p21l1933t3383r1961b3411],
19	,	,	O	,	_	0	SENT_289	[p21l1933t3383r1961b3411],
20	Stratiﬁed	NNP	O	Stratiﬁed	appos	18	SENT_289	[p21l119t3422r246b3447],
21	According	VBG	O	accord	_	0	SENT_289	[p21l257t3422r398b3455],
22	to	TO	O	to	prepc_according_to	1	SENT_289	[p21l406t3426r434b3447],
23	Metabolizer	NNP	O	Metabolizer	nn	24	SENT_289	[p21l446t3422r610b3447],
24	Phenotype	NN	O	phenotype	pobj	1	SENT_289	[p21l622t3422r775b3455],
25	.	.	O	.	_	0	SENT_289	[p21l622t3422r775b3455],

1	Hazard	NN	O	hazard	nn	2	SENT_290	[p21l122t3472r219b3497],
2	ratios	NNS	O	ratio	nsubj	14	SENT_290	[p21l234t3475r309b3497],
3	for	IN	O	for	_	0	SENT_290	[p21l320t3472r359b3497],
4	clopidogrel	NN	O	clopidogrel	prep_for	2	SENT_290	[p21l369t3472r523b3505],
5	as	IN	O	as	_	0	SENT_290	[p21l537t3481r564b3497],
6	compared	VBN	O	compare	prepc_as	4	SENT_290	[p21l576t3472r714b3505],
7	with	IN	O	with	pcomp	6	SENT_290	[p21l726t3472r783b3497],
8	placebo	NN	O	placebo	pobj	7	SENT_290	[p21l797t3472r903b3505],
9	are	VBP	O	be	auxpass	10	SENT_290	[p21l915t3481r956b3497],
10	shown	VBN	O	show	_	0	SENT_290	[p21l968t3472r1056b3497],
11	for	IN	O	for	_	0	SENT_290	[p21l1068t3472r1107b3497],
12	efficacy	NN	O	efficacy	prep_for	10	SENT_290	[p21l1117t3472r1223b3505],
13	and	CC	O	and	_	0	SENT_290	[p21l1234t3472r1283b3497],
14	bleed	VB	O	bleed	conj_and	10	SENT_290	[p21l1297t3472r1378b3497],
15	’	CD	NUMBER	’	num	16	SENT_290	[p21l1297t3472r1378b3497],
16	outcomes	NNS	O	outcome	dobj	14	SENT_290	[p21l1426t3477r1562b3497],
17	according	VBG	O	accord	_	0	SENT_290	[p21l1575t3472r1710b3505],
18	to	TO	O	to	prepc_according_to	14	SENT_290	[p21l1719t3477r1746b3497],
19	metabolizer	NN	O	metabolizer	nn	20	SENT_290	[p21l1759t3472r1924b3497],
20	phenotype	NN	O	phenotype	pobj	14	SENT_290	[p21l1936t3472r2032b3505, p21l119t3519r185b3547],
21	.	.	O	.	_	0	SENT_290	[p21l1936t3472r2032b3505, p21l119t3519r185b3547],

1	The	DT	O	the	det	4	SENT_291	[p21l197t3514r248b3539],
2	size	NN	O	size	nn	4	SENT_291	[p21l260t3516r311b3539],
3	ofeach	NN	O	ofeach	nn	4	SENT_291	[p21l323t3514r421b3539],
4	symbol	NN	O	symbol	nsubj	5	SENT_291	[p21l434t3514r532b3547],
5	is	VBZ	O	be	_	0	SENT_291	[p21l546t3516r565b3539],
6	in	IN	O	in	_	0	SENT_291	[p21l578t3516r600b3539],
7	inverse	JJ	O	inverse	amod	8	SENT_291	[p21l614t3516r711b3539],
8	proportion	NN	O	proportion	prep_in	5	SENT_291	[p21l724t3516r871b3547],
9	to	TO	O	to	_	0	SENT_291	[p21l883t3519r910b3539],
10	the	DT	O	the	det	14	SENT_291	[p21l920t3514r964b3539],
11	standard	JJ	O	standard	amod	14	SENT_291	[p21l976t3514r1096b3539],
12	deviation	NN	O	deviation	nn	14	SENT_291	[p21l1109t3514r1235b3539],
13	ofthe	NN	O	ofthe	nn	14	SENT_291	[p21l1247t3514r1326b3539],
14	ef	NN	O	ef	prep_to	5	SENT_291	[p21l1338t3514r1366b3539],
15	-	:	O	-	_	0	SENT_291	[p21l1417t3516r1479b3539],
16	size	NN	O	size	nn	17	SENT_291	[p21l1417t3516r1479b3539],
17	estimates	NNS	O	estimate	dep	14	SENT_291	[p21l1490t3516r1632b3539],
18	.	.	O	.	_	0	SENT_291	[p21l1490t3516r1632b3539],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_292	[p21l1643t3514r1764b3547],
2	were	VBD	O	be	auxpass	3	SENT_292	[p21l1776t3523r1840b3539],
3	performed	VBN	O	perform	_	0	SENT_292	[p21l1853t3514r1998b3547],
4	on	IN	O	on	_	0	SENT_292	[p21l2011t3523r2044b3539],
5	data	NNS	O	datum	prep_on	3	SENT_292	[p21l120t3556r178b3581],
6	from	IN	O	from	_	0	SENT_292	[p21l190t3555r254b3581],
7	patients	NNS	O	patient	prep_from	3	SENT_292	[p21l268t3558r378b3588],
8	of	IN	O	of	_	0	SENT_292	[p21l390t3555r420b3581],
9	European	JJ	MISC	european	amod	11	SENT_292	[p21l429t3558r557b3588],
10	ance	NN	O	ance	nn	11	SENT_292	[p21l571t3564r633b3581],
11	r	NN	O	r	prep_of	7	SENT_292	[p21l663t3565r672b3580],
12	,	,	O	,	_	0	SENT_292	[p21l688t3577r692b3585],
13	with	IN	O	with	_	0	SENT_292	[p21l704t3556r761b3581],
14	adjustment	NN	O	adjustment	prep_with	3	SENT_292	[p21l774t3556r933b3589],
15	for	IN	O	for	_	0	SENT_292	[p21l943t3555r981b3581],
16	age	NN	O	age	prep_for	14	SENT_292	[p21l992t3564r1038b3589],
17	and	CC	O	and	_	0	SENT_292	[p21l1050t3556r1099b3581],
18	sex	NN	O	sex	conj_and	16	SENT_292	[p21l1112t3564r1162b3581],
19	.	.	O	.	_	0	SENT_292	[p21l1112t3564r1162b3581],

1	Patients	NNS	O	patient	dep	169	SENT_293	[p21l1177t3558r1286b3581],
2	with	IN	O	with	dep	169	SENT_293	[p21l1297t3556r1354b3581],
3	two	CD	NUMBER	two	dep	169	SENT_293	[p21l1366t3560r1417b3581],
4	*	NN	O	*	dep	169	SENT_293	[p21l1428t3558r1460b3580],
5	2	CD	NUMBER	2	dep	169	SENT_293	[p21l1428t3558r1460b3580],
6	or	CC	O	or	dep	169	SENT_293	[p21l1472t3564r1500b3581],
7	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1510t3558r1539b3581],
8	3	CD	NUMBER	3	dep	169	SENT_293	[p21l1510t3558r1539b3581],
9	alleles	NNS	O	allele	dep	169	SENT_293	[p21l1553t3556r1638b3581],
10	(	CD	NUMBER	(	dep	169	SENT_293	[p21l1653t3558r1708b3589],
11	i.e.	FW	O	i.e.	dep	169	SENT_293	[p21l1653t3558r1708b3589],
12	,	,	O	,	_	0	SENT_293	[p21l1653t3558r1708b3589],
13	*	NN	O	*	dep	169	SENT_293	[p21l1721t3558r1808b3589],
14	2	CD	NUMBER	2	dep	169	SENT_293	[p21l1721t3558r1808b3589],
15	/	:	O	/	dep	169	SENT_293	[p21l1721t3558r1808b3589],
16	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1721t3558r1808b3589],
17	2	CD	NUMBER	2	dep	169	SENT_293	[p21l1721t3558r1808b3589],
18	,	,	O	,	_	0	SENT_293	[p21l1721t3558r1808b3589],
19	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1820t3558r1835b3572],
20	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1867t3558r1905b3585],
21	3	CD	NUMBER	3	dep	169	SENT_293	[p21l1867t3558r1905b3585],
22	,	,	O	,	_	0	SENT_293	[p21l1867t3558r1905b3585],
23	or	CC	O	or	dep	169	SENT_293	[p21l1918t3564r1946b3581],
24	*	NN	O	*	dep	169	SENT_293	[p21l1956t3558r2041b3589],
25	3	CD	NUMBER	3	dep	169	SENT_293	[p21l1956t3558r2041b3589],
26	/	:	O	/	dep	169	SENT_293	[p21l1956t3558r2041b3589],
27	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1956t3558r2041b3589],
28	3	CD	NUMBER	3	dep	169	SENT_293	[p21l1956t3558r2041b3589],
29	)	NN	O	)	dep	169	SENT_293	[p21l1956t3558r2041b3589],
30	were	VBD	O	be	dep	169	SENT_293	[p21l119t3606r184b3623],
31	classified	VBN	O	classify	dep	169	SENT_293	[p21l195t3597r323b3622],
32	as	IN	O	as	dep	169	SENT_293	[p21l336t3606r364b3622],
33	having	VBG	O	have	dep	169	SENT_293	[p21l377t3597r467b3631],
34	the	DT	O	the	dep	169	SENT_293	[p21l477t3597r520b3622],
35	poor-met	JJ	O	poor-met	dep	169	SENT_293	[p21l533t3602r660b3630],
36	olizer	NN	O	olizer	dep	169	SENT_293	[p21l697t3597r773b3622],
37	phenotype	NN	O	phenotype	dep	169	SENT_293	[p21l785t3597r938b3630],
38	,	,	O	,	_	0	SENT_293	[p21l785t3597r938b3630],
39	those	DT	O	those	dep	169	SENT_293	[p21l950t3597r1026b3622],
40	with	IN	O	with	dep	169	SENT_293	[p21l1037t3597r1094b3623],
41	one	CD	NUMBER	one	dep	169	SENT_293	[p21l1107t3606r1157b3622],
42	*	NN	O	*	dep	169	SENT_293	[p21l1168t3600r1199b3622],
43	2	CD	NUMBER	2	dep	169	SENT_293	[p21l1168t3600r1199b3622],
44	or	CC	O	or	dep	169	SENT_293	[p21l1211t3606r1239b3622],
45	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1249t3599r1279b3622],
46	3	CD	NUMBER	3	dep	169	SENT_293	[p21l1249t3599r1279b3622],
47	allele	NN	O	allele	dep	169	SENT_293	[p21l1292t3597r1363b3622],
48	(	CD	NUMBER	(	dep	169	SENT_293	[p21l1377t3599r1433b3630],
49	i.e.	FW	O	i.e.	dep	169	SENT_293	[p21l1377t3599r1433b3630],
50	,	,	O	,	_	0	SENT_293	[p21l1377t3599r1433b3630],
51	*	NN	O	*	dep	169	SENT_293	[p21l1445t3600r1473b3622],
52	1	CD	NUMBER	1	dep	169	SENT_293	[p21l1445t3600r1473b3622],
53	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1489t3600r1505b3614],
54	or	CC	O	or	dep	169	SENT_293	[p21l1533t3606r1561b3622],
55	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1571t3599r1656b3630],
56	1	CD	NUMBER	1	dep	169	SENT_293	[p21l1571t3599r1656b3630],
57	/	:	O	/	dep	169	SENT_293	[p21l1571t3599r1656b3630],
58	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1571t3599r1656b3630],
59	3	CD	NUMBER	3	dep	169	SENT_293	[p21l1571t3599r1656b3630],
60	)	NN	O	)	dep	169	SENT_293	[p21l1571t3599r1656b3630],
61	were	VBD	O	be	dep	169	SENT_293	[p21l1669t3606r1734b3623],
62	c	NN	O	c	dep	169	SENT_293	[p21l1745t3597r1838b3623],
63	|	CD	NUMBER	|	dep	169	SENT_293	[p21l1745t3597r1838b3623],
64	assif	NN	O	assif	dep	169	SENT_293	[p21l1745t3597r1838b3623],
65	'	''	O	'	_	0	SENT_293	[p21l1745t3597r1838b3623],
66	5	CD	NUMBER	5	dep	169	SENT_293	[p21l1902t3606r1913b3622],
67	having	VBG	O	have	dep	169	SENT_293	[p21l1927t3597r2017b3631],
68	the	DT	O	the	dep	169	SENT_293	[p21l119t3639r162b3664],
69	intermediate-metabolizer	JJ	O	intermediate-metabolizer	dep	169	SENT_293	[p21l173t3639r519b3664],
70	phenotype	NN	O	phenotype	dep	169	SENT_293	[p21l530t3639r680b3672],
71	,	,	O	,	_	0	SENT_293	[p21l530t3639r680b3672],
72	those	DT	O	those	dep	169	SENT_293	[p21l691t3639r765b3664],
73	without	IN	O	without	dep	169	SENT_293	[p21l775t3639r879b3664],
74	a	DT	O	a	dep	169	SENT_293	[p21l889t3648r902b3664],
75	*	NN	O	*	dep	169	SENT_293	[p21l913t3641r951b3669],
76	2	CD	NUMBER	2	dep	169	SENT_293	[p21l913t3641r951b3669],
77	,	,	O	,	_	0	SENT_293	[p21l913t3641r951b3669],
78	*	CD	NUMBER	*	dep	169	SENT_293	[p21l963t3641r1000b3669],
79	3	CD	NUMBER	3	dep	169	SENT_293	[p21l963t3641r1000b3669],
80	,	,	O	,	_	0	SENT_293	[p21l963t3641r1000b3669],
81	or	CC	O	or	dep	169	SENT_293	[p21l1012t3648r1040b3664],
82	*	NN	O	*	dep	169	SENT_293	[p21l1049t3641r1094b3664],
83	17	CD	NUMBER	17	dep	169	SENT_293	[p21l1049t3641r1094b3664],
84	allele	NN	O	allele	dep	169	SENT_293	[p21l1105t3639r1173b3664],
85	(	CD	NUMBER	(	dep	169	SENT_293	[p21l1187t3641r1240b3672],
86	i.e.	FW	O	i.e.	dep	169	SENT_293	[p21l1187t3641r1240b3672],
87	,	,	O	,	_	0	SENT_293	[p21l1187t3641r1240b3672],
88	*	NN	O	*	dep	169	SENT_293	[p21l1252t3641r1332b3672],
89	1	CD	NUMBER	1	dep	169	SENT_293	[p21l1252t3641r1332b3672],
90	/	:	O	/	dep	169	SENT_293	[p21l1252t3641r1332b3672],
91	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1252t3641r1332b3672],
92	1	CD	NUMBER	1	dep	169	SENT_293	[p21l1252t3641r1332b3672],
93	)	NN	O	)	dep	169	SENT_293	[p21l1252t3641r1332b3672],
94	were	VBD	O	be	dep	169	SENT_293	[p21l1345t3648r1408b3664],
95	clas	NNS	O	cla	dep	169	SENT_293	[p21l1419t3639r1469b3664],
96	'	POS	O	'	_	0	SENT_293	[p21l1487t3641r1490b3645],
97	'	''	O	'	_	0	SENT_293	[p21l1506t3641r1509b3645],
98	d	NN	O	d	dep	169	SENT_293	[p21l1528t3639r1543b3664],
99	as	IN	O	as	dep	169	SENT_293	[p21l1555t3648r1582b3664],
100	having	VBG	O	have	dep	169	SENT_293	[p21l1595t3639r1683b3672],
101	the	DT	O	the	dep	169	SENT_293	[p21l1692t3639r1734b3664],
102	extensive-metabolizer	JJ	O	extensive-metabolizer	dep	169	SENT_293	[p21l1745t3639r2044b3664],
103	phenotype	NN	O	phenotype	dep	169	SENT_293	[p21l121t3681r272b3714],
104	,	,	O	,	_	0	SENT_293	[p21l121t3681r272b3714],
105	those	DT	O	those	dep	169	SENT_293	[p21l283t3681r358b3706],
106	with	IN	O	with	dep	169	SENT_293	[p21l367t3681r424b3706],
107	a	DT	O	a	dep	169	SENT_293	[p21l436t3690r449b3706],
108	single	JJ	O	single	dep	169	SENT_293	[p21l461t3681r539b3714],
109	*	NN	O	*	dep	169	SENT_293	[p21l549t3683r594b3706],
110	l7	NN	O	l7	dep	169	SENT_293	[p21l549t3683r594b3706],
111	allele	NN	O	allele	dep	169	SENT_293	[p21l605t3681r674b3706],
112	(	CD	NUMBER	(	dep	169	SENT_293	[p21l687t3683r741b3714],
113	i.e.	FW	O	i.e.	dep	169	SENT_293	[p21l687t3683r741b3714],
114	,	,	O	,	_	0	SENT_293	[p21l687t3683r741b3714],
115	*	NN	O	*	dep	169	SENT_293	[p21l753t3683r851b3714],
116	1	CD	NUMBER	1	dep	169	SENT_293	[p21l753t3683r851b3714],
117	/	:	O	/	dep	169	SENT_293	[p21l753t3683r851b3714],
118	*	CD	NUMBER	*	dep	169	SENT_293	[p21l753t3683r851b3714],
119	17	CD	NUMBER	17	dep	169	SENT_293	[p21l753t3683r851b3714],
120	)	NN	O	)	dep	169	SENT_293	[p21l753t3683r851b3714],
121	and	CC	O	and	dep	169	SENT_293	[p21l865t3681r913b3706],
122	*	NN	O	*	dep	169	SENT_293	[p21l925t3683r970b3706],
123	17	CD	NUMBER	17	dep	169	SENT_293	[p21l925t3683r970b3706],
124	homozygotes	NNS	O	homozygote	dep	169	SENT_293	[p21l982t3681r1163b3714],
125	were	VBD	O	be	dep	169	SENT_293	[p21l1174t3690r1238b3706],
126	classified	VBN	O	classify	dep	169	SENT_293	[p21l1248t3680r1373b3706],
127	as	IN	O	as	dep	169	SENT_293	[p21l1386t3690r1413b3706],
128	having	VBG	O	have	dep	169	SENT_293	[p21l1425t3681r1514b3714],
129	the	DT	O	the	dep	169	SENT_293	[p21l1523t3681r1565b3706],
130	ultrametabolizer	NN	O	ultrametabolizer	dep	169	SENT_293	[p21l1577t3681r1802b3706],
131	phe	NN	O	phe	dep	169	SENT_293	[p21l1813t3681r1861b3713],
132	pe	NN	O	pe	dep	169	SENT_293	[p21l1926t3690r1964b3713],
133	,	,	O	,	_	0	SENT_293	[p21l1926t3690r1964b3713],
134	and	CC	O	and	dep	169	SENT_293	[p21l1976t3681r2024b3706],
135	those	DT	O	those	dep	169	SENT_293	[p21l119t3722r195b3748],
136	with	IN	O	with	dep	169	SENT_293	[p21l206t3722r263b3748],
137	one	CD	NUMBER	one	dep	169	SENT_293	[p21l276t3731r326b3748],
138	*	NN	O	*	dep	169	SENT_293	[p21l337t3725r382b3747],
139	17	CD	NUMBER	17	dep	169	SENT_293	[p21l337t3725r382b3747],
140	allele	NN	O	allele	dep	169	SENT_293	[p21l394t3722r464b3748],
141	and	CC	O	and	dep	169	SENT_293	[p21l476t3722r524b3748],
142	one	CD	NUMBER	one	dep	169	SENT_293	[p21l537t3731r587b3748],
143	loss-of-function	NN	O	loss-of-function	dep	169	SENT_293	[p21l600t3722r817b3748],
144	allele	NN	O	allele	dep	169	SENT_293	[p21l830t3722r900b3748],
145	(	CD	NUMBER	(	dep	169	SENT_293	[p21l914t3724r970b3755],
146	i.e.	FW	O	i.e.	dep	169	SENT_293	[p21l914t3724r970b3755],
147	,	,	O	,	_	0	SENT_293	[p21l914t3724r970b3755],
148	*	NN	O	*	dep	169	SENT_293	[p21l982t3725r1075b3755],
149	2	CD	NUMBER	2	dep	169	SENT_293	[p21l982t3725r1075b3755],
150	/	:	O	/	dep	169	SENT_293	[p21l982t3725r1075b3755],
151	*	CD	NUMBER	*	dep	169	SENT_293	[p21l982t3725r1075b3755],
152	17	CD	NUMBER	17	dep	169	SENT_293	[p21l982t3725r1075b3755],
153	or	CC	O	or	dep	169	SENT_293	[p21l1087t3731r1115b3748],
154	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1125t3724r1226b3755],
155	3	CD	NUMBER	3	dep	169	SENT_293	[p21l1125t3724r1226b3755],
156	/	:	O	/	dep	169	SENT_293	[p21l1125t3724r1226b3755],
157	*	CD	NUMBER	*	dep	169	SENT_293	[p21l1125t3724r1226b3755],
158	17	CD	NUMBER	17	dep	169	SENT_293	[p21l1125t3724r1226b3755],
159	)	NN	O	)	dep	169	SENT_293	[p21l1125t3724r1226b3755],
160	were	VBD	O	be	dep	169	SENT_293	[p21l1239t3731r1304b3748],
161	classified	VBN	O	classify	dep	169	SENT_293	[p21l1315t3722r1443b3748],
162	as	IN	O	as	dep	169	SENT_293	[p21l1456t3731r1484b3748],
163	having	VBG	O	have	dep	169	SENT_293	[p21l1497t3722r1587b3756],
164	an	DT	O	a	dep	169	SENT_293	[p21l1598t3731r1628b3747],
165	unknown	JJ	O	unknown	dep	169	SENT_293	[p21l1642t3722r1767b3748],
166	metab	NN	O	metab	dep	169	SENT_293	[p21l1781t3722r1867b3748],
167	i	FW	O	i	dep	169	SENT_293	[p21l1897t3725r1901b3747],
168	er	FW	O	er	dep	169	SENT_293	[p21l1920t3731r1946b3748],
169	phenotype	NN	O	phenotype	_	0	SENT_293	[p21l1958t3722r2017b3755, p21l121t3769r222b3797],
170	.	.	O	.	_	0	SENT_293	[p21l1958t3722r2017b3755, p21l121t3769r222b3797],

1	Only	RB	O	only	advmod	2	SENT_294	[p21l235t3764r299b3797],
2	patients	NNS	O	patient	nsubjpass	13	SENT_294	[p21l311t3766r421b3797],
3	who	WP	O	who	nsubjpass	6	SENT_294	[p21l432t3764r489b3789],
4	were	VBD	O	be	auxpass	6	SENT_294	[p21l500t3773r565b3789],
5	successfully	RB	O	successfully	advmod	6	SENT_294	[p21l577t3764r742b3797],
6	genotyped	VBN	O	genotype	rcmod	2	SENT_294	[p21l753t3764r898b3797],
7	for	IN	O	for	_	0	SENT_294	[p21l910t3764r949b3789],
8	all	DT	O	all	det	11	SENT_294	[p21l959t3764r987b3789],
9	three	CD	NUMBER	three	num	11	SENT_294	[p21l999t3764r1070b3789],
10	single-nucleotide	JJ	O	single-nucleotide	amod	11	SENT_294	[p21l1082t3764r1321b3797],
11	polymorphisms	NNS	O	polymorphism	prep_for	6	SENT_294	[p21l1334t3764r1550b3797],
12	were	VBD	O	be	auxpass	13	SENT_294	[p21l1561t3773r1626b3789],
13	included	VBN	O	include	_	0	SENT_294	[p21l1638t3764r1755b3789],
14	in	IN	O	in	_	0	SENT_294	[p21l1769t3766r1790b3789],
15	these	DT	O	these	det	16	SENT_294	[p21l1802t3764r1877b3789],
16	analyses	NNS	O	analysis	prep_in	13	SENT_294	[p21l1888t3764r2012b3797],
17	.	.	O	.	_	0	SENT_294	[p21l1888t3764r2012b3797],

1	treated	JJ	O	treated	amod	2	SENT_295	[p22l21t207r312b285],
2	patients	NNS	O	patient	nsubj	5	SENT_295	[p22l342t208r675b306],
3	was	VBD	O	be	cop	5	SENT_295	[p22l706t233r868b286],
4	the	DT	O	the	det	5	SENT_295	[p22l905t207r1037b285],
5	effect	NN	O	effect	_	0	SENT_295	[p22l1072t206r1313b285],
6	on	IN	O	on	_	0	SENT_295	[p22l1343t233r1449b286],
7	stent	NN	O	stent	nn	8	SENT_295	[p22l1485t224r1693b285],
8	thrombosis	NN	O	thrombosis	prep_on	5	SENT_295	[p22l1722t207r2134b285, p22l22t336r156b431],
9	,	,	O	,	_	0	SENT_295	[p22l1722t207r2134b285, p22l22t336r156b431],
10	a	DT	O	a	det	11	SENT_295	[p22l215t361r259b413],
11	finding	NN	O	finding	appos	8	SENT_295	[p22l311t334r641b436],
12	that	WDT	O	that	nsubj	14	SENT_295	[p22l692t335r867b413],
13	is	VBZ	O	be	cop	14	SENT_295	[p22l915t336r981b413],
14	consistent	JJ	O	consistent	rcmod	11	SENT_295	[p22l1039t336r1485b414],
15	with	IN	O	with	_	0	SENT_295	[p22l1530t335r1728b414],
16	such	JJ	O	such	amod	18	SENT_295	[p22l1783t335r1979b414],
17	an	DT	O	a	det	18	SENT_295	[p22l2032t361r2135b413],
18	interaction	NN	O	interaction	prep_with	14	SENT_295	[p22l20t464r509b541],
19	.	.	O	.	_	0	SENT_295	[p22l20t464r509b541],

1	Previous	JJ	O	previous	amod	2	SENT_296	[p22l148t591r508b668],
2	studies	NNS	O	study	_	0	SENT_296	[p22l559t590r858b668],
3	that	WDT	O	that	nsubj	5	SENT_296	[p22l908t590r1079b667],
4	have	VBP	O	have	aux	5	SENT_296	[p22l1121t590r1310b668],
5	shown	VBN	O	show	rcmod	2	SENT_296	[p22l1360t590r1640b668],
6	an	DT	O	a	det	8	SENT_296	[p22l1686t615r1789b667],
7	attenu	NN	O	attenu	nn	8	SENT_296	[p22l1836t606r2134b668],
8	—	NN	O	—	dobj	5	SENT_296	[p22l1836t606r2134b668],

1	ated	VBN	O	ate	_	0	SENT_297	[p22l20t717r201b796],
2	benefit	NN	O	benefit	dobj	1	SENT_297	[p22l258t716r568b796],
3	of	IN	O	of	_	0	SENT_297	[p22l620t716r720b796],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_297	[p22l760t717r1251b818],
5	among	IN	O	among	_	0	SENT_297	[p22l1306t743r1609b818],
6	carriers	NNS	O	carrier	prep_among	1	SENT_297	[p22l1663t718r1994b795],
7	of	IN	O	of	_	0	SENT_297	[p22l2053t716r2153b796],
8	loss	NN	O	loss	nn	9	SENT_297	[p22l20t844r720b924],
9	—	NN	O	—	prep_of	6	SENT_297	[p22l20t844r720b924],
10	of	IN	O	of	_	0	SENT_297	[p22l20t844r720b924],
11	—	CD	NUMBER	—	num	13	SENT_297	[p22l20t844r720b924],
12	function	NN	O	function	nn	13	SENT_297	[p22l20t844r720b924],
13	alleles	NNS	O	allele	prep_of	9	SENT_297	[p22l775t845r1046b923],
14	did	VBD	O	do	aux	16	SENT_297	[p22l1104t845r1241b924],
15	not	RB	O	not	neg	16	SENT_297	[p22l1296t862r1440b924],
16	include	VB	O	include	dep	1	SENT_297	[p22l1490t845r1805b924],
17	a	DT	O	a	nsubj	1	SENT_297	[p22l1861t871r1905b923],
18	randomized	VBN	O	randomize	partmod	17	SENT_297	[p22l1959t871r2134b923, p22l21t973r395b1052],

1	control	JJ	O	control	amod	2	SENT_298	[p22l441t973r746b1052],
2	group	NN	O	group	nsubj	16	SENT_298	[p22l791t999r1064b1074],
3	,	,	O	,	_	0	SENT_298	[p22l791t999r1064b1074],
4	and	CC	O	and	_	0	SENT_298	[p22l1115t973r1272b1052],
5	therefore	RB	O	therefore	advmod	2	SENT_298	[p22l1318t972r1705b1052],
6	potential	JJ	O	potential	amod	8	SENT_298	[p22l1750t973r2136b1073],
7	pleiotropic	JJ	O	pleiotropic	amod	8	SENT_298	[p22l20t1100r480b1199],
8	effects	NNS	O	effect	conj_and	2	SENT_298	[p22l512t1099r791b1178],
9	of	IN	O	of	_	0	SENT_298	[p22l827t1099r926b1178],
10	loss	NN	O	loss	nn	11	SENT_298	[p22l938t1099r1622b1179],
11	—	NN	O	—	prep_of	8	SENT_298	[p22l938t1099r1622b1179],
12	of	IN	O	of	_	0	SENT_298	[p22l938t1099r1622b1179],
13	—	CD	NUMBER	—	num	15	SENT_298	[p22l938t1099r1622b1179],
14	function	NN	O	function	nn	15	SENT_298	[p22l938t1099r1622b1179],
15	alleles	NNS	O	allele	prep_of	2	SENT_298	[p22l1654t1100r1918b1178],
16	(	VBP	O	(	ccomp	33	SENT_298	[p22l1957t1101r2130b1195],
17	i.e.	FW	O	i.e.	dobj	16	SENT_298	[p22l1957t1101r2130b1195],
18	,	,	O	,	_	0	SENT_298	[p22l1957t1101r2130b1195],
19	independent	JJ	O	independent	nsubjpass	33	SENT_298	[p22l20t1227r557b1326],
20	of	IN	O	of	_	0	SENT_298	[p22l589t1226r688b1305],
21	their	PRP$	O	they	poss	22	SENT_298	[p22l706t1227r909b1305],
22	effects	NNS	O	effect	prep_of	19	SENT_298	[p22l943t1226r1223b1305],
23	on	IN	O	on	_	0	SENT_298	[p22l1262t1253r1367b1305],
24	active	JJ	O	active	amod	26	SENT_298	[p22l1403t1228r1643b1306],
25	metabolite	NN	O	metabolite	nn	26	SENT_298	[p22l1679t1227r2135b1306],
26	levels	NNS	O	level	prep_on	22	SENT_298	[p22l20t1355r249b1434],
27	of	IN	O	of	_	0	SENT_298	[p22l292t1354r392b1434],
28	clopidogrel	NN	O	clopidogrel	nn	29	SENT_298	[p22l415t1355r923b1456],
29	)	NN	O	)	prep_of	26	SENT_298	[p22l415t1355r923b1456],
30	could	MD	O	could	aux	33	SENT_298	[p22l969t1355r1202b1434],
31	not	RB	O	not	neg	33	SENT_298	[p22l1243t1372r1385b1434],
32	be	VB	O	be	auxpass	33	SENT_298	[p22l1421t1355r1517b1434],
33	excluded	VBN	O	exclude	_	0	SENT_298	[p22l1558t1355r1952b1434],
34	.	.	O	.	_	0	SENT_298	[p22l1558t1355r1952b1434],

1	For	IN	O	for	_	0	SENT_299	[p22l1996t1363r2139b1434],
2	instance	NN	O	instance	prep_for	21	SENT_299	[p22l20t1483r403b1577],
3	,	,	O	,	_	0	SENT_299	[p22l20t1483r403b1577],
4	in	IN	O	in	_	0	SENT_299	[p22l450t1483r533b1559],
5	analyses	NNS	O	analysis	prep_in	21	SENT_299	[p22l576t1482r933b1581],
6	of	IN	O	of	_	0	SENT_299	[p22l979t1481r1079b1561],
7	the	DT	O	the	det	10	SENT_299	[p22l1103t1482r1236b1560],
8	ACTIVE	NNP	O	ACTIVE	nn	10	SENT_299	[p22l1275t1488r1613b1561],
9	A	NN	O	a	nn	10	SENT_299	[p22l1654t1490r1720b1559],
10	database	NN	O	database	prep_of	5	SENT_299	[p22l1761t1482r2135b1561],
11	that	WDT	O	that	nsubjpass	13	SENT_299	[p22l21t1609r196b1687],
12	were	VBD	O	be	auxpass	13	SENT_299	[p22l224t1635r429b1688],
13	confined	VBN	O	confine	rcmod	10	SENT_299	[p22l467t1608r857b1687],
14	to	TO	O	to	_	0	SENT_299	[p22l895t1626r977b1687],
15	patients	NNS	O	patient	prep_to	13	SENT_299	[p22l1014t1610r1362b1708],
16	treated	VBN	O	treat	partmod	15	SENT_299	[p22l1402t1609r1706b1687],
17	with	IN	O	with	_	0	SENT_299	[p22l1739t1609r1936b1688],
18	clopidogrel	NN	O	clopidogrel	prep_with	16	SENT_299	[p22l1975t1609r2134b1687, p22l20t1737r407b1838],
19	,	,	O	,	_	0	SENT_299	[p22l1975t1609r2134b1687, p22l20t1737r407b1838],
20	we	PRP	O	we	nsubj	21	SENT_299	[p22l450t1763r569b1816],
21	observed	VBD	O	observe	_	0	SENT_299	[p22l612t1737r998b1816],
22	an	DT	O	a	det	24	SENT_299	[p22l1040t1763r1143b1815],
23	increased	VBN	O	increase	amod	24	SENT_299	[p22l1184t1737r1600b1816],
24	risk	NN	O	risk	dobj	21	SENT_299	[p22l1641t1737r1808b1816],
25	of	IN	O	of	_	0	SENT_299	[p22l1846t1736r1946b1816],
26	major	JJ	O	major	amod	27	SENT_299	[p22l1970t1763r2134b1815, p22l7t1866r136b1965],
27	bleeding	NN	O	bleeding	prep_of	24	SENT_299	[p22l178t1865r555b1966],
28	among	IN	O	among	_	0	SENT_299	[p22l595t1891r898b1966],
29	carriers	NNS	O	carrier	prep_among	21	SENT_299	[p22l940t1866r1270b1943],
30	of	IN	O	of	_	0	SENT_299	[p22l1318t1864r1418b1944],
31	loss	NN	O	loss	nn	32	SENT_299	[p22l1443t1864r2135b1944],
32	—	NN	O	—	prep_of	29	SENT_299	[p22l1443t1864r2135b1944],
33	of	IN	O	of	_	0	SENT_299	[p22l1443t1864r2135b1944],
34	—	CD	NUMBER	—	num	36	SENT_299	[p22l1443t1864r2135b1944],
35	function	NN	O	function	nn	36	SENT_299	[p22l1443t1864r2135b1944],
36	alleles	NNS	O	allele	prep_of	32	SENT_299	[p22l20t1993r291b2071],
37	as	IN	O	as	prep	21	SENT_299	[p22l335t2019r421b2070],
38	compared	VBN	O	compare	_	0	SENT_299	[p22l466t1993r898b2092],
39	with	IN	O	with	prepc_compared_with	21	SENT_299	[p22l935t1993r1133b2072],
40	noncarriers	JJ	O	noncarriers	amod	42	SENT_299	[p22l1175t1994r1676b2071],
41	(	NN	O	(	nn	42	SENT_299	[p22l1725t1999r2130b2083],
42	P	NN	O	p	pobj	21	SENT_299	[p22l1725t1999r2130b2083],
43	=	JJ	O	=	amod	42	SENT_299	[p22l1725t1999r2130b2083],
44	0.01	CD	NUMBER	0.01	num	45	SENT_299	[p22l1725t1999r2130b2083],
45	)	NN	O	)	dep	43	SENT_299	[p22l1725t1999r2130b2083],
46	.	.	O	.	_	0	SENT_299	[p22l1725t1999r2130b2083],

1	However	RB	O	however	advmod	11	SENT_300	[p22l20t2129r413b2217],
2	,	,	O	,	_	0	SENT_300	[p22l20t2129r413b2217],
3	a	DT	O	a	det	5	SENT_300	[p22l453t2147r497b2199],
4	similar	JJ	O	similar	amod	5	SENT_300	[p22l531t2121r836b2199],
5	pattern	NN	O	pattern	nsubjpass	11	SENT_300	[p22l866t2138r1177b2221],
6	of	IN	O	of	_	0	SENT_300	[p22l1212t2120r1311b2200],
7	increased	VBN	O	increase	amod	8	SENT_300	[p22l1327t2121r1733b2200],
8	bleeding	NN	O	bleeding	prep_of	5	SENT_300	[p22l1769t2121r2138b2222],
9	was	VBD	O	be	auxpass	11	SENT_300	[p22l16t2274r181b2326],
10	also	RB	O	also	advmod	11	SENT_300	[p22l236t2248r409b2326],
11	observed	VBN	O	observe	_	0	SENT_300	[p22l466t2248r853b2326],
12	among	IN	O	among	_	0	SENT_300	[p22l906t2273r1209b2348],
13	those	DT	O	those	prep_among	11	SENT_300	[p22l1260t2248r1495b2326],
14	who	WP	O	who	nsubj	15	SENT_300	[p22l1544t2248r1729b2326],
15	received	VBD	O	receive	rcmod	13	SENT_300	[p22l1784t2248r2135b2326],
16	placebo	NN	O	placebo	dobj	15	SENT_300	[p22l20t2375r369b2474],
17	,	,	O	,	_	0	SENT_300	[p22l20t2375r369b2474],
18	such	JJ	O	such	dep	21	SENT_300	[p22l422t2375r615b2454],
19	that	IN	O	that	dep	21	SENT_300	[p22l662t2375r834b2453],
20	there	EX	O	there	expl	21	SENT_300	[p22l875t2375r1091b2453],
21	was	VBD	O	be	dep	15	SENT_300	[p22l1133t2401r1295b2454],
22	no	DT	O	no	det	23	SENT_300	[p22l1342t2401r1447b2453],
23	evidence	NN	O	evidence	nsubj	21	SENT_300	[p22l1495t2375r1859b2454],
24	of	IN	O	of	_	0	SENT_300	[p22l1906t2374r2005b2453],
25	an	DT	O	a	det	26	SENT_300	[p22l2032t2401r2135b2453],
26	interaction	NN	O	interaction	prep_of	23	SENT_300	[p22l20t2504r497b2582],
27	between	IN	O	between	_	0	SENT_300	[p22l570t2503r932b2582],
28	study	NN	O	study	nn	29	SENT_300	[p22l1005t2503r1239b2603],
29	drug	NN	O	drug	prep_between	26	SENT_300	[p22l1307t2503r1513b2604],
30	and	CC	O	and	_	0	SENT_300	[p22l1581t2503r1741b2582],
31	loss	NN	O	loss	nn	34	SENT_300	[p22l1811t2502r2134b2582],
32	—	CD	NUMBER	—	num	34	SENT_300	[p22l1811t2502r2134b2582],
33	oﬁ	NN	O	oﬁ	nn	34	SENT_300	[p22l1811t2502r2134b2582],
34	function	NN	O	function	prep_between	26	SENT_300	[p22l21t2630r386b2710],
35	carrier	NN	O	carrier	nn	36	SENT_300	[p22l435t2632r719b2709],
36	status	NN	O	status	dep	41	SENT_300	[p22l765t2648r1016b2710],
37	(	CD	NUMBER	(	num	38	SENT_300	[p22l1071t2637r1411b2722],
38	P	NN	O	p	dep	36	SENT_300	[p22l1071t2637r1411b2722],
39	=	JJ	O	=	amod	40	SENT_300	[p22l1071t2637r1411b2722],
40	O.	NNP	O	O.	dep	41	SENT_300	[p22l1071t2637r1411b2722],
41	16	CD	NUMBER	16	dep	23	SENT_300	[p22l1071t2637r1411b2722],
42	for	IN	O	for	_	0	SENT_300	[p22l1460t2630r1583b2710],
43	heterogeneity	NN	O	heterogeneity	nn	44	SENT_300	[p22l1628t2631r2134b2732, p22l21t2760r174b2858],
44	)	NN	O	)	prep_for	41	SENT_300	[p22l1628t2631r2134b2732, p22l21t2760r174b2858],
45	.	.	O	.	_	0	SENT_300	[p22l1628t2631r2134b2732, p22l21t2760r174b2858],

1	In	IN	O	in	_	0	SENT_301	[p22l220t2766r309b2836],
2	other	JJ	O	other	amod	3	SENT_301	[p22l352t2759r579b2837],
3	words	NNS	O	word	prep_in	10	SENT_301	[p22l613t2759r898b2854],
4	,	,	O	,	_	0	SENT_301	[p22l613t2759r898b2854],
5	the	DT	O	the	det	6	SENT_301	[p22l946t2759r1078b2837],
6	association	NN	O	association	nsubjpass	10	SENT_301	[p22l1120t2760r1602b2837],
7	would	MD	O	would	aux	10	SENT_301	[p22l1639t2759r1904b2838],
8	have	VB	O	have	aux	10	SENT_301	[p22l1946t2759r2135b2838],
9	been	VBN	O	be	auxpass	10	SENT_301	[p22l22t2887r226b2966],
10	considered	VBN	O	consider	_	0	SENT_301	[p22l280t2887r751b2966],
11	significant	JJ	O	significant	acomp	10	SENT_301	[p22l806t2886r1283b2988],
12	if	IN	O	if	mark	16	SENT_301	[p22l1332t2886r1409b2965],
13	we	PRP	O	we	nsubj	16	SENT_301	[p22l1441t2913r1559b2966],
14	had	VBD	O	have	aux	16	SENT_301	[p22l1613t2887r1771b2966],
15	not	RB	O	not	neg	16	SENT_301	[p22l1825t2904r1969b2966],
16	included	VBN	O	include	advcl	10	SENT_301	[p22l2018t2888r2134b2965, p22l22t3014r304b3092],
17	the	DT	O	the	det	19	SENT_301	[p22l351t3014r485b3091],
18	placebo	NN	O	placebo	nn	19	SENT_301	[p22l530t3014r864b3113],
19	group	NN	O	group	dobj	16	SENT_301	[p22l911t3039r1166b3114],
20	in	IN	O	in	_	0	SENT_301	[p22l1213t3015r1297b3091],
21	the	DT	O	the	det	22	SENT_301	[p22l1344t3014r1478b3091],
22	analysis	NN	O	analysis	prep_in	19	SENT_301	[p22l1523t3014r1895b3113],
23	.	.	O	.	_	0	SENT_301	[p22l1523t3014r1895b3113],

1	This	DT	O	this	nsubj	2	SENT_302	[p22l1943t3014r2134b3091],
2	illustrates	VBZ	O	illustrate	_	0	SENT_302	[p22l21t3142r443b3221],
3	the	DT	O	the	det	5	SENT_302	[p22l501t3142r633b3220],
4	potential	JJ	O	potential	amod	5	SENT_302	[p22l688t3142r1074b3242],
5	pitfalls	NNS	O	pitfall	dobj	2	SENT_302	[p22l1127t3141r1425b3242],
6	of	IN	O	of	_	0	SENT_302	[p22l1483t3141r1583b3221],
7	interpreting	VBG	O	interpret	prepc_of	5	SENT_302	[p22l1619t3143r2138b3243],
8	subgroup	NN	O	subgroup	nn	9	SENT_302	[p22l13t3270r416b3371],
9	data	NNS	O	datum	dobj	7	SENT_302	[p22l456t3270r638b3349],
10	and	CC	O	and	_	0	SENT_302	[p22l673t3270r831b3349],
11	highlights	VBZ	O	highlight	conj_and	2	SENT_302	[p22l867t3270r1310b3371],
12	the	DT	O	the	det	13	SENT_302	[p22l1349t3270r1481b3348],
13	importance	NN	O	importance	dobj	11	SENT_302	[p22l1518t3271r2014b3370],
14	of	IN	O	of	_	0	SENT_302	[p22l2053t3269r2152b3349],
15	including	VBG	O	include	prepc_of	13	SENT_302	[p22l11t3398r422b3499],
16	a	DT	O	a	det	18	SENT_302	[p22l462t3424r506b3476],
17	placebo	NN	O	placebo	nn	18	SENT_302	[p22l547t3398r875b3498],
18	group	NN	O	group	dobj	15	SENT_302	[p22l920t3424r1173b3499],
19	to	TO	O	to	aux	20	SENT_302	[p22l1218t3415r1300b3477],
20	control	VB	O	control	xcomp	15	SENT_302	[p22l1346t3398r1651b3477],
21	for	IN	O	for	_	0	SENT_302	[p22l1694t3397r1818b3477],
22	potential	JJ	O	potential	amod	23	SENT_302	[p22l1857t3415r2133b3498, p22l12t3526r154b3604],
23	confounding	NN	O	confounding	prep_for	20	SENT_302	[p22l214t3525r781b3627],
24	in	IN	O	in	_	0	SENT_302	[p22l837t3527r922b3604],
25	analyses	NNS	O	analysis	prep_in	20	SENT_302	[p22l981t3526r1347b3626],
26	of	IN	O	of	_	0	SENT_302	[p22l1410t3525r1511b3605],
27	pharmacoge	NN	O	pharmacoge	nn	30	SENT_302	[p22l1552t3526r2133b3627],
28	—	NN	O	—	nn	30	SENT_302	[p22l1552t3526r2133b3627],
29	netic	JJ	O	netic	amod	30	SENT_302	[p22l12t3656r220b3733],
30	data	NNS	O	datum	prep_of	25	SENT_302	[p22l259t3655r464b3734],
31	.	.	O	.	_	0	SENT_302	[p22l259t3655r464b3734],

1	The	DT	O	the	det	3	SENT_303	[p23l137t32r298b110],
2	increased	VBN	O	increase	amod	3	SENT_303	[p23l341t32r749b111],
3	beneﬁt	NN	O	beneﬁt	nsubj	17	SENT_303	[p23l793t31r1098b111],
4	of	IN	O	of	_	0	SENT_303	[p23l1137t31r1236b111],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_303	[p23l1262t32r1745b133],
6	in	IN	O	in	_	0	SENT_303	[p23l1787t33r1870b110],
7	gainof	JJ	O	gainof	amod	11	SENT_303	[p23l1913t33r2133b133, p23l12t158r493b238],
8	—	NN	O	—	nn	11	SENT_303	[p23l1913t33r2133b133, p23l12t158r493b238],
9	function	NN	O	function	nn	11	SENT_303	[p23l1913t33r2133b133, p23l12t158r493b238],
10	allele	NN	O	allele	nn	11	SENT_303	[p23l546t159r768b237],
11	carriers	NNS	O	carrier	prep_in	5	SENT_303	[p23l823t160r1147b237],
12	in	IN	O	in	_	0	SENT_303	[p23l1202t160r1285b237],
13	the	DT	O	the	det	15	SENT_303	[p23l1339t159r1471b237],
14	CURE	NN	O	cure	nn	15	SENT_303	[p23l1525t165r1781b242],
15	trial	NN	O	trial	prep_in	11	SENT_303	[p23l1836t159r2014b237],
16	is	VBZ	O	be	cop	17	SENT_303	[p23l2066t160r2132b237],
17	consistent	JJ	O	consistent	_	0	SENT_303	[p23l12t289r452b366],
18	with	IN	O	with	_	0	SENT_303	[p23l476t288r671b367],
19	pharmacodynamic	JJ	O	pharmacodynamic	amod	20	SENT_303	[p23l703t288r1515b387],
20	data	NNS	O	datum	prep_with	17	SENT_303	[p23l1549t288r1732b366],
21	associating	VBG	O	associate	xcomp	17	SENT_303	[p23l1764t289r2133b366, p23l11t417r149b517],
22	this	DT	O	this	det	24	SENT_303	[p23l182t416r339b494],
23	genetic	JJ	O	genetic	amod	24	SENT_303	[p23l377t417r679b517],
24	variant	NN	O	variant	dobj	21	SENT_303	[p23l711t417r1008b495],
25	with	IN	O	with	_	0	SENT_303	[p23l1035t416r1227b495],
26	increased	VBN	O	increase	amod	28	SENT_303	[p23l1263t416r1663b495],
27	enzymatic	JJ	O	enzymatic	amod	28	SENT_303	[p23l1700t417r2134b516],
28	activity	NN	O	activity	prep_with	24	SENT_303	[p23l11t545r334b643],
29	,	,	O	,	_	0	SENT_303	[p23l11t545r334b643],
30	an	DT	O	a	det	33	SENT_303	[p23l373t570r477b621],
31	enhanced	VBN	O	enhance	amod	33	SENT_303	[p23l512t544r926b622],
32	platelet	NN	O	platelet	nn	33	SENT_303	[p23l959t544r1278b643],
33	response	NN	O	response	dobj	21	SENT_303	[p23l1307t570r1688b643],
34	to	TO	O	to	_	0	SENT_303	[p23l1724t561r1805b622],
35	clopidogrel	NN	O	clopidogrel	prep_to	33	SENT_303	[p23l1842t544r2133b643, p23l12t672r254b773],
36	,	,	O	,	_	0	SENT_303	[p23l1842t544r2133b643, p23l12t672r254b773],
37	and	CC	O	and	_	0	SENT_303	[p23l317t672r474b751],
38	an	DT	O	a	det	40	SENT_303	[p23l532t698r635b750],
39	increased	VBN	O	increase	amod	40	SENT_303	[p23l692t672r1101b751],
40	risk	NN	O	risk	dobj	21	SENT_303	[p23l1159t672r1323b751],
41	of	IN	O	of	_	0	SENT_303	[p23l1377t671r1476b751],
42	bleeding	VBG	O	bleed	prepc_of	40	SENT_303	[p23l1517t672r2134b773],
43	.6	CD	NUMBER	.6	number	44	SENT_303	[p23l1517t672r2134b773],
44	»	CD	NUMBER	»	num	46	SENT_303	[p23l1517t672r2134b773],
45	16	CD	NUMBER	16	number	46	SENT_303	[p23l1517t672r2134b773],
46	’17	CD	NUMBER	’17	dobj	42	SENT_303	[p23l1517t672r2134b773],
47	Although	IN	O	although	mark	52	SENT_303	[p23l8t800r415b901],
48	this	DT	O	this	nsubj	52	SENT_303	[p23l456t800r616b878],
49	is	VBZ	O	be	cop	52	SENT_303	[p23l657t801r723b878],
50	a	DT	O	a	det	52	SENT_303	[p23l764t826r808b878],
51	new	JJ	O	new	amod	52	SENT_303	[p23l847t826r1025b879],
52	finding	NN	O	finding	advcl	66	SENT_303	[p23l1061t799r1404b901],
53	,	,	O	,	_	0	SENT_303	[p23l1061t799r1404b901],
54	the	DT	O	the	det	55	SENT_303	[p23l1450t800r1582b878],
55	lack	NN	O	lack	nsubj	66	SENT_303	[p23l1622t800r1797b879],
56	of	IN	O	of	_	0	SENT_303	[p23l1834t799r1934b879],
57	validation	NN	O	validation	prep_of	55	SENT_303	[p23l1951t800r2133b879, p23l12t928r286b1007],
58	of	IN	O	of	_	0	SENT_303	[p23l350t927r450b1007],
59	this	DT	O	this	det	60	SENT_303	[p23l496t928r656b1006],
60	observation	NN	O	observation	prep_of	57	SENT_303	[p23l722t928r1222b1007],
61	among	IN	O	among	_	0	SENT_303	[p23l1286t954r1586b1029],
62	patients	NNS	O	patient	prep_among	60	SENT_303	[p23l1645t929r1986b1028],
63	in	IN	O	in	_	0	SENT_303	[p23l2051t929r2134b1006],
64	ACTIVE	NNP	O	ACTIVE	nn	65	SENT_303	[p23l8t1062r348b1135],
65	A	NNP	O	A	prep_in	62	SENT_303	[p23l387t1064r453b1134],
66	highlights	VBZ	O	highlight	rcmod	46	SENT_303	[p23l490t1056r932b1157],
67	the	DT	O	the	det	68	SENT_303	[p23l975t1056r1107b1134],
68	need	NN	O	need	dobj	66	SENT_303	[p23l1148t1056r1350b1135],
69	for	IN	O	for	_	0	SENT_303	[p23l1390t1055r1512b1135],
70	replication	NN	O	replication	prep_for	68	SENT_303	[p23l1550t1056r2012b1156],
71	in	IN	O	in	_	0	SENT_303	[p23l2051t1057r2134b1134],
72	larger	JJR	O	larger	amod	73	SENT_303	[p23l11t1184r266b1285],
73	studies	NNS	O	study	prep_in	70	SENT_303	[p23l321t1184r646b1263],
74	.	.	O	.	_	0	SENT_303	[p23l321t1184r646b1263],

1	Apart	RB	O	apart	_	0	SENT_304	[p23l705t1192r950b1284],
2	from	IN	O	from	_	0	SENT_304	[p23l1002t1183r1212b1263],
3	the	DT	O	the	det	6	SENT_304	[p23l1270t1184r1403b1262],
4	modest	JJ	O	modest	amod	6	SENT_304	[p23l1460t1184r1778b1263],
5	sample	NN	O	sample	nn	6	SENT_304	[p23l1832t1184r2134b1284],
6	size	NN	O	size	prep_apart_from	18	SENT_304	[p23l13t1312r175b1389],
7	in	IN	O	in	_	0	SENT_304	[p23l223t1312r306b1389],
8	ACTIVE	NNP	O	ACTIVE	nn	9	SENT_304	[p23l352t1317r691b1390],
9	A	NNP	O	A	prep_in	6	SENT_304	[p23l739t1319r826b1407],
10	,	,	O	,	_	0	SENT_304	[p23l739t1319r826b1407],
11	population	NN	O	population	nsubj	18	SENT_304	[p23l879t1310r1719b1411],
12	—	CD	NUMBER	—	num	15	SENT_304	[p23l879t1310r1719b1411],
13	specific	JJ	O	specific	amod	15	SENT_304	[p23l879t1310r1719b1411],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_304	[p23l1765t1311r2133b1411, p23l12t1441r420b1541],
15	effects	NNS	O	effect	dep	11	SENT_304	[p23l467t1439r749b1518],
16	could	MD	O	could	aux	18	SENT_304	[p23l799t1440r1033b1519],
17	also	RB	O	also	advmod	18	SENT_304	[p23l1079t1440r1250b1519],
18	explain	VB	O	explain	_	0	SENT_304	[p23l1299t1440r1613b1540],
19	this	DT	O	this	det	20	SENT_304	[p23l1660t1440r1820b1518],
20	observation	NN	O	observation	dobj	18	SENT_304	[p23l1870t1440r2133b1519, p23l7t1569r294b1646],
21	.	.	O	.	_	0	SENT_304	[p23l1870t1440r2133b1519, p23l7t1569r294b1646],

1	Our	PRP$	O	we	poss	2	SENT_305	[p23l141t1701r308b1774],
2	study	NN	O	study	nsubj	3	SENT_305	[p23l341t1695r571b1794],
3	has	VBZ	O	have	_	0	SENT_305	[p23l601t1695r745b1772],
4	some	DT	O	some	det	5	SENT_305	[p23l783t1721r1007b1773],
5	limitations	NNS	O	limitation	dobj	3	SENT_305	[p23l1041t1695r1538b1773],
6	.	.	O	.	_	0	SENT_305	[p23l1041t1695r1538b1773],

1	First	RB	ORDINAL	first	advmod	21	SENT_306	[p23l1577t1696r1792b1790],
2	,	,	O	,	_	0	SENT_306	[p23l1577t1696r1792b1790],
3	despite	IN	O	despite	_	0	SENT_306	[p23l1833t1695r2134b1794],
4	the	DT	O	the	det	6	SENT_306	[p23l12t1823r145b1901],
5	large	JJ	O	large	amod	6	SENT_306	[p23l192t1823r406b1924],
6	number	NN	O	number	prep_despite	21	SENT_306	[p23l454t1823r792b1902],
7	of	IN	O	of	_	0	SENT_306	[p23l838t1822r937b1902],
8	participants	NNS	O	participant	prep_of	6	SENT_306	[p23l966t1824r1483b1923],
9	and	CC	O	and	_	0	SENT_306	[p23l1532t1823r1690b1902],
10	events	NNS	O	event	prep_of	6	SENT_306	[p23l1738t1840r2001b1902],
11	in	IN	O	in	_	0	SENT_306	[p23l2051t1824r2134b1901],
12	the	DT	O	the	det	13	SENT_306	[p23l12t1951r145b2029],
13	CURE	NN	O	cure	prep_in	8	SENT_306	[p23l192t1957r447b2034],
14	genetic	JJ	O	genetic	amod	16	SENT_306	[p23l496t1952r804b2052],
15	data	NNS	O	datum	nn	16	SENT_306	[p23l852t1951r1034b2030],
16	sets	NNS	O	set	dep	13	SENT_306	[p23l1080t1968r1265b2047],
17	,	,	O	,	_	0	SENT_306	[p23l1080t1968r1265b2047],
18	we	PRP	O	we	nsubj	21	SENT_306	[p23l1312t1977r1430b2030],
19	can	MD	O	can	aux	21	SENT_306	[p23l1477t1968r1776b2030],
20	not	RB	O	not	neg	21	SENT_306	[p23l1477t1968r1776b2030],
21	exclude	VB	O	exclude	_	0	SENT_306	[p23l1818t1951r2134b2030],
22	the	DT	O	the	det	23	SENT_306	[p23l12t2079r147b2157],
23	possibility	NN	O	possibility	dobj	21	SENT_306	[p23l204t2079r665b2178],
24	that	IN	O	that	complm	26	SENT_306	[p23l720t2079r895b2156],
25	there	EX	O	there	expl	26	SENT_306	[p23l949t2079r1170b2157],
26	are	VBP	O	be	ccomp	21	SENT_306	[p23l1228t2105r1359b2157],
27	smaller	JJR	O	smaller	amod	28	SENT_306	[p23l1419t2079r1746b2157],
28	interactions	NNS	O	interaction	nsubj	26	SENT_306	[p23l1801t2080r2133b2157, p23l12t2208r248b2286],
29	.	.	O	.	_	0	SENT_306	[p23l1801t2080r2133b2157, p23l12t2208r248b2286],

1	Second	RB	ORDINAL	second	advmod	9	SENT_307	[p23l314t2207r641b2303],
2	,	,	O	,	_	0	SENT_307	[p23l314t2207r641b2303],
3	the	DT	O	the	det	7	SENT_307	[p23l706t2207r838b2285],
4	ACTIVE	NNP	O	ACTIVE	nn	7	SENT_307	[p23l893t2213r1233b2286],
5	A	NNP	O	A	nn	7	SENT_307	[p23l1290t2215r1356b2285],
6	genetic	JJ	O	genetic	amod	7	SENT_307	[p23l1411t2208r1720b2308],
7	data	NNS	O	datum	nsubj	9	SENT_307	[p23l1778t2207r1961b2286],
8	set	VBN	O	set	partmod	7	SENT_307	[p23l2019t2224r2139b2285],
9	contained	VBD	O	contain	_	0	SENT_307	[p23l12t2334r438b2413],
10	fewer	JJR	O	fewer	amod	11	SENT_307	[p23l469t2333r705b2413],
11	participants	NNS	O	participant	nsubj	23	SENT_307	[p23l732t2335r1248b2434],
12	and	CC	O	and	_	0	SENT_307	[p23l1280t2334r1438b2413],
13	outcome	NN	O	outcome	nn	14	SENT_307	[p23l1469t2351r1837b2413],
14	events	NNS	O	event	conj_and	11	SENT_307	[p23l1869t2351r2132b2413],
15	than	IN	O	than	advmod	16	SENT_307	[p23l12t2463r208b2541],
16	did	VBD	O	do	ccomp	9	SENT_307	[p23l260t2463r394b2542],
17	the	DT	O	the	det	20	SENT_307	[p23l444t2463r576b2541],
18	CURE	NN	O	cure	nn	20	SENT_307	[p23l626t2469r882b2546],
19	data	NN	O	datum	nn	20	SENT_307	[p23l934t2463r1118b2542],
20	set	NN	O	set	dobj	16	SENT_307	[p23l1167t2480r1287b2541],
21	and	CC	O	and	_	0	SENT_307	[p23l1331t2463r1489b2542],
22	therefore	RB	O	therefore	advmod	16	SENT_307	[p23l1539t2462r1928b2542],
23	had	VBD	O	have	ccomp	9	SENT_307	[p23l1978t2463r2134b2542],

1	1712	CD	DATE	1712	num	4	SENT_308	[p23l149t2622r225b2644],
2	N	NN	O	n	nn	4	SENT_308	[p23l938t2632r951b2647],
3	ENGLJ	NN	O	englj	nn	4	SENT_308	[p23l966t2632r1044b2654],
4	MED	NN	O	med	_	0	SENT_308	[p23l1059t2632r1110b2647],
5	363	CD	NUMBER	363	dep	4	SENT_308	[p23l1121t2626r1197b2654],
6	;	:	O	;	_	0	SENT_308	[p23l1121t2626r1197b2654],
7	18	CD	NUMBER	18	num	9	SENT_308	[p23l1121t2626r1197b2654],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_308	[p23l1232t2632r1356b2654],
9	OCTOBER	NN	DATE	october	dep	5	SENT_308	[p23l1392t2632r1504b2647],
10	28	CD	DATE	28	dep	9	SENT_308	[p23l1514t2626r1549b2652],
11	,	,	DATE	,	_	0	SENT_308	[p23l1514t2626r1549b2652],
12	2010	CD	DATE	2010	appos	10	SENT_308	[p23l1560t2632r1621b2648],

1	The	DT	O	the	det	4	SENT_309	[p23l935t2665r986b2689],
2	New	NNP	O	New	nn	4	SENT_309	[p23l995t2666r1057b2689],
3	England	NNP	O	England	nn	4	SENT_309	[p23l1066t2665r1177b2696],
4	Journal	NNP	O	Journal	_	0	SENT_309	[p23l1186t2665r1283b2689],
5	of	IN	O	of	_	0	SENT_309	[p23l1293t2665r1322b2689],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_309	[p23l1329t2665r1454b2689],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_310	[p23l506t2790r627b2810],
2	GENOTYPE	NN	O	genotype	dep	1	SENT_310	[p23l642t2790r815b2809],
3	AND	CC	O	and	_	0	SENT_310	[p23l828t2790r900b2809],
4	CLOPIDOGREL	NN	O	clopidogrel	nn	5	SENT_310	[p23l914t2790r1151b2809],
5	TREATMENT	NN	O	treatment	dep	1	SENT_310	[p23l1163t2790r1368b2809],

1	A	DT	O	a	det	4	SENT_311	[p24l109t41r131b67],
2	Primary	JJ	O	primary	amod	4	SENT_311	[p24l155t44r253b74],
3	Composite	NNP	O	Composite	nn	4	SENT_311	[p24l262t44r401b74],
4	Outcome	NNP	O	Outcome	_	0	SENT_311	[p24l410t45r530b67],
5	According	VBG	O	accord	_	0	SENT_311	[p24l538t43r668b74],
6	to	TO	O	to	prepc_according_to	4	SENT_311	[p24l676t47r701b67],
7	Loss-of-Function	NNP	O	Loss-of-Function	nn	8	SENT_311	[p24l712t43r924b67],
8	Allele	NNP	O	Allele	pobj	4	SENT_311	[p24l934t43r1004b67],

1	Carrier	NN	O	carrier	nn	2	SENT_312	[p24l182t79r270b102],
2	Status	NN	O	status	_	0	SENT_312	[p24l278t81r358b102],

1	B	NN	O	b	_	0	SENT_313	[p24l1104t41r1122b67],
2	Primary	JJ	O	primary	amod	3	SENT_313	[p24l1147t44r1245b74],
3	Composite	NN	O	composite	nn	4	SENT_313	[p24l1254t44r1393b74],
4	Outcome	NNP	O	Outcome	dep	1	SENT_313	[p24l1402t45r1522b67],
5	According	VBG	O	accord	_	0	SENT_313	[p24l1530t43r1660b74],
6	to	TO	O	to	prepc_according_to	1	SENT_313	[p24l1668t47r1693b67],
7	Gain-of-Function	NNP	O	Gain-of-Function	nn	8	SENT_313	[p24l1702t43r1919b67],
8	Allele	NNP	O	Allele	pobj	1	SENT_313	[p24l1929t43r1998b67],

1	Carrier	NN	O	carrier	nn	2	SENT_314	[p24l1174t79r1262b102],
2	Status	NN	O	status	_	0	SENT_314	[p24l1270t81r1350b102],

1	—	NN	O	—	nn	2	SENT_315	[p24l626t117r653b121],
2	Carriers	NNS	O	carrier	_	0	SENT_315	[p24l659t110r744b131],
3	,	,	O	,	_	0	SENT_315	[p24l659t110r744b131],
4	clopidogrel	NN	O	clopidogrel	appos	2	SENT_315	[p24l752t108r865b133],
5	(	CD	NUMBER	(	number	6	SENT_315	[p24l877t110r907b133],
6	29	CD	NUMBER	29	num	7	SENT_315	[p24l877t110r907b133],
7	events	NNS	O	event	dep	2	SENT_315	[p24l915t110r987b133],
8	)	IN	O	)	amod	7	SENT_315	[p24l915t110r987b133],

1	1	CD	NUMBER	1	number	2	SENT_316	[p24l422t121r470b142],
2	'00	CD	NUMBER	'00	num	4	SENT_316	[p24l422t121r470b142],
3	—	NN	O	—	nn	4	SENT_316	[p24l626t146r653b150],
4	Noncarriers	NNS	O	noncarrier	_	0	SENT_316	[p24l660t139r785b160],
5	,	,	O	,	_	0	SENT_316	[p24l660t139r785b160],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_316	[p24l794t138r907b163],
7	(	CD	NUMBER	(	number	8	SENT_316	[p24l918t139r949b163],
8	84	CD	NUMBER	84	num	9	SENT_316	[p24l918t139r949b163],
9	events	NNS	O	event	dep	4	SENT_316	[p24l957t139r1029b163],
10	)	JJ	O	)	amod	11	SENT_316	[p24l957t139r1029b163],
11	Loo	NN	O	loo	dep	9	SENT_316	[p24l1414t121r1462b142],
12	035	CD	NUMBER	035	num	11	SENT_316	[p24l420t175r468b196],
13	.	.	O	.	_	0	SENT_316	[p24l626t167r831b201],

1	—	NN	O	—	_	0	SENT_317	[p24l626t167r831b201],
2	.	.	O	.	_	0	SENT_317	[p24l626t167r831b201],

1	Carners	NNP	O	Carners	dep	10	SENT_318	[p24l626t167r831b201],
2	,	,	O	,	_	0	SENT_318	[p24l626t167r831b201],
3	'	''	O	'	_	0	SENT_318	[p24l626t167r831b201],
4	p	NN	O	p	prep	1	SENT_318	[p24l626t167r831b201],
5	|	CD	NUMBER	|	dep	4	SENT_318	[p24l626t167r831b201],
6	acebo	NN	O	acebo	prep	1	SENT_318	[p24l626t167r831b201],
7	(	CD	NUMBER	(	num	9	SENT_318	[p24l842t168r871b192],
8	35	CD	NUMBER	35	num	9	SENT_318	[p24l842t168r871b192],
9	events	NNS	O	event	dep	6	SENT_318	[p24l880t168r952b192],
10	)	JJ	O	)	_	0	SENT_318	[p24l880t168r952b192],
11	095	CD	NUMBER	095	tmod	10	SENT_318	[p24l1412t175r1460b196],

1	—	NN	O	—	nn	2	SENT_319	[p24l626t205r653b208],
2	Noncarrlers	NNS	O	noncarrler	_	0	SENT_319	[p24l660t198r785b218],
3	,	,	O	,	_	0	SENT_319	[p24l660t198r785b218],
4	placebo	NN	O	placebo	nn	5	SENT_319	[p24l795t196r873b221],
5	(	NN	O	(	appos	2	SENT_319	[p24l883t197r926b221],
6	118	CD	NUMBER	118	num	7	SENT_319	[p24l883t197r926b221],
7	events	NNS	O	event	dep	2	SENT_319	[p24l934t198r1007b221],
8	)	IN	O	)	amod	7	SENT_319	[p24l934t198r1007b221],

1	—	NN	O	—	nn	2	SENT_320	[p24l1618t117r1645b121],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_320	[p24l1651t110r1735b131],
3	,	,	O	,	_	0	SENT_320	[p24l1651t110r1735b131],
4	clopidogrel	NN	O	clopidogrel	appos	2	SENT_320	[p24l1744t108r1857b133],
5	(	CD	NUMBER	(	number	6	SENT_320	[p24l1869t110r1899b133],
6	57	CD	NUMBER	57	num	7	SENT_320	[p24l1869t110r1899b133],
7	events	NNS	O	event	dep	4	SENT_320	[p24l1907t110r1979b133],
8	)	VBP	O	)	_	0	SENT_320	[p24l1907t110r1979b133],
9	—	CD	NUMBER	—	num	10	SENT_320	[p24l1617t146r1645b150],
10	Noncarriers	NNS	O	noncarrier	dobj	8	SENT_320	[p24l1652t139r1777b160],
11	,	,	O	,	_	0	SENT_320	[p24l1652t139r1777b160],
12	clopidogrel	NN	O	clopidogrel	appos	10	SENT_320	[p24l1786t138r1899b163],
13	(	CD	NUMBER	(	number	14	SENT_320	[p24l1910t139r1941b163],
14	56	CD	NUMBER	56	num	15	SENT_320	[p24l1910t139r1941b163],
15	events	NNS	O	event	dep	12	SENT_320	[p24l1949t139r2021b163],
16	)	CD	NUMBER	)	dep	12	SENT_320	[p24l1949t139r2021b163],
17	.	.	O	.	_	0	SENT_320	[p24l1618t168r1735b189],

1	—	NN	O	—	_	0	SENT_321	[p24l1618t168r1735b189],
2	.	.	O	.	_	0	SENT_321	[p24l1618t168r1735b189],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_322	[p24l1618t168r1735b189],
2	,	,	O	,	_	0	SENT_322	[p24l1618t168r1735b189],
3	placebo	NN	O	placebo	appos	1	SENT_322	[p24l1745t167r1823b192],
4	(	CD	NUMBER	(	number	5	SENT_322	[p24l1834t168r1863b192],
5	61	CD	NUMBER	61	num	6	SENT_322	[p24l1834t168r1863b192],
6	events	NNS	O	event	dep	3	SENT_322	[p24l1872t168r1944b192],
7	)	VBP	O	)	_	0	SENT_322	[p24l1872t168r1944b192],
8	—	CD	NUMBER	—	num	9	SENT_322	[p24l1618t205r1645b208],
9	Noncarriers	NNS	O	noncarrier	dobj	7	SENT_322	[p24l1652t198r1777b218],
10	,	,	O	,	_	0	SENT_322	[p24l1652t198r1777b218],
11	placebo	NN	O	placebo	appos	9	SENT_322	[p24l1787t196r1865b221],
12	(	CD	NUMBER	(	number	13	SENT_322	[p24l1875t198r1904b221],
13	93	CD	NUMBER	93	num	14	SENT_322	[p24l1875t198r1904b221],
14	events	NNS	O	event	dep	11	SENT_322	[p24l1914t198r1986b221],
15	)	IN	O	)	prep	7	SENT_322	[p24l1914t198r1986b221],

1	Freedom	NNP	O	Freedom	dep	6	SENT_323	[p24l331t372r354b482],
2	from	IN	O	from	_	0	SENT_323	[p24l330t302r354b362],
3	Primary	JJ	O	primary	amod	4	SENT_323	[p24l331t192r361b290],
4	Composite	NN	O	composite	prep_from	1	SENT_323	[p24l367t333r397b472],
5	Outcome	NNP	O	Outcome	nn	6	SENT_323	[p24l368t204r390b324],
6	Freedom	NNP	O	Freedom	dep	7	SENT_323	[p24l1323t372r1346b482],
7	from	IN	O	from	_	0	SENT_323	[p24l1322t302r1346b362],
8	Primary	JJ	O	primary	amod	10	SENT_323	[p24l1323t192r1353b290],
9	Composite	NNP	O	Composite	nn	10	SENT_323	[p24l1359t333r1389b472],
10	Outcome	NNP	O	Outcome	pobj	7	SENT_323	[p24l1360t204r1382b324],

1	P	NN	O	p	_	0	SENT_324	[p24l525t470r596b487],
2	=	JJ	O	=	amod	1	SENT_324	[p24l525t470r596b487],
3	0.87	CD	NUMBER	0.87	tmod	2	SENT_324	[p24l525t470r596b487],
4	by	IN	O	by	_	0	SENT_324	[p24l605t468r627b493],
5	log-rank	JJ	O	log-rank	amod	6	SENT_324	[p24l635t468r717b493],
6	test	NN	O	test	prep_by	2	SENT_324	[p24l724t472r762b487],
7	for	IN	O	for	_	0	SENT_324	[p24l769t468r797b487],
8	P	NN	O	p	prep_for	1	SENT_324	[p24l1516t470r1588b487],
9	=	JJ	O	=	amod	8	SENT_324	[p24l1516t470r1588b487],
10	0.34	CD	NUMBER	0.34	tmod	9	SENT_324	[p24l1516t470r1588b487],
11	by	IN	O	by	dep	1	SENT_324	[p24l1597t468r1618b493],
12	log-rank	JJ	O	log-rank	amod	13	SENT_324	[p24l1627t468r1709b493],
13	test	NN	O	test	pobj	11	SENT_324	[p24l1716t472r1754b487],
14	for	IN	O	for	dep	1	SENT_324	[p24l1760t468r1789b487],

1	I	PRP	O	I	dep	2	SENT_325	[p24l473t491r500b558],
2	clopidogrel-treated	JJ	O	clopidogrel-treated	_	0	SENT_325	[p24l523t502r716b527],
3	participants	NNS	O	participant	nsubj	4	SENT_325	[p24l726t503r846b526],
4	j	VBP	O	j	ccomp	2	SENT_325	[p24l1465t491r1492b558],
5	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	6	SENT_325	[p24l1515t502r1708b527],
6	participants	NNS	O	participant	dobj	4	SENT_325	[p24l1718t503r1837b526],

1	I	PRP	O	I	_	0	SENT_326	[p24l879t542r882b558],
2	l	NN	O	l	tmod	1	SENT_326	[p24l1009t542r1013b558],
3	l	NN	O	l	tmod	1	SENT_326	[p24l1609t545r1612b558],
4	2000	CD	DATE	2000	num	5	SENT_326	[p24l983t565r1040b585],
5	o	NN	O	o	dep	1	SENT_326	[p24l1473t565r1486b585],
6	500	CD	NUMBER	500	dep	5	SENT_326	[p24l1590t565r1632b585],

1	I	PRP	O	I	_	0	SENT_327	[p24l1871t545r1874b558],
2	1500	CD	DATE	1500	dep	1	SENT_327	[p24l1846t565r1901b586],

1	Days	NNS	DURATION	day	nsubj	2	SENT_328	[p24l1576t616r1638b645],
2	aﬁer	VBP	O	aﬁer	_	0	SENT_328	[p24l1647t613r1705b637],
3	Randomization	NN	O	randomization	dobj	2	SENT_328	[p24l1716t614r1907b637],

1	I	PRP	O	I	dep	2	SENT_329	[p24l617t545r620b558],
2	l	NN	O	l	_	0	SENT_329	[p24l747t542r752b558],
3	I	PRP	O	I	dep	2	SENT_329	[p24l1740t545r1743b558],
4	l	NN	O	l	tmod	3	SENT_329	[p24l2001t542r2005b558],
5	o	NN	O	o	dep	2	SENT_329	[p24l481t565r494b585],
6	500 1000 1000 2000	CD	NUMBER	500 1000 1000 2000	num	5	SENT_329	[p24l1975t565r2032b586],[p24l598t565r640b585],

1	Days	NNS	DURATION	day	nsubj	2	SENT_330	[p24l584t616r646b645],
2	aﬁer	VBP	O	aﬁer	_	0	SENT_330	[p24l655t613r713b637],
3	Randomization	NN	O	randomization	dobj	2	SENT_330	[p24l723t614r915b637],

1	No.	NN	O	no.	dep	14	SENT_331	[p24l1135t671r1179b692],
2	at	IN	O	at	_	0	SENT_331	[p24l1189t673r1213b692],
3	Risk	NN	O	risk	nn	4	SENT_331	[p24l1223t669r1275b692],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_331	[p24l1134t707r1233b732],
5	,	,	O	,	_	0	SENT_331	[p24l1134t707r1233b732],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_331	[p24l1243t706r1375b735],
7	261 232 195	CD	NUMBER	261 232 195	number	8	SENT_331	[p24l1731t707r1769b728],[p24l1466t707r1506b728],
8	79	CD	NUMBER	79	num	9	SENT_331	[p24l1869t707r1895b728],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_331	[p24l1136t741r1282b765],
10	,	,	O	,	_	0	SENT_331	[p24l1136t741r1282b765],
11	clopidogrel	NN	O	clopidogrel	dep	14	SENT_331	[p24l1292t739r1424b768],
12	305 274 236	CD	NUMBER	305 274 236	num	11	SENT_331	[p24l1729t741r1771b761],[p24l1466t740r1506b761],
13	84	CD	NUMBER	84	num	14	SENT_331	[p24l1868t740r1895b761],
14	Carriers	NNS	O	carrier	_	0	SENT_331	[p24l1134t774r1233b798],
15	,	,	O	,	_	0	SENT_331	[p24l1134t774r1233b798],
16	placebo	NN	O	placebo	appos	14	SENT_331	[p24l1244t772r1335b801],
17	236 207 169	CD	NUMBER	236 207 169	number	18	SENT_331	[p24l1731t774r1770b795],[p24l1465t774r1507b794],
18	64	CD	NUMBER	64	num	19	SENT_331	[p24l1868t774r1895b794],
19	Noncarriers	NNS	O	noncarrier	dep	16	SENT_331	[p24l1135t808r1282b832],
20	,	,	O	,	_	0	SENT_331	[p24l1135t808r1282b832],
21	placebo	NN	O	placebo	prep	14	SENT_331	[p24l1293t806r1384b834],
22	342 296 241	CD	NUMBER	342 296 241	num	23	SENT_331	[p24l1729t808r1770b827],[p24l1466t807r1507b828],
23	95	CD	NUMBER	95	dep	21	SENT_331	[p24l1868t808r1894b828],

1	No.	NN	O	no.	_	0	SENT_332	[p24l143t671r187b692],
2	at	IN	O	at	_	0	SENT_332	[p24l197t673r221b692],
3	Risk	NN	O	risk	nn	4	SENT_332	[p24l231t669r283b692],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_332	[p24l142t707r241b732],
5	,	,	O	,	_	0	SENT_332	[p24l142t707r241b732],
6	clopidogrel	NN	O	clopidogrel	appos	1	SENT_332	[p24l251t706r383b735],
7	139 125 110	CD	NUMBER	139 125 110	number	8	SENT_332	[p24l739t707r779b728],[p24l475t707r515b728],
8	40	CD	NUMBER	40	num	9	SENT_332	[p24l875t707r904b728],
9	Noncarriers	NNS	O	noncarrier	dep	6	SENT_332	[p24l144t741r290b765],
10	,	,	O	,	_	0	SENT_332	[p24l144t741r290b765],
11	clopidogrel	NN	O	clopidogrel	appos	1	SENT_332	[p24l300t739r432b768],
12	422 376 316 122	CD	NUMBER	422 376 316 122	num	13	SENT_332	[p24l863t741r903b761],[p24l473t741r515b761],
13	Carriers	NNS	O	carrier	dep	1	SENT_332	[p24l142t774r241b798],
14	,	,	O	,	_	0	SENT_332	[p24l142t774r241b798],
15	placebo	NN	O	placebo	appos	13	SENT_332	[p24l252t772r343b801],
16	140 117 106	CD	NUMBER	140 117 106	number	17	SENT_332	[p24l739t774r779b794],[p24l475t774r516b794],
17	40	CD	NUMBER	40	num	18	SENT_332	[p24l875t774r904b794],
18	Noncarriers	NNS	O	noncarrier	dep	15	SENT_332	[p24l144t808r290b832],
19	,	,	O	,	_	0	SENT_332	[p24l144t808r290b832],
20	placebo	NN	O	placebo	appos	13	SENT_332	[p24l301t806r392b834],
21	438 386 305 120	CD	NUMBER	438 386 305 120	num	20	SENT_332	[p24l863t807r904b828],[p24l473t807r515b828],

1	C	NNP	O	C	nn	2	SENT_333	[p24l110t902r131b928],
2	Freedom	NNP	O	Freedom	_	0	SENT_333	[p24l155t904r266b928],
3	from	IN	O	from	_	0	SENT_333	[p24l275t904r335b928],
4	Major	NNP	O	Major	nn	5	SENT_333	[p24l348t905r422b935],
5	Bleeding	NNP	O	Bleeding	prep_from	2	SENT_333	[p24l432t904r542b935],
6	According	VBG	O	accord	_	0	SENT_333	[p24l550t904r680b935],
7	to	TO	O	to	prepc_according_to	2	SENT_333	[p24l687t908r713b928],
8	Loss-of-Function	NNP	O	Loss-of-Function	nn	9	SENT_333	[p24l724t904r936b928],
9	Allele	NNP	O	Allele	pobj	2	SENT_333	[p24l946t904r1016b928],

1	Carrier	NN	O	carrier	nn	2	SENT_334	[p24l182t940r270b963],
2	Status	NN	O	status	_	0	SENT_334	[p24l278t941r358b963],

1	D	NNP	O	D	nn	2	SENT_335	[p24l1102t902r1125b928],
2	Freedom	NNP	O	Freedom	_	0	SENT_335	[p24l1147t904r1258b928],
3	from	IN	O	from	_	0	SENT_335	[p24l1267t904r1327b928],
4	Major	NNP	O	Major	nn	5	SENT_335	[p24l1340t905r1414b935],
5	Bleeding	NNP	O	Bleeding	prep_from	2	SENT_335	[p24l1424t904r1534b935],
6	According	VBG	O	accord	_	0	SENT_335	[p24l1542t904r1672b935],
7	to	TO	O	to	prepc_according_to	2	SENT_335	[p24l1679t908r1705b928],
8	Gain-of-Function	NNP	O	Gain-of-Function	nn	9	SENT_335	[p24l1714t904r1930b928],
9	Allele	NNP	O	Allele	pobj	2	SENT_335	[p24l1940t904r2010b928],

1	Carrier	NN	O	carrier	nn	2	SENT_336	[p24l1174t940r1262b963],
2	Status	NN	O	status	_	0	SENT_336	[p24l1270t941r1350b963],

1	P	NN	O	p	_	0	SENT_337	[p24l523t1189r594b1207],
2	=	JJ	O	=	amod	1	SENT_337	[p24l523t1189r594b1207],
3	0.01	CD	NUMBER	0.01	tmod	2	SENT_337	[p24l523t1189r594b1207],
4	by	IN	O	by	dep	1	SENT_337	[p24l604t1187r625b1212],
5	log-rank	JJ	O	log-rank	amod	6	SENT_337	[p24l633t1187r715b1212],
6	test	NN	O	test	pobj	4	SENT_337	[p24l722t1191r760b1207],
7	for	IN	O	for	_	0	SENT_337	[p24l767t1187r796b1206],
8	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	9	SENT_337	[p24l522t1221r714b1246],
9	participants	NNS	O	participant	prep_for	6	SENT_337	[p24l724t1223r844b1246],

1	P	NN	O	p	_	0	SENT_338	[p24l1512t1189r1584b1207],
2	=	JJ	O	=	amod	1	SENT_338	[p24l1512t1189r1584b1207],
3	0.29	CD	NUMBER	0.29	tmod	2	SENT_338	[p24l1512t1189r1584b1207],
4	by	IN	O	by	dep	1	SENT_338	[p24l1593t1187r1614b1212],
5	log-rank	JJ	O	log-rank	amod	6	SENT_338	[p24l1623t1187r1705b1212],
6	test	NN	O	test	pobj	4	SENT_338	[p24l1711t1191r1749b1207],
7	for	IN	O	for	_	0	SENT_338	[p24l1756t1187r1785b1207],
8	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	9	SENT_338	[p24l1511t1221r1703b1246],
9	participants	NNS	O	participant	prep_for	6	SENT_338	[p24l1713t1223r1833b1246],

1	—	NN	O	—	nn	2	SENT_339	[p24l1509t1282r1536b1285],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_339	[p24l1542t1274r1627b1295],
3	,	,	O	,	_	0	SENT_339	[p24l1542t1274r1627b1295],
4	clopidogrel	NN	O	clopidogrel	appos	2	SENT_339	[p24l1636t1273r1749b1298],
5	(	CD	NUMBER	(	number	6	SENT_339	[p24l1760t1274r1790b1298],
6	14	CD	NUMBER	14	num	7	SENT_339	[p24l1760t1274r1790b1298],
7	events	NNS	O	event	dep	4	SENT_339	[p24l1798t1274r1871b1298],
8	)	VBP	O	)	_	0	SENT_339	[p24l1798t1274r1871b1298],
9	—	CD	NUMBER	—	num	10	SENT_339	[p24l1509t1311r1537b1314],
10	Noncarriers	NNS	O	noncarrier	dobj	8	SENT_339	[p24l1544t1304r1669b1324],
11	,	,	O	,	_	0	SENT_339	[p24l1544t1304r1669b1324],
12	clopidogrel	NN	O	clopidogrel	appos	10	SENT_339	[p24l1678t1302r1791b1327],
13	(	CD	NUMBER	(	number	14	SENT_339	[p24l1802t1303r1832b1327],
14	18	CD	NUMBER	18	num	15	SENT_339	[p24l1802t1303r1832b1327],
15	events	NNS	O	event	dep	12	SENT_339	[p24l1840t1304r1913b1327],
16	)	CD	NUMBER	)	dep	12	SENT_339	[p24l1840t1304r1913b1327],
17	.	.	O	.	_	0	SENT_339	[p24l1509t1333r1627b1354],

1	—	NN	O	—	_	0	SENT_340	[p24l1509t1333r1627b1354],
2	.	.	O	.	_	0	SENT_340	[p24l1509t1333r1627b1354],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_341	[p24l1509t1333r1627b1354],
2	,	,	O	,	_	0	SENT_341	[p24l1509t1333r1627b1354],
3	placebo	NN	O	placebo	nn	4	SENT_341	[p24l1637t1331r1715b1356],
4	(	NN	O	(	appos	1	SENT_341	[p24l1725t1333r1743b1356],
5	6	CD	NUMBER	6	num	6	SENT_341	[p24l1725t1333r1743b1356],
6	events	NNS	O	event	dep	4	SENT_341	[p24l1751t1333r1823b1356],
7	)	VBP	O	)	_	0	SENT_341	[p24l1751t1333r1823b1356],
8	—	CD	NUMBER	—	num	9	SENT_341	[p24l1510t1369r1536b1372],
9	Noncarriers	NNS	O	noncarrier	dobj	7	SENT_341	[p24l1544t1362r1669b1383],
10	,	,	O	,	_	0	SENT_341	[p24l1544t1362r1669b1383],
11	placebo	NN	O	placebo	nn	12	SENT_341	[p24l1679t1360r1757b1385],
12	(	NN	O	(	appos	9	SENT_341	[p24l1767t1362r1797b1385],
13	17	CD	NUMBER	17	num	14	SENT_341	[p24l1767t1362r1797b1385],
14	events	NNS	O	event	dep	12	SENT_341	[p24l1805t1362r1878b1385],
15	)	IN	O	)	prep	7	SENT_341	[p24l1805t1362r1878b1385],

1	—	NN	O	—	nn	2	SENT_342	[p24l520t1282r547b1285],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_342	[p24l553t1274r638b1295],
3	,	,	O	,	_	0	SENT_342	[p24l553t1274r638b1295],
4	clopidogrel	NN	O	clopidogrel	appos	2	SENT_342	[p24l647t1273r760b1298],
5	(	CD	NUMBER	(	number	6	SENT_342	[p24l771t1274r801b1298],
6	14	CD	NUMBER	14	num	7	SENT_342	[p24l771t1274r801b1298],
7	events	NNS	O	event	dep	4	SENT_342	[p24l809t1274r882b1298],
8	)	VBP	O	)	_	0	SENT_342	[p24l809t1274r882b1298],
9	—	CD	NUMBER	—	num	10	SENT_342	[p24l520t1311r548b1314],
10	Noncarriers	NNS	O	noncarrier	nsubj	16	SENT_342	[p24l554t1304r680b1324],
11	,	,	O	,	_	0	SENT_342	[p24l554t1304r680b1324],
12	clopidogrel	NN	O	clopidogrel	appos	10	SENT_342	[p24l689t1302r802b1327],
13	(	CD	NUMBER	(	number	14	SENT_342	[p24l813t1303r843b1327],
14	18	CD	NUMBER	18	num	15	SENT_342	[p24l813t1303r843b1327],
15	events	NNS	O	event	dep	12	SENT_342	[p24l851t1304r924b1327],
16	)	VBP	O	)	ccomp	8	SENT_342	[p24l851t1304r924b1327],
17	—	CD	NUMBER	—	num	18	SENT_342	[p24l520t1340r547b1343],
18	Carriers	NNS	O	carrier	nsubj	24	SENT_342	[p24l553t1333r638b1354],
19	,	,	O	,	_	0	SENT_342	[p24l553t1333r638b1354],
20	placebo	NN	O	placebo	nn	21	SENT_342	[p24l648t1331r726b1356],
21	(	NN	O	(	appos	18	SENT_342	[p24l736t1333r754b1356],
22	6	CD	NUMBER	6	num	23	SENT_342	[p24l736t1333r754b1356],
23	events	NNS	O	event	dep	21	SENT_342	[p24l762t1333r834b1356],
24	)	VBP	O	)	ccomp	16	SENT_342	[p24l762t1333r834b1356],
25	—	CD	NUMBER	—	num	26	SENT_342	[p24l520t1369r547b1372],
26	Noncarriers	NNS	O	noncarrier	dobj	24	SENT_342	[p24l554t1362r680b1383],
27	,	,	O	,	_	0	SENT_342	[p24l554t1362r680b1383],
28	placebo	NN	O	placebo	nn	29	SENT_342	[p24l690t1360r768b1385],
29	(	NN	O	(	appos	26	SENT_342	[p24l778t1362r808b1385],
30	17	CD	NUMBER	17	num	31	SENT_342	[p24l778t1362r808b1385],
31	events	NNS	O	event	dep	29	SENT_342	[p24l816t1362r888b1385],
32	)	IN	O	)	prep	24	SENT_342	[p24l816t1362r888b1385],

1	on	IN	O	on	_	0	SENT_343	[p24l376t1004r399b1020],
2	.	.	O	.	_	0	SENT_343	[p24l369t1022r391b1043],

1	E	NN	O	e	_	0	SENT_344	[p24l369t1022r391b1043],
2	-5	CD	NUMBER	-5	num	1	SENT_344	[p24l368t1047r392b1061],
3	en	IN	O	en	_	0	SENT_344	[p24l376t1062r392b1076],
4	_	CD	NUMBER	_	number	5	SENT_344	[p24l368t1077r392b1097],
5	‘	CD	NUMBER	‘	num	7	SENT_344	[p24l368t1077r392b1097],
6	l.	NN	O	l.	nn	7	SENT_344	[p24l368t1077r392b1097],
7	’	NN	O	’	prep_en	1	SENT_344	[p24l368t1077r392b1097],
8	on	IN	O	on	_	0	SENT_344	[p24l370t1099r391b1114],
9	I.	NN	O	i.	prep_on	1	SENT_344	[p24l376t1124r391b1134, p24l369t1136r399b1159],
10	2	CD	NUMBER	2	num	9	SENT_344	[p24l376t1124r391b1134, p24l369t1136r399b1159],
11	.	.	O	.	_	0	SENT_344	[p24l376t1124r391b1134, p24l369t1136r399b1159],

1	(	NN	O	(	nn	2	SENT_345	[p24l376t1160r392b1173],
2	B	NN	O	b	_	0	SENT_345	[p24l376t1160r392b1173],
3	2	CD	NUMBER	2	num	4	SENT_345	[p24l370t1177r391b1199],
4	E	NN	O	e	dep	2	SENT_345	[p24l376t1211r392b1251],
5	to	TO	O	to	_	0	SENT_345	[p24l368t1251r391b1271],
6	‘	CD	NUMBER	‘	prep_to	4	SENT_345	[p24l368t1251r391b1271],
7	:	:	O	:	_	0	SENT_345	[p24l368t1251r391b1271],
8	E	NN	O	e	dep	2	SENT_345	[p24l376t1280r391b1303],
9	o	NN	O	o	nn	11	SENT_345	[p24l376t1305r392b1320],
10	‘	CD	NUMBER	‘	num	11	SENT_345	[p24l368t1322r392b1337],
11	U	NNP	O	U	dep	8	SENT_345	[p24l368t1322r392b1337],
12	o	NN	O	o	nn	14	SENT_345	[p24l376t1338r392b1351],
13	2	CD	NUMBER	2	num	14	SENT_345	[p24l376t1352r392b1375],
14	LI	NNP	O	LI	dep	8	SENT_345	[p24l370t1378r391b1391],
15	.	.	O	.	_	0	SENT_345	[p24l370t1378r391b1391],

1	Freedom	NNP	O	Freedom	_	0	SENT_346	[p24l1360t1280r1384b1391],
2	from	IN	O	from	_	0	SENT_346	[p24l1360t1211r1384b1271],
3	Major	NNP	O	Major	nn	4	SENT_346	[p24l1361t1124r1391b1199],
4	Bleeding	NNP	O	Bleeding	prep_from	1	SENT_346	[p24l1360t1004r1391b1114],

1	Days	NNS	DURATION	day	_	0	SENT_347	[p24l584t1477r646b1506],
2	after	IN	O	after	dep	1	SENT_347	[p24l655t1474r713b1498],
3	Randomization	NN	O	randomization	nn	4	SENT_347	[p24l723t1475r915b1498],
4	Days	NNS	DURATION	day	pobj	2	SENT_347	[p24l1576t1477r1638b1506],
5	after	IN	O	after	dep	1	SENT_347	[p24l1647t1474r1705b1498],
6	Randomization	NN	O	randomization	pobj	5	SENT_347	[p24l1715t1475r1907b1498],

1	No.	NN	O	no.	_	0	SENT_348	[p24l1135t1532r1179b1553],
2	at	IN	O	at	_	0	SENT_348	[p24l1189t1533r1213b1553],
3	Risk	NN	O	risk	nn	4	SENT_348	[p24l1223t1529r1275b1553],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_348	[p24l1134t1568r1233b1592],
5	,	,	O	,	_	0	SENT_348	[p24l1134t1568r1233b1592],
6	clopidogrel	NN	O	clopidogrel	appos	4	SENT_348	[p24l1243t1566r1375b1596],
7	240	CD	NUMBER	240	number	8	SENT_348	[p24l1597t1568r1639b1589],
8	201	CD	NUMBER	201	num	10	SENT_348	[p24l1729t1568r1769b1589],
9	83	CD	NUMBER	83	num	10	SENT_348	[p24l1868t1568r1894b1589],
10	Noncarriers	NNS	O	noncarrier	dep	6	SENT_348	[p24l1136t1602r1282b1626],
11	,	,	O	,	_	0	SENT_348	[p24l1136t1602r1282b1626],
12	clopidogrel	NN	O	clopidogrel	appos	4	SENT_348	[p24l1292t1600r1424b1629],
13	278	CD	NUMBER	278	number	14	SENT_348	[p24l1597t1601r1639b1622],
14	237	CD	NUMBER	237	dep	12	SENT_348	[p24l1729t1602r1771b1622],
15	85	CD	NUMBER	85	num	16	SENT_348	[p24l1868t1601r1894b1622],
16	Carriers	NNS	O	carrier	dep	1	SENT_348	[p24l1134t1635r1233b1659],
17	,	,	O	,	_	0	SENT_348	[p24l1134t1635r1233b1659],
18	placebo	NN	O	placebo	appos	16	SENT_348	[p24l1244t1633r1335b1662],
19	216	CD	NUMBER	216	num	18	SENT_348	[p24l1597t1635r1639b1655],
20	180	CD	NUMBER	180	number	21	SENT_348	[p24l1731t1635r1771b1655],
21	71	CD	NUMBER	71	num	22	SENT_348	[p24l1869t1635r1894b1655],
22	Noncarriers	NNS	O	noncarrier	dep	18	SENT_348	[p24l1136t1669r1282b1693],
23	,	,	O	,	_	0	SENT_348	[p24l1136t1669r1282b1693],
24	placebo	NN	O	placebo	appos	16	SENT_348	[p24l1293t1667r1384b1695],
25	315 262 113	CD	NUMBER	315 262 113	num	24	SENT_348	[p24l1855t1668r1894b1689],[p24l1598t1668r1638b1689],

1	No.	NN	O	no.	_	0	SENT_349	[p24l143t1532r187b1553],
2	at	IN	O	at	_	0	SENT_349	[p24l197t1533r221b1553],
3	Risk	NN	O	risk	nn	4	SENT_349	[p24l231t1529r283b1553],
4	Carriers	NNS	O	carrier	prep_at	1	SENT_349	[p24l142t1568r241b1592],
5	,	,	O	,	_	0	SENT_349	[p24l142t1568r241b1592],
6	clopidogrel	NN	O	clopidogrel	appos	1	SENT_349	[p24l251t1566r383b1596],
7	126	CD	NUMBER	126	num	6	SENT_349	[p24l607t1568r647b1589],
8	108	CD	NUMBER	108	number	9	SENT_349	[p24l739t1568r778b1589],
9	38	CD	NUMBER	38	num	10	SENT_349	[p24l876t1568r903b1589],
10	Noncarriers	NNS	O	noncarrier	dep	6	SENT_349	[p24l144t1602r290b1626],
11	,	,	O	,	_	0	SENT_349	[p24l144t1602r290b1626],
12	clopidogrel	NN	O	clopidogrel	appos	1	SENT_349	[p24l300t1600r432b1629],
13	387 325 128	CD	NUMBER	387 325 128	num	14	SENT_349	[p24l863t1601r903b1622],[p24l606t1601r647b1622],
14	Carriers	NNS	O	carrier	dep	1	SENT_349	[p24l142t1635r241b1659],
15	,	,	O	,	_	0	SENT_349	[p24l142t1635r241b1659],
16	placebo	NN	O	placebo	appos	14	SENT_349	[p24l253t1633r343b1662],
17	124	CD	NUMBER	124	num	16	SENT_349	[p24l607t1635r647b1655],
18	110	CD	NUMBER	110	number	19	SENT_349	[p24l739t1635r779b1655],
19	44	CD	NUMBER	44	num	20	SENT_349	[p24l875t1635r903b1655],
20	Noncarriers	NNS	O	noncarrier	dep	16	SENT_349	[p24l144t1669r290b1693],
21	,	,	O	,	_	0	SENT_349	[p24l144t1669r290b1693],
22	placebo	NN	O	placebo	appos	14	SENT_349	[p24l301t1667r392b1695],
23	407 333 141	CD	NUMBER	407 333 141	num	22	SENT_349	[p24l863t1669r902b1688],[p24l605t1668r647b1689],

1	Figure	NNP	O	Figure	_	0	SENT_350	[p24l122t1769r206b1801],
2	4	CD	NUMBER	4	dep	1	SENT_350	[p24l216t1771r240b1793],
3	.	.	O	.	_	0	SENT_350	[p24l216t1771r240b1793],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_351	[p24l253t1768r447b1801],
2	.	.	O	.	_	0	SENT_351	[p24l253t1768r447b1801],

1	—	NN	O	—	_	0	SENT_352	[p24l253t1768r447b1801],
2	.	.	O	.	_	0	SENT_352	[p24l253t1768r447b1801],

1	Meier	NNP	O	Meier	dep	119	SENT_353	[p24l253t1768r447b1801],
2	Curves	NNP	O	Curves	dep	119	SENT_353	[p24l456t1770r551b1793],
3	for	IN	O	for	dep	119	SENT_353	[p24l561t1768r601b1793],
4	Event-free	JJ	O	event-free	dep	119	SENT_353	[p24l612t1768r750b1793],
5	Survival	NNP	O	Survival	dep	119	SENT_353	[p24l760t1768r869b1793],
6	According	VBG	O	accord	dep	119	SENT_353	[p24l880t1768r1020b1801],
7	to	TO	O	to	dep	119	SENT_353	[p24l1029t1772r1057b1793],
8	CYP2C19	NN	O	cyp2c19	dep	119	SENT_353	[p24l1068t1770r1195b1793],
9	Loss-of-Function	NN	O	loss-of-function	dep	119	SENT_353	[p24l1207t1768r1437b1793],
10	and	CC	O	and	dep	119	SENT_353	[p24l1449t1768r1498b1793],
11	Gain-of-Function	NNP	O	Gain-of-Function	dep	119	SENT_353	[p24l1510t1768r1745b1793],
12	Allele	NN	O	allele	dep	119	SENT_353	[p24l1756t1768r1832b1793],
13	Carrier	NN	O	carrier	dep	119	SENT_353	[p24l1842t1769r1937b1793],
14	Status	NN	O	status	dep	119	SENT_353	[p24l1947t1770r2033b1793],
15	among	IN	O	among	dep	119	SENT_353	[p24l120t1818r215b1843],
16	European	JJ	O	european	dep	119	SENT_353	[p24l227t1812r356b1843],
17	Patients	NNS	O	patient	dep	119	SENT_353	[p24l370t1811r480b1835],
18	with	IN	O	with	dep	119	SENT_353	[p24l491t1810r549b1835],
19	Atrial	NNP	O	Atrial	dep	119	SENT_353	[p24l560t1810r633b1835],
20	Fibrillation	NNP	O	Fibrillation	dep	119	SENT_353	[p24l647t1810r792b1835],
21	in	IN	O	in	dep	119	SENT_353	[p24l805t1811r828b1835],
22	ACTIVE	NNP	O	ACTIVE	dep	119	SENT_353	[p24l839t1812r944b1835],
23	A.	NNP	O	A.	dep	119	SENT_353	[p24l954t1812r982b1835],
24	Loss-of-function	NNP	O	Loss-of-function	dep	119	SENT_353	[p24l122t1860r347b1885],
25	allele	NN	O	allele	dep	119	SENT_353	[p24l360t1860r430b1885],
26	carriers	NNS	O	carrier	dep	119	SENT_353	[p24l442t1862r545b1885],
27	were	VBD	O	be	dep	119	SENT_353	[p24l556t1869r621b1885],
28	defined	VBN	O	define	dep	119	SENT_353	[p24l632t1860r736b1885],
29	as	IN	O	as	dep	119	SENT_353	[p24l749t1869r776b1885],
30	patients	NNS	O	patient	dep	119	SENT_353	[p24l790t1862r900b1893],
31	with	IN	O	with	dep	119	SENT_353	[p24l911t1860r968b1885],
32	at	IN	O	at	dep	119	SENT_353	[p24l981t1865r1006b1885],
33	least	JJS	O	least	dep	119	SENT_353	[p24l1018t1860r1081b1885],
34	one	CD	NUMBER	one	dep	119	SENT_353	[p24l1092t1869r1142b1885],
35	loss-of-function	NN	O	loss-of-function	dep	119	SENT_353	[p24l1155t1860r1372b1885],
36	allele	NN	O	allele	dep	119	SENT_353	[p24l1385t1860r1455b1885],
37	(	CD	NUMBER	(	dep	119	SENT_353	[p24l1469t1862r1525b1893],
38	i.e.	FW	O	i.e.	dep	119	SENT_353	[p24l1469t1862r1525b1893],
39	,	,	O	,	_	0	SENT_353	[p24l1469t1862r1525b1893],
40	*	NN	O	*	dep	119	SENT_353	[p24l1537t1862r1569b1885],
41	2	CD	NUMBER	2	dep	119	SENT_353	[p24l1537t1862r1569b1885],
42	or	CC	O	or	dep	119	SENT_353	[p24l1581t1869r1609b1885],
43	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1619t1862r1668b1893],
44	3	CD	NUMBER	3	dep	119	SENT_353	[p24l1619t1862r1668b1893],
45	)	NN	O	)	dep	119	SENT_353	[p24l1619t1862r1668b1893],
46	:	:	O	:	_	0	SENT_353	[p24l1619t1862r1668b1893],
47	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1680t1862r1764b1893],
48	1	CD	NUMBER	1	dep	119	SENT_353	[p24l1680t1862r1764b1893],
49	/	:	O	/	dep	119	SENT_353	[p24l1680t1862r1764b1893],
50	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1680t1862r1764b1893],
51	2	CD	NUMBER	2	dep	119	SENT_353	[p24l1680t1862r1764b1893],
52	,	,	O	,	_	0	SENT_353	[p24l1680t1862r1764b1893],
53	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1776t1862r1859b1893],
54	1	CD	NUMBER	1	dep	119	SENT_353	[p24l1776t1862r1859b1893],
55	/	:	O	/	dep	119	SENT_353	[p24l1776t1862r1859b1893],
56	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1776t1862r1859b1893],
57	3	CD	NUMBER	3	dep	119	SENT_353	[p24l1776t1862r1859b1893],
58	,	,	O	,	_	0	SENT_353	[p24l1776t1862r1859b1893],
59	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1871t1862r1958b1893],
60	2	CD	NUMBER	2	dep	119	SENT_353	[p24l1871t1862r1958b1893],
61	/	:	O	/	dep	119	SENT_353	[p24l1871t1862r1958b1893],
62	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1871t1862r1958b1893],
63	2	CD	NUMBER	2	dep	119	SENT_353	[p24l1871t1862r1958b1893],
64	,	,	O	,	_	0	SENT_353	[p24l1871t1862r1958b1893],
65	"	``	O	"	dep	119	SENT_353	[p24l120t1904r205b1935],
66	2	CD	NUMBER	2	dep	119	SENT_353	[p24l120t1904r205b1935],
67	/	:	O	/	dep	119	SENT_353	[p24l120t1904r205b1935],
68	*	CD	NUMBER	*	dep	119	SENT_353	[p24l120t1904r205b1935],
69	3	CD	NUMBER	3	dep	119	SENT_353	[p24l120t1904r205b1935],
70	,	,	O	,	_	0	SENT_353	[p24l120t1904r205b1935],
71	*	CD	NUMBER	*	dep	119	SENT_353	[p24l217t1904r301b1935],
72	3	CD	NUMBER	3	dep	119	SENT_353	[p24l217t1904r301b1935],
73	/	:	O	/	dep	119	SENT_353	[p24l217t1904r301b1935],
74	*	CD	NUMBER	*	dep	119	SENT_353	[p24l217t1904r301b1935],
75	3	CD	NUMBER	3	dep	119	SENT_353	[p24l217t1904r301b1935],
76	,	,	O	,	_	0	SENT_353	[p24l217t1904r301b1935],
77	*	CD	NUMBER	*	dep	119	SENT_353	[p24l313t1904r411b1935],
78	2	CD	NUMBER	2	dep	119	SENT_353	[p24l313t1904r411b1935],
79	/	:	O	/	dep	119	SENT_353	[p24l313t1904r411b1935],
80	"	``	O	"	dep	119	SENT_353	[p24l313t1904r411b1935],
81	17	CD	NUMBER	17	dep	119	SENT_353	[p24l313t1904r411b1935],
82	,	,	O	,	_	0	SENT_353	[p24l313t1904r411b1935],
83	or	CC	O	or	dep	119	SENT_353	[p24l424t1911r452b1927],
84	*	NN	O	*	dep	119	SENT_353	[p24l462t1904r559b1935],
85	3	CD	NUMBER	3	dep	119	SENT_353	[p24l462t1904r559b1935],
86	/	:	O	/	dep	119	SENT_353	[p24l462t1904r559b1935],
87	*	CD	NUMBER	*	dep	119	SENT_353	[p24l462t1904r559b1935],
88	l7	NN	O	l7	dep	119	SENT_353	[p24l462t1904r559b1935],
89	;	:	O	;	_	0	SENT_353	[p24l462t1904r559b1935],
90	loss-of-function	NN	O	loss-of-function	dep	119	SENT_353	[p24l573t1901r790b1927],
91	noncarriers	NNS	O	noncarrier	dep	119	SENT_353	[p24l804t1904r961b1927],
92	were	VBD	O	be	dep	119	SENT_353	[p24l972t1911r1037b1927],
93	defined	VBN	O	define	dep	119	SENT_353	[p24l1048t1901r1152b1927],
94	as	IN	O	as	dep	119	SENT_353	[p24l1165t1911r1193b1927],
95	patients	NNS	O	patient	dep	119	SENT_353	[p24l1206t1904r1316b1934],
96	with	IN	O	with	dep	119	SENT_353	[p24l1327t1902r1384b1927],
97	no	DT	O	no	dep	119	SENT_353	[p24l1399t1911r1431b1927],
98	loss-of-function	JJ	O	loss-of-function	dep	119	SENT_353	[p24l1444t1901r1661b1927],
99	allele	NN	O	allele	dep	119	SENT_353	[p24l1674t1902r1752b1927],
100	:	:	O	:	_	0	SENT_353	[p24l1674t1902r1752b1927],
101	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1764t1904r1845b1935],
102	1	CD	NUMBER	1	dep	119	SENT_353	[p24l1764t1904r1845b1935],
103	/	:	O	/	dep	119	SENT_353	[p24l1764t1904r1845b1935],
104	"	``	O	"	dep	119	SENT_353	[p24l1764t1904r1845b1935],
105	"	``	O	"	dep	119	SENT_353	[p24l1764t1904r1845b1935],
106	1	CD	NUMBER	1	dep	119	SENT_353	[p24l1764t1904r1845b1935],
107	,	,	O	,	_	0	SENT_353	[p24l1764t1904r1845b1935],
108	*	CD	NUMBER	*	dep	119	SENT_353	[p24l1857t1904r1952b1935],
109	1	CD	NUMBER	1	dep	119	SENT_353	[p24l1857t1904r1952b1935],
110	/	:	O	/	dep	119	SENT_353	[p24l1857t1904r1952b1935],
111	"	``	O	"	dep	119	SENT_353	[p24l1857t1904r1952b1935],
112	17	CD	NUMBER	17	dep	119	SENT_353	[p24l1857t1904r1952b1935],
113	,	,	O	,	_	0	SENT_353	[p24l1857t1904r1952b1935],
114	or	CC	O	or	dep	119	SENT_353	[p24l1965t1911r1993b1927],
115	*	NN	O	*	dep	119	SENT_353	[p24l120t1946r229b1976],
116	17	CD	NUMBER	17	dep	119	SENT_353	[p24l120t1946r229b1976],
117	/	:	O	/	dep	119	SENT_353	[p24l120t1946r229b1976],
118	*	CD	NUMBER	*	dep	119	SENT_353	[p24l120t1946r229b1976],
119	17	CD	NUMBER	17	_	0	SENT_353	[p24l120t1946r229b1976],
120	.	.	O	.	_	0	SENT_353	[p24l120t1946r229b1976],

1	Gain-of-function	NN	O	gain-of-function	nn	2	SENT_354	[p24l242t1943r470b1969],
2	carriers	NNS	O	carrier	nsubjpass	4	SENT_354	[p24l483t1946r586b1969],
3	were	VBD	O	be	auxpass	4	SENT_354	[p24l598t1952r662b1969],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_354	[p24l674t1943r777b1969],
5	as	IN	O	as	_	0	SENT_354	[p24l790t1952r818b1969],
6	carriers	NNS	O	carrier	prep_as	4	SENT_354	[p24l830t1946r933b1969],
7	of	IN	O	of	_	0	SENT_354	[p24l945t1943r975b1968],
8	at	IN	O	at	quantmod	10	SENT_354	[p24l982t1948r1007b1968],
9	least	JJS	O	least	mwe	8	SENT_354	[p24l1019t1943r1082b1969],
10	one	CD	NUMBER	one	num	12	SENT_354	[p24l1093t1952r1143b1969],
11	gain-of-function	NN	O	gain-of-function	nn	12	SENT_354	[p24l1155t1943r1377b1977],
12	allele	NN	O	allele	prep_of	6	SENT_354	[p24l1390t1943r1460b1969],
13	(	CD	NUMBER	(	dep	6	SENT_354	[p24l1475t1945r1530b1976],
14	i.e.	FW	O	i.e.	dep	13	SENT_354	[p24l1475t1945r1530b1976],
15	,	,	O	,	_	0	SENT_354	[p24l1475t1945r1530b1976],
16	*	CD	NUMBER	*	number	17	SENT_354	[p24l1543t1945r1608b1976],
17	17	CD	NUMBER	17	num	18	SENT_354	[p24l1543t1945r1608b1976],
18	)	NN	O	)	appos	6	SENT_354	[p24l1543t1945r1608b1976],
19	:	:	O	:	_	0	SENT_354	[p24l1543t1945r1608b1976],
20	*	CD	NUMBER	*	number	21	SENT_354	[p24l1620t1946r1715b1976],
21	1	CD	NUMBER	1	dep	18	SENT_354	[p24l1620t1946r1715b1976],
22	/	:	O	/	punct	24	SENT_354	[p24l1620t1946r1715b1976],
23	*	CD	NUMBER	*	num	24	SENT_354	[p24l1620t1946r1715b1976],
24	17	CD	NUMBER	17	dep	21	SENT_354	[p24l1620t1946r1715b1976],
25	,	,	O	,	_	0	SENT_354	[p24l1620t1946r1715b1976],
26	*	CD	NUMBER	*	number	27	SENT_354	[p24l1727t1946r1836b1976],
27	17	CD	NUMBER	17	dep	21	SENT_354	[p24l1727t1946r1836b1976],
28	/	:	O	/	punct	30	SENT_354	[p24l1727t1946r1836b1976],
29	*	CD	NUMBER	*	num	30	SENT_354	[p24l1727t1946r1836b1976],
30	17	CD	NUMBER	17	dep	27	SENT_354	[p24l1727t1946r1836b1976],
31	,	,	O	,	_	0	SENT_354	[p24l1727t1946r1836b1976],
32	*	CD	NUMBER	*	num	33	SENT_354	[p24l1848t1946r1946b1976],
33	2	CD	NUMBER	2	appos	30	SENT_354	[p24l1848t1946r1946b1976],
34	/	:	O	/	punct	30	SENT_354	[p24l1848t1946r1946b1976],
35	*	CD	NUMBER	*	num	36	SENT_354	[p24l1848t1946r1946b1976],
36	17	CD	NUMBER	17	dep	27	SENT_354	[p24l1848t1946r1946b1976],
37	,	,	O	,	_	0	SENT_354	[p24l1848t1946r1946b1976],
38	or	CC	O	or	_	0	SENT_354	[p24l1959t1952r1987b1968],
39	*	NN	O	*	dep	21	SENT_354	[p24l120t1987r217b2018],
40	3	CD	NUMBER	3	num	39	SENT_354	[p24l120t1987r217b2018],
41	/	:	O	/	punct	24	SENT_354	[p24l120t1987r217b2018],
42	*	CD	NUMBER	*	number	43	SENT_354	[p24l120t1987r217b2018],
43	17	CD	NUMBER	17	num	21	SENT_354	[p24l120t1987r217b2018],
44	;	:	O	;	_	0	SENT_354	[p24l120t1987r217b2018],
45	gain-of-function	NN	O	gain-of-function	nn	46	SENT_354	[p24l230t1985r452b2018],
46	noncarriers	NNS	O	noncarrier	nsubjpass	48	SENT_354	[p24l466t1987r623b2010],
47	were	VBD	O	be	auxpass	48	SENT_354	[p24l635t1994r699b2010],
48	defined	VBN	O	define	parataxis	4	SENT_354	[p24l711t1985r814b2010],
49	as	IN	O	as	_	0	SENT_354	[p24l827t1994r855b2010],
50	patients	NNS	O	patient	prep_as	48	SENT_354	[p24l868t1987r978b2018],
51	with	IN	O	with	_	0	SENT_354	[p24l989t1985r1046b2010],
52	no	DT	O	no	det	54	SENT_354	[p24l1061t1994r1093b2010],
53	gain-of-function	NN	O	gain-of-function	nn	54	SENT_354	[p24l1105t1985r1327b2018],
54	allele	NN	O	allele	prep_with	50	SENT_354	[p24l1340t1985r1418b2010],
55	:	:	O	:	_	0	SENT_354	[p24l1340t1985r1418b2010],
56	*	CD	NUMBER	*	number	57	SENT_354	[p24l1430t1987r1511b2018],
57	1	CD	NUMBER	1	dep	54	SENT_354	[p24l1430t1987r1511b2018],
58	/	:	O	/	punct	60	SENT_354	[p24l1430t1987r1511b2018],
59	*	CD	NUMBER	*	num	60	SENT_354	[p24l1430t1987r1511b2018],
60	1	CD	NUMBER	1	dep	57	SENT_354	[p24l1430t1987r1511b2018],
61	,	,	O	,	_	0	SENT_354	[p24l1430t1987r1511b2018],
62	*	CD	NUMBER	*	number	63	SENT_354	[p24l1523t1987r1608b2018],
63	1	CD	NUMBER	1	dep	57	SENT_354	[p24l1523t1987r1608b2018],
64	/	:	O	/	punct	66	SENT_354	[p24l1523t1987r1608b2018],
65	*	CD	NUMBER	*	num	66	SENT_354	[p24l1523t1987r1608b2018],
66	2	CD	NUMBER	2	dep	63	SENT_354	[p24l1523t1987r1608b2018],
67	,	,	O	,	_	0	SENT_354	[p24l1523t1987r1608b2018],
68	*	CD	NUMBER	*	num	69	SENT_354	[p24l1620t1987r1703b2018],
69	1	CD	NUMBER	1	appos	66	SENT_354	[p24l1620t1987r1703b2018],
70	/	:	O	/	punct	66	SENT_354	[p24l1620t1987r1703b2018],
71	*	CD	NUMBER	*	number	72	SENT_354	[p24l1620t1987r1703b2018],
72	3	CD	NUMBER	3	num	63	SENT_354	[p24l1620t1987r1703b2018],
73	,	,	O	,	_	0	SENT_354	[p24l1620t1987r1703b2018],
74	*	CD	NUMBER	*	number	75	SENT_354	[p24l1715t1987r1802b2018],
75	2	CD	NUMBER	2	appos	63	SENT_354	[p24l1715t1987r1802b2018],
76	/	:	O	/	punct	78	SENT_354	[p24l1715t1987r1802b2018],
77	*	CD	NUMBER	*	num	78	SENT_354	[p24l1715t1987r1802b2018],
78	2	CD	NUMBER	2	dep	75	SENT_354	[p24l1715t1987r1802b2018],
79	,	,	O	,	_	0	SENT_354	[p24l1715t1987r1802b2018],
80	*	CD	NUMBER	*	num	81	SENT_354	[p24l1814t1987r1900b2018],
81	2	CD	NUMBER	2	appos	78	SENT_354	[p24l1814t1987r1900b2018],
82	/	:	O	/	punct	78	SENT_354	[p24l1814t1987r1900b2018],
83	*	CD	NUMBER	*	number	84	SENT_354	[p24l1814t1987r1900b2018],
84	3	CD	NUMBER	3	num	75	SENT_354	[p24l1814t1987r1900b2018],
85	,	,	O	,	_	0	SENT_354	[p24l1814t1987r1900b2018],
86	or	CC	O	or	_	0	SENT_354	[p24l1913t1994r1941b2010],
87	*	NN	O	*	dep	57	SENT_354	[p24l1950t1987r2034b2018],
88	3	CD	NUMBER	3	num	87	SENT_354	[p24l1950t1987r2034b2018],
89	/	:	O	/	punct	60	SENT_354	[p24l1950t1987r2034b2018],
90	*	CD	NUMBER	*	number	91	SENT_354	[p24l1950t1987r2034b2018],
91	3	CD	NUMBER	3	num	57	SENT_354	[p24l1950t1987r2034b2018],
92	.	.	O	.	_	0	SENT_354	[p24l1950t1987r2034b2018],

1	less	JJR	O	less	_	0	SENT_355	[p24l93t2133r153b2164],
2	statistical	JJ	O	statistical	amod	3	SENT_355	[p24l175t2133r336b2164],
3	power	NN	O	power	dep	1	SENT_355	[p24l355t2143r466b2173],
4	.	.	O	.	_	0	SENT_355	[p24l355t2143r466b2173],

1	Third	NNP	ORDINAL	Third	nsubj	8	SENT_356	[p24l487t2133r589b2171],
2	,	,	O	,	_	0	SENT_356	[p24l487t2133r589b2171],
3	our	PRP$	O	we	poss	4	SENT_356	[p24l611t2143r668b2165],
4	results	NNS	O	result	nsubj	8	SENT_356	[p24l687t2133r796b2165],
5	might	MD	O	might	aux	8	SENT_356	[p24l817t2134r918b2173],
6	common	JJ	O	common	amod	8	SENT_356	[p24l957t2143r1104b2164],
7	functional	JJ	O	functional	amod	8	SENT_356	[p24l1125t2133r1298b2165],
8	alleles	NNS	O	allele	_	0	SENT_356	[p24l1318t2133r1431b2164],
9	.	.	O	.	_	0	SENT_356	[p24l1318t2133r1431b2164],

1	The	DT	O	the	det	5	SENT_357	[p24l1452t2133r1515b2164],
2	low	JJ	O	low	amod	5	SENT_357	[p24l1535t2134r1595b2164],
3	allele	NN	O	allele	nn	5	SENT_357	[p24l1614t2133r1700b2164],
4	frebe	NN	O	frebe	nn	5	SENT_357	[p24l1721t2133r1779b2164, p24l94t2183r131b2214],
5	speciﬁc	NN	O	speciﬁc	nsubjpass	16	SENT_357	[p24l144t2183r272b2222],
6	to	TO	O	to	_	0	SENT_357	[p24l284t2190r316b2214],
7	our	PRP$	O	we	poss	9	SENT_357	[p24l329t2193r385b2214],
8	patient	NN	O	patient	nn	9	SENT_357	[p24l396t2184r513b2222],
9	population	NN	O	population	prep_to	5	SENT_357	[p24l523t2183r706b2222],
10	and	CC	O	and	_	0	SENT_357	[p24l717t2183r779b2214],
11	the	DT	O	the	det	12	SENT_357	[p24l791t2183r843b2214],
12	way	NN	O	way	conj_and	5	SENT_357	[p24l853t2194r918b2222],
13	their	PRP$	O	they	poss	14	SENT_357	[p24l94t2233r173b2263],
14	cases	NNS	O	case	dep	12	SENT_357	[p24l189t2243r275b2263],
15	were	VBD	O	be	auxpass	16	SENT_357	[p24l291t2243r369b2264],
16	managed	VBN	O	manage	_	0	SENT_357	[p24l386t2233r549b2272],
17	.	.	O	.	_	0	SENT_357	[p24l386t2233r549b2272],

1	Fourth	JJ	ORDINAL	fourth	advmod	14	SENT_358	[p24l568t2233r690b2270],
2	,	,	O	,	_	0	SENT_358	[p24l568t2233r690b2270],
3	only	RB	O	only	advmod	4	SENT_358	[p24l709t2233r781b2272],
4	participants	NNS	O	participant	nsubjpass	14	SENT_358	[p24l795t2233r916b2272, p24l93t2289r184b2321],
5	of	IN	O	of	_	0	SENT_358	[p24l201t2282r239b2313],
6	European	JJ	MISC	european	amod	10	SENT_358	[p24l247t2285r407b2321],
7	or	CC	O	or	_	0	SENT_358	[p24l423t2292r457b2313],
8	Latin	JJ	MISC	latin	amod	10	SENT_358	[p24l471t2283r557b2313],
9	American	JJ	MISC	american	amod	10	SENT_358	[p24l571t2283r734b2313],
10	ancestries	NNS	O	ancestry	prep_of	4	SENT_358	[p24l749t2283r916b2313],
11	could	MD	O	could	aux	14	SENT_358	[p24l94t2332r185b2363],
12	be	VB	O	be	auxpass	14	SENT_358	[p24l198t2332r236b2362],
13	adequately	RB	O	adequately	advmod	14	SENT_358	[p24l249t2332r426b2371],
14	analyzed	VBN	O	analyze	_	0	SENT_358	[p24l438t2332r594b2371],
15	.	.	O	.	_	0	SENT_358	[p24l438t2332r594b2371],

1	Even	RB	O	even	advmod	4	SENT_359	[p24l609t2335r686b2363],
2	though	IN	O	though	dep	4	SENT_359	[p24l699t2332r819b2371],
3	there	EX	O	there	expl	4	SENT_359	[p24l832t2332r917b2362],
4	is	VBZ	O	be	advcl	30	SENT_359	[p24l93t2382r119b2412],
5	no	DT	O	no	det	6	SENT_359	[p24l146t2391r187b2412],
6	reason	NN	O	reason	nsubj	4	SENT_359	[p24l213t2391r323b2412],
7	to	TO	O	to	aux	8	SENT_359	[p24l350t2388r381b2412],
8	suspect	VB	O	suspect	infmod	6	SENT_359	[p24l408t2388r541b2421],
9	,	,	O	,	_	0	SENT_359	[p24l408t2388r541b2421],
10	a	DT	O	a	det	11	SENT_359	[p24l569t2392r586b2412],
11	priori	FW	O	priori	nsubjpass	30	SENT_359	[p24l611t2382r713b2421],
12	,	,	O	,	_	0	SENT_359	[p24l611t2382r713b2421],
13	that	IN	O	that	dep	18	SENT_359	[p24l741t2381r808b2412],
14	there	EX	O	there	expl	18	SENT_359	[p24l832t2381r916b2412],
15	would	MD	O	would	aux	18	SENT_359	[p24l92t2431r195b2462],
16	be	VB	O	be	cop	18	SENT_359	[p24l212t2431r249b2462],
17	different	JJ	O	different	amod	18	SENT_359	[p24l266t2431r412b2462],
18	results	NNS	O	result	dep	30	SENT_359	[p24l427t2431r536b2462],
19	in	IN	O	in	_	0	SENT_359	[p24l553t2432r586b2461],
20	other	JJ	O	other	amod	21	SENT_359	[p24l603t2432r691b2462],
21	populations	NNS	O	population	prep_in	18	SENT_359	[p24l706t2431r914b2470],
22	,	,	O	,	_	0	SENT_359	[p24l706t2431r914b2470],
23	further	JJ	O	further	amod	24	SENT_359	[p24l94t2480r213b2512],
24	studies	NNS	O	study	nsubjpass	30	SENT_359	[p24l236t2480r352b2512],
25	in	IN	O	in	_	0	SENT_359	[p24l376t2481r408b2511],
26	diverse	JJ	O	diverse	amod	27	SENT_359	[p24l432t2480r547b2512],
27	populations	NNS	O	population	prep_in	24	SENT_359	[p24l570t2480r769b2520],
28	will	MD	O	will	aux	30	SENT_359	[p24l792t2480r856b2512],
29	be	VB	O	be	auxpass	30	SENT_359	[p24l879t2481r916b2511],
30	needed	VBN	O	need	_	0	SENT_359	[p24l94t2530r220b2561],
31	.	.	O	.	_	0	SENT_359	[p24l94t2530r220b2561],

1	Finally	RB	O	finally	advmod	4	SENT_360	[p24l239t2530r357b2570],
2	,	,	O	,	_	0	SENT_360	[p24l239t2530r357b2570],
3	we	PRP	O	we	nsubj	4	SENT_360	[p24l375t2541r420b2562],
4	studied	VBD	O	study	_	0	SENT_360	[p24l438t2530r560b2562],
5	only	RB	O	only	quantmod	7	SENT_360	[p24l577t2530r648b2570],
6	the	DT	O	the	quantmod	7	SENT_360	[p24l664t2531r715b2561],
7	three	CD	NUMBER	three	dobj	4	SENT_360	[p24l732t2530r818b2561],
8	most	RBS	O	most	advmod	4	SENT_360	[p24l835t2537r919b2561],

1	N	NN	O	n	nn	2	SENT_361	[p24l596t2655r609b2670],
2	ENGLJ	NN	O	englj	nsubj	3	SENT_361	[p24l624t2655r702b2677],
3	MED	VBD	O	med	_	0	SENT_361	[p24l717t2655r769b2670],
4	36338	CD	NUMBER	36338	dobj	3	SENT_361	[p24l779t2649r856b2677],

1	quency	NN	O	quency	nsubj	9	SENT_362	[p24l957t2193r1074b2222],
2	of	IN	O	of	_	0	SENT_362	[p24l1088t2183r1126b2214],
3	other	JJ	O	other	amod	5	SENT_362	[p24l1135t2183r1223b2214],
4	known	JJ	O	known	amod	5	SENT_362	[p24l1237t2184r1353b2214],
5	alleles	NNS	O	allele	prep_of	1	SENT_362	[p24l1368t2183r1471b2214],
6	should	MD	O	should	aux	9	SENT_362	[p24l1488t2183r1599b2214],
7	not	RB	O	not	neg	9	SENT_362	[p24l1615t2190r1670b2214],
8	materially	RB	O	materially	advmod	9	SENT_362	[p24l1684t2190r1779b2214, p24l956t2233r1042b2272],
9	alter	VB	O	alter	_	0	SENT_362	[p24l1058t2233r1133b2263],
10	our	PRP$	O	we	poss	11	SENT_362	[p24l1150t2243r1206b2264],
11	conclusions	NNS	O	conclusion	dobj	9	SENT_362	[p24l1223t2233r1418b2264],
12	but	CC	O	but	_	0	SENT_362	[p24l1437t2233r1492b2264],
13	may	MD	O	may	aux	15	SENT_362	[p24l1508t2243r1577b2272],
14	be	VB	O	be	cop	15	SENT_362	[p24l1594t2233r1631b2263],
15	relevant	JJ	O	relevant	conj_but	9	SENT_362	[p24l1649t2233r1781b2264],
16	for	IN	O	for	_	0	SENT_362	[p24l956t2282r1004b2313],
17	individual	JJ	O	individual	amod	18	SENT_362	[p24l1018t2282r1185b2313],
18	patients	NNS	O	patient	prep_for	15	SENT_362	[p24l1200t2283r1342b2321],
19	.	.	O	.	_	0	SENT_362	[p24l1200t2283r1342b2321],

1	Our	PRP$	O	we	poss	2	SENT_363	[p24l1006t2334r1070b2363],
2	study	NN	O	study	nsubj	4	SENT_363	[p24l1083t2332r1170b2371],
3	also	RB	O	also	advmod	4	SENT_363	[p24l1181t2332r1247b2362],
4	has	VBZ	O	have	_	0	SENT_363	[p24l1260t2332r1315b2362],
5	several	JJ	O	several	amod	6	SENT_363	[p24l1330t2332r1440b2363],
6	strengths	NNS	O	strength	dobj	4	SENT_363	[p24l1454t2332r1616b2371],
7	.	.	O	.	_	0	SENT_363	[p24l1454t2332r1616b2371],

1	First	RB	ORDINAL	first	advmod	13	SENT_364	[p24l1631t2332r1713b2369],
2	,	,	O	,	_	0	SENT_364	[p24l1631t2332r1713b2369],
3	the	DT	O	the	det	4	SENT_364	[p24l1728t2332r1779b2362],
4	inclusion	NN	O	inclusion	nsubj	13	SENT_364	[p24l956t2381r1108b2413],
5	of	IN	O	of	_	0	SENT_364	[p24l1124t2381r1163b2412],
6	a	DT	O	a	prep_of	4	SENT_364	[p24l1170t2392r1188b2412],
7	randomized	VBN	O	randomize	partmod	6	SENT_364	[p24l1203t2381r1405b2412],
8	placebo	NN	O	placebo	nn	9	SENT_364	[p24l1419t2381r1547b2421],
9	group	NN	O	group	dobj	7	SENT_364	[p24l1563t2391r1661b2421],
10	in	IN	O	in	_	0	SENT_364	[p24l1676t2382r1708b2412],
11	our	PRP$	O	we	poss	12	SENT_364	[p24l1724t2391r1781b2413],
12	analyses	NNS	O	analysis	prep_in	9	SENT_364	[p24l956t2431r1095b2470],
13	reduces	VBZ	O	reduce	_	0	SENT_364	[p24l1118t2431r1243b2462],
14	various	JJ	O	various	amod	15	SENT_364	[p24l1263t2432r1384b2462],
15	sources	NNS	O	source	dobj	13	SENT_364	[p24l1407t2441r1531b2462],
16	of	IN	O	of	_	0	SENT_364	[p24l1554t2431r1593b2462],
17	confounding	NN	O	confounding	prep_of	15	SENT_364	[p24l1607t2431r1779b2462, p24l956t2481r1017b2520],
18	,	,	O	,	_	0	SENT_364	[p24l1607t2431r1779b2462, p24l956t2481r1017b2520],
19	such	JJ	O	such	_	0	SENT_364	[p24l1035t2480r1110b2512],
20	as	IN	O	as	_	0	SENT_364	[p24l1125t2491r1158b2511],
21	potential	JJ	O	potential	amod	24	SENT_364	[p24l1174t2480r1324b2520],
22	pleiotropic	JJ	O	pleiotropic	amod	24	SENT_364	[p24l1338t2481r1518b2520],
23	genetic	JJ	O	genetic	amod	24	SENT_364	[p24l1532t2481r1652b2520],
24	effects	NNS	O	effect	prep_such_as	15	SENT_364	[p24l1667t2480r1778b2511],
25	or	CC	O	or	_	0	SENT_364	[p24l957t2540r991b2561],
26	population	NN	O	population	nn	27	SENT_364	[p24l1010t2531r1196b2570],
27	stratification	NN	O	stratification	prep_such_as	15	SENT_364	[p24l1216t2530r1448b2561],
28	.	.	O	.	_	0	SENT_364	[p24l1216t2530r1448b2561],

1	Second	RB	ORDINAL	second	_	0	SENT_365	[p24l1471t2530r1601b2568],
2	,	,	O	,	_	0	SENT_365	[p24l1471t2530r1601b2568],
3	the	DT	O	the	det	4	SENT_365	[p24l1623t2530r1675b2561],
4	large	JJ	O	large	appos	1	SENT_365	[p24l1695t2530r1779b2570],

1	NEjM.ORG	NN	O	nejm.org	nn	2	SENT_366	[p24l891t2655r1015b2677],
2	OCTOBER	NN	DATE	october	_	0	SENT_366	[p24l1050t2655r1162b2670],
3	28	CD	DATE	28	dep	2	SENT_366	[p24l1173t2649r1208b2675],
4	,	,	DATE	,	_	0	SENT_366	[p24l1173t2649r1208b2675],
5	2010	CD	DATE	2010	appos	3	SENT_366	[p24l1219t2655r1279b2671],

1	The	DT	O	the	det	4	SENT_367	[p24l752t2712r803b2736],
2	New	NNP	O	New	nn	4	SENT_367	[p24l812t2713r874b2736],
3	England	NNP	O	England	nn	4	SENT_367	[p24l883t2712r994b2743],
4	Journal	NNP	O	Journal	_	0	SENT_367	[p24l1003t2712r1100b2736],
5	of	IN	O	of	_	0	SENT_367	[p24l1110t2712r1139b2736],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_367	[p24l1145t2712r1270b2736],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_368	[p24l649t2900r770b2920],
2	GENOTYPE	NN	O	genotype	dep	1	SENT_368	[p24l785t2900r959b2919],
3	AND	CC	O	and	_	0	SENT_368	[p24l971t2900r1043b2919],
4	CLOPIDOGREL	NN	O	clopidogrel	nn	5	SENT_368	[p24l1057t2900r1294b2919],
5	TREATMENT	NN	O	treatment	dep	1	SENT_368	[p24l1306t2900r1511b2919],

1	numbers	NNS	O	number	nsubj	9	SENT_369	[p24l10t3116r396b3196],
2	of	IN	O	of	_	0	SENT_369	[p24l459t3115r560b3195],
3	patients	NNS	O	patient	prep_of	1	SENT_369	[p24l600t3117r952b3216],
4	and	CC	O	and	_	0	SENT_369	[p24l1012t3116r1174b3195],
5	events	NNS	O	event	conj_and	3	SENT_369	[p24l1234t3133r1504b3195],
6	in	IN	O	in	_	0	SENT_369	[p24l1566t3117r1651b3194],
7	our	PRP$	O	we	poss	8	SENT_369	[p24l1711t3142r1860b3196],
8	study	NN	O	study	prep_in	3	SENT_369	[p24l1917t3116r2154b3216],
9	ensure	VB	O	ensure	_	0	SENT_369	[p24l10t3271r300b3324],
10	adequate	JJ	O	adequate	amod	12	SENT_369	[p24l363t3245r756b3345],
11	statistical	JJ	O	statistical	amod	12	SENT_369	[p24l822t3245r1252b3323],
12	power	NN	O	power	dobj	9	SENT_369	[p24l1314t3271r1588b3345],
13	and	CC	O	and	_	0	SENT_369	[p24l1648t3245r1810b3324],
14	robust	JJ	O	robust	amod	15	SENT_369	[p24l1873t3245r2154b3324],
15	estimates	NNS	O	estimate	dobj	9	SENT_369	[p24l10t3375r421b3453],
16	of	IN	O	of	_	0	SENT_369	[p24l471t3373r572b3454],
17	genetic	JJ	O	genetic	amod	19	SENT_369	[p24l601t3375r912b3476],
18	effect	NN	O	effect	nn	19	SENT_369	[p24l959t3373r1203b3453],
19	sizes	NNS	O	size	prep_of	15	SENT_369	[p24l1247t3375r1478b3454],
20	.	.	O	.	_	0	SENT_369	[p24l1247t3375r1478b3454],

1	Third	NNP	ORDINAL	Third	nsubj	4	SENT_370	[p24l1527t3374r1793b3471],
2	,	,	O	,	_	0	SENT_370	[p24l1527t3374r1793b3471],
3	we	PRP	O	we	nsubj	4	SENT_370	[p24l1842t3401r1960b3454],
4	observed	VBD	O	observe	_	0	SENT_370	[p24l2009t3374r2148b3454, p24l11t3503r289b3583],

1	consistent	JJ	O	consistent	amod	2	SENT_371	[p24l340t3504r793b3583],
2	benefits	NNS	O	benefit	_	0	SENT_371	[p24l839t3502r1193b3583],
3	of	IN	O	of	_	0	SENT_371	[p24l1247t3502r1349b3583],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_371	[p24l1382t3503r1903b3605],
5	,	,	O	,	_	0	SENT_371	[p24l1382t3503r1903b3605],
6	irrespective	RB	O	irrespective	advmod	4	SENT_371	[p24l1959t3504r2148b3582, p24l11t3633r352b3733],

1	of	IN	O	of	_	0	SENT_372	[p24l406t3631r507b3712],
2	CYPZCI9	NN	O	cypzci9	nn	3	SENT_372	[p24l542t3639r890b3711],
3	genotype	NN	O	genotype	prep_of	12	SENT_372	[p24l943t3649r1364b3734],
4	,	,	O	,	_	0	SENT_372	[p24l943t3649r1364b3734],
5	in	IN	O	in	_	0	SENT_372	[p24l1422t3633r1506b3710],
6	two	CD	NUMBER	two	num	9	SENT_372	[p24l1560t3649r1719b3712],
7	different	JJ	O	different	amod	9	SENT_372	[p24l1775t3631r2154b3712],
8	patient	NN	O	patient	nn	9	SENT_372	[p25l8t21r313b120],
9	populations	NNS	O	population	prep_in	12	SENT_372	[p25l366t20r908b120],
10	,	,	O	,	_	0	SENT_372	[p25l366t20r908b120],
11	which	WDT	O	which	nsubj	12	SENT_372	[p25l969t20r1234b100],
12	validates	VBZ	O	validate	_	0	SENT_372	[p25l1290t20r1668b100],
13	our	PRP$	O	we	poss	14	SENT_372	[p25l1732t46r1879b99],
14	findings	NNS	O	finding	dobj	12	SENT_372	[p25l1936t19r2148b99, p25l9t150r189b250],
15	and	CC	O	and	_	0	SENT_372	[p25l235t149r394b228],
16	suggests	VBZ	O	suggest	conj_and	12	SENT_372	[p25l440t166r809b250],
17	that	IN	O	that	complm	22	SENT_372	[p25l856t149r1030b227],
18	they	PRP	O	they	nsubj	22	SENT_372	[p25l1069t149r1253b249],
19	could	MD	O	could	aux	22	SENT_372	[p25l1293t149r1530b228],
20	be	VB	O	be	cop	22	SENT_372	[p25l1574t149r1672b228],
21	generaliz	NN	O	generaliz	nn	22	SENT_372	[p25l1716t149r2148b250],
22	—	NN	O	—	ccomp	16	SENT_372	[p25l1716t149r2148b250],
23	able	JJ	O	able	amod	22	SENT_372	[p25l9t277r181b356],
24	to	TO	O	to	_	0	SENT_372	[p25l222t294r304b356],
25	other	JJ	O	other	amod	26	SENT_372	[p25l345t277r575b356],
26	populations	NNS	O	population	prep_to	23	SENT_372	[p25l610t277r1152b377],
27	.	.	O	.	_	0	SENT_372	[p25l610t277r1152b377],

1	In	IN	O	in	_	0	SENT_373	[p25l138t414r227b484],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_373	[p25l274t406r761b502],
3	,	,	O	,	_	0	SENT_373	[p25l274t406r761b502],
4	our	PRP$	O	we	poss	5	SENT_373	[p25l812t432r959b485],
5	study	NN	O	study	nsubj	6	SENT_373	[p25l1002t406r1234b506],
6	shows	VBZ	O	show	_	0	SENT_373	[p25l1275t406r1541b485],
7	that	IN	O	that	complm	17	SENT_373	[p25l1588t406r1762b484],
8	CYPZCI9	NN	O	cypzci9	nn	10	SENT_373	[p25l1801t412r2149b484],
9	loss	NN	O	loss	nn	10	SENT_373	[p25l8t533r717b613],
10	—	NN	O	—	nsubj	17	SENT_373	[p25l8t533r717b613],
11	of	IN	O	of	_	0	SENT_373	[p25l8t533r717b613],
12	—	CD	NUMBER	—	num	14	SENT_373	[p25l8t533r717b613],
13	function	NN	O	function	nn	14	SENT_373	[p25l8t533r717b613],
14	variants	NNS	O	variant	prep_of	10	SENT_373	[p25l758t535r1111b614],
15	do	VBP	O	do	aux	17	SENT_373	[p25l1160t534r1264b613],
16	not	RB	O	not	neg	17	SENT_373	[p25l1311t551r1457b613],
17	modify	VB	O	modify	ccomp	6	SENT_373	[p25l1498t533r1817b634],
18	the	DT	O	the	det	19	SENT_373	[p25l1859t534r1994b612],
19	efficacy	NN	O	efficacy	dobj	17	SENT_373	[p25l2041t533r2148b612, p25l10t662r270b764],
20	and	CC	O	and	_	0	SENT_373	[p25l344t663r505b743],
21	safety	NN	O	safety	dobj	17	SENT_373	[p25l587t662r847b764],
22	of	IN	O	of	_	0	SENT_373	[p25l923t662r1024b743],
23	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_373	[p25l1087t663r1608b765],
24	.	.	O	.	_	0	SENT_373	[p25l1087t663r1608b765],

1	Therefore	RB	O	therefore	advmod	13	SENT_374	[p25l1690t662r2143b760],
2	,	,	O	,	_	0	SENT_374	[p25l1690t662r2143b760],
3	loss	NN	O	loss	nn	4	SENT_374	[p25l8t792r706b873],
4	—	NN	O	—	nsubj	13	SENT_374	[p25l8t792r706b873],
5	of	IN	O	of	_	0	SENT_374	[p25l8t792r706b873],
6	—	CD	NUMBER	—	num	7	SENT_374	[p25l8t792r706b873],
7	function	NN	O	function	prep_of	4	SENT_374	[p25l8t792r706b873],
8	allele	NN	O	allele	nn	10	SENT_374	[p25l755t793r980b873],
9	carrier	NN	O	carrier	nn	10	SENT_374	[p25l1030t794r1317b872],
10	status	NN	O	status	dep	7	SENT_374	[p25l1365t810r1618b873],
11	should	MD	O	should	aux	13	SENT_374	[p25l1671t793r1961b873],
12	not	RB	O	not	neg	13	SENT_374	[p25l2010t810r2154b873],
13	preclude	VB	O	preclude	_	0	SENT_374	[p25l8t922r375b1023],
14	the	DT	O	the	det	15	SENT_374	[p25l419t922r554b1001],
15	use	NN	O	use	dobj	13	SENT_374	[p25l597t949r739b1002],
16	of	IN	O	of	_	0	SENT_374	[p25l783t921r884b1002],
17	clopidogrel	NN	O	clopidogrel	prep_of	15	SENT_374	[p25l910t922r1396b1024],
18	at	IN	O	at	_	0	SENT_374	[p25l1439t939r1518b1001],
19	currently	RB	DATE	currently	advmod	21	SENT_374	[p25l1557t922r1950b1023],
20	recommended	VBN	O	recommend	amod	21	SENT_374	[p25l1989t948r2148b1001, p25l10t1051r499b1130],
21	doses	NNS	O	dose	prep_at	13	SENT_374	[p25l556t1051r794b1130],
22	in	IN	O	in	_	0	SENT_374	[p25l853t1052r937b1129],
23	patients	NNS	O	patient	prep_in	21	SENT_374	[p25l992t1052r1336b1151],
24	with	IN	O	with	_	0	SENT_374	[p25l1391t1051r1587b1131],
25	acute	JJ	O	acute	amod	27	SENT_374	[p25l1643t1068r1867b1130],
26	coronary	JJ	O	coronary	amod	27	SENT_374	[p25l1925t1077r2148b1130, p25l10t1206r205b1280],
27	syndromes	NNS	O	syndrome	prep_with	23	SENT_374	[p25l245t1180r714b1280],
28	whose	WP$	O	whose	poss	29	SENT_374	[p25l754t1180r1030b1259],
29	condition	NN	O	condition	nsubj	34	SENT_374	[p25l1074t1180r1487b1259],
30	is	VBZ	O	be	aux	34	SENT_374	[p25l1530t1181r1595b1258],
31	being	VBG	O	be	cop	34	SENT_374	[p25l1641t1180r1884b1281],
32	man	NN	O	man	npadvmod	34	SENT_374	[p25l1923t1206r2148b1258],
33	—	CD	NUMBER	—	num	32	SENT_374	[p25l1923t1206r2148b1258],
34	aged	JJ	O	aged	rcmod	21	SENT_374	[p25l9t1308r205b1409],
35	conservatively	RB	O	conservatively	advmod	34	SENT_374	[p25l240t1308r841b1408],
36	.	.	O	.	_	0	SENT_374	[p25l240t1308r841b1408],

1	Although	IN	O	although	mark	5	SENT_375	[p25l877t1308r1276b1409],
2	similar	JJ	O	similar	amod	3	SENT_375	[p25l1312t1308r1611b1386],
3	results	NNS	O	result	nsubjpass	5	SENT_375	[p25l1642t1308r1918b1387],
4	were	VBD	O	be	auxpass	5	SENT_375	[p25l1950t1334r2149b1387],
5	observed	VBN	O	observe	advcl	16	SENT_375	[p25l10t1435r402b1515],
6	in	IN	O	in	_	0	SENT_375	[p25l474t1436r560b1513],
7	patients	NNS	O	patient	prep_in	5	SENT_375	[p25l631t1436r983b1535],
8	with	IN	O	with	_	0	SENT_375	[p25l1055t1435r1254b1515],
9	atrial	JJ	O	atrial	amod	10	SENT_375	[p25l1328t1435r1560b1513],
10	fibrillation	NN	O	fibrillation	prep_with	7	SENT_375	[p25l1634t1434r2144b1531],
11	,	,	O	,	_	0	SENT_375	[p25l1634t1434r2144b1531],
12	larger	JJR	O	larger	amod	13	SENT_375	[p25l8t1564r266b1666],
13	studies	NNS	O	study	nsubjpass	16	SENT_375	[p25l305t1564r607b1644],
14	will	MD	O	will	aux	16	SENT_375	[p25l645t1564r811b1644],
15	be	VB	O	be	auxpass	16	SENT_375	[p25l851t1564r948b1644],
16	needed	VBN	O	need	_	0	SENT_375	[p25l989t1564r1294b1644],
17	to	TO	O	to	aux	19	SENT_375	[p25l1335t1581r1417b1644],
18	definitively	RB	O	definitively	advmod	19	SENT_375	[p25l1459t1563r1946b1665],
19	rule	VB	O	rule	xcomp	16	SENT_375	[p25l1981t1564r2149b1644],
20	out	RP	O	out	prt	19	SENT_375	[p25l10t1710r151b1773],
21	a	DT	O	a	det	23	SENT_375	[p25l178t1720r223b1772],
22	genetic	JJ	O	genetic	amod	23	SENT_375	[p25l254t1694r565b1795],
23	effect	NN	O	effect	dobj	19	SENT_375	[p25l599t1692r843b1772],
24	of	IN	O	of	_	0	SENT_375	[p25l872t1692r972b1773],
25	the	DT	O	the	det	27	SENT_375	[p25l988t1693r1122b1772],
26	loss	NN	O	loss	nn	27	SENT_375	[p25l1154t1692r1847b1773],
27	—	NN	O	—	prep_of	23	SENT_375	[p25l1154t1692r1847b1773],
28	of	IN	O	of	_	0	SENT_375	[p25l1154t1692r1847b1773],
29	—	CD	NUMBER	—	num	31	SENT_375	[p25l1154t1692r1847b1773],
30	function	NN	O	function	nn	31	SENT_375	[p25l1154t1692r1847b1773],
31	alleles	NNS	O	allele	prep_of	27	SENT_375	[p25l1879t1693r2147b1772],
32	in	IN	O	in	_	0	SENT_375	[p25l9t1823r93b1900],
33	this	DT	O	this	det	35	SENT_375	[p25l133t1822r294b1900],
34	patient	NN	O	patient	nn	35	SENT_375	[p25l335t1823r639b1922],
35	population	NN	O	population	prep_in	31	SENT_375	[p25l672t1822r1170b1922],
36	.	.	O	.	_	0	SENT_375	[p25l672t1822r1170b1922],

1	The	DT	O	the	det	2	SENT_376	[p25l93t1958r216b2017],
2	CURE	NN	O	cure	nsubjpass	8	SENT_376	[p25l258t1962r455b2021],
3	and	CC	O	and	_	0	SENT_376	[p25l497t1957r619b2017],
4	ACTIVE	NN	O	active	nn	6	SENT_376	[p25l658t1962r919b2017],
5	A	NN	O	a	nn	6	SENT_376	[p25l960t1963r1010b2016],
6	studies	NNS	O	study	conj_and	2	SENT_376	[p25l1051t1958r1283b2017],
7	were	VBD	O	be	auxpass	8	SENT_376	[p25l1323t1978r1479b2018],
8	funded	VBN	O	fund	_	0	SENT_376	[p25l1521t1957r1755b2017],
9	by	IN	O	by	_	0	SENT_376	[p25l1798t1957r1872b2034],
10	SanofiAventis	NNP	PERSON	SanofiAventis	agent	8	SENT_376	[p25l1912t1957r2149b2017, p25l6t2044r247b2103],
11	and	CC	O	and	_	0	SENT_376	[p25l273t2044r395b2103],
12	Bristol	NNP	LOCATION	Bristol	agent	8	SENT_376	[p25l419t2044r858b2120],
13	.	.	O	.	_	0	SENT_376	[p25l419t2044r858b2120],

1	—	NN	O	—	_	0	SENT_377	[p25l419t2044r858b2120],
2	.	.	O	.	_	0	SENT_377	[p25l419t2044r858b2120],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_378	[p25l419t2044r858b2120],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_378	[p25l887t2044r1131b2120],
3	.	.	O	.	_	0	SENT_378	[p25l887t2044r1131b2120],

1	Dr.	NNP	O	Dr.	nn	2	SENT_379	[p25l93t2146r190b2201],
2	Paré	NNP	PERSON	Paré	nsubj	3	SENT_379	[p25l223t2140r365b2200],
3	reports	VBZ	O	report	_	0	SENT_379	[p25l394t2154r630b2217],
4	receiving	VBG	O	receive	xcomp	3	SENT_379	[p25l661t2142r962b2218],
5	consulting	NN	O	consulting	nn	6	SENT_379	[p25l990t2141r1343b2218],
6	fees	NNS	O	fee	dobj	4	SENT_379	[p25l1370t2141r1497b2200],
7	from	IN	O	from	_	0	SENT_379	[p25l1528t2141r1689b2201],
8	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	4	SENT_379	[p25l1720t2141r2139b2201, p25l7t2241r85b2298],
9	.	.	O	.	_	0	SENT_379	[p25l1720t2141r2139b2201, p25l7t2241r85b2298],

1	—	NN	O	—	_	0	SENT_380	[p25l1720t2141r2139b2201, p25l7t2241r85b2298],
2	.	.	O	.	_	0	SENT_380	[p25l1720t2141r2139b2201, p25l7t2241r85b2298],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_381	[p25l1720t2141r2139b2201, p25l7t2241r85b2298],
2	and	CC	O	and	_	0	SENT_381	[p25l125t2240r245b2299],
3	Bristol	NNP	LOCATION	Bristol	conj_and	1	SENT_381	[p25l283t2240r720b2315],
4	.	.	O	.	_	0	SENT_381	[p25l283t2240r720b2315],

1	—	NN	O	—	_	0	SENT_382	[p25l283t2240r720b2315],
2	.	.	O	.	_	0	SENT_382	[p25l283t2240r720b2315],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_383	[p25l283t2240r720b2315],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_383	[p25l762t2240r1006b2315],
3	;	:	O	;	_	0	SENT_383	[p25l762t2240r1006b2315],
4	Dr.	NNP	O	Dr.	nn	5	SENT_383	[p25l1046t2245r1143b2299],
5	Mehta	NNP	PERSON	Mehta	dep	2	SENT_383	[p25l1184t2240r1410b2311],
6	,	,	O	,	_	0	SENT_383	[p25l1184t2240r1410b2311],
7	receiving	VBG	O	receive	partmod	2	SENT_383	[p25l1452t2241r1753b2316],
8	consulting	NN	O	consulting	nn	9	SENT_383	[p25l1789t2240r2143b2316],
9	fees	NNS	O	fee	dobj	7	SENT_383	[p25l7t2338r134b2397],
10	from	IN	O	from	_	0	SENT_383	[p25l160t2338r321b2397],
11	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	prep_from	7	SENT_383	[p25l342t2344r773b2410],
12	,	,	O	,	_	0	SENT_383	[p25l342t2344r773b2410],
13	Eli	NNP	PERSON	Eli	nn	14	SENT_383	[p25l800t2338r887b2396],
14	Lilly	NNP	PERSON	Lilly	prep_from	7	SENT_383	[p25l909t2338r1064b2413],
15	,	,	O	,	_	0	SENT_383	[p25l909t2338r1064b2413],
16	and	CC	O	and	_	0	SENT_383	[p25l1092t2338r1213b2397],
17	Novartis	NNP	ORGANIZATION	Novartis	prep_from	7	SENT_383	[p25l1236t2339r1516b2398],
18	and	CC	O	and	_	0	SENT_383	[p25l1542t2338r1662b2397],
19	grant	NN	O	grant	nn	20	SENT_383	[p25l1687t2351r1866b2414],
20	support	NN	O	support	prep_from	7	SENT_383	[p25l1888t2351r2144b2413],
21	and	CC	O	and	_	0	SENT_383	[p25l7t2436r128b2495],
22	consulting	NN	O	consulting	nn	23	SENT_383	[p25l184t2436r537b2512],
23	fees	NNS	O	fee	conj_and	11	SENT_383	[p25l591t2436r717b2495],
24	from	IN	O	from	_	0	SENT_383	[p25l775t2436r935b2495],
25	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	7	SENT_383	[p25l993t2436r1468b2495],
26	.	.	O	.	_	0	SENT_383	[p25l993t2436r1468b2495],

1	—	NN	O	—	_	0	SENT_384	[p25l993t2436r1468b2495],
2	.	.	O	.	_	0	SENT_384	[p25l993t2436r1468b2495],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_385	[p25l993t2436r1468b2495],
2	and	CC	O	and	_	0	SENT_385	[p25l1525t2436r1646b2495],
3	Bristol	NNP	LOCATION	Bristol	conj_and	1	SENT_385	[p25l1701t2436r2138b2511],
4	.	.	O	.	_	0	SENT_385	[p25l1701t2436r2138b2511],

1	—	NN	O	—	_	0	SENT_386	[p25l1701t2436r2138b2511],
2	.	.	O	.	_	0	SENT_386	[p25l1701t2436r2138b2511],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_387	[p25l1701t2436r2138b2511],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_387	[p25l9t2534r253b2609],
3	;	:	O	;	_	0	SENT_387	[p25l9t2534r253b2609],
4	Dr.	NNP	O	Dr.	nn	5	SENT_387	[p25l287t2539r385b2593],
5	Yusuf	NNP	PERSON	Yusuf	dep	2	SENT_387	[p25l418t2534r619b2606],
6	,	,	O	,	_	0	SENT_387	[p25l418t2534r619b2606],
7	receiving	VBG	O	receive	partmod	2	SENT_387	[p25l655t2535r955b2610],
8	consulting	NN	O	consulting	nn	9	SENT_387	[p25l985t2534r1339b2610],
9	fees	NNS	O	fee	dobj	7	SENT_387	[p25l1368t2534r1494b2593],
10	and	CC	O	and	_	0	SENT_387	[p25l1527t2534r1648b2593],
11	grant	NN	O	grant	nn	12	SENT_387	[p25l1679t2547r1858b2610],
12	support	NN	O	support	dobj	7	SENT_387	[p25l1887t2547r2143b2609],
13	from	IN	O	from	_	0	SENT_387	[p25l7t2632r168b2691],
14	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	7	SENT_387	[p25l207t2632r682b2692],
15	.	.	O	.	_	0	SENT_387	[p25l207t2632r682b2692],

1	—	NN	O	—	_	0	SENT_388	[p25l207t2632r682b2692],
2	.	.	O	.	_	0	SENT_388	[p25l207t2632r682b2692],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_389	[p25l207t2632r682b2692],
2	and	CC	O	and	_	0	SENT_389	[p25l720t2632r841b2691],
3	Bristol	NNP	LOCATION	Bristol	conj_and	1	SENT_389	[p25l876t2633r1314b2708],
4	.	.	O	.	_	0	SENT_389	[p25l876t2633r1314b2708],

1	—	NN	O	—	_	0	SENT_390	[p25l876t2633r1314b2708],
2	.	.	O	.	_	0	SENT_390	[p25l876t2633r1314b2708],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_391	[p25l876t2633r1314b2708],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_391	[p25l1354t2633r1598b2708],
3	;	:	O	;	_	0	SENT_391	[p25l1354t2633r1598b2708],
4	Dr.	NNP	O	Dr.	nn	5	SENT_391	[p25l1637t2637r1735b2691],
5	Anand	NNP	PERSON	Anand	dep	2	SENT_391	[p25l1773t2632r2011b2704],
6	,	,	O	,	_	0	SENT_391	[p25l1773t2632r2011b2704],
7	receiving	VBG	O	receive	partmod	2	SENT_391	[p25l2052t2652r2139b2691, p25l8t2731r243b2806],
8	lecture	NN	O	lecture	nn	9	SENT_391	[p25l279t2730r505b2790],
9	fees	NNS	O	fee	dobj	7	SENT_391	[p25l545t2730r672b2789],
10	from	IN	O	from	_	0	SENT_391	[p25l713t2730r875b2789],
11	Bristol	NNP	LOCATION	Bristol	prep_from	7	SENT_391	[p25l914t2731r1352b2806],
12	.	.	O	.	_	0	SENT_391	[p25l914t2731r1352b2806],

1	—	NN	O	—	_	0	SENT_392	[p25l914t2731r1352b2806],
2	.	.	O	.	_	0	SENT_392	[p25l914t2731r1352b2806],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_393	[p25l914t2731r1352b2806],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_393	[p25l1395t2730r1639b2806],
3	;	:	O	;	_	0	SENT_393	[p25l1395t2730r1639b2806],
4	Dr.	NNP	O	Dr.	nn	5	SENT_393	[p25l1682t2735r1779b2789],
5	Connolly	NNP	PERSON	Connolly	dep	2	SENT_393	[p25l1824t2730r2135b2806],
6	,	,	O	,	_	0	SENT_393	[p25l1824t2730r2135b2806],
7	receiving	VBG	O	receive	partmod	2	SENT_393	[p25l7t2829r308b2904],
8	board	NN	O	board	nn	10	SENT_393	[p25l346t2828r537b2887],
9	membership	NN	O	membership	nn	10	SENT_393	[p25l577t2829r990b2904],
10	fees	NNS	O	fee	dobj	7	SENT_393	[p25l1032t2828r1178b2900],
11	,	,	O	,	_	0	SENT_393	[p25l1032t2828r1178b2900],
12	consulting	VBG	O	consult	amod	13	SENT_393	[p25l1223t2828r1576b2904],
13	fees	NNS	O	fee	appos	10	SENT_393	[p25l1614t2828r1760b2900],
14	,	,	O	,	_	0	SENT_393	[p25l1614t2828r1760b2900],
15	and	CC	O	and	_	0	SENT_393	[p25l1804t2829r1924b2887],
16	grant	NN	O	grant	nn	17	SENT_393	[p25l1964t2841r2144b2904],
17	support	NN	O	support	conj_and	10	SENT_393	[p25l8t2939r264b3002],
18	from	IN	O	from	_	0	SENT_393	[p25l296t2926r457b2985],
19	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	17	SENT_393	[p25l494t2926r970b2986],
20	.	.	O	.	_	0	SENT_393	[p25l494t2926r970b2986],

1	—	NN	O	—	_	0	SENT_394	[p25l494t2926r970b2986],
2	.	.	O	.	_	0	SENT_394	[p25l494t2926r970b2986],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_395	[p25l494t2926r970b2986],
2	and	CC	O	and	_	0	SENT_395	[p25l1007t2927r1127b2985],
3	Bristol	NNP	LOCATION	Bristol	conj_and	1	SENT_395	[p25l1162t2927r1599b3002],
4	.	.	O	.	_	0	SENT_395	[p25l1162t2927r1599b3002],

1	—	NN	O	—	_	0	SENT_396	[p25l1162t2927r1599b3002],
2	.	.	O	.	_	0	SENT_396	[p25l1162t2927r1599b3002],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_397	[p25l1162t2927r1599b3002],
2	Squibb	NNP	PERSON	Squibb	nsubjpass	10	SENT_397	[p25l1639t2927r1883b3002],
3	;	:	O	;	_	0	SENT_397	[p25l1639t2927r1883b3002],
4	Dr.	NNP	O	Dr.	nn	5	SENT_397	[p25l1920t2932r2017b2985],
5	Si	NNP	O	Si	dep	2	SENT_397	[p25l2060t2927r2139b2985],
6	—	CD	NUMBER	—	num	7	SENT_397	[p25l2060t2927r2139b2985],
7	monsen	NN	O	monsen	dep	2	SENT_397	[p25l7t3045r287b3097],
8	,	,	O	,	_	0	SENT_397	[p25l7t3045r287b3097],
9	being	VBG	O	be	auxpass	10	SENT_397	[p25l322t3026r506b3101],
10	employed	VBN	O	employ	_	0	SENT_397	[p25l533t3026r848b3101],
11	by	IN	O	by	prep	10	SENT_397	[p25l877t3026r951b3101],
12	and	CC	O	and	_	0	SENT_397	[p25l977t3026r1098b3084],
13	owning	VBG	O	own	conj_and	10	SENT_397	[p25l1127t3026r1380b3101],
14	stock	NN	O	stock	dobj	13	SENT_397	[p25l1407t3026r1583b3085],
15	in	IN	O	in	_	0	SENT_397	[p25l1609t3026r1673b3083],
16	Bristol	NNP	LOCATION	Bristol	prep_in	14	SENT_397	[p25l1701t3026r2138b3101],
17	.	.	O	.	_	0	SENT_397	[p25l1701t3026r2138b3101],

1	—	NN	O	—	_	0	SENT_398	[p25l1701t3026r2138b3101],
2	.	.	O	.	_	0	SENT_398	[p25l1701t3026r2138b3101],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_399	[p25l1701t3026r2138b3101],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_399	[p25l9t3124r253b3199],
3	;	:	O	;	_	0	SENT_399	[p25l9t3124r253b3199],
4	Dr.	NNP	O	Dr.	nn	5	SENT_399	[p25l283t3129r381b3182],
5	Bhatt	NNP	PERSON	Bhatt	dep	2	SENT_399	[p25l412t3124r607b3195],
6	,	,	O	,	_	0	SENT_399	[p25l412t3124r607b3195],
7	receiving	VBG	O	receive	partmod	2	SENT_399	[p25l639t3124r940b3199],
8	grant	NN	O	grant	nn	9	SENT_399	[p25l965t3136r1145b3199],
9	support	NN	O	support	dobj	7	SENT_399	[p25l1170t3136r1426b3199],
10	from	IN	O	from	_	0	SENT_399	[p25l1450t3123r1611b3182],
11	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	7	SENT_399	[p25l1641t3123r2135b3195],
12	.	.	O	.	_	0	SENT_399	[p25l1641t3123r2135b3195],

1	—	NN	O	—	_	0	SENT_400	[p25l1641t3123r2135b3195],
2	.	.	O	.	_	0	SENT_400	[p25l1641t3123r2135b3195],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_401	[p25l1641t3123r2135b3195],
2	,	,	O	,	_	0	SENT_401	[p25l1641t3123r2135b3195],
3	Bristol	NNP	LOCATION	Bristol	appos	1	SENT_401	[p25l6t3223r444b3298],
4	.	.	O	.	_	0	SENT_401	[p25l6t3223r444b3298],

1	—	NN	O	—	_	0	SENT_402	[p25l6t3223r444b3298],
2	.	.	O	.	_	0	SENT_402	[p25l6t3223r444b3298],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_403	[p25l6t3223r444b3298],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_403	[p25l490t3223r733b3298],
3	,	,	O	,	_	0	SENT_403	[p25l490t3223r733b3298],
4	Eisai	NNP	ORGANIZATION	Eisai	conj_and	2	SENT_403	[p25l779t3223r955b3294],
5	,	,	O	,	_	0	SENT_403	[p25l779t3223r955b3294],
6	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	conj_and	2	SENT_403	[p25l1000t3228r1430b3294],
7	,	,	O	,	_	0	SENT_403	[p25l1000t3228r1430b3294],
8	and	CC	O	and	_	0	SENT_403	[p25l1477t3223r1598b3281],
9	The	DT	ORGANIZATION	the	det	11	SENT_403	[p25l1639t3223r1761b3281],
10	Medicines	NNP	ORGANIZATION	Medicines	nn	11	SENT_403	[p25l1802t3223r2138b3281],
11	Company	NN	ORGANIZATION	company	conj_and	2	SENT_403	[p25l7t3324r337b3395],
12	;	:	O	;	_	0	SENT_403	[p25l7t3324r337b3395],
13	Dr.	NNP	O	Dr.	nn	14	SENT_403	[p25l362t3325r460b3379],
14	Fox	NNP	PERSON	Fox	dep	2	SENT_403	[p25l487t3325r620b3391],
15	,	,	O	,	_	0	SENT_403	[p25l487t3325r620b3391],
16	receiving	VBG	O	receive	partmod	14	SENT_403	[p25l648t3321r949b3395],
17	consulting	NN	O	consulting	nn	18	SENT_403	[p25l971t3320r1324b3395],
18	fees	NNS	O	fee	dobj	16	SENT_403	[p25l1345t3319r1491b3391],
19	,	,	O	,	_	0	SENT_403	[p25l1345t3319r1491b3391],
20	grant	NN	O	grant	nn	21	SENT_403	[p25l1519t3332r1698b3395],
21	support	NN	O	support	conj_and	18	SENT_403	[p25l1719t3332r1991b3395],
22	,	,	O	,	_	0	SENT_403	[p25l1719t3332r1991b3395],
23	and	CC	O	and	_	0	SENT_403	[p25l2019t3320r2139b3379],
24	lecture	NN	O	lecture	nn	25	SENT_403	[p25l6t3418r231b3478],
25	fees	NNS	O	fee	conj_and	18	SENT_403	[p25l254t3417r381b3476],
26	from	IN	O	from	_	0	SENT_403	[p25l405t3417r567b3477],
27	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	16	SENT_403	[p25l591t3417r1086b3489],
28	.	.	O	.	_	0	SENT_403	[p25l591t3417r1086b3489],

1	—	NN	O	—	_	0	SENT_404	[p25l591t3417r1086b3489],
2	.	.	O	.	_	0	SENT_404	[p25l591t3417r1086b3489],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_405	[p25l591t3417r1086b3489],
2	,	,	O	,	_	0	SENT_405	[p25l591t3417r1086b3489],
3	grant	NN	O	grant	nn	4	SENT_405	[p25l1113t3431r1292b3493],
4	support	NN	O	support	appos	1	SENT_405	[p25l1312t3431r1568b3493],
5	and	CC	O	and	_	0	SENT_405	[p25l1587t3418r1708b3477],
6	lectures	VBZ	O	lecture	appos	1	SENT_405	[p25l1729t3418r1987b3478],
7	fees	NNS	O	fee	dobj	6	SENT_405	[p25l2012t3417r2138b3476],
8	from	IN	O	from	_	0	SENT_405	[p25l7t3515r168b3575],
9	Bayer	NNP	ORGANIZATION	Bayer	prep_from	7	SENT_405	[p25l190t3521r370b3591],
10	and	CC	O	and	_	0	SENT_405	[p25l391t3516r511b3575],
11	Johnson	NNP	ORGANIZATION	Johnson	conj_and	7	SENT_405	[p25l527t3516r804b3585],
12	&	CC	ORGANIZATION	&	_	0	SENT_405	[p25l827t3520r876b3577],
13	Johnson	NNP	ORGANIZATION	Johnson	conj_and	7	SENT_405	[p25l892t3516r1187b3587],
14	,	,	O	,	_	0	SENT_405	[p25l892t3516r1187b3587],
15	grant	NN	O	grant	nn	16	SENT_405	[p25l1214t3529r1393b3591],
16	support	NN	O	support	appos	11	SENT_405	[p25l1413t3529r1669b3591],
17	from	IN	O	from	_	0	SENT_405	[p25l1688t3515r1850b3575],
18	Eli	NNP	PERSON	Eli	nn	19	SENT_405	[p25l1872t3516r1958b3574],
19	Lilly	NNP	PERSON	Lilly	prep_from	16	SENT_405	[p25l1979t3516r2135b3591],
20	,	,	O	,	_	0	SENT_405	[p25l1979t3516r2135b3591],
21	and	CC	O	and	_	0	SENT_405	[p25l7t3614r128b3673],
22	reimbursement	NN	O	reimbursement	conj_and	11	SENT_405	[p25l150t3614r659b3673],
23	for	IN	O	for	_	0	SENT_405	[p25l678t3614r773b3673],
24	travel	NN	O	travel	nn	25	SENT_405	[p25l793t3614r972b3673],
25	accommodations	NNS	O	accommodation	prep_for	22	SENT_405	[p25l994t3614r1562b3673],
26	from	IN	O	from	_	0	SENT_405	[p25l1586t3614r1747b3673],
27	Boehringer	NNP	LOCATION	Boehringer	nn	28	SENT_405	[p25l1768t3614r2142b3690],
28	Ingelheim	NNP	LOCATION	Ingelheim	prep_from	25	SENT_405	[p25l6t3712r363b3788],
29	;	:	O	;	_	0	SENT_405	[p25l6t3712r363b3788],
30	and	CC	O	and	_	0	SENT_405	[p25l394t3712r515b3771],
31	Dr.	NNP	O	Dr.	nn	32	SENT_405	[p25l542t3717r640b3771],
32	Eikelboom	NNP	PERSON	Eikelboom	dobj	6	SENT_405	[p25l672t3712r1046b3784],
33	,	,	O	,	_	0	SENT_405	[p25l672t3712r1046b3784],
34	receiving	VBG	O	receive	partmod	6	SENT_405	[p25l1079t3713r1380b3788],
35	consulting	NN	O	consulting	nn	36	SENT_405	[p25l1406t3712r1759b3788],
36	fees	NNS	O	fee	dobj	34	SENT_405	[p25l1785t3712r1931b3783],
37	,	,	O	,	_	0	SENT_405	[p25l1785t3712r1931b3783],
38	grant	NN	O	grant	nn	39	SENT_405	[p25l1964t3725r2143b3788],
39	support	NN	O	support	dobj	34	SENT_405	[p26l8t31r281b93],
40	,	,	O	,	_	0	SENT_405	[p26l8t31r281b93],
41	and	CC	O	and	_	0	SENT_405	[p26l331t18r452b77],
42	lecture	NN	O	lecture	nn	43	SENT_405	[p26l498t18r723b78],
43	fees	NNS	O	fee	conj_and	36	SENT_405	[p26l770t18r897b77],
44	from	IN	O	from	_	0	SENT_405	[p26l946t18r1107b77],
45	Sanofi	NNP	ORGANIZATION	Sanofi	prep_from	34	SENT_405	[p26l1156t18r1651b90],
46	.	.	O	.	_	0	SENT_405	[p26l1156t18r1651b90],

1	—	NN	O	—	_	0	SENT_406	[p26l1156t18r1651b90],
2	.	.	O	.	_	0	SENT_406	[p26l1156t18r1651b90],

1	Aventis	NNP	ORGANIZATION	Aventis	_	0	SENT_407	[p26l1156t18r1651b90],
2	,	,	O	,	_	0	SENT_407	[p26l1156t18r1651b90],
3	Bristol	NNP	LOCATION	Bristol	appos	1	SENT_407	[p26l1701t18r2138b93],
4	.	.	O	.	_	0	SENT_407	[p26l1701t18r2138b93],

1	—	NN	O	—	_	0	SENT_408	[p26l1701t18r2138b93],
2	.	.	O	.	_	0	SENT_408	[p26l1701t18r2138b93],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_409	[p26l1701t18r2138b93],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_409	[p26l9t116r252b191],
3	,	,	O	,	_	0	SENT_409	[p26l9t116r252b191],
4	and	CC	O	and	_	0	SENT_409	[p26l299t116r419b175],
5	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	conj_and	2	SENT_409	[p26l460t122r891b188],
6	,	,	O	,	_	0	SENT_409	[p26l460t122r891b188],
7	consulting	VBG	O	consult	amod	8	SENT_409	[p26l939t116r1292b192],
8	fees	NNS	O	fee	dep	2	SENT_409	[p26l1333t116r1459b175],
9	and	CC	O	and	_	0	SENT_409	[p26l1504t116r1624b175],
10	grant	NN	O	grant	nn	11	SENT_409	[p26l1667t129r1847b192],
11	support	NN	O	support	dep	2	SENT_409	[p26l1887t129r2144b191],
12	from	IN	O	from	_	0	SENT_409	[p26l7t214r168b273],
13	Novartis	NNP	ORGANIZATION	Novartis	prep_from	11	SENT_409	[p26l205t215r506b286],
14	,	,	O	,	_	0	SENT_409	[p26l205t215r506b286],
15	and	CC	O	and	_	0	SENT_409	[p26l549t214r669b273],
16	consulting	NN	O	consulting	nn	17	SENT_409	[p26l709t214r1062b290],
17	fees	NNS	O	fee	dep	2	SENT_409	[p26l1099t214r1225b273],
18	and	CC	O	and	_	0	SENT_409	[p26l1265t214r1385b273],
19	lecture	NN	O	lecture	nn	20	SENT_409	[p26l1424t214r1648b273],
20	fees	NNS	O	fee	conj_and	8	SENT_409	[p26l1688t214r1814b273],
21	from	IN	O	from	_	0	SENT_409	[p26l1855t214r2016b273],
22	Eli	NNP	PERSON	Eli	nn	23	SENT_409	[p26l2054t214r2140b272],
23	Lilly	NNP	PERSON	Lilly	prep_from	17	SENT_409	[p26l6t313r162b388],
24	.	.	O	.	_	0	SENT_409	[p26l6t313r162b388],

1	N	NN	O	n	nn	2	SENT_410	[p26l190t319r246b373],
2	o	NN	O	o	nsubjpass	13	SENT_410	[p26l249t332r285b373],
3	other	JJ	O	other	amod	5	SENT_410	[p26l312t313r487b373],
4	potential	JJ	O	potential	amod	5	SENT_410	[p26l509t313r808b388],
5	conflict	NN	O	conflict	npadvmod	2	SENT_410	[p26l833t313r1093b373],
6	of	IN	O	of	_	0	SENT_410	[p26l1115t313r1191b373],
7	interest	NN	O	interest	prep_of	2	SENT_410	[p26l1202t314r1454b372],
8	relevant	JJ	O	relevant	amod	7	SENT_410	[p26l1476t313r1739b373],
9	to	TO	O	to	_	0	SENT_410	[p26l1761t326r1823b373],
10	this	DT	O	this	det	11	SENT_410	[p26l1850t313r1973b372],
11	article	NN	O	article	prep_to	8	SENT_410	[p26l2000t314r2139b372, p26l8t412r94b470],
12	Was	VBD	O	be	auxpass	13	SENT_410	[p26l117t431r242b471],
13	reported	VBN	O	report	_	0	SENT_410	[p26l269t412r568b487],
14	.	.	O	.	_	0	SENT_410	[p26l269t412r568b487],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_411	[p26l93t509r441b569],
2	forms	VBZ	O	form	_	0	SENT_411	[p26l474t509r668b568],
3	provided	VBN	O	provide	csubj	8	SENT_411	[p26l701t510r989b585],
4	by	IN	O	by	_	0	SENT_411	[p26l1022t510r1097b585],
5	the	DT	O	the	det	6	SENT_411	[p26l1126t510r1228b568],
6	authors	NNS	O	author	prep_by	3	SENT_411	[p26l1261t510r1508b569],
7	are	VBP	O	be	cop	8	SENT_411	[p26l1543t529r1642b568],
8	available	JJ	O	available	ccomp	2	SENT_411	[p26l1674t510r1960b569],
9	with	IN	O	with	_	0	SENT_411	[p26l1991t510r2140b569],
10	the	DT	O	the	det	12	SENT_411	[p26l7t608r110b666],
11	full	JJ	O	full	amod	12	SENT_411	[p26l135t607r250b667],
12	text	NN	O	text	prep_with	8	SENT_411	[p26l275t620r398b666],
13	of	IN	O	of	_	0	SENT_411	[p26l420t607r497b666],
14	this	DT	O	this	det	15	SENT_411	[p26l508t608r631b666],
15	article	NN	O	article	prep_of	12	SENT_411	[p26l657t608r864b666],
16	at	IN	O	at	_	0	SENT_411	[p26l889t620r949b666],
17	NEJM.org	NN	O	nejm.org	prep_at	15	SENT_411	[p26l969t613r1310b683],
18	.	.	O	.	_	0	SENT_411	[p26l969t613r1310b683],

1	We	PRP	O	we	nsubj	2	SENT_412	[p26l91t712r192b766],
2	thank	VBP	O	thank	_	0	SENT_412	[p26l227t707r423b767],
3	Nihar	NNP	PERSON	Nihar	nn	6	SENT_412	[p26l453t707r646b766],
4	Bhakta	NNP	PERSON	Bhakta	nn	6	SENT_412	[p26l676t707r928b779],
5	,	,	O	,	_	0	SENT_412	[p26l676t707r928b779],
6	M.D.	NNP	O	M.D.	dobj	2	SENT_412	[p26l965t712r1143b779],
7	,	,	O	,	_	0	SENT_412	[p26l965t712r1143b779],
8	and	CC	O	and	_	0	SENT_412	[p26l1180t707r1301b766],
9	Eileen	NNP	PERSON	Eileen	nn	10	SENT_412	[p26l1334t707r1535b766],
10	Emison	NNP	PERSON	Emison	conj_and	6	SENT_412	[p26l1569t707r1837b779],
11	,	,	O	,	_	0	SENT_412	[p26l1569t707r1837b779],
12	M.S.	NNP	LOCATION	M.S.	appos	6	SENT_412	[p26l1873t711r2038b779],
13	,	,	O	,	_	0	SENT_412	[p26l1873t711r2038b779],
14	of	IN	O	of	_	0	SENT_412	[p26l2077t706r2153b766],
15	Bristol	NNP	LOCATION	Bristol	prep_of	6	SENT_412	[p26l6t806r444b881],
16	.	.	O	.	_	0	SENT_412	[p26l6t806r444b881],

1	—	NN	O	—	_	0	SENT_413	[p26l6t806r444b881],
2	.	.	O	.	_	0	SENT_413	[p26l6t806r444b881],

1	Myers	NNP	PERSON	Myers	nn	2	SENT_414	[p26l6t806r444b881],
2	Squibb	NNP	PERSON	Squibb	_	0	SENT_414	[p26l477t806r703b881],
3	and	CC	O	and	_	0	SENT_414	[p26l734t806r854b864],
4	Deborah	NNP	PERSON	Deborah	nn	5	SENT_414	[p26l883t806r1168b864],
5	Bauer	NNP	PERSON	Bauer	conj_and	2	SENT_414	[p26l1197t811r1401b877],
6	,	,	O	,	_	0	SENT_414	[p26l1197t811r1401b877],
7	M.S.	NNP	LOCATION	M.S.	conj_and	2	SENT_414	[p26l1433t810r1598b877],
8	,	,	O	,	_	0	SENT_414	[p26l1433t810r1598b877],
9	Catherine	NNP	PERSON	Catherine	nn	10	SENT_414	[p26l1632t806r1954b864],
10	Marchese	NNP	PERSON	Marchese	conj_and	2	SENT_414	[p26l1982t811r2139b864, p26l8t905r205b977],
11	,	,	O	,	_	0	SENT_414	[p26l1982t811r2139b864, p26l8t905r205b977],
12	M.D.	NNP	O	M.D.	conj_and	2	SENT_414	[p26l239t910r418b977],
13	,	,	O	,	_	0	SENT_414	[p26l239t910r418b977],
14	and	CC	O	and	_	0	SENT_414	[p26l454t905r575b964],
15	Pascal	NNP	PERSON	Pascal	nn	16	SENT_414	[p26l605t905r813b964],
16	Rufi	NNP	PERSON	Rufi	conj_and	2	SENT_414	[p26l843t904r1006b977],
17	,	,	O	,	_	0	SENT_414	[p26l843t904r1006b977],
18	M.D.	NNP	O	M.D.	appos	16	SENT_414	[p26l1040t910r1218b977],
19	,	,	O	,	_	0	SENT_414	[p26l1040t910r1218b977],
20	of	IN	O	of	conj_and	2	SENT_414	[p26l1255t904r1331b964],
21	Sanofi-Aventis	NNP	ORGANIZATION	Sanofi-Aventis	pobj	20	SENT_414	[p26l1351t904r1827b964],
22	for	IN	O	for	_	0	SENT_414	[p26l1860t904r1955b964],
23	their	PRP$	O	they	poss	24	SENT_414	[p26l1986t905r2142b964],
24	support	NN	O	support	prep_for	21	SENT_414	[p26l8t1015r264b1078],
25	with	IN	O	with	_	0	SENT_414	[p26l283t1003r432b1062],
26	the	DT	O	the	det	27	SENT_414	[p26l459t1003r560b1061],
27	analyses	NNS	O	analysis	prep_with	24	SENT_414	[p26l586t1003r862b1078],
28	and	CC	O	and	_	0	SENT_414	[p26l889t1003r1010b1061],
29	the	DT	O	the	det	30	SENT_414	[p26l1036t1003r1138b1061],
30	review	NN	O	review	prep_for	21	SENT_414	[p26l1164t1003r1379b1062],
31	of	IN	O	of	_	0	SENT_414	[p26l1403t1002r1479b1061],
32	this	DT	O	this	det	33	SENT_414	[p26l1491t1003r1614b1061],
33	manuscript	NN	O	manuscript	prep_of	30	SENT_414	[p26l1641t1003r2037b1078],
34	.	.	O	.	_	0	SENT_414	[p26l1641t1003r2037b1078],

1	REFERENCES	NNS	O	reference	_	0	SENT_415	[p26l19t1245r684b1310],

1	1	LS	NUMBER	1	_	0	SENT_416	[p26l15t1390r90b1469],
2	.	.	O	.	_	0	SENT_416	[p26l15t1390r90b1469],

1	The	DT	O	the	det	2	SENT_417	[p26l205t1378r393b1469],
2	ACTWE	NNP	O	ACTWE	_	0	SENT_417	[p26l456t1386r854b1469],
3	Investigators	NNS	O	investigator	dep	2	SENT_417	[p26l922t1380r1605b1495],
4	.	.	O	.	_	0	SENT_417	[p26l922t1380r1605b1495],

1	Effect	NN	O	effect	nsubj	4	SENT_418	[p26l1676t1378r1975b1469],
2	of	IN	O	of	_	0	SENT_418	[p26l2038t1378r2153b1469],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_418	[p26l13t1527r581b1644],
4	added	VBD	O	add	_	0	SENT_418	[p26l640t1527r940b1618],
5	to	TO	O	to	_	0	SENT_418	[p26l1001t1547r1096b1618],
6	aspirin	NN	O	aspirin	prep_to	4	SENT_418	[p26l1159t1529r1510b1642],
7	in	IN	O	in	_	0	SENT_418	[p26l1571t1529r1668b1616],
8	patients	NNS	O	patient	prep_in	4	SENT_418	[p26l1727t1529r2129b1642],
9	with	IN	O	with	_	0	SENT_418	[p26l7t1676r231b1767],
10	atrial	JJ	O	atrial	amod	11	SENT_418	[p26l266t1676r526b1767],
11	fibrillation	NN	O	fibrillation	prep_with	8	SENT_418	[p26l561t1676r1126b1767],
12	.	.	O	.	_	0	SENT_418	[p26l561t1676r1126b1767],

1	N	NN	O	n	nn	3	SENT_419	[p26l1167t1684r1254b1767],
2	Engl	NNP	O	Engl	nn	3	SENT_419	[p26l1288t1676r1579b1793],
3	]	NNP	O	]	nsubj	4	SENT_419	[p26l1288t1676r1579b1793],
4	Med	VBD	O	med	_	0	SENT_419	[p26l1610t1676r1825b1767],
5	2009	CD	DATE	2009	dobj	4	SENT_419	[p26l1862t1684r2128b1785],
6	;	:	O	;	_	0	SENT_419	[p26l1862t1684r2128b1785],
7	360:2066	CD	NUMBER	360:2066	num	8	SENT_419	[p26l13t1832r657b1915],
8	—	NN	O	—	dep	5	SENT_419	[p26l13t1832r657b1915],
9	78	CD	NUMBER	78	dep	8	SENT_419	[p26l13t1832r657b1915],
10	.	.	O	.	_	0	SENT_419	[p26l13t1832r657b1915],

1	2	LS	NUMBER	2	_	0	SENT_420	[p26l9t1985r92b2064],
2	.	.	O	.	_	0	SENT_420	[p26l9t1985r92b2064],

1	Yusuf	NNP	PERSON	Yusuf	nn	2	SENT_421	[p26l205t1973r506b2064],
2	S	NNP	PERSON	S	_	0	SENT_421	[p26l535t1981r615b2082],
3	,	,	O	,	_	0	SENT_421	[p26l535t1981r615b2082],
4	Zhao	NNP	PERSON	Zhao	nn	5	SENT_421	[p26l666t1973r916b2064],
5	P	NN	PERSON	p	appos	2	SENT_421	[p26l963t1981r1042b2084],
6	,	,	O	,	_	0	SENT_421	[p26l963t1981r1042b2084],
7	Mehta	NNP	ORGANIZATION	Mehta	nn	8	SENT_421	[p26l1094t1973r1411b2064],
8	SR	NN	ORGANIZATION	sr	appos	2	SENT_421	[p26l1460t1981r1615b2084],
9	,	,	O	,	_	0	SENT_421	[p26l1460t1981r1615b2084],
10	Chrolavi	NNP	O	Chrolavi	appos	2	SENT_421	[p26l1670t1973r2131b2064],
11	—	CD	NUMBER	—	num	13	SENT_421	[p26l1670t1973r2131b2064],
12	cius	NN	O	cius	nn	13	SENT_421	[p26l13t2124r205b2213],
13	S	NN	O	s	dep	10	SENT_421	[p26l282t2130r360b2233],
14	,	,	O	,	_	0	SENT_421	[p26l282t2130r360b2233],
15	Tognoni	NNP	PERSON	Tognoni	nn	16	SENT_421	[p26l433t2124r859b2239],
16	G	NNP	O	G	appos	2	SENT_421	[p26l929t2130r1037b2233],
17	,	,	O	,	_	0	SENT_421	[p26l929t2130r1037b2233],
18	Fox	NNP	ORGANIZATION	Fox	nn	19	SENT_421	[p26l1113t2130r1292b2213],
19	KK	NNP	ORGANIZATION	KK	appos	2	SENT_421	[p26l1359t2130r1542b2215],
20	.	.	O	.	_	0	SENT_421	[p26l1359t2130r1542b2215],

1	Effects	NNS	O	effect	_	0	SENT_422	[p26l1618t2122r1963b2213],
2	of	IN	O	of	_	0	SENT_422	[p26l2038t2122r2153b2213],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_422	[p26l13t2271r581b2388],
4	in	IN	O	in	_	0	SENT_422	[p26l636t2273r733b2360],
5	addition	NN	O	addition	_	0	SENT_422	[p26l789t2271r1209b2362],
6	to	TO	O	to	_	0	SENT_422	[p26l1266t2291r1361b2362],
7	aspirin	NN	O	aspirin	prep_in_addition_to	1	SENT_422	[p26l1418t2273r1769b2386],
8	in	IN	O	in	_	0	SENT_422	[p26l1826t2273r1923b2360],
9	patients	NNS	O	patient	prep_in	1	SENT_422	[p26l1977t2301r2131b2386, p26l11t2422r290b2511],
10	with	IN	O	with	_	0	SENT_422	[p26l377t2420r605b2511],
11	acute	JJ	O	acute	amod	13	SENT_422	[p26l694t2440r955b2511],
12	coronary	JJ	O	coronary	amod	13	SENT_422	[p26l1046t2450r1498b2535],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_422	[p26l1585t2420r2130b2535],
14	without	IN	O	without	_	0	SENT_422	[p26l7t2569r405b2660],
15	ST	JJ	O	st	amod	18	SENT_422	[p26l466t2577r1058b2686],
16	—	NN	O	—	nn	18	SENT_422	[p26l466t2577r1058b2686],
17	segment	NN	O	segment	nn	18	SENT_422	[p26l466t2577r1058b2686],
18	elevation	NN	O	elevation	prep_without	13	SENT_422	[p26l1118t2569r1595b2660],
19	.	.	O	.	_	0	SENT_422	[p26l1118t2569r1595b2660],

1	N	NN	O	n	nn	3	SENT_423	[p26l1664t2577r1749b2660],
2	Engl	NNP	O	Engl	nn	3	SENT_423	[p26l1812t2569r2038b2686],
3	J	NNP	O	J	nsubj	4	SENT_423	[p26l2092t2579r2135b2674],
4	Med	VBD	O	med	_	0	SENT_423	[p26l7t2718r225b2809],
5	2001	CD	DATE	2001	dobj	4	SENT_423	[p26l278t2726r1195b2829],
6	;	:	O	;	_	0	SENT_423	[p26l278t2726r1195b2829],
7	345:494	CD	NUMBER	345:494	num	8	SENT_423	[p26l278t2726r1195b2829],
8	-502	CD	NUMBER	-502	dep	5	SENT_423	[p26l278t2726r1195b2829],
9	.	.	O	.	_	0	SENT_423	[p26l278t2726r1195b2829],

1	[	NN	O	[	nsubj	6	SENT_424	[p26l1264t2726r1634b2829],
2	Errata	NNP	O	Errata	nn	5	SENT_424	[p26l1264t2726r1634b2829],
3	,	,	O	,	_	0	SENT_424	[p26l1264t2726r1634b2829],
4	N	NNP	O	N	appos	5	SENT_424	[p26l1690t2726r1777b2809],
5	EnglJ	NNP	O	EnglJ	dep	1	SENT_424	[p26l1824t2718r2135b2835],
6	Med	VBD	O	med	_	0	SENT_424	[p26l7t2867r225b2958],
7	2001	CD	DATE	2001	dobj	6	SENT_424	[p26l264t2875r1025b2978],
8	;	:	O	;	_	0	SENT_424	[p26l264t2875r1025b2978],
9	345:1306	CD	NUMBER	345:1306	dep	7	SENT_424	[p26l264t2875r1025b2978],
10	,	,	O	,	_	0	SENT_424	[p26l264t2875r1025b2978],
11	1716	CD	DATE	1716	dep	9	SENT_424	[p26l1074t2875r1363b2972],
12	.	.	O	.	_	0	SENT_424	[p26l1074t2875r1363b2972],
13	]	SYM	O	]	dep	7	SENT_424	[p26l1074t2875r1363b2972],

1	3	LS	NUMBER	3	_	0	SENT_425	[p26l11t3028r88b3107],
2	.	.	O	.	_	0	SENT_425	[p26l11t3028r88b3107],

1	Collet	NNP	ORGANIZATION	Collet	nn	2	SENT_426	[p26l209t3016r508b3107],
2	HP	NNP	ORGANIZATION	HP	_	0	SENT_426	[p26l527t3024r652b3127],
3	,	,	O	,	_	0	SENT_426	[p26l527t3024r652b3127],
4	Hulot	NNP	PERSON	Hulot	nn	5	SENT_426	[p26l694t3016r983b3107],
5	JS	NNP	O	JS	appos	2	SENT_426	[p26l1002t3024r1129b3127],
6	,	,	O	,	_	0	SENT_426	[p26l1002t3024r1129b3127],
7	Pena	NNP	PERSON	Pena	nn	8	SENT_426	[p26l1169t3024r1409b3107],
8	A	NNP	O	A	appos	2	SENT_426	[p26l1438t3026r1541b3127],
9	,	,	O	,	_	0	SENT_426	[p26l1438t3026r1541b3127],
10	et	FW	O	et	nn	11	SENT_426	[p26l1585t3036r1674b3107],
11	al.	FW	O	al.	appos	2	SENT_426	[p26l1704t3016r1819b3107],
12	.	.	O	.	_	0	SENT_426	[p26l1704t3016r1819b3107],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_427	[p26l1862t3024r2131b3131, p26l13t3165r397b3256],
2	P4	NN	O	p4	_	0	SENT_427	[p26l492t3173r732b3256],
3	§	CD	NUMBER	§	number	4	SENT_427	[p26l492t3173r732b3256],
4	0	CD	NUMBER	0	num	6	SENT_427	[p26l492t3173r732b3256],
5	2C19	NN	O	2c19	nn	6	SENT_427	[p26l830t3173r1082b3256],
6	polymorphism	NN	O	polymorphism	nsubj	10	SENT_427	[p26l1179t3165r1939b3280],
7	in	IN	O	in	_	0	SENT_427	[p26l2034t3167r2133b3254],
8	young	JJ	O	young	amod	9	SENT_427	[p26l7t3344r322b3431],
9	patients	NNS	O	patient	prep_in	6	SENT_427	[p26l375t3316r787b3429],
10	treated	VBN	O	treat	rcmod	2	SENT_427	[p26l848t3314r1207b3405],
11	with	IN	O	with	_	0	SENT_427	[p26l1260t3314r1492b3405],
12	clopidogrel	NN	O	clopidogrel	prep_with	10	SENT_427	[p26l1553t3314r2133b3431],
13	after	IN	O	after	_	0	SENT_427	[p26l11t3463r243b3554],
14	myocardial	JJ	O	myocardial	amod	15	SENT_427	[p26l272t3463r823b3578],
15	infarction	NN	O	infarction	prep_after	10	SENT_427	[p26l856t3463r1373b3554],
16	:	:	O	:	_	0	SENT_427	[p26l856t3463r1373b3554],
17	a	DT	O	a	det	18	SENT_427	[p26l1411t3493r1462b3554],
18	cohort	NN	O	cohort	dep	2	SENT_427	[p26l1495t3463r1818b3554],
19	study	NN	O	study	dep	18	SENT_427	[p26l1848t3463r2126b3578],
20	.	.	O	.	_	0	SENT_427	[p26l1848t3463r2126b3578],

1	Lancet	NNP	O	Lancet	_	0	SENT_428	[p26l9t3620r347b3703],
2	2009	CD	DATE	2009	num	1	SENT_428	[p26l381t3620r1223b3721],
3	;	:	O	;	_	0	SENT_428	[p26l381t3620r1223b3721],
4	373:309	CD	NUMBER	373:309	number	5	SENT_428	[p26l381t3620r1223b3721],
5	—	CD	NUMBER	—	dep	1	SENT_428	[p26l381t3620r1223b3721],
6	17	CD	NUMBER	17	dep	5	SENT_428	[p26l381t3620r1223b3721],
7	.	.	O	.	_	0	SENT_428	[p26l381t3620r1223b3721],

1	4	LS	NUMBER	4	_	0	SENT_429	[p27l9t39r90b118],
2	.	.	O	.	_	0	SENT_429	[p27l9t39r90b118],

1	Mega	JJ	O	mega	amod	2	SENT_430	[p27l205t35r480b144],
2	IL	NN	O	il	_	0	SENT_430	[p27l518t37r653b138],
3	,	,	O	,	_	0	SENT_430	[p27l518t37r653b138],
4	Close	NNP	O	Close	nn	5	SENT_430	[p27l712t27r983b118],
5	SL	NNP	O	SL	appos	2	SENT_430	[p27l1038t35r1179b138],
6	,	,	O	,	_	0	SENT_430	[p27l1038t35r1179b138],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_430	[p27l1234t29r1611b118],
8	SD	NN	O	sd	appos	2	SENT_430	[p27l1660t35r1817b138],
9	,	,	O	,	_	0	SENT_430	[p27l1660t35r1817b138],
10	et	FW	O	et	nn	11	SENT_430	[p27l1876t47r1967b118],
11	al.	FW	O	al.	appos	2	SENT_430	[p27l2012t27r2126b118],
12	.	.	O	.	_	0	SENT_430	[p27l2012t27r2126b118],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_431	[p27l11t176r617b291],
2	p-450	NN	O	p-450	nn	3	SENT_431	[p27l650t184r930b291],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_431	[p27l965t176r1747b291],
4	and	CC	O	and	_	0	SENT_431	[p27l1784t176r1965b267],
5	response	NN	O	response	conj_and	3	SENT_431	[p27l2002t206r2131b267, p27l13t355r358b440],

1	to	TO	O	to	_	0	SENT_432	[p27l395t345r490b416],
2	clopidogrel	NN	O	clopidogrel	pobj	1	SENT_432	[p27l527t325r1124b442],
3	.	.	O	.	_	0	SENT_432	[p27l527t325r1124b442],

1	N	NN	O	n	nn	2	SENT_433	[p27l1163t333r1249b416],
2	EnglJ	NN	O	englj	nsubj	3	SENT_433	[p27l1280t325r1573b442],
3	Med	VBD	O	med	_	0	SENT_433	[p27l1603t325r1821b416],
4	2009	CD	DATE	2009	dobj	3	SENT_433	[p27l1856t333r2127b434],
5	;	:	O	;	_	0	SENT_433	[p27l1856t333r2127b434],

1	360:3	CD	NUMBER	360:3	num	2	SENT_434	[p27l13t481r601b564],
2	S4	NN	O	s4	_	0	SENT_434	[p27l13t481r601b564],
3	—	CD	NUMBER	—	number	4	SENT_434	[p27l13t481r601b564],
4	62	CD	NUMBER	62	num	2	SENT_434	[p27l13t481r601b564],
5	.	.	O	.	_	0	SENT_434	[p27l13t481r601b564],

1	5	CD	NUMBER	5	_	0	SENT_435	[p27l13t634r88b713],
2	.	.	O	.	_	0	SENT_435	[p27l13t634r88b713],

1	Shuldiner	NNP	PERSON	Shuldiner	_	0	SENT_436	[p27l211t622r700b713],
2	AR	NNS	O	ar	dep	1	SENT_436	[p27l761t630r944b733],
3	,	,	O	,	_	0	SENT_436	[p27l761t630r944b733],
4	O’Connell	NN	O	o’connell	nn	5	SENT_436	[p27l1021t622r1531b713],
5	JR	NN	O	jr	appos	2	SENT_436	[p27l1589t630r1738b733],
6	,	,	O	,	_	0	SENT_436	[p27l1589t630r1738b733],
7	Bliden	NNP	PERSON	Bliden	appos	2	SENT_436	[p27l1812t622r2133b713],

1	KP	NN	O	kp	_	0	SENT_437	[p27l11t779r169b882],
2	,	,	O	,	_	0	SENT_437	[p27l11t779r169b882],
3	et	FW	O	et	nn	4	SENT_437	[p27l216t791r306b862],
4	al.	FW	O	al.	appos	1	SENT_437	[p27l339t771r453b862],
5	.	.	O	.	_	0	SENT_437	[p27l339t771r453b862],

1	Association	NNP	O	Association	_	0	SENT_438	[p27l494t773r1088b862],
2	of	IN	O	of	_	0	SENT_438	[p27l1128t771r1245b862],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_438	[p27l1264t771r1858b886],
4	P4S0	NN	O	p4s0	prep_of	1	SENT_438	[p27l1895t779r2131b862],

1	2C19	NN	O	2c19	nn	2	SENT_439	[p27l11t928r260b1011],
2	genotype	NN	O	genotype	_	0	SENT_439	[p27l298t940r760b1037],
3	with	IN	O	with	_	0	SENT_439	[p27l791t920r1021b1011],
4	the	DT	O	the	det	6	SENT_439	[p27l1056t920r1213b1011],
5	antiplatelet	JJ	O	antiplatelet	amod	6	SENT_439	[p27l1248t920r1823b1035],
6	effect	NN	O	effect	prep_with	2	SENT_439	[p27l1854t920r2139b1011],
7	and	CC	O	and	_	0	SENT_439	[p27l11t1069r197b1160],
8	clinical	JJ	O	clinical	amod	9	SENT_439	[p27l244t1069r623b1160],
9	efficacy	NN	O	efficacy	prep_with	2	SENT_439	[p27l670t1069r1074b1184],
10	of	IN	O	of	_	0	SENT_439	[p27l1117t1069r1235b1160],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_439	[p27l1260t1069r1842b1186],
12	therapy	NN	O	therapy	prep_of	2	SENT_439	[p27l1888t1069r2131b1160, p27l11t1248r199b1333],
13	.	.	O	.	_	0	SENT_439	[p27l1888t1069r2131b1160, p27l11t1248r199b1333],

1	JAMA	NNP	O	JAMA	_	0	SENT_440	[p27l233t1228r534b1323],
2	2009	CD	DATE	2009	num	1	SENT_440	[p27l571t1226r1421b1327],
3	;	:	O	;	_	0	SENT_440	[p27l571t1226r1421b1327],
4	302:849	CD	NUMBER	302:849	number	5	SENT_440	[p27l571t1226r1421b1327],
5	—	CD	NUMBER	—	dep	1	SENT_440	[p27l571t1226r1421b1327],
6	57	CD	NUMBER	57	dep	5	SENT_440	[p27l571t1226r1421b1327],
7	.	.	O	.	_	0	SENT_440	[p27l571t1226r1421b1327],

1	6	CD	NUMBER	6	_	0	SENT_441	[p27l11t1379r92b1458],
2	.	.	O	.	_	0	SENT_441	[p27l11t1379r92b1458],

1	Sibbing	VBG	O	sibb	_	0	SENT_442	[p27l211t1367r593b1484],
2	D	NN	O	d	dobj	1	SENT_442	[p27l630t1375r734b1478],
3	,	,	O	,	_	0	SENT_442	[p27l630t1375r734b1478],
4	Koch	NNP	PERSON	Koch	nn	5	SENT_442	[p27l783t1367r1040b1460],
5	W	NNP	O	W	appos	2	SENT_442	[p27l1078t1377r1203b1478],
6	,	,	O	,	_	0	SENT_442	[p27l1078t1377r1203b1478],
7	Gebhard	NNP	PERSON	Gebhard	nn	8	SENT_442	[p27l1252t1367r1690b1458],
8	D	NNP	O	D	appos	2	SENT_442	[p27l1731t1375r1835b1478],
9	,	,	O	,	_	0	SENT_442	[p27l1731t1375r1835b1478],
10	et	FW	O	et	nn	11	SENT_442	[p27l1886t1387r1975b1458],
11	al.	FW	O	al.	appos	2	SENT_442	[p27l2012t1367r2126b1458],
12	.	.	O	.	_	0	SENT_442	[p27l2012t1367r2126b1458],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_443	[p27l11t1516r615b1631],
2	2C19	NN	O	2c19	_	0	SENT_443	[p27l652t1516r1074b1607],
3	*	CD	NUMBER	*	number	4	SENT_443	[p27l652t1516r1074b1607],
4	17	CD	NUMBER	17	num	6	SENT_443	[p27l652t1516r1074b1607],
5	allelic	JJ	O	allelic	amod	6	SENT_443	[p27l1113t1516r1403b1607],
6	variant	NN	O	variant	dep	2	SENT_443	[p27l1436t1518r1807b1627],
7	,	,	O	,	_	0	SENT_443	[p27l1436t1518r1807b1627],
8	platelet	NN	O	platelet	appos	6	SENT_443	[p27l1850t1516r2131b1631, p27l9t1665r134b1756],

1	aggregation	NN	O	aggregation	_	0	SENT_444	[p27l167t1667r787b1782],
2	,	,	O	,	_	0	SENT_444	[p27l167t1667r787b1782],
3	bleeding	VBG	O	bleed	amod	4	SENT_444	[p27l834t1665r1262b1782],
4	events	NNS	O	event	appos	1	SENT_444	[p27l1298t1685r1630b1776],
5	,	,	O	,	_	0	SENT_444	[p27l1298t1685r1630b1776],
6	and	CC	O	and	_	0	SENT_444	[p27l1676t1665r1856b1756],
7	stent	NN	O	stent	nn	8	SENT_444	[p27l1898t1685r2139b1756],
8	thrombosis	NN	O	thrombosis	conj_and	1	SENT_444	[p27l11t1814r578b1905],
9	in	IN	O	in	_	0	SENT_444	[p27l620t1816r716b1903],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_444	[p27l757t1814r1698b1931],
11	—	NN	O	—	prep_in	8	SENT_444	[p27l757t1814r1698b1931],
12	treated	VBN	O	treat	partmod	1	SENT_444	[p27l757t1814r1698b1931],
13	patients	NNS	O	patient	dobj	12	SENT_444	[p27l1737t1816r2129b1929],
14	with	IN	O	with	_	0	SENT_444	[p27l7t2075r118b2120],
15	coronary	JJ	O	coronary	amod	17	SENT_444	[p27l149t2089r369b2131],
16	stent	NN	O	stent	nn	17	SENT_444	[p27l398t2084r518b2119],
17	placement	NN	O	placement	prep_with	12	SENT_444	[p27l545t2075r812b2131],
18	.	.	O	.	_	0	SENT_444	[p27l545t2075r812b2131],

1	Circulation	NN	O	circulation	_	0	SENT_445	[p27l847t2075r1041b2120, p27l9t2147r106b2191],
2	2010	CD	DATE	2010	num	1	SENT_445	[p27l125t2150r511b2200],
3	;	:	O	;	_	0	SENT_445	[p27l125t2150r511b2200],
4	121:512	CD	NUMBER	121:512	number	5	SENT_445	[p27l125t2150r511b2200],
5	-8	CD	NUMBER	-8	dep	1	SENT_445	[p27l125t2150r511b2200],
6	.	.	O	.	_	0	SENT_445	[p27l125t2150r511b2200],

1	7	CD	NUMBER	7	_	0	SENT_446	[p27l10t2223r43b2261],
2	.	.	O	.	_	0	SENT_446	[p27l10t2223r43b2261],

1	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_447	[p27l104t2217r258b2261],
2	SR	JJ	ORGANIZATION	sr	amod	5	SENT_447	[p27l276t2221r352b2271],
3	,	,	O	,	_	0	SENT_447	[p27l276t2221r352b2271],
4	Yusuf	NNP	PERSON	Yusuf	dep	5	SENT_447	[p27l370t2217r516b2262],
5	S.	NNP	O	S.	_	0	SENT_447	[p27l524t2221r563b2262],
6	The	NNP	O	The	nn	7	SENT_447	[p27l581t2217r673b2261],
7	Clopidogrel	NNP	O	Clopidogrel	nsubj	12	SENT_447	[p27l690t2217r977b2274],
8	in	IN	O	in	_	0	SENT_447	[p27l994t2218r1041b2261],
9	Unstable	JJ	O	unstable	amod	10	SENT_447	[p27l9t2288r224b2333],
10	angina	NN	O	angina	prep_in	7	SENT_447	[p27l269t2289r438b2345],
11	to	TO	O	to	aux	12	SENT_447	[p27l483t2298r529b2332],
12	prevent	VB	O	prevent	infmod	5	SENT_447	[p27l574t2297r757b2344],
13	Recurrent	JJ	O	recurrent	amod	14	SENT_447	[p27l799t2292r1044b2335],
14	Events	NNS	O	event	dobj	12	SENT_447	[p27l8t2363r165b2404],
15	(	JJ	O	(	amod	17	SENT_447	[p27l206t2363r383b2410],
16	CURE	NN	O	cure	nn	17	SENT_447	[p27l206t2363r383b2410],
17	)	NN	O	)	dep	5	SENT_447	[p27l206t2363r383b2410],
18	trial	NN	O	trial	nn	19	SENT_447	[p27l424t2359r526b2403],
19	programme	NN	O	programme	dep	17	SENT_447	[p27l562t2373r867b2416],
20	:	:	O	:	_	0	SENT_447	[p27l562t2373r867b2416],
21	rationale	NN	O	rationale	nn	26	SENT_447	[p27l907t2360r1041b2403, p27l9t2430r124b2484],
22	,	,	O	,	_	0	SENT_447	[p27l907t2360r1041b2403, p27l9t2430r124b2484],
23	design	NN	O	design	nn	26	SENT_447	[p27l153t2430r314b2487],
24	and	CC	O	and	_	0	SENT_447	[p27l339t2430r429b2474],
25	baseline	NN	O	baseline	nn	26	SENT_447	[p27l456t2430r657b2474],
26	characteristics	NNS	O	characteristic	dep	5	SENT_447	[p27l683t2430r1040b2474],
27	including	VBG	O	include	_	0	SENT_447	[p27l9t2501r244b2558],
28	a	DT	O	a	det	31	SENT_447	[p27l259t2516r284b2545],
29	meta	NN	O	meta	nn	31	SENT_447	[p27l301t2501r637b2557],
30	—	NN	O	—	nn	31	SENT_447	[p27l301t2501r637b2557],
31	analysis	NN	O	analysis	prep_including	26	SENT_447	[p27l301t2501r637b2557],
32	of	IN	O	of	_	0	SENT_447	[p27l656t2501r713b2545],
33	the	DT	O	the	det	34	SENT_447	[p27l721t2501r796b2545],
34	effects	NNS	O	effect	prep_of	31	SENT_447	[p27l814t2501r976b2545],
35	of	IN	O	of	_	0	SENT_447	[p27l995t2501r1051b2546],
36	thienopyridines	NNS	O	thienopyridine	prep_of	34	SENT_447	[p27l9t2573r396b2629],
37	in	IN	O	in	_	0	SENT_447	[p27l427t2574r474b2617],
38	vascular	JJ	O	vascular	amod	39	SENT_447	[p27l501t2573r706b2618],
39	disease	NN	O	disease	prep_in	36	SENT_447	[p27l734t2573r926b2617],
40	.	.	O	.	_	0	SENT_447	[p27l734t2573r926b2617],

1	Eur	NNP	O	Eur	nn	2	SENT_448	[p27l958t2577r1043b2618],
2	Heart	NNP	O	Heart	_	0	SENT_448	[p27l9t2648r181b2695],
3	]	CD	NUMBER	]	num	4	SENT_448	[p27l9t2648r181b2695],
4	2000	CD	DATE	2000	dep	2	SENT_448	[p27l199t2648r619b2698],
5	;	:	O	;	_	0	SENT_448	[p27l199t2648r619b2698],
6	21:2033	CD	NUMBER	21:2033	num	7	SENT_448	[p27l199t2648r619b2698],
7	-41	CD	NUMBER	-41	dep	2	SENT_448	[p27l199t2648r619b2698],
8	.	.	O	.	_	0	SENT_448	[p27l199t2648r619b2698],

1	8	CD	NUMBER	8	_	0	SENT_449	[p27l8t2719r48b2759],
2	.	.	O	.	_	0	SENT_449	[p27l8t2719r48b2759],

1	Mehta	NNP	ORGANIZATION	Mehta	nn	2	SENT_450	[p27l104t2714r258b2758],
2	SR	NN	ORGANIZATION	sr	_	0	SENT_450	[p27l289t2718r364b2768],
3	,	,	O	,	_	0	SENT_450	[p27l289t2718r364b2768],
4	Yusuf	NNP	PERSON	Yusuf	nn	5	SENT_450	[p27l395t2714r542b2759],
5	S	NNP	PERSON	S	appos	2	SENT_450	[p27l562t2718r601b2768],
6	,	,	O	,	_	0	SENT_450	[p27l562t2718r601b2768],
7	Peters	NNP	PERSON	Peters	nn	9	SENT_450	[p27l633t2718r780b2758],
8	R	NNP	O	R	nn	9	SENT_450	[p27l810t2718r879b2768],
9	]	NN	O	]	appos	2	SENT_450	[p27l810t2718r879b2768],
10	,	,	O	,	_	0	SENT_450	[p27l810t2718r879b2768],
11	et	FW	O	et	nn	12	SENT_450	[p27l912t2723r956b2758],
12	al.	FW	O	al.	appos	2	SENT_450	[p27l982t2714r1038b2758],
13	.	.	O	.	_	0	SENT_450	[p27l982t2714r1038b2758],

1	Effects	NNS	O	effect	nsubj	8	SENT_451	[p27l8t2785r176b2829],
2	of	IN	O	of	_	0	SENT_451	[p27l206t2785r262b2829],
3	pretreatment	NN	O	pretreatment	prep_of	1	SENT_451	[p27l279t2794r603b2841],
4	with	IN	O	with	_	0	SENT_451	[p27l625t2785r736b2830],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_451	[p27l765t2785r1042b2842],
6	and	CC	O	and	_	0	SENT_451	[p27l9t2856r99b2901],
7	aspirin	NN	O	aspirin	conj_and	5	SENT_451	[p27l115t2857r285b2912],
8	followed	VBN	O	follow	_	0	SENT_451	[p27l302t2856r514b2901],
9	by	IN	O	by	_	0	SENT_451	[p27l531t2856r586b2912],
10	long	JJ	O	long	amod	13	SENT_451	[p27l599t2856r843b2913],
11	—	JJ	O	—	amod	13	SENT_451	[p27l599t2856r843b2913],
12	term	NN	O	term	nn	13	SENT_451	[p27l599t2856r843b2913],
13	therapy	NN	O	therapy	prep_by	8	SENT_451	[p27l860t2856r1044b2912],
14	in	IN	O	in	_	0	SENT_451	[p27l9t2928r56b2971],
15	patients	NNS	O	patient	prep_in	13	SENT_451	[p27l75t2928r271b2983],
16	undergoing	VBG	O	undergo	partmod	15	SENT_451	[p27l292t2927r578b2984],
17	percutaneous	JJ	O	percutaneous	amod	19	SENT_451	[p27l595t2936r926b2983],
18	coronary	JJ	O	coronary	amod	19	SENT_451	[p27l947t2941r1041b2971, p27l9t3013r150b3055],
19	intervention	NN	O	intervention	dobj	16	SENT_451	[p27l174t3000r488b3044],
20	:	:	O	:	_	0	SENT_451	[p27l174t3000r488b3044],
21	the	DT	O	the	det	22	SENT_451	[p27l517t2999r593b3043],
22	PCI	NN	O	pcus	dep	19	SENT_451	[p27l618t3003r870b3046],
23	.	.	O	.	_	0	SENT_451	[p27l618t3003r870b3046],

1	—	NN	O	—	_	0	SENT_452	[p27l618t3003r870b3046],
2	.	.	O	.	_	0	SENT_452	[p27l618t3003r870b3046],

1	CURE	VB	O	cure	_	0	SENT_453	[p27l618t3003r870b3046],
2	study	NN	O	study	dobj	1	SENT_453	[p27l899t2999r1038b3055],
3	.	.	O	.	_	0	SENT_453	[p27l899t2999r1038b3055],

1	Lancet	NNP	O	Lancet	_	0	SENT_454	[p27l8t3073r172b3113],
2	2001	CD	DATE	2001	num	1	SENT_454	[p27l189t3073r597b3122],
3	;	:	O	;	_	0	SENT_454	[p27l189t3073r597b3122],
4	358:527	CD	NUMBER	358:527	number	5	SENT_454	[p27l189t3073r597b3122],
5	-33	CD	NUMBER	-33	dep	1	SENT_454	[p27l189t3073r597b3122],
6	.	.	O	.	_	0	SENT_454	[p27l189t3073r597b3122],

1	9	CD	NUMBER	9	_	0	SENT_455	[p27l9t3145r46b3184],
2	.	.	O	.	_	0	SENT_455	[p27l9t3145r46b3184],

1	Connolly	NNP	PERSON	Connolly	nn	2	SENT_456	[p27l105t3140r328b3196],
2	S	NNP	O	S	_	0	SENT_456	[p27l357t3144r395b3194],
3	,	,	O	,	_	0	SENT_456	[p27l357t3144r395b3194],
4	Yusuf	NNP	PERSON	Yusuf	nn	5	SENT_456	[p27l426t3140r573b3185],
5	S	NNP	PERSON	S	appos	2	SENT_456	[p27l593t3144r632b3194],
6	,	,	O	,	_	0	SENT_456	[p27l593t3144r632b3194],
7	Budaj	NNP	PERSON	Budaj	nn	8	SENT_456	[p27l664t3140r799b3196],
8	A	NNP	O	A	appos	2	SENT_456	[p27l829t3144r879b3194],
9	,	,	O	,	_	0	SENT_456	[p27l829t3144r879b3194],
10	et	FW	O	et	nn	11	SENT_456	[p27l912t3149r956b3184],
11	al.	FW	O	al.	appos	2	SENT_456	[p27l982t3140r1038b3184],
12	.	.	O	.	_	0	SENT_456	[p27l982t3140r1038b3184],

1	Rationale	NN	O	rationale	_	0	SENT_457	[p27l8t3212r239b3259],
2	and	CC	O	and	_	0	SENT_457	[p27l255t3212r343b3256],
3	design	NN	O	design	conj_and	1	SENT_457	[p27l359t3212r517b3269],
4	of	IN	O	of	_	0	SENT_457	[p27l533t3212r589b3256],
5	ACTIVE	NNP	O	ACTIVE	prep_of	1	SENT_457	[p27l593t3216r797b3257],
6	:	:	O	:	_	0	SENT_457	[p27l593t3216r797b3257],
7	the	DT	O	the	det	11	SENT_457	[p27l815t3212r889b3256],
8	Atrial	NNP	O	Atrial	nn	11	SENT_457	[p27l904t3212r1042b3256],
9	Fibrillation	NNP	O	Fibrillation	nn	11	SENT_457	[p27l8t3283r285b3328],
10	Clopidogrel	NNP	O	Clopidogrel	nn	11	SENT_457	[p27l317t3283r604b3340],
11	Trial	NN	O	trial	dep	1	SENT_457	[p27l635t3283r751b3327],
12	with	IN	O	with	_	0	SENT_457	[p27l780t3283r891b3328],
13	Irbe	NN	O	irbe	nn	15	SENT_457	[p27l923t3283r1041b3327],
14	—	CD	NUMBER	—	num	15	SENT_457	[p27l923t3283r1041b3327],
15	sartan	NN	O	sartan	prep_with	11	SENT_457	[p27l10t3364r165b3399],
16	for	IN	O	for	_	0	SENT_457	[p27l189t3355r259b3399],
17	Prevention	NNP	O	Prevention	prep_for	15	SENT_457	[p27l280t3356r542b3400],
18	of	IN	O	of	_	0	SENT_457	[p27l566t3355r623b3399],
19	Vascular	JJ	O	vascular	amod	20	SENT_457	[p27l635t3355r846b3400],
20	Events	NNS	O	event	prep_of	17	SENT_457	[p27l867t3359r1038b3400],
21	.	.	O	.	_	0	SENT_457	[p27l867t3359r1038b3400],

1	Am	VBP	O	be	dep	2	SENT_458	[p27l7t3429r93b3469],
2	Heart	NNP	O	Heart	_	0	SENT_458	[p27l112t3429r285b3476],
3	]	CD	NUMBER	]	number	4	SENT_458	[p27l112t3429r285b3476],
4	2006	CD	DATE	2006	amod	2	SENT_458	[p27l303t3429r746b3479],
5	;	:	O	;	_	0	SENT_458	[p27l303t3429r746b3479],
6	151:1187	CD	NUMBER	151:1187	dep	4	SENT_458	[p27l303t3429r746b3479],
7	—	CD	NUMBER	—	num	8	SENT_458	[p27l303t3429r746b3479],
8	93	CD	NUMBER	93	dep	6	SENT_458	[p27l303t3429r746b3479],
9	.	.	O	.	_	0	SENT_458	[p27l303t3429r746b3479],

1	10	CD	NUMBER	10	_	0	SENT_459	[p27l11t3501r75b3540],
2	.	.	O	.	_	0	SENT_459	[p27l11t3501r75b3540],

1	Ingelman	NNP	O	Ingelman	_	0	SENT_460	[p27l104t3496r608b3553],
2	.	.	O	.	_	0	SENT_460	[p27l104t3496r608b3553],

1	—	NN	O	—	_	0	SENT_461	[p27l104t3496r608b3553],
2	.	.	O	.	_	0	SENT_461	[p27l104t3496r608b3553],

1	Sundberg	NNP	PERSON	Sundberg	nn	2	SENT_462	[p27l104t3496r608b3553],
2	M	NNP	O	M	_	0	SENT_462	[p27l631t3500r693b3550],
3	,	,	O	,	_	0	SENT_462	[p27l631t3500r693b3550],
4	Sim	NNP	ORGANIZATION	Sim	nn	5	SENT_462	[p27l723t3497r816b3541],
5	SC	NNP	ORGANIZATION	SC	appos	2	SENT_462	[p27l844t3500r920b3550],
6	,	,	O	,	_	0	SENT_462	[p27l844t3500r920b3550],
7	Gomez	NNP	PERSON	Gomez	nn	8	SENT_462	[p27l950t3500r1040b3541, p27l9t3582r109b3611],
8	A	NNP	O	A	appos	2	SENT_462	[p27l126t3571r176b3621],
9	,	,	O	,	_	0	SENT_462	[p27l126t3571r176b3621],
10	Rodriguez	NNP	PERSON	Rodriguez	appos	2	SENT_462	[p27l198t3567r654b3624],
11	.	.	O	.	_	0	SENT_462	[p27l198t3567r654b3624],

1	—	NN	O	—	_	0	SENT_463	[p27l198t3567r654b3624],
2	.	.	O	.	_	0	SENT_463	[p27l198t3567r654b3624],

1	Antona	NNP	O	Antona	nn	3	SENT_464	[p27l198t3567r654b3624],
2	C.	NNP	O	C.	nn	3	SENT_464	[p27l672t3571r720b3611],
3	Influence	NN	O	influence	_	0	SENT_464	[p27l741t3567r975b3612],
4	of	IN	O	of	_	0	SENT_464	[p27l995t3567r1051b3611],
5	cytochrome	NN	O	cytochrome	nn	7	SENT_464	[p27l9t3638r299b3694],
6	P450	NN	O	p450	nn	7	SENT_464	[p27l314t3642r429b3683],
7	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_464	[p27l444t3638r832b3694],
8	on	IN	O	on	_	0	SENT_464	[p27l849t3652r909b3682],
9	drug	NN	O	drug	nn	10	SENT_464	[p27l925t3638r1043b3695],
10	therapies	NNS	O	therapy	prep_on	7	SENT_464	[p27l9t3709r253b3765],
11	:	:	O	:	_	0	SENT_464	[p27l9t3709r253b3765],
12	pharmacogenetic	JJ	O	pharmacogenetic	dep	3	SENT_464	[p27l284t3709r735b3766],
13	,	,	O	,	_	0	SENT_464	[p27l284t3709r735b3766],
14	pharmaco12	NN	O	pharmaco12	appos	12	SENT_464	[p27l767t3709r1041b3765, p27l1118t2081r1182b2119],
15	.	.	O	.	_	0	SENT_464	[p27l767t3709r1041b3765, p27l1118t2081r1182b2119],

1	Desai	NNP	PERSON	Desai	nn	2	SENT_465	[p27l1212t2076r1347b2119],
2	NR	NNP	O	NR	_	0	SENT_465	[p27l1373t2079r1465b2129],
3	,	,	O	,	_	0	SENT_465	[p27l1373t2079r1465b2129],
4	Mega	JJ	O	mega	amod	5	SENT_465	[p27l1494t2079r1626b2132],
5	JL	NN	O	jl	appos	2	SENT_465	[p27l1647t2079r1711b2129],
6	,	,	O	,	_	0	SENT_465	[p27l1647t2079r1711b2129],
7	Jiang	NNP	PERSON	Jiang	nn	8	SENT_465	[p27l1736t2076r1864b2132],
8	S	NNP	O	S	appos	2	SENT_465	[p27l1891t2079r1929b2129],
9	,	,	O	,	_	0	SENT_465	[p27l1891t2079r1929b2129],
10	Cannon	NNP	O	Cannon	nn	11	SENT_465	[p27l1960t2079r2149b2119],
11	CP	NNP	O	CP	conj_and	5	SENT_465	[p27l1117t2150r1189b2200],
12	,	,	O	,	_	0	SENT_465	[p27l1117t2150r1189b2200],
13	Sabatine	NNP	PERSON	Sabatine	nn	15	SENT_465	[p27l1209t2146r1413b2191],
14	MS.	NNP	O	MS.	nn	15	SENT_465	[p27l1428t2150r1517b2190],
15	Interaction	NN	O	interaction	conj_and	5	SENT_465	[p27l1536t2147r1802b2191],
16	between	IN	O	between	_	0	SENT_465	[p27l1818t2146r2019b2191],
17	cigarette	NN	O	cigarette	nn	18	SENT_465	[p27l2036t2147r2148b2203, p27l1116t2226r1225b2261],
18	smoking	NN	O	smoking	prep_between	15	SENT_465	[p27l1243t2217r1455b2274],
19	and	CC	O	and	_	0	SENT_465	[p27l1469t2217r1558b2261],
20	clinical	JJ	O	clinical	amod	21	SENT_465	[p27l1575t2217r1751b2261],
21	benefit	NN	O	benefit	appos	2	SENT_465	[p27l1768t2217r1938b2262],
22	of	IN	O	of	_	0	SENT_465	[p27l1953t2217r2009b2262],
23	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_465	[p27l2016t2217r2148b2273, p27l1117t2288r1283b2345],
24	.	.	O	.	_	0	SENT_465	[p27l2016t2217r2148b2273, p27l1117t2288r1283b2345],

1	I	PRP	O	I	nsubj	4	SENT_466	[p27l1299t2292r1320b2339],
2	Am	VBP	O	be	cop	4	SENT_466	[p27l1335t2292r1421b2332],
3	Coll	NNP	O	Coll	nn	4	SENT_466	[p27l1438t2288r1536b2333],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_466	[p27l1553t2288r1730b2333],
5	2009	CD	DATE	2009	dep	4	SENT_466	[p27l1747t2292r2129b2341],
6	;	:	O	;	_	0	SENT_466	[p27l1747t2292r2129b2341],
7	53:1273	CD	NUMBER	53:1273	number	8	SENT_466	[p27l1747t2292r2129b2341],
8	—	CD	NUMBER	—	dep	4	SENT_466	[p27l1747t2292r2129b2341],
9	8	CD	NUMBER	8	dep	8	SENT_466	[p27l1747t2292r2129b2341],
10	.	.	O	.	_	0	SENT_466	[p27l1747t2292r2129b2341],

1	13	CD	NUMBER	13	_	0	SENT_467	[p27l1118t2365r1183b2403],
2	.	.	O	.	_	0	SENT_467	[p27l1118t2365r1183b2403],

1	Berger	NNP	PERSON	Berger	nn	2	SENT_468	[p27l1212t2363r1377b2416],
2	JS	NNP	O	JS	_	0	SENT_468	[p27l1392t2363r1455b2413],
3	,	,	O	,	_	0	SENT_468	[p27l1392t2363r1455b2413],
4	Bhatt	NNP	PERSON	Bhatt	nn	5	SENT_468	[p27l1479t2359r1615b2403],
5	DL	NNP	O	DL	appos	2	SENT_468	[p27l1633t2363r1717b2413],
6	,	,	O	,	_	0	SENT_468	[p27l1633t2363r1717b2413],
7	Steinhubl	NNP	O	Steinhubl	nn	8	SENT_468	[p27l1744t2359r1981b2404],
8	SR	NN	O	sr	appos	2	SENT_468	[p27l2004t2363r2082b2413],
9	,	,	O	,	_	0	SENT_468	[p27l2004t2363r2082b2413],
10	et	FW	O	et	nn	11	SENT_468	[p27l2107t2368r2151b2403],
11	al.	FW	O	al.	appos	2	SENT_468	[p27l1116t2430r1173b2474],
12	.	.	O	.	_	0	SENT_468	[p27l1116t2430r1173b2474],

1	Smoking	NN	O	smoking	_	0	SENT_469	[p27l1205t2430r1439b2487],
2	,	,	O	,	_	0	SENT_469	[p27l1205t2430r1439b2487],
3	clopidogrel	NN	O	clopidogrel	conj_and	1	SENT_469	[p27l1470t2430r1767b2487],
4	,	,	O	,	_	0	SENT_469	[p27l1470t2430r1767b2487],
5	and	CC	O	and	_	0	SENT_469	[p27l1797t2430r1888b2475],
6	mortality	NN	O	mortality	conj_and	1	SENT_469	[p27l1916t2430r2151b2486],
7	in	IN	O	in	_	0	SENT_469	[p27l1116t2502r1164b2545],
8	patients	NNS	O	patient	prep_in	1	SENT_469	[p27l1188t2502r1384b2557],
9	with	IN	O	with	_	0	SENT_469	[p27l1405t2501r1517b2546],
10	established	JJ	O	established	amod	12	SENT_469	[p27l1540t2501r1817b2546],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_469	[p27l1841t2501r2148b2546, p27l1116t2573r1181b2617],
12	disease	NN	O	disease	prep_with	1	SENT_469	[p27l1197t2573r1384b2617],
13	.	.	O	.	_	0	SENT_469	[p27l1197t2573r1384b2617],

1	Circulation	NN	O	circulation	_	0	SENT_470	[p27l1405t2573r1673b2618],
2	2009	CD	DATE	2009	num	1	SENT_470	[p27l1691t2577r2129b2626],
3	;	:	O	;	_	0	SENT_470	[p27l1691t2577r2129b2626],
4	120:2337	CD	NUMBER	120:2337	number	5	SENT_470	[p27l1691t2577r2129b2626],
5	—	CD	NUMBER	—	dep	1	SENT_470	[p27l1691t2577r2129b2626],
6	44	CD	NUMBER	44	dep	5	SENT_470	[p27l1691t2577r2129b2626],
7	.	.	O	.	_	0	SENT_470	[p27l1691t2577r2129b2626],

1	14	CD	NUMBER	14	_	0	SENT_471	[p27l1118t2650r1182b2688],
2	.	.	O	.	_	0	SENT_471	[p27l1118t2650r1182b2688],

1	Yusuf	NNP	PERSON	Yusuf	nn	2	SENT_472	[p27l1211t2644r1357b2689],
2	S	NNP	PERSON	S	_	0	SENT_472	[p27l1366t2648r1405b2698],
3	,	,	O	,	_	0	SENT_472	[p27l1366t2648r1405b2698],
4	Mehta	NNP	ORGANIZATION	Mehta	nn	5	SENT_472	[p27l1424t2644r1579b2688],
5	SR	NN	ORGANIZATION	sr	appos	2	SENT_472	[p27l1597t2648r1673b2698],
6	,	,	O	,	_	0	SENT_472	[p27l1597t2648r1673b2698],
7	Zhao	NNP	PERSON	Zhao	nn	8	SENT_472	[p27l1693t2644r1814b2688],
8	P	NN	PERSON	p	appos	2	SENT_472	[p27l1832t2648r1871b2698],
9	,	,	O	,	_	0	SENT_472	[p27l1832t2648r1871b2698],
10	et	FW	O	et	nn	11	SENT_472	[p27l1892t2654r1936b2688],
11	al.	FW	O	al.	appos	2	SENT_472	[p27l1951t2644r2007b2688],
12	.	.	O	.	_	0	SENT_472	[p27l1951t2644r2007b2688],

1	Early	RB	O	early	advmod	4	SENT_473	[p27l2027t2644r2151b2700],
2	and	CC	O	and	_	0	SENT_473	[p27l1116t2714r1206b2758],
3	late	RB	O	late	advmod	4	SENT_473	[p27l1227t2714r1313b2758],
4	effects	NNS	O	effect	_	0	SENT_473	[p27l1335t2714r1496b2758],
5	of	IN	O	of	_	0	SENT_473	[p27l1519t2714r1576b2759],
6	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_473	[p27l1587t2714r1864b2771],
7	in	IN	O	in	_	0	SENT_473	[p27l1884t2715r1932b2758],
8	patients	NNS	O	patient	prep_in	6	SENT_473	[p27l1952t2715r2148b2770],
9	with	IN	O	with	_	0	SENT_473	[p27l1114t2785r1226b2830],
10	acute	JJ	O	acute	amod	12	SENT_473	[p27l1250t2795r1377b2830],
11	coronary	JJ	O	coronary	amod	12	SENT_473	[p27l1403t2799r1622b2841],
12	syndromes	NNS	O	syndrome	prep_with	8	SENT_473	[p27l1646t2785r1926b2841],
13	.	.	O	.	_	0	SENT_473	[p27l1646t2785r1926b2841],

1	Circulation	NN	O	circulation	_	0	SENT_474	[p27l1954t2785r2148b2830, p27l1117t2857r1214b2901],
2	2003	CD	DATE	2003	num	1	SENT_474	[p27l1233t2860r1643b2909],
3	;	:	O	;	_	0	SENT_474	[p27l1233t2860r1643b2909],
4	107:966	CD	NUMBER	107:966	number	5	SENT_474	[p27l1233t2860r1643b2909],
5	-72	CD	NUMBER	-72	dep	1	SENT_474	[p27l1233t2860r1643b2909],
6	.	.	O	.	_	0	SENT_474	[p27l1233t2860r1643b2909],

1	15	CD	NUMBER	15	_	0	SENT_475	[p27l1118t2933r1181b2971],
2	.	.	O	.	_	0	SENT_475	[p27l1118t2933r1181b2971],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_476	[p27l1214t2928r1369b2971],
2	T	NN	PERSON	t	_	0	SENT_476	[p27l1385t2931r1428b2981],
3	,	,	O	,	_	0	SENT_476	[p27l1385t2931r1428b2981],
4	Verstuyft	NN	O	verstuyft	nn	5	SENT_476	[p27l1447t2927r1672b2983],
5	C	NN	O	c	appos	2	SENT_476	[p27l1687t2931r1734b2981],
6	,	,	O	,	_	0	SENT_476	[p27l1687t2931r1734b2981],
7	Mary	NNP	PERSON	Mary	appos	5	SENT_476	[p27l1753t2931r2068b2983],
8	.	.	O	.	_	0	SENT_476	[p27l1753t2931r2068b2983],

1	—	NN	O	—	_	0	SENT_477	[p27l1753t2931r2068b2983],
2	.	.	O	.	_	0	SENT_477	[p27l1753t2931r2068b2983],

1	Krause	NNP	PERSON	Krause	nn	2	SENT_478	[p27l1753t2931r2068b2983],
2	M	NNP	O	M	_	0	SENT_478	[p27l2084t2931r2146b2981],
3	,	,	O	,	_	0	SENT_478	[p27l2084t2931r2146b2981],
4	et	FW	O	et	nn	5	SENT_478	[p27l1117t3009r1161b3043],
5	al.	FW	O	al.	appos	2	SENT_478	[p27l1175t2999r1230b3043],
6	.	.	O	.	_	0	SENT_478	[p27l1175t2999r1230b3043],

1	Genetic	JJ	O	genetic	amod	2	SENT_479	[p27l1250t3000r1439b3043],
2	determinants	NNS	O	determinant	_	0	SENT_479	[p27l1456t2999r1785b3043],
3	of	IN	O	of	_	0	SENT_479	[p27l1804t2999r1860b3043],
4	response	NN	O	response	prep_of	2	SENT_479	[p27l1867t3013r2085b3055],
5	to	TO	O	to	_	0	SENT_479	[p27l2102t3009r2148b3043],
6	clopidogrel	NN	O	clopidogrel	nn	9	SENT_479	[p27l1117t3069r1394b3126],
7	and	CC	O	and	_	0	SENT_479	[p27l1439t3069r1529b3113],
8	cardiovascular	JJ	O	cardiovascular	nn	9	SENT_479	[p27l1576t3069r1935b3114],
9	events	NNS	O	event	prep_to	2	SENT_479	[p27l1980t3078r2146b3114],
10	.	.	O	.	_	0	SENT_479	[p27l1980t3078r2146b3114],

1	N	NN	O	n	nn	2	SENT_480	[p27l1115t3144r1157b3185],
2	EnglJ	NN	O	englj	nsubj	3	SENT_480	[p27l1175t3140r1320b3197],
3	Med	VBD	O	med	_	0	SENT_480	[p27l1337t3140r1442b3185],
4	2009	CD	DATE	2009	dobj	3	SENT_480	[p27l1462t3144r1878b3193],
5	;	:	O	;	_	0	SENT_480	[p27l1462t3144r1878b3193],
6	360:363	CD	NUMBER	360:363	num	7	SENT_480	[p27l1462t3144r1878b3193],
7	-75	CD	NUMBER	-75	dep	4	SENT_480	[p27l1462t3144r1878b3193],
8	.	.	O	.	_	0	SENT_480	[p27l1462t3144r1878b3193],

1	16	CD	NUMBER	16	_	0	SENT_481	[p27l1118t3217r1182b3256],
2	.	.	O	.	_	0	SENT_481	[p27l1118t3217r1182b3256],

1	Frére	NN	O	frére	nn	2	SENT_482	[p27l1212t3211r1335b3256],
2	C	NN	O	c	nsubj	14	SENT_482	[p27l1363t3216r1410b3266],
3	,	,	O	,	_	0	SENT_482	[p27l1363t3216r1410b3266],
4	Cuisset	NN	O	cuisset	nn	5	SENT_482	[p27l1440t3213r1620b3257],
5	T	NN	O	t	appos	2	SENT_482	[p27l1642t3216r1686b3266],
6	,	,	O	,	_	0	SENT_482	[p27l1642t3216r1686b3266],
7	Gaborit	NN	O	gaborit	nn	8	SENT_482	[p27l1716t3212r1906b3257],
8	B	NN	O	b	appos	2	SENT_482	[p27l1929t3216r1975b3266],
9	,	,	O	,	_	0	SENT_482	[p27l1929t3216r1975b3266],
10	Alessi	NNP	PERSON	Alessi	nn	11	SENT_482	[p27l2003t3212r2149b3256],
11	MC	NNP	O	MC	appos	2	SENT_482	[p27l1115t3287r1212b3337],
12	,	,	O	,	_	0	SENT_482	[p27l1115t3287r1212b3337],
13	Hulot	NNP	PERSON	Hulot	appos	2	SENT_482	[p27l1244t3283r1385b3328],
14	IS	VBZ	O	be	_	0	SENT_482	[p27l1405t3287r1467b3334],
15	.	.	O	.	_	0	SENT_482	[p27l1405t3287r1467b3334],

1	The	DT	O	the	det	5	SENT_483	[p27l1497t3283r1588b3327],
2	CYP2C19	NN	O	cyp2c19	nn	5	SENT_483	[p27l1616t3283r1925b3328],
3	*	NN	O	*	nn	5	SENT_483	[p27l1616t3283r1925b3328],
4	17	CD	NUMBER	17	num	5	SENT_483	[p27l1616t3283r1925b3328],
5	allele	NN	O	allele	nsubjpass	7	SENT_483	[p27l1954t3283r2082b3327],
6	is	VBZ	O	be	auxpass	7	SENT_483	[p27l2110t3284r2148b3327],
7	associated	VBN	O	associate	_	0	SENT_483	[p27l1116t3355r1371b3399],
8	with	IN	O	with	_	0	SENT_483	[p27l1385t3355r1496b3400],
9	better	JJR	O	better	amod	11	SENT_483	[p27l1513t3355r1657b3399],
10	platelet	NN	O	platelet	nn	11	SENT_483	[p27l1670t3355r1854b3411],
11	response	NN	O	response	prep_with	7	SENT_483	[p27l1867t3369r2085b3411],
12	to	TO	O	to	_	0	SENT_483	[p27l2102t3364r2148b3399],
13	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_483	[p27l1117t3425r1394b3482],
14	in	IN	O	in	_	0	SENT_483	[p27l1415t3426r1463b3469],
15	patients	NNS	O	patient	prep_in	7	SENT_483	[p27l1484t3426r1680b3481],
16	admitted	VBN	O	admit	partmod	15	SENT_483	[p27l1703t3425r1924b3469],
17	for	IN	O	for	_	0	SENT_483	[p27l1946t3425r2016b3469],
18	nonST	JJ	O	nonst	amod	21	SENT_483	[p27l2037t3439r2148b3469, p27l1118t3500r1179b3541],
19	acute	JJ	O	acute	amod	21	SENT_483	[p27l1209t3505r1335b3541],
20	coronary	JJ	O	coronary	amod	21	SENT_483	[p27l1367t3510r1587b3552],
21	syndrome	NN	O	syndrome	prep_for	16	SENT_483	[p27l1616t3496r1871b3552],
22	.	.	O	.	_	0	SENT_483	[p27l1616t3496r1871b3552],

1	J	NNP	O	J	nn	3	SENT_484	[p27l1900t3500r1921b3547],
2	Thromb	NNP	O	Thromb	nn	3	SENT_484	[p27l1949t3496r2148b3540],
3	Haemost	NNP	O	Haemost	_	0	SENT_484	[p27l1116t3571r1338b3611],
4	2009	CD	DATE	2009	num	3	SENT_484	[p27l1354t3571r1735b3620],
5	;	:	O	;	_	0	SENT_484	[p27l1354t3571r1735b3620],
6	7:1409	CD	DATE	7:1409	number	7	SENT_484	[p27l1354t3571r1735b3620],
7	-11	CD	DATE	-11	dep	3	SENT_484	[p27l1354t3571r1735b3620],
8	.	.	O	.	_	0	SENT_484	[p27l1354t3571r1735b3620],

1	17	CD	NUMBER	17	_	0	SENT_485	[p27l1118t3644r1178b3682],
2	.	.	O	.	_	0	SENT_485	[p27l1118t3644r1178b3682],

1	Sim	NNP	PERSON	Sim	nn	2	SENT_486	[p27l1214t3639r1307b3683],
2	SC	NNP	O	SC	_	0	SENT_486	[p27l1334t3642r1411b3692],
3	,	,	O	,	_	0	SENT_486	[p27l1334t3642r1411b3692],
4	Risinger	NNP	PERSON	Risinger	nn	5	SENT_486	[p27l1439t3639r1652b3695],
5	C	NNP	O	C	appos	2	SENT_486	[p27l1676t3642r1724b3692],
6	,	,	O	,	_	0	SENT_486	[p27l1676t3642r1724b3692],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_486	[p27l1752t3638r1873b3682],
8	ML	NNP	O	ML	appos	2	SENT_486	[p27l1897t3642r1991b3692],
9	,	,	O	,	_	0	SENT_486	[p27l1897t3642r1991b3692],
10	et	FW	O	et	nn	11	SENT_486	[p27l2021t3647r2066b3682],
11	al.	FW	O	al.	appos	2	SENT_486	[p27l2089t3638r2146b3682],
12	.	.	O	.	_	0	SENT_486	[p27l2089t3638r2146b3682],

1	A	DT	O	a	det	5	SENT_487	[p27l1115t3713r1152b3753],
2	common	JJ	O	common	amod	5	SENT_487	[p27l1177t3723r1398b3754],
3	novel	JJ	O	novel	amod	5	SENT_487	[p27l1425t3709r1555b3754],
4	CYPZC19	NN	O	cypzc19	nn	5	SENT_487	[p27l1582t3713r1806b3754],
5	gene	NN	O	gene	_	0	SENT_487	[p27l1834t3724r1949b3766],
6	variant	JJ	O	variant	amod	7	SENT_487	[p27l1974t3710r2151b3754],
7	epigenetic	NN	O	epigenetic	dep	5	SENT_487	[p28l9t15r265b71],
8	and	CC	O	and	_	0	SENT_487	[p28l287t14r379b59],
9	clinical	JJ	O	clinical	amod	10	SENT_487	[p28l402t14r586b58],
10	aspects	NNS	O	aspect	dep	5	SENT_487	[p28l609t24r806b70],
11	.	.	O	.	_	0	SENT_487	[p28l609t24r806b70],

1	Pharma	NNP	O	Pharma	_	0	SENT_488	[p28l832t14r1040b58],
2	-	:	O	-	_	0	SENT_488	[p28l832t14r1040b58],
3	causes	VBZ	O	cause	dep	1	SENT_488	[p28l1117t29r1278b59],
4	ultrarapid	JJ	O	ultrarapid	amod	7	SENT_488	[p28l1303t14r1553b70],
5	drug	NN	O	drug	nn	7	SENT_488	[p28l1577t14r1695b71],
6	metabolism	NN	O	metabolism	nn	7	SENT_488	[p28l1717t14r2014b58],
7	relecolTher	NN	O	relecolther	dobj	3	SENT_488	[p28l2038t14r2148b58, p28l9t85r211b129],
8	2007	CD	DATE	2007	dep	7	SENT_488	[p28l229t89r671b139],
9	;	:	O	;	_	0	SENT_488	[p28l229t89r671b139],
10	116:496	CD	NUMBER	116:496	num	11	SENT_488	[p28l229t89r671b139],
11	-526	CD	NUMBER	-526	dep	7	SENT_488	[p28l229t89r671b139],
12	.	.	O	.	_	0	SENT_488	[p28l229t89r671b139],

1	vant	NN	O	vant	_	0	SENT_489	[p28l1114t94r1222b130],
2	for	IN	O	for	_	0	SENT_489	[p28l1257t85r1329b129],
3	the	DT	O	the	det	5	SENT_489	[p28l1365t85r1442b129],
4	drug	NN	O	drug	nn	5	SENT_489	[p28l1481t85r1599b142],
5	response	NN	O	response	prep_for	1	SENT_489	[p28l1635t99r1857b141],
6	to	TO	O	to	aux	7	SENT_489	[p28l1896t95r1942b129],
7	proton	VB	O	proton	infmod	1	SENT_489	[p28l1980t94r2149b141],
8	11	CD	NUMBER	11	dobj	7	SENT_489	[p28l11t163r74b201],
9	.	.	O	.	_	0	SENT_489	[p28l11t163r74b201],

1	Human	JJ	O	human	amod	5	SENT_490	[p28l105t161r289b202],
2	Cytochrome	NN	O	cytochrome	nn	5	SENT_490	[p28l316t157r616b213],
3	P450	NN	O	p450	nn	5	SENT_490	[p28l643t161r758b201],
4	Allele	NNP	O	Allele	nn	5	SENT_490	[p28l784t157r923b201],
5	No	NNP	O	No	_	0	SENT_490	[p28l949t161r1041b202],
6	-	:	O	-	_	0	SENT_490	[p28l949t161r1041b202],
7	pump	NN	O	pump	nn	8	SENT_490	[p28l1116t172r1259b213],
8	inhibitors	NNS	O	inhibitor	dep	5	SENT_490	[p28l1305t157r1552b201],
9	and	CC	O	and	_	0	SENT_490	[p28l1598t157r1689b201],
10	antidepressants	NNS	O	antidepressant	dep	5	SENT_490	[p28l1734t157r2145b213],
11	.	.	O	.	_	0	SENT_490	[p28l1734t157r2145b213],

1	menclature	NNP	O	menclature	nn	4	SENT_491	[p28l9t227r280b272],
2	Committee	NNP	O	Committee	nn	4	SENT_491	[p28l296t228r566b271],
3	home	NN	O	home	nn	4	SENT_491	[p28l583t227r717b271],
4	page	NN	O	page	_	0	SENT_491	[p28l732t242r858b284],
5	.	.	O	.	_	0	SENT_491	[p28l732t242r858b284],

1	(	NN	O	(	nn	5	SENT_492	[p28l881t227r1040b283],
2	httpzll	NN	O	httpzll	nn	5	SENT_492	[p28l881t227r1040b283],
3	Clin	NNP	O	Clin	nn	5	SENT_492	[p28l1117t227r1220b272],
4	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_492	[p28l1239t227r1508b271],
5	Ther	NNP	O	Ther	_	0	SENT_492	[p28l1526t227r1642b271],
6	2006	CD	DATE	2006	num	5	SENT_492	[p28l1661t231r2053b280],
7	;	:	O	;	_	0	SENT_492	[p28l1661t231r2053b280],
8	79:103	CD	NUMBER	79:103	number	9	SENT_492	[p28l1661t231r2053b280],
9	-13	CD	NUMBER	-13	dep	5	SENT_492	[p28l1661t231r2053b280],
10	.	.	O	.	_	0	SENT_492	[p28l1661t231r2053b280],

1	wWw.cypalleles.ki.sel	NN	O	www.cypalleles.ki.sel	_	0	SENT_493	[p28l7t299r569b355],
2	.	.	O	.	_	0	SENT_493	[p28l7t299r569b355],
3	)	SYM	O	)	dep	1	SENT_493	[p28l7t299r569b355],

1	Copyright	NN	O	copyright	_	0	SENT_494	[p28l1118t307r1298b355],
2	©	CD	NUMBER	©	num	6	SENT_494	[p28l1316t310r1356b351],
3	2010	CD	DATE	2010	num	6	SENT_494	[p28l1375t309r1471b343],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_494	[p28l1487t307r1756b343],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_494	[p28l1774t307r1922b343],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_494	[p28l1937t308r2076b354],
7	.	.	O	.	_	0	SENT_494	[p28l1937t308r2076b354],

1	1714	CD	DATE	1714	num	3	SENT_495	[p28l149t430r225b452],
2	NENGLJ	NNP	O	NENGLJ	nn	3	SENT_495	[p28l938t440r1044b462],
3	MED	NN	O	med	_	0	SENT_495	[p28l1059t440r1110b455],
4	363	CD	NUMBER	363	dep	3	SENT_495	[p28l1121t434r1197b462],
5	;	:	O	;	_	0	SENT_495	[p28l1121t434r1197b462],
6	18	CD	NUMBER	18	num	8	SENT_495	[p28l1121t434r1197b462],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_495	[p28l1232t440r1356b462],
8	ocToBER28	NN	O	october28	dep	4	SENT_495	[p28l1392t434r1621b460],
9	,2	CD	NUMBER	,2	num	10	SENT_495	[p28l1392t434r1621b460],
10	o1o	NN	O	o1o	dep	8	SENT_495	[p28l1392t434r1621b460],

1	The	DT	O	the	det	4	SENT_496	[p28l935t473r986b497],
2	New	NNP	O	New	nn	4	SENT_496	[p28l995t474r1057b497],
3	England	NNP	O	England	nn	4	SENT_496	[p28l1066t473r1177b504],
4	Joumal	NNP	O	Joumal	_	0	SENT_496	[p28l1186t473r1283b497],
5	of	IN	O	of	_	0	SENT_496	[p28l1293t473r1322b497],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_496	[p28l1329t473r1454b497],

